Citrus Sinensis ID: 013693

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------44
Protein Sequence
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL
Secondary Structure (PSIPRED)
cccccccccccccEEEEEccccccccEEEEEEccccccHHHHHHHHHHHHHHcccccccccEEEEEccEEEEEccccEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccEEcccccccccccccccccEEEcccccHHHHHHHHHHHHHHHHHHcccccccEEEccccEEEcccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEccccccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccEEEEcc
Secondary Structure Prediction (SSPRO)
ccccccccccccccEEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHccccccccccEEEcccccccccHHHHHHHHHHHHHHHHHHHHccccHHHccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEccEEEEEEEEcccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEcHHHHHHHHHcccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEccccccHHHEEEcccccEEEccccHHHEccHHHcEccEEEEEcc
Coil and Loop (DISEMBL)
MEILSQLITANTHFAtfnlnktpyvpiyALAQCHLDLSHTDCLLCFAasrtklprclpslsatiffdgcflryDIYSFyqesvspslddvkcsaenatvenenendavDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWEslgrdgcrECLDKAGmrvrrscrmrkegrgfnagcylrystdkffnhddetgddrgssRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKAtnyfnpskklgqggagsvymgslpngtTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLgcsiegpesllvyeyvpnrsldqfifdknktkLLNWNKRFNIILGTAEGLaylhggsetriIHRDiktsnilldkdftpkiadfglarcfaadrthVSTAVAGTL
Flexible Loop (DISEMBL)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENAtvenenendavDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKagmrvrrscrmrkegrgfnagcyLRYSTDKFFNHDDetgddrgssRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL
Low Complexity Region (SEG)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSaenatvenenendavdGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL
Disordered region (IsUnstruct)
***LSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESV***********************AVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNH***********RLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV********
Disordered Region (DISOPRED)
*EI****ITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFN**************GVMIAIVLSTTAFLMLSLFAAYAAY***********************CLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL
Disordered Region (DISEMBL)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL
Disordered Region (DISPRO)
*****QL*TANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDD********SRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSK****************KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	438	2.2.26 [Sep-21-2011]
Q9FNE1	651	Cysteine-rich receptor-li	yes	no	0.958	0.645	0.602	1e-145
Q9CAL2	646	Cysteine-rich receptor-li	no	no	0.977	0.662	0.507	1e-119
Q9LMB9	615	Cysteine-rich receptor-li	no	no	0.878	0.626	0.491	1e-105
Q9CAL3	649	Cysteine-rich receptor-li	no	no	0.922	0.622	0.466	1e-101
Q9M0G5	625	Putative cysteine-rich re	no	no	0.924	0.648	0.372	1e-69
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.915	0.594	0.346	2e-62
O49564	642	Cysteine-rich receptor-li	no	no	0.910	0.621	0.359	1e-60
Q9SYS3	654	Cysteine-rich receptor-li	no	no	0.974	0.652	0.361	7e-60
O65476	662	Putative cysteine-rich re	no	no	0.696	0.460	0.387	8e-59
O65483	636	Cysteine-rich receptor-li	no	no	0.659	0.454	0.406	1e-57

>sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1

 Score =  515 bits (1327), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 264/438 (60%), Positives = 317/438 (72%), Gaps = 18/438 (4%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M  LS  +T    FAT +LN T    IYAL QCH DLS +DC LC+A +RT++PRCLPS 
Sbjct: 61  MHSLSLKLTTR-RFATESLNST--TSIYALIQCHDDLSPSDCQLCYAIARTRIPRCLPSS 117

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRY+ Y FY ESVS + D   CS       N+   D   GF  S      
Sbjct: 118 SARIFLDGCFLRYETYEFYDESVSDASDSFSCS-------NDTVLDPRFGFQVS-----E 165

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
             +R+AV KGG FG     GV+ALAQCWESLG++ CR CL+KA   V+R C  R+EGR  
Sbjct: 166 TAARVAVRKGG-FGVAGENGVHALAQCWESLGKEDCRVCLEKAVKEVKR-CVSRREGRAM 223

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           N GCYLRYS  KF+N D         ++ GV++AIVL+T+AF+ML L A Y    ++SK 
Sbjct: 224 NTGCYLRYSDHKFYNGDGHHKFHVLFNK-GVIVAIVLTTSAFVMLILLATYVIMTKVSKT 282

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K+++ NLGL +     S   FKYETLEKAT+YF+  K LGQGG G+V++G LPNG  VAV
Sbjct: 283 KQEKRNLGLVSRKFNNSKTKFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAV 342

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL+FNTR WV+EFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPN+SLDQF+FD
Sbjct: 343 KRLVFNTRDWVEEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFD 402

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           ++++K+LNW++R NIILGTAEGLAYLHGGS  RIIHRDIKTSN+LLD    PKIADFGLA
Sbjct: 403 ESQSKVLNWSQRLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLA 462

Query: 421 RCFAADRTHVSTAVAGTL 438
           RCF  D+TH+ST +AGTL
Sbjct: 463 RCFGLDKTHLSTGIAGTL 480

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1

 Score =  428 bits (1100), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 227/447 (50%), Positives = 291/447 (65%), Gaps = 19/447 (4%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M+ +S L+ A  +     +N T  + +YA  +C  DL   DC LCFA  + K+PRCLP  
Sbjct: 52  MDAVSPLVEAKGYGQV--VNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQ 109

Query: 61  SAT----IFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVG 116
             T    +F DGC++RYD Y+FY E++S   D   C+ +  T  N         F ++  
Sbjct: 110 KGTRGGQVFSDGCYIRYDDYNFYNETLSLQ-DRTVCAPKEITGVNRTV------FRDNAA 162

Query: 117 YAVGNVSRIAVEKGG---GFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRM 173
             V N+S  AV  GG   GF     + V+ LAQCWE+L R GC ECL KA +R+  SC +
Sbjct: 163 ELVKNMSVEAVRNGGFYAGFVDRHNVTVHGLAQCWETLNRSGCVECLSKASVRIG-SCLV 221

Query: 174 RKEGRGFNAGCYLRYSTDKFFNHDDETGDDR--GSSRLGVMIAIVLSTTAFLMLSLFAAY 231
            +EGR  +AGCY+R+ST KF+N+   +  D   G + LGV++A+  S  AF++L   A +
Sbjct: 222 NEEGRVLSAGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGF 281

Query: 232 AAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS 291
               R +K + ++  LG       KS L F YE LE+AT+YF+   KLGQGG+GSVY G 
Sbjct: 282 LLKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGV 341

Query: 292 LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           L NG TVAVKRL FNT+QWVD FFNEVNLIS ++HKNLVKLLGCSI GPESLLVYEY+ N
Sbjct: 342 LTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIAN 401

Query: 352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT 411
           +SL  ++F +   + LNW KRF IILGTAEG+AYLH  S  RIIHRDIK SNILL+ DFT
Sbjct: 402 QSLHDYLFVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFT 461

Query: 412 PKIADFGLARCFAADRTHVSTAVAGTL 438
           P+IADFGLAR F  D+TH+STA+AGTL
Sbjct: 462 PRIADFGLARLFPEDKTHISTAIAGTL 488

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2

 Score =  382 bits (981), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 213/433 (49%), Positives = 264/433 (60%), Gaps = 48/433 (11%)

Query: 26  PIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSP 85
           PIY   QC  DLS +DC  CF  SR +L R        I  D CFLR+D   F +E V P
Sbjct: 79  PIYVFLQCREDLSVSDCRHCFNESRLELERKCSGSGGRIHSDRCFLRFDDRDFSEEFVDP 138

Query: 86  SLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGA---VKVMGVY 142
           + D   C         E        F   +  A+ NV+  AV K GGFGA   +K   VY
Sbjct: 139 TFDKANC---------EETGTGFGEFWRFLDEALVNVTLKAV-KNGGFGAASVIKTEAVY 188

Query: 143 ALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETG- 201
           ALAQCW++L  + CRECL  A   +R +C    E R F  GCYL+YST KFF+   E   
Sbjct: 189 ALAQCWQTLDENTCRECLVNARSSLR-ACDGH-EARAFFTGCYLKYSTHKFFDDAAEHKP 246

Query: 202 ----------------DDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRN 245
                            DR  +RL +  AI LS     +L+   A+ +Y R+S+ ++   
Sbjct: 247 DADQRNFIRSSFFPHLSDRDVTRLAIA-AISLS-----ILTSLGAFISYRRVSRKRK--- 297

Query: 246 NLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIF 305
                  +   SC++FKYE LEKAT  F+ S KLGQGGAGSVY G LP+G  VAVK+L F
Sbjct: 298 -------AQVPSCVNFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFF 350

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK 365
           NTR+W D+FFNEVNLIS ++HKNLV+LLGCSIEGP+SLLVYEYV NRSLDQ +F KN   
Sbjct: 351 NTREWADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVH 410

Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           +L+W +RFNII+G +EGL YLH GSE +IIHRDIKTSNILLD++ +PKIADFGL R    
Sbjct: 411 ILSWKQRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGT 470

Query: 426 DRTHVSTAVAGTL 438
           D+T  +T +AGTL
Sbjct: 471 DKTQTNTGIAGTL 483

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1

 Score =  368 bits (944), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 193/414 (46%), Positives = 255/414 (61%), Gaps = 10/414 (2%)

Query: 28  YALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSL 87
           Y LAQC+ DL   DC+LC+A +RT LP+C P     IF DGCF+R + YSFY E   P  
Sbjct: 84  YGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSFYNEYKGPE- 142

Query: 88  DDVKCSAENATVENENENDAV-DGFVESVGYA--VGNVSRIAVEKGGGFGAVKVMGVYAL 144
           D + C   N T +N+   DAV  G   +V  A   G  +R + + G      +    + L
Sbjct: 143 DSIVCG--NTTRKNKTFGDAVRQGLRNAVTEASGTGGYARASAKAG----ESESESAFVL 196

Query: 145 AQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDR 204
           A CW +L  D C++CL+ A   V + C    EGR  + GC+LRYS   F N     G  R
Sbjct: 197 ANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNGRSR 256

Query: 205 GSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYE 264
           GS  + V+  +       + +++         + + +    ++   A ++K S L+FKY 
Sbjct: 257 GSVVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFKYS 316

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
           TLEKAT  F+ + KLGQGG G+VY G LP+G  +AVKRL FN R    +F+NEVN+IS++
Sbjct: 317 TLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMISTV 376

Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           EHKNLV+LLGCS  GPESLLVYEY+ N+SLD+FIFD N+ K L+W +R+ II+GTAEGL 
Sbjct: 377 EHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEGLV 436

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           YLH  S  +IIHRDIK SNILLD     KIADFGLAR F  D++H+STA+AGTL
Sbjct: 437 YLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTL 490

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1

 Score =  264 bits (674), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 163/437 (37%), Positives = 226/437 (51%), Gaps = 32/437 (7%)

Query: 23  PYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQES 82
           P   +Y L+QC  DLS  +C LC++ +   L +C P+       DGCF+R D YSFYQE 
Sbjct: 75  PPERMYVLSQCVSDLSSDECSLCWSRATDLLSQCFPATGGWFHLDGCFVRADNYSFYQEP 134

Query: 83  VSPSLDDVKCSAENATVENEN-ENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGV 141
           VS     +  S +  + E +    +     VE+  Y+ G     +V K G    ++ + V
Sbjct: 135 VSHQDTKICASDKEKSAEFKGLVKEVTKSIVEAAPYSRG----FSVAKMG----IRDLTV 186

Query: 142 YALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETG 201
           Y L  CW +L  + C+ CL    + V  SC   KEG   NAGCYLRYS   F+N      
Sbjct: 187 YGLGVCWRTLNDELCKLCLADGALSVT-SCLPSKEGFALNAGCYLRYSNYTFYNERGLLA 245

Query: 202 DDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKED--------------RNNL 247
                  L  +  I +     +    +     Y R S  K+               R   
Sbjct: 246 MSFTKENLTYIFVISMVGVLAIAAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEK 305

Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT 307
              +   +   +SF+Y TL+KATN FN S KLG GG G V+ G+L +G  +A+KRL  + 
Sbjct: 306 ESESICTESHLMSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSG 365

Query: 308 RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLL 367
           ++  DE  NE+++IS  +HKNLV+LLGC      S +VYE++ N SLD  +F+  K K L
Sbjct: 366 KKPRDEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKEL 425

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           +W KR  IILGTAEGL YLH     +IIHRDIK SNILLD  + PKI+DFGLA+ +    
Sbjct: 426 DWKKRRTIILGTAEGLEYLH--ETCKIIHRDIKASNILLDLKYKPKISDFGLAKFYPEGG 483

Query: 428 THV------STAVAGTL 438
             +       +++AGTL
Sbjct: 484 KDIPASSLSPSSIAGTL 500

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  239 bits (611), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 153/441 (34%), Positives = 218/441 (49%), Gaps = 40/441 (9%)

Query: 27  IYALAQCHLDLSHTDCLLC--FAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFY-QESV 83
           +Y +  C  D+S   C  C  FAA+ T L RC     A I++D C +RY   S   Q  +
Sbjct: 82  VYGVFLCRGDVSAEICRDCVAFAANET-LQRCPREKVAVIWYDECMVRYSNQSIVGQMRI 140

Query: 84  SPSLDDVKCSAENATVENENE--NDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGV 141
            P    V  + +    EN+    N+++   +  V       SR    +   F   +   +
Sbjct: 141 RPG---VFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFTVFQT--I 195

Query: 142 YALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNH----- 196
           Y+L QC   L    C  CL +    + R C     GR     C  RY    F+N      
Sbjct: 196 YSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAA 255

Query: 197 -----------------DDETGDDRGSSRLGVMIAIVLSTTAFLM--LSLFAAYAAYARL 237
                              E G  +  + +   IA+ +S    L+  +    A     +L
Sbjct: 256 PMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKL 315

Query: 238 SKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTT 297
           S   ED +  G+ +T      L F++  +E ATN F+ S KLG GG G VY G L  G T
Sbjct: 316 SAETEDLDEDGITSTET----LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGET 371

Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           VA+KRL   + Q  +EF NEV++++ ++H+NL KLLG  ++G E +LVYE+VPN+SLD F
Sbjct: 372 VAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYF 431

Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
           +FD  K ++L+W +R+ II G A G+ YLH  S   IIHRD+K SNILLD D  PKI+DF
Sbjct: 432 LFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDF 491

Query: 418 GLARCFAADRTHVSTA-VAGT 437
           G+AR F  D+T  +T  + GT
Sbjct: 492 GMARIFGVDQTQANTKRIVGT 512

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2

 Score =  234 bits (596), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 156/434 (35%), Positives = 224/434 (51%), Gaps = 35/434 (8%)

Query: 27  IYALAQCHLDL-SHTDCLLCFAASRTKLPRCLPSL-SATIFFDGCFLRYD--IYSFYQES 82
           + A+A C  D+  + DC+ C   +  +L    P++  A I+ + C  RY   I     E 
Sbjct: 77  VNAIALCRGDVKPNQDCISCITTAAKQLVESCPNIIEANIWLEKCMFRYTSRIILGQMEP 136

Query: 83  VSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVY 142
           V  S      S+  +  + E  +  +   ++S+G  +   +     K   F A     +Y
Sbjct: 137 VPFSY----TSSNVSVTDKEGFSKGLGDLLDSLGAKIDAANETKEVK---FAAGVKGTIY 189

Query: 143 ALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFN------- 195
           ALAQC   L    CR CL +    V   C  +  G   N  CY R+    FF+       
Sbjct: 190 ALAQCTPDLSESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQ 249

Query: 196 ------HDDETG-DDRGSS--RLGVMIAIVLSTTAFLM--LSLFAAYAAYARLSKMKEDR 244
                 H++ T   D+G S  R   +I  V+   A ++  + LF       +   +KE+ 
Sbjct: 250 KQPLSSHNNNTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKENA 309

Query: 245 NNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI 304
            N            L F +ET+  AT+ F+ + K+G+GG G VY G LP+G  +AVKRL 
Sbjct: 310 EN-----EFESTDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLS 364

Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT 364
            ++ Q   EF  EV L++ ++HKNLVKL G SI+  E LLVYE++PN SLD+F+FD  K 
Sbjct: 365 IHSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQ 424

Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           K L+W KR+NII+G + GL YLH GSE  IIHRD+K+SN+LLD+   PKI+DFG+AR F 
Sbjct: 425 KQLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFD 484

Query: 425 ADRTH-VSTAVAGT 437
            D T  V+  V GT
Sbjct: 485 FDNTQAVTRRVVGT 498

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SYS3|CRK40_ARATH Cysteine-rich receptor-like protein kinase 40 OS=Arabidopsis thaliana GN=CRK40 PE=2 SV=1

 Score =  231 bits (589), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 169/468 (36%), Positives = 227/468 (48%), Gaps = 41/468 (8%)

Query: 4   LSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAA-SRTKLPRCLPSLSA 62
           L+  +  N  F   +L + P   +YAL  C        C  C  + ++  L  C     +
Sbjct: 53  LADKVIINDGFYNASLGQDPD-KVYALVSCARGYDQDACYNCVQSLTQNTLTDCRSRRDS 111

Query: 63  TIFFDG----CFLRYDIYSFY------QESVSPSLDDVKCSAENATVENENENDAVDGFV 112
            I+       C +R    S +         V PS D ++ S++N T+  +   + V+  +
Sbjct: 112 FIWGGNDDVTCLVRSSNQSTFGSVQLKPPVVWPSPDTIE-SSKNITLFKQQWEEMVNRTL 170

Query: 113 ESVGYAVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCR 172
           E+   A G+ S +   K    G  +   VY L QC   L    C++CL    M  R+   
Sbjct: 171 EAATKAEGS-SVLKYYKAEKAGFTEFPDVYMLMQCTPDLSSRDCKQCLGDCVMYFRKDYM 229

Query: 173 MRKEGRGFNAGCYLRYSTDKFFN---------------HDDE-----TGDDRGSSRLGVM 212
            RK G      CY R+    F N               H  E     T     S   G +
Sbjct: 230 GRKGGMASLPSCYFRWDLYSFHNAFDNVTRVPAPPPRPHAQEKESCITVKKGKSIGYGGI 289

Query: 213 IAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGL--YATSMKKSCLSFKYETLEKAT 270
           IAIV+  T   +L        YAR  K+    NN+G   Y+ S  +  L F    +  AT
Sbjct: 290 IAIVVVFTFINLLVFIGFIKVYARRGKL----NNVGSAEYSDSDGQFMLRFDLGMIVMAT 345

Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + F+    LGQGG G+VY G+ PNG  VAVKRL   + Q   EF NEV+L++ ++HKNLV
Sbjct: 346 DDFSSENTLGQGGFGTVYKGTFPNGQEVAVKRLTKGSGQGDMEFKNEVSLLTRLQHKNLV 405

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           KLLG   EG E +LVYE+VPN SLD FIFD++K  LL W  RF II G A GL YLH  S
Sbjct: 406 KLLGFCNEGDEEILVYEFVPNSSLDHFIFDEDKRSLLTWEVRFRIIEGIARGLLYLHEDS 465

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGT 437
           + +IIHRD+K SNILLD +  PK+ADFG AR F +D T   T  +AGT
Sbjct: 466 QLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAGT 513

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2

 Score =  228 bits (580), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 126/325 (38%), Positives = 173/325 (53%), Gaps = 20/325 (6%)

Query: 130 GGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYS 189
           G G G + +  VYA   C + +    C  CL       + SC  +  G  F+  CY+R+ 
Sbjct: 181 GAGTGKIGIQTVYAFVLCSKDISPWNCSRCLRGNVDNYKLSCSGKPRGHSFSPSCYMRWD 240

Query: 190 TDKFFNHDD---------------ETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAY 234
             +F+   +               E  DD G      ++ I ++   F+ + L   YA  
Sbjct: 241 LYQFYGFIEYRASPTLPREKGRISELSDDGGKISTRNILGITVALAFFITVLLVLGYA-- 298

Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN 294
             LS+ ++                L F ++ +E ATN F  S KLG GG G V+ G+ PN
Sbjct: 299 --LSRRRKAYQEFATENDITTSGSLQFDFKAIEAATNNFQKSNKLGHGGFGEVFKGTFPN 356

Query: 295 GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
           GT VAVKRL   + Q  +EF NEV L++ ++H+NLV+LLG S+EG E +LVYEY+PN+SL
Sbjct: 357 GTEVAVKRLSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNKSL 416

Query: 355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI 414
           D F+FD  +   L+W  R+NII G   G+ YLH  S   IIHRD+K  NILLD D  PKI
Sbjct: 417 DYFLFDHRRRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNPKI 476

Query: 415 ADFGLARCFAADRTHVSTA-VAGTL 438
           ADFG+AR F  D+T  +T  V GT 
Sbjct: 477 ADFGVARNFRVDQTEATTGRVVGTF 501

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65483|CRK24_ARATH Cysteine-rich receptor-like protein kinase 24 OS=Arabidopsis thaliana GN=CRK24 PE=3 SV=2

 Score =  224 bits (570), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 124/305 (40%), Positives = 173/305 (56%), Gaps = 16/305 (5%)

Query: 141 VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKF---FNHD 197
           +Y   QC   L    C +CL +  +  R  CR R+ G      C++R+    F   F++ 
Sbjct: 183 IYGFVQCSRDLSLQNCTKCLQQNVVEYRSCCRGRQGGIILRPSCFIRWELYPFLGLFDNI 242

Query: 198 DETGDDRGSSRLGVMIAIVLSTTAFLMLS--LFAAYAAY-ARLSKMKEDRNNLGLYATSM 254
                D  S   G ++AI++     L L   L+    AY  + +K+ +D    G      
Sbjct: 243 RPRQKDGKSISTGAIVAIIVVPILLLALGVGLWKRRKAYKTKTTKIADDITTSG------ 296

Query: 255 KKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEF 314
               L F+++ +E AT  F+   KLG GG G VY G+ PNGT VAVKRL   + Q  +EF
Sbjct: 297 ---SLQFEFKAIEAATCNFHNVNKLGHGGFGEVYKGTFPNGTEVAVKRLSKTSGQGEEEF 353

Query: 315 FNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            NEV L++ ++H+NLVKLLG +++G E +LVYE++PN+SLD F+FD  K   L+W +R+N
Sbjct: 354 KNEVFLVAKLQHRNLVKLLGYAVKGDEKILVYEFLPNKSLDHFLFDPVKKGQLDWTRRYN 413

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA- 433
           II G   G+ YLH  S   IIHRD+K  NILLD D  PKI DFG+AR F  D+T  +TA 
Sbjct: 414 IINGITRGIVYLHQDSRLTIIHRDLKAGNILLDADMNPKIVDFGVARNFRVDQTEATTAR 473

Query: 434 VAGTL 438
           V GT+
Sbjct: 474 VVGTI 478

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	438
255567375	605	kinase, putative [Ricinus communis] gi|2	0.984	0.712	0.689	1e-169
224060104	605	predicted protein [Populus trichocarpa]	0.968	0.700	0.648	1e-159
225452394	659	PREDICTED: cysteine-rich receptor-like p	0.984	0.654	0.659	1e-157
147765625	653	hypothetical protein VITISV_038880 [Viti	0.984	0.660	0.657	1e-157
356573847	673	PREDICTED: cysteine-rich receptor-like p	0.984	0.640	0.640	1e-155
297805658	651	predicted protein [Arabidopsis lyrata su	0.958	0.645	0.609	1e-145
334188090	651	cysteine-rich receptor-like protein kina	0.958	0.645	0.602	1e-143
449446869	601	PREDICTED: cysteine-rich receptor-like p	0.979	0.713	0.598	1e-143
297733755	696	unnamed protein product [Vitis vinifera]	0.945	0.594	0.584	1e-139
225456979	611	PREDICTED: cysteine-rich receptor-like p	0.945	0.677	0.584	1e-139

>gi|255567375|ref|XP_002524667.1| kinase, putative [Ricinus communis] gi|223536028|gb|EEF37686.1| kinase, putative [Ricinus communis]

 Score =  601 bits (1550), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 302/438 (68%), Positives = 355/438 (81%), Gaps = 7/438 (1%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME LSQLIT N+HFAT++LN +  +P+Y LAQCH DLS TDCLLC+A SRTK+PRCLPS+
Sbjct: 1   METLSQLIT-NSHFATYHLNSS--LPMYVLAQCHQDLSQTDCLLCYAVSRTKIPRCLPSV 57

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRYD Y+F++ESVS S D+VKCS EN +  N  END +  FV+SV +A+G
Sbjct: 58  SARIFLDGCFLRYDNYNFFEESVSVSFDEVKCSQENVSGSN-GENDKLR-FVKSVEHAIG 115

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
           NVS  AVE GG FG V + GVYALAQCWES+G+DGCRECL KAG  V+  C  +KEGRG 
Sbjct: 116 NVSSKAVENGG-FGVVGIEGVYALAQCWESVGKDGCRECLRKAGKEVK-GCGAKKEGRGL 173

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           NAGCYLRYST++F+N   E       S LGV IA+VL+  A LMLS+FA YA Y R  K 
Sbjct: 174 NAGCYLRYSTERFYNVGGELEAGHTISGLGVAIAVVLAAAAVLMLSIFAVYAVYVRRMKN 233

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K +R NL   + +  K+ L+FKYETLEKAT+YFN S+K+GQGGAGSVY G+LPNG TVAV
Sbjct: 234 KAERINLEKISINFSKTSLNFKYETLEKATDYFNASRKIGQGGAGSVYAGTLPNGETVAV 293

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL FNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPN+SLDQFIF 
Sbjct: 294 KRLTFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFIFG 353

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           K+K   LNW +RF+II+GTAEGLAYLHGGS+ RIIHRDIK+SN+LLD+DFTPKIADFGL 
Sbjct: 354 KDKPTTLNWKQRFDIIVGTAEGLAYLHGGSQERIIHRDIKSSNVLLDEDFTPKIADFGLV 413

Query: 421 RCFAADRTHVSTAVAGTL 438
           RCF AD++H+ST +AGT+
Sbjct: 414 RCFGADKSHLSTGIAGTM 431

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224060104|ref|XP_002300041.1| predicted protein [Populus trichocarpa] gi|222847299|gb|EEE84846.1| predicted protein [Populus trichocarpa]

 Score =  567 bits (1461), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 290/447 (64%), Positives = 348/447 (77%), Gaps = 23/447 (5%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M  LSQL++  +HFAT NLN +  +  YALAQCH DLS TDCLLC+AASRTKLP CLPSL
Sbjct: 1   MGTLSQLLST-SHFATNNLNHSSTLTFYALAQCHQDLSQTDCLLCYAASRTKLPLCLPSL 59

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           S  I+ DGCFLRYD YSFYQESVS S D  KC   N  ++ ++++  +D F   VGYAVG
Sbjct: 60  SGRIYLDGCFLRYDNYSFYQESVSSSFDTFKCG--NEYLDVDDDDKHLD-FPTRVGYAVG 116

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
           NV+  AVE GG F  V V G+YALAQCW+S+GR+GCR CL+ AG +  R C  +KEGRG 
Sbjct: 117 NVTIQAVENGG-FAVVNVDGIYALAQCWDSVGREGCRGCLEMAG-KAARGCVPKKEGRGM 174

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGS---------SRLGVMIAIVLSTTAFLMLSLFAAY 231
           NAGCYLRYSTDKF+N+    GD+R +         + + ++  +VL+T A LMLS+FAAY
Sbjct: 175 NAGCYLRYSTDKFYNNGG--GDERNARGNFLHQYFATVSLLCFVVLATAACLMLSIFAAY 232

Query: 232 AAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS 291
           A+Y RL K K  R N      S+K S L+FKYE LEKAT++F+PS+KLGQGGAGSV++G+
Sbjct: 233 ASYVRLLKAK--RGNY----CSLKISNLNFKYEILEKATDFFSPSRKLGQGGAGSVFIGT 286

Query: 292 LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           LPNG TVAVKRLIFNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYV N
Sbjct: 287 LPNGETVAVKRLIFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVRN 346

Query: 352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT 411
           +SLDQF+FDK K++ LNW +RF IILGTAEGLAYLHGGS+ RIIHRDIK+SN+LLD +  
Sbjct: 347 KSLDQFLFDKTKSRTLNWKQRFEIILGTAEGLAYLHGGSQVRIIHRDIKSSNVLLDDNLN 406

Query: 412 PKIADFGLARCFAADRTHVSTAVAGTL 438
           PKIADFGL RCF AD++H+ST +AGT+
Sbjct: 407 PKIADFGLVRCFGADKSHLSTGIAGTI 433

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452394|ref|XP_002273718.1| PREDICTED: cysteine-rich receptor-like protein kinase 42 [Vitis vinifera]

 Score =  562 bits (1449), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 291/441 (65%), Positives = 344/441 (78%), Gaps = 10/441 (2%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME LSQL+T N   + F +N TP  P+Y LAQCH DLSH DCLLC+AA RTKLPRCLP+ 
Sbjct: 55  MEFLSQLVTLNLWGSHF-VNSTP--PMYGLAQCHQDLSHLDCLLCYAAGRTKLPRCLPAT 111

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA I+ DGCFLRYD YSF+ ESV P  D V CS+ +  + ++    A   FV++V   + 
Sbjct: 112 SARIYLDGCFLRYDNYSFFSESVDPDHDTVNCSSGSGAIVDQV---AKLEFVKNVHRVIN 168

Query: 121 NVSRIAVEKGG-GFGAVK--VMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
           NV+  AV  GG G   V+   +GVYALA+CW+++   GCR CL KA   VR  C   KEG
Sbjct: 169 NVTATAVANGGYGVAVVEGGAVGVYALAECWKTVNSSGCRACLQKASNEVR-GCLPGKEG 227

Query: 178 RGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARL 237
           RG NAGCYLRYST+KF+++  E+    GSSR G+ IAIVL+  A +++SLFAAYA YA L
Sbjct: 228 RGLNAGCYLRYSTEKFYDNGGESEGGSGSSRTGLTIAIVLAAAALILVSLFAAYAGYASL 287

Query: 238 SKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTT 297
           SK+KE+R NLG  A+ + KS L+FKYETLE+AT YFNPS+KLGQGGAGSVYMG+LPNG  
Sbjct: 288 SKIKEERKNLGKVASIINKSSLNFKYETLERATEYFNPSRKLGQGGAGSVYMGTLPNGEI 347

Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           VAVKRLIFNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF
Sbjct: 348 VAVKRLIFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 407

Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
           +FDKNK + LNW +RF+II+GTAEGLAYLHGG + RIIHRDIK SNILLD++ TPKIADF
Sbjct: 408 MFDKNKIQTLNWEQRFDIIVGTAEGLAYLHGGLQMRIIHRDIKGSNILLDENLTPKIADF 467

Query: 418 GLARCFAADRTHVSTAVAGTL 438
           GLARC  AD+TH+ST +AGTL
Sbjct: 468 GLARCLGADKTHLSTGIAGTL 488

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765625|emb|CAN69244.1| hypothetical protein VITISV_038880 [Vitis vinifera]

 Score =  559 bits (1441), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 290/441 (65%), Positives = 344/441 (78%), Gaps = 10/441 (2%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME LSQL+T N   + F +N TP  P+Y LAQCH DLSH DCLLC+AA RTKLPRCLP+ 
Sbjct: 1   MEFLSQLVTLNLWGSHF-VNSTP--PMYGLAQCHQDLSHLDCLLCYAAGRTKLPRCLPAT 57

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA I+ DGCFLRYD YSF+ ESV P  D V CS+ +  + ++    A   FV++V   + 
Sbjct: 58  SARIYLDGCFLRYDNYSFFSESVDPDHDTVNCSSGSGAIVDQV---AKLEFVKNVHRVIN 114

Query: 121 NVSRIAVEKGG-GFGAVK--VMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
           NV+  AV  GG G   V+   +GVYALA+CW+++   GCR CL KA   VR  C   KEG
Sbjct: 115 NVTATAVANGGYGVAVVEGGAVGVYALAECWKTVNSSGCRACLQKASNEVR-GCLPGKEG 173

Query: 178 RGFNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARL 237
           RG NAGCYLRYST+KF+++  E+    GSSR G+ IAIVL+  A +++SLFAAYA YA L
Sbjct: 174 RGLNAGCYLRYSTEKFYDNGGESEGGSGSSRTGLTIAIVLAAAALILVSLFAAYAGYASL 233

Query: 238 SKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTT 297
           SK+KE+R NLG  A+ + KS L+FKYETLE+AT YFNPS+KLGQGGAGSVYMG+LPNG  
Sbjct: 234 SKIKEERKNLGKVASIINKSSLNFKYETLERATEYFNPSRKLGQGGAGSVYMGTLPNGEI 293

Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           VAVKRLIFNTRQWVDEFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPNRSJDQF
Sbjct: 294 VAVKRLIFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNRSJDQF 353

Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
           +FDKNK + LNW +RF+II+GTAEGLAYLHGG + RIIHRDIK SNILLD++ TPKIADF
Sbjct: 354 MFDKNKIQTLNWEQRFDIIVGTAEGLAYLHGGLQMRIIHRDIKGSNILLDENLTPKIADF 413

Query: 418 GLARCFAADRTHVSTAVAGTL 438
           GLARC  AD+TH+ST +AGTL
Sbjct: 414 GLARCLGADKTHLSTGIAGTL 434

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356573847|ref|XP_003555067.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Glycine max]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 283/442 (64%), Positives = 337/442 (76%), Gaps = 11/442 (2%)

Query: 1   MEILSQLITAN---THFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCL 57
           ME LSQL+T+N   TH    + + +  +PIY  AQC  DLSHTDCLLC+AASRT+LPRCL
Sbjct: 67  MESLSQLVTSNNWGTHSVKISGSGSS-IPIYGFAQCFRDLSHTDCLLCYAASRTRLPRCL 125

Query: 58  PSLSATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGY 117
           PS+SA I+ DGCFLRYD YSFY E   PS D V C+   A  E E          E VG 
Sbjct: 126 PSVSARIYLDGCFLRYDNYSFYSEGTDPSRDAVNCTGVAAGDEAERVE-----LQERVGR 180

Query: 118 AVGNVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
            V NV  IA   G GFG  +V GVYALAQCW +LG  GCRECL KAG  V+  C  +KEG
Sbjct: 181 VVDNVVNIAERDGNGFGVGEVEGVYALAQCWNTLGSGGCRECLRKAGREVK-GCLPKKEG 239

Query: 178 RGFNAGCYLRYSTDKFFNHDDETGDDRG-SSRLGVMIAIVLSTTAFLMLSLFAAYAAYAR 236
           R  NAGCYLRYST KF+N D + G   G   R GV++A VL+  A +ML+L A+YAA+ +
Sbjct: 240 RALNAGCYLRYSTQKFYNEDGDAGGGNGFLRRRGVIVAEVLAAAAVIMLALSASYAAFTK 299

Query: 237 LSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT 296
            SK+K++ NNLG  ++S+ KS L++KYETLEKAT+YFN S+K+GQGGAGSV+ G LPNG 
Sbjct: 300 FSKIKKENNNLGQISSSISKSSLNYKYETLEKATDYFNSSRKVGQGGAGSVFKGILPNGK 359

Query: 297 TVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQ 356
            VAVKRLIFN RQWVDEFFNEVNLIS IEHKNLVKLLGCSIEGPESLLVYEY+P +SLDQ
Sbjct: 360 VVAVKRLIFNNRQWVDEFFNEVNLISGIEHKNLVKLLGCSIEGPESLLVYEYLPKKSLDQ 419

Query: 357 FIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD 416
           FIF+KN+T++LNW +RFNIILGTAEGLAYLH G++ RIIHRDIK+SN+LLD++ TPKIAD
Sbjct: 420 FIFEKNRTQILNWKQRFNIILGTAEGLAYLHEGTKIRIIHRDIKSSNVLLDENLTPKIAD 479

Query: 417 FGLARCFAADRTHVSTAVAGTL 438
           FGLARCF  D++H+ST +AGTL
Sbjct: 480 FGLARCFGGDKSHLSTGIAGTL 501

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805658|ref|XP_002870713.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297316549|gb|EFH46972.1| predicted protein [Arabidopsis lyrata subsp. lyrata]

 Score =  522 bits (1345), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 267/438 (60%), Positives = 319/438 (72%), Gaps = 18/438 (4%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M  LS  +T    FAT +LN TP   IYAL QCH DLS +DC LC+A +RT+LPRCLPS 
Sbjct: 61  MHSLSLKLTTR-RFATESLNSTP--SIYALIQCHDDLSPSDCQLCYAIARTRLPRCLPSS 117

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRY+ Y FY ESVS + D   CS       N+   D + GF  S      
Sbjct: 118 SARIFLDGCFLRYETYEFYDESVSDTSDSFSCS-------NDTVLDPLFGFRVS-----E 165

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
              R+AV KGG FG     GV+ALAQCWESLG++ CR CL+KA   V+R C  R+EGR  
Sbjct: 166 TAVRVAVRKGG-FGVAGESGVHALAQCWESLGKEDCRVCLEKAIKEVKR-CVSRREGRAM 223

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           N GCYLRYS  KF+N D         ++ GV++AIVL+T+AF+ML L A Y    ++SK 
Sbjct: 224 NTGCYLRYSDHKFYNGDGHHNFHVFFNK-GVIVAIVLTTSAFVMLILLATYVIMIKVSKT 282

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K+++ NLGL +     S   FKYETLEKAT+YF+P K LGQGG G+V++G LPNG  VAV
Sbjct: 283 KQEQRNLGLVSRKFNNSKTKFKYETLEKATDYFSPKKILGQGGNGTVFLGILPNGKNVAV 342

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL+FNTR+WV+EFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPN+SLDQF+FD
Sbjct: 343 KRLVFNTREWVEEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFD 402

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           + ++K+LNW++R NIILGTAEGLAYLHGGS  RIIHRDIKTSN+LLD    PKIADFGLA
Sbjct: 403 ETQSKVLNWSQRLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLA 462

Query: 421 RCFAADRTHVSTAVAGTL 438
           RCF  D+TH+ST +AGTL
Sbjct: 463 RCFGLDKTHLSTGIAGTL 480

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334188090|ref|NP_198854.3| cysteine-rich receptor-like protein kinase 42 [Arabidopsis thaliana] gi|75334121|sp|Q9FNE1.1|CRK42_ARATH RecName: Full=Cysteine-rich receptor-like protein kinase 42; Short=Cysteine-rich RLK42; Flags: Precursor gi|10178148|dbj|BAB11593.1| receptor-like serine/threonine kinase [Arabidopsis thaliana] gi|332007157|gb|AED94540.1| cysteine-rich receptor-like protein kinase 42 [Arabidopsis thaliana]

 Score =  515 bits (1327), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 264/438 (60%), Positives = 317/438 (72%), Gaps = 18/438 (4%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           M  LS  +T    FAT +LN T    IYAL QCH DLS +DC LC+A +RT++PRCLPS 
Sbjct: 61  MHSLSLKLTTR-RFATESLNST--TSIYALIQCHDDLSPSDCQLCYAIARTRIPRCLPSS 117

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRY+ Y FY ESVS + D   CS       N+   D   GF  S      
Sbjct: 118 SARIFLDGCFLRYETYEFYDESVSDASDSFSCS-------NDTVLDPRFGFQVS-----E 165

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
             +R+AV KGG FG     GV+ALAQCWESLG++ CR CL+KA   V+R C  R+EGR  
Sbjct: 166 TAARVAVRKGG-FGVAGENGVHALAQCWESLGKEDCRVCLEKAVKEVKR-CVSRREGRAM 223

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           N GCYLRYS  KF+N D         ++ GV++AIVL+T+AF+ML L A Y    ++SK 
Sbjct: 224 NTGCYLRYSDHKFYNGDGHHKFHVLFNK-GVIVAIVLTTSAFVMLILLATYVIMTKVSKT 282

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K+++ NLGL +     S   FKYETLEKAT+YF+  K LGQGG G+V++G LPNG  VAV
Sbjct: 283 KQEKRNLGLVSRKFNNSKTKFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAV 342

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL+FNTR WV+EFFNEVNLIS I+HKNLVKLLGCSIEGPESLLVYEYVPN+SLDQF+FD
Sbjct: 343 KRLVFNTRDWVEEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFD 402

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           ++++K+LNW++R NIILGTAEGLAYLHGGS  RIIHRDIKTSN+LLD    PKIADFGLA
Sbjct: 403 ESQSKVLNWSQRLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLA 462

Query: 421 RCFAADRTHVSTAVAGTL 438
           RCF  D+TH+ST +AGTL
Sbjct: 463 RCFGLDKTHLSTGIAGTL 480

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446869|ref|XP_004141193.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus] gi|449515394|ref|XP_004164734.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus]

 Score =  513 bits (1321), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 262/438 (59%), Positives = 323/438 (73%), Gaps = 9/438 (2%)

Query: 1   MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
           ME +S+L+T  + + T  +N TP  P++AL+QC  DLSHTDCLLC+AASRT LPRCLP++
Sbjct: 1   MEAISELLTTRS-WTTHFVNSTP--PMFALSQCFNDLSHTDCLLCYAASRTSLPRCLPAI 57

Query: 61  SATIFFDGCFLRYDIYSFYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVG 120
           SA IF DGCFLRYD YSFY+ES     D V C++E   ++          F E+V   V 
Sbjct: 58  SARIFLDGCFLRYDNYSFYKESTDSVRDSVNCTSELGEIDQSERL----VFGENVRVVVE 113

Query: 121 NVSRIAVEKGGGFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGF 180
            V+  A+EKGG FG  +V G++ LAQCW S+  +GCR CL+KA  R   SC   KEGR  
Sbjct: 114 TVTTKAMEKGG-FGMGEVSGMFGLAQCWGSVEPEGCRACLEKA-KRSIGSCLPSKEGRAM 171

Query: 181 NAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKM 240
           NAGCYLRYST KF+N  DE  D  G S    ++ I L++ A L++   A +A Y R+SK 
Sbjct: 172 NAGCYLRYSTVKFYNDKDEDRDHDGFSGRRAVVTIALASAASLIIFFSAVFACYTRISKF 231

Query: 241 KEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAV 300
           K+++    L   S+K S L+FKYETLEKATNYFN S K+GQGGAGSVY G+LPNG  VAV
Sbjct: 232 KKEKKRQSLIPVSLKDSDLNFKYETLEKATNYFNLSNKIGQGGAGSVYKGTLPNGQIVAV 291

Query: 301 KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           KRL+F+TRQWVDEFFNEVNLI  I+HKNLV LLGCSIEGPESLLVYE+V N SLD FIFD
Sbjct: 292 KRLVFHTRQWVDEFFNEVNLIRGIQHKNLVALLGCSIEGPESLLVYEFVSNGSLDHFIFD 351

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           KNK ++L+W +RFNII+GTAEGLA+LH G + RIIHRDIK+SN+LLD++F PKIADFGLA
Sbjct: 352 KNKAQILSWKQRFNIIVGTAEGLAHLHEGCKIRIIHRDIKSSNVLLDENFNPKIADFGLA 411

Query: 421 RCFAADRTHVSTAVAGTL 438
           R F AD++H+ST +AGTL
Sbjct: 412 RHFGADQSHLSTGIAGTL 429

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733755|emb|CBI15002.3| unnamed protein product [Vitis vinifera]

 Score =  502 bits (1293), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 249/426 (58%), Positives = 310/426 (72%), Gaps = 12/426 (2%)

Query: 18  NLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYS 77
           N+ K+P   I+ L+QC+ DLS  DCL CFA SRTKLPRCLP+++A I+ DGCFLRYD YS
Sbjct: 54  NITKSPV--IFGLSQCYSDLSKDDCLSCFAESRTKLPRCLPAIAARIYLDGCFLRYDNYS 111

Query: 78  FYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVK 137
           F+ ES+ P+ D V+CS  +  ++   +N     F + V   + NV++ AV+K G F    
Sbjct: 112 FFNESIDPNHDMVRCSEPSGVLK---DNYTRSEFSKKVDEVINNVTKTAVQKQG-FAVAG 167

Query: 138 VMG----VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKF 193
           + G     YALAQCW+++ + GCR+CL  A   VRR C    EGR  NAGCYLRYST+KF
Sbjct: 168 MKGGAVVAYALAQCWKTVDQKGCRDCLVNAESAVRR-CLPGSEGRALNAGCYLRYSTEKF 226

Query: 194 FNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNN-LGLYAT 252
           +N        +G S  G++IA +LS  A  +L+   A+  Y  LSK K + NN L    T
Sbjct: 227 YNDGTAKKSGKGLSDTGMIIAFILSVLAVCLLAFLGAFVGYILLSKRKRNNNNALARIPT 286

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
            + +S L+FKYETLE+ATN+F+ S+KLGQGGAGSV+ G+LP+G TVAVKRL FNTRQWVD
Sbjct: 287 CINRSDLNFKYETLERATNFFDSSRKLGQGGAGSVFKGTLPDGRTVAVKRLFFNTRQWVD 346

Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           EFFNEVNLIS I+HKNLV LLGCSIEGPESLLVYEYVPN+S+DQ +F KN T  L+W +R
Sbjct: 347 EFFNEVNLISRIQHKNLVGLLGCSIEGPESLLVYEYVPNKSVDQILFGKNPTSCLSWQQR 406

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           F II+GTAEGLAYLHGGSE +IIHRDIK SNILLD++  PKIADFGLARC A D++HVST
Sbjct: 407 FEIIVGTAEGLAYLHGGSEVKIIHRDIKGSNILLDENLNPKIADFGLARCVAPDKSHVST 466

Query: 433 AVAGTL 438
            +AGTL
Sbjct: 467 GIAGTL 472

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456979|ref|XP_002278823.1| PREDICTED: cysteine-rich receptor-like protein kinase 1-like [Vitis vinifera]

 Score =  502 bits (1293), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 249/426 (58%), Positives = 310/426 (72%), Gaps = 12/426 (2%)

Query: 18  NLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYS 77
           N+ K+P   I+ L+QC+ DLS  DCL CFA SRTKLPRCLP+++A I+ DGCFLRYD YS
Sbjct: 17  NITKSPV--IFGLSQCYSDLSKDDCLSCFAESRTKLPRCLPAIAARIYLDGCFLRYDNYS 74

Query: 78  FYQESVSPSLDDVKCSAENATVENENENDAVDGFVESVGYAVGNVSRIAVEKGGGFGAVK 137
           F+ ES+ P+ D V+CS  +  ++   +N     F + V   + NV++ AV+K G F    
Sbjct: 75  FFNESIDPNHDMVRCSEPSGVLK---DNYTRSEFSKKVDEVINNVTKTAVQKQG-FAVAG 130

Query: 138 VMG----VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKF 193
           + G     YALAQCW+++ + GCR+CL  A   VRR C    EGR  NAGCYLRYST+KF
Sbjct: 131 MKGGAVVAYALAQCWKTVDQKGCRDCLVNAESAVRR-CLPGSEGRALNAGCYLRYSTEKF 189

Query: 194 FNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNN-LGLYAT 252
           +N        +G S  G++IA +LS  A  +L+   A+  Y  LSK K + NN L    T
Sbjct: 190 YNDGTAKKSGKGLSDTGMIIAFILSVLAVCLLAFLGAFVGYILLSKRKRNNNNALARIPT 249

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
            + +S L+FKYETLE+ATN+F+ S+KLGQGGAGSV+ G+LP+G TVAVKRL FNTRQWVD
Sbjct: 250 CINRSDLNFKYETLERATNFFDSSRKLGQGGAGSVFKGTLPDGRTVAVKRLFFNTRQWVD 309

Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           EFFNEVNLIS I+HKNLV LLGCSIEGPESLLVYEYVPN+S+DQ +F KN T  L+W +R
Sbjct: 310 EFFNEVNLISRIQHKNLVGLLGCSIEGPESLLVYEYVPNKSVDQILFGKNPTSCLSWQQR 369

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           F II+GTAEGLAYLHGGSE +IIHRDIK SNILLD++  PKIADFGLARC A D++HVST
Sbjct: 370 FEIIVGTAEGLAYLHGGSEVKIIHRDIKGSNILLDENLNPKIADFGLARCVAPDKSHVST 429

Query: 433 AVAGTL 438
            +AGTL
Sbjct: 430 GIAGTL 435

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	438
TAIR|locus:2026785	646	CRK3 "cysteine-rich RLK (RECEP	0.977	0.662	0.505	2.1e-109
TAIR|locus:2026821	649	CRK2 "cysteine-rich RLK (RECEP	0.920	0.620	0.469	4.2e-95
TAIR|locus:2139845	625	AT4G28670 [Arabidopsis thalian	0.874	0.612	0.395	2.5e-65
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.545	0.354	0.434	2e-61
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.550	0.361	0.430	9.6e-60
TAIR|locus:2121606	673	CRK13 "cysteine-rich RLK (RECE	0.541	0.352	0.443	5.7e-58
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.666	0.452	0.416	7.8e-58
TAIR|locus:2125766	654	CRK40 "cysteine-rich RLK (RECE	0.509	0.340	0.504	1.3e-57
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.543	0.350	0.442	4.2e-57
TAIR|locus:2127323	642	CRK27 "cysteine-rich RLK (RECE	0.913	0.623	0.360	4.6e-57

TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
 Identities = 226/447 (50%), Positives = 289/447 (64%)

Query:     1 MEILSQLITANTHFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSL 60
             M+ +S L+ A  +     +N T  + +YA  +C  DL   DC LCFA  + K+PRCLP  
Sbjct:    52 MDAVSPLVEAKGYGQV--VNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQ 109

Query:    61 SAT----IFFDGCFLRYDIYSFYQESVSPSLDDVKCSXXXXXXXXXXXXXXXXGFVESVG 116
               T    +F DGC++RYD Y+FY E++S   D   C+                 F ++  
Sbjct:   110 KGTRGGQVFSDGCYIRYDDYNFYNETLSLQ-DRTVCAPKEITGVNRTV------FRDNAA 162

Query:   117 YAVGNVSRIAVEKGG---GFGAVKVMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRM 173
               V N+S  AV  GG   GF     + V+ LAQCWE+L R GC ECL KA +R+  SC +
Sbjct:   163 ELVKNMSVEAVRNGGFYAGFVDRHNVTVHGLAQCWETLNRSGCVECLSKASVRIG-SCLV 221

Query:   174 RKEGRGFNAGCYLRYSTDKFFNHD-DETGDDRGS-SRLGVMIAIVLSTTAFLMLSLFAAY 231
              +EGR  +AGCY+R+ST KF+N+  + T D  G  + LGV++A+  S  AF++L   A +
Sbjct:   222 NEEGRVLSAGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGF 281

Query:   232 AAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS 291
                 R +K + ++  LG       KS L F YE LE+AT+YF+   KLGQGG+GSVY G 
Sbjct:   282 LLKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGV 341

Query:   292 LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
             L NG TVAVKRL FNT+QWVD FFNEVNLIS ++HKNLVKLLGCSI GPESLLVYEY+ N
Sbjct:   342 LTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIAN 401

Query:   352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT 411
             +SL  ++F +   + LNW KRF IILGTAEG+AYLH  S  RIIHRDIK SNILL+ DFT
Sbjct:   402 QSLHDYLFVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFT 461

Query:   412 PKIADFGLARCFAADRTHVSTAVAGTL 438
             P+IADFGLAR F  D+TH+STA+AGTL
Sbjct:   462 PRIADFGLARLFPEDKTHISTAIAGTL 488

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
 Identities = 195/415 (46%), Positives = 252/415 (60%)

Query:    28 YALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPSL 87
             Y LAQC+ DL   DC+LC+A +RT LP+C P     IF DGCF+R + YSFY E   P  
Sbjct:    84 YGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSFYNEYKGPE- 142

Query:    88 DDVKCSXXXXXXXXXXXXXXXXGFVESVGYA--VGNVSRIAVEKGGGFGAVKVMGVYALA 145
             D + C                 G   +V  A   G  +R + + G      +    + LA
Sbjct:   143 DSIVCGNTTRKNKTFGDAVRQ-GLRNAVTEASGTGGYARASAKAGES----ESESAFVLA 197

Query:   146 QCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDDRG 205
              CW +L  D C++CL+ A   V + C    EGR  + GC+LRYS   F N     G  RG
Sbjct:   198 NCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNGRSRG 257

Query:   206 SSRLGVMIAIVLSTTAFLMLSL-FAAYAAYARLSKMKE-DRNNLGLYATSMKKSCLSFKY 263
             S  + V++  VLS+    M+ +  + Y    R  K K     ++   A ++K S L+FKY
Sbjct:   258 S--VVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFKY 315

Query:   264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS 323
              TLEKAT  F+ + KLGQGG G+VY G LP+G  +AVKRL FN R    +F+NEVN+IS+
Sbjct:   316 STLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMIST 375

Query:   324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
             +EHKNLV+LLGCS  GPESLLVYEY+ N+SLD+FIFD N+ K L+W +R+ II+GTAEGL
Sbjct:   376 VEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEGL 435

Query:   384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              YLH  S  +IIHRDIK SNILLD     KIADFGLAR F  D++H+STA+AGTL
Sbjct:   436 VYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTL 490

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010193 "response to ozone" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006457 "protein folding" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0009408 "response to heat" evidence=RCA

GO:0009644 "response to high light intensity" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)]

 Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
 Identities = 164/415 (39%), Positives = 221/415 (53%)

Query:    27 IYALAQCHLDLSHTDCLLCFAASRTKLPRCLPSLSATIFFDGCFLRYDIYSFYQESVSPS 86
             +Y L+QC  DLS  +C LC++ +   L +C P+       DGCF+R D YSFYQE VS  
Sbjct:    79 MYVLSQCVSDLSSDECSLCWSRATDLLSQCFPATGGWFHLDGCFVRADNYSFYQEPVSHQ 138

Query:    87 LDDVK-CSXXXXXXXXXXXXXX--XXGFVESVGYAVGNVSRIAVEKGGGFGAVKVMGVYA 143
               D K C+                    VE+  Y+ G     +V K G    ++ + VY 
Sbjct:   139 --DTKICASDKEKSAEFKGLVKEVTKSIVEAAPYSRG----FSVAKMG----IRDLTVYG 188

Query:   144 LAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDETGDD 203
             L  CW +L  + C+ CL    + V  SC   KEG   NAGCYLRYS   F+N        
Sbjct:   189 LGVCWRTLNDELCKLCLADGALSVT-SCLPSKEGFALNAGCYLRYSNYTFYNERGLLAMS 247

Query:   204 RGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRN------NLGLYATSMKKS 257
                  L  +  I +     +    +     Y R S  K+ +       +L  +    K+S
Sbjct:   248 FTKENLTYIFVISMVGVLAIAAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEKES 307

Query:   258 ---C-----LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ 309
                C     +SF+Y TL+KATN FN S KLG GG G V+ G+L +G  +A+KRL  + ++
Sbjct:   308 ESICTESHLMSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKK 367

Query:   310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
               DE  NE+++IS  +HKNLV+LLGC      S +VYE++ N SLD  +F+  K K L+W
Sbjct:   368 PRDEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDW 427

Query:   370 NKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
              KR  IILGTAEGL YLH   ET +IIHRDIK SNILLD  + PKI+DFGLA+ +
Sbjct:   428 KKRRTIILGTAEGLEYLH---ETCKIIHRDIKASNILLDLKYKPKISDFGLAKFY 479

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 512 (185.3 bits), Expect = 2.0e-61, Sum P(2) = 2.0e-61
 Identities = 107/246 (43%), Positives = 151/246 (61%)

Query:   195 NHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSL--FAAYAAYARLSKMKEDRNNLGLYAT 252
             N   E G  +  + +   IA+ +S    L+ ++    A     +LS   ED +  G+ +T
Sbjct:   271 NIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLDEDGITST 330

Query:   253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
                   L F++  +E ATN F+ S KLG GG G VY G L  G TVA+KRL   + Q  +
Sbjct:   331 ET----LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAE 386

Query:   313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
             EF NEV++++ ++H+NL KLLG  ++G E +LVYE+VPN+SLD F+FD  K ++L+W +R
Sbjct:   387 EFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRR 446

Query:   373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             + II G A G+ YLH  S   IIHRD+K SNILLD D  PKI+DFG+AR F  D+T  +T
Sbjct:   447 YKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANT 506

Query:   433 A-VAGT 437
               + GT
Sbjct:   507 KRIVGT 512

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 508 (183.9 bits), Expect = 9.6e-60, Sum P(3) = 9.6e-60
 Identities = 105/244 (43%), Positives = 148/244 (60%)

Query:   195 NHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATSM 254
             + D+ T +D      GV++AI + T   +++ L   +  + R  +    R      +   
Sbjct:   274 DQDNPTNNDSKGISAGVVVAITVPTVIAILILLVLGFVLFRR--RKSYQRTKTESESDIS 331

Query:   255 KKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEF 314
                 L + ++T+E ATN F+ S KLG+GG G+VY G L NGT VAVKRL   + Q   EF
Sbjct:   332 TTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREF 391

Query:   315 FNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
              NE  L++ ++H+NLV+LLG  +E  E +L+YE+V N+SLD F+FD  K   L+W +R+ 
Sbjct:   392 RNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYK 451

Query:   375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-A 433
             II G A G+ YLH  S  +IIHRD+K SNILLD D  PKIADFGLA  F  ++T  +T  
Sbjct:   452 IIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNR 511

Query:   434 VAGT 437
             +AGT
Sbjct:   512 IAGT 515

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2121606 CRK13 "cysteine-rich RLK (RECEPTOR-like protein kinase) 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 502 (181.8 bits), Expect = 5.7e-58, Sum P(3) = 5.7e-58
 Identities = 109/246 (44%), Positives = 153/246 (62%)

Query:   195 NHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSK--MKEDRNNLGLYAT 252
             N D +  +  G   +  ++AIV+     L++        +AR  K   + + N  G+  T
Sbjct:   284 NRDKKRDNSSGKISMKTILAIVVVGIVILIIISGILARRFARKEKPYQEVELNQTGI--T 341

Query:   253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD 312
             S++   L +K++T+E ATN F  S++LG GG+G V+ G LP+G  +AVKRL   T Q   
Sbjct:   342 SVRS--LQYKFKTIETATNNF--SERLGHGGSGHVFKGRLPDGKEIAVKRLSEKTEQSKK 397

Query:   313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
             EF NEV L++ ++H+NLV+LLG S++G E ++VYEY+PNRSLD  +FD  K   L+W KR
Sbjct:   398 EFKNEVVLVAKLQHRNLVRLLGFSVKGEEKIIVYEYLPNRSLDYILFDPTKQGELDWKKR 457

Query:   373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             + II GTA G+ YLH  S+  IIHRD+K  NILLD    PK+ADFG AR F  D++   T
Sbjct:   458 YKIIGGTARGILYLHQDSQPTIIHRDLKAGNILLDAHMNPKVADFGTARIFGMDQSVAIT 517

Query:   433 A-VAGT 437
             A  AGT
Sbjct:   518 ANAAGT 523

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=IEP;RCA

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 538 (194.4 bits), Expect = 7.8e-58, Sum P(2) = 7.8e-58
 Identities = 128/307 (41%), Positives = 172/307 (56%)

Query:   141 VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFNHDDE- 199
             +Y + +C   L    C +CL K G  + +    +  GR     C  RY    F+N  +  
Sbjct:   190 LYGMVRCTPDLREQDCLDCL-KIG--INQVTYDKIGGRILLPSCASRYDNYAFYNESNVG 246

Query:   200 TGDD------RGSSRLGVMIAIVLSTTA-FLML-SLFAAYAAYARLSKMKEDRNNLGLYA 251
             T  D      +G +   ++IA+V+  T  FL+L ++F+  A   R    KE     G   
Sbjct:   247 TPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVAEDGNDI 306

Query:   252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV 311
             T+     L F ++ +E ATN F P  KLGQGG G VY G+L +G  VAVKRL   + Q  
Sbjct:   307 TTA--GSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGE 364

Query:   312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
              EF NEV +++ ++H+NLVKLLG  +EG E +LVYE+VPN+SLD F+FD      L+W +
Sbjct:   365 KEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTR 424

Query:   372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
             R+ II G A G+ YLH  S   IIHRD+K  NILLD D  PKIADFG+AR F  D+T   
Sbjct:   425 RYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAM 484

Query:   432 TA-VAGT 437
             T  V GT
Sbjct:   485 TRRVVGT 491

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2125766 CRK40 "cysteine-rich RLK (RECEPTOR-like protein kinase) 40" [Arabidopsis thaliana (taxid:3702)]

 Score = 517 (187.1 bits), Expect = 1.3e-57, Sum P(2) = 1.3e-57
 Identities = 117/232 (50%), Positives = 148/232 (63%)

Query:   210 GVMIAIVLSTTAFLMLSLFAAYA-AYARLSKMKEDRNNLGL--YATSMKKSCLSFKYETL 266
             G +IAIV+  T F+ L +F  +   YAR  K+    NN+G   Y+ S  +  L F    +
Sbjct:   287 GGIIAIVVVFT-FINLLVFIGFIKVYARRGKL----NNVGSAEYSDSDGQFMLRFDLGMI 341

Query:   267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH 326
               AT+ F+    LGQGG G+VY G+ PNG  VAVKRL   + Q   EF NEV+L++ ++H
Sbjct:   342 VMATDDFSSENTLGQGGFGTVYKGTFPNGQEVAVKRLTKGSGQGDMEFKNEVSLLTRLQH 401

Query:   327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
             KNLVKLLG   EG E +LVYE+VPN SLD FIFD++K  LL W  RF II G A GL YL
Sbjct:   402 KNLVKLLGFCNEGDEEILVYEFVPNSSLDHFIFDEDKRSLLTWEVRFRIIEGIARGLLYL 461

Query:   387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA-VAGT 437
             H  S+ +IIHRD+K SNILLD +  PK+ADFG AR F +D T   T  +AGT
Sbjct:   462 HEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAGT 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 479 (173.7 bits), Expect = 4.2e-57, Sum P(2) = 4.2e-57
 Identities = 111/251 (44%), Positives = 152/251 (60%)

Query:   198 DETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSKMKEDRNNLGLYATS---- 253
             + TG  +G S+  V+IAIV+      +L++        R +K       LG    S    
Sbjct:   276 ERTGKGKGGSK--VIIAIVIPILLVALLAICLCLVLKWRKNKSGYKNKVLGKSPLSGSIA 333

Query:   254 ----MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ 309
                      L   +ETL+ AT+ F+   +LG+GG GSVY G  P G  +AVKRL  N+ Q
Sbjct:   334 EDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQ 393

Query:   310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
               +EF NE+ L++ ++H+NLV+L+G  I+G E LLVYE++ N SLDQFIFD  K +LL+W
Sbjct:   394 GDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDW 453

Query:   370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT- 428
               R+ +I G A GL YLH  S  RIIHRD+K SNILLD++  PKIADFGLA+ F + +T 
Sbjct:   454 VVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTM 513

Query:   429 -HVSTA-VAGT 437
              H  T+ +AGT
Sbjct:   514 THRFTSRIAGT 524

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 4.6e-57, P = 4.6e-57
 Identities = 156/433 (36%), Positives = 220/433 (50%)

Query:    27 IYALAQCHLDLS-HTDCLLCFAASRTKLPRCLPSL-SATIFFDGCFLRYDIYSFYQESVS 84
             + A+A C  D+  + DC+ C   +  +L    P++  A I+ + C  RY         + 
Sbjct:    77 VNAIALCRGDVKPNQDCISCITTAAKQLVESCPNIIEANIWLEKCMFRYT-----SRIIL 131

Query:    85 PSLDDVKCSXXXXXXXXXXXXXXXXGFVESVGYAVGNVSRIAVEKGGGFGAVKVMG-VYA 143
               ++ V  S                G  + +      +      K   F A  V G +YA
Sbjct:   132 GQMEPVPFSYTSSNVSVTDKEGFSKGLGDLLDSLGAKIDAANETKEVKFAA-GVKGTIYA 190

Query:   144 LAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGCYLRYSTDKFFN-------- 195
             LAQC   L    CR CL +    V   C  +  G   N  CY R+    FF+        
Sbjct:   191 LAQCTPDLSESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQK 250

Query:   196 -----HDDETG-DDRGSS--RLGVMIAIVLSTTAFLMLSLFA-AYAAYARLSK-MKEDRN 245
                  H++ T   D+G S  R   +I  V+   A ++  +F   Y    R  K +KE+  
Sbjct:   251 QPLSSHNNNTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKENAE 310

Query:   246 NLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIF 305
             N    +T      L F +ET+  AT+ F+ + K+G+GG G VY G LP+G  +AVKRL  
Sbjct:   311 N-EFESTDS----LHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSI 365

Query:   306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK 365
             ++ Q   EF  EV L++ ++HKNLVKL G SI+  E LLVYE++PN SLD+F+FD  K K
Sbjct:   366 HSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQK 425

Query:   366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
              L+W KR+NII+G + GL YLH GSE  IIHRD+K+SN+LLD+   PKI+DFG+AR F  
Sbjct:   426 QLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDF 485

Query:   426 DRTH-VSTAVAGT 437
             D T  V+  V GT
Sbjct:   486 DNTQAVTRRVVGT 498

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FNE1	CRK42_ARATH	2, ., 7, ., 1, 1, ., -	0.6027	0.9589	0.6451	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	438
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-11
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-11
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	5e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-10
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-04
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.001
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.001
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.002
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.002
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.002
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	0.002
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.003
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.003
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.003
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.004
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (346), Expect = 4e-38
 Identities = 57/163 (34%), Positives = 84/163 (51%), Gaps = 9/163 (5%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+GG G+VY+      G  VA+K +        ++E   E+ ++  + H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     LV EY    SL   + +      L+ ++   I+L   EGL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 397 RDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGTL 438
           RD+K  NILLD D    K+ADFGL++   +D++ + T V GT 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTP 157

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  135 bits (343), Expect = 5e-37
 Identities = 54/151 (35%), Positives = 80/151 (52%), Gaps = 10/151 (6%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           KKLG+G  G VY G+L          VAVK L  +   Q ++EF  E  ++  ++H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           KLLG   E    ++V EY+P   L  ++  KN+ K L+ +   +  L  A G+ YL    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               IHRD+   N L+ ++   KI+DFGL+R
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  135 bits (342), Expect = 6e-37
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 11/152 (7%)

Query: 276 SKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
            KKLG+G  G VY G L          VAVK L  + + Q ++EF  E  ++  ++H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLLG   E     +V EY+    L  ++  +     L+ +   +  L  A G+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                IHRD+   N L+ ++   KI+DFGL+R
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  133 bits (336), Expect = 4e-36
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 14/156 (8%)

Query: 277 KKLGQGGAGSVYMGSL----PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           KKLG+G  G VY G L       T VAVK L    + +   +F  E  ++  + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFI------FDKNKTKLLNWNKRFNIILGTAEGLAY 385
           LLG   E     LV EY+    L  ++      F   +   L+     +  +  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L      + +HRD+   N L+ +D   KI+DFGL+R
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  132 bits (335), Expect = 6e-36
 Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 11/151 (7%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           KKLG+G  G VY G+L        T VAVK L    + +  +EF  E +++  + H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG   +G    +V EY+P   L  F+  +   + L       + L  A+G+ YL    
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE--- 119

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               +HRD+   N L+ ++   KI+DFGL+R
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (329), Expect = 5e-35
 Identities = 55/165 (33%), Positives = 80/165 (48%), Gaps = 10/165 (6%)

Query: 277 KKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +KLG G  G+VY       G  VAVK L   + +   D+    E+ ++  + H N+V+L+
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               +     LV EY     L  ++        L+ ++   I L    GL YLH      
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH---SNG 118

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           IIHRD+K  NILLD++   KIADFGLA+      + ++T V GT 
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTP 162

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  118 bits (299), Expect = 7e-31
 Identities = 54/165 (32%), Positives = 78/165 (47%), Gaps = 12/165 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G  G VY+      G  VA+K +     ++  +    E+ ++  ++H N+V+L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 335 CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
              E  + L LV EY     L   +  K + +L     RF  +      L YLH      
Sbjct: 65  -VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLH---SKG 117

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           I+HRD+K  NILLD+D   K+ADFGLAR    D     T   GT 
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTP 160

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  116 bits (293), Expect = 6e-30
 Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 29/159 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIF--NTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           + LG+G  GSVY+      G  +AVK +    ++ + ++    E+ ++SS++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 334 GCSI-EGPESLLVY-EYVPNRSLDQFIFDKNKTKLLNWNKRFNI---------ILGTAEG 382
           G    E   +L ++ EYV   SL   +  K          +            IL   EG
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL--KK-------FGKLPEPVIRKYTRQIL---EG 113

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           LAYLH      I+HRDIK +NIL+D D   K+ADFG A+
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAK 149

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 4e-27
 Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 10/163 (6%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLG 334
            +G+G  G VY G +L  G  VA+K++       + +     E++L+ +++H N+VK +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                    ++ EY  N SL Q I    K      +     +    +GLAYLH   E  +
Sbjct: 67  SIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLH---EQGV 120

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           IHRDIK +NIL  KD   K+ADFG+A            +V GT
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  108 bits (271), Expect = 7e-27
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 18/160 (11%)

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
            F   +K+G+GG G VY       G  VA+K +   +++  ++  NE+ ++   +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           K  G  ++  E  +V E+    SL           L + N+         +     +GL 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDL--------LKSTNQTLTESQIAYVCKELLKGLE 112

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           YLH      IIHRDIK +NILL  D   K+ DFGL+   +
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 98.3 bits (246), Expect = 4e-23
 Identities = 57/156 (36%), Positives = 82/156 (52%), Gaps = 21/156 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLV 330
           +KLG+G  G VY       G  VA+K++  +     +E        E++L+  ++H N+V
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIV 61

Query: 331 KLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNI-ILGTAEGLAYLH 387
           KLL   I     L LV+EY  +  L +++ DK    L  N  K     +L    GLAY H
Sbjct: 62  KLL-DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLL---RGLAYCH 115

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
                RI+HRD+K  NIL+++D   K+ADFGLAR F
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLARAF 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 97.2 bits (243), Expect = 4e-23
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 22/172 (12%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K++G+G  G VY+     +G    +K +  +  + +  ++  NEV ++  + H N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKT-------KLLNWNKRF-NIILGTAEGLAY 385
               E  +  +V EY     L Q I  + K        ++L+W   F  + L     L Y
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLCLA----LKY 118

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           LH     +I+HRDIK  NI L  +   K+ DFG+++  ++      T V GT
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 21/159 (13%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
              +   +K+G+G +G VY       G  VA+K++    +Q  +   NE+ ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPN 76

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN-KRFN------IILGTAE 381
           +V      + G E  +V EY+   SL         T ++  N  R N      +     +
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQ 127

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           GL YLH      +IHRDIK+ NILL KD + K+ADFG A
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 13/160 (8%)

Query: 276 SKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNL 329
            K+LG+G  G V +          G  VAVK L  +   Q   +F  E+ ++ +++H+N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 330 VKLLGCSIE--GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           VK  G   +  G    L+ EY+P+ SL  ++  +++ ++    +         +G+ YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINL-KRLLLFSSQICKGMDYLG 126

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                R IHRD+   NIL++ +   KI+DFGLA+    D+
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.0 bits (234), Expect = 7e-22
 Identities = 56/159 (35%), Positives = 82/159 (51%), Gaps = 32/159 (20%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIF-----NTRQWVDEFFNEVNLISSIEHKNLVKL 332
           LG G  GSVY G +L +G   AVK +         ++ V +   E+ L+S ++H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 333 LGCSIEGPESLLVY-EYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAE---G 382
           LG   E  ++L ++ E VP  SL          KLL   K++       I L T +   G
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSL---------AKLL---KKYGSFPEPVIRLYTRQILLG 114

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L YLH       +HRDIK +NIL+D +   K+ADFG+A+
Sbjct: 115 LEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.8 bits (233), Expect = 8e-22
 Identities = 53/145 (36%), Positives = 76/145 (52%), Gaps = 6/145 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG     T VA+K L   +    + F  E NL+  ++H  LV+L    
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+      KL   NK  ++    AEG+A++        IH
Sbjct: 71  TQEP-IYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ +    KIADFGLAR
Sbjct: 126 RDLRAANILVSETLCCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 95.6 bits (236), Expect = 1e-21
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 10/165 (6%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSI-EHKN 328
           +   +KLG+G  G VY+    +   VA+K L   + +  + V+ F  E+ +++S+    N
Sbjct: 2   YRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +VKL     +     LV EYV   SL+  +    +   L+ ++   I+      L YLH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118

Query: 389 GSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVST 432
                IIHRDIK  NILLD+D    K+ DFGLA+      +  S 
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161

Length = 384

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 35/169 (20%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF----FNEVNLISSIEHK 327
           +    KLG+G  G VY    +  G  VA+K+++ +  +  D F      E+ ++  ++H 
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHP 67

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------DKNKTKLLNWNKRFN------ 374
           N+V L+          +  E        +          D + + LL  N          
Sbjct: 68  NVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQI 117

Query: 375 --IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +L   EG+ YLH   E  I+HRDIK +NIL+D     KIADFGLAR
Sbjct: 118 KCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 7e-21
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 37/169 (21%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF----FNEVNLISSIEHKNLVK 331
            ++G+G  G VY   +   G  VA+K++     +  + F      E+ L+  + H N+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62

Query: 332 LLG--CSIEGPESLLVYEYVPN--RSLDQFIFDKNKTKLLNWNKRFNI---------ILG 378
           L     S       +V+EY+ +    L           L +   +F           +L 
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGL-----------LDSPEVKFTESQIKCYMKQLL- 110

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
             EGL YLH      I+HRDIK SNIL++ D   K+ADFGLAR +    
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 1e-20
 Identities = 53/149 (35%), Positives = 78/149 (52%), Gaps = 10/149 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN--EVNLISSI-EHKNLVKL 332
           K+LG G  GSVY+  +   G  VA+K++      W +E  N  EV  +  + EH N+VKL
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKL 63

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                E  E   V+EY+   +L Q + D+   K  + +   +II    +GLA++H   + 
Sbjct: 64  KEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH---KH 118

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              HRD+K  N+L+      KIADFGLAR
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 8/144 (5%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG+G  GSVY       G  VA+K  +    + + E   E++++   +   +VK  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +  +  +V EY    S+   +   NKT  L   +   I+  T +GL YLH     + IH
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLH---SNKKIH 122

Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RDIK  NILL+++   K+ADFG++
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 59/165 (35%), Positives = 75/165 (45%), Gaps = 8/165 (4%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGC 335
            +G G    VY    LPN   VA+KR+     Q  VDE   EV  +S   H N+VK    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  LV  Y+   SL   +        L+      ++    +GL YLH       I
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA--ADRTH-VSTAVAGT 437
           HRDIK  NILL +D + KIADFG++   A   DRT  V     GT
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 88.1 bits (219), Expect = 9e-20
 Identities = 56/151 (37%), Positives = 75/151 (49%), Gaps = 7/151 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           +KLG G  G V+MG+    T VAVK L   T    + F  E  ++  + H  LV+L   C
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           S E P   +V EY+   SL  F+      KL    +  ++    AEG+AYL        I
Sbjct: 71  SEEEP-IYIVTEYMSKGSLLDFLKSGEGKKL-RLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           HRD+   NIL+ ++   KIADFGLAR    D
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 9/152 (5%)

Query: 278 KLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQ-WV-DEFFNEVNLISSIEHKNLVKLLG 334
           ++G+G  G V+       G TVA+K++     +  + ++   E+  + + +H  +VKLL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
               G   +LV EY+P   L + + D+ +       K +  +L   +G+AY+H      I
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA---NGI 120

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +HRD+K +N+L+  D   KIADFGLAR F+ +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEE 152

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 19/171 (11%)

Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
             K+G G  G VY   +L  G  +AVK  R+  N  + + E  +E+ ++  ++H NLVK 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQF-----IFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            G  +   +  +  EY    +L++      I D++  +       + + L   EGLAYLH
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR------VYTLQL--LEGLAYLH 116

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
                 I+HRDIK +NI LD +   K+ DFG A     + T +   V    
Sbjct: 117 ---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 13/163 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN--EVNLISSIEHKNLVKLL 333
            K+G+G  G VY       G  VA+K++               E+ L+  + H N++KLL
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
                  +  LV+E++ +  L + I  K++ + L  +   + +    +GLA+ H      
Sbjct: 65  DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---TH-VST 432
           I+HRD+K  N+L++ +   K+ADFGLAR F +     TH V T
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT 161

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 57/167 (34%), Positives = 85/167 (50%), Gaps = 25/167 (14%)

Query: 276 SKKLGQGGAGSVYMGSL--PNG----TTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKN 328
            ++LG+G  G VY G L  PN     T+VA+K L  N    V  EF  E  L+S ++H N
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFN 374
           +V LLG C+ E P  +L +EY+ +  L +F+              D+     L+ +   +
Sbjct: 70  IVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           I +  A G+ YL   S    +HRD+   N L+ +  T KI+DFGL+R
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.5 bits (211), Expect = 7e-19
 Identities = 54/145 (37%), Positives = 75/145 (51%), Gaps = 5/145 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG   N T VAVK L   T   V  F  E NL+ +++H  LV+L    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+   SL  F+      K+L   K  +     AEG+AY+        IH
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +N+L+ +    KIADFGLAR
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 28/168 (16%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTT----VAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G      VA+K L   T  +   E  +E  +++S++H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK-----LLNWNKRFNIILGTAEGLAY 385
           +LLG  +   +  L+ + +P   L  ++ + +K       LLNW  +       A+G++Y
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQI------AKGMSY 124

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTP---KIADFGLARCFAADRTHV 430
           L    E R++HRD+   N+L+    TP   KI DFGLA+    D    
Sbjct: 125 L---EEKRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEY 166

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 24/171 (14%)

Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIF----NTRQWVDEFFNEVNLISSIEHKNLVK 331
           K LGQG +G VY     P G   A+K++        R+ +     E+  + S E   +VK
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVK 63

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA-----EGLAYL 386
             G   +  E  +V EY+   SL   +      K+    +    +L        +GL YL
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP---VLAYIARQILKGLDYL 115

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           H  ++  IIHRDIK SN+L++     KIADFG+++         +T V GT
Sbjct: 116 H--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GT 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)

Query: 279 LGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVK 331
           LG+G  G V++G   +         VAVK L         + F  E  L+++ +H+N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF-----------IFDKNKTKLLNWNKRFNIILGTA 380
             G   EG   ++V+EY+ +  L++F               +    L  ++   I +  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            G+ YL   +    +HRD+ T N L+  D   KI DFG++R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 18/168 (10%)

Query: 277 KKLGQGGAGSVYMG--SLPNGT--TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           K+LG G  GSV  G   + +G    VAVK L          EF  E ++++ ++H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT---KLLNWNKRFNIILGTAEGLAYLHG 388
           L+G   +G   +LV E  P   L +++  + +     L             A G+AYL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE- 112

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
                 +HRD+   N+LL      KI+DFG++R   A   +     AG
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 12/164 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLV 330
           KKLG+G    VY       G  VA+K++    R+   +  N     E+ L+  ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            LL          LV+E++    L++ I DK+   L   + + + +L T  GL YLH   
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIV-LTPADIK-SYMLMTLRGLEYLH--- 119

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
              I+HRD+K +N+L+  D   K+ADFGLAR F +    ++  V
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 6/143 (4%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G V +G    G  VAVK L  +       F  E ++++++ H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           G    +V EY+   SL  ++  + +  ++   ++    L   EG+ YL    E   +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 399 IKTSNILLDKDFTPKIADFGLAR 421
           +   N+L+ +D   K++DFGLA+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 29/160 (18%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNT----------RQWVDEFFNEVNLISSIEHK 327
           +G+G  G VY+  ++  G  +AVK++              +  V    +E+  +  ++H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 328 NLVKLLGCSIEGPESLLVY-EYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
           N+V+ LG      E L ++ EYVP  S+   +     F++   +               E
Sbjct: 69  NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           GLAYLH      I+HRD+K  N+L+D D   KI+DFG+++
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 52/155 (33%), Positives = 71/155 (45%), Gaps = 20/155 (12%)

Query: 277 KKLGQGGAGSVYMG--SLPNGTT--VAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           KKLG G  G V  G  S   G    VAVK L        +D+F  E  ++ S++H+NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-----TKLLNWNKRFNIILGTAEGLAYL 386
           L G  +  P  ++V E  P  SL   +          + L ++       +  A G+ YL
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA------VQIANGMRYL 113

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 R IHRD+   NILL  D   KI DFGL R
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 4/149 (2%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           F   +KLG G  G V+ G   N   VA+K L  +      +F  EV  +  + HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                 G    ++ E +   SL  F+    + ++L      ++    AEG+AYL    E 
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQ 123

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             IHRD+   NIL+ +D   K+ADFGLAR
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 52/160 (32%), Positives = 70/160 (43%), Gaps = 23/160 (14%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE------ 325
           F   K +G+G   +V +          A+K  I + RQ + E   +V  +  IE      
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIK--ILDKRQLIKE--KKVKYVK-IEKEVLTR 57

Query: 326 ---HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
              H  ++KL   + +  E+L  V EY PN  L Q+I    K   L+             
Sbjct: 58  LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILL 113

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH      IIHRD+K  NILLDKD   KI DFG A+
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAK 150

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 28/159 (17%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNT---------RQWVDEFFNEVNLISSIEHKN 328
           +G G  GSVY+G +  +G  +AVK++   +         R  +D    E+ L+  ++H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEG 382
           +V+ LG S++     +  EYVP  S+           LLN    F      N +    +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L YLH      IIHRDIK +NIL+D     KI+DFG+++
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 9/160 (5%)

Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
              P   ++ E++   +L  ++ + N+   +N      +    +  + YL   +    IH
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           RD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 164

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 24/157 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LGQG  G VY+   +  G  +AVK++ F+     T++ V+    E+ L+ +++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 331 KLLGCSIEGPESLLVY-EYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGLA 384
           +  GC +   E+L ++ EY+P  S+   +       +  T+     K    IL   EG+ 
Sbjct: 68  QYYGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-----KYTRQIL---EGVE 118

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YLH      I+HRDIK +NIL D     K+ DFG ++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 12/151 (7%)

Query: 277 KKLGQGGAGSVYMGSL--PNGT--TVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K +G G  G V  G L  P      VA+K L    + +Q +D F  E +++   +H N++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNII 68

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L G   +    +++ EY+ N SLD+F+  +         +   ++ G A G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           E   +HRD+   NIL++ +   K++DFGL+R
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 8e-17
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 7/151 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           +KLG G  G V+ G   N T VAVK L   T     +F  E  ++  + H  L++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           ++E P   +V E +   SL +++      + L   +  ++    A G+AYL        I
Sbjct: 71  TLEEP-IYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           HRD+   N+L+ ++   K+ADFGLAR    D
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKED 156

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.9 bits (197), Expect = 9e-17
 Identities = 56/158 (35%), Positives = 77/158 (48%), Gaps = 15/158 (9%)

Query: 272 YFNPSKKLGQGGAGSVYMGSL-PN----GTTVAVKRLIF-NTRQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G V +    P     G  VAVK L     +Q    +  E+N++ ++ 
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64

Query: 326 HKNLVKLLGCSIEGPES--LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           H+N+VK  GC  E       L+ EYVP  SL  ++  K+K   LN  +         EG+
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHK---LNLAQLLLFAQQICEGM 120

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           AYLH       IHRD+   N+LLD D   KI DFGLA+
Sbjct: 121 AYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 56/165 (33%), Positives = 82/165 (49%), Gaps = 12/165 (7%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F   +++G G  G+VY    +     VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQQLRHP 75

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D  I + +K K L   +   I  G  +GLAYLH
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLH 132

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             S  RI HRDIK  NILL +  T K+ADFG A   +   + V T
Sbjct: 133 --SHERI-HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 22/163 (13%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV +          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNK-----TKLLNWNKRFNIILGTAEGLA 384
             G C   G  +L LV EY+P  SL  ++  K++      KLL +  +        +G+ 
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQI------CKGME 122

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           YL      R +HRD+ T NIL++ +   KI DFGL +    D+
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 22/174 (12%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNE 317
           L ++YE  E           LG+G  G VY    L     +A+K +     ++V     E
Sbjct: 1   LEYEYEYDEN-----GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEE 55

Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK------NKTKLLNWNK 371
           + L S ++H+N+V+ LG   E     +  E VP  SL   +  K      N+  ++ + K
Sbjct: 56  IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115

Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFA 424
           +   IL   EGL YLH   + +I+HRDIK  N+L++      KI+DFG ++  A
Sbjct: 116 Q---IL---EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 17/177 (9%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFN-----TRQWVDEFFNEVNLIS 322
              F   KK+G+G    VY    L +G  VA+K++ IF       RQ   +   E++L+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 323 SIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTA 380
            ++H N++K L   IE  E  +V E      L + I  F K K +L+     +   +   
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLC 116

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             L ++H     RI+HRDIK +N+ +      K+ D GL R F++  T   + V GT
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.0 bits (189), Expect = 6e-16
 Identities = 50/147 (34%), Positives = 77/147 (52%), Gaps = 10/147 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL    
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIF--DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            + P   ++ E++   SL  F+   + +K  L    K  +     AEG+A++    +   
Sbjct: 71  TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIE---QRNY 123

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
           IHRD++ +NIL+      KIADFGLAR
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 55/175 (31%), Positives = 84/175 (48%), Gaps = 30/175 (17%)

Query: 279 LGQGGAGSVY----MGSLPNG--TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK 331
           +GQG  G V+     G LP    T VAVK L    +     +F  E  L++  +H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------------------LNWNKR 372
           LLG    G    L++EY+    L++F+  ++                       L+  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAAD 426
             I    A G+AYL   SE + +HRD+ T N L+ ++   KIADFGL+R  ++AD
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 49/163 (30%), Positives = 74/163 (45%), Gaps = 36/163 (22%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           K+G+G  G VY       G  VA+K++   T    DE        E++L+  + H N+V+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVR 62

Query: 332 LLGCSIEGPESLLVYEY-----------VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           LL       +  LV+E+            P   LD  +      +LL             
Sbjct: 63  LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ------------ 110

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
            G+AY H     R++HRD+K  N+L+D++   K+ADFGLAR F
Sbjct: 111 -GIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 30/161 (18%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEF-FNEVNL---ISSIEHKNLVKL 332
           +G+G  G+VY    L  G  VA+K++ +  + + +      E+ L   + S EH N+V+L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 333 L----GCSIEGPESL-LVYEYVPNRSLDQFI-------FDKNKTKLLNWNKRFNIILGTA 380
           L    G   +    L LV+E+V ++ L  ++             K L        +L   
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ-----LLR-- 118

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            G+ +LH     RI+HRD+K  NIL+  D   KIADFGLAR
Sbjct: 119 -GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 12/178 (6%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           E   ++    K +G G  G V+ G L         VA+K L   +  +Q  D F +E ++
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASI 59

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +    H N+++L G   +   ++++ EY+ N +LD+++ D +     +  +   ++ G A
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIA 117

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            G+ YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 14/160 (8%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNT-------RQWVDEFFNEVNLISSIEHKNLVK 331
           LG+G  G+VY G    G  +AVK++  +T       +++ ++   EV+L+ S++H N+V+
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY-EKLQEEVDLLKSLKHVNIVQ 66

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
            LG  ++     +  E+VP  S+   +          + K    IL   +G+AYLH    
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLH---N 120

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
             ++HRDIK +N++L  +   K+ DFG AR  A    H +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 20/160 (12%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G TV    A+K L   T    + EF +E  +++S++H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +  P   LV + +P+  L  ++ +         LLNW       +  A+G+ YL
Sbjct: 73  RLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               E R++HRD+   N+L+      KI DFGLAR    D
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 50/150 (33%), Positives = 78/150 (52%), Gaps = 14/150 (9%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKR----LIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +K+G+G  G VY G L   T VAVK     L  + ++   +F  E  ++   +H N+VKL
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKL 57

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +G  ++     +V E VP  SL  F+  + K   L   K   + L  A G+ YL    E+
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL----ES 111

Query: 393 R-IIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +  IHRD+   N L+ ++   KI+DFG++R
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 52/145 (35%), Positives = 73/145 (50%), Gaps = 6/145 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG+    T VAVK L   T    + F  E  ++  + H  LV+L    
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F+ D  + + L      ++    A G+AY+        IH
Sbjct: 71  SEEP-IYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++++NIL+      KIADFGLAR
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 21/168 (12%)

Query: 279 LGQGGAGSVYMGSLPN-GTTVAV----KRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+G  G V +    + G   A+    K+ I   ++ V+    E N++S I H  +VKL 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VEHTLTERNILSRINHPFIVKLH 59

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGG 389
             + +  E L LV EY P   L   +    + +      RF      AE    L YLH  
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYA----AEIVLALEYLH-- 110

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               II+RD+K  NILLD D   K+ DFGLA+  +++ +  +T   GT
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 58/156 (37%), Positives = 86/156 (55%), Gaps = 11/156 (7%)

Query: 269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEH 326
           AT+Y N  +KLG+G   +VY G S  NG  VA+K +   T + V      E +L+  ++H
Sbjct: 4   ATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 327 KNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
            N+V LL   I   E+L  V+EY+ +  L Q++  ++   L  +N R   +     GLAY
Sbjct: 63  ANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRL-FMFQLLRGLAY 118

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +HG     I+HRD+K  N+L+      K+ADFGLAR
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 52/156 (33%), Positives = 82/156 (52%), Gaps = 12/156 (7%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 330 VKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLH 387
           VKLL   I     L LV+E++ ++ L +F+     + + L   K +   L   +GLA+ H
Sbjct: 62  VKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH 117

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
                R++HRD+K  N+L++ +   K+ADFGLAR F
Sbjct: 118 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 18/160 (11%)

Query: 277 KKLGQGGAGSVYMGSL--PNGTT--VAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG+G  GSV  G L   +G+   VAVK  +L  +T   ++EF +E   +   +H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 331 KLLGCSIEG------PESLLVYEYVPNRSLDQFIFD---KNKTKLLNWNKRFNIILGTAE 381
           KL+G   E       P+ +++  ++ +  L  F+         + L        ++  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+ YL   S    IHRD+   N +L +D T  +ADFGL++
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 28/168 (16%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V              +TVAVK L  + T + + +  +E+ ++  I +HKN
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG--------- 378
           ++ LLG C+ EGP  ++V EY  + +L  F+    +      +                 
Sbjct: 78  IINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRA-RRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 379 -----TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 A G+ +L   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 15/151 (9%)

Query: 279 LGQGGAGSVYMGSL----PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +G+G  G VY G+L          AVK L  I +  + V++F  E  ++    H N++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVLSL 61

Query: 333 LGCSI--EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           LG  +  EG   L+V  Y+ +  L  FI  +++T            L  A+G+ YL   +
Sbjct: 62  LGICLPSEG-SPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 50/144 (34%), Positives = 73/144 (50%), Gaps = 6/144 (4%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V E++   SL  F+  +   K L   +  ++    A+G+AY+        IHR
Sbjct: 72  EEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+  +   KIADFGLAR
Sbjct: 127 DLRAANILVGDNLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 6/157 (3%)

Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            +++G G  G V++G       VA+K  I       ++F  E  ++  + H  LV+L G 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             E     LV+E++ +  L  ++  + +    +      + L   EG+AYL     + +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVI 122

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           HRD+   N L+ ++   K++DFG+ R    D+   ST
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 19/161 (11%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG+G  G V++    N         VAVK L   +     +F  E  L+++++H+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFI----------FDKNKTKLLNWNKRFNIILGTA 380
           K  G  +EG   ++V+EY+ +  L++F+           + N+   L  ++  +I    A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            G+ YL   +    +HRD+ T N L+ ++   KI DFG++R
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV---DEFFNEVNLISSIEHKNLVKLL 333
           K+LG G  G V++G       VA+K +    R+     D+F  E  ++  + H NLV+L 
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLY 65

Query: 334 G-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           G C+ + P   +V EY+ N  L  ++  + +   L      ++     E + YL      
Sbjct: 66  GVCTKQRP-IFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLE---SN 119

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             IHRD+   N L+ +D   K++DFGLAR +  D  + S+
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSS 158

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 16/162 (9%)

Query: 278 KLGQGGAGSVYMGSLPNGTT---VAVKRLIFNTRQ----WVDEFFNEVNLISSIEHKNLV 330
           ++G G  G+VY  +  N  T   VAVK++ ++ +Q    W D    EV  +  ++H N +
Sbjct: 28  EIGHGSFGAVYFAT--NSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPNTI 84

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +  GC ++   + LV EY    + D     K   K L   +   I  G  +GLAYLH  +
Sbjct: 85  EYKGCYLKEHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
              +IHRDIK  NILL +    K+ADFG A   +   + V T
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 53/165 (32%), Positives = 79/165 (47%), Gaps = 12/165 (7%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F   +++G G  G+VY    +     VA+K++ ++ +Q    W D    EV  +  I+H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHP 85

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   I  G  +GLAYLH
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH 142

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             +   +IHRDIK  NILL +    K+ADFG A   +   + V T
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 39/163 (23%), Positives = 80/163 (49%), Gaps = 8/163 (4%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           K+G+G  G V+      +    A+K++  +   R+  +E  +E  +++ ++   +++   
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             ++  +  +V EY  N  L + +    + + L  ++ +   +    GLA+LH     +I
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKI 122

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           +HRDIK+ N+ LD     KI D G+A+  + +    +T V GT
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   +  G  +GLAYLH
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 132

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
             +   +IHRD+K  NILL +    K+ DFG A   A     V T
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 6/143 (4%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG G  G VY       G   A K +   + + +++F  E++++S  +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
              +  ++ E+    +LD  I  + +  L     R+ +     E L +LH     ++IHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIHR 127

Query: 398 DIKTSNILLDKDFTPKIADFGLA 420
           D+K  NILL  D   K+ADFG++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.2 bits (178), Expect = 6e-14
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 31/161 (19%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF-----FNEVNLISSIEHKNLV 330
           K +G G  G V        G  VA+K+ I N     D         E+ L+  + H+N++
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKK-ISNVFD--DLIDAKRILREIKLLRHLRHENII 62

Query: 331 KLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTA 380
            LL   I  P S        +V E +    L + I  K+   L + + ++    I+    
Sbjct: 63  GLL--DILRPPSPEDFNDVYIVTELMET-DLHKVI--KSPQPLTDDHIQYFLYQILR--- 114

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            GL YLH  +   +IHRD+K SNIL++ +   KI DFGLAR
Sbjct: 115 -GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 14/149 (9%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIF--NTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +LG+G  GSV    L N   +   + I          +   E+ +  S +   +VK  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 336 SIEGPESLL--VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE----GLAYLHGG 389
            ++   S +    EY    SLD  I+ K K +     ++  ++   AE    GL+YLH  
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK--VLGKIAESVLKGLSYLH-- 122

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFG 418
              +IIHRDIK SNILL +    K+ DFG
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 9e-14
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
               N+     K+G+G  G V + +    G  VAVK++    +Q  +  FNEV ++   +
Sbjct: 19  SYLDNF----VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ 74

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H N+V++    + G E  +V E++   +L   +        +N  +   + L   + L++
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSF 130

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFG 418
           LH      +IHRDIK+ +ILL  D   K++DFG
Sbjct: 131 LHA---QGVIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 54/162 (33%), Positives = 81/162 (50%), Gaps = 30/162 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF---------FNEVNLISSI-E 325
           +KLG+G  G V+          VA+K+ IF      D F         F E+  +  + +
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKK-IF------DAFRNATDAQRTFREIMFLQELGD 65

Query: 326 HKNLVKLLGC--SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLL-NWNKRFNIILGTAEG 382
           H N+VKLL    +    +  LV+EY+    L   I    +  +L + +KR+ I+    + 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLLKA 119

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           L Y+H G    +IHRD+K SNILL+ D   K+ADFGLAR  +
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 7/153 (4%)

Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKR--LIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   KKLG+G  GSVY +  L +    A+K   L   +++  ++  NE+ +++S+ H N+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHG 388
           +      ++G +  +V EY P   L + I  + K  KL+   + + I +    GL  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH- 120

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             E +I+HRD+K++NILL  +   KI D G+++
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISK 151

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 12/146 (8%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +G+G  G V +G    G  VAVK  I N  T Q    F  E ++++ + H NLV+LLG  
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVK-CIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVI 68

Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL   +    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N+L+ +D   K++DFGL +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 55/160 (34%), Positives = 74/160 (46%), Gaps = 20/160 (12%)

Query: 279 LGQGGAGSVYMGS----LPNGT---TVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLV 330
           LG G  G VY G+    L  G+    VAVK L    T Q   EF  E +L+S+  H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK----LLNWNKRFNIILGTAEGLAYL 386
           KLLG  +      ++ E +    L  ++ D    +    LL   +  +I L  A+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 387 HGGSETRIIHRDIKTSNILL-----DKDFTPKIADFGLAR 421
               +   IHRD+   N L+     D D   KI DFGLAR
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 58/173 (33%), Positives = 76/173 (43%), Gaps = 35/173 (20%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG G  G V +     +G   A+K L    I   +Q V+   NE  ++ SI H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHP 61

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN----------II 376
            LV L G S +   +L LV EYVP   L    F       L  + RF           ++
Sbjct: 62  FLVNLYG-SFQDDSNLYLVMEYVPGGEL----FS-----HLRKSGRFPEPVARFYAAQVV 111

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           L     L YLH      I++RD+K  N+LLD D   KI DFG A+     RT+
Sbjct: 112 LA----LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTY 156

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 6/144 (4%)

Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G V+ G+L + T VAVK    +  Q +  +F +E  ++   +H N+VKL+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           +     +V E VP    D   F + K   L   +     L  A G+AYL        IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+   N L+ ++   KI+DFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 35/184 (19%)

Query: 267 EKATNYFNPSKKLGQGGAGSVY------------MGSLPNG-----TTVAVKRL----IF 305
           E      N  +KLG+G  G V+                 N        VAVK L      
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI------- 358
           N R+   +F  EV ++S +   N+ +LLG     P   ++ EY+ N  L+QF+       
Sbjct: 61  NARE---DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117

Query: 359 -FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
                 +K L+++    +    A G+ YL        +HRD+ T N L+ K++T KIADF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADF 174

Query: 418 GLAR 421
           G++R
Sbjct: 175 GMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 28/170 (16%)

Query: 277 KKLGQGGAGSV----------YMGSLPNGTT-----VAVKRLIFN-TRQWVDEFFNEVNL 320
           +KLG+G  G V          ++G            VAVK L  + T+   ++F  E+ +
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK---------NKTKLLNWNK 371
           +S +++ N+++LLG  +      ++ EY+ N  L+QF+  +         N    ++   
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              + +  A G+ YL   +    +HRD+ T N L+   +T KIADFG++R
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +++G G  G VY    +  G  VA+K +        +    E++++    H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGSET 392
            +   +  +V EY    SL Q I+   +  L        I     E   GLAYLH   ET
Sbjct: 69  YLRRDKLWIVMEYCGGGSL-QDIYQVTRGPL----SELQIAYVCRETLKGLAYLH---ET 120

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA 420
             IHRDIK +NILL +D   K+ADFG++
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 31/190 (16%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFN--TRQWVDEFFNEV 318
            YE LE           +G+G  G+V  +    +G  +  K + +   T +   +  +EV
Sbjct: 1   DYEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRF-- 373
           N++  ++H N+V+     I    +  +Y   EY     L Q I  +   K     K    
Sbjct: 51  NILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE---RKYIEE 104

Query: 374 ----NIILGTAEGLAYLHGGS--ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                I+      L   H  S     ++HRD+K +NI LD +   K+ DFGLA+    D 
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164

Query: 428 THVSTAVAGT 437
           +   T V GT
Sbjct: 165 SFAKTYV-GT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 21/162 (12%)

Query: 278 KLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++    N         VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF---------IFDKNKTKL---LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F         I    +      L   +   I    
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A G+ YL        +HRD+ T N L+ +    KI DFG++R
Sbjct: 132 ASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 21/168 (12%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEH---KNLVKLL 333
           +G+G  G+VY G  +P G  VA+K +  +T    V +   EV L+S +      N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           G  ++GP   ++ EY    S+   +      +    +        II      L Y+H  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV--------IIREVLVALKYIH-- 118

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            +  +IHRDIK +NIL+      K+ DFG+A     + +  ST V GT
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 8/122 (6%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E  L+ ++ H +++++    + G  + +V   +P+ S D + +   +++ L  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
               EGL YLH     RIIHRD+KT NI ++      I D G A+        +   +AG
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GLAG 218

Query: 437 TL 438
           T+
Sbjct: 219 TV 220

Length = 357

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 9/157 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V  G       VA+K +I       DEF  E  ++  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           + + P   +V EY+ N  L  ++  +   K    ++   +     EG+AYL      + I
Sbjct: 69  TKQRP-IYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           HRD+   N L+D     K++DFGL+R +  D  + S+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSS 158

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 17/159 (10%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           ++LGQG  G VY G           T VA+K +  N + +   EF NE +++      ++
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI-------FDKNKTKLLNWNKRFNIILGTAEG 382
           V+LLG    G  +L+V E +    L  ++        +          K   +    A+G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +AYL      + +HRD+   N ++ +D T KI DFG+ R
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 48/159 (30%), Positives = 66/159 (41%), Gaps = 17/159 (10%)

Query: 277 KKLGQGGAGSVYMG---SLPNGTT---VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G             VAVK L  + + Q   +F  E  ++S   H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+L+G S E     ++ E +    L  F+ +      +   L            A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KIADFG+AR
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 19/165 (11%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEF-FNEV 318
           KYE LEK          +G+G  G+V+   +      VA+KR+ + +  + V      E+
Sbjct: 1   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            L+  ++HKN+V+L        +  LV+EY  ++ L ++    N        K F   L 
Sbjct: 51  CLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL- 108

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
             +GLA+ H      ++HRD+K  N+L++K+   K+ADFGLAR F
Sbjct: 109 -LKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 12/147 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           + +G+G  G+V  G    G  VAVK +  + T Q    F  E  +++ + HKNLV+LLG 
Sbjct: 12  EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQ---AFLEETAVMTKLHHKNLVRLLGV 67

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            +     L +V E +   +L  F+  + +  L++  +     L  AEG+ YL      ++
Sbjct: 68  ILH--NGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLE---SKKL 121

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
           +HRD+   NIL+ +D   K++DFGLAR
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 68.4 bits (167), Expect = 6e-13
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 18/162 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIF------NTRQWVDEFFNEVNLISSIEHKNL 329
           ++LG G   S Y    +  GT +AVK++ +         + V+    E+ L++ + H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +++LG + E     L  E++   S+   +  +   K  ++      N       GL+YLH
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLH 120

Query: 388 GGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRT 428
              E +IIHRD+K +N+L+D      +IADFG A   AA  T
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 21/157 (13%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE------FFNEVNLISSIEHKNL 329
           +K+G+G  G VY G +   G  VA+K++    R   +E         E++L+  ++H N+
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 330 VKLLGCSIEGPESLLVYEYVP---NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           V L    ++     L++E++     + LD     +     L  +  + I+    +G+ + 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFC 117

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           H     R++HRD+K  N+L+D     K+ADFGLAR F
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 44/150 (29%), Positives = 79/150 (52%), Gaps = 8/150 (5%)

Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
            Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 20  TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +     T+ +N  +   + L   + L+ LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV---THTR-MNEEQIAAVCLAVLKALSVLHAQ 135

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGL 419
               +IHRDIK+ +ILL  D   K++DFG 
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 45/170 (26%), Positives = 67/170 (39%), Gaps = 33/170 (19%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE L            +G+G  G V    +   G  VA+K+  F   +  ++       
Sbjct: 2   KYEVLGV----------VGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALR 49

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNK 371
           EV ++  + H+N+V L           LV+EYV    L+           +  +   W  
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ- 108

Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                    + +AY H      IIHRDIK  NIL+ +    K+ DFG AR
Sbjct: 109 -------LLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 8/143 (5%)

Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V + +  + G  VAVK++    +Q  +  FNEV ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  +V E++   +L   +     T+ +N  +   + L     L+YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV---THTR-MNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 397 RDIKTSNILLDKDFTPKIADFGL 419
           RDIK+ +ILL  D   K++DFG 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 22/161 (13%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLI-----FNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G  +P G ++ +   I      + RQ   E  + +  + S++H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK----NKTKLLNWNKRFNIILGTAEGLAY 385
           +LLG C   G    LV +  P  SL   +       +  +LLNW       +  A+G+ Y
Sbjct: 73  RLLGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           L    E R++HR++   NILL  D   +IADFG+A     D
Sbjct: 125 LE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 33/174 (18%)

Query: 277 KKLGQGGAGSVYMGS------LPNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNL 329
           K LG+G  G V   +          TTVAVK L  N     + +  +E NL+  + H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 66  IKLYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 +     + G+ YL   +E +++HRD+   N+L+ +    KI+DFGL+R
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 24/174 (13%)

Query: 277 KKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLV 330
           K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N++
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNII 68

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGLA 384
            L G   +    ++V EY+ N SLD F        L   + +F +I       G A G+ 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAF--------LRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 50/172 (29%), Positives = 71/172 (41%), Gaps = 27/172 (15%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLI--- 321
           L   T  F   + +G+G  G VY       G  VA+K ++       +E   E N++   
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59

Query: 322 SSIEHKNLVKLLGC------SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN- 374
           S+  H N+    G            +  LV E     S+   +       L    KR   
Sbjct: 60  SN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKE 112

Query: 375 -----IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                I+  T  GLAYLH   E ++IHRDIK  NILL K+   K+ DFG++ 
Sbjct: 113 EWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)

Query: 279 LGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +G G  G V  G L         VA+K L    T +   +F +E +++   +H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGLAYLH 387
           G   +    +++ E++ N +LD F+   +         +F +I       G A G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL- 122

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
             SE   +HRD+   NIL++ +   K++DFGL+R    D +
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 45/149 (30%), Positives = 80/149 (53%), Gaps = 6/149 (4%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G   +VY G +   G  VA+K +  +  +        E++L+  ++H+N+V+L  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 + +LV+EY+    L +++        L+ N   +      +G+A+ H   E R+
Sbjct: 66  VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF 423
           +HRD+K  N+L++K    K+ADFGLAR F
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAF 150

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 12/148 (8%)

Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDE---FFNEVNLISSIEHKNLVKLL 333
           ++GQGG G V++    + G  VA+KR+  +    ++E      E +++++ + + LVKLL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
             + +  E L L  EYVP       +   N   L   + RF +    AE    +    E 
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYM----AEMFEAVDALHEL 120

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA 420
             IHRD+K  N L+D     K+ DFGL+
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.9 bits (160), Expect = 5e-12
 Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 8/160 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA+K++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVI 137

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           HRDIK+ NILL  D + K+ DFG       +++  ST V 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA+K++    +   +   NE+ ++   +H N+V  L  
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 137

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           HRDIK+ NILL  D + K+ DFG       +++  ST V GT
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 60/169 (35%), Positives = 86/169 (50%), Gaps = 28/169 (16%)

Query: 277 KKLGQGGAGSVYMG-------SLPNGT-TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V          S P+ T TVAVK L  N T + + +  +E+ L+  I +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ EGP  ++V EY    +L +F+           FD  K   + L++   
Sbjct: 78  KNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL      R IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 137 VSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 51/153 (33%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 275 PSKKLGQGGAGSVYMG--SLPNG--TTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNL 329
             + +G+G  G VY G    P      VAVK     T   V E F  E  ++   +H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHG 388
           VKL+G   E P   +V E  P   L  ++   NK  L L     ++  L TA  LAYL  
Sbjct: 70  VKLIGVITENP-VWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTA--LAYLES 125

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               R +HRDI   N+L+      K+ DFGL+R
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 13/148 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNLVKL 332
           + +G+G  G VY          VA+K  + +  +  DE  +   E+  +S      + K 
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIK--VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G  ++G +  ++ EY    S      D  K   L+      I+     GL YLH     
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE--- 117

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA 420
             IHRDIK +NILL ++   K+ADFG++
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 26/157 (16%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLLG 334
            ++G G  G+VY     P G   A+K +  N    V  +   E+ ++  + H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 335 CSIEGPESLLVYEYVPNRSLD-------QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
                 E  ++ E++   SL+       QF+ D  + ++L+             G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-QILS-------------GIAYLH 185

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
                 I+HRDIK SN+L++     KIADFG++R  A
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219

Length = 353

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)

Query: 277 KKLGQGGAGSVYMGSLPNGTT------VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG+G  G V++    N +       VAVK L   T     +F  E  L+++++H+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------------LNWNKRFNIIL 377
           K  G   +G   ++V+EY+ +  L++F+       +             L  ++  +I  
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             A G+ YL   +    +HRD+ T N L+  +   KI DFG++R
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 12/170 (7%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           +K T Y    +K+GQG +G+V+    +  G  VA+K++    +   +   NE+ ++  ++
Sbjct: 19  KKYTRY----EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           + N+V  L   + G E  +V EY+   SL   + +      ++  +   +     + L +
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEF 130

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           LH     ++IHRDIK+ N+LL  D + K+ DFG       +++  ST V 
Sbjct: 131 LHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 8/150 (5%)

Query: 278 KLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V +     +G  VAVK +    +Q  +  FNEV ++   +H+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  ++ E++   +L   +   ++T+L N  +   +     + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV---SQTRL-NEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           RDIK+ +ILL  D   K++DFG     + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKD 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 23/162 (14%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF-----NEVNLISSIEHKNLVK 331
           K+GQG  G V+          VA+K+++    +   E F      E+ ++  ++H+N+V 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 75

Query: 332 LLG-CSIEG-------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           L+  C  +            LV+E+     L   + +KN    L+  K+  ++     GL
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLSEIKK--VMKMLLNGL 132

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
            Y+H     +I+HRD+K +NIL+ KD   K+ADFGLAR F+ 
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)

Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++               +   + L++   
Sbjct: 84  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 54/183 (29%), Positives = 80/183 (43%), Gaps = 42/183 (22%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE------F 314
            YE LEK          +G+G  G VY       G  VA+K+    TR  +DE       
Sbjct: 2   AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTA 47

Query: 315 FNEVNLISSIEHKN-LVKLLGCSIEGPES-------LLVYEYVPNRSLDQFI---FDKNK 363
             E++L+  +     +V+LL   +E  E         LV+EY+ +  L +F+        
Sbjct: 48  LREISLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPG 104

Query: 364 TKL-LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLAR 421
             L     K F   L   +G+A+ H      ++HRD+K  N+L+DK     KIAD GL R
Sbjct: 105 RPLPAKTIKSFMYQL--LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Query: 422 CFA 424
            F+
Sbjct: 160 AFS 162

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 16/154 (10%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LGQG  G VY+      G  +AVK++ F+     T + V+    E+ L+ ++ H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 331 KLLGCSIEGPESLL--VYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +  GC  +  E  L    E++P  S+ DQ       T+  N  +++   +   EG++YLH
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE--NVTRKYTRQI--LEGVSYLH 123

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 I+HRDIK +NIL D     K+ DFG ++
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 18/174 (10%)

Query: 279 LGQGGAGSVYMGSLPNG--TTVAVKRLIFNTRQW----------VDEFFNEVNLI-SSIE 325
           LG G  G VY     N     +A+K +  +   +          + +  +EV +I   + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N+V+     +E     +V + +    L + F   K K +     + +NI +     L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           YLH   E RI+HRD+  +NI+L +D    I DFGLA+          T+V GT+
Sbjct: 128 YLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTI 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 22/165 (13%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTT----VAVKRLIFNTRQWVD-EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G      VA+K L   T    + E  +E  +++S+++
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK-----LLNWNKRFNIILGTAE 381
            ++ +LLG  +     L + + +P   L  ++  ++K       LLNW       +  A+
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAK 120

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           G+ YL    E R++HRD+   N+L+      KI DFGLA+   AD
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 13/159 (8%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++  +NK K+ N  ++    +   +G+ YL  
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKI-NLKQQLKYAVQICKGMDYL-- 125

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           GS  + +HRD+   N+L++ +   KI DFGL +    D+
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 56/169 (33%), Positives = 85/169 (50%), Gaps = 28/169 (16%)

Query: 277 KKLGQGGAGSVYMGSL-------PN-GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M          PN   TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNK--TKLLNWNKR 372
           KN++ LLG C+ +GP  +LV EY    +L +++           FD  K   + L +   
Sbjct: 78  KNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.6 bits (154), Expect = 3e-11
 Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 16/154 (10%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LGQG  G VY+   +  G  +A K++ F+     T + V     E+ L+ +++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 331 KLLGCSIE-GPESLLVY-EYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +  GC  +   ++L ++ EY+P  S+ DQ       T+ +       I+    EG++YLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 I+HRDIK +NIL D     K+ DFG ++
Sbjct: 124 S---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 6/144 (4%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY   +   G   A K +   + + ++++  E+ ++++  H  +VKLLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
               +  ++ E+ P  ++D  + + ++   L   +   I     E L YLH     +IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLH---SMKIIH 133

Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RD+K  N+LL  D   K+ADFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 59.4 bits (144), Expect = 3e-11
 Identities = 25/53 (47%), Positives = 33/53 (62%), Gaps = 1/53 (1%)

Query: 27  IYALAQCHLDLSHTDCLLCFAASRTKLPRCLP-SLSATIFFDGCFLRYDIYSF 78
           +Y LAQC  DLS +DC  C A + ++L RC P      I++D CFLRY+ Y F
Sbjct: 54  VYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 34/171 (19%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL--------IFNTRQWVDE------FFNEVNLI 321
             LG+G  G V        G  VA+K++        +   RQ V           E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------I 375
           + I+H+N++ L+   +EG    LV + +            +  K+++   R        I
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +L    GL  LH       +HRD+  +NI ++     KIADFGLAR +   
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172

Length = 335

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 18/136 (13%)

Query: 298 VAVKRLIF----NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS 353
           VAVK L      N R   ++F  E+ ++S ++  N+++LL   I      ++ EY+ N  
Sbjct: 49  VAVKMLREDANKNAR---NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 354 LDQFI--------FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL 405
           L+QF+         +K     ++++    +    A G+ YL   S    +HRD+ T N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162

Query: 406 LDKDFTPKIADFGLAR 421
           + K++T KIADFG++R
Sbjct: 163 VGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)

Query: 276 SKKLGQGGAGSVYMGSLPNG-------TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
           S++LGQG  G VY G +  G       T VA+K +    + R+ + EF NE +++     
Sbjct: 11  SRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNC 68

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGT 379
            ++V+LLG   +G  +L++ E +         RSL   + +       +  K   +    
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 129 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 14/171 (8%)

Query: 273 FNPSKKLGQGGAGSVYM------GSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH 326
           + P + LG+G  G   +       SL     V + RL    R    +  NE+ ++S ++H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQH 58

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            N++      ++    L+  EY    +L   I  + K +L         +      ++Y+
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           H   +  I+HRDIKT NI L K    K+ DFG+++   ++ +   T V GT
Sbjct: 118 H---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 59.0 bits (143), Expect = 5e-11
 Identities = 29/76 (38%), Positives = 34/76 (44%), Gaps = 4/76 (5%)

Query: 122 VSRIAVEKGGGFGAVKVMG----VYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEG 177
            S  A   G GF A         VY LAQC   L    CR CL  A   +RR C  +K G
Sbjct: 31  SSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGG 90

Query: 178 RGFNAGCYLRYSTDKF 193
           R +   C+LRY +  F
Sbjct: 91  RIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 12/167 (7%)

Query: 274 NPS-----KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
           NPS     K+LG G  G V++G       VA+K  I       ++F  E  ++  + H  
Sbjct: 2   NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPK 60

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           LV+L G   +     +V E++ N  L  ++  + +   L+ +   ++     EG+ YL  
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLER 118

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            S    IHRD+   N L+      K++DFG+ R +  D  + S++ A
Sbjct: 119 NS---FIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGA 161

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 33/162 (20%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIF-NTRQWVD-EFFNEVNLISSIEHKNLVKLLG 334
           ++G+G  G VY      +G  VA+K++   N R  +      E+ L+ ++ H N+V+L  
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK- 72

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIF------DKNKTKLLNWNKR-FN------IILGTAE 381
                       E V  + LD  IF      +++   LL+     F+      ++L    
Sbjct: 73  ------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           GL YLH   E  IIHRD+K SN+LL      KIADFGLAR +
Sbjct: 120 GLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 30/160 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K +G G  G V        G  VA+K+L   F         + E+ L+  + HKN++ LL
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 334 GCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTAE- 381
                         + P +SL++F        + D N  +++     ++R + +L     
Sbjct: 82  NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 14/171 (8%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IF-----NTRQWVDEFFNEVNLISSIE 325
           F   KK+G+G    VY  + L +   VA+K++ IF       RQ   +   E++L+  + 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLN 60

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++K L   IE  E  +V E      L Q I + K + +L+     +   +     + 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           ++H     R++HRDIK +N+ +      K+ D GL R F++  T   + V 
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 8/160 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           HRDIK+ NILL  D + K+ DFG       +++  ST V 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.8 bits (152), Expect = 7e-11
 Identities = 53/148 (35%), Positives = 80/148 (54%), Gaps = 10/148 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G   +VY G S  NG  VA+K +     +        E +L+  ++H N+V LL 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLH 69

Query: 335 CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I   E+L LV+EYV +  L Q++ DK+   L   N +   +     GL+Y+H   +  
Sbjct: 70  DIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKL-FLFQLLRGLSYIH---QRY 123

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLAR 421
           I+HRD+K  N+L+      K+ADFGLAR
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 6/144 (4%)

Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY         +A  ++I   + + ++++  E+++++S +H N+VKLL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
                  ++ E+    ++D  + +  +   L   +   +   T E L YLH   E +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLH---ENKIIH 126

Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RD+K  NIL   D   K+ADFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 19/163 (11%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVDE--FFNEV 318
           KYE L K          +G+G  G V+   +   G  VA+K+ + +    V +     E+
Sbjct: 2   KYEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREI 51

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  ++H NLV L+       +  LV+EY  +  L++   +KN  + +  +    II  
Sbjct: 52  RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKN-PRGVPEHLIKKIIWQ 108

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           T + + + H   +   IHRD+K  NIL+ K    K+ DFG AR
Sbjct: 109 TLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 49/147 (33%), Positives = 76/147 (51%), Gaps = 10/147 (6%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +VY G S   G  VA+K +     +        E +L+  ++H N+V  L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I   ++L LV+EY+ +  L Q++ D      ++  + F   L    GLAY H     R+
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL--LRGLAYCHQ---RRV 124

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
           +HRD+K  N+L+ +    K+ADFGLAR
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 26/178 (14%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           ++LG+   G +Y G L      +   VA+K L  I N +QW + F  E +L++ + H N+
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNI 69

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF--------------DKNKTKLLNWNKRFNI 375
           V LLG   +     +++EY+    L +F+               D      L+     +I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAADRTHVST 432
            +  A G+ YL   S    +H+D+   NIL+ +    KI+D GL+R  ++AD   V  
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 17/174 (9%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IFN-----TRQWVDEFFNEVNLISSIE 325
           F   KK+G+G    VY  + L +G  VA+K++ IF+      R    +   E++L+  + 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLN 60

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGL 383
           H N++K     IE  E  +V E      L + I  F K K +L+     +   +     L
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPEKTVWKYFVQLCSAL 119

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            ++H     R++HRDIK +N+ +      K+ D GL R F++ +T  + ++ GT
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 25/162 (15%)

Query: 279 LGQGGAGSVYMGSL-PNGTTVAVKRLIF--NTRQWVD-------EFFNEVNLISSIEHKN 328
           LGQG   ++Y G L        V          + +         FF   +L+S + HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLH 387
           LVKL G  +   E+++V EYV    LD F+  + K  + L+W  + ++    A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 388 GGSETRIIHRDIKTSNILLDKD-----FTP--KIADFGLARC 422
              + +++H ++   NIL+ +      + P  K++D G+   
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 44/152 (28%), Positives = 61/152 (40%), Gaps = 9/152 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVA---VKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
            ++G G  G V +G    G + A   VK L    T      F  EV     + H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG--TAEGLAYLHGGS 390
           LG  IE    LLV E+ P   L  ++            K     +    A GL +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           +   IH D+   N  L  D + KI D+GLA  
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALE 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 52/206 (25%)

Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW----- 310
           +  L FK              +KLG+G  G V++  + N   +   +  FN R+      
Sbjct: 4   RGHLLFK--------------EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLV 49

Query: 311 -------------VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
                         ++F  EV ++S ++  N+++LLG  ++     ++ EY+ N  L+QF
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 358 I-----FDKNKTK-----------LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKT 401
           +      DK +              ++++   ++ L  A G+ YL   S    +HRD+ T
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLAT 166

Query: 402 SNILLDKDFTPKIADFGLAR-CFAAD 426
            N L+ ++ T KIADFG++R  +A D
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGD 192

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 29/178 (16%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF-----NEVNL 320
           ++  + F+   ++G+G  G VY       G  VA+K++  +  +   E F      E+ +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKI 59

Query: 321 ISSIEHKNLVKLLGCSIEGPESL----------LVYEYVPNRSLDQFIFDKNKTKLLNWN 370
           +  + H+N+V L     +  ++L          LV+EY+     D  +    ++ L++++
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFS 114

Query: 371 KRFN--IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +      +    EGL Y H   +   +HRDIK SNILL+     K+ADFGLAR + ++
Sbjct: 115 EDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 22/153 (14%)

Query: 279 LGQGGAGSVYMGSLPN-GTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           + +G  G V++    + G   A+K   +     +  VD+   E +++S  +   +VKL  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 335 CSIEGPESL-LVYEYVPN----RSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            S +G ++L LV EY+P       L+     D++  +          I      L YLH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYLH- 110

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                IIHRD+K  NIL+D +   K+ DFGL++
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 29/141 (20%)

Query: 295 GTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
           G  VAVK+L   F  +      + E+ L+  + HKN++ LL              + P +
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93

Query: 353 SLDQF--------IFDKNKTKLLNWN---KRFNIIL-GTAEGLAYLHGGSETRIIHRDIK 400
           SL++F        + D N  ++++     +R + +L     G+ +LH      IIHRD+K
Sbjct: 94  SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150

Query: 401 TSNILLDKDFTPKIADFGLAR 421
            SNI++  D T KI DFGLAR
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 28/169 (16%)

Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D  +   + + +   
Sbjct: 81  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 36/146 (24%)

Query: 295 GTTVAVKRLIFNTRQWVDEFF-----NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
           G  VA+K+L         E F      E+N++  ++H N+V              V E V
Sbjct: 30  GEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIVT-------------VKEVV 73

Query: 350 PNRSLDQ------FIFDKNKTKLLNWNKRF------NIILGTAEGLAYLHGGSETRIIHR 397
              +LD+      ++    K+ +    + F       ++L    G+A+LH   +  I+HR
Sbjct: 74  VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHR 130

Query: 398 DIKTSNILLDKDFTPKIADFGLARCF 423
           D+KTSN+LL+     KI DFGLAR +
Sbjct: 131 DLKTSNLLLNNRGILKICDFGLAREY 156

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 19/167 (11%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQ-WVDEF-FNEV 318
           KYE L            +G+G  G V        G  VA+K+ + +     V +    E+
Sbjct: 2   KYENLGL----------VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI 51

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  + H+NLV L+          LV+E+V +  LD     +     L+ ++    +  
Sbjct: 52  RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQ 108

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
              G+ + H  +   IIHRDIK  NIL+ +    K+ DFG AR  AA
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 9/165 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE---FFNEVNLISSIEHKNLVKLL 333
           KK+G+G  G +Y+    + +   V + I  T+  V E      EV L++ ++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               E     +V EY     L + I ++ +  L + ++  +  +  + GL ++H   + +
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121

Query: 394 IIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGT 437
           I+HRDIK+ NI L K+    K+ DFG+AR    D   ++    GT
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 16/160 (10%)

Query: 275 PSKKLGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHK 327
               LG+G  G V++            T V VK L     + +  EF  E+++   + HK
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFI------FDKNKTKLLNWNKRFNIILGTAE 381
           N+V+LLG   E     ++ EY     L QF+       +K K   L+  ++  +    A 
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+ +L   S  R +HRD+   N L+      K++   L++
Sbjct: 129 GMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 19/160 (11%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 70

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI------FDKNKTKLL-NWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +  L  ++       + N  +      +   +    A+
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 34/187 (18%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           +T+ +  + +     +G G  G V        G  VA+K+L   F +       + E+ L
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI----------FDKN---KTKLL 367
           +  ++H+N++ LL              + P  SL+ F            D N   K + L
Sbjct: 68  LKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL 115

Query: 368 NWNK-RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + +  +F ++     GL Y+H      IIHRD+K SNI +++D   KI DFGLAR    +
Sbjct: 116 SDDHIQF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171

Query: 427 RT-HVST 432
            T +V+T
Sbjct: 172 MTGYVAT 178

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 9/152 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKL 332
           K++G G  G V +G + +G     V VK L  +   Q   +F  E     S++H NL++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF--NIILGTAEGLAYLHGGS 390
           LG   E    LLV E+ P   L  ++    K +L+  +      +    A GL +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           +   IH D+   N LL  D T KI D+GL+  
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 36/176 (20%)

Query: 277 KKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLV 330
            +LG G +G V  +   P G  +AVK +    R  ++E        E++++       +V
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTI----RLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGL 383
              G     G  S+ + EY+   SLD+         L     R        I +   +GL
Sbjct: 63  GFYGAFYNNGDISICM-EYMDGGSLDKI--------LKEVQGRIPERILGKIAVAVLKGL 113

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVS 431
            YLH   + +IIHRD+K SNIL++     K+ DFG        LA+ F    ++++
Sbjct: 114 TYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMA 167

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 20/156 (12%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLV 330
           K LG+G  G VY+      G  +AVK++ F+     T + V+    E+ L+ ++ H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 331 KLLGCSIEGPE----SLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           +  GC +  PE    S+ V EY+P  S+ DQ       T+  N  +R+   +   +G++Y
Sbjct: 68  QYYGC-LRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTE--NVTRRYTRQI--LQGVSY 121

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           LH      I+HRDIK +NIL D     K+ DFG ++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 21/164 (12%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            +G+G  G V      P G  VA+K++  F  + +      E+ ++   +H+N++ +L  
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGIL-- 69

Query: 336 SIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            I  P S        +V E +    L + I    KT+ L+ +     +     GL Y+H 
Sbjct: 70  DIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHS 124

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +   ++HRD+K SN+LL+ +   KI DFGLAR   AD  H  T
Sbjct: 125 AN---VLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHT 163

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 51/164 (31%), Positives = 73/164 (44%), Gaps = 14/164 (8%)

Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V       +        VAVK L         E   +E+ ++S +  H+N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +V LLG C+I GP  L++ EY     L  F+  + +   L      +     A+G+A+L 
Sbjct: 101 IVNLLGACTIGGP-ILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFL- 157

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
             +    IHRD+   N+LL      KI DFGLAR    D  +V 
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 34/172 (19%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLI 321
           T+ + TN +   + +G G  G V        G  VA+K+++  F+T       + E+ L+
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63

Query: 322 SSIEHKNLVKLLGCSIEGPESL-LVYEYVP---NRSL------DQFI--FDKNKTKLLNW 369
             + H+N++ L    I   E +  V E +    +R L       QFI  F          
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYF---------- 113

Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              + I+     GL Y+H      ++HRD+K SNIL++++   KI DFGLAR
Sbjct: 114 --LYQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 17/159 (10%)

Query: 277 KKLGQGGAGSVYMGSLPNGTT---VAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K LG+G  GSV  G L    +   VAVK  ++   TR  +++F +E   +   +H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 332 LLGCSIEG------PESLLVYEYVPNRSLDQFIFDK---NKTKLLNWNKRFNIILGTAEG 382
           L+G  ++       P  +++  ++ +  L  F+      +  + L        +   A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           + YL   S    IHRD+   N +L+++    +ADFGL++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 22/163 (13%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTT----VAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P+G      VA+K L  NT    + E  +E  +++ +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK-----LLNWNKRFNIILGTAEGLAY 385
           +LLG  +     L V + +P   L  ++  +NK +     LLNW       +  A+G++Y
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYV-RENKDRIGSQDLLNW------CVQIAKGMSY 124

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
           L    E R++HRD+   N+L+      KI DFGLAR    D T
Sbjct: 125 LE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 24/157 (15%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE----FFNEVNLISSIEHKNLVKL 332
           + +G+G  G V++        + + + I    Q   +      NE  ++  + H N+++ 
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY------- 385
               +E    ++V EY P  +L ++I            KR N +L     L +       
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI-----------QKRCNSLLDEDTILHFFVQILLA 113

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLAR 421
           LH      I+HRD+KT NILLDK     KI DFG+++
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 21/167 (12%)

Query: 272 YFNPSKKLGQGGAGSV----YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSI- 324
            +   K+LGQG  G V       +     TVA+K++  +F+ +        E+ L+    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSE-EETVAIKKITNVFSKKILAKRALRELKLLRHFR 59

Query: 325 EHKNLVKLLGCSIEGPES---LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGT 379
            HKN+  L    I  P +   L +YE +    L Q I  ++   L + + +  I  IL  
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQILC- 116

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
             GL Y+H  +   ++HRD+K  N+L++ D   KI DFGLAR F+ +
Sbjct: 117 --GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 33/173 (19%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FF 315
           +YE +EK           G+G  G VY         T+A+K++        DE       
Sbjct: 3   QYEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRLEQE---DEGVPSTAI 49

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E++L+  ++H N+V+L           LV+EY+    LD     K+     ++ K   +
Sbjct: 50  REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLD---LKKHMDSSPDFAKNPRL 103

Query: 376 I----LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCF 423
           I         G+AY H     R++HRD+K  N+L+D+     K+ADFGLAR F
Sbjct: 104 IKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153

Length = 294

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLG 334
           +KLG+G   +V+ G S      VA+K +     +        EV+L+  ++H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                    LV+EY+ ++ L Q++ D      ++  K F  +     GLAY H     ++
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
           +HRD+K  N+L+++    K+ADFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 24/56 (42%), Positives = 30/56 (53%), Gaps = 5/56 (8%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            L YLH      IIHRDIK  NILLD+     I DF +A     D   ++T+ +GT
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGT 162

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 24/167 (14%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIE 325
           F   + LG+G  GSV    L     +   VAVK L   IF++   ++EF  E   +   +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFD 59

Query: 326 HKNLVKLLGCSIEG------PESLLVYEYVPNRSLDQFIF-----DKNKTKLLNWNKRFN 374
           H N++KL+G S+        P  +++  ++ +  L  F+      ++  T  L    RF 
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF- 118

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            ++  A G+ YL   S    IHRD+   N +L+++ T  +ADFGL++
Sbjct: 119 -MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 10/147 (6%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +VY G S      VA+K +     +        EV+L+  ++H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I   +SL LV+EY+ ++ L Q++ D   +  ++  K F  +     GL Y H     ++
Sbjct: 73  -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKV 125

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
           +HRD+K  N+L+++    K+ADFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 36/116 (31%), Positives = 55/116 (47%), Gaps = 13/116 (11%)

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE  ++  + H  +++L     +     ++ EYVP   L  F + +N  +  N    F  
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFY- 106

Query: 376 ILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               +E    L YLH      I++RD+K  NILLDK+   K+ DFG A+    DRT
Sbjct: 107 ---ASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRT 155

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 55/178 (30%), Positives = 76/178 (42%), Gaps = 21/178 (11%)

Query: 255 KKSCLSFKYETLEKATNY--FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL----IFN 306
           KK   S K    +    Y  FN  + LG G  G V + +  N     VA+KR     I  
Sbjct: 12  KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71

Query: 307 TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
            +Q VD  F+E  +++ I H   V L G   +     LV E+V       F         
Sbjct: 72  QKQ-VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTF--------- 121

Query: 367 LNWNKRFNIILG---TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L  NKRF   +G    A+ +          I++RD+K  N+LLDKD   K+ DFG A+
Sbjct: 122 LRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179

Length = 340

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 24/186 (12%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLI 321
           E+L   T+ +   + +G+G  G VY + +  +G+  AVK  I +    VDE    E N++
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK--ILDPISDVDEEIEAEYNIL 72

Query: 322 SSI-EHKNLVKLLGC-----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN- 374
            S+  H N+VK  G       + G +  LV E     S+ + +       LL   +R + 
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127

Query: 375 -----IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
                I+ G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++    + R  
Sbjct: 128 AMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 430 VSTAVA 435
            +T+V 
Sbjct: 185 RNTSVG 190

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)

Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 81  LLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128

Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 16/163 (9%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN-GTTVAVK--RLIFNTRQWVDEFFNEVNLISSIE---H 326
           + P  ++G G  G+VY    P+ G  VA+K  R+  N          EV L+  +E   H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 327 KNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
            N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++     
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLR 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           GL +LH      I+HRD+K  NIL+      K+ADFGLAR ++
Sbjct: 120 GLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 24/171 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNGT------TVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L           VA+K L       + +EF +E  + S ++H N+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFNII 376
           V LLG   +     +++ Y  +  L +F+              DK     L      +I+
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAAD 426
              A G+ +L   S   ++H+D+ T N+L+      KI+D GL R  +AAD
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 24/164 (14%)

Query: 277 KKLGQGGAGSVYMG---SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVK 331
            +LG G  G+V  G      +  TVAVK L    N     DE   E N++  +++  +V+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF------IFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           ++G   E    +LV E      L++F      + +KN T+L++           + G+ Y
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVH---------QVSMGMKY 110

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           L    ET  +HRD+   N+LL      KI+DFGL++   AD  +
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 49/204 (24%)

Query: 237 LSKMKEDRNNLGLYATSMKKSCLSF--KYETLEKATNYFNPSKKLGQGGAGSV---YMGS 291
           +S+ K D N    Y+  +  S  +   +Y+ L          K +G G  G V   Y   
Sbjct: 1   MSRSKRDNN---FYSVEIGDSTFTVLKRYQNL----------KPIGSGAQGIVCAAYDAI 47

Query: 292 LPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
           L     VA+K+L   F  +      + E+ L+  + HKN++ LL              + 
Sbjct: 48  LER--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FT 93

Query: 350 PNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTAE-GLAYLHGGSETRIIHR 397
           P +SL++F        + D N  +++     ++R + +L     G+ +LH      IIHR
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHR 150

Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+K SNI++  D T KI DFGLAR
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)

Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +V+ G S      VA+K +     +        EV+L+ +++H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I     L LV+EY+ +  L Q++   N   L++ +     +     GL+Y H   + +I
Sbjct: 72  -IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
           +HRD+K  N+L+++    K+ADFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 32/173 (18%)

Query: 277 KKLGQGGAGSVYMGSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL-- 332
           + LG G  G V+  ++ +     VAVK+++    Q V     E+ +I  ++H N+VK+  
Sbjct: 11  RPLGCGSNGLVF-SAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 333 --------LGCSIEGPESL----LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIIL 377
                   L   +     L    +V EY+       L+Q    +   +L  +        
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ------- 122

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTH 429
               GL Y+H  +   ++HRD+K +N+ ++ +D   KI DFGLAR      +H
Sbjct: 123 -LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 12/117 (10%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF- 373
           E+ L+  ++H+N+V L+   +E  +    L+++Y     L Q I    + K ++      
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA-EHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCFAA 425
            +++     G+ YLH      ++HRD+K +NIL+  +       KI D GLAR F A
Sbjct: 111 KSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 17/164 (10%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQ--WVDEFFNEVNLI---SSIE 325
           +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++    + E
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 326 HKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           H N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      +++    
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
            GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++
Sbjct: 121 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.0 bits (135), Expect = 7e-09
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 25/160 (15%)

Query: 279 LGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           LGQG    ++ G           + T V +K L  + R + + FF   +++S + HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAY-LHG 388
              G  + G ES++V EYV   SLD ++  KNK  + ++W       L  A+ LA+ LH 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWK------LEVAKQLAWALHF 115

Query: 389 GSETRIIHRDIKTSNILL-----DKDFTP---KIADFGLA 420
             +  + H ++   N+LL      K   P   K++D G++
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 15/151 (9%)

Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEHKNLV 330
           +++G+G  G V+ G L  + T VAVK    + R+ +      +F  E  ++    H N+V
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L+G   +     +V E V       F+  + +   L   +   ++   A G+ YL    
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLE--- 111

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               IHRD+   N L+ +    KI+DFG++R
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)

Query: 281 QGGAGSVYMGSLPNGTT-----VAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLG 334
           +G  G ++ G L +        V VK +  +  +  V     E  L+  + H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 335 CSIEGPESLLV-YEYVPNRSLDQF-----IFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
             IE  E   V Y Y+   +L  F     + + N  + L+  +  ++ +  A G++YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAAD 426
             +  +IH+DI   N ++D++   KI D  L+R  F  D
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           GL Y+H  +   +IHRD+K SN+L+++D   +I DFG+AR  +
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 37/161 (22%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G V  M  +P GT +AVKR+                 ++S E K L+  L  S+
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT--------------VNSQEQKRLLMDLDISM 54

Query: 338 EGPESLLVYEY---------------VPNRSLDQF---IFDKNKTKLLNWNKRFNIILGT 379
              +      +               V + SLD+F   ++DK  T   +   +  I +  
Sbjct: 55  RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSI 112

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            + L YLH  S+  +IHRD+K SN+L++++   K+ DFG++
Sbjct: 113 VKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 11/151 (7%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNL 329
           F   +++G+G  G VY G + N T   V   I +  +  DE  +   E+ ++S  +   +
Sbjct: 6   FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            +  G  ++G +  ++ EY+   S      D  K   L       I+    +GL YLH  
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLH-- 118

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           SE R IHRDIK +N+LL +    K+ADFG+A
Sbjct: 119 SE-RKIHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 27/164 (16%)

Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 6/155 (3%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K++G G  GSV        G  VA+K+L   F +  +    + E+ L+  ++H+N++ LL
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
                        ++       Q    K     L+ +K   ++     GL Y+H      
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--- 137

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
           IIHRD+K  N+ +++D   KI DFGLAR   A+ T
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 31/161 (19%)

Query: 277 KKLGQGGAGSV-YMGSLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K++G G  G+V        G  VA+K+L   F +  +    + E+ L+  ++H+N++ LL
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 334 GCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNWNK----RFN-IILGTA 380
                         + P+ SLD+F            +  KL+   K    R   ++    
Sbjct: 81  DV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +GL Y+H      IIHRD+K  N+ +++D   KI DFGLAR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 16/170 (9%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEF--------FNEVNLISSIEHKN 328
           ++LG+G  G+VY+  + +   VA +RL       V E           E  L+S ++H  
Sbjct: 6   QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +VK     +E     ++ EY   R LD  + + K+  K L+ N+     +    G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
              + RI+HRD+K  NI L  +   KI DFG++         ++T   GT
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNLL-KIGDFGVS-RLLMGSCDLATTFTGT 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 7/146 (4%)

Query: 277 KKLGQGGAGSV-YMGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLLG 334
             LG G  GSV  +  +P GT +A K +    +  V  +   E+ ++       +V   G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             +      +  E++   SLD+      K   +       I +   EGL YL+  +  RI
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLY--NVHRI 125

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLA 420
           +HRDIK SNIL++     K+ DFG++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 14/149 (9%)

Query: 279 LGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG GG G V +        T A+K +    I  T Q  +  F+E  ++    H  +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
             + +  + + ++ EY     L   + D+       +  RF  I        YLH     
Sbjct: 60  -RTFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARF-YIACVVLAFEYLH---NR 112

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            II+RD+K  N+LLD +   K+ DFG A+
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK 141

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 12/164 (7%)

Query: 278 KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVKLL 333
           +LG G  G V  G          VA+K L     + V DE   E  ++  +++  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 334 G-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           G C  E    +LV E      L++F+  K     +  +    ++   + G+ YL G +  
Sbjct: 62  GVCEAEA--LMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKN-- 115

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
             +HRD+   N+LL      KI+DFGL++   AD ++     AG
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 34/172 (19%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 85  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 131

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVST 432
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    + T +V+T
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 11/151 (7%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   V   I +  +  DE  +   E+ ++S  +   +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 118

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           SE +I HRDIK +N+LL +    K+ADFG+A
Sbjct: 119 SEKKI-HRDIKAANVLLSEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 24/155 (15%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLI-SSIEHKNLVK 331
           +G+G  G+V  M   P+GT +AVKR+    R  VDE        +++++  S +   +VK
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAY 385
             G      +  +  E + + SLD+F     K                 I + T + L Y
Sbjct: 68  FYGALFREGDCWICMELM-DISLDKFY----KYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           L    E +IIHRD+K SNILLD++   K+ DFG++
Sbjct: 123 LK--EELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 37/152 (24%), Positives = 68/152 (44%), Gaps = 18/152 (11%)

Query: 278 KLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEF--FNEVNLISSIE-HKNLVKLL 333
           K+G+G    V    S   G   A+K +     + +++     E+  +  +  H N+++L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 334 GCSIEGPE-SL-LVYEYVPNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
               +     L LV+E      +D  +++  K + + L   +  + +    + L ++H  
Sbjct: 65  EVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               I HRDIK  NIL+  D   K+ADFG  R
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 215 IVLSTTAFLMLSLFAAYAAYAR---LSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATN 271
           I  +  AFL+L+L A    + R     ++K   N  G +      S +S K  T+    +
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVS-KSITINDILS 690

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS------- 323
                  + +G  G+ Y G S+ NG    VK +            N+VN I S       
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEI------------NDVNSIPSSEIADMG 738

Query: 324 -IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
            ++H N+VKL+G       + L++EY+  ++L + + +      L+W +R  I +G A+ 
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKI 414
           L +LH      ++  ++    I++D    P +
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 39/169 (23%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
             P + +G G  G V+  + P +G  VA+K++  +F         F E+ ++   +H N+
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 330 VKLLGCSIEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILG----TAE-- 381
           +  L   I  P  +  +E  YV        + +  ++ L        II+     +++  
Sbjct: 62  LSAL--DILQPPHIDPFEEIYV--------VTELMQSDL------HKIIVSPQPLSSDHV 105

Query: 382 ---------GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                    GL YLH      I+HRDIK  N+L++ +   KI DFGLAR
Sbjct: 106 KVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 19/155 (12%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNL 329
           F   +++G+G  G V+ G + N T   V   I +  +  DE  +   E+ ++S  +   +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLAY 385
            K  G  ++G +  ++ EY+   S    +    FD+ +   +        IL   +GL Y
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM-----LKEIL---KGLDY 116

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           LH  SE +I HRDIK +N+LL +    K+ADFG+A
Sbjct: 117 LH--SEKKI-HRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 41/148 (27%), Positives = 77/148 (52%), Gaps = 7/148 (4%)

Query: 277 KKLGQGGAG-SVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           KK+G+G  G ++ + S  +G    +K +  +  + +  +E   EV ++S+++H N+V+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               E     +V +Y     L + I +  +  L   ++  +  +     L ++H   + +
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLAR 421
           I+HRDIK+ NI L KD T K+ DFG+AR
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIAR 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 7/145 (4%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +++G G  G VY   +L  G   AVK +             E+ ++   +H N+V   G 
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            +   +  +  EY    SL Q I+  + T  L+  +   +   T +GLAYLH   +   +
Sbjct: 75  YLSREKLWICMEYCGGGSL-QDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128

Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRDIK +NILL  +   K+ADFG+A
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 7/149 (4%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   +++G G  G VY   ++  G   A+K +     +       E+ ++   +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
             G  +   +  +  E+    SL Q I+  + T  L+ ++   +   T +GL YLH   +
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSL-QDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              +HRDIK +NILL  +   K+ADFG++
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 7/104 (6%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E++++ +I H+ ++ L+          +V   +P    D F +      L    +   I 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPL-PLEQAITIQ 191

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
               E LAYLHG     IIHRD+KT NI LD+     + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 25/160 (15%)

Query: 275 PSKKLGQGGAGSVYMGSLPNGTT---VAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
           P K +G+G  G V   S  N  T   VA+K++   F+ R        E+ L+  ++H+N+
Sbjct: 9   PIKPIGRGAYGIVC--SAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 330 VKLLGCSIEGPES------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTAE 381
           + +    +  P         +VYE + +  L Q I  ++   L + + ++ +  +L    
Sbjct: 67  IAIKDI-MPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYFLYQLL---R 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           GL Y+H  +   ++HRD+K SN+LL+ +   KI DFGLAR
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 39/120 (32%), Positives = 56/120 (46%), Gaps = 7/120 (5%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
           E  L+S ++H N+V     S EG + LL  V  +     L   +  + K KLL  N+   
Sbjct: 49  EAQLLSQLKHPNIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVE 106

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
             +  A  L YLH   E  I+HRD+KT N+ L +    K+ D G+AR         ST +
Sbjct: 107 WFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 21/161 (13%)

Query: 279 LGQGGAGSVYMGSLP---NGTTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+K L  F +     +F  E+ ++  +  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY-------- 385
           G         +  EY P  +L  F+    K+++L  +  F    GTA  L          
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 386 -----LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                +   SE + IHRD+   N+L+ ++   KIADFGL+R
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 23/126 (18%)

Query: 313 EFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           +F  E+ ++  +  H N++ LLG         L  EY P+ +L  F+    K+++L  + 
Sbjct: 41  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDP 97

Query: 372 RFNIILGTAE----------------GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA 415
            F I   TA                 G+ YL   S+ + IHRD+   NIL+ +++  KIA
Sbjct: 98  AFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIA 154

Query: 416 DFGLAR 421
           DFGL+R
Sbjct: 155 DFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 6/119 (5%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E  L++ ++H N+V     S E    L +V EY     L Q I  + + KL   +     
Sbjct: 48  EAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQW 105

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
            +    G+ ++H   E R++HRDIK+ NI L ++   K+ DFG AR   +   +  T V
Sbjct: 106 FVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 48/159 (30%), Positives = 70/159 (44%), Gaps = 24/159 (15%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G  G V++      G   A+K L    +    Q +     E ++++  +  
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSP 61

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE 381
            +VKL   S +  E L LV EY+P   L      + +F +          RF I    AE
Sbjct: 62  WIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-------RFYI----AE 109

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            +  L    +   IHRDIK  NIL+D D   K+ADFGL 
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 12/113 (10%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           FF   +++  + HK++V L G  +   E+++V E+V    LD F+    K+ +L    +F
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKSDVLTTPWKF 108

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTP--KIADFGL 419
            +    A  L+YL    +  ++H ++ T NILL     D +  P  K++D G+
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 33/147 (22%), Positives = 54/147 (36%), Gaps = 15/147 (10%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV--KLLG 334
           K L  G    VY+  L       V ++  +  +  D    EV ++  +  K L   K+L 
Sbjct: 4   KLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLA 60

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                  S L+ E++   +LD+   ++ +             L     LA LH      +
Sbjct: 61  SGESDGWSYLLMEWIEGETLDEVSEEEKEDIA--------EQLAEL--LAKLHQLPLLVL 110

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR 421
            H D+   NIL+D      I D+  A 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 21/38 (55%), Positives = 27/38 (71%), Gaps = 3/38 (7%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL 419
           GL YLH   E +I++RD+K  N+LLD +   KIADFGL
Sbjct: 113 GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 5/105 (4%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           F  E   +   +H N+V+L G    G   ++V EY+ N +LD F+  +     L   +  
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLM 110

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG 418
            ++ G A G+ YL   SE   +H+ +    +L++ D   KI+ F 
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 15/151 (9%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL-- 333
           +G G  GSV           VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 334 ---GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                SIE    + +   +    L+  +      KL + + +F +I     GL Y+H   
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIHSAG 138

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              IIHRD+K SN+ +++D   +I DFGLAR
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 29/159 (18%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTV-AVKRL---IFNTRQWVDEFFNEVNLIS-SIEHKNLVK 331
           K LG+G  G V +  L     + AVK L   +      V+    E  +++ + +H  L +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRF---NIILGTAEG 382
           L  C  +  + L  V EYV    L   I     FD+ +        RF    I+LG    
Sbjct: 61  LHSC-FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAEIVLG---- 108

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L +LH   E  II+RD+K  N+LLD +   KIADFG+ +
Sbjct: 109 LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 15/169 (8%)

Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLV 330
           F    +LG G  G V  +   P+G  +A K +    +  + ++   E+ ++       +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
              G      E  +  E++   SLDQ + +  +       K   + +    GLAYL    
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAVLRGLAYLR--E 121

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVS 431
           + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 170

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 20/153 (13%)

Query: 278 KLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEF-FNEVNLISSIEHK----NLVK 331
           +LG+G  GSVY +   P G T+A+K +    R  +DE  FN++ +   I HK     +V 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI----RLELDESKFNQIIMELDILHKAVSPYIVD 63

Query: 332 LLGC-SIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
             G   IEG     VY   EY+   SLD+       T+ +  +    I     +GL +L 
Sbjct: 64  FYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              E  IIHRD+K +N+L++ +   K+ DFG++
Sbjct: 120 --EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)

Query: 234 YARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP 293
           +  L K K   N L  Y   ++K         L+     ++  K +G+G  G V +    
Sbjct: 12  FPALRKNKNIDNFLNRYEKIVRK------IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK 65

Query: 294 NGTTVAVKRLI--FNTRQWVDE-FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYV 349
           +   V   +L+  F   +  D  FF E   I +  +   V  L C+ +  + L +V EY+
Sbjct: 66  SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125

Query: 350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD 409
           P   L   + + +  +   W K +     TAE +  L       +IHRD+K  N+LLDK 
Sbjct: 126 PGGDLVNLMSNYDVPE--KWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 178

Query: 410 FTPKIADFGLARCFAADRT---HVSTAVA 435
              K+ADFG   C   D T      TAV 
Sbjct: 179 GHLKLADFG--TCMKMDETGMVRCDTAVG 205

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 47/157 (29%), Positives = 65/157 (41%), Gaps = 32/157 (20%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIF------NTRQWVDEFFNEVNLISSIEHKNLVK 331
           +G G  G VY M     G  +AVK++        N R  +D    +V L S  +   +VK
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL---DVVLKSH-DCPYIVK 78

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG-----TAEGLAYL 386
             G  I   +  +  E      L     DK   ++         ILG       + L YL
Sbjct: 79  CYGYFITDSDVFICME------LMSTCLDKLLKRIQGPIPED--ILGKMTVAIVKALHYL 130

Query: 387 ---HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              HG     +IHRD+K SNILLD     K+ DFG++
Sbjct: 131 KEKHG-----VIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 24/171 (14%)

Query: 279 LGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSI-EHKNLVKLLGC 335
           +G+G  G V+ + +  NG+  AVK  I +    +DE    E N++ ++ +H N+VK  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK--ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 336 -----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
                   G +  LV E     S+   +        L   +R        I+     GL 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +LH     + IHRD+K +NILL  +   K+ DFG++    + R   +T+V 
Sbjct: 139 HLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 22/56 (39%), Positives = 33/56 (58%), Gaps = 3/56 (5%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           L +LH   +  II+RDIK  NILLD +    + DFGL++ F A+    + +  GT+
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 15/171 (8%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI- 324
           L      F   + +G G  G VY G       +A  +++  T    +E   E+N++    
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60

Query: 325 EHKNLVKLLGCSIE-GPESL-----LVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIIL 377
            H+N+    G  I+  P  +     LV E+    S+   I + K  T    W     I  
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               GL++LH   + ++IHRDIK  N+LL ++   K+ DFG++     DRT
Sbjct: 119 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRT 164

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 36/145 (24%), Positives = 66/145 (45%), Gaps = 12/145 (8%)

Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG G  G+VY    L     +AVK +  + T +   +  +E+ ++   +   ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
                  +  E++   SLD  ++ K    +L       I +   +GL YL      +I+H
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD+K SN+L++     K+ DFG++ 
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 19/171 (11%)

Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLV 330
           F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT--KLLNWNKRFNIILGTAEGLAYLHG 388
              G      E  +  E++   SLDQ +    +   ++L       + +   +GL YL  
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLR- 120

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVS 431
             + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S
Sbjct: 121 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 170

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 26/171 (15%)

Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G  G V +      G   A+K+L    +    Q V     E ++++  ++ 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNP 61

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQF-----IFDKNKTKLLNWNKRFNIILGTAE 381
            +VKL   S +    L L+ EY+P   +         F + +T       RF I    AE
Sbjct: 62  WVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET-------RFYI----AE 109

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            +  +    +   IHRDIK  N+LLD     K++DFGL  C    ++H + 
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL--CTGLKKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 20/154 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVA---VKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKL 332
           +++G G  G V +  +   T VA   VK L  N + +  +EF  + +    ++H N+++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL-------GTAEGLAY 385
           LG  +E    LLV+EY     L  ++  +       W++R + +L         A G+ +
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL 419
           +H   +   +H D+   N  L  D T K+ D+G+
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 13/180 (7%)

Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFF 315
           +S        L      F   + +G G  G VY G       +A  +++  T    +E  
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK 60

Query: 316 NEVNLISSI-EHKNLVKLLGCSIEGP------ESLLVYEYVPNRSLDQFIFDKNKTKLLN 368
            E+N++     H+N+    G  I+        +  LV E+    S+   +    K   L 
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALK 119

Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
            +    I      GLA+LH     ++IHRDIK  N+LL ++   K+ DFG++     DRT
Sbjct: 120 EDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRT 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 48/191 (25%), Positives = 64/191 (33%), Gaps = 64/191 (33%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKR--------LIFNTR----------Q 309
           F   KKLG+G  G VY  SL N          +K+        +  N R           
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-----KT 364
           +V  F   V+                S +  E  LV+ Y    +L   +  K      + 
Sbjct: 194 FVYGFLEPVS----------------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEP 237

Query: 365 KLL-------NWNKRFNIILGTA-----EGLAYLHGGSETRIIHRDIKTSNILLD---KD 409
            LL          +R N I+ T        L  LH    T I+HRD+K  NI+       
Sbjct: 238 YLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGS 294

Query: 410 FTPKIADFGLA 420
           F  KI D G A
Sbjct: 295 F--KIIDLGAA 303

Length = 566

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 41/133 (30%), Positives = 61/133 (45%), Gaps = 22/133 (16%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVP--------NRSLDQFIFDKNKT 364
           FF E   I SI +   +  L  + +  ++L LV EY P        NR  DQF  D++  
Sbjct: 47  FFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDMA 104

Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
                  +F +    AE +  +H   +   +HRDIK  N+L+D+    K+ADFG A    
Sbjct: 105 -------QFYL----AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153

Query: 425 ADRTHVSTAVAGT 437
           A++   S    GT
Sbjct: 154 ANKMVNSKLPVGT 166

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 3/39 (7%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L YLH      +++RD+K  N++LDKD   KI DFGL +
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 38/106 (35%), Positives = 50/106 (47%), Gaps = 14/106 (13%)

Query: 320 LISSIEHKNLVKLLGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NI 375
           L  + EH  L  L  C+ +  E L  V EY+    L   I    +        RF    I
Sbjct: 49  LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARFYAAEI 105

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           I G    L +LH   +  II+RD+K  N+LLDKD   KIADFG+ +
Sbjct: 106 ICG----LQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 43/151 (28%), Positives = 62/151 (41%), Gaps = 13/151 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K + +G  GSVY+      G   A+K L    +    Q  +       ++   E   + K
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHGGS 390
           L           LV EY+        I  K    L  +W K++  I     G+  LH   
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              IIHRDIK  N+L+D+    K+ DFGL+R
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 30/141 (21%), Positives = 65/141 (46%), Gaps = 13/141 (9%)

Query: 286 SVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES 342
           S+Y G   N   V ++         +  +D   NE+  +  I+  N++K+ G  I+  + 
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 343 L----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
           L    L+ EY     L + +   +K K L++  + ++ +   +GL  L+    T   +++
Sbjct: 94  LPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKN 148

Query: 399 IKTSNILLDKDFTPKIADFGL 419
           + + + L+ +++  KI   GL
Sbjct: 149 LTSVSFLVTENYKLKIICHGL 169

Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 10/110 (9%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           F  E  L + + H N+V LL      P  L  V+EYVP R+L + +        L   + 
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADG---ALPAGET 81

Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTP--KIADFGL 419
             ++L   + LA  H      I+HRD+K  NI++      P  K+ DFG+
Sbjct: 82  GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 21/159 (13%)

Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG G  G V +      G   A+K L    I   +Q V     E +++  + H  +V ++
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVNMM 84

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGG 389
            CS +    +  + E+V    L  F   +   +  N   +F    ++L       YLH  
Sbjct: 85  -CSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLA----FEYLH-- 135

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               II+RD+K  N+LLD     K+ DFG A+    DRT
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRT 172

Length = 329

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 28/174 (16%)

Query: 277 KKLGQGGAGSVYMGSLP----------------NGTTVAVKRLIFNTRQWVDEFFNEVNL 320
           K +G GG G VY                        T+ ++ L++N    +D+     N 
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN- 76

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK--TKLLNWNKRF--NII 376
           I +I+H  + K  GC        + Y ++    L++ + +  +   ++   NK+   NI+
Sbjct: 77  IHNIDHLGIPKYYGCG-SFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIM 132

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
                 L Y+H   E  I H DIK  NI++D +    I D+G+A  F     H+
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183

Length = 294

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A GL +LH      II+RD+K  N++LD +   KIADFG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 21/58 (36%), Positives = 32/58 (55%), Gaps = 10/58 (17%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVS 431
           GL YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S
Sbjct: 111 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 166

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 3/57 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            L +LH   +  II+RDIK  NILLD +    + DFGL++ F  D    + +  GT+
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 1e-04
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 9/100 (9%)

Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           ++ N +KL          +L+ +Y+ +   D F   K + KL +  +   II    E L 
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKD--GDLFDLLKKEGKL-SEAEVKKIIRQLVEALN 123

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARC 422
            LH      IIH DIK  N+L D+    +I   D+GL + 
Sbjct: 124 DLHK---HNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKI 159

Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 3/45 (6%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            L Y+H  +   + HRD+K  NIL + D   KI DFGLAR    D
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND 156

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 30/133 (22%), Positives = 49/133 (36%), Gaps = 11/133 (8%)

Query: 282 GGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE----FFNEVNLISSIEHKNLVKLLGCS 336
                V++    P  T VAVK+   N      E       E+     ++H N++  +   
Sbjct: 11  EDLMIVHLAKHKPTNTLVAVKK--INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           I   E  +V   +   S +  +   +  + L       I+      L Y+H       IH
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIH 124

Query: 397 RDIKTSNILLDKD 409
           R +K S+ILL  D
Sbjct: 125 RSVKASHILLSGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 49/156 (31%), Positives = 69/156 (44%), Gaps = 23/156 (14%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEF---FNEVNLIS-SIEHKNLVK 331
           K LG+G  G V++  L       A+K L  +     D+      E  ++S + EH  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 332 LLGCSIEGPESLL-VYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGLAY 385
           L  C+ +  E+L  V EY+    L   I     FD  +           II G    L +
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICG----LQF 111

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           LH      I++RD+K  NILLD D   KIADFG+ +
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 22/149 (14%)

Query: 300 VKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE---YVPNRSLD- 355
           + + +    +   +  NE+  +  + H+N++K+        E +L  E   Y+  +  D 
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247

Query: 356 ---QFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD 409
               F++D+    K + L    R  I+      + Y+H   + ++IHRDIK  NI L+ D
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303

Query: 410 FTPKIADFGLARCFAADRTHVSTAVAGTL 438
               + DFG A  F  +R        GT+
Sbjct: 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Length = 501

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 2/40 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 23/156 (14%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEF---FNEVNLISSIEHKNLVKL 332
           K LG+G  G V +  L   G   AVK L  +     D+      E  +++       +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 333 LGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT---AE---GLAY 385
           L C+ +  E L  V E++    L   I DK          RF++   T   AE   GL +
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQF 111

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           LH      II+RD+K  N++LD+D   KIADFG+ +
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 21/56 (37%), Positives = 30/56 (53%), Gaps = 5/56 (8%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           GL +LH   + RI++RD+K  N+LLD     +I+D GLA      +       AGT
Sbjct: 107 GLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGT 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH G   +I++RD+K  N++LDKD   KI DFGL +
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 20/39 (51%), Positives = 27/39 (69%), Gaps = 3/39 (7%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           GL +LH   + RII+RD+K  N+LLD D   +I+D GLA
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 16/29 (55%), Positives = 21/29 (72%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF 423
           IHRDIK  NIL+D+    K++DFGL+  F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 20/37 (54%), Positives = 23/37 (62%), Gaps = 2/37 (5%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
           IHRDIK  NIL+D+D   K+ DFGL  C     TH S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL--CTGFRWTHDS 157

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 20/51 (39%), Positives = 27/51 (52%), Gaps = 3/51 (5%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
           A+G+ +L   +    IHRD+   N+LL      KI DFGLAR    D  +V
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 22/172 (12%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   + L  G  G V+  S P+    V VK        W     +E  L+  + H  ++ 
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPAVLA 224

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           LL   + G  + LV   +P    D + +   + + L   +   +       + Y+HG   
Sbjct: 225 LLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG- 280

Query: 392 TRIIHRDIKTSNILLDKDFTPK---IADFGLARCFA--ADRTHVSTAVAGTL 438
             IIHRDIKT N+L++    P+   + DFG A CFA  +  T     +AGT+
Sbjct: 281 --IIHRDIKTENVLVN---GPEDICLGDFG-AACFARGSWSTPFHYGIAGTV 326

Length = 461

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 22/46 (47%), Positives = 25/46 (54%), Gaps = 6/46 (13%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRT---HVSTAVAGT 437
           IHRD+K  N+LLDK    K+ADFG   C   D        TAV GT
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMVRCDTAV-GT 206

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           FF   +L+S + H +L  + G  + G E+++V E+V +  LD  +  +     + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
            +    A  L+YL    +  ++H ++   NILL
Sbjct: 121 TVAQQLASALSYLE---DKNLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 8/112 (7%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E +++ +I H ++++L G       + L+   +P    D + +   K  +   +    I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
                 + YLH   E RIIHRDIK  NI ++      + DFG A CF  D  
Sbjct: 189 RSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN 236

Length = 391

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 21/155 (13%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTV-AVKRL---IFNTRQWVDEFFNEVNLIS-SIEHKNLVK 331
           K LG+G  G V +  L     V A+K L   +      VD    E  +++ + +H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 332 LLGCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNK-RFNIILGTAE---GLAYL 386
           L  C  +  + L  V EYV    L   +F   +++  +  + RF      AE    L +L
Sbjct: 61  LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFY----AAEVTLALMFL 112

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           H      +I+RD+K  NILLD +   K+ADFG+ +
Sbjct: 113 H---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 9e-04
 Identities = 18/43 (41%), Positives = 27/43 (62%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           L  +H      +IHRDIK++NILL  +   K+ DFG ++ +AA
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA 195

Length = 496

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 22/81 (27%), Positives = 36/81 (44%), Gaps = 11/81 (13%)

Query: 341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK 400
             ++V EY+    L   + + N  + L  ++    ++G       LH      IIH D+ 
Sbjct: 73  NFIIVMEYIEGEPLKD-LINSNGMEELELSREIGRLVGK------LH---SAGIIHGDLT 122

Query: 401 TSNILLDKDFTPKIADFGLAR 421
           TSN++L       + DFGLA 
Sbjct: 123 TSNMILSGG-KIYLIDFGLAE 142

Length = 211

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 21/51 (41%), Positives = 28/51 (54%), Gaps = 3/51 (5%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
           A+G+++L   +    IHRD+   NILL      KI DFGLAR    D  +V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 13/149 (8%)

Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRL---IFNTRQWVDEFFNEVNLIS-SIEHKNLVKLL 333
           LG+G  G V +  L  +G   AVK L   +      V+    E  ++S +  H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 334 GCSIEGPESLL-VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            C  + P+ L  V E+V    L   +F   K++  +  +           L +LH   + 
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLH---DK 115

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            II+RD+K  N+LLD +   K+ADFG+ +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 27/105 (25%), Positives = 53/105 (50%), Gaps = 6/105 (5%)

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++ +++ +N+V+L        +  LV+EYV    L+  + ++    +    K  + I
Sbjct: 50  ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPP-EKVRSYI 106

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               + + + H   +  I+HRDIK  N+L+  +   K+ DFG AR
Sbjct: 107 YQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 20/57 (35%), Positives = 33/57 (57%), Gaps = 3/57 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    G +
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 162

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 23/86 (26%), Positives = 39/86 (45%), Gaps = 4/86 (4%)

Query: 346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL 405
           Y+   +  +   + D + ++ L      +     A G+ +L   +    +HRD+   N+L
Sbjct: 214 YKGSNDSEVKNLLSD-DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVL 269

Query: 406 LDKDFTPKIADFGLARCFAADRTHVS 431
           L +    KI DFGLAR    D  +VS
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVS 295

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 20/55 (36%), Positives = 32/55 (58%), Gaps = 3/55 (5%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S    G
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 19/39 (48%), Positives = 25/39 (64%), Gaps = 3/39 (7%)

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L YLH      +++RDIK  N++LDKD   KI DFGL +
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A  L +LH      II+RD+K  NILLD++   K+ DFGL++
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 13/151 (8%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVK 331
           K +G+G  G V +     +G+  AVK L   T   ++  +    E N L+ +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L   S +  E L  V +YV    L  F   + +   L    RF      A  + YLH   
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYLH--- 113

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              II+RD+K  NILLD      + DFGL +
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 19/42 (45%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A G+ +L   +  + IHRD+   NILL ++   KI DFGLAR
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 22/56 (39%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           A G+ +L   +  + IHRD+   NILL ++   KI DFGLAR    D  +V    A
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 45/151 (29%), Positives = 64/151 (42%), Gaps = 13/151 (8%)

Query: 277 KKLGQGGAGSVYMGSLP-NGTTVAVKRL---IFNTRQWVDEFFNEVN-LISSIEHKNLVK 331
           K +G+G  G V +     +G   AVK L       ++       E N L+ +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L   S +  + L  V +YV    L  F   + +        RF      A  L YLH   
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLH--- 113

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              II+RD+K  NILLD      + DFGL +
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 12/99 (12%)

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEG 382
           H  LV L  C         V E+V    L  F   + + KL   + RF    I L     
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL-MFHMQRQR-KLPEEHARFYSAEISLA---- 108

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L +LH   E  II+RD+K  N+LLD +   K+ D+G+ +
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 21/58 (36%), Positives = 30/58 (51%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           AE +  +H   +   +HRDIK  N+LLD +   ++ADFG       D T  S+   GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGT 166

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 21/51 (41%), Positives = 30/51 (58%), Gaps = 3/51 (5%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
           A+G+ +L   +  + IHRD+   NILL ++   KI DFGLAR    D  +V
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 20/45 (44%), Positives = 25/45 (55%)

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             +HRDIK  N+LLDK+   ++ADFG      AD T  S    GT
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGT 166

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 26/159 (16%)

Query: 277 KKLGQGGAGSVYM-----GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           K LG+GG G V+      G+   G   A+K L    I   ++       E N++ +++H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAEG 382
            +V L+     G +  L+ EY+    L      + IF ++            I L     
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY----LSEISLA---- 112

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L +LH   +  II+RD+K  NILLD     K+ DFGL +
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 19/39 (48%), Positives = 25/39 (64%), Gaps = 3/39 (7%)

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           GL  LH   + RI++RD+K  NILLD     +I+D GLA
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 17/29 (58%), Positives = 20/29 (68%)

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF 423
           IHRDIK  NIL+D+D   K+ DFGL   F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           + GL +LH      II+RD+K  N++LD +   KIADFG+ +
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.0 bits (89), Expect = 0.004
 Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 14/86 (16%)

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            ++    L+V EY+    L   + ++ +  LL   +    ++G       LH   +  I+
Sbjct: 68  DVDPDNGLIVMEYIEGELLKDAL-EEARPDLL---REVGRLVGK------LH---KAGIV 114

Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           H D+ TSNI+L         DFGL  
Sbjct: 115 HGDLTTSNIILSGG-RIYFIDFGLGE 139

Length = 204

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 13/126 (10%)

Query: 300 VKRLIFNTRQWVDEFFNEVNLI-SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
           VK+ + N  + +D    E ++   +  H  LV L  C         V EYV     D   
Sbjct: 28  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV--NGGDLMF 85

Query: 359 FDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA 415
             + + KL   + RF     +AE    L YLH   E  II+RD+K  N+LLD +   K+ 
Sbjct: 86  HMQRQRKLPEEHARFY----SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLT 138

Query: 416 DFGLAR 421
           D+G+ +
Sbjct: 139 DYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	438
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.97
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.96
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.95
KOG0578	550	consensus p21-activated serine/threonine protein k	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.94
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.94
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.94
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.94
KOG0589	426	consensus Serine/threonine protein kinase [General	99.94
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.93
KOG0610	459	consensus Putative serine/threonine protein kinase	99.93
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.93
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.93
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.93
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.93
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.93
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.93
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.92
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.92
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.92
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.92
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.92
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.92
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.92
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.92
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.92
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.92
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.92
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.92
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.92
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.92
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.92
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.92
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.92
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.92
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.92
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.92
PTZ00283	496	serine/threonine protein kinase; Provisional	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.92
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.92
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.92
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.92
KOG0584	632	consensus Serine/threonine protein kinase [General	99.92
KOG0586	596	consensus Serine/threonine protein kinase [General	99.92
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.92
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.92
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.92
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.92
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.92
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.92
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.92
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.91
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.91
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.91
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.91
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.91
PHA03211	461	serine/threonine kinase US3; Provisional	99.91
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.91
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.91
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.91
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.91
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.91
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.91
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.91
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.91
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.91
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.91
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.91
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.91
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.91
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.91
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.91
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.91
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.91
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.91
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.91
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.91
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.91
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.91
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.91
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.91
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.91
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.91
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.91
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.91
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.91
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.91
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.91
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.91
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.91
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.91
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.91
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.91
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.91
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.91
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.91
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.91
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.91
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.91
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.91
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.91
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.91
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.91
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.91
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.91
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.91
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.91
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.91
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.9
PTZ00036	440	glycogen synthase kinase; Provisional	99.9
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.9
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.9
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.9
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.9
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.9
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.9
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.9
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.9
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.9
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.9
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.9
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.9
PHA03207	392	serine/threonine kinase US3; Provisional	99.9
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.9
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.9
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.9
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.9
PHA03209	357	serine/threonine kinase US3; Provisional	99.9
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.9
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.9
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.9
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.9
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.9
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.9
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.9
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.9
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.9
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.9
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.9
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.9
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.9
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.9
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.9
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.9
PHA03210	501	serine/threonine kinase US3; Provisional	99.9
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.9
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.9
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.89
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.89
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.89
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.89
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.89
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.89
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.89
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.89
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.89
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.89
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.89
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.89
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.89
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.89
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.89
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.89
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.89
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.89
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.89
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.89
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.89
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.89
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.89
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.89
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.89
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.89
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.89
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.88
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.88
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.88
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.88
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.88
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.88
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.88
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.88
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.88
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.88
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.88
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.88
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.88
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.88
PTZ00284	467	protein kinase; Provisional	99.88
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.88
PLN00009	294	cyclin-dependent kinase A; Provisional	99.88
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.88
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.88
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.88
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.87
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.87
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.87
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.87
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.87
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.87
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.87
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.87
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.87
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.87
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.87
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.86
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.86
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.86
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.86
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.86
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.86
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.86
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.86
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.86
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.86
PHA02882	294	putative serine/threonine kinase; Provisional	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.86
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.86
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.85
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.85
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.85
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.85
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.84
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.84
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.84
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.84
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.83
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.83
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.82
smart00090	237	RIO RIO-like kinase.	99.82
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.82
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.79
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.76
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.76
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.75
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.74
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.73
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.66
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
PLN00181	793	protein SPA1-RELATED; Provisional	99.38
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.36
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.28
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.1
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.07
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.01
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.96
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.92
KOG1243	690	consensus Protein kinase [General function predict	98.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.88
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.88
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
PRK09902	216	hypothetical protein; Provisional	98.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.62
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.61
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.54
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.54
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.53
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.49
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.42
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.42
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.36
PLN02876	822	acyl-CoA dehydrogenase	98.27
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
PRK10593	297	hypothetical protein; Provisional	98.12
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.05
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.98
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.96
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.91
PRK05231	319	homoserine kinase; Provisional	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.78
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.73
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.64
PLN02236	344	choline kinase	97.41
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.33
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.31
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.18
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.13
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.12
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.12
KOG2270	520	consensus Serine/threonine protein kinase involved	97.06
PLN02756	418	S-methyl-5-thioribose kinase	96.92
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.72
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.71
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.68
PRK11768	325	serine/threonine protein kinase; Provisional	96.54
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.35
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.31
PRK12396	409	5-methylribose kinase; Reviewed	96.23
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.05
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.04
COG2334	331	Putative homoserine kinase type II (protein kinase	95.97
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.84
PRK06148	1013	hypothetical protein; Provisional	95.82
COG4248	637	Uncharacterized protein with protein kinase and he	95.8
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.8
PTZ00384	383	choline kinase; Provisional	95.18
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.04
KOG2137	700	consensus Protein kinase [Signal transduction mech	94.58

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-38  Score=301.81  Aligned_cols=168  Identities=54%  Similarity=0.858  Sum_probs=153.4

Q ss_pred             cccccCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEE
Q 013693          257 SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (438)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (438)
                      ....|++++++.+|++|...+.||+|+||.||+|.++++..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988765433145699999999999999999999999


Q ss_pred             EeCC-eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 013693          337 IEGP-ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       337 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      .+.+ +.+||||||++|+|.++|+..... +++|..+++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999765444 78999999999999999999998877899999999999999999999999


Q ss_pred             cccccccccC
Q 013693          416 DFGLARCFAA  425 (438)
Q Consensus       416 DFGla~~~~~  425 (438)
                      |||+|+....
T Consensus       220 DFGLa~~~~~  229 (361)
T KOG1187|consen  220 DFGLAKLGPE  229 (361)
T ss_pred             CccCcccCCc
Confidence            9999977665

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=265.23  Aligned_cols=161  Identities=31%  Similarity=0.516  Sum_probs=141.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..+|...+.||+|+|+.||+|++ .++.+||||.+...  .+...+.+..|+.+|+.++|||||+++++...++..||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35688888899999999999955 46799999999766  5666778899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC------CCeEEeccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD------FTPKIADFGLA  420 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~------~~~kl~DFGla  420 (438)
                      |||.||+|.++++.+   ..+++..+..++.||+.||++||   +++||||||||.||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999643   35899999999999999999999   9999999999999999764      46899999999


Q ss_pred             ccccCCCceeeeeeeecC
Q 013693          421 RCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       421 ~~~~~~~~~~~~~~~Gt~  438 (438)
                      |.+.+..-.  .+++|||
T Consensus       163 R~L~~~~~a--~tlcGSp  178 (429)
T KOG0595|consen  163 RFLQPGSMA--ETLCGSP  178 (429)
T ss_pred             hhCCchhHH--HHhhCCc
Confidence            999855432  3467775

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-33  Score=259.68  Aligned_cols=162  Identities=30%  Similarity=0.412  Sum_probs=138.5

Q ss_pred             HhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecch-------hhHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR-------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (438)
                      ..+.|.+.+.||+|+||.|-+| ..++++.||||++.....       .....+.+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4566888999999999999999 667899999999975421       12234679999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CCeEEecc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADF  417 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~DF  417 (438)
                      ..||||||++||+|.+.+-.   .+.+.+..-..+++|++.|+.|||   +.||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999844   344677777889999999999999   9999999999999999755   78999999


Q ss_pred             cccccccCCCceeeeeeeecC
Q 013693          418 GLARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       418 Gla~~~~~~~~~~~~~~~Gt~  438 (438)
                      |+|+..+...  ...+.+|||
T Consensus       324 GlAK~~g~~s--fm~TlCGTp  342 (475)
T KOG0615|consen  324 GLAKVSGEGS--FMKTLCGTP  342 (475)
T ss_pred             chhhccccce--ehhhhcCCc
Confidence            9999987333  345678886

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-32  Score=267.33  Aligned_cols=161  Identities=29%  Similarity=0.431  Sum_probs=146.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..|...+.||+|+|+.+|.+.. .+|+.||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|++.++.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999965 88999999999753   4456778999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++.++|.++++   +.+++++.++..++.||+.||.|||   +.+|||||||..|+||++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999994   4567999999999999999999999   899999999999999999999999999999999877


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ..+. .+++|||
T Consensus       172 ~Erk-~TlCGTP  182 (592)
T KOG0575|consen  172 GERK-KTLCGTP  182 (592)
T ss_pred             cccc-ceecCCC
Confidence            6544 3589997

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.1e-32  Score=256.24  Aligned_cols=155  Identities=30%  Similarity=0.489  Sum_probs=135.6

Q ss_pred             cCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  345 (438)
                      +.|+.+++||+|.||.||+| +..+|+.||+|++..+.  +....-..+||.||++|+||||++|.+.....  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            34666788999999999999 66789999999998764  44556678999999999999999999988876  689999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +|||+. ||.-++.  .....|++.++..++.|++.||+|+|   ..+|+|||||.+|||||.+|.+||+|||||+.+..
T Consensus       197 FeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999976 8888873  34556999999999999999999999   99999999999999999999999999999999887


Q ss_pred             CCceee
Q 013693          426 DRTHVS  431 (438)
Q Consensus       426 ~~~~~~  431 (438)
                      ......
T Consensus       271 ~~~~~~  276 (560)
T KOG0600|consen  271 SGSAPY  276 (560)
T ss_pred             CCCccc
Confidence            665433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=245.67  Aligned_cols=155  Identities=29%  Similarity=0.453  Sum_probs=135.7

Q ss_pred             CCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-eEEEEEeccCC
Q 013693          275 PSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-ESLLVYEYVPN  351 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  351 (438)
                      ..+.||+|..|+|||+.+ ++++.+|+|.+..+ ++...+++.+|++++++.+||+||+++|.|..++ ...|+||||.+
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            357899999999999954 56889999999655 4556788999999999999999999999999999 59999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCceee
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  431 (438)
                      |+|+.++..   .+.+++..+-+|+.+|++||.|||+  +.+||||||||+|||++..|+|||+|||.++.+.+.   ..
T Consensus       163 GSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a  234 (364)
T KOG0581|consen  163 GSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA  234 (364)
T ss_pred             CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence            999999943   3558999999999999999999994  489999999999999999999999999999998665   22


Q ss_pred             eeeeec
Q 013693          432 TAVAGT  437 (438)
Q Consensus       432 ~~~~Gt  437 (438)
                      .+.+||
T Consensus       235 ~tfvGT  240 (364)
T KOG0581|consen  235 NTFVGT  240 (364)
T ss_pred             cccccc
Confidence            235565

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=256.46  Aligned_cols=159  Identities=38%  Similarity=0.549  Sum_probs=135.8

Q ss_pred             CCCccccCCceeEEEEEccCCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-eEEEEEeccCC
Q 013693          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-ESLLVYEYVPN  351 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  351 (438)
                      ..+.||+|+||+||+|.+.....||||++.....  ...++|.+|+.+|.+++|||||+++|++.... ...|||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3456999999999999996655599999975432  22668999999999999999999999999988 79999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeeCCCCCCCeeeCCCC-CeEEecccccccccCCCce
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR-IIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRTH  429 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~dlkp~Nill~~~~-~~kl~DFGla~~~~~~~~~  429 (438)
                      |+|.++++.. ....+++..++.|+.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus       125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999764 4567999999999999999999999   677 99999999999999997 99999999999876543 1


Q ss_pred             eeeeeeecC
Q 013693          430 VSTAVAGTL  438 (438)
Q Consensus       430 ~~~~~~Gt~  438 (438)
                      ..+...||+
T Consensus       200 ~~~~~~GT~  208 (362)
T KOG0192|consen  200 SMTSVAGTY  208 (362)
T ss_pred             cccCCCCCc
Confidence            122256664

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=249.02  Aligned_cols=158  Identities=35%  Similarity=0.519  Sum_probs=134.9

Q ss_pred             CCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhc--cCCCceeeEEeEEEeCC----eEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS--IEHKNLVKLLGCSIEGP----ESLLV  345 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv  345 (438)
                      ..+..++||+|+||.||||.+ +++.||||++..   +..+.|++|-.|.+.  ++|+||+++++.-....    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            345678899999999999988 459999999854   345668888887775  48999999999877665    89999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhc------CCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG------GSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~------~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      +||.+.|+|.++|    ....++|.+..+|+..+++||+|||+      +++++|+|||||.+|||+.+|+++.|+||||
T Consensus       287 t~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999    45679999999999999999999996      4678999999999999999999999999999


Q ss_pred             cccccCCCceeee-eeeec
Q 013693          420 ARCFAADRTHVST-AVAGT  437 (438)
Q Consensus       420 a~~~~~~~~~~~~-~~~Gt  437 (438)
                      |.++........+ .-+||
T Consensus       363 Al~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             eEEecCCCCCcchhhhhhh
Confidence            9999866554433 23565

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=246.40  Aligned_cols=162  Identities=28%  Similarity=0.329  Sum_probs=142.9

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .+.|++.++||+|+||+|+.++ .++++.+|+|++++.   .....+....|..||.+++||.||+++..|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4678899999999999999994 456899999999765   234567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +||+.||.|..+|.+   ...+++..+.-++.+|+.||.|||   +.+||||||||+|||||.+|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            999999999999943   455899989999999999999999   99999999999999999999999999999998766


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      +..... +.+||+
T Consensus       178 ~~~~t~-tfcGT~  189 (357)
T KOG0598|consen  178 DGDATR-TFCGTP  189 (357)
T ss_pred             CCCccc-cccCCc
Confidence            654433 478885

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.7e-33  Score=244.93  Aligned_cols=165  Identities=28%  Similarity=0.447  Sum_probs=140.4

Q ss_pred             CCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeE-EEeCCe-EEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGC-SIEGPE-SLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~  346 (438)
                      +|++.++||+|.||+||++ .+.+|..||.|.+...  +.+..+....|+.+|++|+|||||+++++ +..+.+ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4667789999999999999 6778999999999754  45667789999999999999999999994 444444 89999


Q ss_pred             eccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||+..|+|.++++..+ ..+.+++..+++++.|++.||.++|..- .+  |+||||||.||+|+.+|.+||.||||++.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999996543 3456999999999999999999999311 44  999999999999999999999999999999


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      +.+.+-.. ..+|||
T Consensus       179 ~s~~tfA~-S~VGTP  192 (375)
T KOG0591|consen  179 SSKTTFAH-SLVGTP  192 (375)
T ss_pred             cchhHHHH-hhcCCC
Confidence            87665443 477887

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=1.1e-30  Score=229.37  Aligned_cols=152  Identities=33%  Similarity=0.550  Sum_probs=135.1

Q ss_pred             cCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchh--hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .+|...++||+|.||.||+| ...+|+.||||+++.....  ......+||+.|+.++|+||+.+++++.+.+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35777899999999999999 5668999999999865322  23456799999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||+. +|+..+++  +...++..++..++.++++||+|||   .+.|+||||||.|+||+.+|.+||+|||+|+.+....
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9965 99999965  4567999999999999999999999   8999999999999999999999999999999998654


Q ss_pred             c
Q 013693          428 T  428 (438)
Q Consensus       428 ~  428 (438)
                      .
T Consensus       156 ~  156 (318)
T KOG0659|consen  156 R  156 (318)
T ss_pred             c
Confidence            3

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-31  Score=251.35  Aligned_cols=152  Identities=34%  Similarity=0.567  Sum_probs=135.2

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      +.+...+.||+|-||.||.|.++....||+|.++... ...+.|.+|+.+|++|+|+|||+++|+|..++.++||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3344567899999999999999888899999997652 234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      .|+|.++|+. .....+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+||||||...++.
T Consensus       285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9999999965 34556888999999999999999999   8999999999999999999999999999999655443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-31  Score=260.82  Aligned_cols=176  Identities=28%  Similarity=0.495  Sum_probs=150.1

Q ss_pred             ccccccCHHHHHHHhcCC---------CCCCccccCCceeEEEEEccC----CCEEEEEEeeec-chhhHHHHHHHHHHH
Q 013693          256 KSCLSFKYETLEKATNYF---------NPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLI  321 (438)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l  321 (438)
                      .....++||+.-.+...|         .+.++||.|.||+|++|.++.    ...||||.++.. .+....+|+.|..||
T Consensus       605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM  684 (996)
T KOG0196|consen  605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM  684 (996)
T ss_pred             eecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence            334556677655444443         456899999999999997653    467999999865 456678899999999


Q ss_pred             hccCCCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 013693          322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKT  401 (438)
Q Consensus       322 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  401 (438)
                      .+++||||++|.|+.......+||+|||++|+|+.||+.+  ...+++.++..++++|+.||+||-   +.++|||||.+
T Consensus       685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAA  759 (996)
T KOG0196|consen  685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAA  759 (996)
T ss_pred             ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhh
Confidence            9999999999999999999999999999999999999654  355999999999999999999999   99999999999


Q ss_pred             CCeeeCCCCCeEEecccccccccCCCceeeeeeee
Q 013693          402 SNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG  436 (438)
Q Consensus       402 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~G  436 (438)
                      +|||++.+..+|++||||+|.+.++.....++..|
T Consensus       760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GG  794 (996)
T KOG0196|consen  760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGG  794 (996)
T ss_pred             hheeeccceEEEeccccceeecccCCCccccccCC
Confidence            99999999999999999999998877555554444

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-30  Score=227.40  Aligned_cols=158  Identities=30%  Similarity=0.385  Sum_probs=140.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||.|+||+|.+++. .++..+|+|++.+..   ....+...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            3466789999999999999954 468899999997653   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||++||.|..+++.   ...+++..+.-++.||+.||+|||   +.+|++|||||+|||||.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999953   455899999999999999999999   899999999999999999999999999999998654


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                          +-+++|||
T Consensus       198 ----T~TlCGTP  205 (355)
T KOG0616|consen  198 ----TWTLCGTP  205 (355)
T ss_pred             ----EEEecCCc
Confidence                34688987

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.3e-30  Score=240.64  Aligned_cols=152  Identities=26%  Similarity=0.454  Sum_probs=137.8

Q ss_pred             hcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ..+|++.+.||+|.||.|-++ ....|+.||||.++++   ++++.-.+.+||+||+.|+||||+.++.+|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            345777889999999999999 4568999999998764   456666789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||..+|.|.+++.+   ...+++.+...+++||..|+.|+|   +++++|||||.+|||+|.++++||+||||+-.+..
T Consensus       132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999954   345899999999999999999999   99999999999999999999999999999998865


Q ss_pred             CC
Q 013693          426 DR  427 (438)
Q Consensus       426 ~~  427 (438)
                      +.
T Consensus       206 ~k  207 (668)
T KOG0611|consen  206 KK  207 (668)
T ss_pred             cc
Confidence            54

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=2.5e-30  Score=230.90  Aligned_cols=150  Identities=25%  Similarity=0.382  Sum_probs=130.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +.|+...++|+|+||.||+++. .+|+.||||++...  ++.-.+-.++|+++|++|+|||+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4577888999999999999955 46999999999643  23344557899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |++..-|.++- .  ....++...+.+++.|+++|+.|+|   +.++|||||||+||||+.++.+||+|||+||.+..+
T Consensus        82 ~~dhTvL~eLe-~--~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDHTVLHELE-R--YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecchHHHHHHH-h--ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99875554443 2  3445889999999999999999999   899999999999999999999999999999999853

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=242.89  Aligned_cols=154  Identities=31%  Similarity=0.386  Sum_probs=137.3

Q ss_pred             HHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCe
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (438)
                      ..-.++|...+.||+|+|++|++| ...+++++|||++.+.   .+...+-+.+|-.+|.+| .||.|++|+-.|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344567899999999999999999 5567899999998653   334455677899999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      +|+|+||.++|+|.++|..   ...|++.....++.+|+.||+|||   +.|||||||||+|||||.||++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999954   356899999999999999999999   9999999999999999999999999999999


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .+.+.
T Consensus       223 ~l~~~  227 (604)
T KOG0592|consen  223 ILSPS  227 (604)
T ss_pred             cCChh
Confidence            98653

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=2.6e-29  Score=240.38  Aligned_cols=150  Identities=25%  Similarity=0.356  Sum_probs=136.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ..++|+.+..||+|+||.||++. ..+|..+|+|++++.   .....+.++.|-.+|...++|+||+|+..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45678999999999999999994 457999999999865   34456778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||++||++..+|.   +...|++..+..++.+++.|++-||   +.|+|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   4567999999999999999999999   9999999999999999999999999999997553

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=244.97  Aligned_cols=152  Identities=32%  Similarity=0.496  Sum_probs=133.9

Q ss_pred             HhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHH-HHHHHHHHhccC-CCceeeEEeEEEeCC-eEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIE-HKNLVKLLGCSIEGP-ESLL  344 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  344 (438)
                      ..++|...++||.|.||.||+| ....+..||||+++..-..+.+. =.+|+..|++|+ ||||++|.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4467888899999999999999 55678999999997654433332 358999999998 999999999999888 8999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |||||+. +|.++++++  .++++++.+..|+.||++||+|+|   ++|+.||||||+|||+.....+||+|||+||.+.
T Consensus        88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence            9999954 999999765  677999999999999999999999   9999999999999999988899999999999886


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       162 Sk  163 (538)
T KOG0661|consen  162 SK  163 (538)
T ss_pred             cC
Confidence            44

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.96  E-value=1.3e-29  Score=242.83  Aligned_cols=160  Identities=31%  Similarity=0.432  Sum_probs=143.0

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|.+.+.||+|.||.||||+ ..+.+.||+|.+.+.  .++..+.+.+|++|++.++||||+.++++|+...+.|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            567888999999999999994 446789999998654  34567789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+.| +|..+|.+   ...++++.+..|+.+++.||.|||   +.+|+|||+||.|||++.++.+|++|||+||..+.+.
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9977 99999954   455999999999999999999999   9999999999999999999999999999999988754


Q ss_pred             ceeeeeeeecC
Q 013693          428 THVSTAVAGTL  438 (438)
Q Consensus       428 ~~~~~~~~Gt~  438 (438)
                       ...+.+.|||
T Consensus       155 -~vltsikGtP  164 (808)
T KOG0597|consen  155 -SVLTSIKGTP  164 (808)
T ss_pred             -eeeeeccCcc
Confidence             4556788987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-28  Score=228.45  Aligned_cols=164  Identities=33%  Similarity=0.468  Sum_probs=137.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC--eEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  346 (438)
                      ..+|...+.||+|+||.||++.. ++|...|||.+...+....+.+.+|+.+|.+++|||||+.+|......  .+.+.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            34577789999999999999955 458999999987664333677999999999999999999999754444  689999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~~~~  425 (438)
                      ||+++|+|.+++.....  .+++..+..+..||++||.|||   +++|||+||||+|||++. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999965432  6999999999999999999999   899999999999999999 79999999999998874


Q ss_pred             --CCceeeeeeeecC
Q 013693          426 --DRTHVSTAVAGTL  438 (438)
Q Consensus       426 --~~~~~~~~~~Gt~  438 (438)
                        ..........|||
T Consensus       171 ~~~~~~~~~~~~Gtp  185 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTP  185 (313)
T ss_pred             ccccccccccccCCc
Confidence              2222222355664

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=8e-29  Score=223.99  Aligned_cols=150  Identities=29%  Similarity=0.431  Sum_probs=129.4

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchh--hHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  346 (438)
                      +|+..+.|++|.||.||+|. .++++.||+|+++...+.  .--.-.+||.+|.+++|||||.+-.+.+-  -+..||||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            46678899999999999994 456889999999865422  22345799999999999999999988664  45799999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||++. +|..++..  ...++...++.-++.|+++||+|||   ...|+||||||+|+|+.+.|.+||+||||||.++..
T Consensus       157 e~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  157 EYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            99966 99998854  3467999999999999999999999   899999999999999999999999999999999876


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       231 ~  231 (419)
T KOG0663|consen  231 L  231 (419)
T ss_pred             c
Confidence            3

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=8e-29  Score=238.15  Aligned_cols=151  Identities=31%  Similarity=0.517  Sum_probs=135.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +.+...+.++||+|.||+|.++....+.+||||+++.... ....+|.+|+++|.+|+||||++|+|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            3445667899999999999999987889999999987654 445899999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||++|+|.+++..+.... +..+...+|+.||+.||+||.   +.++|||||.++|+|+|.++++||+|||++|.+
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccc
Confidence            999999999996654333 456667889999999999999   899999999999999999999999999999955

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-28  Score=236.71  Aligned_cols=164  Identities=24%  Similarity=0.375  Sum_probs=139.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec----ch-hhHHHHHHHHHHHhccC-CCceeeEEeEEEeCC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN----TR-QWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGP  340 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  340 (438)
                      ....+|.+.+.||+|.||.|+.| ...++..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44567899999999999999999 5557899999976543    11 23456778999999998 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEecccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGL  419 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFGl  419 (438)
                      ..++||||+.+|+|.+++.+   ...+.+.++..++.|++.|++|+|   +.+|+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999954   345888999999999999999999   8999999999999999999 9999999999


Q ss_pred             cccccCCCceeeeeeeecC
Q 013693          420 ARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       420 a~~~~~~~~~~~~~~~Gt~  438 (438)
                      +.... .......+.+|||
T Consensus       168 s~~~~-~~~~~l~t~cGsp  185 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSP  185 (370)
T ss_pred             ccccC-CCCCcccCCCCCc
Confidence            99985 1222233466765

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=231.40  Aligned_cols=168  Identities=29%  Similarity=0.386  Sum_probs=136.7

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecch--------------hhHHHHHHHHHHHhccCCCc
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR--------------QWVDEFFNEVNLISSIEHKN  328 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~n  328 (438)
                      .+-.+..++|++.+.||+|.||.|-+| ...+++.||||++.+...              ...+...+||.+|+++.|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            334456688999999999999999999 445689999999864211              12357889999999999999


Q ss_pred             eeeEEeEEEeC--CeEEEEEeccCCCCHHHHhhccCCCCc-CCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          329 LVKLLGCSIEG--PESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       329 iv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      ||+|+.+..+.  +..|||+||+..|.+.+.-    ..++ +++.++..++++++.||+|||   .++||||||||+|+|
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLL  242 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLL  242 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheE
Confidence            99999997764  4799999999988875443    3444 899999999999999999999   899999999999999


Q ss_pred             eCCCCCeEEecccccccccCCCce----eeeeeeecC
Q 013693          406 LDKDFTPKIADFGLARCFAADRTH----VSTAVAGTL  438 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~~~~~----~~~~~~Gt~  438 (438)
                      |+++|++||+|||.+-.+......    .-...+|||
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTP  279 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTP  279 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCc
Confidence            999999999999999987432211    112356776

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.7e-29  Score=216.00  Aligned_cols=162  Identities=30%  Similarity=0.436  Sum_probs=139.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|.||.||.|+. +++..||+|++.+..   .+-...+.+|++|-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            35688899999999999999954 567899999997542   23345789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +||.+.|+|...|.+. +...+++.....++.|+|.||.|+|   .++||||||||+|+|++..+..||+|||-+-.-..
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999999999643 4456888899999999999999999   89999999999999999999999999998876543


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      +.   ..+.+||+
T Consensus       177 ~k---R~tlcgt~  186 (281)
T KOG0580|consen  177 NK---RKTLCGTL  186 (281)
T ss_pred             CC---ceeeeccc
Confidence            22   23467774

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.95  E-value=3.1e-28  Score=223.70  Aligned_cols=153  Identities=29%  Similarity=0.454  Sum_probs=130.9

Q ss_pred             cCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchh--hHHHHHHHHHHHhccCCCc-eeeEEeEEEeCC------
Q 013693          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKN-LVKLLGCSIEGP------  340 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  340 (438)
                      ..|+..++||+|+||.||+| ...+|+.||+|++....+.  .-....+|+.+|++++|+| |++|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34556677999999999999 4557899999999866432  3345689999999999999 999999998877      


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCC-CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      ..++|+||+.. +|..++...... ..++...+..++.||++||+|||   +.+|+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            78999999954 999998654432 45777889999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCC
Q 013693          420 ARCFAADR  427 (438)
Q Consensus       420 a~~~~~~~  427 (438)
                      |+.+.-+.
T Consensus       167 Ara~~ip~  174 (323)
T KOG0594|consen  167 ARAFSIPM  174 (323)
T ss_pred             HHHhcCCc
Confidence            99887444

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=237.03  Aligned_cols=162  Identities=30%  Similarity=0.505  Sum_probs=146.2

Q ss_pred             HhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ....|..-++||+|+.|.||.+ ...+++.||||++........+-+.+|+.+|+..+|+|||++++.+...+++|+|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            3456777889999999999999 556789999999988776667788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||++|+|.+.+    ....+++.++..|++++++||+|||   ..+|+|||||.+|||++.+|.+||+|||++..+....
T Consensus       351 ym~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  351 YMEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             ecCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999998    3345999999999999999999999   8999999999999999999999999999999998887


Q ss_pred             ceeeeeeeecC
Q 013693          428 THVSTAVAGTL  438 (438)
Q Consensus       428 ~~~~~~~~Gt~  438 (438)
                      .... +.+|||
T Consensus       424 ~KR~-TmVGTP  433 (550)
T KOG0578|consen  424 SKRS-TMVGTP  433 (550)
T ss_pred             Cccc-cccCCC
Confidence            6544 477987

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=2.2e-28  Score=246.20  Aligned_cols=156  Identities=30%  Similarity=0.503  Sum_probs=136.6

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (438)
                      ..+....+....+.||+|+||+||+|+..      ..+.||||.++..... ..++|++|+++++.|+|||||+|+|+|.
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            34444556667789999999999999653      3467999999876544 7889999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCC-----------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNK-----------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  406 (438)
                      .++..++|+|||..|||.+||....+           ..+++..+.+.|+.|||.||.||-   +..+|||||..+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhcee
Confidence            99999999999999999999964321           234889999999999999999998   8899999999999999


Q ss_pred             CCCCCeEEecccccccc
Q 013693          407 DKDFTPKIADFGLARCF  423 (438)
Q Consensus       407 ~~~~~~kl~DFGla~~~  423 (438)
                      .++..|||+||||+|.+
T Consensus       637 ge~l~VKIsDfGLsRdi  653 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDI  653 (774)
T ss_pred             ccceEEEecccccchhh
Confidence            99999999999999964

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=236.70  Aligned_cols=156  Identities=31%  Similarity=0.511  Sum_probs=140.3

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (438)
                      ....+++++..+.+.+.+.||+|.||+||+|.|..  .||||++...  ..+..+.|++|+..+++-+|.||+-+.|++.
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            34457788888888899999999999999998854  7999999865  4457889999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      .++. .||+.+++|.+|..+|+..+  ..|+....+.|+.||++|+.|||   .++|||||||..||++.++++|||.||
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecc
Confidence            8888 99999999999999997543  55889999999999999999999   899999999999999999999999999


Q ss_pred             cccccc
Q 013693          418 GLARCF  423 (438)
Q Consensus       418 Gla~~~  423 (438)
                      ||+..-
T Consensus       533 GLatvk  538 (678)
T KOG0193|consen  533 GLATVK  538 (678)
T ss_pred             cceeee
Confidence            998753

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-28  Score=235.75  Aligned_cols=150  Identities=34%  Similarity=0.515  Sum_probs=131.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC--C---CEEEEEEeee---cchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN--G---TTVAVKRLIF---NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      .++....++||+|+||.||+|.+..  +   ..||||..+.   .......+|.+|.++|++++|||||+++|+......
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3444456899999999999996643  2   2389999875   246678899999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      ++||||+++||+|.++|....  ..++..+.+.++.+.|.||+|||   +.++|||||..+|+|++.++.+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            999999999999999996533  35899999999999999999999   8999999999999999999999999999988


Q ss_pred             ccc
Q 013693          422 CFA  424 (438)
Q Consensus       422 ~~~  424 (438)
                      .-.
T Consensus       311 ~~~  313 (474)
T KOG0194|consen  311 AGS  313 (474)
T ss_pred             CCc
Confidence            653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-27  Score=221.91  Aligned_cols=165  Identities=27%  Similarity=0.394  Sum_probs=143.2

Q ss_pred             hcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .+.|++.+.||.|..+.||+| ..+.+..||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            456889999999999999999 56778999999997653 3347889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||.+|++.++++..-+ ..+++..+..|++++++||.|||   .+|.||||||+.||||+.+|.|||+|||.+..+-...
T Consensus       105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999976533 34899999999999999999999   8999999999999999999999999999877665444


Q ss_pred             ceee---eeeeecC
Q 013693          428 THVS---TAVAGTL  438 (438)
Q Consensus       428 ~~~~---~~~~Gt~  438 (438)
                      ++..   .+.+|||
T Consensus       181 ~R~~~rf~tfvgtp  194 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTP  194 (516)
T ss_pred             ceeeEeeccccCcc
Confidence            3322   3456775

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=2.6e-27  Score=232.38  Aligned_cols=165  Identities=23%  Similarity=0.266  Sum_probs=138.3

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      +....++|++.+.||+|+||.||++.. .+++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++..++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            334457799999999999999999965 45789999998642   22334568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||+++|+|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999999843    24788899999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCceeeeeeeec
Q 013693          422 CFAADRTHVSTAVAGT  437 (438)
Q Consensus       422 ~~~~~~~~~~~~~~Gt  437 (438)
                      .+............||
T Consensus       191 ~~~~~~~~~~~~~~gt  206 (370)
T cd05621         191 KMDETGMVRCDTAVGT  206 (370)
T ss_pred             ecccCCceecccCCCC
Confidence            8754433222234454

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=5.7e-27  Score=229.75  Aligned_cols=148  Identities=24%  Similarity=0.347  Sum_probs=132.1

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||+|+||.||++. ..+++.+|+|++....   ......+.+|+.++.+++||||+++++.+.+....+|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            468889999999999999995 4468999999997532   233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+++|+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999854   345899999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=232.33  Aligned_cols=163  Identities=29%  Similarity=0.387  Sum_probs=141.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (438)
                      ...++|...++||+|.||.|+++..+ +++.+|||++++.   ..+..+..+.|..|+... +||.+++|+.+|++.+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34567888999999999999999654 5789999999876   345677888999998888 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+.||++..+.    ....+++..+.-++..|+.||.|||   +++||+||||.+|||||.+|++||+||||++.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999955444    3456999999999999999999999   99999999999999999999999999999998


Q ss_pred             ccCCCceeeeeeeecC
Q 013693          423 FAADRTHVSTAVAGTL  438 (438)
Q Consensus       423 ~~~~~~~~~~~~~Gt~  438 (438)
                      -..... .+++++|||
T Consensus       518 ~m~~g~-~TsTfCGTp  532 (694)
T KOG0694|consen  518 GMGQGD-RTSTFCGTP  532 (694)
T ss_pred             cCCCCC-ccccccCCh
Confidence            765554 345689997

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.94  E-value=9.6e-28  Score=220.33  Aligned_cols=151  Identities=30%  Similarity=0.446  Sum_probs=124.7

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESLLV  345 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  345 (438)
                      .|...+++|.|+||.||+|... +++.||||++..+.+-    =.+|+++|++++|||||+|+-++....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            3566789999999999999654 4689999998765432    236999999999999999998877533     23589


Q ss_pred             EeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEecccccccc
Q 013693          346 YEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCF  423 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFGla~~~  423 (438)
                      |||||. +|.+.++.. .....++..++.-+..||.+||.|||   ..+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999977 898888542 12345788888889999999999999   8999999999999999966 89999999999999


Q ss_pred             cCCCcee
Q 013693          424 AADRTHV  430 (438)
Q Consensus       424 ~~~~~~~  430 (438)
                      ..++...
T Consensus       177 ~~~epni  183 (364)
T KOG0658|consen  177 VKGEPNI  183 (364)
T ss_pred             ccCCCce
Confidence            8766553

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.9e-27  Score=220.44  Aligned_cols=154  Identities=28%  Similarity=0.421  Sum_probs=132.4

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc--CCCceeeEEeEEEeCC----
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLLGCSIEGP----  340 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----  340 (438)
                      ..+.+...+.+.||+|.||+||+|.+ .|+.||||++...++   +.+.+|.+|.+..  +|+||+.+++.-..+.    
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            34556677889999999999999999 689999999964433   4577888888764  9999999999866544    


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhc-----CCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-----GSETRIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      ++|||++|.+.|||.++|.    ...++.+..++++..+|.||+|||.     ..++.|.|||||+.|||+..++.+-|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            6899999999999999993    3568999999999999999999994     457889999999999999999999999


Q ss_pred             cccccccccCCCc
Q 013693          416 DFGLARCFAADRT  428 (438)
Q Consensus       416 DFGla~~~~~~~~  428 (438)
                      |+|||-....+..
T Consensus       359 DLGLAv~h~~~t~  371 (513)
T KOG2052|consen  359 DLGLAVRHDSDTD  371 (513)
T ss_pred             eceeeEEecccCC
Confidence            9999998876643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.94  E-value=6.6e-27  Score=227.09  Aligned_cols=155  Identities=29%  Similarity=0.416  Sum_probs=130.7

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (438)
                      ...++|++.++||+|+||.||+|..      ..+..||||++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3456788999999999999999953      235689999987542 33456789999999999 899999999988764


Q ss_pred             C-eEEEEEeccCCCCHHHHhhccCC-------------------------------------------------------
Q 013693          340 P-ESLLVYEYVPNRSLDQFIFDKNK-------------------------------------------------------  363 (438)
Q Consensus       340 ~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  363 (438)
                      + ..++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 58899999999999999864211                                                       


Q ss_pred             ----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          364 ----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       364 ----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                          ...+++.++..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~  226 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK  226 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeeccccccccc
Confidence                134788899999999999999999   89999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=9.6e-27  Score=228.55  Aligned_cols=168  Identities=23%  Similarity=0.252  Sum_probs=140.5

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ..++....++|++.+.||+|+||.||++.. .+++.+|+|.+...   .....+.+.+|+.+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            444555668899999999999999999955 46789999998642   22334567899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      ++..++||||+++|+|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999843    34788888999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCceeeeeeeec
Q 013693          419 LARCFAADRTHVSTAVAGT  437 (438)
Q Consensus       419 la~~~~~~~~~~~~~~~Gt  437 (438)
                      +++.+............||
T Consensus       188 ~a~~~~~~~~~~~~~~~gt  206 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGT  206 (371)
T ss_pred             ceeEcCcCCcccccCcccC
Confidence            9988754433222234455

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-26  Score=228.33  Aligned_cols=147  Identities=23%  Similarity=0.348  Sum_probs=131.2

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++. ..+++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            468889999999999999994 457899999998653   2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999853   345888999999999999999999   899999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-26  Score=223.34  Aligned_cols=152  Identities=24%  Similarity=0.260  Sum_probs=133.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.||+|++...   .....+.+.+|+.++..++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999964 46889999998642   2234556889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998532  345889999999999999999999   899999999999999999999999999999876544


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       156 ~  156 (331)
T cd05597         156 G  156 (331)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.94  E-value=3.3e-27  Score=232.63  Aligned_cols=161  Identities=29%  Similarity=0.434  Sum_probs=138.3

Q ss_pred             CCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC------CeEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------PESLL  344 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  344 (438)
                      |...+.||+|+||.||+|+ ..+|+.||||.+... .....+...+|+++|++|+|||||++++.-...      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4556889999999999996 567999999998764 344567788999999999999999999975543      36789


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCC--CeEEeccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDF--TPKIADFGLA  420 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~--~~kl~DFGla  420 (438)
                      ||||+.+|||...|.+..+...|++.+.+.++.++..||.|||   +++|+||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999988777778999999999999999999999   89999999999999993  334  3699999999


Q ss_pred             ccccCCCceeeeeeeecC
Q 013693          421 RCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       421 ~~~~~~~~~~~~~~~Gt~  438 (438)
                      |.+++++.  -+.++||+
T Consensus       172 rel~d~s~--~~S~vGT~  187 (732)
T KOG4250|consen  172 RELDDNSL--FTSLVGTE  187 (732)
T ss_pred             ccCCCCCe--eeeecCch
Confidence            99988773  34477884

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=7.1e-27  Score=229.46  Aligned_cols=151  Identities=25%  Similarity=0.281  Sum_probs=132.4

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ..++|++.+.||+|+||.||++.. .+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            356788899999999999999954 46889999998643   22334557899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999843    24788888899999999999999   8999999999999999999999999999998775


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       194 ~~  195 (370)
T cd05596         194 AN  195 (370)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.94  E-value=2.8e-26  Score=221.25  Aligned_cols=141  Identities=26%  Similarity=0.299  Sum_probs=125.9

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.||+|+||.||++.. .+++.||+|++...   .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 57899999999754   2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99998853   345899999999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=1.8e-26  Score=227.66  Aligned_cols=146  Identities=26%  Similarity=0.360  Sum_probs=130.7

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .|+..+.||+|+||.||++. ..+++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            57888999999999999994 456889999999753   23445678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++++||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            9999999999853   345888899999999999999999   899999999999999999999999999998755

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.94  E-value=3.1e-26  Score=218.99  Aligned_cols=153  Identities=30%  Similarity=0.514  Sum_probs=131.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC-----------------CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceee
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN-----------------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK  331 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  331 (438)
                      .++|.+.++||+|+||.||++.+.+                 +..||+|.+... ......+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3568888999999999999996432                 346999998754 3344567999999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHhhccC----------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 013693          332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRII  395 (438)
Q Consensus       332 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii  395 (438)
                      +++++...+..++||||+++++|.+++....                ....+++..++.++.||+.||.|||   +.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999885421                1134788899999999999999999   88999


Q ss_pred             eCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          396 HRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       396 H~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||||||+|||++.++.+||+|||+++.+..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceeccc
Confidence            999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=1.6e-26  Score=223.59  Aligned_cols=149  Identities=23%  Similarity=0.303  Sum_probs=132.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46788899999999999999654 68899999987542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999854   345788899999999999999999   89999999999999999999999999999987754

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=2.3e-26  Score=222.58  Aligned_cols=153  Identities=23%  Similarity=0.280  Sum_probs=134.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999954 468999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999543  245899999999999999999999   899999999999999999999999999999887654


Q ss_pred             Cc
Q 013693          427 RT  428 (438)
Q Consensus       427 ~~  428 (438)
                      ..
T Consensus       156 ~~  157 (330)
T cd05601         156 KM  157 (330)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=2.8e-26  Score=222.04  Aligned_cols=162  Identities=24%  Similarity=0.232  Sum_probs=136.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.||+|.+...   .....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688899999999999999965 46788999998642   2233456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  245888999999999999999999   899999999999999999999999999999887654


Q ss_pred             Cceeeeeeeec
Q 013693          427 RTHVSTAVAGT  437 (438)
Q Consensus       427 ~~~~~~~~~Gt  437 (438)
                      .........||
T Consensus       156 ~~~~~~~~~gt  166 (331)
T cd05624         156 GTVQSSVAVGT  166 (331)
T ss_pred             CceeeccccCC
Confidence            43322233454

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-26  Score=226.77  Aligned_cols=148  Identities=25%  Similarity=0.356  Sum_probs=132.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||+|+||.||++.. .+++.||||++....   ......+.+|+.++..++||||+++++++.+++..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4688899999999999999955 468999999997532   334566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999854   235899999999999999999999   8999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-26  Score=223.55  Aligned_cols=149  Identities=28%  Similarity=0.411  Sum_probs=132.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++..++||||+++++++...+..+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999654 58899999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999943   345889999999999999999999   89999999999999999999999999999987643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=2.1e-26  Score=223.41  Aligned_cols=150  Identities=29%  Similarity=0.379  Sum_probs=131.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC--CCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN--GTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.+.||+|+||.||+|....  +..||+|++...   .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3458888999999999999996433  368999998643   23345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999854   345889999999999999999999   8999999999999999999999999999998764


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       183 ~  183 (340)
T PTZ00426        183 T  183 (340)
T ss_pred             C
Confidence            3

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.94  E-value=3.3e-27  Score=208.00  Aligned_cols=167  Identities=25%  Similarity=0.388  Sum_probs=142.9

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecc--------hhhHHHHHHHHHHHhcc-CCCceeeEE
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSI-EHKNLVKLL  333 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~  333 (438)
                      ..-+..-++|+..+.||+|..+.|-++ ...++.++|+|++....        ....++-.+|+.||+++ .||+|+++.
T Consensus        10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            344555677889999999999999888 55678999999986421        12345567899999998 699999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeE
Q 013693          334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (438)
Q Consensus       334 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  413 (438)
                      ++++.+...++|+|.|+.|.|.++|.   ....+++++..+|++|+.+|+.|||   ...||||||||+|||+|++.++|
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceE
Confidence            99999999999999999999999993   3456999999999999999999999   89999999999999999999999


Q ss_pred             EecccccccccCCCceeeeeeeecC
Q 013693          414 IADFGLARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       414 l~DFGla~~~~~~~~~~~~~~~Gt~  438 (438)
                      |+|||+|..+.+...-  ..++|||
T Consensus       164 isDFGFa~~l~~GekL--relCGTP  186 (411)
T KOG0599|consen  164 ISDFGFACQLEPGEKL--RELCGTP  186 (411)
T ss_pred             EeccceeeccCCchhH--HHhcCCC
Confidence            9999999998766532  3467776

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=5.9e-27  Score=224.33  Aligned_cols=163  Identities=26%  Similarity=0.430  Sum_probs=143.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-EEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-SLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  346 (438)
                      ++|...+++|+|+||.++.... .++..+++|++....  ....+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5688899999999999998844 357789999997543  3344567899999999999999999999999888 99999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +|++||+|.+.+.+.+ ...++++.++.++.|++.|+.|||   +..|+|||||+.||+++.++.|||.|||+|+.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997654 567999999999999999999999   899999999999999999999999999999999888


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ..... +++|||
T Consensus       160 ~~~a~-tvvGTp  170 (426)
T KOG0589|consen  160 DSLAS-TVVGTP  170 (426)
T ss_pred             hhhhh-eecCCC
Confidence            74443 477886

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.5e-27  Score=213.42  Aligned_cols=152  Identities=30%  Similarity=0.491  Sum_probs=133.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEee--ecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe-----C
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-----G  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  339 (438)
                      .....|...+.||+|+||.|..+ ...++..||||++.  .......++..+|+.+|+.++|+||+.+.+.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34556666899999999999999 55678999999997  5566678889999999999999999999998765     3


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      +..|+|+|+| +.+|.+.++.   ...++..++..++.|+++||+|+|   +.+|+||||||+|+|++.+..+||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence            4689999999 6699999943   344899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCC
Q 013693          420 ARCFAAD  426 (438)
Q Consensus       420 a~~~~~~  426 (438)
                      ||.....
T Consensus       172 AR~~~~~  178 (359)
T KOG0660|consen  172 ARYLDKF  178 (359)
T ss_pred             eeecccc
Confidence            9998653

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=4.8e-26  Score=220.05  Aligned_cols=142  Identities=27%  Similarity=0.314  Sum_probs=126.4

Q ss_pred             CccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.||+|+||.||++. ..+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999995 456899999999754   2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +|..++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            99988843   345899999999999999999999   8999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.7e-26  Score=219.43  Aligned_cols=149  Identities=23%  Similarity=0.336  Sum_probs=132.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999654 68899999986532   234566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999853   345889999999999999999999   89999999999999999999999999999987754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=2.7e-26  Score=226.56  Aligned_cols=146  Identities=25%  Similarity=0.365  Sum_probs=130.2

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .|+..++||+|+||.||++.. .+++.+|+|++....   ....+.+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999954 568899999987542   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            9999999999854   245788889999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=3.2e-26  Score=225.57  Aligned_cols=147  Identities=24%  Similarity=0.352  Sum_probs=130.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|++++++++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688899999999999999954 468999999986432   233566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|..+
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999999999854   345788888999999999999999   899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=4.1e-26  Score=220.09  Aligned_cols=141  Identities=27%  Similarity=0.293  Sum_probs=125.7

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.||+|+||.||++.. .++..||+|++...   .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999954 56899999999754   2334566788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            99988843   345899999999999999999999   899999999999999999999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6.5e-26  Score=217.66  Aligned_cols=140  Identities=21%  Similarity=0.233  Sum_probs=125.1

Q ss_pred             cccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ||+|+||.||++.. .+++.||+|++...   .......+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999955 46889999998743   234456788999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      .+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            999854   345889999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=5e-26  Score=220.59  Aligned_cols=163  Identities=27%  Similarity=0.370  Sum_probs=141.8

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch---hhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCe
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPE  341 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  341 (438)
                      ......|++.+.||+|.||.||++..+ +|+.+|+|.+.+...   ...+.+.+|+.+|++++ |||||.+.+.+.+...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            345567888899999999999999554 599999999976533   24568999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC----CCCeEEecc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK----DFTPKIADF  417 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kl~DF  417 (438)
                      .++|||++.||.|.+.+...    .+++..+..++.|++.++.|||   ..+|+||||||+|+|+..    ++.+|++||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            99999999999999998554    2999999999999999999999   899999999999999953    357999999


Q ss_pred             cccccccCCCceeeeeeeecC
Q 013693          418 GLARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       418 Gla~~~~~~~~~~~~~~~Gt~  438 (438)
                      |+|.....  ......++|||
T Consensus       184 Gla~~~~~--~~~~~~~~Gtp  202 (382)
T KOG0032|consen  184 GLAKFIKP--GERLHTIVGTP  202 (382)
T ss_pred             CCceEccC--CceEeeecCCc
Confidence            99999987  33445678886

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=4.9e-26  Score=220.42  Aligned_cols=150  Identities=25%  Similarity=0.306  Sum_probs=130.6

Q ss_pred             CCCCCCccccCCceeEEEEEc----cCCCEEEEEEeeec----chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFN----TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (438)
                      +|++.+.||+|+||.||++..    .+++.||+|++...    .....+.+.+|+.++..+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999854    35789999998643    223345688999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999854   345889999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +....
T Consensus       155 ~~~~~  159 (332)
T cd05614         155 FLSEE  159 (332)
T ss_pred             ccccC
Confidence            65433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=1.2e-25  Score=217.02  Aligned_cols=142  Identities=26%  Similarity=0.292  Sum_probs=125.4

Q ss_pred             CccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.||+|+||.||++. ..+++.||+|.+...   .......+.+|++++..++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999995 457899999999753   2334566788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +|..++..   ...+++..+..++.||+.||.|||   + .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            99988843   345899999999999999999999   5 799999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=8.1e-26  Score=214.11  Aligned_cols=149  Identities=26%  Similarity=0.314  Sum_probs=130.6

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      |+..+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66788999999999999954 578999999986542   22334678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++.+..
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            9999998887543 2335899999999999999999999   89999999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.7e-26  Score=225.65  Aligned_cols=150  Identities=28%  Similarity=0.406  Sum_probs=133.7

Q ss_pred             CCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      -|++.+.||.|+-|.|-+| +..+|+.+|||++...   .......+.+||.||+.+.||||+++++++.+..++|||.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3778899999999999999 5568999999999654   22334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+++|-|.+++..   .+++++.++.+++.||+.|+.|+|   ..+|+||||||+|+|||.++++||+|||||.+-.++.
T Consensus        93 yv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   93 YVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             ecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            9999999999954   455889999999999999999999   8999999999999999999999999999998765544

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=6.4e-26  Score=219.59  Aligned_cols=162  Identities=23%  Similarity=0.243  Sum_probs=136.1

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.++||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.++..++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999654 5788999998642   2233455889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  235889999999999999999999   899999999999999999999999999999876544


Q ss_pred             Cceeeeeeeec
Q 013693          427 RTHVSTAVAGT  437 (438)
Q Consensus       427 ~~~~~~~~~Gt  437 (438)
                      .........||
T Consensus       156 ~~~~~~~~~gt  166 (332)
T cd05623         156 GTVQSSVAVGT  166 (332)
T ss_pred             CcceecccccC
Confidence            33322233454

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=7e-26  Score=229.59  Aligned_cols=151  Identities=18%  Similarity=0.286  Sum_probs=133.2

Q ss_pred             CCCCCccccCCceeEEEEEc-cC-CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      |.+.+.||+|+||.||++.. .+ ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            78889999999999999944 33 67889998766665556678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          351 NRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       351 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +|+|.+++... ....++++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999988543 23346889999999999999999999   899999999999999999999999999999987543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.93  E-value=8.3e-26  Score=214.37  Aligned_cols=148  Identities=28%  Similarity=0.446  Sum_probs=129.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|+..++||+|+||.||++.. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4688899999999999999954 468899999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            975 898888432  345788999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=4.6e-26  Score=222.17  Aligned_cols=151  Identities=28%  Similarity=0.380  Sum_probs=134.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++... +++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999654 68999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999543   46899999999999999999999   899999999999999999999999999999877654


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       155 ~  155 (350)
T cd05573         155 K  155 (350)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.93  E-value=7.5e-26  Score=214.39  Aligned_cols=150  Identities=24%  Similarity=0.361  Sum_probs=130.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|++.+.||+|+||.||++... +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999664 57899999987542  3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |++++.+..+..   ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999887765542   2345889999999999999999999   899999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-26  Score=231.51  Aligned_cols=155  Identities=30%  Similarity=0.447  Sum_probs=134.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCC-CEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeE-EEe---C--
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNG-TTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGC-SIE---G--  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~---~--  339 (438)
                      ....++++.+.|.+|||+.||.+....+ .++|+|++...++...+.+.+||++|++|+ |||||.+++. ...   .  
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3344567788999999999999976665 999999999889999999999999999996 9999999993 221   1  


Q ss_pred             -CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          340 -PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       340 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                       -+.+|.||||++|.|-+++..+.... |++.++++|+.++++|+.+||.. +.+|||||||.|||||+.+++.||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence             25789999999999999997554433 99999999999999999999964 6789999999999999999999999999


Q ss_pred             cccccc
Q 013693          419 LARCFA  424 (438)
Q Consensus       419 la~~~~  424 (438)
                      .|....
T Consensus       192 Satt~~  197 (738)
T KOG1989|consen  192 SATTKI  197 (738)
T ss_pred             cccccc
Confidence            987543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=191.51  Aligned_cols=150  Identities=27%  Similarity=0.465  Sum_probs=129.9

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..++||+|.||+||+++ +.+++.||+|+++.++  +.--....+|+.+|+.++|+|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45667889999999999994 4568899999998653  23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +. .+|..+...  -...++.+...+++.|+++||.|+|   +..+.||||||.|.||+.+|+.||+|||+||.++-+-
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            94 478777633  2345889999999999999999999   8899999999999999999999999999999987553

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.93  E-value=8.6e-26  Score=222.23  Aligned_cols=155  Identities=32%  Similarity=0.444  Sum_probs=132.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (438)
                      ..++|++.+.||+|+||.||++..      .++..||||+++... ....+.+.+|+.++..+ +||||+++++++..++
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345688899999999999999853      245689999986442 33456788999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC---------------------------------------------------------
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNK---------------------------------------------------------  363 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  363 (438)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999999854211                                                         


Q ss_pred             ---------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          364 ---------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       364 ---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                                     ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                           124788999999999999999999   899999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=6.8e-26  Score=210.62  Aligned_cols=149  Identities=27%  Similarity=0.310  Sum_probs=133.2

Q ss_pred             CCCCCCccccCCceeEEEEEccC-CCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .|+..+.||.|.-|.||++++.+ +..+|+|++.+.   ..+...+.+-|-+||+.++||.++.|+..++.+...+|+||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            34556889999999999997764 588999999765   34455677889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+||+|..+++. +..+.+++..+.-++.+|+-||+|||   ..|||.|||||+||||.++|++.|+||.|+....
T Consensus       158 yCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  158 YCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             cCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            9999999988865 45667999999999999999999999   9999999999999999999999999999998763

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.93  E-value=1.4e-25  Score=219.78  Aligned_cols=148  Identities=24%  Similarity=0.347  Sum_probs=131.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||+|+||.||++.. .+++.||+|++...   .......+.+|+.++..++||||+++++.+.+.+..+|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3678889999999999999954 46899999999743   2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            99999999999853   345889999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.93  E-value=1e-25  Score=214.46  Aligned_cols=156  Identities=28%  Similarity=0.343  Sum_probs=131.2

Q ss_pred             CCccccCCceeEEEE-EccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      .++||+|.||+||-| +.++|+.||||++.+.  .....+.+++|+.||+++.||.||.+...++..+..+.|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            478999999999999 4457999999998653  23344778999999999999999999999999999999999995 5


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEecccccccccCCCce
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFAADRTH  429 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGla~~~~~~~~~  429 (438)
                      ++.+++....+ ..+++....-++.||+.||.|||   .++|+|.||||+|||+..   --.+||+|||+||++++.+-+
T Consensus       648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            66666644433 34788777889999999999999   899999999999999953   347999999999999877654


Q ss_pred             eeeeeeecC
Q 013693          430 VSTAVAGTL  438 (438)
Q Consensus       430 ~~~~~~Gt~  438 (438)
                      .  .++|||
T Consensus       724 r--sVVGTP  730 (888)
T KOG4236|consen  724 R--SVVGTP  730 (888)
T ss_pred             h--hhcCCc
Confidence            3  477886

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-27  Score=213.10  Aligned_cols=158  Identities=31%  Similarity=0.480  Sum_probs=139.9

Q ss_pred             CCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      |++.++||+|+||.||++ +...|+.+|||++...  .+.+++..|+.|+++.+.|++|+++|.+.....+|+||||+..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            566789999999999999 4557999999998654  4578899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCceee
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  431 (438)
                      |++.++++.  +.+++++.++..+++..++||+|||   ...-||||||..|||++.+|.+||+|||.|..+.+.-....
T Consensus       113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence            999999954  4567999999999999999999999   88999999999999999999999999999998865443332


Q ss_pred             eeeeecC
Q 013693          432 TAVAGTL  438 (438)
Q Consensus       432 ~~~~Gt~  438 (438)
                       ++.|||
T Consensus       188 -TVIGTP  193 (502)
T KOG0574|consen  188 -TVIGTP  193 (502)
T ss_pred             -ccccCc
Confidence             467876

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.2e-25  Score=222.06  Aligned_cols=141  Identities=22%  Similarity=0.280  Sum_probs=125.1

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ++|++.+.||+|+||.||++. ..+++.||+|...      .+.+.+|+.++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            569999999999999999994 4578999999653      235678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      . ++|..++..   ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            5 688888743   235889999999999999999999   8899999999999999999999999999997654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=1.9e-25  Score=215.49  Aligned_cols=142  Identities=28%  Similarity=0.349  Sum_probs=124.7

Q ss_pred             CccccCCceeEEEEEc----cCCCEEEEEEeeecc----hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +.||+|+||.||++..    ..++.||+|.+....    ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999954    357899999987532    23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            999999999843   345788888999999999999999   8999999999999999999999999999998543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=2.3e-25  Score=214.36  Aligned_cols=144  Identities=26%  Similarity=0.273  Sum_probs=126.6

Q ss_pred             CccccCCceeEEEEEc----cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          277 KKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      +.||+|+||.||++..    .+++.+|+|++....  ......+.+|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999853    357899999997542  2234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            9999999843   345899999999999999999999   899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=1.9e-25  Score=215.49  Aligned_cols=145  Identities=32%  Similarity=0.425  Sum_probs=125.2

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHH---hccCCCceeeEEeEEEeCCeEEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLI---SSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      |++.+.||+|+||.||++.. .+++.||||+++...   ....+.+.+|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56678999999999999954 468999999997542   23345666776655   566899999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |||+++++|...+.    ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999998883    245899999999999999999999   8999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.93  E-value=1.9e-25  Score=209.32  Aligned_cols=149  Identities=25%  Similarity=0.409  Sum_probs=131.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc----CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            346888899999999999999542    35689999987552 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||||+++++|.+++...  ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999998543  345899999999999999999999   899999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.5e-27  Score=238.85  Aligned_cols=170  Identities=26%  Similarity=0.237  Sum_probs=151.6

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ..+++.-.++|++.++||+|+||.|..++. .+++.+|+|++.+.   ......-|..|-++|..-+.++|+.++-.|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            445566667899999999999999999965 45788999998752   34455679999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      +.++|+|||||+||+|..++...   ..+++.-+.-++..|+.||.-||   +.|+|||||||+|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccch
Confidence            99999999999999999999543   36888888899999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCceeeeeeeecC
Q 013693          419 LARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       419 la~~~~~~~~~~~~~~~Gt~  438 (438)
                      .+-.+..++...+...+|||
T Consensus       221 sClkm~~dG~V~s~~aVGTP  240 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTP  240 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCC
Confidence            99999999988888889998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.93  E-value=2.6e-25  Score=212.56  Aligned_cols=149  Identities=30%  Similarity=0.441  Sum_probs=129.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367899999999999999999654 688999999875432 233467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |++ ++|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            995 5787777432  345888999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=3.2e-25  Score=214.43  Aligned_cols=141  Identities=24%  Similarity=0.302  Sum_probs=125.0

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .+++.||+|+++..   .....+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999954 46889999999754   233456688999999998 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            999988843   345899999999999999999999   899999999999999999999999999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=3.6e-25  Score=213.61  Aligned_cols=146  Identities=27%  Similarity=0.288  Sum_probs=127.2

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCC-CceeeEEeEEEeCCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  346 (438)
                      +|++.+.||+|+||.||+|.. .+++.||||++...   .....+.+..|..++..++| ++|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            477889999999999999955 45789999998754   23345678889999999976 46888999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999999998843   345889999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.93  E-value=1.9e-25  Score=218.15  Aligned_cols=144  Identities=28%  Similarity=0.437  Sum_probs=125.6

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +|+..++||+|+||.||++.. .+++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            345568899999999999954 468999999986543 334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|....       ..++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999986432       2456778889999999999999   89999999999999999999999999999987653

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.93  E-value=1.6e-25  Score=220.20  Aligned_cols=157  Identities=31%  Similarity=0.457  Sum_probs=133.4

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      ....++|++.+.||+|+||.||++..      .++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            34456788999999999999999853      234579999997543 33456788999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccC--------------------------------------------------------
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKN--------------------------------------------------------  362 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  362 (438)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999885321                                                        


Q ss_pred             -----------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          363 -----------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       363 -----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                                 ....+++.++..|+.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++.+..+
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~  265 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND  265 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence                       1134788899999999999999999   899999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=4e-25  Score=213.71  Aligned_cols=141  Identities=26%  Similarity=0.307  Sum_probs=124.4

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .+++.+|+|++...   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999964 46789999999754   233456678899988877 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999888843   345899999999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.93  E-value=3.4e-25  Score=212.97  Aligned_cols=143  Identities=29%  Similarity=0.341  Sum_probs=122.9

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .+++.||+|.++...   ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 457899999997542   23345566777777654 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|..++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            999998853   235889999999999999999999   89999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=3.6e-25  Score=213.36  Aligned_cols=142  Identities=28%  Similarity=0.336  Sum_probs=124.5

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      ++||+|+||.||+|.. .+++.||+|++...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999965 45789999998754   233455677899999876 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|...+..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence            999988843   345889999999999999999999   8999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.93  E-value=4.9e-25  Score=212.78  Aligned_cols=141  Identities=28%  Similarity=0.333  Sum_probs=121.6

Q ss_pred             CccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++. ..+++.+|+|++...   .......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999995 456899999998754   2233445556654 56778999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            999888843   345899999999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=4.2e-25  Score=205.71  Aligned_cols=149  Identities=25%  Similarity=0.419  Sum_probs=132.1

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      +.|+..+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4577788999999999999988778899999876432 234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++|.+++....  ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999985432  35889999999999999999999   89999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=6.6e-25  Score=212.42  Aligned_cols=151  Identities=25%  Similarity=0.374  Sum_probs=132.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|+..+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            46788999999999999999955 46888999998765 33445679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999999854   2358899999999999999999993  24699999999999999999999999999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=5e-25  Score=212.55  Aligned_cols=147  Identities=27%  Similarity=0.282  Sum_probs=127.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +|++.+.||+|+||.||++.. .+++.||+|.+....   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            477889999999999999954 457899999987542   23345567788888877 5899999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999988843   245889999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.93  E-value=4.7e-25  Score=218.01  Aligned_cols=156  Identities=26%  Similarity=0.372  Sum_probs=132.8

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccC-CCceeeEEeEEEe
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIE  338 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  338 (438)
                      +...+.|.+.++||+|+||.||+|...      .+..||||++.... ....+.+.+|+.+++++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344567889999999999999999642      23479999997543 334567999999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCC-------------------------------------------------------
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNK-------------------------------------------------------  363 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  363 (438)
                      .+..+|||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999998854210                                                       


Q ss_pred             --------------------------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          364 --------------------------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       364 --------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                                                            ...+++.+++.++.||++||.|||   +.+|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEE
Confidence                                                  124788889999999999999999   899999999999999


Q ss_pred             eCCCCCeEEecccccccccC
Q 013693          406 LDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~  425 (438)
                      ++.++.+||+|||+++.+..
T Consensus       270 l~~~~~~kL~DfGla~~~~~  289 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMH  289 (400)
T ss_pred             EeCCCEEEEEeCCcceeccc
Confidence            99999999999999987644

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=7.6e-25  Score=212.15  Aligned_cols=150  Identities=24%  Similarity=0.366  Sum_probs=132.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467999999999999999999654 6788999988754 33345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+  ..+|+|+||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            9999999999853   2357888999999999999999993  3479999999999999999999999999998664

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=7.2e-25  Score=207.06  Aligned_cols=145  Identities=26%  Similarity=0.343  Sum_probs=126.3

Q ss_pred             cccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ||+|+||.||++.. .+++.+|+|.+....   ....+.+..|+.++++++||||+++.+++...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999954 468899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             HHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          355 DQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       355 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      .+++... .....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            9887542 23346899999999999999999999   899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.93  E-value=4.8e-25  Score=212.36  Aligned_cols=142  Identities=28%  Similarity=0.371  Sum_probs=124.4

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .+++.||+|++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999955 46889999998753   233456677888888877 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~  147 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  147 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence            999988853   345889999999999999999999   8999999999999999999999999999988643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.92  E-value=5.4e-25  Score=205.48  Aligned_cols=152  Identities=34%  Similarity=0.529  Sum_probs=135.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++.+...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            45688899999999999999988788899999886543 23578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999998643 3345888999999999999999999   899999999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.92  E-value=6.7e-25  Score=204.44  Aligned_cols=150  Identities=29%  Similarity=0.459  Sum_probs=132.5

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      ++|+..+.||+|+||.||++...++..+|+|.+.... ...+++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3577788999999999999987777789999886433 234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++|.+++....  ..+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.+||+|||+++....+
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            999999985432  35899999999999999999999   899999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.92  E-value=6.8e-25  Score=211.41  Aligned_cols=141  Identities=28%  Similarity=0.348  Sum_probs=120.8

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      ++||+|+||.||++.. .+++.||+|++....   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 468899999987532   222344555554 67889999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|...+..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999888843   345788889999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.92  E-value=4.9e-25  Score=212.59  Aligned_cols=147  Identities=27%  Similarity=0.299  Sum_probs=127.5

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +|+..+.||+|+||.||++.. .+++.||+|++....   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            367788999999999999954 468899999987532   234456788999998885 578888999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999998843   345899999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.92  E-value=8.1e-25  Score=211.07  Aligned_cols=141  Identities=28%  Similarity=0.342  Sum_probs=121.3

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .+++.||+|++....   ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999955 468999999987532   223344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999998853   345889999999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-25  Score=233.19  Aligned_cols=151  Identities=34%  Similarity=0.551  Sum_probs=133.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC--C----CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN--G----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      ..+.+..+.||+|.||.||.|...+  +    ..||||.+... +.+...+|.+|..+|++++|||||+++|++.+.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3445567889999999999995532  3    35899999765 567788999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCC----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      +|++|||++|+|..+|++.+.    ...++..+++.++.|||+|+.||+   ++++|||||..+|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999975421    445889999999999999999999   8999999999999999999999999999


Q ss_pred             ccccc
Q 013693          419 LARCF  423 (438)
Q Consensus       419 la~~~  423 (438)
                      |||.+
T Consensus       848 lArDi  852 (1025)
T KOG1095|consen  848 LARDI  852 (1025)
T ss_pred             hhHhh
Confidence            99944

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.92  E-value=5.1e-25  Score=216.67  Aligned_cols=148  Identities=28%  Similarity=0.438  Sum_probs=128.3

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESL  343 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  343 (438)
                      +|+..+.||+|+||.||++.. .+++.||||++...  .....+++.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999964 57899999998643  2334567889999999999999999999998776     789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+. ++|.+.+..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 578777733   345899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCC
Q 013693          424 AAD  426 (438)
Q Consensus       424 ~~~  426 (438)
                      ...
T Consensus       154 ~~~  156 (372)
T cd07853         154 EPD  156 (372)
T ss_pred             ccC
Confidence            543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.92  E-value=6.4e-25  Score=211.10  Aligned_cols=151  Identities=29%  Similarity=0.498  Sum_probs=129.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCC----EEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGT----TVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+... .....+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45888999999999999999653 333    4899998654 334567899999999999999999999998765 5679


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998543  335888999999999999999999   8999999999999999999999999999999876


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      .+.
T Consensus       161 ~~~  163 (316)
T cd05108         161 ADE  163 (316)
T ss_pred             CCC
Confidence            443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=1.1e-24  Score=206.03  Aligned_cols=151  Identities=32%  Similarity=0.533  Sum_probs=132.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-----cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  343 (438)
                      ++|++.+.||+|+||.||++..     .++..||+|++........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4678889999999999999863     35789999998776666677899999999999999999999987543  4689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998542  235899999999999999999999   899999999999999999999999999999987


Q ss_pred             cCC
Q 013693          424 AAD  426 (438)
Q Consensus       424 ~~~  426 (438)
                      ...
T Consensus       159 ~~~  161 (284)
T cd05081         159 PQD  161 (284)
T ss_pred             cCC
Confidence            543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.92  E-value=1e-24  Score=210.70  Aligned_cols=141  Identities=26%  Similarity=0.306  Sum_probs=124.8

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .+++.+|+|++...   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999954 46789999999754   233456688999999888 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999988843   345899999999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=6e-25  Score=205.27  Aligned_cols=152  Identities=29%  Similarity=0.428  Sum_probs=135.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..++|++.+.||+|++|.||++...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            345688899999999999999987777889999986543 2356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999995432 346899999999999999999999   89999999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=5.2e-25  Score=213.61  Aligned_cols=146  Identities=25%  Similarity=0.392  Sum_probs=125.5

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESL  343 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  343 (438)
                      +|++.+.||+|+||.||++. ..+++.||||++...  .......+.+|+.++++++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            47788999999999999995 456899999998643  2234457889999999999999999999876433     479


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+. ++|.+++..   ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 689888843   345899999999999999999999   899999999999999999999999999999865


Q ss_pred             c
Q 013693          424 A  424 (438)
Q Consensus       424 ~  424 (438)
                      .
T Consensus       154 ~  154 (338)
T cd07859         154 F  154 (338)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.92  E-value=4.6e-26  Score=218.56  Aligned_cols=149  Identities=27%  Similarity=0.484  Sum_probs=130.5

Q ss_pred             ccccCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 013693          258 CLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (438)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (438)
                      .+.+.+++|.+       ++-||.|+.|.||+|.+ .++.||||+++...+       .+|+-|++|+||||+.+.|+|.
T Consensus       118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             hccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeec
Confidence            34555555544       68899999999999998 568999998753322       4788899999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      ...-++|||||+..|-|.++|+   ...++.......+..+||.|+.|||   .+.|||||||.-||||..+..|||+||
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             CCceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccc
Confidence            9999999999999999999994   4556888999999999999999999   899999999999999999999999999


Q ss_pred             cccccccCCC
Q 013693          418 GLARCFAADR  427 (438)
Q Consensus       418 Gla~~~~~~~  427 (438)
                      |-++.+.+.+
T Consensus       257 GTS~e~~~~S  266 (904)
T KOG4721|consen  257 GTSKELSDKS  266 (904)
T ss_pred             cchHhhhhhh
Confidence            9999887654

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.92  E-value=4.3e-25  Score=206.12  Aligned_cols=154  Identities=32%  Similarity=0.479  Sum_probs=138.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ....+|+..++||+|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34566888999999999999999877789999999987666567789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999653 3356899999999999999999999   89999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=9.1e-25  Score=206.93  Aligned_cols=150  Identities=26%  Similarity=0.314  Sum_probs=130.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +|+..++||+|+||.||++.. .+++.||+|++....   ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            377788999999999999954 468899999986532   2223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++|.+++... ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++....
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999888543 2345899999999999999999999   88999999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.92  E-value=5.7e-27  Score=203.58  Aligned_cols=161  Identities=27%  Similarity=0.356  Sum_probs=135.1

Q ss_pred             hcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .+.|++.+.||+|.|+.|++. +.++|+.+|+|.+..+  .....+++.+|+.|.+.|+||||++|+......+..+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            456777789999999999998 6678999999988643  3346788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGla~~~  423 (438)
                      |+|.|++|..-+-.+   ..+++..+-..++||+++|.|+|   .++|||||+||+|+|+..   ..-+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999996655322   44788888899999999999999   899999999999999953   346899999999999


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      + +.. .-...+|||
T Consensus       164 ~-~g~-~~~G~~GtP  176 (355)
T KOG0033|consen  164 N-DGE-AWHGFAGTP  176 (355)
T ss_pred             C-Ccc-ccccccCCC
Confidence            8 332 223456776

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.92  E-value=1.2e-24  Score=210.14  Aligned_cols=142  Identities=25%  Similarity=0.300  Sum_probs=120.0

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHH-HHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEV-NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .+++.+|+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999955 457889999987532   12233444444 456788999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|.+++..   ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            999999853   344778888889999999999999   8999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-26  Score=220.79  Aligned_cols=155  Identities=32%  Similarity=0.521  Sum_probs=133.2

Q ss_pred             CCCCCccccCCceeEEEE-EccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      |..++.||.|+||.||.+ ...+.+.||||++....   ....+++..|+..|.+++|||++.+-|++..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            555678999999999999 45578899999997543   33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      |- |+-.+++.-  ..+++.+.++..|..+.+.||.|||   +.+.||||||+.|||+++.|.|||+|||.|.+..+..+
T Consensus       108 Cl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns  181 (948)
T KOG0577|consen  108 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS  181 (948)
T ss_pred             Hh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence            94 477777632  3456899999999999999999999   89999999999999999999999999999998866543


Q ss_pred             eeeeeeeecC
Q 013693          429 HVSTAVAGTL  438 (438)
Q Consensus       429 ~~~~~~~Gt~  438 (438)
                           ++|||
T Consensus       182 -----FvGTP  186 (948)
T KOG0577|consen  182 -----FVGTP  186 (948)
T ss_pred             -----ccCCc
Confidence                 55665

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-26  Score=214.56  Aligned_cols=161  Identities=25%  Similarity=0.418  Sum_probs=143.0

Q ss_pred             cCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..|+..+.||+|.||.||+| ....++.||+|++... .+...+++++|+.+|..++++||.++++.+..+..+|++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34677799999999999999 4557899999999865 456678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      +.+|++.+.+.   ....+++.++.-|+++++.||.|||   ..+.+|||||+.|||+..+|.+||+|||++-.+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999993   3444588888889999999999999   89999999999999999999999999999999987776


Q ss_pred             eeeeeeeecC
Q 013693          429 HVSTAVAGTL  438 (438)
Q Consensus       429 ~~~~~~~Gt~  438 (438)
                      .. .+.+|||
T Consensus       167 rr-~tfvGTP  175 (467)
T KOG0201|consen  167 RR-KTFVGTP  175 (467)
T ss_pred             cc-ccccccc
Confidence            65 4577886

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.92  E-value=1.4e-24  Score=208.71  Aligned_cols=141  Identities=30%  Similarity=0.363  Sum_probs=122.9

Q ss_pred             CccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++... +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999654 57899999997542   23345567788888764 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999999853   245889999999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=5.4e-25  Score=223.44  Aligned_cols=159  Identities=24%  Similarity=0.308  Sum_probs=135.3

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (438)
                      .+.+...++|.+.+.||+|+||.||++. ..+++.||||++...  .......+.+|+.++..++|+||++++..+...+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            3444556789999999999999999995 457899999998754  3445667889999999999999999988765432


Q ss_pred             --------eEEEEEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC
Q 013693          341 --------ESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (438)
Q Consensus       341 --------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  411 (438)
                              ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCC
Confidence                    3689999999999999986432 3356899999999999999999999   899999999999999999999


Q ss_pred             eEEecccccccccC
Q 013693          412 PKIADFGLARCFAA  425 (438)
Q Consensus       412 ~kl~DFGla~~~~~  425 (438)
                      +||+|||+++.+..
T Consensus       182 vkL~DFGls~~~~~  195 (496)
T PTZ00283        182 VKLGDFGFSKMYAA  195 (496)
T ss_pred             EEEEecccCeeccc
Confidence            99999999988754

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=1.4e-24  Score=203.61  Aligned_cols=152  Identities=28%  Similarity=0.510  Sum_probs=132.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-C---CCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-N---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|++.+.||+|+||.||+|... +   +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999653 2   3379999886542 33456889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++...  ...+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999543  245899999999999999999999   89999999999999999999999999999998765


Q ss_pred             CC
Q 013693          426 DR  427 (438)
Q Consensus       426 ~~  427 (438)
                      ..
T Consensus       159 ~~  160 (267)
T cd05066         159 DP  160 (267)
T ss_pred             cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.92  E-value=1.2e-24  Score=209.20  Aligned_cols=141  Identities=29%  Similarity=0.354  Sum_probs=122.8

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++.. .++..||+|.++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999965 468899999997542   23345667788888765 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|..++..   ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999998853   245888999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.92  E-value=1.7e-24  Score=202.71  Aligned_cols=150  Identities=29%  Similarity=0.532  Sum_probs=132.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|+..+.||+|+||.||+|.+..    ...||||.+... ......+|.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568889999999999999996642    457999988654 33445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+|+|+||||+|||+++++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999998543  236899999999999999999999   8999999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.92  E-value=1.7e-24  Score=202.84  Aligned_cols=149  Identities=28%  Similarity=0.385  Sum_probs=133.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++.+..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            34688999999999999999964 56889999999766555566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            999999998853   245889999999999999999999   8899999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.7e-24  Score=201.68  Aligned_cols=148  Identities=28%  Similarity=0.445  Sum_probs=131.1

Q ss_pred             CCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            477889999999999999987777789999886432 2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999985432  35899999999999999999999   89999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.92  E-value=1.2e-24  Score=205.09  Aligned_cols=154  Identities=29%  Similarity=0.471  Sum_probs=132.0

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (438)
                      ...++|+..+.||+|+||.||+|...      .+..||+|++... ......++.+|+.+++.++||||+++++++..+.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34677999999999999999998542      2467999988643 2334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC-------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeE
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNK-------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  413 (438)
                      ..++||||+++++|.+++.....       ...+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence            99999999999999999854321       234678889999999999999999   88999999999999999999999


Q ss_pred             Eeccccccccc
Q 013693          414 IADFGLARCFA  424 (438)
Q Consensus       414 l~DFGla~~~~  424 (438)
                      |+|||+++.+.
T Consensus       160 l~dfg~~~~~~  170 (277)
T cd05062         160 IGDFGMTRDIY  170 (277)
T ss_pred             ECCCCCccccC
Confidence            99999998654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=2.2e-25  Score=217.16  Aligned_cols=158  Identities=25%  Similarity=0.401  Sum_probs=133.2

Q ss_pred             CCCCccccCCceeEEEEEc-cCCCEEEEEEeee----cchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe--EEEEE
Q 013693          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIF----NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE--SLLVY  346 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  346 (438)
                      +...+||+|+|-+||+|.. .+|.+||.-.++.    .++...++|..|+.+|+.|+||||++++.+|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4457899999999999944 4577887654432    345667899999999999999999999999988765  78999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~DFGla~~~~~  425 (438)
                      |.+..|+|..|+.+.   +.++...+..|++||++||.|||++ .++|||||||-+||+|+ .-|.|||.|+|||.....
T Consensus       123 EL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999554   4477889999999999999999976 68999999999999997 458999999999999865


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      ....   .+.|||
T Consensus       199 s~ak---svIGTP  208 (632)
T KOG0584|consen  199 SHAK---SVIGTP  208 (632)
T ss_pred             cccc---eeccCc
Confidence            4432   378997

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=9e-25  Score=212.64  Aligned_cols=152  Identities=27%  Similarity=0.435  Sum_probs=134.0

Q ss_pred             HhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      -...|.+...||+|.|+.|.++ +..++..||||.+.+.  +....+.+.+|+++|+.|+|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3456888999999999999999 4457999999998754  334445688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||..+|.+.+++....+   +.+.++..++.|+..+++|||   ...|+|||||++||||+.++++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999965433   455778889999999999999   89999999999999999999999999999998864


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       208 ~  208 (596)
T KOG0586|consen  208 G  208 (596)
T ss_pred             c
Confidence            3

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.92  E-value=2.2e-24  Score=204.66  Aligned_cols=151  Identities=28%  Similarity=0.444  Sum_probs=124.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc--cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhcc---CCCceeeEEeEEEe-----
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL--PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIE-----  338 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  338 (438)
                      ++|++.+.||+|+||.||++..  .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999964  346889999887542  22334566777777665   69999999998853     


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      ....++||||++ ++|.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            446899999996 5898888543 2345899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCC
Q 013693          419 LARCFAAD  426 (438)
Q Consensus       419 la~~~~~~  426 (438)
                      +++.....
T Consensus       156 ~~~~~~~~  163 (290)
T cd07862         156 LARIYSFQ  163 (290)
T ss_pred             ceEeccCC
Confidence            99876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.92  E-value=2.2e-24  Score=204.00  Aligned_cols=152  Identities=28%  Similarity=0.474  Sum_probs=131.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-----cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      +.|+..+.||+|+||.||+|..     ..+..+++|.+... .......+.+|+.++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577789999999999999963     34678999998743 33445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCC--------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013693          345 VYEYVPNRSLDQFIFDKNK--------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  410 (438)
                      ||||+++++|.+++.....              ...+++.+++.++.|++.||.|||   +.+++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            9999999999999853221              234788999999999999999999   88999999999999999999


Q ss_pred             CeEEecccccccccC
Q 013693          411 TPKIADFGLARCFAA  425 (438)
Q Consensus       411 ~~kl~DFGla~~~~~  425 (438)
                      .+||+|||+++.+..
T Consensus       162 ~~kl~dfg~~~~~~~  176 (283)
T cd05090         162 HVKISDLGLSREIYS  176 (283)
T ss_pred             cEEeccccccccccC
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.92  E-value=1.7e-24  Score=227.00  Aligned_cols=150  Identities=21%  Similarity=0.327  Sum_probs=131.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.++||+|+||.||+|.. .+++.||+|++...   .....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4688899999999999999954 46899999998653   2334567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccC--------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          347 EYVPNRSLDQFIFDKN--------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      ||+++++|.+++....        ....+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1233567788999999999999999   8899999999999999999999999999


Q ss_pred             ccccc
Q 013693          419 LARCF  423 (438)
Q Consensus       419 la~~~  423 (438)
                      +++..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99987

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.92  E-value=2.9e-24  Score=199.52  Aligned_cols=143  Identities=27%  Similarity=0.472  Sum_probs=126.8

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      +.||+|+||.||++.. .+++.+|+|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999965 46889999987643 334456799999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      .+++...  ...+++.+++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccc
Confidence            9998532  335889999999999999999999   8999999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=2.4e-24  Score=203.87  Aligned_cols=144  Identities=21%  Similarity=0.355  Sum_probs=125.4

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecch---hhHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeEEEEEec
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLLVYEY  348 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  348 (438)
                      ...|++|+++.||+|.. +++.||||++.....   ...+.+.+|+.+|++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999987 788999999875432   225778899999999999999999999877    3468999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++|+|.+++..   ...+++.....++.+++.||.|||.  ..+++||||||+|||+++++.+||+|||+++.+..
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            999999999954   2458899999999999999999992  25888999999999999999999999999987654

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.92  E-value=2.5e-24  Score=207.26  Aligned_cols=141  Identities=30%  Similarity=0.366  Sum_probs=124.5

Q ss_pred             CccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++... +++.||+|++...   .....+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999654 5789999999754   233456678899999888 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|..++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999988843   335899999999999999999999   899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=2.2e-24  Score=206.74  Aligned_cols=149  Identities=28%  Similarity=0.452  Sum_probs=129.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            5688899999999999999955 367889999987543 22344678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            975 888877443  345788999999999999999999   89999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.5e-24  Score=203.20  Aligned_cols=151  Identities=26%  Similarity=0.422  Sum_probs=136.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            45688889999999999999965 46889999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            9999999998542  345899999999999999999999   89999999999999999999999999999876643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.92  E-value=2.4e-24  Score=212.96  Aligned_cols=157  Identities=25%  Similarity=0.409  Sum_probs=133.3

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccC-CCceeeEEeEEE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSI  337 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  337 (438)
                      ++...++|.+.++||+|+||.||++.+.      .+..||+|+++... ....+.+.+|+.+|.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4455566888899999999999999753      34689999997542 333457889999999997 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCC------------------------------------------------------
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNK------------------------------------------------------  363 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  363 (438)
                      ..+..++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999864311                                                      


Q ss_pred             -----------------------------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCC
Q 013693          364 -----------------------------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTS  402 (438)
Q Consensus       364 -----------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  402 (438)
                                                               ...+++..++.++.||+.||.|||   +.+++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence                                                     124677888999999999999999   899999999999


Q ss_pred             CeeeCCCCCeEEecccccccccC
Q 013693          403 NILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       403 Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++.+||+|||+++.+..
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~  291 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMR  291 (401)
T ss_pred             eEEEeCCCEEEEEecCcceeccc
Confidence            99999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=2.2e-24  Score=226.34  Aligned_cols=149  Identities=26%  Similarity=0.350  Sum_probs=132.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|.+.++||+|+||.||+|... +++.||||++...   .......+..|+.+++.++||||+++++++...+..+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888999999999999999654 6889999998653   2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++..   ...+++..++.|+.||+.||.|||   ..+|+||||||+||||+.++.+||+|||+++....
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            99999999999853   235788999999999999999999   78999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.92  E-value=3.2e-24  Score=201.21  Aligned_cols=144  Identities=28%  Similarity=0.416  Sum_probs=122.9

Q ss_pred             CccccCCceeEEEEEccC---CCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          277 KKLGQGGAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999995433   3568888775442 334567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCC--CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          353 SLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       353 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +|.+++.....  ....++.....++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEecccccccc
Confidence            99999965432  233567788899999999999999   899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=4.2e-24  Score=204.72  Aligned_cols=149  Identities=26%  Similarity=0.362  Sum_probs=130.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.+.||+|+||.||++.. .++..+|+|.+... .....+++.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3688899999999999999954 46788999988654 333456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|.+++...   ..+++..+..++.|+++||.|||+  ..+++|+||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999999542   458899999999999999999992  2689999999999999999999999999988654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.92  E-value=4.3e-24  Score=202.59  Aligned_cols=153  Identities=27%  Similarity=0.526  Sum_probs=133.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35688889999999999999963      234568999887666566778999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccC----------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeE
Q 013693          344 LVYEYVPNRSLDQFIFDKN----------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  413 (438)
                      +||||+++++|.+++....          ....+++..++.++.|++.+|+|||   +.+++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999986432          2234899999999999999999999   89999999999999999999999


Q ss_pred             EecccccccccC
Q 013693          414 IADFGLARCFAA  425 (438)
Q Consensus       414 l~DFGla~~~~~  425 (438)
                      |+|||+++....
T Consensus       161 l~dfg~~~~~~~  172 (288)
T cd05093         161 IGDFGMSRDVYS  172 (288)
T ss_pred             eccCCccccccC
Confidence            999999986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=4.4e-24  Score=199.40  Aligned_cols=149  Identities=30%  Similarity=0.479  Sum_probs=131.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-----hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|+..+.||+|++|.||++.. .+++++|+|.+....     ....+.+.+|+.++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5688999999999999999954 568999999886432     2234578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853   245888999999999999999999   8999999999999999999999999999998764


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       156 ~  156 (263)
T cd06625         156 T  156 (263)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.92  E-value=3.3e-24  Score=200.50  Aligned_cols=151  Identities=31%  Similarity=0.499  Sum_probs=130.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|++.++||+|+||.||+|...+...||+|++..... ..+.+.+|+.++++++||||+++++.+. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356889999999999999999776777899999875332 3457899999999999999999999864 45689999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++.+...
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999543 2345789999999999999999999   899999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=4.5e-24  Score=201.97  Aligned_cols=151  Identities=26%  Similarity=0.525  Sum_probs=131.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-----cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (438)
                      +.|++.+.||+|+||.||++..     .++..||+|.+.... ....+.+.+|+.++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467889999999999999863     357889999987543 44456899999999999999999999998875  568


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999998543  235899999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCC
Q 013693          423 FAAD  426 (438)
Q Consensus       423 ~~~~  426 (438)
                      +...
T Consensus       159 ~~~~  162 (284)
T cd05079         159 IETD  162 (284)
T ss_pred             cccC
Confidence            7543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.91  E-value=2.6e-24  Score=204.10  Aligned_cols=154  Identities=29%  Similarity=0.465  Sum_probs=130.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (438)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            44677899999999999999998542      24579999876442 233456889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC-------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeE
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNK-------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  413 (438)
                      ..++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999964321       234567788899999999999999   89999999999999999999999


Q ss_pred             Eeccccccccc
Q 013693          414 IADFGLARCFA  424 (438)
Q Consensus       414 l~DFGla~~~~  424 (438)
                      |+|||+++.+.
T Consensus       160 L~Dfg~~~~~~  170 (288)
T cd05061         160 IGDFGMTRDIY  170 (288)
T ss_pred             ECcCCcccccc
Confidence            99999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.4e-24  Score=207.39  Aligned_cols=140  Identities=25%  Similarity=0.267  Sum_probs=119.8

Q ss_pred             cccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       279 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      ||+|+||.||++.. .+++.||+|++....   ......+..|..++..+   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999954 468999999986432   22234455677777655   699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|.+++..   ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            999988853   345889999999999999999999   8999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.91  E-value=4.3e-24  Score=203.58  Aligned_cols=150  Identities=27%  Similarity=0.471  Sum_probs=134.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            46788899999999999999964 57899999999766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++..    ..+++.++..++.|++.+|.|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            999999999842    34788999999999999999999   899999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.91  E-value=3.4e-24  Score=203.51  Aligned_cols=150  Identities=31%  Similarity=0.378  Sum_probs=133.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.+|+|.+....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4688889999999999999955 468999999986532   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+++|+||+|+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998543   45889999999999999999999   899999999999999999999999999999887544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=2.3e-24  Score=215.90  Aligned_cols=145  Identities=25%  Similarity=0.319  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ...|.+.+.||+|+||.||++... .++.||||...      ...+.+|+.+|++++||||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            446888999999999999999654 57889999642      23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +. ++|.+++...  ...+++.+++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            95 6888887432  346899999999999999999999   899999999999999999999999999999877543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.91  E-value=6.1e-24  Score=197.01  Aligned_cols=143  Identities=31%  Similarity=0.508  Sum_probs=127.5

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHH
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  355 (438)
                      ++||+|+||.||++...++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4699999999999988788999999886543 333457889999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       356 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++...  ...+++..+..++.|++.+|.|||   +.+++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecc
Confidence            998543  235789999999999999999999   8999999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.91  E-value=5.6e-24  Score=199.79  Aligned_cols=150  Identities=27%  Similarity=0.524  Sum_probs=125.7

Q ss_pred             CCCCCccccCCceeEEEEEccC-CC--EEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC------Ce
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPN-GT--TVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------PE  341 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  341 (438)
                      +.+.+.||+|+||.||+|.... +.  .+|+|.++..  .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999997644 32  6899988653  344567889999999999999999999987532      24


Q ss_pred             EEEEEeccCCCCHHHHhhcc---CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDK---NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      .+++|||+++++|.+++...   .....+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887422   12345899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++.+..
T Consensus       158 ~~~~~~~  164 (272)
T cd05075         158 LSKKIYN  164 (272)
T ss_pred             cccccCc
Confidence            9998754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.91  E-value=2.7e-24  Score=201.16  Aligned_cols=151  Identities=30%  Similarity=0.478  Sum_probs=132.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ..|+..+.||+|+||.||++.. +.+..||+|.+... ....+++.+|++++++++||||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            4477788999999999999955 45789999988644 334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++++|.+++... ....+++..++.++.|+++||.|||   +.+++||||||+|||+++++.+||+|||+++.....
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999998543 2345899999999999999999999   899999999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=5e-25  Score=198.28  Aligned_cols=154  Identities=30%  Similarity=0.374  Sum_probs=136.6

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEE
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSI  337 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  337 (438)
                      .-+++++.+.++     +.||+|+|+.|--+ .+.++.++|||++.+.......++.+|++++...+ |+||++|+++|+
T Consensus        72 ~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   72 SGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             cchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            345677777664     68999999999987 67889999999999887788889999999999995 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---CeEE
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKI  414 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl  414 (438)
                      ++...|||||-|.||+|..++++   .+.+++.++..++.+|+.||.|||   .+||.||||||+|||-.+..   -+||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence            99999999999999999999854   345899999999999999999999   99999999999999996544   3799


Q ss_pred             eccccccccc
Q 013693          415 ADFGLARCFA  424 (438)
Q Consensus       415 ~DFGla~~~~  424 (438)
                      +||.|..-+.
T Consensus       221 CDfDLgSg~k  230 (463)
T KOG0607|consen  221 CDFDLGSGIK  230 (463)
T ss_pred             eccccccccc
Confidence            9999887654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=222.93  Aligned_cols=153  Identities=33%  Similarity=0.518  Sum_probs=133.8

Q ss_pred             CCCCccccCCceeEEEEEc-cCC----CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          274 NPSKKLGQGGAGSVYMGSL-PNG----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ...++||+|+||+||+|.+ +.+    .+||+|++... ..+..+++..|+-+|.+++|||+++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3468899999999999954 333    47899988754 4556788999999999999999999999998876 889999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||+.|+|.++++.+  ...+.....+.|..||++||.|||   +.+++||||..+|||+..-.++||.|||+|+.+..+.
T Consensus       778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999764  345888889999999999999999   8999999999999999999999999999999998877


Q ss_pred             ceeee
Q 013693          428 THVST  432 (438)
Q Consensus       428 ~~~~~  432 (438)
                      ..-++
T Consensus       853 ~ey~~  857 (1177)
T KOG1025|consen  853 KEYSA  857 (1177)
T ss_pred             ccccc
Confidence            65443

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.91  E-value=3.7e-24  Score=199.76  Aligned_cols=150  Identities=34%  Similarity=0.522  Sum_probs=132.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..+.|++.++||+|+||.||++...+++.+|+|.+..... ..+.+.+|+.++++++||||+++++++ ..+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            4567888999999999999999888889999999875432 346789999999999999999999986 45678999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|.+++... ....+++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++.+.
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            9999999998543 3346899999999999999999999   8999999999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.91  E-value=2.1e-24  Score=209.25  Aligned_cols=154  Identities=29%  Similarity=0.429  Sum_probs=129.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC-
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG-  339 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  339 (438)
                      ..++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457889999999999999999432      34789999986432 33456788999999999 899999999987654 


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCC--------------------------------------------------------
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNK--------------------------------------------------------  363 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  363 (438)
                      ...+++|||+++++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            568899999999999998853211                                                        


Q ss_pred             --CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          364 --TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       364 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                        ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~  225 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK  225 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence              125899999999999999999999   89999999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.91  E-value=1.7e-24  Score=202.21  Aligned_cols=146  Identities=38%  Similarity=0.620  Sum_probs=126.1

Q ss_pred             CCCccccCCceeEEEEEcc-----CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          275 PSKKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.. .....+.|.+|++++++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3468999999999999775     2578999999654 334578899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++|+|.++|... ....+++..++.|+.||++||.|||   +.+++|+||+|+|||++.++.+||+|||+++...
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999654 2345899999999999999999999   7899999999999999999999999999999873

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.91  E-value=8.5e-24  Score=200.93  Aligned_cols=150  Identities=27%  Similarity=0.440  Sum_probs=134.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .+.|++.++||+|+||.||++.. .++..+++|.+........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            35688899999999999999965 45889999999877766778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|..++.+.  ...+++..+..++.|++.+|.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999998887442  245899999999999999999999   8999999999999999999999999999987643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.91  E-value=3.1e-24  Score=201.05  Aligned_cols=148  Identities=26%  Similarity=0.389  Sum_probs=132.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ++|+..+.||+|+||.||++.. .+++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4567778899999999999954 568899999987665555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++++|.+++..   ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..+.
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            99999999843   335889999999999999999999   8899999999999999999999999999987664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.91  E-value=3.3e-24  Score=203.70  Aligned_cols=157  Identities=30%  Similarity=0.468  Sum_probs=134.9

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI  337 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  337 (438)
                      ++...++|+..+.||+|+||.||++...      ....+|+|.+... ......++.+|+.++.++ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3444567888899999999999999653      2367999988754 334456788999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhcc-------------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  404 (438)
                      .++..+++|||+++++|.+++...             .....+++..++.++.|++.||.|||   +.+|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeE
Confidence            999999999999999999998642             22356899999999999999999999   89999999999999


Q ss_pred             eeCCCCCeEEecccccccccC
Q 013693          405 LLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       405 ll~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++.+||+|||+++.+..
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHH  184 (293)
T ss_pred             EEcCCCeEEeCcccccccccc
Confidence            999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=4.4e-24  Score=203.23  Aligned_cols=152  Identities=28%  Similarity=0.499  Sum_probs=130.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC---------------CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN---------------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL  333 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  333 (438)
                      .++|++.+.||+|+||.||++....               ...||+|.+... .....+.+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578899999999999999985432               235899998754 334456799999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHhhccCC---------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013693          334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNK---------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (438)
Q Consensus       334 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  404 (438)
                      +++...+..++||||+++++|.+++.....         ...+++..++.++.|++.||.|||   +.+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            999999999999999999999999854321         123688899999999999999999   89999999999999


Q ss_pred             eeCCCCCeEEeccccccccc
Q 013693          405 LLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       405 ll~~~~~~kl~DFGla~~~~  424 (438)
                      ++++++.+||+|||+++.+.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             EEcCCCcEEecccccccccc
Confidence            99999999999999998764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.91  E-value=6.1e-24  Score=200.93  Aligned_cols=149  Identities=27%  Similarity=0.509  Sum_probs=131.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|++|.||+|.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            477789999999999999965 468999999986442  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++ ++|.+++........+++..+..++.|+++||.|||   +.+++|+||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            97 689888865444467899999999999999999999   8999999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=4.8e-24  Score=199.02  Aligned_cols=153  Identities=34%  Similarity=0.508  Sum_probs=136.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ...++|.+.+.||+|+||.||++...+++.+|||.+.... ...+++.+|+.++++++||||+++++++......++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3456789999999999999999987778899999987543 235678999999999999999999999999899999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++.+..
T Consensus        82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999653 2345899999999999999999999   88999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.91  E-value=4.3e-24  Score=201.44  Aligned_cols=151  Identities=30%  Similarity=0.535  Sum_probs=132.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+...... ..+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45778899999999999999653      3478999998755433 4578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccC-----------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          344 LVYEYVPNRSLDQFIFDKN-----------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      +||||+++++|.+++....           ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999996432           1245788999999999999999999   8899999999999999999999


Q ss_pred             EEeccccccccc
Q 013693          413 KIADFGLARCFA  424 (438)
Q Consensus       413 kl~DFGla~~~~  424 (438)
                      ||+|||+++.+.
T Consensus       162 kl~d~g~~~~~~  173 (280)
T cd05049         162 KIGDFGMSRDVY  173 (280)
T ss_pred             EECCcccceecc
Confidence            999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=4.8e-24  Score=200.81  Aligned_cols=141  Identities=26%  Similarity=0.388  Sum_probs=121.0

Q ss_pred             ccccCCceeEEEEEccC-------------------------CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeE
Q 013693          278 KLGQGGAGSVYMGSLPN-------------------------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL  332 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  332 (438)
                      .||+|+||.||+|.+..                         ...|++|.+.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999985421                         13589998876555556778899999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC--
Q 013693          333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF--  410 (438)
Q Consensus       333 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~--  410 (438)
                      ++++..++..++||||+++++|..++...  ...+++..+..++.||++||+|||   +.+|+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999998542  345889999999999999999999   88999999999999997543  


Q ss_pred             -----CeEEecccccccc
Q 013693          411 -----TPKIADFGLARCF  423 (438)
Q Consensus       411 -----~~kl~DFGla~~~  423 (438)
                           .+||+|||++...
T Consensus       157 ~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             cCccceeeecCCcccccc
Confidence                 3899999988654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=7.7e-24  Score=198.29  Aligned_cols=152  Identities=26%  Similarity=0.427  Sum_probs=132.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+...   .......+.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688999999999999999954 46899999987642   2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885322 2345788999999999999999999   89999999999999999999999999999887653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.91  E-value=6.5e-24  Score=199.04  Aligned_cols=156  Identities=29%  Similarity=0.395  Sum_probs=134.0

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++..++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345566666778999999999999964 4678899999877666667789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEecccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCF  423 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~~  423 (438)
                      |+||+++++|.+++.........++..+..++.||+.||.|||   ..+|+||||||+||+++. ++.+||+|||++..+
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999864322212378888899999999999999   899999999999999976 679999999998866


Q ss_pred             c
Q 013693          424 A  424 (438)
Q Consensus       424 ~  424 (438)
                      .
T Consensus       160 ~  160 (268)
T cd06624         160 A  160 (268)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.91  E-value=7.2e-24  Score=200.34  Aligned_cols=147  Identities=29%  Similarity=0.451  Sum_probs=131.3

Q ss_pred             CCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      |++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999654 5778899988766666677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|..++..  ....+++..+..++.|+++||.|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence            999988753  2345899999999999999999999   8999999999999999999999999999997654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=3.9e-24  Score=202.49  Aligned_cols=152  Identities=24%  Similarity=0.384  Sum_probs=133.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35788899999999999999664 6899999988754 334456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|.+++........+++..+..++.|++.||.|||+  +.+|+|+||||+||+++.++.+||+|||++..+.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9999999998553333468999999999999999999993  3689999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=6.6e-24  Score=197.58  Aligned_cols=149  Identities=30%  Similarity=0.583  Sum_probs=133.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|+..+.||+|+||.||++.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35688889999999999999976 478999999976544 5678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++++|.+++.... ...+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence            9999999985432 235899999999999999999999   8999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.91  E-value=5.1e-24  Score=199.88  Aligned_cols=149  Identities=28%  Similarity=0.513  Sum_probs=131.2

Q ss_pred             CCCCCCccccCCceeEEEEEccC-C---CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPN-G---TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .|++.+.||+|+||.||+|.... +   ..||||.+... .....++|.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778999999999999996543 2   36999998754 3445678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++...  ...+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.+..
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998543  345899999999999999999999   89999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.91  E-value=7.2e-24  Score=200.76  Aligned_cols=148  Identities=26%  Similarity=0.309  Sum_probs=129.4

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      |+..+.||+|+||.||++.. .+++.+|+|.+....   ......+.+|++++++++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56678899999999999954 568899999986542   22344578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++....
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999998885432 345899999999999999999999   8999999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.91  E-value=4.5e-24  Score=199.22  Aligned_cols=150  Identities=33%  Similarity=0.518  Sum_probs=131.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            456888899999999999999887888999999875433 3457899999999999999999999875 45689999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++..+..
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            999999998643 2345899999999999999999999   88999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.91  E-value=7.5e-24  Score=201.08  Aligned_cols=151  Identities=30%  Similarity=0.462  Sum_probs=129.6

Q ss_pred             CCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678899999999999999542      23568888886543 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccC---------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013693          345 VYEYVPNRSLDQFIFDKN---------------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  403 (438)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999985321                     1235889999999999999999999   8999999999999


Q ss_pred             eeeCCCCCeEEecccccccccC
Q 013693          404 ILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       404 ill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++.+||+|||+++.+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~  179 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYE  179 (290)
T ss_pred             EEEcCCCcEEeccccccccccC
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.91  E-value=1.2e-23  Score=198.53  Aligned_cols=144  Identities=23%  Similarity=0.297  Sum_probs=124.4

Q ss_pred             cccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ||+|+||.||++.. .+++.+|+|.+....   ....+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999954 468999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      .+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            9888543 2345889999999999999999999   899999999999999999999999999999877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=1.1e-23  Score=195.98  Aligned_cols=152  Identities=23%  Similarity=0.398  Sum_probs=134.0

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.||.+. ..+++.+++|.+...  .....+++.+|++++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47888999999999999884 456889999998654  344566789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +++++|.+++.... ...+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999986432 345899999999999999999999   8899999999999999999999999999998775443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.91  E-value=6.5e-24  Score=202.16  Aligned_cols=153  Identities=28%  Similarity=0.487  Sum_probs=131.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-----------------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceee
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-----------------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK  331 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  331 (438)
                      .++|++.+.||+|+||.||++...                 ++..+|+|++... .....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356889999999999999998432                 2346899998754 3345578999999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHhhccCC--------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013693          332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK--------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (438)
Q Consensus       332 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  403 (438)
                      +++++..++..++||||+++++|.+++.....        ...+++..+..++.|++.||.|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            99999999999999999999999999865321        134778899999999999999999   8899999999999


Q ss_pred             eeeCCCCCeEEecccccccccC
Q 013693          404 ILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       404 ill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||++.++.+||+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             EEEcCCCCEEeccCcccccccC
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.91  E-value=1.1e-23  Score=196.49  Aligned_cols=143  Identities=27%  Similarity=0.492  Sum_probs=123.4

Q ss_pred             ccccCCceeEEEEEcc---CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCC
Q 013693          278 KLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  353 (438)
                      .||+|+||.||+|.+.   .+..||+|++.... ....+++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999653   35579999887553 334567999999999999999999999875 457899999999999


Q ss_pred             HHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |.+++...  ...+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            99998532  345899999999999999999999   889999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.91  E-value=7.6e-24  Score=199.96  Aligned_cols=150  Identities=32%  Similarity=0.451  Sum_probs=126.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCC----EEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|+..+.||+|+||.||+|.+. +++    .+++|.+.... .....++..|+.++++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            35777899999999999999653 344    47778775432 334567888999999999999999999875 456789


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++||+++|+|.+++...  ...+++..+..++.||+.||.|||   +.+++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999543  345899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       161 ~~  162 (279)
T cd05111         161 PD  162 (279)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.91  E-value=8.2e-24  Score=199.94  Aligned_cols=151  Identities=32%  Similarity=0.553  Sum_probs=130.8

Q ss_pred             cCCCCCCccccCCceeEEEEEccC------CCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ++|++.+.||+|+||.||+|....      ...|++|.+.... .....++.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            457888999999999999996532      2579999886543 344567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013693          344 LVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  410 (438)
                      ++|||+++++|.+++.....             ...+++.+++.++.|++.||.|||   +.+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999864321             145888999999999999999999   88999999999999999999


Q ss_pred             CeEEeccccccccc
Q 013693          411 TPKIADFGLARCFA  424 (438)
Q Consensus       411 ~~kl~DFGla~~~~  424 (438)
                      .+||+|||+++...
T Consensus       162 ~~~L~dfg~~~~~~  175 (283)
T cd05048         162 TVKISDFGLSRDIY  175 (283)
T ss_pred             cEEECCCcceeecc
Confidence            99999999998653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.91  E-value=1.2e-23  Score=198.65  Aligned_cols=145  Identities=23%  Similarity=0.394  Sum_probs=128.2

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|+..++||+|+||.||++. ..+++.+|+|.+... .....+++.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            357788999999999999995 457889999998654 334456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|..+.       .+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++..+..
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            9999997553       3678888999999999999999   89999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.91  E-value=7.1e-24  Score=201.93  Aligned_cols=148  Identities=27%  Similarity=0.485  Sum_probs=133.2

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .+|+..+.||+|+||.||++. ..+++.+++|.+........+.+.+|+.+++.+.||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            468888999999999999995 4568999999998765555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++..    ..+++.++..++.|++.||.|||   ..+|+|+||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            99999999842    34788999999999999999999   89999999999999999999999999999887543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.91  E-value=5.5e-24  Score=203.42  Aligned_cols=150  Identities=28%  Similarity=0.496  Sum_probs=128.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCC--EEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGT--TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.+.||+|+||.||+|... ++.  .+++|.+... .....+.+.+|++++.++ +||||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            356788899999999999999653 443  4677776543 334556788999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC
Q 013693          345 VYEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  411 (438)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999986432             1235889999999999999999999   899999999999999999999


Q ss_pred             eEEeccccccc
Q 013693          412 PKIADFGLARC  422 (438)
Q Consensus       412 ~kl~DFGla~~  422 (438)
                      +||+|||+++.
T Consensus       163 ~kl~dfg~~~~  173 (303)
T cd05088         163 AKIADFGLSRG  173 (303)
T ss_pred             EEeCccccCcc
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.91  E-value=4.4e-24  Score=207.67  Aligned_cols=152  Identities=29%  Similarity=0.435  Sum_probs=128.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC-C
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG-P  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  340 (438)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45788999999999999999952      346789999997543 33456788999999999 789999999987654 4


Q ss_pred             eEEEEEeccCCCCHHHHhhccCC---------------------------------------------------------
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNK---------------------------------------------------------  363 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  363 (438)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999854210                                                         


Q ss_pred             -------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          364 -------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       364 -------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                             ...+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                   123688888999999999999999   8999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-25  Score=214.05  Aligned_cols=160  Identities=30%  Similarity=0.459  Sum_probs=142.1

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEccC-CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      .++++....+....++||-|.||.||.|.|+. .-.||||.++.+. ...++|+.|..+|+.++|||+|+|+|+|..+..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            35666666677788999999999999998765 5689999987543 457899999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .|||+|||..|+|.++|++..+ ..++...++.++.||..||+||.   .+.+|||||..+|.|+.++..+|++||||+|
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999977644 34777888999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCC
Q 013693          422 CFAADR  427 (438)
Q Consensus       422 ~~~~~~  427 (438)
                      ++..+.
T Consensus       414 lMtgDT  419 (1157)
T KOG4278|consen  414 LMTGDT  419 (1157)
T ss_pred             hhcCCc
Confidence            987654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=1.7e-23  Score=230.26  Aligned_cols=145  Identities=22%  Similarity=0.423  Sum_probs=124.2

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .....+...+.||+|+||.||+|.. .++..||||++......    ...|++++++++||||++++|++.+++..++||
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3345678889999999999999965 57899999988643221    235688999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||+++|+|.++++      .++|.++..|+.|+++||+|||+.++.+|+||||||+||+++.++.+++. ||.+...
T Consensus       763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            9999999999993      28899999999999999999997667899999999999999999888876 6665543

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.91  E-value=2.3e-24  Score=200.82  Aligned_cols=145  Identities=36%  Similarity=0.533  Sum_probs=128.1

Q ss_pred             CCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhH--HHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWV--DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      |+..+.||+|+||.||++... +++.+|+|.+........  ....+|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999654 466899999987644332  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++++|.+++.   ....+++.++..++.|+++||.+||   +.+++|+||||+||+++.++.++|+|||++..+
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            9999999995   3456899999999999999999999   889999999999999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.91  E-value=7.9e-24  Score=199.20  Aligned_cols=150  Identities=25%  Similarity=0.404  Sum_probs=131.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ++|+..+.||+|+||.||++...      ..+.+++|.+...... ..+++.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999653      2467999988654433 4678999999999999999999999999989999


Q ss_pred             EEEeccCCCCHHHHhhccCCC------CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKT------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      +||||+++++|.+++......      ..+++..+..++.|++.+|.|||   +.+|+||||||+|||++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654321      25899999999999999999999   889999999999999999999999999


Q ss_pred             cccccc
Q 013693          418 GLARCF  423 (438)
Q Consensus       418 Gla~~~  423 (438)
                      |+++..
T Consensus       162 ~~~~~~  167 (275)
T cd05046         162 SLSKDV  167 (275)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.91  E-value=1.1e-23  Score=199.54  Aligned_cols=149  Identities=26%  Similarity=0.327  Sum_probs=129.6

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      |+..+.||+|+||.||++.. .+++.+|+|.+....   ....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778899999999999954 468899999986542   22335577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            9999999988543 2345889999999999999999999   89999999999999999999999999999986643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.2e-23  Score=197.49  Aligned_cols=150  Identities=29%  Similarity=0.526  Sum_probs=128.2

Q ss_pred             CCCCCccccCCceeEEEEEccC----CCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-----
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-----  341 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  341 (438)
                      |.+.+.||+|+||.||+|....    +..||+|+++..  .....+.+.+|+++++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999996532    367999998754  23445679999999999999999999998876554     


Q ss_pred             -EEEEEeccCCCCHHHHhhccC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          342 -SLLVYEYVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       342 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                       .++++||+++++|..++....   ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             799999999999999885432   2345899999999999999999999   899999999999999999999999999


Q ss_pred             cccccccC
Q 013693          418 GLARCFAA  425 (438)
Q Consensus       418 Gla~~~~~  425 (438)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=3.9e-24  Score=205.70  Aligned_cols=147  Identities=21%  Similarity=0.218  Sum_probs=118.1

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcc--CCCEEEEEEeeec-----chhhHHHHHHHHHHHhccCCCceee-EEeE
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP--NGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVK-LLGC  335 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~  335 (438)
                      +......+.|+..+.||+|+||.||+|...  +++.+|||++...     .....+.|.+|+++|++++|+||+. +++ 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            344556678999999999999999999653  5777899987533     1223567999999999999999985 443 


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC-CCCCeeeCCCCCeEE
Q 013693          336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI-KTSNILLDKDFTPKI  414 (438)
Q Consensus       336 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl-kp~Nill~~~~~~kl  414 (438)
                         .+..+|||||+++++|....    ...      ...++.+++++|.|||   +.+|+|||| ||+|||++.++.+||
T Consensus        90 ---~~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         90 ---TGKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             ---cCCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEE
Confidence               24679999999999996321    111      1457889999999999   899999999 999999999999999


Q ss_pred             ecccccccccCCC
Q 013693          415 ADFGLARCFAADR  427 (438)
Q Consensus       415 ~DFGla~~~~~~~  427 (438)
                      +|||+|+.+....
T Consensus       154 iDFGlA~~~~~~~  166 (365)
T PRK09188        154 IDFQLASVFRRRG  166 (365)
T ss_pred             EECccceecccCc
Confidence            9999999876543

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.91  E-value=9.8e-24  Score=199.28  Aligned_cols=151  Identities=28%  Similarity=0.488  Sum_probs=132.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|...++||+|+||.||++...      ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45777899999999999998532      356789998876666667789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          345 VYEYVPNRSLDQFIFDKNK------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      +|||+++++|.+++.....            ...+++..++.++.|++.||.|||   +.+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999999864321            134889999999999999999999   8999999999999999999999


Q ss_pred             EEeccccccccc
Q 013693          413 KIADFGLARCFA  424 (438)
Q Consensus       413 kl~DFGla~~~~  424 (438)
                      ||+|||+++...
T Consensus       162 kL~dfg~~~~~~  173 (280)
T cd05092         162 KIGDFGMSRDIY  173 (280)
T ss_pred             EECCCCceeEcC
Confidence            999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.91  E-value=1.2e-23  Score=197.29  Aligned_cols=145  Identities=31%  Similarity=0.403  Sum_probs=124.1

Q ss_pred             CccccCCceeEEEEEcc---CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          277 KKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.||+|+||.||+|...   .+..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999653   34579999887543 233457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCC--CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          353 SLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       353 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +|.+++.....  ....++..+..++.|++.||.|||   +.+++|+||||+||+++.++++||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999864322  234677788899999999999999   8999999999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.91  E-value=1e-23  Score=197.67  Aligned_cols=151  Identities=28%  Similarity=0.542  Sum_probs=132.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CC---CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NG---TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|+..+.||+|+||.||+|... ++   ..+++|.+... .....+.+.+|++++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788899999999999999654 23   37999988754 34446779999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...  ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998542  345899999999999999999999   8899999999999999999999999999998775


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       159 ~  159 (268)
T cd05063         159 D  159 (268)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=1.1e-23  Score=196.88  Aligned_cols=143  Identities=28%  Similarity=0.463  Sum_probs=123.5

Q ss_pred             CccccCCceeEEEEEccC-------------CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          277 KKLGQGGAGSVYMGSLPN-------------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      +.||+|+||.||+|.+..             ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999996432             2358999887655556678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC-------eEEec
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-------PKIAD  416 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-------~kl~D  416 (438)
                      +||||+++++|..++...  ...+++..++.++.||++||.|||   +.+|+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999888532  345899999999999999999999   899999999999999986654       89999


Q ss_pred             cccccccc
Q 013693          417 FGLARCFA  424 (438)
Q Consensus       417 FGla~~~~  424 (438)
                      ||++..+.
T Consensus       156 ~g~~~~~~  163 (262)
T cd05077         156 PGIPITVL  163 (262)
T ss_pred             CCCCcccc
Confidence            99987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.91  E-value=1.2e-23  Score=200.07  Aligned_cols=153  Identities=31%  Similarity=0.514  Sum_probs=132.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC-----------------CCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceee
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN-----------------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK  331 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  331 (438)
                      ..+|++.+.||+|+||.||++....                 +..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999985432                 2468999987543 345678999999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHhhccC--------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013693          332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKN--------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (438)
Q Consensus       332 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  403 (438)
                      +++++..++..+++||++++++|.+++....        ....+++..++.++.|++.||.|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999985432        1235899999999999999999999   8999999999999


Q ss_pred             eeeCCCCCeEEecccccccccC
Q 013693          404 ILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       404 ill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++.++.++|+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             eeecCCCceEEccccceeeccc
Confidence            9999999999999999987543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=1.6e-23  Score=196.07  Aligned_cols=152  Identities=27%  Similarity=0.456  Sum_probs=134.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999665 7899999988642   2334667899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++... .....+++.+++.++.+++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988543 22345899999999999999999999   89999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.91  E-value=1.1e-23  Score=198.62  Aligned_cols=150  Identities=30%  Similarity=0.511  Sum_probs=128.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCC----EEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGT----TVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|+..++||+|+||.||+|.+ .++.    .||+|.+... .....+++.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            4678889999999999999964 3444    4899998654 33445678899999999999999999999875 45789


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++||+++|+|.+++...  ...+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999998543  345899999999999999999999   8999999999999999999999999999999875


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       161 ~~  162 (279)
T cd05109         161 ID  162 (279)
T ss_pred             cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=8.5e-24  Score=196.94  Aligned_cols=142  Identities=29%  Similarity=0.472  Sum_probs=122.5

Q ss_pred             CccccCCceeEEEEEccCCC-----------EEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          277 KKLGQGGAGSVYMGSLPNGT-----------TVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999665432           5788877544333 6788999999999999999999999888 778999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-------CeEEeccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-------TPKIADFG  418 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-------~~kl~DFG  418 (438)
                      |||+++++|.+++....  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999996432  25889999999999999999999   89999999999999999887       79999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++....
T Consensus       154 ~a~~~~~  160 (259)
T cd05037         154 IPITVLS  160 (259)
T ss_pred             ccccccc
Confidence            9987543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=7.9e-24  Score=198.23  Aligned_cols=152  Identities=26%  Similarity=0.445  Sum_probs=133.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .++..++||.+...   .....+++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999964 57899999988643   2334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 22346899999999999999999999   89999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=1.2e-23  Score=198.95  Aligned_cols=146  Identities=36%  Similarity=0.538  Sum_probs=126.8

Q ss_pred             CCCCCccccCCceeEEEEE-----ccCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGS-----LPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLL  344 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  344 (438)
                      |+..+.||+|+||.||++.     ..++..||+|.+.... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            4788999999999998753     2357789999987543 33456788999999999999999999987654  35889


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++..    ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    34899999999999999999999   8999999999999999999999999999998765


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       159 ~  159 (283)
T cd05080         159 E  159 (283)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.91  E-value=3.3e-24  Score=210.69  Aligned_cols=148  Identities=24%  Similarity=0.345  Sum_probs=129.3

Q ss_pred             CCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-C-----CceeeEEeEEEeCCeEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-H-----KNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  344 (438)
                      +|++.+.||+|.||+|.++ +..+++.||||+++.. +....+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999 6667999999999754 344556678999999996 4     389999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC--CCeEEeccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD--FTPKIADFGLARC  422 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kl~DFGla~~  422 (438)
                      |+|.+ ..+|.++|+.. +...++...+..|+.||+.||.+||   +.+|||.||||+||||.+-  ..+||+|||.|..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 55999999764 4456999999999999999999999   8999999999999999643  3799999999987


Q ss_pred             ccC
Q 013693          423 FAA  425 (438)
Q Consensus       423 ~~~  425 (438)
                      ...
T Consensus       341 ~~q  343 (586)
T KOG0667|consen  341 ESQ  343 (586)
T ss_pred             cCC
Confidence            654

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=8.7e-24  Score=197.34  Aligned_cols=149  Identities=32%  Similarity=0.511  Sum_probs=129.7

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      ++|.+.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++||||+++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999987777789999876443 23467889999999999999999999875 456889999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            99999999643 2345889999999999999999999   88999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=1.5e-23  Score=194.92  Aligned_cols=151  Identities=24%  Similarity=0.413  Sum_probs=133.9

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|++|.||++.. .++..|++|.+...  .....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            367788999999999999955 46889999998643  344567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++... ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999998653 2356899999999999999999999   899999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.91  E-value=9.7e-24  Score=201.75  Aligned_cols=155  Identities=28%  Similarity=0.478  Sum_probs=132.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc--------cCCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI  337 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  337 (438)
                      ...++|.+.+.||+|+||.||++..        ..+..||+|.+... .....+++.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            3355678889999999999999853        12457999988644 234467799999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  404 (438)
                      ..+..++||||+++++|.+++.....             ...+++.++..++.||++||.|||   +.+++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence            99999999999999999999965321             235788899999999999999999   89999999999999


Q ss_pred             eeCCCCCeEEecccccccccC
Q 013693          405 LLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       405 ll~~~~~~kl~DFGla~~~~~  425 (438)
                      |++.++.+||+|||+++.+..
T Consensus       169 li~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNN  189 (304)
T ss_pred             EEcCCCcEEECCCccceeccc
Confidence            999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.91  E-value=1.2e-23  Score=199.74  Aligned_cols=152  Identities=28%  Similarity=0.480  Sum_probs=132.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|...+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777899999999999999532      345689998876665556789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC
Q 013693          345 VYEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  411 (438)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999986432             1234889999999999999999999   899999999999999999999


Q ss_pred             eEEecccccccccC
Q 013693          412 PKIADFGLARCFAA  425 (438)
Q Consensus       412 ~kl~DFGla~~~~~  425 (438)
                      +||+|||+++....
T Consensus       162 ~~l~dfg~a~~~~~  175 (291)
T cd05094         162 VKIGDFGMSRDVYS  175 (291)
T ss_pred             EEECCCCcccccCC
Confidence            99999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=7e-24  Score=206.31  Aligned_cols=150  Identities=28%  Similarity=0.397  Sum_probs=128.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  339 (438)
                      ...++|...+.||+|+||.||++. ..+++.||||++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            456789999999999999999995 4568899999986532  23345678999999999999999999987543     


Q ss_pred             -CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          340 -PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       340 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                       ...++++|++ +++|.+++.    ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence             3578999988 779988873    345899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++....
T Consensus       164 ~~~~~~~  170 (343)
T cd07878         164 LARQADD  170 (343)
T ss_pred             cceecCC
Confidence            9987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=6.9e-24  Score=199.72  Aligned_cols=153  Identities=29%  Similarity=0.462  Sum_probs=132.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|++.+.||+|+||.||++...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            457888899999999999999653      24689999986543 34456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCC-------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 013693          343 LLVYEYVPNRSLDQFIFDKNK-------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      ++||||+++++|.+++.....       ...+++..++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            999999999999999864322       234788899999999999999999   8999999999999999999999999


Q ss_pred             cccccccccC
Q 013693          416 DFGLARCFAA  425 (438)
Q Consensus       416 DFGla~~~~~  425 (438)
                      |||+++.+..
T Consensus       162 dfg~~~~~~~  171 (277)
T cd05032         162 DFGMTRDIYE  171 (277)
T ss_pred             Ccccchhhcc
Confidence            9999987644

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.91  E-value=9.2e-24  Score=199.33  Aligned_cols=154  Identities=25%  Similarity=0.411  Sum_probs=133.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC-----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  342 (438)
                      .++|.+.+.||+|+||.||+|....     +..|++|++... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999997654     688999988754 33446778999999999999999999998776 4678


Q ss_pred             EEEEeccCCCCHHHHhhccCCC-----CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKT-----KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      ++++||+++++|.+++......     ..+++..++.++.|++.||.|||   +.+++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654322     46899999999999999999999   899999999999999999999999999


Q ss_pred             cccccccCC
Q 013693          418 GLARCFAAD  426 (438)
Q Consensus       418 Gla~~~~~~  426 (438)
                      |+++.+..+
T Consensus       162 g~~~~~~~~  170 (280)
T cd05043         162 ALSRDLFPM  170 (280)
T ss_pred             CCcccccCC
Confidence            999876443

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=1.9e-23  Score=197.65  Aligned_cols=150  Identities=26%  Similarity=0.413  Sum_probs=131.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|+..+.||+|++|.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999654 58999999886542  2234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++++|..++..   ...+++..+..++.|++.+|.|||   +.+++|+||||+||+++.++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999888887632   335899999999999999999999   899999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.91  E-value=1.1e-23  Score=200.63  Aligned_cols=150  Identities=27%  Similarity=0.447  Sum_probs=128.9

Q ss_pred             cCCCCCCccccCCceeEEEEEccC-C--CEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN-G--TTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568889999999999999996543 3  34788887642 334456789999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          346 YEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999985432             1235889999999999999999999   8999999999999999999999


Q ss_pred             EEecccccccc
Q 013693          413 KIADFGLARCF  423 (438)
Q Consensus       413 kl~DFGla~~~  423 (438)
                      ||+|||++...
T Consensus       159 kl~dfg~~~~~  169 (297)
T cd05089         159 KIADFGLSRGE  169 (297)
T ss_pred             EECCcCCCccc
Confidence            99999998643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.5e-23  Score=195.55  Aligned_cols=151  Identities=30%  Similarity=0.430  Sum_probs=135.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|+..+.||+|+||.||++.. .++..+++|.+........+.+.+|++++++++||||+++++.+...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            35788889999999999999965 45788999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++...  ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..+..
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            9999999988542  245889999999999999999999   89999999999999999999999999999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=1.2e-23  Score=200.75  Aligned_cols=148  Identities=29%  Similarity=0.454  Sum_probs=129.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            4688889999999999999955 467899999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++ ++|.+++...  ...+++..+..++.|+++||.|||   +.+|+|+||||+|||++.++.+||+|||+++...
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            97 5898888543  345889999999999999999999   8999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.91  E-value=1e-23  Score=201.84  Aligned_cols=152  Identities=30%  Similarity=0.489  Sum_probs=131.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc--------CCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (438)
                      .++|.+.+.||+|+||.||++...        ....+|+|.+... ......++.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            456889999999999999998542        2357999998754 234456788999999999 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  406 (438)
                      +..++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||   +.+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            999999999999999999965321             235889999999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeccccccccc
Q 013693          407 DKDFTPKIADFGLARCFA  424 (438)
Q Consensus       407 ~~~~~~kl~DFGla~~~~  424 (438)
                      +.++.+||+|||+++.+.
T Consensus       174 ~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         174 TEDNVMKIADFGLARDIH  191 (307)
T ss_pred             cCCCcEEECCCccccccc
Confidence            999999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=1.8e-23  Score=194.60  Aligned_cols=149  Identities=32%  Similarity=0.441  Sum_probs=132.0

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc-----hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     .+..+.+.+|+.+++.++||||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999665 78999999986543     23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   235889999999999999999999   89999999999999999999999999999987654


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       155 ~  155 (258)
T cd06632         155 F  155 (258)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.91  E-value=9.5e-24  Score=198.23  Aligned_cols=153  Identities=27%  Similarity=0.422  Sum_probs=131.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC------
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG------  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  339 (438)
                      .+.+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++.++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4566788889999999999999955 457889999886543 3346788999999998 799999999998753      


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            4589999999999999998542 2346889999999999999999999   88999999999999999999999999999


Q ss_pred             cccccC
Q 013693          420 ARCFAA  425 (438)
Q Consensus       420 a~~~~~  425 (438)
                      ++.+..
T Consensus       158 ~~~~~~  163 (272)
T cd06637         158 SAQLDR  163 (272)
T ss_pred             ceeccc
Confidence            987643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=1.6e-23  Score=195.93  Aligned_cols=147  Identities=31%  Similarity=0.490  Sum_probs=130.8

Q ss_pred             CCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc------hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      +|+..+.||+|+||.||+|...+++.+|+|.+....      ....+.+.+|++++++++|+||+++++++...+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999987788999999886432      22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +||+++++|.+++.+.   ..+++..+..++.|++.||.|||   +.+|+|+||+|+||++++++.+||+|||+++.+.
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999542   35789999999999999999999   8899999999999999999999999999998753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=2.5e-23  Score=193.50  Aligned_cols=150  Identities=25%  Similarity=0.375  Sum_probs=132.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +|++.+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            467789999999999999954 46889999998643 3345677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++... ....+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999999988542 3445889999999999999999999   89999999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-24  Score=189.24  Aligned_cols=156  Identities=26%  Similarity=0.378  Sum_probs=136.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----e
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----E  341 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  341 (438)
                      ...++|.+.+.||+|||+-||++ ...++..+|+|++...+.+..+..++|++..++++||||++++++...+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34567999999999999999999 56788999999999888788899999999999999999999998765433     4


Q ss_pred             EEEEEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      .||+++|...|+|.+.+.... ++..+++.+++.|+.+|++||++||+. ..++.||||||.|||+.+++.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            899999999999999986543 344699999999999999999999943 345999999999999999999999999998


Q ss_pred             cccc
Q 013693          421 RCFA  424 (438)
Q Consensus       421 ~~~~  424 (438)
                      ....
T Consensus       177 ~~a~  180 (302)
T KOG2345|consen  177 TQAP  180 (302)
T ss_pred             cccc
Confidence            7653

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.91  E-value=1.2e-23  Score=202.14  Aligned_cols=153  Identities=32%  Similarity=0.483  Sum_probs=131.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc--------CCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      ..++|.+.+.||+|+||.||++...        ....+|+|.+... ......++.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3456788999999999999998531        2457899988754 234456788999999999 69999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      .+..+++|||+++++|.+++....             ....+++.++..++.|++.||.|||   +.+++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence            999999999999999999996532             1245889999999999999999999   899999999999999


Q ss_pred             eCCCCCeEEeccccccccc
Q 013693          406 LDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~  424 (438)
                      +++++.+||+|||+++...
T Consensus       167 l~~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         167 VTEDNVMKIADFGLARGVH  185 (314)
T ss_pred             EcCCCcEEEcccccccccc
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.91  E-value=1.1e-23  Score=196.55  Aligned_cols=151  Identities=31%  Similarity=0.496  Sum_probs=132.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..++|++.+.||+|+||.||++....+..+++|.+.... ...+.+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            456788899999999999999987777889999886442 335678999999999999999999999877 778999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..+..
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999999543 2345788999999999999999999   88999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=1.5e-23  Score=199.77  Aligned_cols=149  Identities=34%  Similarity=0.527  Sum_probs=130.9

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchh-----hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQ-----WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      +|+..+.||+|++|.||+|.. .+++.|+||.+......     ....+.+|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999965 46899999999754322     344577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||   +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999995432  36899999999999999999999   89999999999999999999999999999987754


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       155 ~  155 (298)
T cd07841         155 P  155 (298)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.91  E-value=7.2e-25  Score=196.61  Aligned_cols=153  Identities=28%  Similarity=0.408  Sum_probs=128.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC-----CCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEe-CCe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  341 (438)
                      ...|+....||+|.||.||+|.-.+     ...+|+|+++....  .......+|+.+++.++||||+.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3458889999999999999993322     23789999975422  123456799999999999999999998877 778


Q ss_pred             EEEEEeccCCCCHHHHhhcc--CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC----CCeEEe
Q 013693          342 SLLVYEYVPNRSLDQFIFDK--NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD----FTPKIA  415 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~----~~~kl~  415 (438)
                      .+|++||.+. +|.++++.+  ...+.++...+.+|+.||+.|+.|||   ++=|+||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999976 888887533  33456899999999999999999999   8889999999999999776    899999


Q ss_pred             cccccccccCC
Q 013693          416 DFGLARCFAAD  426 (438)
Q Consensus       416 DFGla~~~~~~  426 (438)
                      |||+||++.+.
T Consensus       179 DlGlaR~~~~p  189 (438)
T KOG0666|consen  179 DLGLARLFNNP  189 (438)
T ss_pred             cccHHHHhhcc
Confidence            99999998754

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.91  E-value=1.6e-23  Score=198.12  Aligned_cols=149  Identities=30%  Similarity=0.494  Sum_probs=132.9

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|++.+.||+|++|.||+|.. .+++.|++|++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477889999999999999965 468999999987543  33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      + +++|.+++....  ..+++.++..++.||+.+|.|||   +.+++|+||||+||+++.++.++|+|||++..+...
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 999999985432  56899999999999999999999   899999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.91  E-value=1e-23  Score=199.57  Aligned_cols=161  Identities=25%  Similarity=0.374  Sum_probs=135.7

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEE-
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI-  337 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  337 (438)
                      +.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            44566777888999999999999999999954 467899999876432 2235678899999999 6999999999874 


Q ss_pred             ----eCCeEEEEEeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          338 ----EGPESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       338 ----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                          .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                345689999999999999987532 23345888999999999999999999   8899999999999999999999


Q ss_pred             EEecccccccccC
Q 013693          413 KIADFGLARCFAA  425 (438)
Q Consensus       413 kl~DFGla~~~~~  425 (438)
                      ||+|||+++.+..
T Consensus       164 kl~dfg~~~~~~~  176 (286)
T cd06638         164 KLVDFGVSAQLTS  176 (286)
T ss_pred             EEccCCceeeccc
Confidence            9999999987643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.91  E-value=1.7e-23  Score=194.87  Aligned_cols=144  Identities=34%  Similarity=0.517  Sum_probs=127.9

Q ss_pred             CccccCCceeEEEEEccC--C--CEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPN--G--TTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|++|.||++.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999996533  2  3689999977655 567789999999999999999999999888 889999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|.+++..... ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.+..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999965432 46899999999999999999999   89999999999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.91  E-value=1.3e-23  Score=200.09  Aligned_cols=149  Identities=26%  Similarity=0.502  Sum_probs=133.9

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .+|+..+.||.|++|.||++. ..+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            458888999999999999995 4578999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++++|.+++..    ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..+...
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999998842    35899999999999999999999   899999999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.90  E-value=1.6e-23  Score=198.50  Aligned_cols=152  Identities=34%  Similarity=0.544  Sum_probs=132.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|+..+.||+|+||.||++...      ++..+|+|.+... .....+++.+|+.++++++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            456888999999999999999653      4678999988754 334456799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccC-------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013693          343 LLVYEYVPNRSLDQFIFDKN-------------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  403 (438)
                      ++||||+++++|.+++....                   ....+++.+++.++.|++.||.|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996421                   1234788899999999999999999   8899999999999


Q ss_pred             eeeCCCCCeEEeccccccccc
Q 013693          404 ILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       404 ill~~~~~~kl~DFGla~~~~  424 (438)
                      ||++.++.+||+|||+++.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             eEecCCCceEECccccceecc
Confidence            999999999999999998653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.90  E-value=1e-23  Score=211.38  Aligned_cols=150  Identities=23%  Similarity=0.359  Sum_probs=122.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--------
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--------  339 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  339 (438)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            345799999999999999999954 568899999885432    2345799999999999999999876432        


Q ss_pred             CeEEEEEeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADF  417 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DF  417 (438)
                      ...++||||+++ +|.+++... .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 676666432 23456899999999999999999999   89999999999999998654 7999999


Q ss_pred             cccccccCC
Q 013693          418 GLARCFAAD  426 (438)
Q Consensus       418 Gla~~~~~~  426 (438)
                      |+|+.+...
T Consensus       216 Gla~~~~~~  224 (440)
T PTZ00036        216 GSAKNLLAG  224 (440)
T ss_pred             ccchhccCC
Confidence            999977543

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.90  E-value=9.2e-24  Score=200.77  Aligned_cols=146  Identities=29%  Similarity=0.503  Sum_probs=129.6

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      |.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            34456799999999999954 46889999998766556667789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|.+++..    ..+++.++..++.||+.||.|||   +.+|+||||||+||++++++.+||+|||++..+..
T Consensus       104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            999998832    34889999999999999999999   88999999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.2e-23  Score=196.74  Aligned_cols=150  Identities=30%  Similarity=0.511  Sum_probs=129.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCC----EEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .+|+..+.||+|+||.||+|... ++.    .+|+|.+.... .....++.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45778899999999999999653 232    58999886553 3455778999999999999999999999887 78899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...  ...+++..++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998543  334899999999999999999999   8999999999999999999999999999998775


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       161 ~~  162 (279)
T cd05057         161 VD  162 (279)
T ss_pred             Cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=2.1e-23  Score=195.39  Aligned_cols=147  Identities=32%  Similarity=0.533  Sum_probs=129.7

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch---------hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR---------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      +|.+...||+|++|.||+|.. .+++.+|+|.+.....         ...+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999954 4678999998864321         123568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999943   245888999999999999999999   8899999999999999999999999999998


Q ss_pred             ccc
Q 013693          422 CFA  424 (438)
Q Consensus       422 ~~~  424 (438)
                      .+.
T Consensus       155 ~~~  157 (267)
T cd06628         155 KLE  157 (267)
T ss_pred             ccc
Confidence            775

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=2.9e-23  Score=193.49  Aligned_cols=143  Identities=30%  Similarity=0.501  Sum_probs=124.1

Q ss_pred             ccccCCceeEEEEEc---cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          278 KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      .||+|+||.||+|.+   .++..+|+|++....  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999954   357889999886442  344678999999999999999999999875 45678999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            99999843   245889999999999999999999   8999999999999999999999999999998875443

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-25  Score=215.38  Aligned_cols=162  Identities=23%  Similarity=0.390  Sum_probs=139.2

Q ss_pred             cCCCCCCccccCCceeEEEEEccC-CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +.|+++..||.|+||.||++..+. +...|.|++...+....++|+-||+||+.++||+||+|++.|...+.+||+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            345566789999999999995543 4456788888888888999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCce
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~  429 (438)
                      .||-.+.++.+-  ...|.+.++..+++|++.||.|||   +.+|||||||+.|||+.-+|.++|+|||.+.........
T Consensus       112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            999999887543  456999999999999999999999   899999999999999999999999999998766544433


Q ss_pred             eeeeeeecC
Q 013693          430 VSTAVAGTL  438 (438)
Q Consensus       430 ~~~~~~Gt~  438 (438)
                      ..+ +.|||
T Consensus       187 RDs-FIGTP  194 (1187)
T KOG0579|consen  187 RDS-FIGTP  194 (1187)
T ss_pred             hcc-ccCCc
Confidence            333 45665

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.90  E-value=1e-23  Score=199.32  Aligned_cols=150  Identities=27%  Similarity=0.438  Sum_probs=128.9

Q ss_pred             CCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      |.+.+.||+|+||.||+|...      .++.||+|++..... ...+.+.+|+.++..++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            556788999999999999653      247899999875432 3356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          346 YEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      +||+++++|.+++....             ....+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence            99999999999984321             1234788899999999999999999   8999999999999999999999


Q ss_pred             EEecccccccccC
Q 013693          413 KIADFGLARCFAA  425 (438)
Q Consensus       413 kl~DFGla~~~~~  425 (438)
                      ||+|||+++....
T Consensus       164 kl~Dfg~~~~~~~  176 (283)
T cd05091         164 KISDLGLFREVYA  176 (283)
T ss_pred             Eeccccccccccc
Confidence            9999999887643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.90  E-value=2.1e-23  Score=199.60  Aligned_cols=146  Identities=24%  Similarity=0.346  Sum_probs=129.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||+|+||.||++.. ..++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            3688889999999999999954 457899999987543   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999999542   45889999999999999999999   88999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.90  E-value=1.5e-23  Score=203.28  Aligned_cols=154  Identities=29%  Similarity=0.474  Sum_probs=131.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc--------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      ...+|++.+.||+|+||.||++...        ....||+|.+.... ....+++.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            3356888999999999999999532        12368999886542 34467899999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      ++..+++|||+++++|.+++....             ....+++.++..++.|++.||.|||   +.+++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence            999999999999999999986432             2235788999999999999999999   899999999999999


Q ss_pred             eCCCCCeEEecccccccccC
Q 013693          406 LDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~  425 (438)
                      ++.++.+||+|||+++.+..
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHN  186 (334)
T ss_pred             EcCCCcEEECCcccceeccc
Confidence            99999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.90  E-value=2.1e-23  Score=195.78  Aligned_cols=143  Identities=24%  Similarity=0.405  Sum_probs=121.2

Q ss_pred             CccccCCceeEEEEEccCC---CEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999965433   345667665443 345678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          353 SLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       353 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      +|.+++..... ...+++..+..++.||+.||.|||   +.+++||||||+|||++.++.+||+|||++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccc
Confidence            99999965322 234667778899999999999999   88999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.90  E-value=2.1e-23  Score=199.29  Aligned_cols=155  Identities=31%  Similarity=0.441  Sum_probs=133.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (438)
                      ...++|...+.||+|+||.||++..      ..+..||+|+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            3345688899999999999999853      134579999887543 34456789999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      +..++||||+++++|.+++.... ...+++.++..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999985432 234899999999999999999999   88999999999999999999999999999


Q ss_pred             cccccCC
Q 013693          420 ARCFAAD  426 (438)
Q Consensus       420 a~~~~~~  426 (438)
                      ++.+...
T Consensus       188 ~~~~~~~  194 (302)
T cd05055         188 ARDIMND  194 (302)
T ss_pred             cccccCC
Confidence            9877543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.90  E-value=1.6e-23  Score=205.07  Aligned_cols=148  Identities=32%  Similarity=0.441  Sum_probs=125.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----  340 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  340 (438)
                      ...++|+..+.||+|+||.||++.. .++..||+|++...  .......+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3457899999999999999999954 46899999998643  3344567889999999999999999999886543    


Q ss_pred             --eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          341 --ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       341 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                        ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCC
Confidence              47999999975 5666652     23788889999999999999999   8999999999999999999999999999


Q ss_pred             cccccc
Q 013693          419 LARCFA  424 (438)
Q Consensus       419 la~~~~  424 (438)
                      +++...
T Consensus       169 ~a~~~~  174 (359)
T cd07876         169 LARTAC  174 (359)
T ss_pred             Cccccc
Confidence            998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.90  E-value=3.6e-23  Score=192.62  Aligned_cols=147  Identities=33%  Similarity=0.559  Sum_probs=130.5

Q ss_pred             CccccCCceeEEEEEccC----CCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++....    +..+++|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999996643    788999998765333 367899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCC------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          352 RSLDQFIFDKNK------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       352 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|.+++.....      ...+++.+++.++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      356899999999999999999999   89999999999999999999999999999998765


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       158 ~  158 (262)
T cd00192         158 D  158 (262)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.90  E-value=2.8e-23  Score=196.12  Aligned_cols=150  Identities=30%  Similarity=0.514  Sum_probs=131.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-----CCCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPES  342 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  342 (438)
                      +.|+..+.||+|+||.||++.+.     .+..+|+|.+...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677789999999999999643     3678999999765443 56789999999999999999999999887  5578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999543  235899999999999999999999   89999999999999999999999999999998


Q ss_pred             ccC
Q 013693          423 FAA  425 (438)
Q Consensus       423 ~~~  425 (438)
                      +..
T Consensus       159 ~~~  161 (284)
T cd05038         159 LPE  161 (284)
T ss_pred             ccc
Confidence            763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.90  E-value=2.3e-23  Score=197.79  Aligned_cols=148  Identities=30%  Similarity=0.466  Sum_probs=129.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|+..+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888899999999999999654 678999999875432 2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++ +|.+++....  ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            975 9998885432  35889999999999999999999   8999999999999999999999999999987653

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=9.6e-24  Score=208.97  Aligned_cols=145  Identities=26%  Similarity=0.347  Sum_probs=126.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc---CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..+|++.+.||+|+||.||++...   .+..||+|.+...     +...+|+.++++++||||+++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            456899999999999999998542   3578999987543     23568999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |++. ++|.+++.   ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 68888883   3356899999999999999999999   899999999999999999999999999999877544

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=1.1e-23  Score=221.84  Aligned_cols=163  Identities=23%  Similarity=0.356  Sum_probs=132.5

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-  339 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  339 (438)
                      .+.+...++|++.+.||+|+||.||++.. ..+..+|+|.+...  .......+..|+.+++.|+||||+++++++... 
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            33445567899999999999999999954 45778999988643  334456789999999999999999999988653 


Q ss_pred             -CeEEEEEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCC----CCCeeeCCCCCCCeeeCC-----
Q 013693          340 -PESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGS----ETRIIHRDIKTSNILLDK-----  408 (438)
Q Consensus       340 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~iiH~dlkp~Nill~~-----  408 (438)
                       ...+|||||+++++|.++|.... ....+++..++.|+.||+.||.|||...    ..+||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence             56899999999999999985432 2346899999999999999999999321    145999999999999964     


Q ss_pred             ------------CCCeEEecccccccccCC
Q 013693          409 ------------DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       409 ------------~~~~kl~DFGla~~~~~~  426 (438)
                                  ...+||+|||+++.+...
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~  195 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE  195 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccc
Confidence                        235899999999877543

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.90  E-value=2.4e-23  Score=194.81  Aligned_cols=148  Identities=30%  Similarity=0.443  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-----hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (438)
                      ++|+..+.||+|+||.||++.. .++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5688899999999999999954 568999999886431     23356788999999999999999999988764  467


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      +++|||+++++|.+++...   ..+++.....++.|++.+|.|||   +.+++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998532   34788889999999999999999   88999999999999999999999999999986


Q ss_pred             cc
Q 013693          423 FA  424 (438)
Q Consensus       423 ~~  424 (438)
                      +.
T Consensus       156 ~~  157 (265)
T cd06652         156 LQ  157 (265)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=2.3e-23  Score=197.65  Aligned_cols=149  Identities=27%  Similarity=0.291  Sum_probs=130.1

Q ss_pred             CCCCCCccccCCceeEEEEEc----cCCCEEEEEEeeecc----hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (438)
                      +|++.+.||+|+||.||++..    .++..||+|++....    ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999864    368899999987532    22346788999999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999854   245788999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCC
Q 013693          423 FAAD  426 (438)
Q Consensus       423 ~~~~  426 (438)
                      +..+
T Consensus       155 ~~~~  158 (290)
T cd05613         155 FHED  158 (290)
T ss_pred             cccc
Confidence            7543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.90  E-value=2.9e-23  Score=195.69  Aligned_cols=152  Identities=32%  Similarity=0.446  Sum_probs=130.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|.+.+.||+|++|.||+|...      .+..|++|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            466888999999999999999654      35678999886443 33446789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCC----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---CeEEe
Q 013693          343 LLVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIA  415 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~  415 (438)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||   +.+++|+||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    235899999999999999999999   88999999999999998654   69999


Q ss_pred             ccccccccc
Q 013693          416 DFGLARCFA  424 (438)
Q Consensus       416 DFGla~~~~  424 (438)
                      |||+++.+.
T Consensus       162 dfg~~~~~~  170 (277)
T cd05036         162 DFGMARDIY  170 (277)
T ss_pred             cCccccccC
Confidence            999998763

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.90  E-value=2.8e-23  Score=199.75  Aligned_cols=145  Identities=26%  Similarity=0.403  Sum_probs=119.4

Q ss_pred             CCccccCCceeEEEEEcc---CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeEEEEEeccC
Q 013693          276 SKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLVYEYVP  350 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  350 (438)
                      .++||+|+||.||+|...   +++.+|+|.+....  ....+.+|+.++++++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999653   46789999886432  23457789999999999999999998854  456889999985


Q ss_pred             CCCHHHHhhccC------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCCeEEeccccc
Q 013693          351 NRSLDQFIFDKN------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLA  420 (438)
Q Consensus       351 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~DFGla  420 (438)
                       ++|.+++....      ....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             48877764321      2235889999999999999999999   8999999999999999    45678999999999


Q ss_pred             ccccCC
Q 013693          421 RCFAAD  426 (438)
Q Consensus       421 ~~~~~~  426 (438)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07868         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            887543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=3.5e-23  Score=194.44  Aligned_cols=147  Identities=29%  Similarity=0.439  Sum_probs=129.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch----------hhHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR----------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (438)
                      +|...+.||+|+||.||+|.. .+++.+|+|.+.....          ...+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999954 4688999998864211          12346888999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   46889999999999999999999   889999999999999999999999999999


Q ss_pred             cccc
Q 013693          421 RCFA  424 (438)
Q Consensus       421 ~~~~  424 (438)
                      +...
T Consensus       156 ~~~~  159 (272)
T cd06629         156 KKSD  159 (272)
T ss_pred             cccc
Confidence            8764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.3e-23  Score=205.47  Aligned_cols=143  Identities=25%  Similarity=0.380  Sum_probs=124.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..+|++.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++||||+++++++...+..++|+|+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            456999999999999999999654 5678999975322      235699999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +. ++|.+++..  ....+++.++..|+.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus       139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            95 588888743  3346899999999999999999999   8899999999999999999999999999998543

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.90  E-value=1.7e-23  Score=199.43  Aligned_cols=146  Identities=29%  Similarity=0.477  Sum_probs=129.4

Q ss_pred             CCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +....||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++|+||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3345799999999999954 468999999987655555677889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +|..++..    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.+..+
T Consensus       104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659         104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            99988732    45889999999999999999999   899999999999999999999999999999866543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.90  E-value=2.4e-23  Score=195.02  Aligned_cols=148  Identities=30%  Similarity=0.493  Sum_probs=130.2

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc------hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      +|+..+.||+|++|.||++. ..+++.+|+|.+....      ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47788999999999999995 4578999999986432      2235678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCF  423 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~  423 (438)
                      |+||+++++|.+++.+   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999854   245889999999999999999999   89999999999999998775 5999999999877


Q ss_pred             cC
Q 013693          424 AA  425 (438)
Q Consensus       424 ~~  425 (438)
                      ..
T Consensus       155 ~~  156 (268)
T cd06630         155 AA  156 (268)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.90  E-value=6.2e-23  Score=191.91  Aligned_cols=154  Identities=33%  Similarity=0.457  Sum_probs=136.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.+.||.|+||.||++.. .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688899999999999999964 467899999986442 33567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +++++|.+++........+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999965433356899999999999999999999   8999999999999999999999999999998776543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.90  E-value=5.5e-23  Score=190.68  Aligned_cols=143  Identities=34%  Similarity=0.540  Sum_probs=128.2

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHH
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  355 (438)
                      ++||+|+||.||++....++.|++|.+..... ...+.+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999776699999998875533 35678999999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       356 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++...  ...+++..+..++.+++.+|.|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            998543  235788999999999999999999   8999999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.90  E-value=2.7e-23  Score=195.08  Aligned_cols=150  Identities=27%  Similarity=0.426  Sum_probs=129.1

Q ss_pred             cCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|.+.+.||+|+||.||+|...+    ...|++|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999996533    3468999886554 4556789999999999999999999998875 557899


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999543  235899999999999999999999   89999999999999999999999999999987654


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       160 ~  160 (270)
T cd05056         160 E  160 (270)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=3.8e-23  Score=193.11  Aligned_cols=149  Identities=30%  Similarity=0.497  Sum_probs=133.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.||++.. .+++.+++|.+.....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            477889999999999999964 4688999999876544  3677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            999999999853   234788999999999999999999   899999999999999999999999999999887544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.90  E-value=4.5e-23  Score=191.98  Aligned_cols=148  Identities=28%  Similarity=0.514  Sum_probs=128.4

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEE-eCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-EGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  349 (438)
                      ++|++.+.||+|+||.||++.. .+..+++|.+....  ..+.+.+|+.++++++|+||+++++++. .++..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4678889999999999999976 47889999885432  3467899999999999999999999765 456789999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++.... ...+++..++.++.|++.||.|||   ..+++||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            9999999986432 335889999999999999999999   89999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.90  E-value=3.5e-23  Score=192.58  Aligned_cols=149  Identities=25%  Similarity=0.477  Sum_probs=131.4

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      .+|+..+.||+|+||.||++.+.++..+|+|.+..... ....+.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35777899999999999999876788999998864322 34578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++|.+++...  ...+++..+..++.|++.+|.|||   +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            99999998542  235789999999999999999999   88999999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.90  E-value=6.2e-23  Score=192.24  Aligned_cols=148  Identities=29%  Similarity=0.462  Sum_probs=128.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-----hhhHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPES  342 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  342 (438)
                      .+|+..+.||+|+||.||++.. .++..+++|++....     ....+.+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999954 468899999886432     2334678899999999999999999998875  3578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   234788999999999999999999   89999999999999999999999999999986


Q ss_pred             cc
Q 013693          423 FA  424 (438)
Q Consensus       423 ~~  424 (438)
                      +.
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.90  E-value=5.6e-23  Score=191.09  Aligned_cols=150  Identities=34%  Similarity=0.587  Sum_probs=131.3

Q ss_pred             CCCCCccccCCceeEEEEEccC-----CCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +++.+.||+|+||.||++....     +..||+|.+...... ..+.+..|+.++..++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999996543     388999999755433 5678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++..... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854322 22899999999999999999999   889999999999999999999999999999877644

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.90  E-value=6.1e-23  Score=192.74  Aligned_cols=143  Identities=29%  Similarity=0.527  Sum_probs=123.3

Q ss_pred             CccccCCceeEEEEEccC-CC--EEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPN-GT--TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||++...+ +.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999996643 33  5688887643 344556789999999999 899999999999999999999999999


Q ss_pred             CCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          352 RSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       352 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      ++|.+++....             ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1234789999999999999999999   8999999999999999999999999999


Q ss_pred             cccc
Q 013693          419 LARC  422 (438)
Q Consensus       419 la~~  422 (438)
                      +++.
T Consensus       158 l~~~  161 (270)
T cd05047         158 LSRG  161 (270)
T ss_pred             Cccc
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.90  E-value=6e-23  Score=198.42  Aligned_cols=145  Identities=21%  Similarity=0.296  Sum_probs=125.6

Q ss_pred             CCCccccC--CceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          275 PSKKLGQG--GAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       275 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +.++||+|  +|++||++.. .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  6789999954 57899999998754  2334556788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++++||+.+...
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            9999999985432 234899999999999999999999   899999999999999999999999999865543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.90  E-value=3.8e-23  Score=196.30  Aligned_cols=149  Identities=30%  Similarity=0.422  Sum_probs=127.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +++|...+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46788899999999999999954 4688999999865432 223467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |+. ++|.+++...  ...+++..+..++.|++.||.|||   ..+|+|+||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            996 6777766432  234778888999999999999999   8899999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=4.3e-23  Score=195.04  Aligned_cols=150  Identities=31%  Similarity=0.525  Sum_probs=131.6

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +|+..+.||+|++|.||+|... ++..||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999654 688999999876532 23456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++ +|.+++........+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++.+..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            85 88888865444456899999999999999999999   88999999999999999999999999999986643

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=2e-23  Score=204.06  Aligned_cols=149  Identities=30%  Similarity=0.419  Sum_probs=126.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----  340 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  340 (438)
                      ...++|+..+.||+|+||.||++.. ..++.||||++...  .....+.+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3557899999999999999999954 46889999998643  3334567889999999999999999999876443    


Q ss_pred             --eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          341 --ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       341 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                        ..++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCc
Confidence              57999999965 6666662     23788899999999999999999   8999999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++....
T Consensus       165 ~~~~~~~  171 (355)
T cd07874         165 LARTAGT  171 (355)
T ss_pred             ccccCCC
Confidence            9987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-23  Score=200.20  Aligned_cols=154  Identities=23%  Similarity=0.371  Sum_probs=134.6

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..-|++.+.||+|-|..|-+++ .-+|..||||++.+..  ......+..|+..|+.++|||||+|+.+......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            3457888999999999999983 3479999999997653  334557889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee-CCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill-~~~~~~kl~DFGla~~~~~  425 (438)
                      |+=.+|+|.+++-.+.  ..+.+....+++.||+.|+.|+|   +..+|||||||+||.+ ..-|-+||.|||++-.|.+
T Consensus        97 ELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999996543  34889999999999999999999   8899999999999887 5668999999999999977


Q ss_pred             CCc
Q 013693          426 DRT  428 (438)
Q Consensus       426 ~~~  428 (438)
                      ...
T Consensus       172 G~k  174 (864)
T KOG4717|consen  172 GKK  174 (864)
T ss_pred             cch
Confidence            653

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.90  E-value=6.3e-23  Score=190.72  Aligned_cols=150  Identities=31%  Similarity=0.498  Sum_probs=134.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC-CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|+..+.||+|+||.||++.... ++.+++|.+.....  .+++.+|++++++++||||+++++.+..+...++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3578889999999999999996654 78999999865433  67899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++...  ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++..+...
T Consensus        80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999998532  346899999999999999999999   889999999999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=5.6e-23  Score=197.52  Aligned_cols=151  Identities=26%  Similarity=0.324  Sum_probs=133.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch---hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||+|++|.||++... +++.+|+|.+.....   ...+.+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999554 589999999875432   24567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++... ....+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999998543 3356899999999999999999999   89999999999999999999999999999887643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.90  E-value=7.5e-23  Score=192.87  Aligned_cols=148  Identities=25%  Similarity=0.436  Sum_probs=131.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..|+..+.||.|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++.+.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            3467778899999999999965 468899999987543 44567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++..    ..+++.++..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            999999998842    35888999999999999999999   89999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=6.1e-23  Score=193.36  Aligned_cols=149  Identities=29%  Similarity=0.481  Sum_probs=132.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++   |||++++++++..++..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999964 57899999998654 3344567889999999996   999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++..    ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999999843    25889999999999999999999   899999999999999999999999999999887544


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       155 ~  155 (277)
T cd06917         155 S  155 (277)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.1e-23  Score=184.57  Aligned_cols=142  Identities=17%  Similarity=0.148  Sum_probs=110.6

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchh--h-------HHH-----------------HHHHHHHHhccCCCce
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ--W-------VDE-----------------FFNEVNLISSIEHKNL  329 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni  329 (438)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ..+|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998778999999999754211  0       112                 2349999999988877


Q ss_pred             eeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeCCCCCCCeeeCC
Q 013693          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL-HGGSETRIIHRDIKTSNILLDK  408 (438)
Q Consensus       330 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~dlkp~Nill~~  408 (438)
                      .....+..  ...+|||||++++++.....   ....+++.++..++.|++.+|.+| |   ..+|+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence            54443322  22389999999887765432   224588899999999999999999 6   78999999999999998 


Q ss_pred             CCCeEEecccccccccCC
Q 013693          409 DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       409 ~~~~kl~DFGla~~~~~~  426 (438)
                      ++.++|+|||+|.....+
T Consensus       153 ~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         153 DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             CCcEEEEEccccccCCCc
Confidence            478999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=4.5e-23  Score=191.74  Aligned_cols=146  Identities=31%  Similarity=0.550  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      ++|++.+.||+|+||.||++.. .++.+|+|.+....  ..+.+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578889999999999999875 67889999886432  345788999999999999999999998655 4799999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++|.+++.... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence            999999996432 345889999999999999999999   8999999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.90  E-value=4.5e-23  Score=196.15  Aligned_cols=148  Identities=28%  Similarity=0.483  Sum_probs=132.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ++|+..+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788899999999999999954 467899999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++..    ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..+..
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            99999999843    34788999999999999999999   89999999999999999999999999999876654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.90  E-value=5e-23  Score=194.46  Aligned_cols=151  Identities=26%  Similarity=0.415  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHH-HhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNL-ISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|++.+.||+|+||.||++.. .++..||+|++.... .....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            3688889999999999999955 468999999987542 2233455566665 566689999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |++ ++|.+++... .....+++..++.++.||+.||.|||   +. +++||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888877542 23356899999999999999999999   65 999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.90  E-value=2.5e-23  Score=196.09  Aligned_cols=146  Identities=27%  Similarity=0.456  Sum_probs=129.3

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      |+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++.+..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            55567899999999999954 467889999886443 3455678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++|.+++.    ...+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.+||+|||+++.+..
T Consensus        86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          86 GGSALDLLK----PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            999999883    245889999999999999999999   89999999999999999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=7e-23  Score=192.67  Aligned_cols=149  Identities=27%  Similarity=0.403  Sum_probs=133.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|+..+.||.|++|.||++.. .+++.+|+|.+.... ......+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            3578889999999999999965 468899999987543 44556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++..    ..+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999843    26899999999999999999999   899999999999999999999999999999887644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.7e-23  Score=213.07  Aligned_cols=165  Identities=22%  Similarity=0.316  Sum_probs=125.0

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccC--CCEEEEE------------------EeeecchhhHHHHHHHHHHHhccCCC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPN--GTTVAVK------------------RLIFNTRQWVDEFFNEVNLISSIEHK  327 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~  327 (438)
                      ...++|++.+.||+|+||.||++..+.  +...+.|                  .+. ........+.+|+.+|++++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999985432  2222222                  111 1222345688999999999999


Q ss_pred             ceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCC--CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       328 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      ||+++++++...+..++|+|++. ++|.+++.....  .......++..|+.||+.||.|||   +.+||||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence            99999999999999999999985 577777643211  122345667789999999999999   899999999999999


Q ss_pred             eCCCCCeEEecccccccccCCCceeeeeeeec
Q 013693          406 LDKDFTPKIADFGLARCFAADRTHVSTAVAGT  437 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt  437 (438)
                      ++.++.+||+|||+++.+............||
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt  331 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT  331 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCC
Confidence            99999999999999998865443332233444

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.90  E-value=5.2e-23  Score=194.96  Aligned_cols=149  Identities=30%  Similarity=0.459  Sum_probs=123.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhcc---CCCceeeEEeEEEe-----CC
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIE-----GP  340 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  340 (438)
                      +|++.+.||+|+||.||++.. .+++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            477889999999999999954 468899999987532  22233456777777765   69999999998764     24


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++||||+++ +|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999975 888888543 2345899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +.+..
T Consensus       156 ~~~~~  160 (288)
T cd07863         156 RIYSC  160 (288)
T ss_pred             ccccC
Confidence            87753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=1e-22  Score=189.66  Aligned_cols=144  Identities=31%  Similarity=0.496  Sum_probs=124.2

Q ss_pred             CccccCCceeEEEEEccC----CCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      ++||+|+||.||+|....    +..+|+|.+..... ...+++.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999995422    26899999875543 34567899999999999999999999875 4568999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++|.+++...   ..+++..+..++.|++.+|.|||   ..+++|+||||+|||++.++.+||+|||+++.+....
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            9999999543   25899999999999999999999   8899999999999999999999999999998775443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7e-24  Score=205.82  Aligned_cols=148  Identities=24%  Similarity=0.370  Sum_probs=130.7

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .-|..++.||-|+||+|.++. .++...+|+|.+++.+   +......+.|.+||+..+.+.||+|+-.|++.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457778899999999999994 4456778999987653   344556788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||++||++..+|-   +...|.+..+.-++.++.-|+++.|   +.|+|||||||+|||||.+|++||+||||+.-|.
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999884   3456888888889999999999999   9999999999999999999999999999998664

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=9.6e-23  Score=189.70  Aligned_cols=150  Identities=27%  Similarity=0.388  Sum_probs=129.6

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  347 (438)
                      .|++.+.||+|++|.||++.. .+++.+|+|++...  .....+.+.+|++++++++|||++++++.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            477889999999999999954 45789999998653  23445678899999999999999999998764 446899999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++|.+++... ....+++.++..++.|++.||.+||   +.+++|+||||+||+++.++.++|+|||+++.+..
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999998643 3345899999999999999999999   89999999999999999999999999999987753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=1.1e-22  Score=191.67  Aligned_cols=147  Identities=27%  Similarity=0.437  Sum_probs=130.2

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      -|+..+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            366788999999999999954 568899999886432 344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++.    ...+++..+..++.|++.+|.|||   +.+++|+||||+||+++.++.++|+|||+++.+..
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            9999999983    235889999999999999999999   89999999999999999999999999999987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=1.8e-23  Score=197.78  Aligned_cols=149  Identities=28%  Similarity=0.431  Sum_probs=130.7

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|+..++||+|+||.||++... +++.+|+|++....  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999664 58899999876432  2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++|.++...   ...+++.++..++.||+.||.|||   +.+++|+||+|+||++++++.+||+|||++..+..
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999887632   234899999999999999999999   88999999999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.3e-24  Score=193.39  Aligned_cols=162  Identities=26%  Similarity=0.294  Sum_probs=138.8

Q ss_pred             hcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|+.+++||+|.||.|.++ ...+++.+|+|++++..   ++....-..|-++|+..+||.+..|.-.++..+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            356778899999999999999 45578999999998653   34445566789999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||..||.|.-+|.   +.+.+++....-+...|+.||.|||   +.+||.||||.+|.|+|.||++||+||||++.-..
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999988884   3456888888889999999999999   89999999999999999999999999999997654


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      .... ..+.+|||
T Consensus       321 ~g~t-~kTFCGTP  332 (516)
T KOG0690|consen  321 YGDT-TKTFCGTP  332 (516)
T ss_pred             ccce-eccccCCh
Confidence            4433 23578886

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.89  E-value=4.3e-23  Score=202.45  Aligned_cols=148  Identities=30%  Similarity=0.413  Sum_probs=126.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC------
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------  339 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  339 (438)
                      ..++|...+.||+|+||.||++.. ..++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999954 46889999998643  234456788999999999999999999987543      


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999965 6777663     23788889999999999999999   89999999999999999999999999999


Q ss_pred             cccccC
Q 013693          420 ARCFAA  425 (438)
Q Consensus       420 a~~~~~  425 (438)
                      ++....
T Consensus       173 a~~~~~  178 (364)
T cd07875         173 ARTAGT  178 (364)
T ss_pred             ccccCC
Confidence            987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.89  E-value=3.6e-23  Score=195.89  Aligned_cols=151  Identities=28%  Similarity=0.381  Sum_probs=131.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|+..+.||+|+||.||++... +++.|++|+++..  .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888899999999999999654 5789999988643  23345778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |++++.+..+...   ...+++.++..++.||+.||.|||   ..+++|+||+|+||++++++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998777666532   344899999999999999999999   8899999999999999999999999999998876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=4.6e-23  Score=195.05  Aligned_cols=149  Identities=26%  Similarity=0.379  Sum_probs=130.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.+.||+|+||.||++.. ++++.+|+|++.... ....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4577788999999999999954 468899999886543 34467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++++|.+++..   ...+++..+..++.+++.+|.|||+  ..+++|+||||+||++++++.++|+|||++..+.
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999999998843   2458999999999999999999993  3589999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.89  E-value=9.4e-23  Score=190.38  Aligned_cols=143  Identities=33%  Similarity=0.521  Sum_probs=121.6

Q ss_pred             CccccCCceeEEEEEcc----CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEE-eCCeEEEEEeccC
Q 013693          277 KKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-EGPESLLVYEYVP  350 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  350 (438)
                      +.||+|+||.||+|...    ....+|+|++... .....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999642    2357999988543 3445678899999999999999999999776 4556899999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++|.+++...  ...+++..+..++.|+++||.|||   +.+++||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999998543  234677888899999999999999   8999999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.89  E-value=1.2e-22  Score=189.65  Aligned_cols=151  Identities=30%  Similarity=0.425  Sum_probs=135.6

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|+..+.||+|++|.||++... +++.|++|++..... ...+.+.+|+..+.+++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999655 589999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +++++|.+++...   ..+++..++.++.|++++|.|||   + .+++|+||+|+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999543   56899999999999999999999   7 999999999999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.89  E-value=1.1e-22  Score=189.29  Aligned_cols=150  Identities=27%  Similarity=0.416  Sum_probs=132.0

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.+|++.. .+++.+|+|++...  .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999944 46889999998643  234456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++... ....+++.+++.++.|++.||.|||   +.+++|+||+|+|||++.++.++|+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999999988543 2335789999999999999999999   89999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.89  E-value=5.6e-23  Score=195.14  Aligned_cols=160  Identities=30%  Similarity=0.397  Sum_probs=136.2

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      +..+++..+.++|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            44566677788999999999999999999955 568899999886432 2345678899999999 89999999999875


Q ss_pred             C-----CeEEEEEeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          339 G-----PESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       339 ~-----~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      .     +..++||||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            4     3589999999999999988532 23456899999999999999999999   8899999999999999999999


Q ss_pred             EEeccccccccc
Q 013693          413 KIADFGLARCFA  424 (438)
Q Consensus       413 kl~DFGla~~~~  424 (438)
                      ||+|||+++.+.
T Consensus       168 kl~dfg~~~~~~  179 (291)
T cd06639         168 KLVDFGVSAQLT  179 (291)
T ss_pred             EEeecccchhcc
Confidence            999999988764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=2.8e-23  Score=193.74  Aligned_cols=144  Identities=28%  Similarity=0.448  Sum_probs=124.1

Q ss_pred             CccccCCceeEEEEEccC--------CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +.||+|+||.||+|....        ..++++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999995432        235888888665555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC--------eEEeccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--------PKIADFGLA  420 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--------~kl~DFGla  420 (438)
                      +++|+|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999995432  35889999999999999999999   899999999999999987665        699999998


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      .....
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1e-22  Score=190.60  Aligned_cols=148  Identities=30%  Similarity=0.466  Sum_probs=128.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-----chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (438)
                      ++|++.+.||+|+||.||++.. .++..+|+|.+...     .......+.+|+.++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5688899999999999999954 56899999987532     233456789999999999999999999998764  468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++++||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999843   234788899999999999999999   88999999999999999999999999999987


Q ss_pred             cc
Q 013693          423 FA  424 (438)
Q Consensus       423 ~~  424 (438)
                      +.
T Consensus       156 ~~  157 (264)
T cd06653         156 IQ  157 (264)
T ss_pred             cc
Confidence            64

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=9.1e-23  Score=193.89  Aligned_cols=150  Identities=28%  Similarity=0.455  Sum_probs=130.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  345 (438)
                      ++|+..+.||+|+||.||+|... +++.+++|.++....  .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999664 588999999975432  2334577899999999999999999998877  889999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++ +|.+++....  ..+++.++..++.||+.||.|||   +.+++|+||||+|||++.++.+||+|||+++.+..
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 8988885432  35899999999999999999999   88999999999999999999999999999997765


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       159 ~  159 (293)
T cd07843         159 P  159 (293)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.89  E-value=1.1e-22  Score=195.42  Aligned_cols=145  Identities=26%  Similarity=0.405  Sum_probs=119.0

Q ss_pred             CCccccCCceeEEEEEcc---CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeEEEEEeccC
Q 013693          276 SKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLVYEYVP  350 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  350 (438)
                      ..+||+|+||.||+|...   .+..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            367999999999999754   35789999886432  23457899999999999999999998854  457899999986


Q ss_pred             CCCHHHHhhcc------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCCeEEeccccc
Q 013693          351 NRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLA  420 (438)
Q Consensus       351 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~DFGla  420 (438)
                      + +|.+++...      .....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777776321      12235889999999999999999999   8999999999999999    56679999999999


Q ss_pred             ccccCC
Q 013693          421 RCFAAD  426 (438)
Q Consensus       421 ~~~~~~  426 (438)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07867         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            987543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.89  E-value=3e-23  Score=193.35  Aligned_cols=149  Identities=27%  Similarity=0.326  Sum_probs=133.0

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +|++.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|+.++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999654 58999999987542   2456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998432   46889999999999999999999   889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.89  E-value=9.1e-23  Score=194.97  Aligned_cols=149  Identities=33%  Similarity=0.540  Sum_probs=126.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCC----EEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGT----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      +.|+..+.||+|+||.||++.+ .++.    .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            4567788999999999999964 3443    57888876543 23345788999999999999999999988654 4679


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++||+++|+|.+++...  ...+++..++.++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998543  335889999999999999999999   8999999999999999999999999999998775


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       161 ~  161 (303)
T cd05110         161 G  161 (303)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.89  E-value=3.9e-23  Score=195.42  Aligned_cols=148  Identities=28%  Similarity=0.481  Sum_probs=128.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.||++.. .+|+.+|+|++....  ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            477889999999999999955 468899999986542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++ ++|.+++...  ...+++..+..++.||++||.|||   ..+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            97 4787777432  345899999999999999999999   89999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.89  E-value=1.1e-22  Score=193.53  Aligned_cols=150  Identities=28%  Similarity=0.456  Sum_probs=127.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCe-----
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE-----  341 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-----  341 (438)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+....  ......+.+|+.+++.+ +||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688899999999999999965 468999999876542  22345788999999999 56999999999887665     


Q ss_pred             EEEEEeccCCCCHHHHhhccCC--CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEeccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNK--TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFG  418 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DFG  418 (438)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||.|||   +.+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 88888754322  346899999999999999999999   899999999999999998 8899999999


Q ss_pred             cccccc
Q 013693          419 LARCFA  424 (438)
Q Consensus       419 la~~~~  424 (438)
                      +++.+.
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            998764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.89  E-value=1.6e-22  Score=190.61  Aligned_cols=143  Identities=26%  Similarity=0.327  Sum_probs=125.2

Q ss_pred             cccCCceeEEEEE-ccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ||+|+||.||++. ..+++.+|+|.+....   ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999995 4468899999986532   22344577899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      .+++..... ..+++.++..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++..+..
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            999864332 45899999999999999999999   89999999999999999999999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.89  E-value=1.9e-22  Score=193.07  Aligned_cols=149  Identities=32%  Similarity=0.498  Sum_probs=128.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +.|+..+.||+|+||.||++.. .+++.||+|.+....   ....+++.+|+++++.++||||+++++++..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4588889999999999999965 468999999886432   234467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||++ |+|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 5777766432  345899999999999999999999   89999999999999999999999999999976643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.89  E-value=1.1e-22  Score=195.40  Aligned_cols=151  Identities=27%  Similarity=0.412  Sum_probs=128.1

Q ss_pred             CCCCCCccccCCceeEEEEEcc---CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESL  343 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  343 (438)
                      +|+..+.||+|+||.||+|...   .++.||+|.+....   ....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677889999999999999654   47899999997633   34456778999999999999999999999988  7899


Q ss_pred             EEEeccCCCCHHHHhhccC--CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC----CCCeEEecc
Q 013693          344 LVYEYVPNRSLDQFIFDKN--KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK----DFTPKIADF  417 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kl~DF  417 (438)
                      +||||+++ +|.+++....  ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6766664322  2236889999999999999999999   899999999999999998    899999999


Q ss_pred             cccccccCC
Q 013693          418 GLARCFAAD  426 (438)
Q Consensus       418 Gla~~~~~~  426 (438)
                      |+++.+...
T Consensus       157 g~~~~~~~~  165 (316)
T cd07842         157 GLARLFNAP  165 (316)
T ss_pred             ccccccCCC
Confidence            999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.5e-22  Score=186.30  Aligned_cols=150  Identities=32%  Similarity=0.481  Sum_probs=133.9

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|++|.||++.. .+++.+++|.+.....  ...+.+.+|++++++++|||++++++++..++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            477889999999999999954 4678999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +++++|.+++...   ..+++..+..++.|++.+|.|||   +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999998533   56899999999999999999999   8999999999999999999999999999999876443

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=2.5e-23  Score=201.71  Aligned_cols=151  Identities=29%  Similarity=0.503  Sum_probs=131.0

Q ss_pred             cCCCCCCccccCCceeEEEEEccC---C--CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN---G--TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      +.....++||.|-||.||+|...+   |  -.||||.-+.+ ..+..+.|+.|..+|++++||||++|+|+|.+. ..||
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            344556889999999999995432   2  35899988764 556688999999999999999999999998764 5799


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |||.++-|.|.++|...  ...++......++.||..+|.|||   +.++|||||..+|||+....-+||+||||+|-+.
T Consensus       468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999999654  344888888999999999999999   8999999999999999999999999999999987


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      ++.
T Consensus       543 d~~  545 (974)
T KOG4257|consen  543 DDA  545 (974)
T ss_pred             ccc
Confidence            654

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.89  E-value=1.5e-22  Score=193.20  Aligned_cols=153  Identities=28%  Similarity=0.473  Sum_probs=130.3

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----  340 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  340 (438)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45677999999999999999999654 58899999987543  223456788999999999999999999887654    


Q ss_pred             ------eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 013693          341 ------ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       341 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  414 (438)
                            ..++|+||+++ ++...+...  ...+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence                  78999999976 777766432  345899999999999999999999   889999999999999999999999


Q ss_pred             ecccccccccCC
Q 013693          415 ADFGLARCFAAD  426 (438)
Q Consensus       415 ~DFGla~~~~~~  426 (438)
                      +|||++..+...
T Consensus       158 ~dfg~~~~~~~~  169 (302)
T cd07864         158 ADFGLARLYNSE  169 (302)
T ss_pred             CcccccccccCC
Confidence            999999877543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=1e-22  Score=190.39  Aligned_cols=148  Identities=26%  Similarity=0.394  Sum_probs=131.9

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +|+..+.||+|++|.||++... +++.+++|.+.... ....+++.+|++++++++||||+++++.+..++..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999654 68899999987653 345567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++++|.+++....  ..+++..+..++.|++.+|.|||   + .+++|+||||+||++++++.+||+|||++..+.
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999985432  56889999999999999999999   7 899999999999999999999999999987664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.89  E-value=1.4e-22  Score=191.55  Aligned_cols=159  Identities=27%  Similarity=0.419  Sum_probs=135.1

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      .++.++..+.+.|++.+.||+|+||.||++.. .+++.+|+|.+.... ....++..|+.+++++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            35556666778899999999999999999955 567899999886543 3345688999999999 79999999998853


Q ss_pred             ------CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          339 ------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       339 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                            ....+++|||+++++|.+++... ....+++..+..++.||+.||.|||   +.+|+|+||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence                  45789999999999999998543 2345788889999999999999999   8899999999999999999999


Q ss_pred             EEeccccccccc
Q 013693          413 KIADFGLARCFA  424 (438)
Q Consensus       413 kl~DFGla~~~~  424 (438)
                      +|+|||+++...
T Consensus       161 ~l~dfg~~~~~~  172 (282)
T cd06636         161 KLVDFGVSAQLD  172 (282)
T ss_pred             EEeeCcchhhhh
Confidence            999999988654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.89  E-value=2.3e-22  Score=188.91  Aligned_cols=150  Identities=27%  Similarity=0.495  Sum_probs=126.2

Q ss_pred             CCCCCccccCCceeEEEEEcc----CCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (438)
                      |.+.+.||+|+||.||+|.+.    +++.||||++..+  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999643    3688999998654  3345677899999999999999999999876542      


Q ss_pred             eEEEEEeccCCCCHHHHhhccC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      ..++++||+++++|.+++....   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999988874321   2235788999999999999999999   889999999999999999999999999


Q ss_pred             cccccccC
Q 013693          418 GLARCFAA  425 (438)
Q Consensus       418 Gla~~~~~  425 (438)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.89  E-value=2.5e-22  Score=188.35  Aligned_cols=153  Identities=27%  Similarity=0.449  Sum_probs=129.0

Q ss_pred             CCCCCCccccCCceeEEEEEccC--CCEEEEEEeeec----------chhhHHHHHHHHHHHhc-cCCCceeeEEeEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPN--GTTVAVKRLIFN----------TRQWVDEFFNEVNLISS-IEHKNLVKLLGCSIE  338 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  338 (438)
                      +|++.+.||+|+||.||++....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999997654  688999987532          12234567788888875 699999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      ++..++||||+++++|.+++... .....+++..++.++.|++.+|.|||.  ..+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887432 234468999999999999999999992  368999999999999999999999999


Q ss_pred             cccccccCC
Q 013693          418 GLARCFAAD  426 (438)
Q Consensus       418 Gla~~~~~~  426 (438)
                      |++......
T Consensus       159 g~~~~~~~~  167 (269)
T cd08528         159 GLAKQKQPE  167 (269)
T ss_pred             cceeecccc
Confidence            999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.4e-23  Score=202.89  Aligned_cols=146  Identities=32%  Similarity=0.418  Sum_probs=128.6

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHH
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  355 (438)
                      -+||+|.||+||-|+. ++...+|||.+...+....+-+..||.+-++|+|.|||+++|.+..++..-|.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            3699999999999954 456789999998777777888999999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCCeEEecccccccccC
Q 013693          356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAA  425 (438)
Q Consensus       356 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~DFGla~~~~~  425 (438)
                      .+|+..-.+-.-.+...-.+.+||++||.|||   +..|||||||-+|||++ -.|.+||+|||-++.+..
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            99965433322377788889999999999999   89999999999999996 679999999999998753

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.89  E-value=4.4e-22  Score=184.03  Aligned_cols=151  Identities=32%  Similarity=0.535  Sum_probs=135.6

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      .|+..+.||+|++|.||++... ++..+++|++........+.+.+|++++++++||||+++++.+..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999664 688999999977655567789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +++|.+++....  ..+++..+..++.|++.+|.|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999985432  46899999999999999999999   8999999999999999999999999999998876543

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=196.46  Aligned_cols=167  Identities=29%  Similarity=0.378  Sum_probs=135.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecch-------hhHHHHHHHHHHHhccCCCceeeEEeEEEe-
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR-------QWVDEFFNEVNLISSIEHKNLVKLLGCSIE-  338 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  338 (438)
                      ...++|-.+++||+|+|+.||++ ++...+.||+|+-..+..       ...+...+|..|-+.|+||-||++++++.- 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            34456677889999999999999 566678899997654321       123446789999999999999999999875 


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCCeEEe
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIA  415 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~  415 (438)
                      .+..+-|+||++|.+|+-+|..   .+.+++.++..|+.||+.||.||.+- +.+|||-||||.|||+.   .-|.+||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            4567899999999999999953   45689999999999999999999865 68999999999999995   45789999


Q ss_pred             cccccccccCCCce------eeeeeeecC
Q 013693          416 DFGLARCFAADRTH------VSTAVAGTL  438 (438)
Q Consensus       416 DFGla~~~~~~~~~------~~~~~~Gt~  438 (438)
                      ||||++++..++..      .++..+||+
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTY  644 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTY  644 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCcee
Confidence            99999999866533      223456764

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.89  E-value=3.3e-22  Score=189.37  Aligned_cols=152  Identities=31%  Similarity=0.499  Sum_probs=135.6

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ...+.|+..+.||+|++|.||++..+ ++..+++|++..... ..+.+.+|+++++.++|+||+++++.+...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34566888899999999999999665 688999999976544 4667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999996532  36899999999999999999999   89999999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.89  E-value=1.1e-22  Score=192.19  Aligned_cols=149  Identities=30%  Similarity=0.516  Sum_probs=129.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||.|++|.||++.. .+++.||||++....  ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            478889999999999999955 468899999886442  22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +. ++|.+++... ....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            96 6898888543 2345899999999999999999999   88999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=2.3e-22  Score=186.93  Aligned_cols=151  Identities=26%  Similarity=0.442  Sum_probs=131.3

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+...  .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999854 46889999998654  234467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++... ....+++..+..++.+++++|.|||   +.+++|+||||+||+++.+ +.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999999543 2345899999999999999999999   8999999999999999854 46899999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=2.7e-22  Score=187.13  Aligned_cols=156  Identities=26%  Similarity=0.415  Sum_probs=132.4

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  346 (438)
                      +|+..+.||.|+||.||++. ..++..+|+|.+...  .....+.+.+|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            47788999999999999994 456789999998643  33445678899999999999999999997764  45689999


Q ss_pred             eccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGS--ETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||..+  +.+++|+||||+||+++.++.+||+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998543 22456899999999999999999999543  578999999999999999999999999999987


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       161 ~~~~  164 (265)
T cd08217         161 GHDS  164 (265)
T ss_pred             cCCc
Confidence            6544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.89  E-value=3.3e-22  Score=189.42  Aligned_cols=146  Identities=29%  Similarity=0.499  Sum_probs=130.4

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      |...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44457899999999999964 56889999998765555566789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|.+++..    ..+++.++..++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            999999843    35889999999999999999999   89999999999999999999999999999886644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.9e-22  Score=189.36  Aligned_cols=153  Identities=32%  Similarity=0.443  Sum_probs=132.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC-----
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP-----  340 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  340 (438)
                      ..+++|++.+.||+|++|.||++... +++.+++|.+..... ..+.+.+|+.+++++ +||||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35678999999999999999999654 578999998875543 346789999999999 7999999999987654     


Q ss_pred             -eEEEEEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          341 -ESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       341 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999885422 2456899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccc
Q 013693          419 LARCFA  424 (438)
Q Consensus       419 la~~~~  424 (438)
                      ++....
T Consensus       159 ~~~~~~  164 (275)
T cd06608         159 VSAQLD  164 (275)
T ss_pred             cceecc
Confidence            987654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.89  E-value=3.1e-22  Score=186.99  Aligned_cols=142  Identities=27%  Similarity=0.357  Sum_probs=126.4

Q ss_pred             cccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ||.|++|.||++... +++.+++|.+....   ....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999654 48899999986532   23456799999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      .+++...   ..+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999542   34889999999999999999999   899999999999999999999999999999987653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-23  Score=205.68  Aligned_cols=150  Identities=29%  Similarity=0.497  Sum_probs=133.0

Q ss_pred             CCCccccCCceeEEEEEccC--C--CEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          275 PSKKLGQGGAGSVYMGSLPN--G--TTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ..++||+|.||.|++|.|..  |  ..||||.++..... ...+|++|+.+|.+|+|||+++|+|+..+ ....+|+|+.
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            45789999999999997753  4  36899999876544 67899999999999999999999999887 6788999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCce
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~  429 (438)
                      +.|+|.+.|++ .....|....+..++.|||.||.||.   .+++|||||..+|+|+.....+||+||||.|.++.++++
T Consensus       193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999976 34456778888999999999999999   899999999999999999999999999999999877654

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.89  E-value=2.2e-22  Score=190.31  Aligned_cols=148  Identities=30%  Similarity=0.478  Sum_probs=129.6

Q ss_pred             CCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEEEEe
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVYE  347 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  347 (438)
                      |++.+.||+|++|.||++... +++.+|+|++....  ....+.+.+|+.++++++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566788999999999999654 57899999997653  33456788999999999999999999999988  88999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++ +|.+++...  ...+++..++.++.||+.||.|||   +.+++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 888888443  246899999999999999999999   889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.88  E-value=5e-23  Score=198.26  Aligned_cols=152  Identities=24%  Similarity=0.348  Sum_probs=128.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch---hh-----HHHHHHHHHHHhccC---CCceeeEEeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR---QW-----VDEFFNEVNLISSIE---HKNLVKLLGCSI  337 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~-----~~~~~~E~~~l~~l~---h~niv~l~~~~~  337 (438)
                      ...|...+.+|+|+||.|+.+.+ .+..+|+||.+.+..-   .+     .-.+-.||.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            34578889999999999999954 4567899998865421   11     223567999999997   999999999999


Q ss_pred             eCCeEEEEEecc-CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 013693          338 EGPESLLVYEYV-PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (438)
Q Consensus       338 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  416 (438)
                      +++.+||+||-- ++.+|.+++..   ...+++.++..|++||+.|+++||   +.+|||||||-+||+++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence            999999999976 45689999843   345899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCC
Q 013693          417 FGLARCFAADR  427 (438)
Q Consensus       417 FGla~~~~~~~  427 (438)
                      ||.|.......
T Consensus       714 fgsaa~~ksgp  724 (772)
T KOG1152|consen  714 FGSAAYTKSGP  724 (772)
T ss_pred             ccchhhhcCCC
Confidence            99998775543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=2.5e-22  Score=178.26  Aligned_cols=142  Identities=18%  Similarity=0.181  Sum_probs=112.6

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhh--------------------------HHHHHHHHHHHhccCCCce
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW--------------------------VDEFFNEVNLISSIEHKNL  329 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni  329 (438)
                      ...||+|++|.||+|...+|+.||||++.......                          ...+.+|.+.+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999987789999999987542110                          1124578999999999988


Q ss_pred             eeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeCC
Q 013693          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDK  408 (438)
Q Consensus       330 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~  408 (438)
                      .....+...  ..+|||||++++++.....   ....++..+...++.|++.+|.+||   . .+|+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence            655444333  2489999999886543321   1234678888999999999999999   6 8999999999999999 


Q ss_pred             CCCeEEecccccccccCC
Q 013693          409 DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       409 ~~~~kl~DFGla~~~~~~  426 (438)
                      ++.++|+|||+|+.+..+
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            789999999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.88  E-value=1.8e-22  Score=191.44  Aligned_cols=149  Identities=27%  Similarity=0.323  Sum_probs=129.0

Q ss_pred             CCCCCCccccCCceeEEEEEc----cCCCEEEEEEeeecc----hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (438)
                      +|++.+.||+|++|.||++..    .++..+|||.++...    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999853    356889999987432    22345688999999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||   ..+++|+||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998843   245888999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCC
Q 013693          423 FAAD  426 (438)
Q Consensus       423 ~~~~  426 (438)
                      +...
T Consensus       155 ~~~~  158 (288)
T cd05583         155 FLAE  158 (288)
T ss_pred             cccc
Confidence            6543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.88  E-value=2e-22  Score=196.01  Aligned_cols=151  Identities=26%  Similarity=0.458  Sum_probs=129.5

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC---
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP---  340 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  340 (438)
                      ....++|+..+.||+|+||.||++. ..++..||||++...  .....+.+.+|+.++++++||||+++++++..+.   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            3456789999999999999999994 557899999998543  2333456889999999999999999999887654   


Q ss_pred             ---eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          341 ---ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       341 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                         ..++||||+ +++|.+++.    ...+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence               358999999 779988873    245899999999999999999999   899999999999999999999999999


Q ss_pred             cccccccC
Q 013693          418 GLARCFAA  425 (438)
Q Consensus       418 Gla~~~~~  425 (438)
                      |+++....
T Consensus       163 g~~~~~~~  170 (343)
T cd07880         163 GLARQTDS  170 (343)
T ss_pred             cccccccc
Confidence            99987654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=2.8e-22  Score=190.02  Aligned_cols=151  Identities=28%  Similarity=0.398  Sum_probs=129.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  346 (438)
                      ++|+..+.||.|++|.||++.. .+++.+|+|.+.... .....++.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3577889999999999999965 467899999887543 34467799999999999999999999988654  4689999


Q ss_pred             eccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999887432 23445888999999999999999999   8999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=3.9e-23  Score=214.06  Aligned_cols=151  Identities=30%  Similarity=0.485  Sum_probs=124.9

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEe------
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------  338 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  338 (438)
                      .+-.++|++.+.||+||||.||+++. -+|+.+|||++... +......+.+|+.+|++|+|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            45667788899999999999999944 47999999999765 34445678899999999999999999875421      


Q ss_pred             -------------------------------------------------C------------------------------
Q 013693          339 -------------------------------------------------G------------------------------  339 (438)
Q Consensus       339 -------------------------------------------------~------------------------------  339 (438)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             ----------------------------------CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHH
Q 013693          340 ----------------------------------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY  385 (438)
Q Consensus       340 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  385 (438)
                                                        ..+||-||||+...|.+++.+.....  .....++++++|++||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                              12477889998888887774432211  467789999999999999


Q ss_pred             hhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       386 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      +|   +.|||||||||.||++|++..|||.|||+|..
T Consensus       713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             HH---hCceeeccCCcceeEEcCCCCeeecccccchh
Confidence            99   89999999999999999999999999999998

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=5.5e-22  Score=184.21  Aligned_cols=153  Identities=25%  Similarity=0.435  Sum_probs=135.0

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.||++... ++..+++|++....  ....+.+.+|+++++.++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999654 68899999987543  25567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +++++|.+++.... ....+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 2356899999999999999999999   8899999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-22  Score=203.82  Aligned_cols=173  Identities=27%  Similarity=0.402  Sum_probs=147.4

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI  337 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  337 (438)
                      ...++.+...+..|++.+.||.|.+|.||++ ..++++..|+|++.... ...+++..|..+|+.. .|||++.++|++.
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            3455666677788999999999999999999 55678999999886543 3346677889999988 7999999999887


Q ss_pred             e-----CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          338 E-----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       338 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      .     ++++|||||||.+||..++++... ...+.|+.+..|++.++.||.|||   ...+||||||-.|||++.++.|
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcE
Confidence            4     568999999999999999997655 677999999999999999999999   8999999999999999999999


Q ss_pred             EEecccccccccCCCceeeeeeeecC
Q 013693          413 KIADFGLARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       413 kl~DFGla~~~~~~~~~~~~~~~Gt~  438 (438)
                      ||.|||++..+.....+..| ..|||
T Consensus       163 KLvDFGvSaQldsT~grRnT-~iGtP  187 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTVGRRNT-FIGTP  187 (953)
T ss_pred             EEeeeeeeeeeecccccccC-cCCCc
Confidence            99999999998766555443 45775

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.88  E-value=1.8e-22  Score=188.39  Aligned_cols=142  Identities=28%  Similarity=0.399  Sum_probs=126.5

Q ss_pred             cccCCceeEEEEEcc-CCCEEEEEEeeecch---hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ||+|+||.||++... +++.+++|.+.....   ...+.+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999765 489999999865432   4566789999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      .+++...   ..+++..+..++.||+.||.|||   +.+++|+||+|+||+++.++.+||+|||++.....+
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9998543   36899999999999999999999   899999999999999999999999999998875443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=202.36  Aligned_cols=153  Identities=25%  Similarity=0.338  Sum_probs=120.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-----------------cCCCEEEEEEeeecchhhHHH--------------HHHHH
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-----------------PNGTTVAVKRLIFNTRQWVDE--------------FFNEV  318 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~  318 (438)
                      .++|++.++||+|+||.||+|..                 ..++.||||++........++              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56799999999999999999953                 235679999987543332233              33467


Q ss_pred             HHHhccCCCce-----eeEEeEEEe--------CCeEEEEEeccCCCCHHHHhhccCC---------------------C
Q 013693          319 NLISSIEHKNL-----VKLLGCSIE--------GPESLLVYEYVPNRSLDQFIFDKNK---------------------T  364 (438)
Q Consensus       319 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~  364 (438)
                      .++.+++|.++     +++++++..        .+..+|||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     677777653        3568999999999999999864211                     1


Q ss_pred             CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       365 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ..+++..+..++.|++.+|.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  361 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT  361 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence            23567788899999999999999   88999999999999999999999999999976543

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.8e-23  Score=194.89  Aligned_cols=171  Identities=26%  Similarity=0.315  Sum_probs=143.1

Q ss_pred             cCHHHHHHHh-cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeE
Q 013693          261 FKYETLEKAT-NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGC  335 (438)
Q Consensus       261 ~~~~~~~~~~-~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~  335 (438)
                      +++-++...+ +.|..-++||+|+||.||-+. ..+|+.+|.|++.+.   .++.....++|-.+|.+++.+.||.+--.
T Consensus       174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA  253 (591)
T KOG0986|consen  174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA  253 (591)
T ss_pred             HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence            3433433333 457788999999999999884 447899999988643   23334457799999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 013693          336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       336 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      +++.+.++||+..|.||+|.-+|+.... ..+++..+.-++.+|+-||++||   +.+||.|||||+|||+|++|+++|+
T Consensus       254 feTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  254 FETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             ecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEee
Confidence            9999999999999999999988865543 45999999999999999999999   8999999999999999999999999


Q ss_pred             cccccccccCCCceeeeeeeec
Q 013693          416 DFGLARCFAADRTHVSTAVAGT  437 (438)
Q Consensus       416 DFGla~~~~~~~~~~~~~~~Gt  437 (438)
                      |+|||..+........  .+||
T Consensus       330 DLGLAvei~~g~~~~~--rvGT  349 (591)
T KOG0986|consen  330 DLGLAVEIPEGKPIRG--RVGT  349 (591)
T ss_pred             ccceEEecCCCCcccc--ccCc
Confidence            9999999988776543  2566

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.88  E-value=2.7e-22  Score=190.67  Aligned_cols=143  Identities=29%  Similarity=0.500  Sum_probs=127.9

Q ss_pred             CCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ..+||+|+||.||++.. .++..||+|++..........+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35799999999999955 56889999998655555567799999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      .+++..    ..+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            998732    34789999999999999999999   88999999999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.88  E-value=5.1e-22  Score=187.52  Aligned_cols=141  Identities=23%  Similarity=0.256  Sum_probs=117.8

Q ss_pred             ccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHh---ccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLIS---SIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      .||+|+||.||++.. .+++.+|+|.+....   ......+.+|..++.   ..+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 468899999886432   122233445544433   3479999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++|.+++..   ...+++..+..++.|++.||.|||   +.+|+|+||||+|||+++++.+||+|||++..+.
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            9999998853   245899999999999999999999   8999999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.88  E-value=6.8e-22  Score=190.20  Aligned_cols=148  Identities=32%  Similarity=0.516  Sum_probs=127.8

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .|+..+.||+|+||.||++.. .++..+|+|++...   .....+.+.+|++++++++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            366788999999999999964 46889999998643   22344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++ +|.+.+...  ...+++.++..++.|++.||.|||   +.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            9975 777776432  345899999999999999999999   89999999999999999999999999999876653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.88  E-value=1.6e-22  Score=196.24  Aligned_cols=148  Identities=26%  Similarity=0.464  Sum_probs=127.2

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  342 (438)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+... .......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4679999999999999999995 457899999998643 2334567889999999999999999999866543     57


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++|+||+++ +|.+++.    ...+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999964 8887773    345899999999999999999999   89999999999999999999999999999987


Q ss_pred             ccC
Q 013693          423 FAA  425 (438)
Q Consensus       423 ~~~  425 (438)
                      ...
T Consensus       156 ~~~  158 (336)
T cd07849         156 ADP  158 (336)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.88  E-value=3.6e-22  Score=191.37  Aligned_cols=151  Identities=31%  Similarity=0.473  Sum_probs=128.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  344 (438)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+.....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            45788999999999999999955 4689999999875432  2233567899999999999999999998765  46899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++ +|.+++...  ...+++.++..++.||++||.|||   +.+++||||||+||+++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999965 888887532  245899999999999999999999   8999999999999999999999999999998875


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       160 ~~  161 (309)
T cd07845         160 LP  161 (309)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.88  E-value=2.4e-22  Score=188.35  Aligned_cols=145  Identities=34%  Similarity=0.521  Sum_probs=124.6

Q ss_pred             CccccCCceeEEEEEccC-------CCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSLPN-------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +.||+|+||.||++...+       +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999996532       2578999876543 34466789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC----CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-----CeEEecccc
Q 013693          349 VPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-----TPKIADFGL  419 (438)
Q Consensus       349 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-----~~kl~DFGl  419 (438)
                      +++++|.+++....    ....+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2234788999999999999999999   88999999999999999877     899999999


Q ss_pred             ccccc
Q 013693          420 ARCFA  424 (438)
Q Consensus       420 a~~~~  424 (438)
                      ++.+.
T Consensus       158 ~~~~~  162 (269)
T cd05044         158 ARDIY  162 (269)
T ss_pred             ccccc
Confidence            98664

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.88  E-value=2.5e-22  Score=194.93  Aligned_cols=150  Identities=31%  Similarity=0.482  Sum_probs=128.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec--chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC--CeE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG--PES  342 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  342 (438)
                      ..++|+..+.||+|+||.||+|... ++..+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888999999999999999654 6789999988542  233445678899999999 999999999988654  368


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 599888843    26888999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCC
Q 013693          423 FAAD  426 (438)
Q Consensus       423 ~~~~  426 (438)
                      +...
T Consensus       157 ~~~~  160 (337)
T cd07852         157 LSEL  160 (337)
T ss_pred             cccc
Confidence            7543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PTZ00284 protein kinase; Provisional

Probab=99.88  E-value=1.9e-22  Score=204.24  Aligned_cols=152  Identities=21%  Similarity=0.252  Sum_probs=121.5

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC------CceeeEEeEE
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH------KNLVKLLGCS  336 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~  336 (438)
                      +++....++|++.++||+|+||.||++.. ..++.||||+++... ...+++..|+.+++.++|      ++|+++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            34445568899999999999999999954 467899999986432 223455667777777654      4588999988


Q ss_pred             EeC-CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeCCCC----
Q 013693          337 IEG-PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDF----  410 (438)
Q Consensus       337 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~----  410 (438)
                      ... +..++|||++ +++|.+++..   ...+++.++..|+.||+.||.|||   . .+||||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccc
Confidence            765 4688999988 7788888743   245899999999999999999999   5 6999999999999998665    


Q ss_pred             ------------CeEEecccccccc
Q 013693          411 ------------TPKIADFGLARCF  423 (438)
Q Consensus       411 ------------~~kl~DFGla~~~  423 (438)
                                  .+||+|||++...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~  298 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDE  298 (467)
T ss_pred             cccccccCCCCceEEECCCCccccC
Confidence                        4999999988643

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.88  E-value=6.8e-22  Score=183.55  Aligned_cols=150  Identities=32%  Similarity=0.452  Sum_probs=134.1

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  346 (438)
                      +|...+.||+|++|.||+|... ++..|++|++....  ....+.+.+|+.++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3677889999999999999665 68899999987654  24567899999999999999999999999988  8899999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++...   ..+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998543   26899999999999999999999   899999999999999999999999999999987655


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       155 ~  155 (260)
T cd06606         155 E  155 (260)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.88  E-value=6.2e-22  Score=188.23  Aligned_cols=150  Identities=28%  Similarity=0.470  Sum_probs=126.8

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|+..+.||+|++|.||++... +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999654 68899999886432  2334578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~~~~  425 (438)
                      |++ ++|.+++... ....+++..+..++.||+.||.|||   +.+++|+||+|+||+++. ++.+||+|||+++....
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 5787777432 2234678888899999999999999   889999999999999985 56799999999987643

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.88  E-value=1.8e-22  Score=190.08  Aligned_cols=150  Identities=30%  Similarity=0.386  Sum_probs=133.0

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|...+.||+|+||.||++... +++.|++|++...   .....+.+.+|.+++.+++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999654 6899999988653   2334567889999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||++++++|.+++...   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999999542   36999999999999999999999   89999999999999999999999999999987754


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       155 ~  155 (280)
T cd05581         155 N  155 (280)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.88  E-value=4.7e-22  Score=190.31  Aligned_cols=150  Identities=28%  Similarity=0.500  Sum_probs=126.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (438)
                      .++|+..+.||+|+||.||++.. .+++.||||.+....  ......+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            35688899999999999999955 468999999886542  222345678999999999999999999887654      


Q ss_pred             --eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          341 --ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       341 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                        ..++||||+.+ +|.+.+..  ....+++.++..++.||++||.|||   +.+++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence              35999999964 78877743  2235899999999999999999999   8899999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      ++..+..
T Consensus       165 ~~~~~~~  171 (310)
T cd07865         165 LARAFSL  171 (310)
T ss_pred             CcccccC
Confidence            9987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.88  E-value=5e-22  Score=187.69  Aligned_cols=147  Identities=30%  Similarity=0.517  Sum_probs=128.6

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      |+..+.||.|++|.||++.. .++..||+|++....  ....+.+.+|++++++++||||+++++++..++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56778999999999999954 478999999987543  223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      + ++|.+++.... ...+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||+++.+.
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            5 68999885432 245899999999999999999999   8899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.88  E-value=5.3e-22  Score=193.23  Aligned_cols=156  Identities=28%  Similarity=0.408  Sum_probs=131.7

Q ss_pred             CHHHHHHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       262 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ...++....++|+..+.||+|+||.||++. ..+++.||+|++...  .....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            345666778999999999999999999995 457889999998643  22335668899999999999999999998764


Q ss_pred             C------CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          339 G------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       339 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      .      ...+++++++ +++|.+++..    ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence            3      3467888876 7899888732    34899999999999999999999   8999999999999999999999


Q ss_pred             EEecccccccccC
Q 013693          413 KIADFGLARCFAA  425 (438)
Q Consensus       413 kl~DFGla~~~~~  425 (438)
                      ||+|||+++....
T Consensus       160 kl~dfg~~~~~~~  172 (345)
T cd07877         160 KILDFGLARHTDD  172 (345)
T ss_pred             EEecccccccccc
Confidence            9999999987543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=6e-22  Score=193.49  Aligned_cols=149  Identities=31%  Similarity=0.426  Sum_probs=127.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  339 (438)
                      ...++|+..+.||+|+||.||++. ..+++.||+|.+...  .....+.+.+|+.++++++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            345789999999999999999995 457899999998642  334456778999999999999999999987644     


Q ss_pred             -CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          340 -PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       340 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                       ...++||||+. ++|.+.+..     .+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence             35799999996 488887732     2788899999999999999999   8899999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++....
T Consensus       164 ~~~~~~~  170 (353)
T cd07850         164 LARTAGT  170 (353)
T ss_pred             cceeCCC
Confidence            9987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.87  E-value=2.7e-22  Score=194.38  Aligned_cols=149  Identities=23%  Similarity=0.437  Sum_probs=128.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  342 (438)
                      .++|+..+.||+|+||.||++.. .++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36788899999999999999954 468999999987542  2345678889999999999999999988763    3468


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+. ++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 589888843   344899999999999999999999   88999999999999999999999999999987


Q ss_pred             ccC
Q 013693          423 FAA  425 (438)
Q Consensus       423 ~~~  425 (438)
                      ...
T Consensus       157 ~~~  159 (334)
T cd07855         157 LSS  159 (334)
T ss_pred             ecc
Confidence            643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.87  E-value=4.6e-22  Score=185.02  Aligned_cols=151  Identities=26%  Similarity=0.445  Sum_probs=130.7

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.||++... ++..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999554 57899999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++... ....+++..+..++.|+++||.|||   ..+++|+||||+||++++++ .+||+|||.+..+...
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998543 2335799999999999999999999   88999999999999998875 5699999999877544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.87  E-value=1.3e-21  Score=184.58  Aligned_cols=141  Identities=24%  Similarity=0.251  Sum_probs=117.8

Q ss_pred             ccccCCceeEEEEEc-cCCCEEEEEEeeecch---hhHHHHHHHH---HHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR---QWVDEFFNEV---NLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      .||+|+||.||++.. .+++.||+|.+.....   .....+..|.   .+++...||||+++++.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999954 4688999998865321   1122233443   34445579999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            9999988843   346899999999999999999999   8999999999999999999999999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-23  Score=216.71  Aligned_cols=155  Identities=29%  Similarity=0.415  Sum_probs=135.0

Q ss_pred             HHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ...+-+|.....||.|.||.||.+ ...+|...|+|.++.+.  ....+.+.+|+.++..++|||+|+++|+-.+.+..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            344556777889999999999998 66789999999887543  344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |.||||++|+|.+.+.   .....++.....+..|++.|+.|||   +.|||||||||.||+|+.+|.+|+.|||.|..+
T Consensus      1311 IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999993   3344666666778899999999999   899999999999999999999999999999998


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ..+-
T Consensus      1385 ~~~~ 1388 (1509)
T KOG4645|consen 1385 KNNA 1388 (1509)
T ss_pred             cCch
Confidence            7764

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.87  E-value=4e-22  Score=193.50  Aligned_cols=150  Identities=27%  Similarity=0.464  Sum_probs=128.2

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----e
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----E  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  341 (438)
                      .++|.+.+.||+|+||.||++. ..++..||||.+...  .......+.+|+.+++.++||||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            4578889999999999999995 456899999998653  2334556788999999999999999999876543     4


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++|+||+. ++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688888843   345899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .....
T Consensus       157 ~~~~~  161 (337)
T cd07858         157 TTSEK  161 (337)
T ss_pred             ccCCC
Confidence            76543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-22  Score=172.61  Aligned_cols=157  Identities=26%  Similarity=0.385  Sum_probs=129.7

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (438)
                      ++...+.....+.||+|++|.|-+- +..+|+..|+|++... ..+..++..+|+.+..+. ..|.+|.++|.....+..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3444444555678999999999877 4568999999999754 345567788899887766 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhc-cCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          343 LLVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      |+.||.| ..||+.+-.+ ...+..+++..+-+|+..+..||.|||+  +..+||||+||+||||+.+|++||+|||++-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 4477766432 1345678898899999999999999995  7899999999999999999999999999998


Q ss_pred             cccC
Q 013693          422 CFAA  425 (438)
Q Consensus       422 ~~~~  425 (438)
                      .+.+
T Consensus       198 ~L~d  201 (282)
T KOG0984|consen  198 YLVD  201 (282)
T ss_pred             eehh
Confidence            7753

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.87  E-value=6.5e-22  Score=183.81  Aligned_cols=152  Identities=31%  Similarity=0.517  Sum_probs=132.9

Q ss_pred             CCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|++.+.||+|+||.||++. ..+++.+++|.+...  ......++.+|++++++++||||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            47788999999999999994 456889999998753  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++.+.. ....+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999985422 2346899999999999999999999   899999999999999999999999999999887544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.4e-21  Score=182.40  Aligned_cols=142  Identities=29%  Similarity=0.318  Sum_probs=119.8

Q ss_pred             CccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHH-hccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLI-SSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||+|.. .+++.||+|.+....   ......+..|..++ ...+||||+++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999955 468899999986542   12223445555444 455899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++...
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            999999843   245889999999999999999999   8899999999999999999999999999988654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.87  E-value=8.2e-22  Score=190.50  Aligned_cols=150  Identities=27%  Similarity=0.434  Sum_probs=128.9

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPES  342 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  342 (438)
                      ...+++|+..+.||+|+||.||++. ..++..||+|++...  .....+.+.+|+++++.++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            4467889999999999999999995 557899999988542  22345678899999999999999999998876 5578


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++|+||+ +++|.+++.    ...+++..+..++.|+++||.|||   +.+|+|+||+|+|||++.++.+||+|||+++.
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999998 568988873    234788888899999999999999   89999999999999999999999999999986


Q ss_pred             cc
Q 013693          423 FA  424 (438)
Q Consensus       423 ~~  424 (438)
                      ..
T Consensus       158 ~~  159 (328)
T cd07856         158 QD  159 (328)
T ss_pred             cC
Confidence            54

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=9.6e-22  Score=190.60  Aligned_cols=147  Identities=27%  Similarity=0.376  Sum_probs=125.9

Q ss_pred             cCCC-CCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhh--------------HHHHHHHHHHHhccCCCceeeEEe
Q 013693          271 NYFN-PSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW--------------VDEFFNEVNLISSIEHKNLVKLLG  334 (438)
Q Consensus       271 ~~~~-~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  334 (438)
                      ++|. +.+.||+|+||.||++.. ..++.||||++.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 457799999999999964 468999999886432211              124779999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 013693          335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       335 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  414 (438)
                      ++..++..++||||++ ++|.+++..   ...+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence            9999999999999996 589888843   345889999999999999999999   899999999999999999999999


Q ss_pred             eccccccccc
Q 013693          415 ADFGLARCFA  424 (438)
Q Consensus       415 ~DFGla~~~~  424 (438)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (335)
T PTZ00024        161 ADFGLARRYG  170 (335)
T ss_pred             CCccceeecc
Confidence            9999998765

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.87  E-value=1.4e-21  Score=184.50  Aligned_cols=146  Identities=23%  Similarity=0.326  Sum_probs=123.1

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccC-CCceeeEEeEEEeC--CeEEEEEe
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEG--PESLLVYE  347 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  347 (438)
                      |++.+.||+|+||.||++.. .+++.+|+|+++... ........+|+.++.++. ||||+++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56678899999999999954 468899999886532 222234457899999885 99999999999987  88999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |++ ++|.+.+...  ...+++.++..++.|++.||.|||   ..+++||||||+||+++. +.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            997 5787777432  245899999999999999999999   889999999999999999 9999999999987643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.87  E-value=3.7e-21  Score=180.43  Aligned_cols=151  Identities=23%  Similarity=0.270  Sum_probs=122.8

Q ss_pred             HHHHHhcCCCCCCcc--ccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 013693          265 TLEKATNYFNPSKKL--GQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (438)
Q Consensus       265 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (438)
                      ++....++|++.+.+  |+|+||.||++.. .++..+|+|.+........     |+.....+ +||||+++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            344445677777766  9999999999954 5678899998864322111     22222222 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGL  419 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGl  419 (438)
                      ..++||||+++++|.+++...   ..+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999998543   36899999999999999999999   88999999999999999888 999999999


Q ss_pred             cccccCC
Q 013693          420 ARCFAAD  426 (438)
Q Consensus       420 a~~~~~~  426 (438)
                      ++.....
T Consensus       157 ~~~~~~~  163 (267)
T PHA03390        157 CKIIGTP  163 (267)
T ss_pred             ceecCCC
Confidence            9876543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.3e-24  Score=187.14  Aligned_cols=150  Identities=27%  Similarity=0.545  Sum_probs=124.7

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--------C
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--------P  340 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  340 (438)
                      .|+...+||+|.||.||+|+. ++++.||+|++....  +..-....+|+++|..|+|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            355567899999999999954 457889998775432  22334567999999999999999999877642        2


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..+||+.+++. +|.-+|..  ....++..++.+++.++..||.|+|   ...|+|||+||+|+||+.++.+||+|||+|
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            47999999965 88888833  3456899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCC
Q 013693          421 RCFAADR  427 (438)
Q Consensus       421 ~~~~~~~  427 (438)
                      |.++...
T Consensus       172 r~fs~~~  178 (376)
T KOG0669|consen  172 RAFSTSK  178 (376)
T ss_pred             cceeccc
Confidence            9886543

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.87  E-value=1.7e-21  Score=188.29  Aligned_cols=143  Identities=25%  Similarity=0.354  Sum_probs=123.4

Q ss_pred             CccccC--CceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQG--GAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      ..||+|  +||+||++.. .+++.||+|.+...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  8999999954 57899999998753  233457789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|++||+.+...
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            99999885432 235889999999999999999999   899999999999999999999999999865443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.87  E-value=7.4e-22  Score=190.93  Aligned_cols=149  Identities=29%  Similarity=0.432  Sum_probs=130.4

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESL  343 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  343 (438)
                      +|++.+.||+|++|.||++... +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999654 58999999987543  445577999999999999999999999988775     789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||++ ++|.+++..   ...+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 488888843   236899999999999999999999   899999999999999999999999999999987


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       154 ~~~~  157 (330)
T cd07834         154 DPDE  157 (330)
T ss_pred             cccc
Confidence            6543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.86  E-value=2.3e-21  Score=186.18  Aligned_cols=145  Identities=19%  Similarity=0.183  Sum_probs=123.9

Q ss_pred             CCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.+.+|.|+++.|+++.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455666666666654 7899999998754  3445678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +|.+++.... ...+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||.+..+.
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeec
Confidence            9999986432 345888999999999999999999   8899999999999999999999999999887653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.86  E-value=1.2e-22  Score=175.08  Aligned_cols=146  Identities=24%  Similarity=0.427  Sum_probs=125.5

Q ss_pred             cCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCC--eEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGP--ESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~  346 (438)
                      ++|++.+++|+|.|++||.| ...+.++++||++++-   ..+.+.+|+.||..|. ||||++|++...++.  .+.||+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            56788899999999999999 5567899999999754   3456889999999996 999999999987654  578999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFGla~~~~~  425 (438)
                      ||+.+.+...+-      ..++..++..++.++++||.|+|   +.||+|||+||.|++||.. -.++|+|+|||..+.+
T Consensus       115 E~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  115 EYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999998887665      33667778889999999999999   9999999999999999954 5799999999999876


Q ss_pred             CCc
Q 013693          426 DRT  428 (438)
Q Consensus       426 ~~~  428 (438)
                      ...
T Consensus       186 ~~e  188 (338)
T KOG0668|consen  186 GKE  188 (338)
T ss_pred             Cce
Confidence            543

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.86  E-value=3.2e-21  Score=184.76  Aligned_cols=148  Identities=30%  Similarity=0.520  Sum_probs=127.1

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .|+..+.||+|+||.||+|.. .++..+++|.+...   .....+++.+|+++++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            366678899999999999964 46788999988642   23345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+. ++|.+.+...  ...+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            996 5787776432  245889999999999999999999   88999999999999999999999999999887654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.86  E-value=7.6e-21  Score=182.56  Aligned_cols=146  Identities=32%  Similarity=0.503  Sum_probs=125.6

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      |...+.||+|+||.||+|.. .++..|++|++....   ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55667899999999999964 468899999986432   23446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +. ++|.+++..  ....+++.++..++.|++.+|.|||   +.+++|+||+|+||+++.++.+||+|||++....
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            96 577777643  2345899999999999999999999   8899999999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.86  E-value=2.3e-21  Score=183.65  Aligned_cols=151  Identities=27%  Similarity=0.396  Sum_probs=124.3

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            345567899999999999954 468999999987542 344567889999999995 99999999999999999999999


Q ss_pred             cCCCCHHHHhhc--cCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFD--KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +.. ++.++...  ......+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55544321  1123568999999999999999999993  35999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.86  E-value=2e-21  Score=183.42  Aligned_cols=149  Identities=30%  Similarity=0.486  Sum_probs=129.6

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      |+..+.||+|++|.||++.. .+++.+++|++.....  .....+.+|+.++++++||||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56678899999999999965 4688999999865432  34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++ +|.+++...  ...+++..+..++.|+++||.|||   ..+|+|+||||+||+++.++.+||+|||.+..+....
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            75 888887542  246899999999999999999999   8999999999999999999999999999998776543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.86  E-value=3.2e-21  Score=183.63  Aligned_cols=151  Identities=23%  Similarity=0.375  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC-CCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .++|+..+.||+|+||.||++.... ++.||||.+.... .....++.+|+.++.+. .||||+++++++..+...+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567888999999999999997654 8999999987542 23445667788777777 4999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||++ ++|.+++...  ...+++..+..++.|++.||.|||.  ..+|+||||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 4777766432  2368999999999999999999992  25899999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=2.7e-21  Score=188.05  Aligned_cols=147  Identities=30%  Similarity=0.488  Sum_probs=124.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (438)
                      .++|...+.||+|+||.||+|.. .+++.||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46788899999999999999964 46899999998643  2233456889999999999999999999887543      


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 776665     234889999999999999999999   889999999999999999999999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +....
T Consensus       165 ~~~~~  169 (342)
T cd07879         165 RHADA  169 (342)
T ss_pred             cCCCC
Confidence            87543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.86  E-value=3.3e-21  Score=186.68  Aligned_cols=147  Identities=31%  Similarity=0.431  Sum_probs=123.0

Q ss_pred             CCCCCCccccCCceeEEEEEcc-C--CCEEEEEEeeec--chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC----Ce
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-N--GTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG----PE  341 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  341 (438)
                      +|++.+.||+|+||.||++... .  +..+|+|++...  .....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999653 3  678999988643  223356788999999999 599999999875432    35


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++++||+. ++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788899885 689888843   345899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccC
Q 013693          422 CFAA  425 (438)
Q Consensus       422 ~~~~  425 (438)
                      .+..
T Consensus       154 ~~~~  157 (332)
T cd07857         154 GFSE  157 (332)
T ss_pred             eccc
Confidence            7653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=2.5e-21  Score=182.88  Aligned_cols=148  Identities=33%  Similarity=0.442  Sum_probs=127.2

Q ss_pred             CCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch-hhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEecc
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      |++.+.||+|++|.||+|... +++.|+||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999764 578899998865422 22234557999999998 999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                       +++|.+++.... ...+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence             789988885432 346899999999999999999999   89999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=2.3e-21  Score=182.85  Aligned_cols=148  Identities=34%  Similarity=0.551  Sum_probs=129.7

Q ss_pred             CCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      |+..+.||+|++|.||++... +++.+++|.+....  ....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999654 58999999987653  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      + ++|.+++....  ..+++..+..++.|++.||.|||   +.+|+|+||+|+||++++++.+||+|||+++.+...
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            7 58999985432  45899999999999999999999   889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.86  E-value=1.8e-21  Score=189.27  Aligned_cols=147  Identities=27%  Similarity=0.460  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC---------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG---------  339 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  339 (438)
                      ..+|...+.||+|+||.||+|.. .++..||+|++........+.+.+|++++++++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36788899999999999999954 56899999998766656667788999999999999999999776543         


Q ss_pred             -----CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCCeE
Q 013693          340 -----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPK  413 (438)
Q Consensus       340 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~k  413 (438)
                           ...++||||++ ++|.+++.    ...+++..+..++.||++||.|||   +.+|+||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 58888873    235889999999999999999999   88999999999999997 456789


Q ss_pred             Eeccccccccc
Q 013693          414 IADFGLARCFA  424 (438)
Q Consensus       414 l~DFGla~~~~  424 (438)
                      |+|||+++.+.
T Consensus       156 l~dfg~~~~~~  166 (342)
T cd07854         156 IGDFGLARIVD  166 (342)
T ss_pred             ECCcccceecC
Confidence            99999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.1e-21  Score=177.81  Aligned_cols=142  Identities=32%  Similarity=0.404  Sum_probs=126.2

Q ss_pred             cccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      ||+|+||.||++... +++.+++|.+....   ....+.+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999654 58899999987542   23456789999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      .+++...   ..+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9998532   35899999999999999999999   899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.86  E-value=4.9e-21  Score=182.21  Aligned_cols=149  Identities=25%  Similarity=0.315  Sum_probs=112.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeecchhhH-----------HHHHHHHHHHhccCCCceeeEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQWV-----------DEFFNEVNLISSIEHKNLVKLLG  334 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~  334 (438)
                      .++|.+.++||+|+||.||+|...+    +..+|+|..........           .....+...+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3678999999999999999996544    34566665433222111           11223344566778999999999


Q ss_pred             EEEeCC----eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013693          335 CSIEGP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       335 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  410 (438)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..|+.|++.||.|||   +.+|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            766544    34778887743 66666532   223578888999999999999999   88999999999999999999


Q ss_pred             CeEEecccccccccC
Q 013693          411 TPKIADFGLARCFAA  425 (438)
Q Consensus       411 ~~kl~DFGla~~~~~  425 (438)
                      .+||+|||+|+.+..
T Consensus       164 ~~~l~DFGla~~~~~  178 (294)
T PHA02882        164 RGYIIDYGIASHFII  178 (294)
T ss_pred             cEEEEEcCCceeecc
Confidence            999999999998754

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=6.8e-21  Score=180.11  Aligned_cols=149  Identities=30%  Similarity=0.456  Sum_probs=124.9

Q ss_pred             CCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc--hhhHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCe-----
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPE-----  341 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  341 (438)
                      |++.+.||+|+||.||++... +++.+|+|++....  ......+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999765 48999999997432  22234566788777666   59999999999988776     


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            9999999975 8988875432 235899999999999999999999   8899999999999999999999999999998


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .+...
T Consensus       156 ~~~~~  160 (287)
T cd07838         156 IYSFE  160 (287)
T ss_pred             eccCC
Confidence            87543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.7e-21  Score=187.11  Aligned_cols=164  Identities=22%  Similarity=0.358  Sum_probs=137.8

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeee--cchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIF--NTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (438)
                      ...+.|++.++||+||.+.||++...+.+.+|+|++..  .+.+..+-|.+|+.+|.+| .|.+||+|++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            33456888999999999999999887888889987754  3566788899999999999 59999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||= ..+|..+|...... ...| .+..+..||+.++.++|   ..||||-||||.|+|+- .|.+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99986 56999999654332 2334 67789999999999999   89999999999999995 5699999999999999


Q ss_pred             CCCceeee-eeeecC
Q 013693          425 ADRTHVST-AVAGTL  438 (438)
Q Consensus       425 ~~~~~~~~-~~~Gt~  438 (438)
                      .+.+.... .-+||+
T Consensus       511 ~DTTsI~kdsQvGT~  525 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTV  525 (677)
T ss_pred             ccccceeeccccCcc
Confidence            88776543 345774

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.86  E-value=2.3e-21  Score=185.55  Aligned_cols=150  Identities=32%  Similarity=0.540  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (438)
                      .++|++.+.||+|+||.||++.. .+++.+|+|++.....  .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46789999999999999999964 4688999999865432  22345778999999999999999999875433      


Q ss_pred             --eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          341 --ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       341 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                        ..++|+||+.+ +|...+..  ....+++..+..++.|+++||.|||   +.+|+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999965 67776643  2345899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++....
T Consensus       161 ~~~~~~~  167 (311)
T cd07866         161 LARPYDG  167 (311)
T ss_pred             cchhccC
Confidence            9987653

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.9e-21  Score=170.12  Aligned_cols=140  Identities=16%  Similarity=0.256  Sum_probs=108.8

Q ss_pred             CCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-----CCCceeeEEeEEEeCC---eEE-
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-----EHKNLVKLLGCSIEGP---ESL-  343 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  343 (438)
                      ++..+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+     +||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34568899999999996 3334444 79988765445567899999999999     5799999999998874   433 


Q ss_pred             EEEec--cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHH-HHhhcCCCCCeeeCCCCCCCeeeCC----CCCeEEec
Q 013693          344 LVYEY--VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL-AYLHGGSETRIIHRDIKTSNILLDK----DFTPKIAD  416 (438)
Q Consensus       344 lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kl~D  416 (438)
                      +|+||  .++++|.+++.+.    .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    +..++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  5579999999432    25544  35678888888 8999   899999999999999973    34899999


Q ss_pred             ccccccc
Q 013693          417 FGLARCF  423 (438)
Q Consensus       417 FGla~~~  423 (438)
                      |+-++.+
T Consensus       153 g~G~~~~  159 (210)
T PRK10345        153 NIGESTF  159 (210)
T ss_pred             CCCCcce
Confidence            5444433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5e-23  Score=181.74  Aligned_cols=149  Identities=29%  Similarity=0.463  Sum_probs=125.6

Q ss_pred             CCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eEEEE
Q 013693          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-----ESLLV  345 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  345 (438)
                      +..+.||-|+||.||.... ++|+.||+|++..-  +-...+++.+|+++|.-++|.|++..++..+-..     ++|.+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4568899999999998854 56899999988632  3345678899999999999999999998876544     46788


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +|.|.. +|..++   -....++..++.-++.||++||+|||   +.+|.||||||.|.|++.+..+||+|||+||.-..
T Consensus       136 TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            898854 787777   35567889999999999999999999   89999999999999999999999999999998776


Q ss_pred             CCce
Q 013693          426 DRTH  429 (438)
Q Consensus       426 ~~~~  429 (438)
                      +...
T Consensus       209 d~~~  212 (449)
T KOG0664|consen  209 RDRL  212 (449)
T ss_pred             hhhh
Confidence            5543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.85  E-value=1.7e-21  Score=189.57  Aligned_cols=150  Identities=27%  Similarity=0.426  Sum_probs=129.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe---
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE---  341 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  341 (438)
                      ...++|+..+.||+|++|.||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34677889999999999999999654 5789999988643  23344667889999999999999999988766554   


Q ss_pred             ---EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          342 ---SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       342 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                         .++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 6699998842    45899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      ++.....
T Consensus       164 ~~~~~~~  170 (343)
T cd07851         164 LARHTDD  170 (343)
T ss_pred             ccccccc
Confidence            9987653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.85  E-value=9.8e-22  Score=173.71  Aligned_cols=150  Identities=21%  Similarity=0.360  Sum_probs=125.2

Q ss_pred             CCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      +.+..||.|..|.|++... .+|..+|||.+... +....++++..++++.+- +.|.||+.+|+|..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            3456799999999999955 45889999999765 455677888888887776 48999999999999999999999983


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCc
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~  428 (438)
                       .-++.++.+.  ..++++..+-++...+.+||.||.+  +++|||||+||+|||+|+.|++||+|||++-.+-+...
T Consensus       175 -~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  175 -TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             -HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence             3556666432  3458888888899999999999986  78999999999999999999999999999998865543

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.85  E-value=4.5e-21  Score=178.85  Aligned_cols=150  Identities=27%  Similarity=0.389  Sum_probs=124.4

Q ss_pred             CCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec-----chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      +|.+.+.||+|+||.||++... .+..+++|.++..     .......+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778899999999999999553 3445555555421     222344577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          346 YEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |||+++++|.+++... .....+++.+++.++.|++.||.|||   +.+++|+||||+||++++ +.+||+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988542 23456899999999999999999999   899999999999999975 569999999998764


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       157 ~  157 (260)
T cd08222         157 G  157 (260)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=4.9e-21  Score=198.34  Aligned_cols=161  Identities=30%  Similarity=0.417  Sum_probs=137.5

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcc--------CCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEe
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLG  334 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~  334 (438)
                      .++...++..+.+.||+|.||.|++|...        ....||||.++.. .....+.+..|+++|+.+ +||||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45556666667779999999999999532        1457999999754 335678899999999999 7999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHhhccC-------C----C--CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 013693          335 CSIEGPESLLVYEYVPNRSLDQFIFDKN-------K----T--KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKT  401 (438)
Q Consensus       335 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  401 (438)
                      ++...+..++|+||++.|+|.++|+..+       .    .  ..++..+.+.++.|||.|++||+   +.++|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence            9999999999999999999999996544       0    0  23888999999999999999999   89999999999


Q ss_pred             CCeeeCCCCCeEEecccccccccCCCc
Q 013693          402 SNILLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       402 ~Nill~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      +|||+..+..+||+|||+||....+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~  473 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDY  473 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCc
Confidence            999999999999999999997655443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=8.1e-22  Score=183.08  Aligned_cols=163  Identities=27%  Similarity=0.283  Sum_probs=135.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (438)
                      ...+|..+.+||+|+||.|.++..+ +.+.+|||+++++.   .++.+--+.|-++|+.. +-|.+++++.+++.-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3456888999999999999999554 46779999997652   23345556788888877 6789999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+.||+|.-.+++-   ..+.+..+.-++.+|+-||-+||   +.+||.||||.+|||+|.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999998888543   34677888889999999999999   999999999999999999999999999999875


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      ..+.. .+.+.+|||
T Consensus       501 i~~~~-TTkTFCGTP  514 (683)
T KOG0696|consen  501 IFDGV-TTKTFCGTP  514 (683)
T ss_pred             ccCCc-ceeeecCCC
Confidence            54443 233578887

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-22  Score=177.59  Aligned_cols=155  Identities=29%  Similarity=0.447  Sum_probs=126.3

Q ss_pred             cccCHHHHHHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeE
Q 013693          259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGC  335 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~  335 (438)
                      ..|+.+.++.       +..||.|+||+|+|- +.+.|+..|||+++... +...++++.|.+...+- +.||||+++|.
T Consensus        59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            3455555554       467999999999988 55679999999998664 46677888998877666 78999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHh---hccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          336 SIEGPESLLVYEYVPNRSLDQFI---FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       336 ~~~~~~~~lv~e~~~~g~L~~~l---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      +..++..|+.||+| ..||+.+-   ++- ....+++.-+-.|..-.+.||.||-+  ...|||||+||+|||++..|.+
T Consensus       132 ~F~EGdcWiCMELM-d~SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  132 LFSEGDCWICMELM-DISLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhcCCceeeeHHHH-hhhHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCE
Confidence            99999999999999 44665543   221 23447787777888888999999986  6789999999999999999999


Q ss_pred             EEeccccccccc
Q 013693          413 KIADFGLARCFA  424 (438)
Q Consensus       413 kl~DFGla~~~~  424 (438)
                      ||+|||++-.+.
T Consensus       208 KLCDFGIcGqLv  219 (361)
T KOG1006|consen  208 KLCDFGICGQLV  219 (361)
T ss_pred             eeecccchHhHH
Confidence            999999988764

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.84  E-value=1.4e-21  Score=174.85  Aligned_cols=148  Identities=25%  Similarity=0.294  Sum_probs=122.5

Q ss_pred             HhcCCCCC-CccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe----CCe
Q 013693          269 ATNYFNPS-KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE----GPE  341 (438)
Q Consensus       269 ~~~~~~~~-~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  341 (438)
                      ++++|.+. ++||-|-.|.|-.+ +..+++++|+|++...     ...++|+++--.. .|||||.+++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45556553 68999999999988 5557899999988532     3356788776655 69999999998764    335


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCCeEEeccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFG  418 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~DFG  418 (438)
                      +.+|||.|+||.|...+.++ ....+++.++-.|+.||..|+.|||   +.+|.||||||+|+|..   .|..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999999999664 4567999999999999999999999   89999999999999995   45679999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +|+.-..
T Consensus       210 FAK~t~~  216 (400)
T KOG0604|consen  210 FAKETQE  216 (400)
T ss_pred             cccccCC
Confidence            9998654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.84  E-value=1.5e-20  Score=173.10  Aligned_cols=133  Identities=20%  Similarity=0.105  Sum_probs=114.5

Q ss_pred             CCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhc
Q 013693          282 GGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD  360 (438)
Q Consensus       282 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  360 (438)
                      |.+|.||++. ..+++.+|+|++....     .+.+|...+....||||+++++++...+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8899999994 4578999999986543     233455555666799999999999999999999999999999998854


Q ss_pred             cCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       361 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      .   ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.++|+|||++..+..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~  137 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED  137 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence            3   34899999999999999999999   89999999999999999999999999998876543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.2e-21  Score=174.86  Aligned_cols=162  Identities=23%  Similarity=0.275  Sum_probs=136.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|.+..+||+|+|..|..+++ ++.+.+|+|++++.   .....+=.+.|-.+.... +||.+|-++.+++.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            45788899999999999999965 45788999998753   333344456677777766 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |.||++||+|.-++.   +...++++++.-+...|..+|.|||   +.|||.||||.+|||||..|++||+|+|+++.--
T Consensus       329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999977663   4456999999999999999999999   8999999999999999999999999999999765


Q ss_pred             CCCceeeeeeeecC
Q 013693          425 ADRTHVSTAVAGTL  438 (438)
Q Consensus       425 ~~~~~~~~~~~Gt~  438 (438)
                      .+.... ++.+|||
T Consensus       403 ~~gd~t-stfcgtp  415 (593)
T KOG0695|consen  403 GPGDTT-STFCGTP  415 (593)
T ss_pred             CCCccc-ccccCCC
Confidence            444433 3578886

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.83  E-value=1.1e-20  Score=194.04  Aligned_cols=151  Identities=25%  Similarity=0.276  Sum_probs=106.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-C----CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeE------EE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-N----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC------SI  337 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  337 (438)
                      ..++|+..++||+|+||.||+|.+. +    +..||+|++......  +.+.+|  .+....+.+++.+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4567899999999999999999654 4    689999987543221  111111  1122222222222211      24


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCC-----------------CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKT-----------------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  400 (438)
                      .+...+|||||+++++|.+++......                 ....+..+..++.||+.||.|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            566799999999999999998543211                 01123345679999999999999   8899999999


Q ss_pred             CCCeeeCC-CCCeEEecccccccccCC
Q 013693          401 TSNILLDK-DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       401 p~Nill~~-~~~~kl~DFGla~~~~~~  426 (438)
                      |+|||++. ++.+||+|||+|+.+...
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~  309 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG  309 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc
Confidence            99999985 579999999999876543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.83  E-value=7.9e-20  Score=166.03  Aligned_cols=149  Identities=36%  Similarity=0.520  Sum_probs=132.3

Q ss_pred             CCCCCccccCCceeEEEEEccC-CCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      |...+.||+|++|.||++.... ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999996654 889999999765544 67789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++|.+++.....  .+++..+..++.+++.+|.+||   +.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999854322  1788999999999999999999   789999999999999999999999999999988654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.82  E-value=1.7e-21  Score=190.74  Aligned_cols=151  Identities=28%  Similarity=0.404  Sum_probs=137.1

Q ss_pred             HhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ..++|+..+.+|.|.||.|||+ +...+...|+|+++.......+-++.|+-+++..+|||||.++|.+...+..|+.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            4567888999999999999999 455789999999998877778888999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+.+|+|++.-+   --.++++.++....+..++||+|||   +.+-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus        93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence            999999988763   3356889999999999999999999   89999999999999999999999999999887754

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=7.7e-20  Score=167.31  Aligned_cols=146  Identities=17%  Similarity=0.111  Sum_probs=114.4

Q ss_pred             cCCCCCCccccCCceeEEEEE--ccCCCEEEEEEeeecchh------------------------hHHHHHHHHHHHhcc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS--LPNGTTVAVKRLIFNTRQ------------------------WVDEFFNEVNLISSI  324 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  324 (438)
                      ..|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+.+|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347788999999999999997  568999999998753210                        112356899999999


Q ss_pred             CCC--ceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeeCCCCC
Q 013693          325 EHK--NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR-IIHRDIKT  401 (438)
Q Consensus       325 ~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~dlkp  401 (438)
                      .+.  .+++++++    ...+|||||+++.+|......   ...+...+...++.|++.+|.+||   ..+ |+||||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp  177 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE  177 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence            753  34455543    235899999999888765422   223555667789999999999999   888 99999999


Q ss_pred             CCeeeCCCCCeEEecccccccccCCC
Q 013693          402 SNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       402 ~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +||+++ ++.++|+|||+|.....+.
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCCcc
Confidence            999999 8899999999999776554

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.5e-21  Score=185.54  Aligned_cols=160  Identities=24%  Similarity=0.299  Sum_probs=136.2

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCC-EEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGT-TVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .+++....||-|+||.|=++...... .+|+|.+++.   +....+.+..|-.||...+.|.||+++-.+.++...|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555678999999999988664433 4888887653   3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |-+-||.|...|+++   ..++.....-++..+++|++|||   .++||.|||||+|.|+|.+|-+||.|||+|+.+..+
T Consensus       500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999654   34777788889999999999999   899999999999999999999999999999999866


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ...  -+.+|||
T Consensus       574 ~KT--wTFcGTp  583 (732)
T KOG0614|consen  574 RKT--WTFCGTP  583 (732)
T ss_pred             Cce--eeecCCc
Confidence            543  3588886

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.82  E-value=2.3e-20  Score=187.24  Aligned_cols=157  Identities=32%  Similarity=0.480  Sum_probs=124.7

Q ss_pred             CCCCCccccCCcee-EEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          273 FNPSKKLGQGGAGS-VYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       273 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      |...+++|.|..|+ ||+|.. .+++||||++-...   .+-..+|+..|+.- +|||||++++.-.+....||..|.+ 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44557899999984 799988 67899999985432   33456899999998 6999999999999999999999999 


Q ss_pred             CCCHHHHhhccCCCCc-CCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---C--CCeEEeccccccccc
Q 013693          351 NRSLDQFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---D--FTPKIADFGLARCFA  424 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~--~~~kl~DFGla~~~~  424 (438)
                      ..+|.+++........ ..-...+.+..|+++||+|||   +.+||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5599999965311111 111445678999999999999   899999999999999975   3  478999999999998


Q ss_pred             CCCceeee--eeeec
Q 013693          425 ADRTHVST--AVAGT  437 (438)
Q Consensus       425 ~~~~~~~~--~~~Gt  437 (438)
                      .+.+..+.  ...||
T Consensus       663 ~~~sS~~r~s~~sGt  677 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGT  677 (903)
T ss_pred             CCcchhhcccCCCCc
Confidence            87765543  34454

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=4.8e-19  Score=158.44  Aligned_cols=143  Identities=36%  Similarity=0.622  Sum_probs=126.8

Q ss_pred             cccCCceeEEEEEccC-CCEEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHHH
Q 013693          279 LGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQ  356 (438)
Q Consensus       279 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  356 (438)
                      ||+|.+|.||++.... ++++++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999997654 899999998765432 45679999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEecccccccccCC
Q 013693          357 FIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       357 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~~~~~  426 (438)
                      ++....  ..+++..+..++.+++++|.+||   +.+++|+||+|.||+++. ++.++|+|||.+......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            985432  35889999999999999999999   889999999999999998 899999999999877544

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=5.2e-20  Score=160.13  Aligned_cols=151  Identities=23%  Similarity=0.358  Sum_probs=126.9

Q ss_pred             hcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC-CceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ..+|.+.++||.|+||.+|.| ...+|.+||||.-.....  ...+..|..+...|+| ..|+.+..+..+...-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            467899999999999999999 677899999997643322  2357789999999975 678888888888889999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGla~~~~  424 (438)
                      .+ |.+|++++.-.  .+.++..+++-++-|++.-++|+|   ..++|||||||+|+|..-   ...+.|+|||||+.+.
T Consensus        92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 78999988543  344888999999999999999999   899999999999999963   3568999999999987


Q ss_pred             CCCc
Q 013693          425 ADRT  428 (438)
Q Consensus       425 ~~~~  428 (438)
                      +..+
T Consensus       166 d~~t  169 (341)
T KOG1163|consen  166 DIRT  169 (341)
T ss_pred             cccc
Confidence            6543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=9.3e-20  Score=163.42  Aligned_cols=142  Identities=13%  Similarity=0.180  Sum_probs=116.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecch---hhHHH------HHHHHHHHhccCCCceeeEEeEEEe
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR---QWVDE------FFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ...++|...++||.|+||.||+... ++..+|||.+.....   .....      +.+|+..+.+++||+|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3467899999999999999999866 577899999975432   22222      6799999999999999999988664


Q ss_pred             C--------CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013693          339 G--------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       339 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  410 (438)
                      .        +..+|||||++|.+|.++..       ++.    ....+++.+|..+|   ..+++|||+||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC
Confidence            3        35899999999999987741       222    24568999999999   89999999999999999888


Q ss_pred             CeEEecccccccccC
Q 013693          411 TPKIADFGLARCFAA  425 (438)
Q Consensus       411 ~~kl~DFGla~~~~~  425 (438)
                       ++|+|||..+....
T Consensus       173 -i~liDfg~~~~~~e  186 (232)
T PRK10359        173 -LRIIDLSGKRCTAQ  186 (232)
T ss_pred             -EEEEECCCcccccc
Confidence             99999999887743

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.8e-19  Score=156.17  Aligned_cols=134  Identities=17%  Similarity=0.116  Sum_probs=107.6

Q ss_pred             CCCCccccCCceeEEEEEccCCCEEEEEEeeecchh----hHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEec
Q 013693          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .+...|++|+||+||.+.- .+.+++.+.+.....-    ....+.+|+++|++|+ |++|++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999998866 6788887777544321    1225889999999995 5889999886    456999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC-CCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI-KTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl-kp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|.+|.+.+..         . ...++.|++++|.++|   ..||+|||| ||+|||++.++.++|+|||+|.....
T Consensus        80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            999998654311         1 1347789999999999   899999999 79999999999999999999986554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=3.6e-19  Score=159.24  Aligned_cols=147  Identities=20%  Similarity=0.189  Sum_probs=114.9

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchh----------------------hHHHHHHHHHHHh
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ----------------------WVDEFFNEVNLIS  322 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  322 (438)
                      ++......|...+.||+|+||.||++..++++.||||++......                      ....+.+|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444447788999999999999998888999999987643210                      1123677899999


Q ss_pred             ccCCC--ceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013693          323 SIEHK--NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (438)
Q Consensus       323 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  400 (438)
                      .+.|+  .+++.++    ....++||||+++++|......         .....++.+++.++.++|   ..+|+|||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCC
Confidence            99887  4455544    2456899999999999765410         234568899999999999   8999999999


Q ss_pred             CCCeeeCCCCCeEEecccccccccCCC
Q 013693          401 TSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       401 p~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+||++++++.++|+|||++..+..+.
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~~~  179 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDHPN  179 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCCcc
Confidence            999999999999999999998776544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.1e-19  Score=161.27  Aligned_cols=136  Identities=21%  Similarity=0.313  Sum_probs=114.9

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecch--------hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      +.||+|++|.||+|.. .+..+++|+......        .....+.+|+.++..++|++|+....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 678899997653221        1224578899999999999998888887788889999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|++|.+++...      .+ ++..++.+++.+|.+||   ..+++|+|++|+|||++ ++.++|+|||+++...
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            9999999998431      12 77889999999999999   89999999999999999 7899999999998643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=4.4e-19  Score=182.06  Aligned_cols=148  Identities=20%  Similarity=0.309  Sum_probs=118.3

Q ss_pred             CHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEee-ec-------chhhHHHHHHHHHHHhccCCCceeeEE
Q 013693          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI-FN-------TRQWVDEFFNEVNLISSIEHKNLVKLL  333 (438)
Q Consensus       262 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~  333 (438)
                      ++...+.....|...++||+|+||.||++.+... .+++|+.. ..       .....+++.+|+++++.++|++|+...
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            3444444455567789999999999999977544 34444322 11       112235688999999999999999888


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeE
Q 013693          334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (438)
Q Consensus       334 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  413 (438)
                      .++......++||||+++++|.+++.           ....++.+++++|.+||   +.+++||||||+|||+ .++.++
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEE
Confidence            88888788899999999999999883           34678999999999999   8999999999999999 677999


Q ss_pred             EecccccccccC
Q 013693          414 IADFGLARCFAA  425 (438)
Q Consensus       414 l~DFGla~~~~~  425 (438)
                      |+|||+++....
T Consensus       468 liDFGla~~~~~  479 (535)
T PRK09605        468 LIDFGLGKYSDL  479 (535)
T ss_pred             EEeCcccccCCc
Confidence            999999987643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.79  E-value=6.2e-19  Score=161.72  Aligned_cols=138  Identities=30%  Similarity=0.444  Sum_probs=123.3

Q ss_pred             CceeEEEEEcc-CCCEEEEEEeeecchhh-HHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhc
Q 013693          283 GAGSVYMGSLP-NGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD  360 (438)
Q Consensus       283 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  360 (438)
                      +||.||++... +++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999765 48999999997654443 67899999999999999999999999999999999999999999999854


Q ss_pred             cCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       361 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ..   .+++..++.++.+++++|.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            32   2889999999999999999999   889999999999999999999999999999987653

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=6.9e-19  Score=157.52  Aligned_cols=133  Identities=23%  Similarity=0.377  Sum_probs=109.0

Q ss_pred             ccccCCceeEEEEEccCCCEEEEEEeeecc--------hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .||+|+||.||++.+ ++..+++|......        .....++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 67889999865321        112356789999999999887666655666777789999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++....    .      .++.+++.+|.+||   ..+++|+|++|+||+++ ++.++++|||+++....
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE  141 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence            9999998873211    0      68999999999999   89999999999999999 88999999999987543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2e-19  Score=159.00  Aligned_cols=146  Identities=19%  Similarity=0.361  Sum_probs=120.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeE-EEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGC-SIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e  347 (438)
                      +.|++.+.||+|.||.+-+++++ ..+.+++|.+... ....++|.+|..---.| .|.||+.-++. ++..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            45778899999999999999664 4678888977533 23467899998776666 59999987764 677788899999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee--CCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill--~~~~~~kl~DFGla~~~~  424 (438)
                      |+|.|+|.+-+.    ...+.+.....++.|++.||.|||   +.++||||||.+||||  .+..++||+|||+.+..+
T Consensus       103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999988872    344777788899999999999999   8999999999999999  345589999999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=1.9e-18  Score=166.28  Aligned_cols=146  Identities=25%  Similarity=0.332  Sum_probs=122.6

Q ss_pred             CCCCCCccccCCceeEEEEEccCC--CEEEEEEeeecchhhHHHHHHHHHHHhccCC----CceeeEEeEE-EeCCeEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPNG--TTVAVKRLIFNTRQWVDEFFNEVNLISSIEH----KNLVKLLGCS-IEGPESLL  344 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  344 (438)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+++    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999965443  4788887765433323368889999999973    6899999988 47778999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-----CCeEEecccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-----FTPKIADFGL  419 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-----~~~kl~DFGl  419 (438)
                      ||+.+ |.+|.++..... ...++....+.|+.|++.+|++||   +.|++||||||+|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889999875544 567999999999999999999999   9999999999999999754     4699999999


Q ss_pred             ccc
Q 013693          420 ARC  422 (438)
Q Consensus       420 a~~  422 (438)
                      |+.
T Consensus       174 ar~  176 (322)
T KOG1164|consen  174 ARR  176 (322)
T ss_pred             Ccc
Confidence            993

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=5.5e-19  Score=173.40  Aligned_cols=146  Identities=26%  Similarity=0.319  Sum_probs=123.0

Q ss_pred             hcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++.|+....+|.|+|+.|-++ ...+++..++|++....    .+-.+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888888999999999888 55678999999986552    2344677676666 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee-CCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill-~~~~~~kl~DFGla~~~~~~  426 (438)
                      .+.++-+.+.+...    .....++..|+.+|+.++.|||   ..|||||||||+|||+ ++.++++|+|||.++....+
T Consensus       397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99998887776322    2223677789999999999999   8999999999999999 58999999999999988765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=2e-18  Score=156.82  Aligned_cols=152  Identities=23%  Similarity=0.336  Sum_probs=127.9

Q ss_pred             hcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .-+|.+.++||+|.||.++.| .+-++++||||.-...+  ..-++..|....+.| ..++|...+-+...+-+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            346899999999999999999 66689999999654332  234567788888887 57999999999888889999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-----CCeEEeccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-----FTPKIADFGLARC  422 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-----~~~kl~DFGla~~  422 (438)
                      ++ |.||++++.-  -.+.++.+.+..++.|++.-++|+|   .+.+|.|||||+|+||..-     ..+.|+|||||+.
T Consensus       105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            98 7799988743  3456999999999999999999999   8899999999999999633     3589999999999


Q ss_pred             ccCCCce
Q 013693          423 FAADRTH  429 (438)
Q Consensus       423 ~~~~~~~  429 (438)
                      +.+..+.
T Consensus       179 YrDp~Tk  185 (449)
T KOG1165|consen  179 YRDPKTK  185 (449)
T ss_pred             hcCcccc
Confidence            9876654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.76  E-value=9.4e-19  Score=163.77  Aligned_cols=150  Identities=25%  Similarity=0.410  Sum_probs=128.7

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcc----CCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      +.+....+.|...++||+|.|+.||++.+.    ..+.||+|.+...+.  ..++.+|+++|..+ -+.||+++.+++..
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            334556677899999999999999999443    467899999865432  34688999999999 59999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEecc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADF  417 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DF  417 (438)
                      ++...+|+||++.....++...      ++..++..+++.++.||.++|   ..|||||||||+|+|.+. -+.-.|.||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEec
Confidence            9999999999999999888832      667888899999999999999   999999999999999974 467899999


Q ss_pred             ccccccc
Q 013693          418 GLARCFA  424 (438)
Q Consensus       418 Gla~~~~  424 (438)
                      |||....
T Consensus       178 gLA~~~d  184 (418)
T KOG1167|consen  178 GLAQRYD  184 (418)
T ss_pred             hhHHHHH
Confidence            9998543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.76  E-value=2.3e-18  Score=159.22  Aligned_cols=155  Identities=21%  Similarity=0.256  Sum_probs=127.9

Q ss_pred             HHHhcCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-C-C----ceeeEEeEEEeC
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-H-K----NLVKLLGCSIEG  339 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~  339 (438)
                      ...+++|.+..++|+|.||.|-.+ ....+..||||+++.- ....+.-+-|+++|.++. + |    -+|++.+|+...
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            344788999999999999999988 3345789999988633 333556678999999994 2 2    378888999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-----------
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-----------  408 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-----------  408 (438)
                      ++.+||+|.+ |-|+.+++.. +...+++..++..|+.|++++++|||   +.+++|-||||+|||+-+           
T Consensus       164 ghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             CceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence            9999999998 6699999954 34567999999999999999999999   999999999999999821           


Q ss_pred             ---------CCCeEEecccccccccCCC
Q 013693          409 ---------DFTPKIADFGLARCFAADR  427 (438)
Q Consensus       409 ---------~~~~kl~DFGla~~~~~~~  427 (438)
                               +..+||+|||.|+.-....
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc
Confidence                     2358999999999865554

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.75  E-value=3.7e-18  Score=158.03  Aligned_cols=159  Identities=24%  Similarity=0.325  Sum_probs=134.2

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeE
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGC  335 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~  335 (438)
                      ..++..-..+++...++.+|.||+||+|.|.      +.+.|-+|.++.+ ++-....+..|.-++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4445556667888889999999999999554      3456778877654 44456788899999999999999999998


Q ss_pred             EEeC-CeEEEEEeccCCCCHHHHhh-----ccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC
Q 013693          336 SIEG-PESLLVYEYVPNRSLDQFIF-----DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (438)
Q Consensus       336 ~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  409 (438)
                      +..+ ..++.++.++.-|+|..+|.     +....+.++..+...++.|++.|++|||   +.+|||.||..+|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence            7654 56899999999999999997     4445566888889999999999999999   9999999999999999999


Q ss_pred             CCeEEeccccccccc
Q 013693          410 FTPKIADFGLARCFA  424 (438)
Q Consensus       410 ~~~kl~DFGla~~~~  424 (438)
                      .++||+|=.++|.+=
T Consensus       433 LqVkltDsaLSRDLF  447 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLF  447 (563)
T ss_pred             eeEEeccchhccccC
Confidence            999999999999763

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.74  E-value=1.8e-18  Score=137.81  Aligned_cols=74  Identities=35%  Similarity=0.667  Sum_probs=57.3

Q ss_pred             ccccccccC--CCeeEEE-ecCCCCcceEEEEEcCCCCChhhHHHHHHHHHhhccc-cCCCcceEEEcceeeEeEecccc
Q 013693            3 ILSQLITAN--THFATFN-LNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPR-CLPSLSATIFFDGCFLRYDIYSF   78 (438)
Q Consensus         3 ~l~~~~~~~--~~~~~~~-~~~~~~~~vy~~~~C~~d~~~~~C~~Cl~~~~~~~~~-c~~~~~~~~~~~~C~~ry~~~~f   78 (438)
                      .|.+.++..  .+|++++ +..++  +|||++||++|+++.+|..||+.++..++. |+..+||+||+++|+||||+++|
T Consensus        29 ~l~~~a~~~~~~~f~~~~~~~~~~--~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   29 SLVSNAASSSSKGFATGSAGSGPD--TVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHHHGGGTT-TEEEEEE--ST-----EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHHHHhhccccCcEEeecCCCCC--eEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCCEEEEEECCCC
Confidence            344454433  5799997 44444  999999999999999999999999999998 77889999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=6.6e-18  Score=160.43  Aligned_cols=134  Identities=26%  Similarity=0.378  Sum_probs=111.4

Q ss_pred             cCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-----C---CceeeEEeEEEeCC-
Q 013693          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----H---KNLVKLLGCSIEGP-  340 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~~-  340 (438)
                      .+|.+.++||-|-|++||++ +..+.+.||+|+.+. .....+.-+.||++|++++     |   ..||+|++.|...+ 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            56888899999999999999 556778999998863 3445667789999999983     3   47999999988644 


Q ss_pred             ---eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC
Q 013693          341 ---ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (438)
Q Consensus       341 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  409 (438)
                         +.+||+|++ |.+|..+|... ..+.++...+..|++||+.||.|||+  +.+|||-||||+|||+..+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeecc
Confidence               799999999 66888887543 34458899999999999999999997  7899999999999999543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2.2e-17  Score=146.20  Aligned_cols=138  Identities=20%  Similarity=0.195  Sum_probs=100.7

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchh--hHHH----------------------HHHHHHHHhccCCC--ce
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ--WVDE----------------------FFNEVNLISSIEHK--NL  329 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni  329 (438)
                      .+.||+|+||.||++...++++||||++......  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998878999999988753211  1111                      13566666666443  34


Q ss_pred             eeEEeEEEeCCeEEEEEeccCCCCHHHH-hhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeC
Q 013693          330 VKLLGCSIEGPESLLVYEYVPNRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLD  407 (438)
Q Consensus       330 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~  407 (438)
                      .++++.    ...++||||++++.+... +... .   .. .+...++.+++.++.++|   . .+|+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-h---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence            555543    246899999999544221 1110 0   11 556789999999999999   6 9999999999999999


Q ss_pred             CCCCeEEecccccccccCC
Q 013693          408 KDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       408 ~~~~~kl~DFGla~~~~~~  426 (438)
                       ++.++|+|||.+.....+
T Consensus       150 -~~~~~liDfg~a~~~~~~  167 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             -CCcEEEEECcccccccCc
Confidence             889999999999877653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.73  E-value=4.3e-18  Score=162.59  Aligned_cols=158  Identities=19%  Similarity=0.210  Sum_probs=135.0

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC------CCceeeEEeEEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE------HKNLVKLLGCSI  337 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~  337 (438)
                      -.+..-.+|.+....|+|-|++|.+|.. ..++.||||+|..+ +...+.=+.|++||++|+      --|+++|+..|.
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            3445556788888999999999999954 45889999999754 344455678999999996      348999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEec
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIAD  416 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~D  416 (438)
                      ..++++||+|.+ .-+|.++|........|....+..++.|+..||..|-   ..+|+|.||||+|||+++. ..+||||
T Consensus       505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeecc
Confidence            999999999998 4599999988777777889999999999999999999   8999999999999999865 4689999


Q ss_pred             ccccccccCCC
Q 013693          417 FGLARCFAADR  427 (438)
Q Consensus       417 FGla~~~~~~~  427 (438)
                      ||.|...+.+.
T Consensus       581 fGSA~~~~ene  591 (752)
T KOG0670|consen  581 FGSASFASENE  591 (752)
T ss_pred             Ccccccccccc
Confidence            99999877654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.73  E-value=3.4e-18  Score=154.64  Aligned_cols=146  Identities=33%  Similarity=0.461  Sum_probs=119.8

Q ss_pred             cCCCCCCccccCCceeEEEE-EccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------e
Q 013693          271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------E  341 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  341 (438)
                      .+|...+.+|.|.- .|..+ +.-.+++||+|++...  .....++..+|..++..++|+||++++.++.-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666778888887 45544 3336889999988533  3334566789999999999999999999887443      5


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .|+|||+| ..+|.+.+.     ..++-+.+..|..|++.|++|||   +.+|+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence            79999999 458888884     23677788899999999999999   9999999999999999999999999999999


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .-..+
T Consensus       167 ~e~~~  171 (369)
T KOG0665|consen  167 TEDTD  171 (369)
T ss_pred             ccCcc
Confidence            86655

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=5.2e-17  Score=137.99  Aligned_cols=137  Identities=23%  Similarity=0.203  Sum_probs=114.4

Q ss_pred             CCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC--CceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  +++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35779999999999998744 7899998865433  4678899999999976  59999999888888999999999887


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      .+..+          +......++.+++++|.+||.....+++|+|++|+||+++.++.++++|||+++...
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            66533          445667789999999999995433689999999999999998999999999998644

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.8e-16  Score=145.31  Aligned_cols=137  Identities=18%  Similarity=0.245  Sum_probs=106.5

Q ss_pred             CCccc-cCCceeEEEEEccCCCEEEEEEeeecc-------------hhhHHHHHHHHHHHhccCCCce--eeEEeEEEeC
Q 013693          276 SKKLG-QGGAGSVYMGSLPNGTTVAVKRLIFNT-------------RQWVDEFFNEVNLISSIEHKNL--VKLLGCSIEG  339 (438)
Q Consensus       276 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  339 (438)
                      ...|| .|+.|+||+... .+..++||++....             ......+.+|+.++.+|+|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 888999999877 47789999875311             1223567889999999998875  6777764432


Q ss_pred             C----eEEEEEeccCC-CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 013693          340 P----ESLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       340 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  414 (438)
                      .    ..++|||++++ .+|.+++..    ..++..    .+.+++.+|.+||   ..||+||||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 689988843    234443    3578999999999   899999999999999998889999


Q ss_pred             eccccccccc
Q 013693          415 ADFGLARCFA  424 (438)
Q Consensus       415 ~DFGla~~~~  424 (438)
                      +|||.++...
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999998865

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.66  E-value=1.7e-15  Score=144.72  Aligned_cols=150  Identities=35%  Similarity=0.520  Sum_probs=127.5

Q ss_pred             CCCCCccccCCceeEEEEEccCCCEEEEEEeeecchh---hHHHHHHHHHHHhccCCC-ceeeEEeEEEeCCeEEEEEec
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ---WVDEFFNEVNLISSIEHK-NLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  348 (438)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999765  78899988755322   467899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~~~~~  427 (438)
                      +.++++.+++........++......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977743221126888999999999999999999   88999999999999999888 79999999999766544

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.63  E-value=3.5e-16  Score=124.60  Aligned_cols=84  Identities=29%  Similarity=0.551  Sum_probs=70.6

Q ss_pred             hHHHHHHHHHHHHHHHHHhc-CCcccccc----cceeeeeEeecCCCChhchHHHHHhhchhhhhcccCCccceEecccc
Q 013693          110 GFVESVGYAVGNVSRIAVEK-GGGFGAVK----VMGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAGC  184 (438)
Q Consensus       110 ~~~~~~~~~~~~l~~~a~~~-~~~fa~~~----~~~~y~l~QC~~dl~~~~C~~Cl~~~~~~~~~~c~~~~~G~v~~~~C  184 (438)
                      .|...+..+|..++..++.+ ..+|+++.    ..++|||+||++||++.+|..||..++..++..|....+|+++..+|
T Consensus        18 ~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C   97 (106)
T PF01657_consen   18 TFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDSC   97 (106)
T ss_dssp             THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSE
T ss_pred             hHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCCE
Confidence            39999999999999998865 36899884    34999999999999999999999999999999888888889999999


Q ss_pred             cccccCCcc
Q 013693          185 YLRYSTDKF  193 (438)
Q Consensus       185 ~~ry~~~~f  193 (438)
                      ++||+.++|
T Consensus        98 ~lRY~~~~F  106 (106)
T PF01657_consen   98 FLRYENYPF  106 (106)
T ss_dssp             EEEEESS--
T ss_pred             EEEEECCCC
Confidence            999999887

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=2.6e-15  Score=149.38  Aligned_cols=143  Identities=20%  Similarity=0.171  Sum_probs=101.4

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhH----------------------------------------HHHH
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----------------------------------------DEFF  315 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  315 (438)
                      .+.||.|++|+||+|.+++|+.||||+.++......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999865421110                                        0244


Q ss_pred             HHHHHHhccC-----CCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHH-HHHHhhcC
Q 013693          316 NEVNLISSIE-----HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE-GLAYLHGG  389 (438)
Q Consensus       316 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~  389 (438)
                      +|...+.++.     +++|.-..-+....+..+|||||++|++|.++......  ..   ....++..++. .+..+|  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHH--
Confidence            5555555552     33332222222334567999999999999887632211  12   23446666665 467888  


Q ss_pred             CCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       390 ~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                       ..|++|+|+||.||+++.+++++|+|||++..+++.
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence             889999999999999999999999999999988643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=6.9e-16  Score=161.77  Aligned_cols=150  Identities=27%  Similarity=0.337  Sum_probs=117.0

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPES  342 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  342 (438)
                      .+.-.+.|.+.+.||+|+||.||+|...+++.||+|+-++....   +|.-=.+++.+|+   -+-|..+.......+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34445567778899999999999998878999999987654432   1222223344444   23455566666677788


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-------CCCCeEEe
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-------KDFTPKIA  415 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-------~~~~~kl~  415 (438)
                      +||+||.+.|+|.+++.   ..+.++|...+.++.|++..+++||   ..+|||+||||+|.||.       +..-++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999994   5667999999999999999999999   89999999999999993       23468999


Q ss_pred             ccccccccc
Q 013693          416 DFGLARCFA  424 (438)
Q Consensus       416 DFGla~~~~  424 (438)
                      |||-+-.+.
T Consensus       844 DfG~siDm~  852 (974)
T KOG1166|consen  844 DFGRSIDMK  852 (974)
T ss_pred             ecccceeee
Confidence            999876543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=2.6e-13  Score=136.75  Aligned_cols=147  Identities=18%  Similarity=0.186  Sum_probs=96.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccC-CCEEEEEEeeecchhh----------------------------------HH-
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQW----------------------------------VD-  312 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-  312 (438)
                      .-..|+. +.||+|++|+||+|.+++ |+.||||++++.....                                  .+ 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3445666 789999999999998877 9999999997542110                                  11 


Q ss_pred             -----HHHHHHHHHhccC----CCceeeEEeEEE-eCCeEEEEEeccCCCCHHHHhhccCCC---CcCCHHHHHHHHHHH
Q 013693          313 -----EFFNEVNLISSIE----HKNLVKLLGCSI-EGPESLLVYEYVPNRSLDQFIFDKNKT---KLLNWNKRFNIILGT  379 (438)
Q Consensus       313 -----~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~~i  379 (438)
                           +|.+|...+.++.    +.+.+.+-.++. .....+|||||++|+++.++-.....+   ..+....+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                 1344444444442    333343333332 245678999999999997753111111   122222233333333


Q ss_pred             HHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----CeEEecccccccccCC
Q 013693          380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFGLARCFAAD  426 (438)
Q Consensus       380 ~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~DFGla~~~~~~  426 (438)
                             +   ..|++|+|+||.||+++.++    +++++|||++..++..
T Consensus       277 -------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   3   56899999999999999888    9999999999988653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=3.8e-13  Score=116.92  Aligned_cols=129  Identities=19%  Similarity=0.108  Sum_probs=95.9

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      .+.|+.|.++.||+.... +..+++|....... ....+.+|+.+++.+.+.++ ++++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356889999999999764 77899998754422 22346789999999865554 4555543  3345899999999877


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR-----IIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ....        .   ....+..+++++|..||   ..+     ++|+|++|.||+++ ++.++++|||.+..-
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            5420        1   11235678999999999   555     59999999999999 668999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=8.7e-12  Score=109.61  Aligned_cols=138  Identities=14%  Similarity=0.088  Sum_probs=100.9

Q ss_pred             CccccCCceeEEEEEccC-------CCEEEEEEeeec-------------c---------hhhHHHHH----HHHHHHhc
Q 013693          277 KKLGQGGAGSVYMGSLPN-------GTTVAVKRLIFN-------------T---------RQWVDEFF----NEVNLISS  323 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~  323 (438)
                      ..||.|.-+.||.|...+       +..+|||+.+..             +         ....+.+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999996542       479999977521             0         01122333    79999999


Q ss_pred             cCC--CceeeEEeEEEeCCeEEEEEeccCCCCHHH-HhhccCCCCcCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeCCC
Q 013693          324 IEH--KNLVKLLGCSIEGPESLLVYEYVPNRSLDQ-FIFDKNKTKLLNWNKRFNIILGTAEGLAYL-HGGSETRIIHRDI  399 (438)
Q Consensus       324 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~dl  399 (438)
                      +..  -++++++++    ...+|||||+.+..+.. .+.    ...++..+...+..+++.+|..| |   +.++||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            953  567777764    45689999997654422 221    12344556677889999999999 7   889999999


Q ss_pred             CCCCeeeCCCCCeEEecccccccccCC
Q 013693          400 KTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       400 kp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++.|||++ ++.+.|+|||.|-....+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCCC
Confidence            99999997 468999999988776543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.38  E-value=3e-13  Score=145.70  Aligned_cols=95  Identities=20%  Similarity=0.307  Sum_probs=74.2

Q ss_pred             hccCC-CceeeEEeEE-------EeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 013693          322 SSIEH-KNLVKLLGCS-------IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR  393 (438)
Q Consensus       322 ~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  393 (438)
                      +.++| +||.++++++       ......++++|++ +++|.++|..  ....+++.+++.++.||++||.|||   +.+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~g  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAH---SQG  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence            34556 6888888876       2334567788987 6699999953  2345899999999999999999999   899


Q ss_pred             eeeCCCCCCCeeeCC-------------------CCCeEEeccccccc
Q 013693          394 IIHRDIKTSNILLDK-------------------DFTPKIADFGLARC  422 (438)
Q Consensus       394 iiH~dlkp~Nill~~-------------------~~~~kl~DFGla~~  422 (438)
                      |+||||||+||||+.                   ++.+||+|||+++.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~  148 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR  148 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence            999999999999954                   44566666666654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=3.3e-13  Score=138.69  Aligned_cols=148  Identities=26%  Similarity=0.343  Sum_probs=113.4

Q ss_pred             CCCCccccCCceeEEEEEc-cCCCEEEEEEee-----ecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLI-----FNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~-----~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ....++|.|++|.|+.... ......+.|...     .... +....+..|+.+-..+.|||++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3567899999997776632 223333444322     1111 12223677888888999999988877777666666669


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++ +|..++...   ..+...++..++.|++.|+.|||   ..||.||||||+|+++..++.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999998432   35788888999999999999999   999999999999999999999999999999988654


Q ss_pred             Cc
Q 013693          427 RT  428 (438)
Q Consensus       427 ~~  428 (438)
                      ..
T Consensus       474 ~e  475 (601)
T KOG0590|consen  474 WE  475 (601)
T ss_pred             cc
Confidence            43

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.4e-11  Score=104.73  Aligned_cols=133  Identities=21%  Similarity=0.315  Sum_probs=101.8

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeec---ch-----hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN---TR-----QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..+.+|+-+.+|.+.+ -|.++++|.=.++   .+     -..++-.+|..++.++.--.|....=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4678999999999977 3445666633221   11     1234567899999999766666666666788888999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|..|.+.+...          ...++..+-.-+.-||   ..+|+|+||.++||++..+. +.++||||+..-.
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            9999999888432          2456777778888999   99999999999999998664 9999999998543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=2.2e-11  Score=110.60  Aligned_cols=143  Identities=20%  Similarity=0.242  Sum_probs=110.2

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecch-hhHHHHHHHHHHHhccCC--CceeeEEeEEEeC---CeEEEEEeccC
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEH--KNLVKLLGCSIEG---PESLLVYEYVP  350 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  350 (438)
                      +.|+.|..+.+|++...+|..+++|....... .....+.+|.++++.+.+  .++++++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999876678999998754322 235578899999999965  4567788776654   25689999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----------------------------------------  389 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  389 (438)
                      +.++.+.+..    ..+++.+...++.++++.|..||+.                                         
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888765521    2466777778888888888888842                                         


Q ss_pred             ------------CCCCeeeCCCCCCCeeeCC--CCCeEEecccccccc
Q 013693          390 ------------SETRIIHRDIKTSNILLDK--DFTPKIADFGLARCF  423 (438)
Q Consensus       390 ------------~~~~iiH~dlkp~Nill~~--~~~~kl~DFGla~~~  423 (438)
                                  ....++|+|++|.|||++.  ++.+.|+||+.+..-
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                        1245799999999999998  667899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.28  E-value=6.2e-13  Score=131.17  Aligned_cols=144  Identities=24%  Similarity=0.212  Sum_probs=118.3

Q ss_pred             ccccCCceeEEEEE----ccCCCEEEEEEeeecchh--hHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEeccC
Q 013693          278 KLGQGGAGSVYMGS----LPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      .+|+|.||.|+++.    .+.+..+|+|.+++....  .......|..++..++ ||.+++++-.++.+...+++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999762    334677888888654221  1124566888899986 9999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +|+|...+..   ...++......+...++-+++++|   +.+|+|||+|++||+++.+|++|+.|||+++.+-...
T Consensus        81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            9999888743   344666677778888999999999   9999999999999999999999999999999875443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.27  E-value=1.1e-12  Score=116.72  Aligned_cols=137  Identities=22%  Similarity=0.437  Sum_probs=113.7

Q ss_pred             CCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      ...+|.+...|+.|+|+++ |..+++|++...  .....++|..|.-.|+.+.||||..++|.|.....+.++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3456888889999999994 566777877543  3334567999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeee-CCCCCCCeeeCCCCCeEEe
Q 013693          353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH-RDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       353 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH-~dlkp~Nill~~~~~~kl~  415 (438)
                      +|...|++. .....+..++.+++.+|++|++|||+.  .+++- --|.+..++||++.+++|+
T Consensus       273 slynvlhe~-t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee
Confidence            999999764 345578889999999999999999952  34443 4788999999999988775

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=1.3e-10  Score=98.35  Aligned_cols=145  Identities=23%  Similarity=0.281  Sum_probs=107.2

Q ss_pred             CCCccccCCceeEEEEEccCCCEEEEEEe-eec-------chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRL-IFN-------TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ....|-+|+-+.|+++.+ .|+..+||.- .+.       ..-..++.++|+.+|.++.--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467889999999999988 5667666633 211       1123456789999999987666655555666777778999


Q ss_pred             eccCC-CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---CeEEeccccccc
Q 013693          347 EYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIADFGLARC  422 (438)
Q Consensus       347 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~DFGla~~  422 (438)
                      ||+++ .++.+++.........+ .....++..|-+.+.-||   ..+|||+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46788875543332222 223678889999999999   89999999999999996554   458999999876


Q ss_pred             cc
Q 013693          423 FA  424 (438)
Q Consensus       423 ~~  424 (438)
                      -.
T Consensus       166 s~  167 (229)
T KOG3087|consen  166 SR  167 (229)
T ss_pred             cc
Confidence            54

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.16  E-value=1.3e-10  Score=107.83  Aligned_cols=148  Identities=22%  Similarity=0.303  Sum_probs=96.2

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccC----------CCceeeEEeEEEe
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIE----------HKNLVKLLGCSIE  338 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~~  338 (438)
                      +...+.||.|+++.||.+.. .+++++|||+.....   ....+++++|.-....+.          |-.++..++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            34567899999999999955 458999999886442   334667777776665543          2233333333221


Q ss_pred             ---------CC--------eEEEEEeccCCCCHHHHhh---ccCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeC
Q 013693          339 ---------GP--------ESLLVYEYVPNRSLDQFIF---DKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR  397 (438)
Q Consensus       339 ---------~~--------~~~lv~e~~~~g~L~~~l~---~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  397 (438)
                               ..        ..+++|+-+ .+||.+++.   .... ...+....++.+..|+++.+++||   ..|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                     11        236778877 568887753   2111 122334445677799999999999   8999999


Q ss_pred             CCCCCCeeeCCCCCeEEeccccccccc
Q 013693          398 DIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       398 dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+|++++.+|.++|+||+.....+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g  196 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAG  196 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecC
Confidence            999999999999999999998776654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=2.4e-10  Score=100.14  Aligned_cols=128  Identities=24%  Similarity=0.255  Sum_probs=84.8

Q ss_pred             eEEEEEccCCCEEEEEEeeecc--------------h------------hhHHHHHHHHHHHhccCCC--ceeeEEeEEE
Q 013693          286 SVYMGSLPNGTTVAVKRLIFNT--------------R------------QWVDEFFNEVNLISSIEHK--NLVKLLGCSI  337 (438)
Q Consensus       286 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  337 (438)
                      .||.|...++..+|||..+...              .            .......+|.+.|.++..-  ++++++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899988889999999775310              0            0012356899999999755  577777552 


Q ss_pred             eCCeEEEEEeccC--CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHH-hhcCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 013693          338 EGPESLLVYEYVP--NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY-LHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       338 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~iiH~dlkp~Nill~~~~~~kl  414 (438)
                         ...|||||++  |..+..+...     .++......+..+++..+.. +|   ..||+|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence               3479999998  6555544321     11234455677788885555 57   8999999999999999888 9999


Q ss_pred             ecccccccccCC
Q 013693          415 ADFGLARCFAAD  426 (438)
Q Consensus       415 ~DFGla~~~~~~  426 (438)
                      +|||.+.....+
T Consensus       148 IDf~qav~~~~p  159 (188)
T PF01163_consen  148 IDFGQAVDSSHP  159 (188)
T ss_dssp             --GTTEEETTST
T ss_pred             EecCcceecCCc
Confidence            999998876643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=1.3e-09  Score=101.28  Aligned_cols=141  Identities=16%  Similarity=0.097  Sum_probs=100.8

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecchh-hHH----------HHHHHHHHHhccCCCce--eeEEeEEEe-----
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVD----------EFFNEVNLISSIEHKNL--VKLLGCSIE-----  338 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~-----  338 (438)
                      +.+-+-....|.+..+ +|+.+.||+....... ..+          .+.+|...+.++...+|  ++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444445777766 6778999976432211 111          37789999988854443  445555543     


Q ss_pred             CCeEEEEEeccCCC-CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-------CC
Q 013693          339 GPESLLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-------DF  410 (438)
Q Consensus       339 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-------~~  410 (438)
                      ....+||||++++. +|.+++.+.. ....+......++.+++..+.-||   ..||+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999886 8988874321 233455667789999999999999   999999999999999975       46


Q ss_pred             CeEEeccccccc
Q 013693          411 TPKIADFGLARC  422 (438)
Q Consensus       411 ~~kl~DFGla~~  422 (438)
                      .+.|+||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998864

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.10  E-value=9.5e-12  Score=129.31  Aligned_cols=142  Identities=19%  Similarity=0.178  Sum_probs=112.4

Q ss_pred             CCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc-hhhHHHHHHHHHH--HhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT-RQWVDEFFNEVNL--ISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++...+.||++.|=+|.++..+.|. |+||++.... .-..+.|.++++-  ...++|||.+.+.-+-..+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4666789999999999999887776 9999987654 3334444443333  4556899999998887777777888888


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      ..+ +|.+.+..   ..-+...+..-|+.|++.||.-+|   +.+|+|||||.+||||+.-+=+.|+||..-+
T Consensus       103 vkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  103 VKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             Hhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccC
Confidence            854 78887732   233666777789999999999999   9999999999999999988889999997554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.9e-10  Score=107.66  Aligned_cols=90  Identities=28%  Similarity=0.451  Sum_probs=70.4

Q ss_pred             CCCceeeEEeEEEe---------------------------CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHH
Q 013693          325 EHKNLVKLLGCSIE---------------------------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL  377 (438)
Q Consensus       325 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  377 (438)
                      +|||||+++++|.+                           +..+|+||.-++. +|.+++...    ..+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            59999999987653                           2247899988744 899988432    244455666899


Q ss_pred             HHHHHHHHhhcCCCCCeeeCCCCCCCeee--CCCC--CeEEeccccccc
Q 013693          378 GTAEGLAYLHGGSETRIIHRDIKTSNILL--DKDF--TPKIADFGLARC  422 (438)
Q Consensus       378 ~i~~~L~~LH~~~~~~iiH~dlkp~Nill--~~~~--~~kl~DFGla~~  422 (438)
                      |+++|+.|||   +++|.|||||++|||+  |+|+  .+.|+|||.+-.
T Consensus       349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA  394 (598)
T KOG4158|consen  349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA  394 (598)
T ss_pred             HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence            9999999999   9999999999999999  4444  468899997653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.01  E-value=5.2e-10  Score=110.45  Aligned_cols=100  Identities=32%  Similarity=0.589  Sum_probs=89.8

Q ss_pred             HhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013693          321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (438)
Q Consensus       321 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  400 (438)
                      |+.+.|.|+.+++|.+.+++..++|.+|+..|+|.+.+..  ....++|.....++++|+.||.|||.  +.-..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            4678999999999999999999999999999999999954  34568999999999999999999994  2333999999


Q ss_pred             CCCeeeCCCCCeEEeccccccccc
Q 013693          401 TSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       401 p~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +.|.++|....+||+|||+.....
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             cccceeeeeEEEEechhhhccccc
Confidence            999999999999999999998874

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.96  E-value=4.4e-09  Score=94.89  Aligned_cols=137  Identities=21%  Similarity=0.216  Sum_probs=98.0

Q ss_pred             CCCCccccCCceeEEEEEccCCCEEEEEEeeecc------------------hh----hHHHHHHHHHHHhccCCC--ce
Q 013693          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT------------------RQ----WVDEFFNEVNLISSIEHK--NL  329 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~----~~~~~~~E~~~l~~l~h~--ni  329 (438)
                      .+...||-|.-+.||.|..+.|.++|||.=+...                  ..    .....++|.++|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4568899999999999999999999999432110                  01    122357899999999755  78


Q ss_pred             eeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC
Q 013693          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (438)
Q Consensus       330 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  409 (438)
                      ++.+++    +...+|||++++-.|...-        ++.+..-.|+..|++-+.-+-   ..||||+|+++=|||+++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence            888765    5668999999986664332        122223334444444444444   5789999999999999999


Q ss_pred             CCeEEecccccccccC
Q 013693          410 FTPKIADFGLARCFAA  425 (438)
Q Consensus       410 ~~~kl~DFGla~~~~~  425 (438)
                      |.+.++||--+-..+.
T Consensus       239 g~~~vIDwPQ~v~~~h  254 (304)
T COG0478         239 GDIVVIDWPQAVPISH  254 (304)
T ss_pred             CCEEEEeCcccccCCC
Confidence            9999999976655443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.92  E-value=7.5e-09  Score=104.02  Aligned_cols=143  Identities=17%  Similarity=0.196  Sum_probs=96.5

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecchhhH------------------------------H----------HHHH
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV------------------------------D----------EFFN  316 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~  316 (438)
                      +.|+.++-|+||+|.+++|++||||+.+++-....                              +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999998865422110                              0          1334


Q ss_pred             HHHHHhcc-----CCCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013693          317 EVNLISSI-----EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE  391 (438)
Q Consensus       317 E~~~l~~l-----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  391 (438)
                      |..-+.++     +.|+|.-..=++...+...|+|||++|..+.+......  ..++...+.....++.  +.-+-   .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~---~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLL---R  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHH---h
Confidence            54444444     23444433334555677899999999999988752222  2244333322222221  22222   3


Q ss_pred             CCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       392 ~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      .|++|.|..|.||+++.++++.+.|||+...+++.
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            58999999999999999999999999999887654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.91  E-value=6.6e-09  Score=104.01  Aligned_cols=124  Identities=15%  Similarity=0.210  Sum_probs=104.5

Q ss_pred             EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHH
Q 013693          291 SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN  370 (438)
Q Consensus       291 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~  370 (438)
                      ...++.+|.|...+.......+...+-++.|+.++||||++++..++..+..|||+|-+.  .|..++.+      +...
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence            445788999988876666555667788999999999999999999999999999999884  56767633      3356


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       371 ~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      .....+.||+.||.|||+  +.+++|++|.-..|+++..|+.||.+|-++....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            667788999999999985  7899999999999999999999999998876543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.88  E-value=4.8e-10  Score=115.52  Aligned_cols=153  Identities=27%  Similarity=0.349  Sum_probs=122.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc--CCCEEEEEEeeec--chhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP--NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  344 (438)
                      ...|.+.+.||+|+|+.|-.....  ....+|+|.+...  .....+....|..+-..+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345777788999999999877543  3455666665433  2344455666888888886 9999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCF  423 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~  423 (438)
                      ++||..++++.+.+.. ......+....-.+..|+..++.|+|.  ..++.|+||||+|.+++..+ ..|++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999999887731 111135556667789999999999994  57899999999999999999 9999999999998


Q ss_pred             cC
Q 013693          424 AA  425 (438)
Q Consensus       424 ~~  425 (438)
                      ..
T Consensus       176 ~~  177 (601)
T KOG0590|consen  176 RN  177 (601)
T ss_pred             cc
Confidence            77

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.88  E-value=1.4e-08  Score=98.81  Aligned_cols=140  Identities=19%  Similarity=0.253  Sum_probs=112.1

Q ss_pred             eeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEE----eCCeEEEEEeccCC-CCHHHHh
Q 013693          285 GSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI----EGPESLLVYEYVPN-RSLDQFI  358 (438)
Q Consensus       285 g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~l  358 (438)
                      .+.||+ ...+|..+++|++.....+....-..-+++++++.|+|||++..++.    .+..+++||+|.|+ ++|.++.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            467888 45589999999995443333333345688999999999999999877    34468999999986 5677765


Q ss_pred             hccC------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          359 FDKN------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       359 ~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ....            .+...++..+|.++.|+..||.++|   +.|+.-+-|.|.+||++.+.+++|+.-|+...+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            4321            2234788999999999999999999   888989999999999999999999999999888776


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            6

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=4.4e-08  Score=87.93  Aligned_cols=108  Identities=21%  Similarity=0.233  Sum_probs=85.2

Q ss_pred             HHHHHHHHHHHhccCC--CceeeEEeEEEeCC----eEEEEEeccCCC-CHHHHhhccCCCCcCCHHHHHHHHHHHHHHH
Q 013693          311 VDEFFNEVNLISSIEH--KNLVKLLGCSIEGP----ESLLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGL  383 (438)
Q Consensus       311 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L  383 (438)
                      .....+|...+..|..  -..++++++.....    ..+||+|++++. +|.+++.....   .+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            3467788888888853  34556677666532    458999999884 79998854222   55666778999999999


Q ss_pred             HHhhcCCCCCeeeCCCCCCCeeeCCCC---CeEEeccccccccc
Q 013693          384 AYLHGGSETRIIHRDIKTSNILLDKDF---TPKIADFGLARCFA  424 (438)
Q Consensus       384 ~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~DFGla~~~~  424 (438)
                      .-||   ..||+|+|++|.|||++.+.   .+.|+||+-++...
T Consensus       132 ~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999   89999999999999998876   89999999888654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.70  E-value=5.5e-07  Score=79.55  Aligned_cols=141  Identities=17%  Similarity=0.135  Sum_probs=103.3

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeec------chhhHHHHHHHHHHHhccCC--CceeeEEeEEEeC----CeEEE
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN------TRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEG----PESLL  344 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~l  344 (438)
                      ---|+||.+.|++-.. +|..+-+|+-...      .+.....|.+|+..|.+|..  -.++++.......    -..+|
T Consensus        24 pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L  102 (216)
T PRK09902         24 PNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL  102 (216)
T ss_pred             CCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence            3457799999999876 3447888876411      13345679999999999953  3355555222221    14689


Q ss_pred             EEeccCC-CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC--eEEecccccc
Q 013693          345 VYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--PKIADFGLAR  421 (438)
Q Consensus       345 v~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--~kl~DFGla~  421 (438)
                      |+|-+++ .+|.+++.+. ...+.+......++.++++.+.-||   +.|+.|+|+-+.|||++.++.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9998764 5888887432 2234567777889999999999999   999999999999999986666  9999998666


Q ss_pred             c
Q 013693          422 C  422 (438)
Q Consensus       422 ~  422 (438)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.70  E-value=1.6e-08  Score=100.25  Aligned_cols=150  Identities=25%  Similarity=0.283  Sum_probs=120.8

Q ss_pred             CCCCCCcccc--CCceeEEEEEc---cCCCEEEEEEee--ecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEE
Q 013693          272 YFNPSKKLGQ--GGAGSVYMGSL---PNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       272 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (438)
                      .|...+.+|.  |.+|.+|.+..   .++..+|+|+-+  ...+.....=.+|+...+++ .|+|.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3566788999  99999999855   457889999743  22233333445677777777 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHH----HHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEeccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE----GLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFG  418 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFG  418 (438)
                      +-+|++. .+|..+.+.  ....++...++.+..+..+    ||.++|   ...++|-|+||.||++..+ ...++.|||
T Consensus       195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcc
Confidence            9999884 688887743  3334677778888888888    999999   8999999999999999988 889999999


Q ss_pred             ccccccCCC
Q 013693          419 LARCFAADR  427 (438)
Q Consensus       419 la~~~~~~~  427 (438)
                      +...++...
T Consensus       269 ~v~~i~~~~  277 (524)
T KOG0601|consen  269 LVSKISDGN  277 (524)
T ss_pred             eeEEccCCc
Confidence            999987655

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.62  E-value=1.7e-08  Score=99.91  Aligned_cols=149  Identities=22%  Similarity=0.264  Sum_probs=118.2

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc--CCCEEEEEEeeecchhhHHH--HHHHHHHHhcc-CCCceeeEEeEEEeCCeE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP--NGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI-EHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  342 (438)
                      ....+|..+..||.|.|+.|+....+  ++..+++|.+........++  -..|+.+...+ .|.+++.....|......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34456788899999999999987543  57788999876543322222  23567777766 599999988888888888


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEecccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLAR  421 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFGla~  421 (438)
                      ++-.||++++++...+   .-...+++..++.+..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.+.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            8999999999887665   22334777888999999999999999   8999999999999999875 788999999886


Q ss_pred             c
Q 013693          422 C  422 (438)
Q Consensus       422 ~  422 (438)
                      .
T Consensus       416 ~  416 (524)
T KOG0601|consen  416 R  416 (524)
T ss_pred             c
Confidence            4

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.61  E-value=7.3e-07  Score=81.12  Aligned_cols=139  Identities=14%  Similarity=0.148  Sum_probs=85.5

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC--ceeeEEeEEEeCCeEEEEEeccCCCC-
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK--NLVKLLGCSIEGPESLLVYEYVPNRS-  353 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~-  353 (438)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-  .+++.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999983   24567788775432  234578899999998643  35777888877888889999999863 


Q ss_pred             HHHHh---------------------hccCCCCcCCHHHHH-HHHHH----------HHH-HHHHhhc-CCCCCeeeCCC
Q 013693          354 LDQFI---------------------FDKNKTKLLNWNKRF-NIILG----------TAE-GLAYLHG-GSETRIIHRDI  399 (438)
Q Consensus       354 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~~----------i~~-~L~~LH~-~~~~~iiH~dl  399 (438)
                      +...+                     +.-. ....+..... .+..+          +.+ ...+|.. .....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            22111                     1100 0001100000 00000          000 1112211 11345789999


Q ss_pred             CCCCeeeCCCCCeEEeccccccc
Q 013693          400 KTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       400 kp~Nill~~~~~~kl~DFGla~~  422 (438)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.61  E-value=2.9e-08  Score=103.79  Aligned_cols=112  Identities=24%  Similarity=0.303  Sum_probs=77.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|+.+++|..|+||.||..+++ ..+.+|+|+- ++.--    +++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccchh----hhc---cccccCCccee------------------
Confidence            356888999999999999999664 4678898532 22110    111   33333444443                  


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                         |+-...++   ....++-        +++.+++|||   +.+|+|||+||+|.||..-|++|+.|||+.+..-
T Consensus       136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ---chhhhhcc---cCCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence               34444442   2222322        2277899999   8999999999999999999999999999998653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.56  E-value=4.7e-08  Score=89.85  Aligned_cols=97  Identities=24%  Similarity=0.332  Sum_probs=81.3

Q ss_pred             HHHHhccCCCceeeEEeEEEeCC-----eEEEEEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013693          318 VNLISSIEHKNLVKLLGCSIEGP-----ESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSE  391 (438)
Q Consensus       318 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  391 (438)
                      +.-|-.+.|.|||+++.|+.+..     +..+++|||..|+|.++|++.+ ....+......+++.||+.||.|||.. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            34455667999999999887543     5789999999999999997643 344577788889999999999999965 7


Q ss_pred             CCeeeCCCCCCCeeeCCCCCeEEe
Q 013693          392 TRIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       392 ~~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      ++|+|+++..+-|++..++.+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             CccccCCcchhheeecCCceEEec
Confidence            999999999999999999888874

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=6.7e-07  Score=89.79  Aligned_cols=161  Identities=19%  Similarity=0.213  Sum_probs=102.2

Q ss_pred             ccccccCHHHHHHH------------hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhH------------
Q 013693          256 KSCLSFKYETLEKA------------TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV------------  311 (438)
Q Consensus       256 ~~~~~~~~~~~~~~------------~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------  311 (438)
                      ..++.++++++...            -..|+ .+.|+.-+.|+||+|++++|+.||||+-++.-+...            
T Consensus       135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~  213 (538)
T KOG1235|consen  135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAK  213 (538)
T ss_pred             ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence            34566666665432            22232 367999999999999999999999998765322110            


Q ss_pred             -------------------H------HHHHHHHHHhc----cCCCc------eeeEEeEEEeCCeEEEEEeccCCCCHHH
Q 013693          312 -------------------D------EFFNEVNLISS----IEHKN------LVKLLGCSIEGPESLLVYEYVPNRSLDQ  356 (438)
Q Consensus       312 -------------------~------~~~~E~~~l~~----l~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~  356 (438)
                                         +      +|.+|.+-..+    +.|-+      |++++  +.......|+|||++|..+.+
T Consensus       214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~D  291 (538)
T KOG1235|consen  214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKIND  291 (538)
T ss_pred             HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCC
Confidence                               1      13334433332    33544      33332  233456799999999987766


Q ss_pred             HhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC----CCCeEEecccccccccCC
Q 013693          357 FIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK----DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       357 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kl~DFGla~~~~~~  426 (438)
                      .-.-.  ...++...+..-+.+...-+-+     ..|++|.|-.|.||++..    ++.+.+-|||+...+...
T Consensus       292 l~~i~--~~gi~~~~i~~~l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  292 LDAID--KRGISPHDILNKLVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHH--HcCCCHHHHHHHHHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            54222  2235555544444443333333     357999999999999983    678999999999877543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.54  E-value=1.5e-07  Score=81.96  Aligned_cols=62  Identities=26%  Similarity=0.235  Sum_probs=53.2

Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+|.+++...  ...+++.+++.|+.|++.||.|||   +.+      ||+|||++.++.+|+  ||+++.....
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc
Confidence            6899998542  345999999999999999999999   554      999999999999999  9999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.53  E-value=1.3e-06  Score=80.70  Aligned_cols=141  Identities=13%  Similarity=0.114  Sum_probs=87.3

Q ss_pred             ccccCCc-eeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEeccCCCCHH
Q 013693          278 KLGQGGA-GSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLD  355 (438)
Q Consensus       278 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  355 (438)
                      .|..|.. ..||+.... +..+.||+.....   ...+.+|+++++.+. +--+++++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3455555 688998764 4678888765432   345678999988883 455778888887777789999999998776


Q ss_pred             HHh-------------------hccCC-CCcCCH--HHHHHH-----------------------HHHHHHHHHHhh-cC
Q 013693          356 QFI-------------------FDKNK-TKLLNW--NKRFNI-----------------------ILGTAEGLAYLH-GG  389 (438)
Q Consensus       356 ~~l-------------------~~~~~-~~~l~~--~~~~~i-----------------------~~~i~~~L~~LH-~~  389 (438)
                      +..                   +.... ..++..  ......                       ...+..-|.... ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            442                   11000 001110  000000                       111111111110 01


Q ss_pred             CCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       390 ~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ....++|+|+.|.|||++++..+.|+||+.|..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            245689999999999999987789999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=1.8e-06  Score=77.50  Aligned_cols=157  Identities=20%  Similarity=0.217  Sum_probs=105.8

Q ss_pred             cccCHHHHHHHhcCCCCCCc---cccCCceeEEEEEccCCCEEEEEEeeecchhhH-------------------HH---
Q 013693          259 LSFKYETLEKATNYFNPSKK---LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV-------------------DE---  313 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~---  313 (438)
                      ...+++.+....+...+.+.   |..|.-+.||+|.-.++..+|||+.+.......                   +.   
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            34556777777777666555   556777789999877899999998864321111                   00   


Q ss_pred             --HHHHHHHHhccC--CCceeeEEeEEEeCCeEEEEEeccCCCCH-HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhc
Q 013693          314 --FFNEVNLISSIE--HKNLVKLLGCSIEGPESLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG  388 (438)
Q Consensus       314 --~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~  388 (438)
                        ..+|+.-|.++.  +-.+++.+++.    .-.|||||+....+ .-.|    +...+..++...+..++++.+.-|-.
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence              235677777763  44555655543    33799999965311 1111    11223333566778888888888872


Q ss_pred             CCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       389 ~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                        ..++||+||+.=|||+. ++.+.|+|||-|-....+
T Consensus       185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             --hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence              48999999999999999 889999999988776543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.49  E-value=1.2e-06  Score=77.72  Aligned_cols=138  Identities=16%  Similarity=0.164  Sum_probs=90.0

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHH---------HHHHHHHHhccCCCce---eeEEeE-
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE---------FFNEVNLISSIEHKNL---VKLLGC-  335 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~ni---v~l~~~-  335 (438)
                      ...+|...+++-......|.+-.. ++..+++|..+.......+.         ..+++..+.+++...+   ..++-+ 
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            345677777777777777776666 56889999876543222221         2334444444432222   222222 


Q ss_pred             ----EEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC
Q 013693          336 ----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (438)
Q Consensus       336 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  411 (438)
                          +......+|+|||++|..|.++..       +++    .+...+.+.+.-||   +.|+.|+|..|.|++++++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-c
Confidence                222345679999999988866541       222    24456778899999   8999999999999999865 5


Q ss_pred             eEEeccccccc
Q 013693          412 PKIADFGLARC  422 (438)
Q Consensus       412 ~kl~DFGla~~  422 (438)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.42  E-value=5.4e-08  Score=94.88  Aligned_cols=81  Identities=25%  Similarity=0.392  Sum_probs=73.4

Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      .++|.|+++...+|.++|.........++...+.++.|++.|++|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999776677778899999999999999999      57899999999999999999999999999


Q ss_pred             ccccCCC
Q 013693          421 RCFAADR  427 (438)
Q Consensus       421 ~~~~~~~  427 (438)
                      .......
T Consensus       404 ts~~~~~  410 (516)
T KOG1033|consen  404 TSQDKDE  410 (516)
T ss_pred             eecccCC
Confidence            8887665

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.42  E-value=7e-06  Score=72.61  Aligned_cols=136  Identities=17%  Similarity=0.259  Sum_probs=94.4

Q ss_pred             CCCCccccCCceeEEEEEccCCCEEEEEEeeecc----------------hhhHHHHHHHHHHHhccC------CCceee
Q 013693          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT----------------RQWVDEFFNEVNLISSIE------HKNLVK  331 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~  331 (438)
                      +....||+|+.-.||.  ++......||+.....                ....++..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3457899999999994  5566778889887654                122455666766555554      889999


Q ss_pred             EEeEEEeCCeEEEEEeccCC------CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          332 LLGCSIEGPESLLVYEYVPN------RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       332 l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      ++|+.+++..+-+|+|.+..      .+|.+++.+    ..+++ .....+.+.   ..||-   +..|+.+||+|+||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEE
Confidence            99999999999999999853      367777732    33555 334444444   44555   566999999999999


Q ss_pred             eCCC---C-CeEEec-cccccc
Q 013693          406 LDKD---F-TPKIAD-FGLARC  422 (438)
Q Consensus       406 l~~~---~-~~kl~D-FGla~~  422 (438)
                      +...   . .+.|+| ||-...
T Consensus       151 ~~~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             EEecCCCceEEEEEeCCCCccc
Confidence            9532   2 577777 454443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=2.6e-06  Score=77.63  Aligned_cols=144  Identities=20%  Similarity=0.180  Sum_probs=85.2

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC--ceeeEEeEEE---eCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK--NLVKLLGCSI---EGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~---~~~~~~lv~e~~~~  351 (438)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..++..+...  .+++++....   .....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568899999999998766 69999986544  4556788899998888533  3567776443   33357899999999


Q ss_pred             CCHHH----------------Hh---hcc-CCCCcCCHHH---------HHHH------------HHHHHH-HHHHhhc-
Q 013693          352 RSLDQ----------------FI---FDK-NKTKLLNWNK---------RFNI------------ILGTAE-GLAYLHG-  388 (438)
Q Consensus       352 g~L~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~L~~LH~-  388 (438)
                      ..+..                .+   +.. .....+.+..         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   111 0111111110         0000            011111 2223321 


Q ss_pred             ---CCCCCeeeCCCCCCCeeeC-CCCCeEEecccccccc
Q 013693          389 ---GSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCF  423 (438)
Q Consensus       389 ---~~~~~iiH~dlkp~Nill~-~~~~~kl~DFGla~~~  423 (438)
                         .....++|+|+.|+|||++ +++.+-|+||+.+..-
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence               1357799999999999999 6666689999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.36  E-value=1.5e-06  Score=76.48  Aligned_cols=105  Identities=25%  Similarity=0.199  Sum_probs=82.1

Q ss_pred             HHHHHHHhccCC-CceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 013693          315 FNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR  393 (438)
Q Consensus       315 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  393 (438)
                      .+|.-+++.+++ +++++++|+|-    .++|.||...+++...-..-......+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999976 69999999983    3789999987765421100011123689999999999999999999765566


Q ss_pred             eeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          394 IIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       394 iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +.-.|++|+|+-+++++++|++|...+-..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            777899999999999999999999876554

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.27  E-value=7.5e-06  Score=88.64  Aligned_cols=79  Identities=14%  Similarity=0.297  Sum_probs=57.2

Q ss_pred             CCccccCCceeEEEEEccCC---CEEEEEEeeecc-hhhHHHHHHHHHHHhccC-CCce--eeEEeEEEeC---CeEEEE
Q 013693          276 SKKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIE-HKNL--VKLLGCSIEG---PESLLV  345 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  345 (438)
                      .+.++.|.+..+|+.....+   ..+++|+..... ......+.+|.++++.+. |++|  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46688999999998866543   367777764332 123356889999999995 6665  7888887664   468999


Q ss_pred             EeccCCCCH
Q 013693          346 YEYVPNRSL  354 (438)
Q Consensus       346 ~e~~~~g~L  354 (438)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=2.2e-05  Score=72.04  Aligned_cols=73  Identities=15%  Similarity=0.282  Sum_probs=46.3

Q ss_pred             CccccCCce-eEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC---ceeeEEeEEEeC---CeEEEEEecc
Q 013693          277 KKLGQGGAG-SVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK---NLVKLLGCSIEG---PESLLVYEYV  349 (438)
Q Consensus       277 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  349 (438)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|.+++..+...   .+.++++.....   +..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            557777776 58875    235677764432  2345788999999888532   345555544332   2458999999


Q ss_pred             CCCCHH
Q 013693          350 PNRSLD  355 (438)
Q Consensus       350 ~~g~L~  355 (438)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.12  E-value=6.3e-05  Score=71.47  Aligned_cols=78  Identities=9%  Similarity=-0.021  Sum_probs=56.9

Q ss_pred             CCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC---CceeeEEeEEEe---CCeEEEEEe
Q 013693          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH---KNLVKLLGCSIE---GPESLLVYE  347 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e  347 (438)
                      ...+.||.|..+.||+....++ .+.+|..+..  .....+..|.+.|+.|..   ..++++++++..   .+..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999876555 4666764321  123578899999998842   468888887754   367899999


Q ss_pred             ccCCCCH
Q 013693          348 YVPNRSL  354 (438)
Q Consensus       348 ~~~~g~L  354 (438)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.05  E-value=4.4e-05  Score=67.11  Aligned_cols=125  Identities=26%  Similarity=0.393  Sum_probs=90.9

Q ss_pred             cCCCCCCccccCCc-eeEEEEEccCCCEEEEEEeee---cch------------------hhHHHHHHHHHHHhccC---
Q 013693          271 NYFNPSKKLGQGGA-GSVYMGSLPNGTTVAVKRLIF---NTR------------------QWVDEFFNEVNLISSIE---  325 (438)
Q Consensus       271 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---  325 (438)
                      ..++..+.||.|.- |.||++.+ +|+.+|+|....   ...                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            66788899999999 99999988 678999998321   100                  12235788998888885   


Q ss_pred             CCce--eeEEeEEEeC------------------CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHH
Q 013693          326 HKNL--VKLLGCSIEG------------------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY  385 (438)
Q Consensus       326 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  385 (438)
                      +.++  |+.+||..-.                  ....||.||++...            .+...    -+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            4456  8999986432                  12357777775532            12222    35667777889


Q ss_pred             hhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       386 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      +|   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            99   999999999999987     4589999865

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.03  E-value=3.5e-05  Score=65.62  Aligned_cols=130  Identities=20%  Similarity=0.252  Sum_probs=89.1

Q ss_pred             CCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCcee-eEEeEEEeCCeEEEEEeccCCCC
Q 013693          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLGCSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~  353 (438)
                      ..+.|++|.+|.||++.+ .+.++|+|+-+.+++  ...+..|.++|..++-.++. +++.+.    ..++.|||+.|..
T Consensus        26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            457899999999999998 456899997655433  46788999999999876664 445443    3356699999988


Q ss_pred             HHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC-CCCeeeCCCCCeEEeccccccccc
Q 013693          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK-TSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk-p~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |.+.-..      .+..++.    .+++.---|-   ..||-|+.|. |...+|-.++.+.|+||.-|+.-.
T Consensus        99 L~~~~~~------~~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          99 LGKLEIG------GDRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhhhhhc------ccHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            8776521      1223333    3344423333   5678888775 555555556699999999998543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.98  E-value=6.5e-05  Score=68.80  Aligned_cols=141  Identities=20%  Similarity=0.211  Sum_probs=81.4

Q ss_pred             CccccCCceeEEEEEccC--CCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEeccCCCC
Q 013693          277 KKLGQGGAGSVYMGSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  353 (438)
                      +.|..|-...+|+....+  +..+++|........ .-...+|+.+++.+. +.-.+++++...    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457778888999987654  678889976543222 123357888888884 333445554332    248999999876


Q ss_pred             HHHH--------------h---hccCCC--------CcC-CHHHHHHHHH----------------------HHH---HH
Q 013693          354 LDQF--------------I---FDKNKT--------KLL-NWNKRFNIIL----------------------GTA---EG  382 (438)
Q Consensus       354 L~~~--------------l---~~~~~~--------~~l-~~~~~~~i~~----------------------~i~---~~  382 (438)
                      +...              +   +.....        ... .+..+..+..                      .+.   ..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321              1   111111        011 1122111111                      111   11


Q ss_pred             HH-Hhhc-CCCCCeeeCCCCCCCeeeCC-CCCeEEeccccccc
Q 013693          383 LA-YLHG-GSETRIIHRDIKTSNILLDK-DFTPKIADFGLARC  422 (438)
Q Consensus       383 L~-~LH~-~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~  422 (438)
                      |. .+-. .....++|+|+.+.|||++. ++.+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            11 1111 12457999999999999997 57899999988764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.96  E-value=6e-05  Score=71.62  Aligned_cols=143  Identities=15%  Similarity=0.158  Sum_probs=85.2

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC--ceeeEEeE------EEeCCeEEEEEe
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK--NLVKLLGC------SIEGPESLLVYE  347 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e  347 (438)
                      .+.|..|....+|+....+ ..+++|+...   .....+..|+.++..+.+.  .+++++..      ...++..++|+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778778999886544 4788887754   2234567788888888432  34555442      233556789999


Q ss_pred             ccCCCCHHH----Hh----------hcc----CC----CCcCCHHHHH----------HHHHHHHHHHHHhhc----CCC
Q 013693          348 YVPNRSLDQ----FI----------FDK----NK----TKLLNWNKRF----------NIILGTAEGLAYLHG----GSE  391 (438)
Q Consensus       348 ~~~~g~L~~----~l----------~~~----~~----~~~l~~~~~~----------~i~~~i~~~L~~LH~----~~~  391 (438)
                      +++|..+..    ..          +..    ..    .....|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    11          110    00    0111221110          011112333444431    123


Q ss_pred             CCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          392 TRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       392 ~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      .+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999887789999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.91  E-value=8.6e-05  Score=69.03  Aligned_cols=139  Identities=12%  Similarity=0.077  Sum_probs=79.1

Q ss_pred             ccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEeccCCCCHHH
Q 013693          278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPNRSLDQ  356 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~  356 (438)
                      .+..|-...+|+... ++..+++|..........-...+|..+++.+....+ ++++...  .  .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence            355677889998874 567888887544332221235788899998854333 4444443  2  368999999876532


Q ss_pred             H-----------------hhccC-CCCcCCHHHH-HHHHHHH---------HHHHHHhhc-----CCCCCeeeCCCCCCC
Q 013693          357 F-----------------IFDKN-KTKLLNWNKR-FNIILGT---------AEGLAYLHG-----GSETRIIHRDIKTSN  403 (438)
Q Consensus       357 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------~~~L~~LH~-----~~~~~iiH~dlkp~N  403 (438)
                      .                 +|... ...+++.... ..+..++         ..-+..+-.     .....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111 1111222111 1111111         111221211     012468999999999


Q ss_pred             eeeCCCCCeEEeccccccc
Q 013693          404 ILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       404 ill~~~~~~kl~DFGla~~  422 (438)
                      |++++++ ++|+||..|..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.79  E-value=0.00043  Score=66.58  Aligned_cols=157  Identities=14%  Similarity=0.186  Sum_probs=84.9

Q ss_pred             cCHHHHHHHhcCCCC-----CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC--CceeeEE
Q 013693          261 FKYETLEKATNYFNP-----SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH--KNLVKLL  333 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~  333 (438)
                      .+.+++....+.|.+     .+.|..|....+|+....++ .+++|+.....   .+.+..|..++..|..  -.+++++
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence            344555555555644     34566777778998876554 68888775212   2334445566655532  1233444


Q ss_pred             e------EEEeCCeEEEEEeccCCCCHH-----------HHh---hccCC--------CCcCCH-HHHHH----------
Q 013693          334 G------CSIEGPESLLVYEYVPNRSLD-----------QFI---FDKNK--------TKLLNW-NKRFN----------  374 (438)
Q Consensus       334 ~------~~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~~~--------~~~l~~-~~~~~----------  374 (438)
                      .      +....+..++++||++|..+.           +.+   +....        ...+.| .....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            2      123456789999999987431           111   11000        001111 11111          


Q ss_pred             --HHHH-HHHHHHHhhc----CCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          375 --IILG-TAEGLAYLHG----GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       375 --i~~~-i~~~L~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                        .+.+ +...+..+..    .-..++||+|+.|.|||++.+...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              1111 1111222221    024589999999999999976556899999875

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.78  E-value=0.00036  Score=68.46  Aligned_cols=75  Identities=17%  Similarity=0.181  Sum_probs=54.8

Q ss_pred             CccccCCceeEEEEEccCC-CEEEEEEeeec-----c--hhhHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeEEEE
Q 013693          277 KKLGQGGAGSVYMGSLPNG-TTVAVKRLIFN-----T--RQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  345 (438)
                      +.||.|.+..||+....+| +.++||.-.+.     .  +...++...|.+.|..+.   ..++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999988776 58999975421     1  123566778888888762   3567888877  44557899


Q ss_pred             EeccCCCC
Q 013693          346 YEYVPNRS  353 (438)
Q Consensus       346 ~e~~~~g~  353 (438)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.73  E-value=0.00088  Score=64.04  Aligned_cols=157  Identities=17%  Similarity=0.205  Sum_probs=89.6

Q ss_pred             CHHHHHHHhcCCCC-----CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC--ceeeEEe
Q 013693          262 KYETLEKATNYFNP-----SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK--NLVKLLG  334 (438)
Q Consensus       262 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~  334 (438)
                      +.+++....+.|.+     .+.++.|-...+|+....++ .+++|+.....  ..+++..|.+++..|...  .+++++.
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~   84 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK   84 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence            34556555556644     34567777789998865444 57788764421  123455677777776422  2445444


Q ss_pred             E------EEeCCeEEEEEeccCCCCHH-----------HH---hhccCC----C-----CcCCHHHHHH-----------
Q 013693          335 C------SIEGPESLLVYEYVPNRSLD-----------QF---IFDKNK----T-----KLLNWNKRFN-----------  374 (438)
Q Consensus       335 ~------~~~~~~~~lv~e~~~~g~L~-----------~~---l~~~~~----~-----~~l~~~~~~~-----------  374 (438)
                      .      ....+..++++||++|..+.           ..   ++....    .     ..-.|.....           
T Consensus        85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~  164 (307)
T TIGR00938        85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA  164 (307)
T ss_pred             CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence            2      12345678999999885432           11   111000    0     0011111100           


Q ss_pred             -HHHHHHHHHHHhhc----CCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          375 -IILGTAEGLAYLHG----GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       375 -i~~~i~~~L~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                       ....+.+.++++..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             01123334555531    225789999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.64  E-value=0.00032  Score=66.91  Aligned_cols=142  Identities=23%  Similarity=0.271  Sum_probs=82.9

Q ss_pred             CccccCCceeEEEEEccC-------CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSLPN-------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~  348 (438)
                      +.|..|-...+|+....+       ++.+++|....... ...+..+|.+++..+.... .+++++.+. +   .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            345556667889887654       57888998654332 2345678888888884322 345555543 2   368999


Q ss_pred             cCCCCHHHH-----------------hhccCCCC------cCC--HHHHHH--------------------------HHH
Q 013693          349 VPNRSLDQF-----------------IFDKNKTK------LLN--WNKRFN--------------------------IIL  377 (438)
Q Consensus       349 ~~~g~L~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~  377 (438)
                      ++|..+...                 +|......      ..+  +..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988766431                 11111110      010  111100                          111


Q ss_pred             HHHHHHHHhhc------CCCCCeeeCCCCCCCeeeCCC----CCeEEecccccccc
Q 013693          378 GTAEGLAYLHG------GSETRIIHRDIKTSNILLDKD----FTPKIADFGLARCF  423 (438)
Q Consensus       378 ~i~~~L~~LH~------~~~~~iiH~dlkp~Nill~~~----~~~kl~DFGla~~~  423 (438)
                      .+..-+.+|-.      .....++|+|+.|.|||++++    +.++|+||..|..-
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            22222334431      135678999999999999874    78999999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.41  E-value=0.0013  Score=63.75  Aligned_cols=141  Identities=21%  Similarity=0.312  Sum_probs=81.1

Q ss_pred             ccccCCceeEEEEEccC-----CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEeccCC
Q 013693          278 KLGQGGAGSVYMGSLPN-----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      .|-.|-.-.+|+....+     ++.+++|..........++ .+|..+++.+..-++ +++++.+.. +   .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            44456677888886432     3678889776544333333 678999888854333 355665532 2   58999988


Q ss_pred             CCHHHH-----------------hhccC-CC-C-cCCHHHHHHHHHHH-----------------HHHHHHh----hc-C
Q 013693          352 RSLDQF-----------------IFDKN-KT-K-LLNWNKRFNIILGT-----------------AEGLAYL----HG-G  389 (438)
Q Consensus       352 g~L~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------~~~L~~L----H~-~  389 (438)
                      .+|...                 +|... .. . ...+.++..+..++                 ..-+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            766421                 11111 00 0 11223322222111                 1111111    11 2


Q ss_pred             CCCCeeeCCCCCCCeeeCC-CCCeEEecccccccc
Q 013693          390 SETRIIHRDIKTSNILLDK-DFTPKIADFGLARCF  423 (438)
Q Consensus       390 ~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~~  423 (438)
                      ....++|+|+++.|||+++ ++.++|+||..|..-
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            2457899999999999986 468999999887743

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.33  E-value=0.0022  Score=60.80  Aligned_cols=146  Identities=14%  Similarity=0.228  Sum_probs=80.6

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEee-ecchhhHHHHHHHHHHHhccC--CCceeeEEeEEEeCC--eEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIE--HKNLVKLLGCSIEGP--ESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~--~~~lv~e~~~~  351 (438)
                      +.+..|-.-.+|..... +++.++.+-. ...........+|..+++.+.  -.-+.+.++.|..+.  ..+.||+|++|
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            33333333345554433 7778887221 122334556678888888874  334556666776665  77999999988


Q ss_pred             CCHHHHhhccC-----------------------------C------CCcCCHHHHHHHH--------HHHHHHHHHhhc
Q 013693          352 RSLDQFIFDKN-----------------------------K------TKLLNWNKRFNII--------LGTAEGLAYLHG  388 (438)
Q Consensus       352 g~L~~~l~~~~-----------------------------~------~~~l~~~~~~~i~--------~~i~~~L~~LH~  388 (438)
                      ..+...+....                             .      .+...|...+..+        -....-..||+.
T Consensus       110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            43322110000                             0      0000111111000        001112333432


Q ss_pred             -----CCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          389 -----GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       389 -----~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                           .....++|+|+.+.||+++.+..+=+.||+++..-
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                 12456899999999999999888999999998754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.31  E-value=0.0022  Score=60.25  Aligned_cols=32  Identities=28%  Similarity=0.474  Sum_probs=26.6

Q ss_pred             CCeeeCCCCCCCeeeCCCCC-eEEecccccccc
Q 013693          392 TRIIHRDIKTSNILLDKDFT-PKIADFGLARCF  423 (438)
Q Consensus       392 ~~iiH~dlkp~Nill~~~~~-~kl~DFGla~~~  423 (438)
                      ..++|+|++|.|||+++++. .-|+||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997555 569999988754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.18  E-value=0.0022  Score=60.29  Aligned_cols=74  Identities=15%  Similarity=0.186  Sum_probs=48.6

Q ss_pred             CCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          275 PSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       275 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      ..+.++-|....+|+.. .+++.+-||.-.   ......|..|.+-|+.|   .--.+++++++....+..+|||||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34568888899999887 477889999765   33345678888888877   345688999998888888999999987


Q ss_pred             C
Q 013693          352 R  352 (438)
Q Consensus       352 g  352 (438)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.13  E-value=9.1e-05  Score=78.37  Aligned_cols=148  Identities=20%  Similarity=0.200  Sum_probs=100.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .+.+.+.+-+.+|.++.++.+.-. .+...++|......   ....+....+-.++-...||-++...--+......+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            344566677888999988876332 23333444332211   11122233333333334556666655555567788999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ++|+.+++|...|+...   ..+.+-....+..+.++++|||   ...+.|+|++|.|+|+..+++.+++|||..+..
T Consensus       883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999885432   3454555566777889999999   666999999999999999999999999965544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.12  E-value=0.0058  Score=58.87  Aligned_cols=73  Identities=14%  Similarity=0.103  Sum_probs=48.7

Q ss_pred             ccccCCceeEEEEEccCC-CEEEEEEeeec-------chhhHHHHHHHHHHHhccC--CC-ceeeEEeEEEeCCeEEEEE
Q 013693          278 KLGQGGAGSVYMGSLPNG-TTVAVKRLIFN-------TRQWVDEFFNEVNLISSIE--HK-NLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  346 (438)
                      .||.|-...||++..+++ +.|+||.-.+.       -+-..++..-|.+.|+...  -| .+++++.+  +++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999987654 58999965321       1223455566777776652  23 46666554  555667999


Q ss_pred             eccCCC
Q 013693          347 EYVPNR  352 (438)
Q Consensus       347 e~~~~g  352 (438)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.12  E-value=0.00036  Score=65.19  Aligned_cols=131  Identities=18%  Similarity=0.260  Sum_probs=90.5

Q ss_pred             CCCCCccccCCceeEEEEEccCCCEEEEEEeeec---------ch---------hh----HHHHHHHHHHHhccCC--Cc
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN---------TR---------QW----VDEFFNEVNLISSIEH--KN  328 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---------~~---------~~----~~~~~~E~~~l~~l~h--~n  328 (438)
                      +...+.||-|.-+.||.+....|++.++|.-+..         ..         .|    .-...+|+..|+.|..  =-
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            5678999999999999999888999999832211         00         11    1124578888888843  23


Q ss_pred             eeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013693          329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK  408 (438)
Q Consensus       329 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  408 (438)
                      +++.+++    +..++|||++.+-.|.+.-+      ..+...++.-+..   -+.-|-   ..|+||+|..-=||++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~---~Iv~la---~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMG---LIVRLA---NHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHH---HHHHHH---HcCceecccchheeEEec
Confidence            4555543    56689999999888765531      1233333333322   233444   679999999999999999


Q ss_pred             CCCeEEecccc
Q 013693          409 DFTPKIADFGL  419 (438)
Q Consensus       409 ~~~~kl~DFGl  419 (438)
                      ++.++++||--
T Consensus       238 d~~i~vIDFPQ  248 (465)
T KOG2268|consen  238 DDKIVVIDFPQ  248 (465)
T ss_pred             CCCEEEeechH
Confidence            99999999953

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.06  E-value=0.0065  Score=57.97  Aligned_cols=139  Identities=17%  Similarity=0.199  Sum_probs=93.4

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeec-----c--------------------hhhHHH-HHHHHHHHhccCCCce
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN-----T--------------------RQWVDE-FFNEVNLISSIEHKNL  329 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--------------------~~~~~~-~~~E~~~l~~l~h~ni  329 (438)
                      -..|..|.-+.||.+.-.+|..+|||+.+..     +                    ....+- ...|+.-|++|+...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4568889999999998889999999977521     1                    111111 2357777888765555


Q ss_pred             eeEEeEEEeCCeEEEEEeccCCCCH-HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013693          330 VKLLGCSIEGPESLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK  408 (438)
Q Consensus       330 v~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  408 (438)
                      +-.--....  ...|||+++..... .-.|    +...++...+..+-.|++.-+.-|.+  ..++||.||.-=|+|+- 
T Consensus       229 P~PePIlLk--~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  229 PCPEPILLK--NHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCceeee--cceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-
Confidence            432222222  23799999953221 1112    23346677777788888888887764  67899999999999984 


Q ss_pred             CCCeEEecccccccc
Q 013693          409 DFTPKIADFGLARCF  423 (438)
Q Consensus       409 ~~~~kl~DFGla~~~  423 (438)
                      +|.+.|+|.+-+-..
T Consensus       300 dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEH  314 (520)
T ss_pred             CCEEEEEEccccccC
Confidence            568999998765443

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.92  E-value=0.015  Score=57.03  Aligned_cols=73  Identities=12%  Similarity=0.176  Sum_probs=50.1

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecc----h---hhHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeEEEE
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT----R---QWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  345 (438)
                      .+.||.|....||+.... +..++||+-....    .   ....+-..|...|+.+.   ..++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998764 5578999765211    1   13344455666666553   357888888876  446889


Q ss_pred             EeccCC
Q 013693          346 YEYVPN  351 (438)
Q Consensus       346 ~e~~~~  351 (438)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.72  E-value=0.031  Score=53.34  Aligned_cols=30  Identities=27%  Similarity=0.325  Sum_probs=26.0

Q ss_pred             CCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       391 ~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            468999999999999987 578999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.71  E-value=0.014  Score=56.45  Aligned_cols=141  Identities=17%  Similarity=0.226  Sum_probs=78.3

Q ss_pred             CccccCCceeEEEEEccC----CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.|..|-...+|+....+    +..+++|+........ -.-.+|..+++.+..-++ +++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            345456667888875433    2378888775543322 223578888888865444 45665552 22   58999987


Q ss_pred             CCHHHH-------h----------hccC-CC-C-cCCHHHHHHHHHHH----------------------HHHHHH---h
Q 013693          352 RSLDQF-------I----------FDKN-KT-K-LLNWNKRFNIILGT----------------------AEGLAY---L  386 (438)
Q Consensus       352 g~L~~~-------l----------~~~~-~~-~-~l~~~~~~~i~~~i----------------------~~~L~~---L  386 (438)
                      ..|..-       +          |... .. . +-.|..+..+..++                      .+-+..   +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            665221       1          1111 00 0 11223222222211                      111111   1


Q ss_pred             hc--CCCCCeeeCCCCCCCeeeCC-CCCeEEeccccccc
Q 013693          387 HG--GSETRIIHRDIKTSNILLDK-DFTPKIADFGLARC  422 (438)
Q Consensus       387 H~--~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~  422 (438)
                      ..  ....-.+|.|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11  11234789999999999974 57899999988764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.68  E-value=0.0002  Score=72.14  Aligned_cols=145  Identities=14%  Similarity=0.056  Sum_probs=95.5

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCeEEEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPESLLV  345 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  345 (438)
                      +..+.-+..-+-+++++++.++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+..++..+++
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            3333334444567889999999875433444444544322     34556899999999999 77777777777889999


Q ss_pred             EeccCCC-CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          346 YEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       346 ~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +++...+ +-....  ......+...+...+.+.-+++|++||   +..-+|+|    ||+..+ +..|..||+.+..+.
T Consensus       313 ~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  313 MRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLT  382 (829)
T ss_pred             hhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccC
Confidence            9999776 221111  011112333344456666778899999   44457888    777665 688999999988876


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       383 ~~  384 (829)
T KOG0576|consen  383 RT  384 (829)
T ss_pred             cc
Confidence            54

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.54  E-value=0.1  Score=50.27  Aligned_cols=95  Identities=12%  Similarity=0.034  Sum_probs=55.8

Q ss_pred             ccccCHHHHHHHhcCCCCC---C-ccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC--ceee
Q 013693          258 CLSFKYETLEKATNYFNPS---K-KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK--NLVK  331 (438)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~---~-~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~  331 (438)
                      ...++.+.+..+.+.+-..   + ..=.+.-..||+....++..+++|...... ....++..|++.+..|...  .++.
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~   86 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA   86 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            3455666666666655332   1 111234467999887778889999875332 2345566788777766321  1222


Q ss_pred             EE---e--EEEeCCeEEEEEeccCCCC
Q 013693          332 LL---G--CSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       332 l~---~--~~~~~~~~~lv~e~~~~g~  353 (438)
                      ..   |  ....++..+.++++++|..
T Consensus        87 p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         87 PLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            11   2  2233567888999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.35  E-value=0.0068  Score=54.46  Aligned_cols=31  Identities=35%  Similarity=0.499  Sum_probs=21.9

Q ss_pred             CCeeeCCCCCCCeee-CCCCCeEEeccccccc
Q 013693          392 TRIIHRDIKTSNILL-DKDFTPKIADFGLARC  422 (438)
Q Consensus       392 ~~iiH~dlkp~Nill-~~~~~~kl~DFGla~~  422 (438)
                      ..+.|.||.|.|||+ +.++.++|+||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            467899999999999 8889999999988764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.31  E-value=0.039  Score=52.73  Aligned_cols=32  Identities=22%  Similarity=0.294  Sum_probs=28.6

Q ss_pred             CCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       391 ~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ..+++|+|+.++|||++.++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999987764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.23  E-value=0.017  Score=56.51  Aligned_cols=74  Identities=16%  Similarity=0.100  Sum_probs=50.5

Q ss_pred             CCccccCCceeEEEEEccC-CCEEEEEEeeec-----c-hhhHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeEEEE
Q 013693          276 SKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFN-----T-RQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  345 (438)
                      .+.||.|.-..||++..++ +..|+||.-.+.     + +-..++..-|.+.|+...   -..+++++.+  +++...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3578999999999998643 568999965321     1 223556667888887663   2356667654  45556789


Q ss_pred             EeccCC
Q 013693          346 YEYVPN  351 (438)
Q Consensus       346 ~e~~~~  351 (438)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999965

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.05  E-value=0.03  Score=49.84  Aligned_cols=101  Identities=18%  Similarity=0.151  Sum_probs=65.9

Q ss_pred             EEEEEEeeecchh-hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHH
Q 013693          297 TVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI  375 (438)
Q Consensus       297 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i  375 (438)
                      +..+|++..-.-. ...-|.++.++++++.  .|+++..-  ..-..-++.|++-..            +...    ..+
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------------~i~~----~N~  146 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------------KINF----SNF  146 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc------------ccch----hHH
Confidence            4456666543322 3445778888988874  46776632  233456888988331            1111    112


Q ss_pred             HHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       376 ~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      +.-=++.|.-.|++ ..+.+|+|-.|+||+-|..|.+||.|-+
T Consensus       147 i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  147 ITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             HHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChh
Confidence            22224667778854 5789999999999999999999999975

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.04  E-value=0.1  Score=46.88  Aligned_cols=75  Identities=20%  Similarity=0.273  Sum_probs=53.0

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCeEEEEEeccCCCC
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI---EHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~  353 (438)
                      +.+.-|.--..|.... ...++-||.-   .......|..|+.-|..|   +--++.+++.+....+..||||||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            4455555555555443 4567777763   344456788888766666   44678899999999999999999999876


Q ss_pred             HH
Q 013693          354 LD  355 (438)
Q Consensus       354 L~  355 (438)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            65

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.97  E-value=0.082  Score=50.76  Aligned_cols=136  Identities=21%  Similarity=0.269  Sum_probs=79.0

Q ss_pred             CceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCc------eeeEEeE--EEeCC--eEEEEEeccCCC
Q 013693          283 GAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN------LVKLLGC--SIEGP--ESLLVYEYVPNR  352 (438)
Q Consensus       283 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~--~~~~~--~~~lv~e~~~~g  352 (438)
                      .-..+|+....+++. ++|.....  ....++..|+..+..|.-..      +..+-|-  ..-.+  ..+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            445688887766666 88877655  33456667788887773111      2222221  11233  788899999998


Q ss_pred             CHHH-H----h----------h----ccC--C---CCcCCHHH----H---------HHHHHHHHHHHHHhhc-----CC
Q 013693          353 SLDQ-F----I----------F----DKN--K---TKLLNWNK----R---------FNIILGTAEGLAYLHG-----GS  390 (438)
Q Consensus       353 ~L~~-~----l----------~----~~~--~---~~~l~~~~----~---------~~i~~~i~~~L~~LH~-----~~  390 (438)
                      .+.. .    +          +    +..  +   .....|..    .         .....++...+..+..     ..
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7772 1    1          1    010  1   11233331    0         1122333344444432     11


Q ss_pred             CCC--eeeCCCCCCCeeeCCCCC-eEEecccccc
Q 013693          391 ETR--IIHRDIKTSNILLDKDFT-PKIADFGLAR  421 (438)
Q Consensus       391 ~~~--iiH~dlkp~Nill~~~~~-~kl~DFGla~  421 (438)
                      ..+  +||+|+.|.||+++.+.. +.++||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            233  999999999999998875 8999999775

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.84  E-value=0.024  Score=54.90  Aligned_cols=61  Identities=18%  Similarity=0.133  Sum_probs=40.9

Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  407 (438)
                      ...|+-+|.+|-++..++...    ..++.....++.-.+++|.-+--  --+.+|.|+.|.||++-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~----~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK----SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhcc----cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            346777888898999888432    23444455555555555443321  45789999999999994

>PRK06148 hypothetical protein; Provisional

Probab=95.82  E-value=0.13  Score=57.23  Aligned_cols=159  Identities=18%  Similarity=0.205  Sum_probs=84.2

Q ss_pred             ccCHHHHHH-HhcCCCCC---CccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC--CCc--eee
Q 013693          260 SFKYETLEK-ATNYFNPS---KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE--HKN--LVK  331 (438)
Q Consensus       260 ~~~~~~~~~-~~~~~~~~---~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n--iv~  331 (438)
                      .++.++++. ..+.|-+.   +.|+ |..-.+|+....++..+++|+......  ......|...|..|.  ++.  +.+
T Consensus        10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~   86 (1013)
T PRK06148         10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPR   86 (1013)
T ss_pred             CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCe
Confidence            344444432 33344432   3453 345678888777788999999875422  223344555665442  122  223


Q ss_pred             EEe--------EEEe-CC--eEEEEEeccCCCCHHHHh-----------------h----ccCC---CCcCCHHH-----
Q 013693          332 LLG--------CSIE-GP--ESLLVYEYVPNRSLDQFI-----------------F----DKNK---TKLLNWNK-----  371 (438)
Q Consensus       332 l~~--------~~~~-~~--~~~lv~e~~~~g~L~~~l-----------------~----~~~~---~~~l~~~~-----  371 (438)
                      ++-        .... ++  ..+-+++|++|..+.+..                 +    +...   ...+.|..     
T Consensus        87 ~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~  166 (1013)
T PRK06148         87 LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGR  166 (1013)
T ss_pred             eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchh
Confidence            221        1111 22  467789999998776511                 0    0000   11122321     


Q ss_pred             ------------HHHHHHHHHHHHH-----HhhcCCCCCeeeCCCCCCCeeeCCCC--CeE-Eeccccccc
Q 013693          372 ------------RFNIILGTAEGLA-----YLHGGSETRIIHRDIKTSNILLDKDF--TPK-IADFGLARC  422 (438)
Q Consensus       372 ------------~~~i~~~i~~~L~-----~LH~~~~~~iiH~dlkp~Nill~~~~--~~k-l~DFGla~~  422 (438)
                                  ...++.++.+...     .|. .-..++||+|+.+.|||++.+.  ++. |+|||.+..
T Consensus       167 l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        167 ARDRLHFIDDPEDRALVERFLARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             hhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                        1122222322221     121 1246799999999999998775  555 999997753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=95.80  E-value=0.076  Score=51.65  Aligned_cols=135  Identities=16%  Similarity=0.190  Sum_probs=86.2

Q ss_pred             CCCCccccCCceeEEEE-EccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEE------EeCC-eEEE
Q 013693          274 NPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCS------IEGP-ESLL  344 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~-~~~l  344 (438)
                      .....||+|+-+.+|-- ..   ..-+.|+..........+   .+..|.+. .||-+-.-+.|=      -+.+ ..-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34678999999999943 22   223446665443322222   23334444 566443312221      1222 2567


Q ss_pred             EEeccCCCC-HHHHh---hccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          345 VYEYVPNRS-LDQFI---FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       345 v~e~~~~g~-L~~~l---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      +|..+++.- +..+.   .++.......|...++.++.++.+.+-||   ..|.+-+|+.++|+|+++++.+.|.|=
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence            788776642 22222   12234455889999999999999999999   889999999999999999888888773

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.80  E-value=0.031  Score=53.40  Aligned_cols=72  Identities=19%  Similarity=0.231  Sum_probs=55.9

Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..|++|++- |++|...       ....+++...|+.+-+.-+.-+..  +.+.-|||+...||||+ +|++-|+||-++
T Consensus       300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence            456777765 5455321       235678889999988777777763  67889999999999999 999999999999


Q ss_pred             ccc
Q 013693          421 RCF  423 (438)
Q Consensus       421 ~~~  423 (438)
                      |.-
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            953

>PTZ00384 choline kinase; Provisional

Probab=95.18  E-value=0.14  Score=50.41  Aligned_cols=74  Identities=22%  Similarity=0.324  Sum_probs=43.5

Q ss_pred             CccccCCceeEEEEEccCC--CE-----EEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSLPNG--TT-----VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  348 (438)
                      +.|..|-...+|++...++  ..     |.++...... ...-+-.+|+.+++.+...++ +++++.+..    ++|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            3455577788998865432  22     3333321111 111223568999999965444 456665532    699999


Q ss_pred             cCCCCHH
Q 013693          349 VPNRSLD  355 (438)
Q Consensus       349 ~~~g~L~  355 (438)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987764

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.04  E-value=0.19  Score=46.29  Aligned_cols=76  Identities=20%  Similarity=0.199  Sum_probs=54.7

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHH---HHHhccCCCceeeEEeEEEeCCeEEEEEecc-CC
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEV---NLISSIEHKNLVKLLGCSIEGPESLLVYEYV-PN  351 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~-~~  351 (438)
                      ...+..|..+.|+++...+|.+.++|.......     +..|.   ..|+..+-...|++++.-  ...-.|++|.+ ++
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g   79 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPG   79 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCC
Confidence            345677889999999988999999998764432     12233   457777778889999864  34557888998 55


Q ss_pred             CCHHHHh
Q 013693          352 RSLDQFI  358 (438)
Q Consensus       352 g~L~~~l  358 (438)
                      .+|.++.
T Consensus        80 ~~L~~~~   86 (253)
T PF04655_consen   80 RSLASLP   86 (253)
T ss_pred             Cchhhcc
Confidence            5776554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=94.58  E-value=0.024  Score=58.13  Aligned_cols=48  Identities=25%  Similarity=0.468  Sum_probs=41.8

Q ss_pred             HHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       376 ~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +.+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+-....
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~  152 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG  152 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCC
Confidence            4456699999996  78999999999999999999999999998766543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	438
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-32
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-30
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-28
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-27
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-26
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-04
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		6e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		7e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		7e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		7e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		8e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 77/180 (42%), Positives = 109/180 (60%), Gaps = 2/180 (1%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVN 319
           F    L+ A++ F+    LG+GG G VY G L +GT VAVKRL     Q  + +F  EV 
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILG 378
           +IS   H+NL++L G  +   E LLVY Y+ N S+   + ++ +++  L+W KR  I LG
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +A GLAYLH   + +IIHRD+K +NILLD++F   + DFGLA+       HV  AV GT+
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTI 207

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 75/180 (41%), Positives = 106/180 (58%), Gaps = 2/180 (1%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVN 319
           F    L+ A++ F     LG+GG G VY G L +G  VAVKRL     Q  + +F  EV 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIILG 378
           +IS   H+NL++L G  +   E LLVY Y+ N S+   + ++ +++  L+W KR  I LG
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +A GLAYLH   + +IIHRD+K +NILLD++F   + DFGLA+       HV  AV G +
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/173 (42%), Positives = 103/173 (59%), Gaps = 14/173 (8%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR 
Sbjct: 127 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 176

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 79/191 (41%), Positives = 112/191 (58%), Gaps = 19/191 (9%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC---FAAD 426
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR    FA  
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-- 187
Query: 427 RTHVSTAVAGT 437
           +T + + + GT
Sbjct: 188 QTVMXSRIVGT 198

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/173 (42%), Positives = 103/173 (59%), Gaps = 14/173 (8%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR 
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 182

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 74/173 (42%), Positives = 100/173 (57%), Gaps = 14/173 (8%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
           SF +  L+  TN F+         K G+GG G VY G + N TTVAVK+L       T +
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ + +  +H+NLV+LLG S +G +  LVY Y PN SL   +   + T  L+W
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR 
Sbjct: 124 HXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 173

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/176 (41%), Positives = 107/176 (60%), Gaps = 7/176 (3%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           LE+ATN F+    +G G  G VY G L +G  VA+KR    + Q ++EF  E+  +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLA 384
           H +LV L+G   E  E +L+Y+Y+ N +L + ++  +  T  ++W +R  I +G A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 385 YLHGGSETR-IIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVAGTL 438
           YLH    TR IIHRD+K+ NILLD++F PKI DFG++ +    D+TH+   V GTL
Sbjct: 154 YLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTL 205

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 72/176 (40%), Positives = 106/176 (60%), Gaps = 7/176 (3%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           LE+ATN F+    +G G  G VY G L +G  VA+KR    + Q ++EF  E+  +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLA 384
           H +LV L+G   E  E +L+Y+Y+ N +L + ++  +  T  ++W +R  I +G A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 385 YLHGGSETR-IIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVAGTL 438
           YLH    TR IIHRD+K+ NILLD++F PKI DFG++ +     +TH+   V GTL
Sbjct: 154 YLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTL 205

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 89/156 (57%), Gaps = 6/156 (3%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNL 329
            N  +K+G G  G+V+     +G+ VAVK L+   F+  + V+EF  EV ++  + H N+
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V  +G   + P   +V EY+   SL + +      + L+  +R ++    A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           +   I+HRD+K+ N+L+DK +T K+ DFGL+R  A+
Sbjct: 157 NPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 97/169 (57%), Gaps = 9/169 (5%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNL 329
            N  +K+G G  G+V+     +G+ VAVK L+   F+  + V+EF  EV ++  + H N+
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V  +G   + P   +V EY+   SL + +      + L+  +R ++    A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST-AVAGT 437
           +   I+HR++K+ N+L+DK +T K+ DFGL+R  A+  T +S+ + AGT
Sbjct: 157 NPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGT 202

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/147 (37%), Positives = 80/147 (54%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G AG V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/147 (36%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 73  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLI 154

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/145 (37%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+    + KIADFGLAR
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLAR 157

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/145 (37%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+    + KIADFGLAR
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLAR 157

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/145 (37%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 84  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 138
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+    + KIADFGLAR
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLAR 163

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/145 (37%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 79  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 133
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+    + KIADFGLAR
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLAR 158

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/147 (36%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/147 (36%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 83  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 137
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLI 164

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/147 (36%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 88  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 142
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLI 169

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/147 (36%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 80  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLI 161

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/145 (37%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 87  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 141
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+    + KIADFGLAR
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLAR 166

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/147 (36%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 86  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 140
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLI 167

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/147 (36%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 84  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 138
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +NIL+    + KIADFGLAR  
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLI 165

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 75/147 (51%), Gaps = 5/147 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+MG   N T VAVK L   T   V  F  E NL+ +++H  LV+L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ E++   SL  F+      K+L   K  +     AEG+AY+        IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +N+L+ +    KIADFGLAR  
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVI 159

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 74/147 (50%), Gaps = 5/147 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V+MG   N T VAVK L   T   V  F  E NL+ +++H  LV+L    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
                  ++ EY+   SL  F+      K+L   K  +     AEG+AY+        IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCF 423
           RD++ +N+L+ +    KIADFGLAR  
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVI 160

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/145 (36%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 74  TQEP-IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           R+++ +NIL+    + KIADFGLAR
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLAR 153

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 128
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLA 153

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 153
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 146
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
              P+  +V ++    SL   +   + K +++   K  +I   TA+G+ YLH  S   II
Sbjct: 74  T-APQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K++NI L +D T KI DFGLA
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 161
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 208

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 148
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 135
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 182

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 184

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 133
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 128
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 175

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 136
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 183

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 129
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 176

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P+  +V ++    SL   +   ++TK     K  +I   TA G+ YLH  S   IIH
Sbjct: 78  TK-PQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RD+K++NI L +D T KI DFGLA
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLA 155

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 148
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
              P+  +V ++    SL   +   ++TK     K  +I   TA G+ YLH  S   IIH
Sbjct: 90  T-APQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RD+K++NI L +D T KI DFGLA
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P+  +V ++    SL   +   ++TK     K  +I   TA G+ YLH  S   IIH
Sbjct: 90  TK-PQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RD+K++NI L +D T KI DFGLA
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 134
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 181

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K ++ +  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 12/180 (6%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLI--FNTRQWVDEFFNEV 318
           T E   +  +  K +G G +G V  G L         VA+K L   +  RQ  D F +E 
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           +++   +H N+++L G    G  +++V EY+ N SLD F+  +         +   ++ G
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRG 159
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              G+ YL   S+   +HRD+   N+L+D +   K++DFGL+R    D     T   G +
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI 216

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 86/167 (51%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ E++P  SL +++  K+K ++ +  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERI-DHIKLLQYTSQICKGMEYL--- 133
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 87/163 (53%), Gaps = 15/163 (9%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           KLG G  G VY+G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG C
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETR 393
           ++E P   +V EY+P  +L  ++ + N+ ++        + + T  +  + YL    +  
Sbjct: 98  TLE-PPFYIVTEYMPYGNLLDYLRECNREEV---TAVVLLYMATQISSAMEYL---EKKN 150
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
            IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGD---TYTAHAG 190

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 74  EEP-IXIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 128 RDLRAANILVGENLVCKVADFGLAR 152

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 12/180 (6%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLI--FNTRQWVDEFFNEV 318
           T E   +  +  K +G G +G V  G L         VA+K L   +  RQ  D F +E 
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           +++   +H N+++L G    G  +++V EY+ N SLD F+  +         +   ++ G
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRG 159
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
              G+ YL   S+   +HRD+   N+L+D +   K++DFGL+R    D     T   G +
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  I H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR 162

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR 328

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR 328

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 77  EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 131 RDLRAANILVGENLVCKVADFGLAR 155

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 86/167 (51%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  K+K + ++  K         +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKER-IDHIKLLQYTSQICKGMEYL--- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHR++ T NIL++ +   KI DFGL +    D+ +      G
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 178

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              R IHRD+   N+LL      KI DFGL R    +  H
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              R IHRD+   N+LL      KI DFGL R    +  H
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              R IHRD+   N+LL      KI DFGL R    +  H
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 127
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              R IHRD+   N+LL      KI DFGL R    +  H
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 127
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              R IHRD+   N+LL      KI DFGL R    +  H
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 12/167 (7%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  +   + ++  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
              R IHRD+ T NIL++ +   KI DFGL +    D+        G
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 127
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              R IHRD+   N+LL      KI DFGL R    +  H
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V +G       VAVK +I       DEFF E   +  + H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           S E P   +V EY+ N  L  ++  ++  K L  ++   +     EG+A+L      + I
Sbjct: 73  SKEYP-IYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFI 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           HRD+   N L+D+D   K++DFG+ R +  D  +VS+ 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSV 163

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 387 RDLRAANILVGENLVCKVADFGLAR 411

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G TV+V     K  + +  + +D+F  EVN + S++H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +       LL    R+ +    AEG+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              R IHRD+   N+LL      KI DFGL R    +  H
Sbjct: 132 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 250 EEP-IYIVGEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR 328

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR 162

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 83/161 (51%), Gaps = 20/161 (12%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G TV    A+K L   T    + EF +E  +++S++H +LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +  P   LV + +P+  L +++ +         LLNW       +  A+G+ YL
Sbjct: 104 RLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 156
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
               E R++HRD+   N+L+      KI DFGLAR    D 
Sbjct: 157 ---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 194

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
           A N     K++G+GG G V+ G L  + + VA+K LI    +          EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +S++ H N+VKL G     P   +V E+VP   L   + DK     + W+ +  ++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTPKIADFGLAR 421
            G+ Y+   +   I+HRD+++ NI L     +     K+ADFGL++
Sbjct: 133 LGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR 162

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 83/161 (51%), Gaps = 20/161 (12%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P G TV    A+K L   T    + EF +E  +++S++H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT----KLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +  P   LV + +P+  L +++ +         LLNW       +  A+G+ YL
Sbjct: 81  RLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 133
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
               E R++HRD+   N+L+      KI DFGLAR    D 
Sbjct: 134 ---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 171

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFL--KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 135 RDLRAANILVGENLVCKVADFGLAR 159

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 73  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 128 DLRAANILVGENLVCKVADFGLAR 151

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 75  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 130 DLRAANILVGENLVCKVADFGLAR 153

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           E P   +V EY+   SL  F+  K +T K L   +  ++    A G+AY+        +H
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFL--KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+ ++   K+ADFGLAR
Sbjct: 135 RDLRAANILVGENLVCKVADFGLAR 159

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR 162

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR 162

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V+MG+    T VA+K L   T    + F  E  ++  ++H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F+ D  + + L      ++    A G+AY+        IH
Sbjct: 74  SEEP-IYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++++NIL+      KIADFGLAR
Sbjct: 129 RDLRSANILVGNGLICKIADFGLAR 153

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+  +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLAAANILVGENLVCKVADFGLAR 162

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+    L  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR 162

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 18/183 (9%)
Query: 268 KATNYFNPS-----KKLGQGGAGSVYMGSLPNGT-----TVAVKRLI--FNTRQWVDEFF 315
           K T   +PS     K +G G  G VY G L   +      VA+K L   +  +Q VD F 
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FL 94
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E  ++    H N+++L G   +    +++ EY+ N +LD+F+ +K+     +  +   +
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGM 152
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           + G A G+ YL   +    +HRD+   NIL++ +   K++DFGL+R    D     T   
Sbjct: 153 LRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 436 GTL 438
           G +
Sbjct: 210 GKI 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 90/188 (47%), Gaps = 15/188 (7%)
Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQW 310
           TSM  S  S  Y+  E          KLG G  G VY G       TVAVK L  +T + 
Sbjct: 1   TSMDPS--SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN 370
           V+EF  E  ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---N 114
Query: 371 KRFNIILGT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               + + T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D  
Sbjct: 115 AVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-- 169
Query: 429 HVSTAVAG 436
              TA AG
Sbjct: 170 -TYTAHAG 176

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 336 SIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             + P   ++ E++   SL  F+  D+   + L   K  +     AEG+A++    +   
Sbjct: 246 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNY 299
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           IHRD++ +NIL+      KIADFGLAR  A
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGA 329

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 90/188 (47%), Gaps = 15/188 (7%)
Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQW 310
           TSM  S  S  Y+  E          KLG G  G VY G       TVAVK L  +T + 
Sbjct: 1   TSMDPS--SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWN 370
           V+EF  E  ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---N 114
Query: 371 KRFNIILGT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               + + T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D  
Sbjct: 115 AVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-- 169
Query: 429 HVSTAVAG 436
              TA AG
Sbjct: 170 -TYTAHAG 176

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+    L  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 84  EEP-IYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGLAR
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR 162

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 18/166 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
           A N     K++G+GG G V+ G L  + + VA+K LI    +          EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +S++ H N+VKL G     P   +V E+VP   L   + DK     + W+ +  ++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDK--DFTP---KIADFGLAR 421
            G+ Y+   +   I+HRD+++ NI L    +  P   K+ADFG ++
Sbjct: 133 LGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 336 SIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             + P   ++ E++   SL  F+  D+   + L   K  +     AEG+A++    +   
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNY 305
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF 423
           IHRD++ +NIL+      KIADFGLAR  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI 334

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 114
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   +  G  +GLAYLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 171
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
             +   +IHRD+K  NILL +    K+ DFG A   A     V T 
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q    W D    EV  +  + H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N ++  GC +    + LV EY    + D     K   K L   +   +  G  +GLAYLH
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH 132
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
             +   +IHRD+K  NILL +    K+ DFG A   A     V T 
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 175

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 2   MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 60
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 117
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA A
Sbjct: 118 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPA 171
Query: 436 G 436
           G
Sbjct: 172 G 172

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 3   MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 118
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA A
Sbjct: 119 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPA 172
Query: 436 G 436
           G
Sbjct: 173 G 173

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 18/166 (10%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
           A N     K++G+GG G V+ G L  + + VA+K LI    +          EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +S++ H N+VKL G     P   +V E+VP   L   + DK     + W+ +  ++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTPKIADFGLAR 421
            G+ Y+   +   I+HRD+++ NI L     +     K+ADF L++
Sbjct: 133 LGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 81/155 (52%), Gaps = 8/155 (5%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           ++    F+  +KLG+G  GSVY       G  VA+K++   +   + E   E++++   +
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCD 82
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
             ++VK  G   +  +  +V EY    S+   I  +NKT  L  ++   I+  T +GL Y
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEY 140
Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           LH     R IHRDIK  NILL+ +   K+ADFG+A
Sbjct: 141 LHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 336 SIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             + P   ++ E++   SL  F+  D+   + L   K  +     AEG+A++    +   
Sbjct: 79  VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNY 132
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF 423
           IHRD++ +NIL+      KIADFGLAR  
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVI 161

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 3   MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 118
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA A
Sbjct: 119 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHA 172
Query: 436 G 436
           G
Sbjct: 173 G 173

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 280 GQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
            +G  G V+   L N   VAVK      +Q W +E+  EV  +  ++H+N+++ +G    
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 339 GP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH------- 387
           G     +  L+  +    SL  F+    K  +++WN+  +I    A GLAYLH       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
            G +  I HRDIK+ N+LL  + T  IADFGLA  F A ++
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 65
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + 
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMA 122
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 123 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAG 176

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 116
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA A
Sbjct: 117 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHA 170
Query: 436 G 436
           G
Sbjct: 171 G 171

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 276 SKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
            ++LG+G  G V++    N         VAVK L   +     +F  E  L+++++H+++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI----------FDKNKTKLLNWNKRFNIILGT 379
           VK  G  +EG   ++V+EY+ +  L++F+           + N    L  ++  +I    
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A G+ YL   +    +HRD+ T N L+ ++   KI DFG++R
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 116
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA A
Sbjct: 117 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHA 170
Query: 436 G 436
           G
Sbjct: 171 G 171

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 61
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + 
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---NAVVLLYMA 118
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 119 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAG 172

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 278 KLGQGGAGSVYMG--SLPNGTTVAVKRLIFNTRQ---WVDEFFNEVNLISSIEHKNLVKL 332
           KLG GG  +VY+   ++ N   VA+K +    R+    +  F  EV+  S + H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +    E     LV EY+   +L ++I        L+ +   N      +G+ + H   + 
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DM 130
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           RI+HRDIK  NIL+D + T KI DFG+A+  +      +  V GT+
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 64
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + 
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMA 121
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 122 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 175

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGLAR    D     T   G +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 65
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + + 
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMA 122
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 123 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 176

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   N    + + T  +  + YL    +   
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQISSAMEYL---EKKNF 134
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 173

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   N    + + T  +  + YL    +   
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYMATQISSAMEYL---EKKNF 145
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 184

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           KLGQG  G V+MG+    T VA+K L        + F  E  ++  + H+ LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           E P   +V EY+   SL  F+      K L   +  ++    A G+AY+        +HR
Sbjct: 251 EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D++ +NIL+ ++   K+ADFGL R
Sbjct: 306 DLRAANILVGENLVCKVADFGLGR 329

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 28/170 (16%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFN 316
           KY+ LEK          +G+G  G VY      G  VA+KR+  +     DE        
Sbjct: 22  KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++L+  + H N+V L+   I     L LV+E++  + L + + D+NKT L +   +  I
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQD--SQIKI 123
Query: 376 IL-GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
            L     G+A+ H   + RI+HRD+K  N+L++ D   K+ADFGLAR F 
Sbjct: 124 YLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K +   +    D+F  E  ++  + H  LV+L G  
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 146
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L+ ++   K++DFG+ R    D+   ST 
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 183

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 28/170 (16%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFN 316
           KY+ LEK          +G+G  G VY      G  VA+KR+  +     DE        
Sbjct: 22  KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++L+  + H N+V L+   I     L LV+E++  + L + + D+NKT L +   +  I
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQD--SQIKI 123
Query: 376 IL-GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
            L     G+A+ H   + RI+HRD+K  N+L++ D   K+ADFGLAR F 
Sbjct: 124 YLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 32  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 148
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 131
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 42  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 158
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   +    + + T  +  + YL    +   
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQISSAMEYL---EKKNF 130
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAG 169

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL R    D     T   G +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---SAVVLLYMA 117
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 118 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 171

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV---SAVVLLYMA 117
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 118 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 171

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMA 117
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 118 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 171

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 6/156 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIH 126
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           RD+   N L+ ++   K++DFG+ R    D+   ST
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   +    + + T  +  + YL    +   
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQISSAMEYL---EKKNF 130
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAG 169

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 65
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + 
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMA 122
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 123 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 176

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + + 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMA 117
Query: 379 T--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           T  +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D     TA AG
Sbjct: 118 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG 171

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNL--ISSIEHKNLVKLL--- 333
           +G+G  G+VY GSL +   VAVK   F  RQ    F NE N+  +  +EH N+ + +   
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 334 -GCSIEGP-ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH---- 387
              + +G  E LLV EY PN SL +++         +W     +      GLAYLH    
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 388 --GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                +  I HRD+ + N+L+  D T  I+DFGL+     +R
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--AEGLAYLHGGSETRI 394
              P   ++ E++   +L  ++ + N+ ++   +    + + T  +  + YL    +   
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYMATQISSAMEYL---EKKNF 130
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           IHRD+   N L+ ++   K+ADFGL+R    D
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 247 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 305
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   N    + +
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---NAVVLLYM 362
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHR++   N L+ ++   K+ADFGL+R    D     TA A
Sbjct: 363 ATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHA 416
Query: 436 G 436
           G
Sbjct: 417 G 417

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 279 LGQGGAG-SVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G ++ +     G  + +K LI    +    F  EV ++  +EH N++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           +      + EY+   +L   I  K+      W++R +     A G+AYLH      IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 398 DIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           D+ + N L+ ++    +ADFGLAR    ++T 
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 126
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L+ ++   K++DFG+ R    D+   ST 
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 163

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L G  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 129
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L+ ++   K++DFG+ R    D+   ST 
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV+E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 124
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L+ ++   K++DFG+ R    D+   ST 
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 8/149 (5%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 139
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFG 418
               +IHRDIK+ +ILL  D   K++DFG
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFG 165

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
            + +G G  G V  G L         VA+K L +  T +   +F  E +++   +H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L G    G   ++V E++ N +LD F+  +         +   ++ G A G+ YL   +
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYL---A 162
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +   +HRD+   NIL++ +   K++DFGL+R    D   V T   G +
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI 210

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 8/149 (5%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 135
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFG 418
               +IHRDIK+ +ILL  D   K++DFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFG 161

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 8/149 (5%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 146
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFG 418
               +IHRDIK+ +ILL  D   K++DFG
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFG 172

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 8/149 (5%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y +   K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           V++    + G E  +V E++   +L   +        +N  +   + L   + L+ LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 144
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFG 418
               +IHRDIK+ +ILL  D   K++DFG
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFG 170

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 13/152 (8%)
Query: 277 KKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVK 331
           + +G+G  G VY G       N    A+K L   T  Q V+ F  E  L+  + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 332 LLGCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           L+G  +  PE L  ++  Y+ +  L QFI    +   +     F   L  A G+ YL   
Sbjct: 87  LIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG--LQVARGMEYL--- 140
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +E + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 26/177 (14%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF--------------NTRQWVDEFFNEVNLIS 322
           +KLG G  G V +    NG +    ++I               N  ++ +E +NE++L+ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 323 SIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           S++H N++KL     +     LV E+     L + I +++K    +     NI+     G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSG 158
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLARCFAAD---RTHVSTA 433
           + YLH   +  I+HRDIK  NILL+        KI DFGL+  F+ D   R  + TA
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 242 EDRNN-LGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP----NGT 296
           ED N  +  +A  ++ SC+     T+E+          +G G  G V  G L        
Sbjct: 6   EDPNQAVHEFAKEIEASCI-----TIERV---------IGAGEFGEVCSGRLKLPGKREL 51
Query: 297 TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD 355
            VA+K L +  T +   +F  E +++   +H N++ L G   +    ++V EY+ N SLD
Sbjct: 52  PVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 111
Query: 356 QFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA 415
            F+  K         +   ++ G + G+ YL   S+   +HRD+   NIL++ +   K++
Sbjct: 112 TFL--KKNDGQFTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 166
Query: 416 DFGLARCFAADRTHVSTAVAGTL 438
           DFGL+R    D     T   G +
Sbjct: 167 DFGLSRVLEDDPEAAYTTRGGKI 189

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V E + N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V + +  + G  VAVK++    +Q  +  FNEV ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  +V E++   +L   +        +N  +   + L     L+YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 397 RDIKTSNILLDKDFTPKIADFG 418
           RDIK+ +ILL  D   K++DFG
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG 186

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +H N+++L G   +    ++V E + N SLD F+  +         +   ++ G A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 15/177 (8%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           ATN  +  K +G G  G V  G   LP+    +VA+K L +  T +   +F  E +++  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAE 381
            +H N+++L G   +    ++V E + N SLD F+   D   T +    +   ++ G A 
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI----QLVGMLRGIAS 129
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           G+ YL   S+   +HRD+   NIL++ +   K++DFGL+R    D     T   G +
Sbjct: 130 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E+V ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 75/142 (52%), Gaps = 8/142 (5%)
Query: 278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+V++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  +V E++   +L   +        +N  +   + L   + L+ LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 397 RDIKTSNILLDKDFTPKIADFG 418
           RDIK+ +ILL  D   K++DFG
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFG 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
           +S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 266
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
             ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ ++   +    + +
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---SAVVLLYM 323
Query: 378 GT--AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
            T  +  + YL    +   IHR++   N L+ ++   K+ADFGL+R    D     TA A
Sbjct: 324 ATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHA 377
Query: 436 G 436
           G
Sbjct: 378 G 378

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 279 LGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLVKL 332
           LG+G   +VY     N    VA+K++    R    +  N     E+ L+  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           L          LV++++     D  +  K+ + +L  +     +L T +GL YLH   + 
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 131
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
            I+HRD+K +N+LLD++   K+ADFGLA+ F +
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 75/142 (52%), Gaps = 8/142 (5%)
Query: 278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V + ++  +G  VAVK++    +Q  +  FNEV ++   +H+N+V++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  +V E++   +L   +        +N  +   + L   + L+ LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 397 RDIKTSNILLDKDFTPKIADFG 418
           RDIK+ +ILL  D   K++DFG
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFG 292

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 11/173 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF-FNEVNLISSIEH 326
           +++ F   +KLG G   +VY G +   G  VA+K +  ++ +        E++L+  ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPN---RSLDQFIFDKNKTKL-LNWNKRFNIILGTAEG 382
           +N+V+L        +  LV+E++ N   + +D          L LN  K F   L   +G
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQG 120
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           LA+ H   E +I+HRD+K  N+L++K    K+ DFGLAR F       S+ V 
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           HRDIK+ NILL  D + K+ DFG       +++  ST V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 8/146 (5%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           S ++G G  G+VY G       V + +++  T +    F NEV ++    H N++  +G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 336 SIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             +     +V ++    SL + +   + K ++    +  +I   TA+G+ YLH  +   I
Sbjct: 101 MTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQGMDYLHAKN---I 153
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLA 420
           IHRD+K++NI L +  T KI DFGLA
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLA 179

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G V++G   N   VA+K +        ++F  E  ++  + H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +E     LV E++ +  L  ++  + +  L        + L   EG+AYL    E  +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L+ ++   K++DFG+ R    D+   ST 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E+V ++ L  F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 166

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++      LP  +   VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-TKL-----------LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F+       KL           L   +   +    
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A G+ YL G      +HRD+ T N L+ +    KI DFG++R
Sbjct: 145 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++      LP  +   VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-TKL-----------LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F+       KL           L   +   +    
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A G+ YL G      +HRD+ T N L+ +    KI DFG++R
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +LG+G  G V++      LP  +   VAVK L   +     +F  E  L++ ++H+++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-TKL-----------LNWNKRFNIILGT 379
             G   EG   L+V+EY+ +  L++F+       KL           L   +   +    
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A G+ YL G      +HRD+ T N L+ +    KI DFG++R
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLLG 334
           K++G+G  G V+MG    G  VAVK + F T +    +F E  +  ++   H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 335 CSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-- 388
             I+G  S     L+ +Y  N SL    +D  K+  L+      +   +  GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 389 ---GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
                +  I HRD+K+ NIL+ K+ T  IAD GLA  F +D   V
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 125 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 89/176 (50%), Gaps = 17/176 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           E   +Y    + +G G  G V  G L       + VA+K L   +  RQ   EF +E ++
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASI 68
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGT 379
           +   EH N+++L G        +++ E++ N +LD F+  +  +  ++   +   ++ G 
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGI 125
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVST 432
           A G+ YL   +E   +HRD+   NIL++ +   K++DFGL+R     ++D T+ S+
Sbjct: 126 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+G+G  G V +    + G  VAVK +    +Q  +  FNEV ++   +H N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           + G E  ++ E++   +L   +        LN  +   +     + LAYLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           RDIK+ +ILL  D   K++DFG     + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKD 194

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L  F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 25  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 81
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 139
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 140 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 86
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 144
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 28  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 84
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 142
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L  F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 51  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 107
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 165
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GL++ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 31  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 87
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 145
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 32  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 88
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 146
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 19/160 (11%)
Query: 272 YFNPSKKLGQG--GAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L  +   Q    +  E++++ ++ 
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 326 HKNLVKLLGCSIE-GPESL-LVYEYVPNRSLDQFIFDKN--KTKLLNWNKRFNIILGTAE 381
           H++++K  GC  + G  SL LV EYVP  SL  ++   +    +LL + ++        E
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CE 145
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYLH       IHRD+   N+LLD D   KI DFGLA+
Sbjct: 146 GMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 32/162 (19%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           +K+G+G  G VY      G T A+K++        DE        E++++  ++H N+VK
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN---------WNKRFNIILGTAEG 382
           L          +LV+E++          D++  KLL+           K F  +L    G
Sbjct: 65  LYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           +AY H   + R++HRD+K  N+L++++   KIADFGLAR F 
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 52  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 108
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 166
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 167 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L +F+ D +    +      + +    +GLA+ H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 32/162 (19%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           +K+G+G  G VY      G T A+K++        DE        E++++  ++H N+VK
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN---------WNKRFNIILGTAEG 382
           L          +LV+E++          D++  KLL+           K F  +L    G
Sbjct: 65  LYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           +AY H   + R++HRD+K  N+L++++   KIADFGLAR F 
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 32/162 (19%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
           +K+G+G  G VY      G T A+K++        DE        E++++  ++H N+VK
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN---------WNKRFNIILGTAEG 382
           L          +LV+E++          D++  KLL+           K F  +L    G
Sbjct: 65  LYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           +AY H   + R++HRD+K  N+L++++   KIADFGLAR F 
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 32  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 88
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 146
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           YL   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L +F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 126 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           HRDIK+ NILL  D + K+ DFG       +++  S  V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV 177

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           HRDIK+ NILL  D + K+ DFG       +++  S  V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV 177

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           HRDIK+ NILL  D + K+ DFG       +++  S  V
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV 178

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           E   +Y    + +G G  G V  G L       + VA+K L   +  RQ   EF +E ++
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASI 70
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGT 379
           +   EH N+++L G        +++ E++ N +LD F+  +  +  ++   +   ++ G 
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGI 127
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVST 432
           A G+ YL   +E   +HRD+   NIL++ +   K++DFGL+R     ++D T  S+
Sbjct: 128 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS 180

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +K+GQG +G+VY    +  G  VA++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
            + G E  +V EY+   SL   + +      ++  +   +     + L +LH     ++I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           HR+IK+ NILL  D + K+ DFG       +++  ST V
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 178

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 24/175 (13%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
            K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGL 383
           + L G   +    +++ EY+ N SLD F+  KN       + RF +I       G   G+
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKN-------DGRFTVIQLVGMLRGIGSGM 129
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFG++R    D     T   G +
Sbjct: 130 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK            F  E ++++ + H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N+L+ +D   K++DFGL +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G GG G VY  +   G  VAVK    +      Q ++    E  L + ++H N++ L G
Sbjct: 15  IGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTK--LLNWNKRFNIILGTAEGLAYLHGGSET 392
             ++ P   LV E+     L++ +  K      L+NW  +       A G+ YLH  +  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAIV 127
Query: 393 RIIHRDIKTSNILL-----DKDFTP---KIADFGLAR 421
            IIHRD+K+SNIL+     + D +    KI DFGLAR
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 32/179 (17%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNL 329
           + +G+G  G V+    P        T VAVK L       +  +F  E  L++  ++ N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL---------------------LN 368
           VKLLG    G    L++EY+    L++F+   +   +                     L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAAD 426
             ++  I    A G+AYL   SE + +HRD+ T N L+ ++   KIADFGL+R  ++AD
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 24/175 (13%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
            K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 92
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGL 383
           + L G   +    +++ EY+ N SLD F+  KN       + RF +I       G   G+
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKN-------DGRFTVIQLVGMLRGIGSGM 144
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFG++R    D     T   G +
Sbjct: 145 KYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 196

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 24/175 (13%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
            K +G G  G V  G L         VA+K L   +  +Q  D F +E +++   +H N+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL------GTAEGL 383
           + L G   +    +++ EY+ N SLD F+  KN       + RF +I       G   G+
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKN-------DGRFTVIQLVGMLRGIGSGM 123
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            YL   S+   +HRD+   NIL++ +   K++DFG++R    D     T   G +
Sbjct: 124 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 175

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 8/146 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK +  +       F  E ++++ + H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N+L+ +D   K++DFGL +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L  F+ D +    +      + +    +GLA+ H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 83/160 (51%), Gaps = 19/160 (11%)
Query: 272 YFNPSKKLGQG--GAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L  +   Q    +  E++++ ++ 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFDKN--KTKLLNWNKRFNIILGTAE 381
           H++++K  GC   +G +SL LV EYVP  SL  ++   +    +LL + ++        E
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CE 128
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYLH       IHR++   N+LLD D   KI DFGLA+
Sbjct: 129 GMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K++  +T           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ +  L  F+ D +    +      + +    +GLA+ H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK            F  E ++++ + H NLV+LLG  
Sbjct: 18  QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 130
Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N+L+ +D   K++DFGL +
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTT------VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
            ++LG+G  G V++    N +       VAVK L   T     +F  E  L+++++H+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------------LNWNKRFNII 376
           VK  G   +G   ++V+EY+ +  L++F+       +             L  ++  +I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              A G+ YL   +    +HRD+ T N L+  +   KI DFG++R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+ ++  +T           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+ ++  +T           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++ ++ L +F+ D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F    RT+    V
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F T   +  V+ +   EV + S + H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA--------TYITELANAL 125
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL  +   KIADFG +    + R    T + GTL
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTL 174

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V +G    G  VAVK            F  E ++++ + H NLV+LLG  
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 337 IEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           +E    L +V EY+   SL  ++  + ++ +L  +      L   E + YL G +    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FV 124
Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N+L+ +D   K++DFGL +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G VY G  L N   +A+K +     ++      E+ L   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 338 EGPESLLVYEYVPNRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           E     +  E VP  SL   +  K      N+  +  + K+        EGL YLH   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLH---D 140
Query: 392 TRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAA 425
            +I+HRDIK  N+L++      KI+DFG ++  A 
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 83/160 (51%), Gaps = 19/160 (11%)
Query: 272 YFNPSKKLGQG--GAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L  +   Q    +  E++++ ++ 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFDKN--KTKLLNWNKRFNIILGTAE 381
           H++++K  GC   +G +SL LV EYVP  SL  ++   +    +LL + ++        E
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CE 128
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYLH       IHR++   N+LLD D   KI DFGLA+
Sbjct: 129 GMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 69
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 130 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVD 312
           F  +  E A      S++LGQG  G VY G           T VA+K +    + R+ + 
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI- 64
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTK 365
           EF NE +++      ++V+LLG   +G  +L++ E +         RSL   + +     
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             + +K   +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 92  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 148
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 206
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LG+G  G VY G  L N   +A+K +     ++      E+ L   ++HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 338 EGPESLLVYEYVPNRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           E     +  E VP  SL   +  K      N+  +  + K+        EGL YLH   +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLH---D 126
Query: 392 TRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAA 425
            +I+HRDIK  N+L++      KI+DFG ++  A 
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 161

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 38  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 94
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 152
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 140 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 34  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 90
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 147
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 31  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 87
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 145
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 133 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
           +FN  + +G+G  G VY G+L   +G  +  AVK L  I +  + V +F  E  ++    
Sbjct: 34  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 90
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++ LLG  +    S L+V  Y+ +  L  FI  +N+T            L  A+G+ 
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMK 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +L   +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 73
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 134 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 73
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 134 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 133 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VA+K  I +  Q     + + F EV ++  + H N+VK
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L L+ EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 79  LFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH--- 131
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           + RI+HRD+K  N+LLD D   KIADFG +  F  
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 64
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 125 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 127 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VA+K  I +  Q     + + F EV ++  + H N+VK
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 75
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L L+ EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 76  LFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH--- 128
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           + RI+HRD+K  N+LLD D   KIADFG +  F  
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 163

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 333 LGCSIEG--PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S     PE  LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 129
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
             R +HRD+   NIL++ +   KIADFGLA+    D+
Sbjct: 130 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++  KNK K+ N  ++    +   +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL-- 142
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           GS  + +HRD+   N+L++ +   KI DFGL +    D+
Sbjct: 143 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++  KNK K+ N  ++    +   +G+ YL  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL-- 130
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           GS  + +HRD+   N+L++ +   KI DFGL +    D+
Sbjct: 131 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 168

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 162 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 140 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 36/189 (19%)
Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQ-----GGAGSVYMGSLPN--GTTVAVKRL--I 304
           M KS +  ++ ++E A + F   K+  Q      GA  +   +     G  VAVK+L   
Sbjct: 1   MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP 60
Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF------- 357
           F  +      + E+ L+  + HKN++ LL              + P ++L++F       
Sbjct: 61  FQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVM 108
Query: 358 -IFDKNKTKLLNW---NKRFNIILGTAE-GLAYLHGGSETRIIHRDIKTSNILLDKDFTP 412
            + D N  ++++    ++R + +L     G+ +LH      IIHRD+K SNI++  D T 
Sbjct: 109 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165
Query: 413 KIADFGLAR 421
           KI DFGLAR
Sbjct: 166 KILDFGLAR 174

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F T   +  V+ +   EV + S + H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA--------TYITELANAL 125
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL  +   KIADFG +
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S   G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 145
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             R +HRD+   NIL++ +   KIADFGLA+    D+ +      G 
Sbjct: 146 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S   G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             R +HRD+   NIL++ +   KIADFGLA+    D+ +      G 
Sbjct: 134 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 179

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   KK+G+G    VY  + L +G  VA+K++    + + +   D    E++L+  + H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 92
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAY 385
           N++K     IE  E  +V E      L + I  F K K +L+     +   +     L +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALEH 151
Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           +H     R++HRDIK +N+ +      K+ D GL R F++ +T  + ++ GT
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGT 199

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
            LY  SMK+          E  T   NP        +LG G  G VY       + +A  
Sbjct: 17  NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           ++I   + + ++++  E+++++S +H N+VKLL          ++ E+    ++D  + +
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             +   L  ++   +   T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++
Sbjct: 128 LERP--LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            G S   G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL  GS
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 132
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             R +HRD+   NIL++ +   KIADFGLA+    D+ +      G 
Sbjct: 133 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 178

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
            LY  SMK+          E  T   NP        +LG G  G VY       + +A  
Sbjct: 17  NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           ++I   + + ++++  E+++++S +H N+VKLL          ++ E+    ++D  + +
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             +   L  ++   +   T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++
Sbjct: 128 LERP--LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
            LY  SMK+          E  T   NP        +LG G  G VY       + +A  
Sbjct: 17  NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD 360
           ++I   + + ++++  E+++++S +H N+VKLL          ++ E+    ++D  + +
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             +   L  ++   +   T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++
Sbjct: 128 LERP--LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 94  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 94  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 122
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG + C A   +   T ++GTL
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-CHAP--SSRRTTLSGTL 171

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 94  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 87  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 79  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 83  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 86  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 9/138 (6%)
Query: 293 PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           P    VA+KR+     Q  +DE   E+  +S   H N+V      +   E  LV + +  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 352 RSLDQFIFD-----KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
            S+   I       ++K+ +L+ +    I+    EGL YLH   +   IHRD+K  NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 407 DKDFTPKIADFGLARCFA 424
            +D + +IADFG++   A
Sbjct: 150 GEDGSVQIADFGVSAFLA 167

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART 175

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
           E A      S++LGQG  G VY G           T VA+K +    + R+ + EF NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNK 371
           +++      ++V+LLG   +G  +L++ E +         RSL   + +       + +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +    A+G+AYL+     + +HRD+   N  + +DFT KI DFG+ R
Sbjct: 127 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  AEG
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 127 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 168

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 26/168 (15%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVY--------EYVPNRSLD--QFIFDK--NKTKLLNWNKRF 373
           KN++ LLG C+ +GP  ++V         EY+  R     +F F+   N  + L+     
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 293 PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
           P    VA+KR+     Q  +DE   E+  +S   H N+V      +   E  LV + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 352 RSLDQFIFD-----KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
            S+   I       ++K+ +L+ +    I+    EGL YLH   +   IHRD+K  NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 407 DKDFTPKIADFGLARCFAA----DRTHVSTAVAGT 437
            +D + +IADFG++   A      R  V     GT
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL--PNGTT--VAVK--RLIFNTRQWVD 312
           L  K E +    N     K LG+G  GSV  G+L   +GT+  VAVK  +L  ++++ ++
Sbjct: 22  LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEG-----PESLLVYEYVPNRSLDQFI-FDKNKT-- 364
           EF +E   +    H N+++LLG  IE      P+ +++  ++    L  ++ + + +T  
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           K +        ++  A G+ YL   S    +HRD+   N +L  D T  +ADFGL++
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 16/167 (9%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVD-EFFNEVNLI---S 322
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N  + +      EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
           + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
               GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 33/186 (17%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V      ++      TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                 +     ++G+ YL   +E +++HRD+   NIL+ +    KI+DFGL+R    + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 428 THVSTA 433
           ++V  +
Sbjct: 205 SYVKRS 210

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +          PN  T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++  +             N  + L+    
Sbjct: 135 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART 175

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 272 YFNPSKKLGQG--GAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L      Q    +  E+ ++ ++ 
Sbjct: 9   YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           H+++VK  GC   +G +S+ LV EYVP  SL  ++        +   +         EG+
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGM 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           AYLH       IHR +   N+LLD D   KI DFGLA+
Sbjct: 125 AYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 30/160 (18%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           K +G G  G V        G  VAVK+L   F  +      + E+ L+  + HKN++ LL
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 334 GCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTAE- 381
                         + P ++L++F        + D N  ++++    ++R + +L     
Sbjct: 88  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 135
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 81  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 128
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 129 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART 168

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 272 YFNPSKKLGQG--GAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIE 325
           Y    + LG+G  G  S+Y     N   G  VAVK L      Q    +  E+ ++ ++ 
Sbjct: 10  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 69
Query: 326 HKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           H+++VK  GC   +G +S+ LV EYVP  SL  ++        +   +         EG+
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGM 125
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           AYLH       IHR +   N+LLD D   KI DFGLA+
Sbjct: 126 AYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 173

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 173

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+    N   +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     ++IHRDIK  N+LL      KIADFG +    + R     A+ GTL
Sbjct: 122 SYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTL 170

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 10/153 (6%)
Query: 279 LGQGGAGSVYMG--SLPNGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +G G  G V  G   LP      VA+K L    T +   +F +E +++   +H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +    +++ E++ N SLD F+  +         +   ++ G A G+ YL   ++  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            +HRD+   NIL++ +   K++DFGL+R    D
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 111 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+
Sbjct: 164 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 204

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 175

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 170

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 125
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 174

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R     A+ GTL
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTL 173

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R     A+ GTL
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTL 170

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 16/167 (9%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVD-EFFNEVNLI---S 322
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N  + +      EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
           + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
               GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 16/167 (9%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVD-EFFNEVNLI---S 322
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N  + +      EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 323 SIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIIL 377
           + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
               GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 15/154 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           +  I+HRD+K  N+LLD D   KIADFG +  F 
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTL 170

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 120
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 121 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 169

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
           KLG+G   +VY G S      VA+K +     +        EV+L+  ++H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 336 SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I   +SL LV+EY+ ++ L Q++ D     ++N +     +     GLAY H     ++
Sbjct: 69  -IHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARC 422
           +HRD+K  N+L+++    K+ADFGLAR 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARA 149

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 175

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIIL-GT 379
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 79/187 (42%), Gaps = 24/187 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+  + K+++L  +  F
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAF 154
Query: 374 NIILGTAEGLAYLHGGSET----------RIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
            I   TA     LH  S+             IHRD+   N+LL      KI DFGLAR  
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 424 AADRTHV 430
             D  ++
Sbjct: 215 MNDSNYI 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           +  I+HRD+K  N+LLD D   KIADFG +  F
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNLVKLLG 334
           KLG+G  G VY         TVA+KR+     +         EV+L+  ++H+N+++L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                    L++EY  N  L +++ DKN    +   K F  +     G+ + H     R 
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSF--LYQLINGVNFCHS---RRC 153
Query: 395 IHRDIKTSNILL---DKDFTP--KIADFGLARCF 423
           +HRD+K  N+LL   D   TP  KI DFGLAR F
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 15/154 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           +  I+HRD+K  N+LLD D   KIADFG +  F 
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKL 332
           K +G+G    V +   +  G  VAV R+I  T+     + + F EV ++  + H N+VKL
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   +
Sbjct: 79  FEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH---Q 131
Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
             I+HRD+K  N+LLD D   KIADFG +  F 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTL 170

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR---QWVDEFFNEVNLISSIEHKNLVKL 332
           K +G+G    V +   +  G  VAV R+I  T+     + + F EV ++  + H N+VKL
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   +
Sbjct: 79  FEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH---Q 131
Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
             I+HRD+K  N+LLD D   KIADFG +  F 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 138
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 139 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 187

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTL 170

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG+G    VY   S+  G  VA+K +          V    NEV +   ++H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
              +     LV E   N  +++++  KN+ K  + N+  + +     G+ YLH      I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHSHG---I 133
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLA 420
           +HRD+  SN+LL ++   KIADFGLA
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTL 175

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 61/112 (54%), Gaps = 7/112 (6%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL---DQ--FIFDKNKTKL 366
           D+F NE+ +I+ I+++  +   G      E  ++YEY+ N S+   D+  F+ DKN T  
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG 418
           +       II       +Y+H   E  I HRD+K SNIL+DK+   K++DFG
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFG 197

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIIHLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V      ++      TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 +     ++G+ YL   +E +++HRD+   NIL+ +    KI+DFGL+R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVPN----RSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     + L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 175

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 122
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTL 171

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART 175

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F  +        +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTL 170

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIITLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 118
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 119 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 167

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 80
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R
Sbjct: 141 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 131 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 19/169 (11%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYM----GSLPNGTTVAVKRLI-FNTRQWVDEF-FN 316
           ++++EK  N       LG  G GS  M     +   G  VA+K+ +  +  + V +    
Sbjct: 21  FQSMEKYEN-------LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ L+  + H+NLV LL    +     LV+E+V +  LD      N    L++      +
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYL 130
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
                G+ + H  +   IIHRDIK  NIL+ +    K+ DFG AR  AA
Sbjct: 131 FQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 280 GQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
            +G  G V+   L N   VAVK      +Q W  E   E+     ++H+NL++ +     
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKR 80
Query: 339 GP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG------ 388
           G     E  L+  +    SL  ++    K  ++ WN+  ++    + GL+YLH       
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 389 --GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
             G +  I HRD K+ N+LL  D T  +ADFGLA  F
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRF 173

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 134 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 175

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 131 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G AG V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAAGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 147
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIADFG +    + R    T + GTL
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 196

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 78
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R
Sbjct: 139 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 34/163 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 124 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 77/184 (41%), Gaps = 22/184 (11%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 88
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-------FDKNKTKL 366
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+        DK   + 
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           L      +     A+G+A+L   +    IHRD+   N+LL      KI DFGLAR    D
Sbjct: 149 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 205
Query: 427 RTHV 430
             ++
Sbjct: 206 SNYI 209

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HRD+   N ++  DFT KI DFG+ R
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLV 330
            K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+V
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 331 KLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           KL    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H  
Sbjct: 78  KLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCH-- 131
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
            +  I+HRD+K  N+LLD D   KIADFG +  F  
Sbjct: 132 -QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTV 166

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 83  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 136 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 177

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 133 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 77/184 (41%), Gaps = 22/184 (11%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-------FDKNKTKL 366
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+        DK   + 
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           L      +     A+G+A+L   +    IHRD+   N+LL      KI DFGLAR    D
Sbjct: 157 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 213
Query: 427 RTHV 430
             ++
Sbjct: 214 SNYI 217

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 126 LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 87  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+
Sbjct: 140 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 180

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F  +        +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N ++++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY   +   G   A K +   + + ++++  E+ ++++ +H  +VKLLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
               +  ++ E+ P  ++D  + + ++   L   +   +     E L +LH     RIIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHS---KRIIH 140
Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RD+K  N+L+  +   ++ADFG++
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 102 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 154
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 155 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 196

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 123
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIE-HKNLVKL 332
           KKLG+G  G V+       G  VAVK++   F         F E+ +++ +  H+N+V L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 333 LGC--SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    +    +  LV++Y+    L   I    +  +L    +  ++    + + YLH G 
Sbjct: 75  LNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
              ++HRD+K SNILL+ +   K+ADFGL+R F   R
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 82/190 (43%), Gaps = 30/190 (15%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+  + K+++L  +  F
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAF 154
Query: 374 NIILGT-------------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            I   T             A+G+A+L   +    IHRD+   N+LL      KI DFGLA
Sbjct: 155 AIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 421 RCFAADRTHV 430
           R    D  ++
Sbjct: 212 RDIMNDSNYI 221

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 122
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +LG G  G VY   +   G   A K +   + + ++++  E+ ++++ +H  +VKLLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
               +  ++ E+ P  ++D  + + ++   L   +   +     E L +LH     RIIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHS---KRIIH 132
Query: 397 RDIKTSNILLDKDFTPKIADFGLA 420
           RD+K  N+L+  +   ++ADFG++
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 121
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   +IADFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 88  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 147 VSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 126 LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 90  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 149 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 93  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 152 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 33/174 (18%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V      ++      TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI---------------------FDKNKTKLL 367
           +KL G CS +GP  LL+ EY    SL  F+                      D    + L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 +     ++G+ YL   +E  ++HRD+   NIL+ +    KI+DFGL+R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 20/163 (12%)
Query: 277 KKLGQGGAGSVYMG-SLPNG----TTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G  +P+G      VA+K L  NT    + E  +E  +++ +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYL 386
           +LLG  +     L V + +P   L   + +         LLNW       +  A+G++YL
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYL 135
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
               + R++HRD+   N+L+      KI DFGLAR    D T 
Sbjct: 136 E---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 26/168 (15%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLV--------YEYVPNRSLD--QFIFDKNKT--KLLNWNKRF 373
           KN++ LLG C+ +GP  ++V         EY+  R     ++ +D N+   + + +    
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI-----------FDKNKT--KLLNWNKR 372
           KN++ LLG C+ +GP  ++V EY    +L +++           +D N+   + + +   
Sbjct: 147 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRL-IFNTRQWVDEF----FNEVNLI- 321
           AT+ + P  ++G G  G+VY    P+ G  VA+K + + N              EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 322 --SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
              + EH N+V+L+  C+    +      LV+E+V ++ L  ++ DK     L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           ++     GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 88
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 89  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 81
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 82  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 123
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIA+FG +    + R    T + GTL
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTL 172

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 132
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +I+HRD+K  N+LLD+    KIADFGL+
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLS 160

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 131
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +I+HRD+K  N+LLD+    KIADFGL+
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLS 159

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 26/168 (15%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L  + T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLV--------YEYVPNRSLD--QFIFDKNKT--KLLNWNKRF 373
           KN++ LLG C+ +GP  ++V         EY+  R     ++ +D N+   + + +    
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +     A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 81  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 81
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 82  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 124
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +Y H     R+IHRDIK  N+LL      KIA+FG +    + R    T + GTL
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTL 173

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 12/165 (7%)
Query: 279 LGQGGAGSVYMGS-LPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+G  G V   +  P G  VA+K++  F+   +      E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 337 IEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           I+ P+S   +   Y+    +   +     T++L+ +     I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAG 436
           IHRD+K SN+L++ +   K+ DFGLAR     AAD +  +   +G
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 83/167 (49%), Gaps = 12/167 (7%)
Query: 279 LGQGGAGSVYMGS-LPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+G  G V   +  P G  VA+K++  F+   +      E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 337 IEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           I+ P+S   +   Y+    +   +     T++L+ +     I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAGTL 438
           IHRD+K SN+L++ +   K+ DFGLAR     AAD +  +   +G +
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 35  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 92
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 93  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 140
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 141 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 179

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 88
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 89  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 81
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 82  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 126
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +I+HRD+K  N+LLD+    KIADFGL+
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLS 154

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 12/165 (7%)
Query: 279 LGQGGAGSVYMGS-LPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           LG+G  G V   +  P G  VA+K++  F+   +      E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 337 IEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           I+ P+S   +   Y+    +   +     T++L+ +     I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCF---AADRTHVSTAVAG 436
           IHRD+K SN+L++ +   K+ DFGLAR     AAD +  +   +G
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 29  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 86
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P ++L++F        + D N  +++     ++R + +L   
Sbjct: 87  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 134
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 135 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 173

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVPN----RSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     + L +   FD+ +T           I   A  L
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--------TYITELANAL 126
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           K LG+G  G V +      G  VA+K   + +            E++ +  + H +++KL
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                   E ++V EY  N   D +I  ++K       + F  I+   E   Y H     
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE---YCH---RH 122
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +I+HRD+K  N+LLD+    KIADFGL+
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLS 150

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV +   + H N+VK
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVK 77
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++    + K      +F  I+   +   Y H   
Sbjct: 78  LFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCH--- 130
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           +  I+HRD+K  N+LLD D   KIADFG +  F
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFSNEF 163

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 37/183 (20%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 25  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A 
Sbjct: 129 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 426 DRT 428
           + T
Sbjct: 185 EMT 187

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 15  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 127
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 73/175 (41%), Gaps = 31/175 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLV 330
           F P + LG+GG G V+   +  +    A+KR+    R+   E    EV  ++ +EH  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 331 KLLGCSIE-------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNW-NKR---------- 372
           +     +E        P S  VY Y+  +          K  L +W N R          
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLC-------RKENLKDWMNGRCTIEERERSV 119
Query: 373 -FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
             +I L  AE + +LH      ++HRD+K SNI    D   K+ DFGL      D
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 89  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VAVK  I +  Q     + + F EV ++  + H N+VK
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 70
Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L LV EY     +  ++      K      +F  I+   +   Y H   
Sbjct: 71  LFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YCH--- 123
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           +  I+HRD+K  N+LLD D   KIADFG +  F 
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 157

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 32  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 89
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 90  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 176

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 34/162 (20%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V   Y   L     VA+K+L   F  +      + E+ L+  + HKN++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF--------IFDKNKTKLLNW---NKRFNIILGTA 380
           LL              + P +SL++F        + D N  +++     ++R + +L   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 381 E-GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             G+ +LH      IIHRD+K SNI++  D T KI DFGLAR
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F     +  V+ +   EV + S + H N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVP----NRSLDQF-IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L G   +     L+ EY P     R L +   FD+ +T           I   A  L
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANAL 147
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 33/182 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A +
Sbjct: 130 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 427 RT 428
            T
Sbjct: 186 MT 187

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 33/182 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A +
Sbjct: 130 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 427 RT 428
            T
Sbjct: 186 MT 187

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 216 VLSTTAFLMLSLFAAYAA-YARLSKM-KEDRNNLGLYATSMKKSCLSFKYETLEKATNYF 273
           V S  A  + SL   +++  A+L ++  E  +N G+  T   K      YE  E+  ++ 
Sbjct: 19  VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREE-VHWM 74
Query: 274 NPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNLV 330
               +LG+G  G V+ M     G   AVK++         E F    L++   +    +V
Sbjct: 75  THQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIV 127
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L G   EGP   +  E +   SL Q I    +   L  ++    +    EGL YLH   
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH--- 181
Query: 391 ETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAAD 426
             RI+H D+K  N+LL  D +   + DFG A C   D
Sbjct: 182 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 218

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ + + + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 105/255 (41%), Gaps = 41/255 (16%)
Query: 180 FNAGCYLRYSTDKFFNHDDETGDDRGSSRLGVMIAIVLSTTAFLMLSLFAAYAAYARLSK 239
            + G + ++S +++  H               +   V S  A  + SL   +AA    S+
Sbjct: 18  LSRGAHEKFSVEEYLVH--------------ALQGSVSSGQAHSLTSLAKTWAARGSRSR 63
Query: 240 MKEDR--NNLGLYATSMKKSCLSFKY-ETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNG 295
               +  +N G+  T   K  + ++Y E +  AT+      +LG+G  G V+ M     G
Sbjct: 64  EPSPKTEDNEGVLLTEKLKP-VDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTG 118
Query: 296 TTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNLVKLLGCSIEGPESLLVYEYVPNRS 353
              AVK++         E F    L++   +    +V L G   EGP   +  E +   S
Sbjct: 119 FQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGS 171
Query: 354 LDQFIFDKNKTKLLNWNKRFNIILGTA-EGLAYLHGGSETRIIHRDIKTSNILLDKDFT- 411
           L Q + ++          R    LG A EGL YLH     RI+H D+K  N+LL  D + 
Sbjct: 172 LGQLVKEQGCLP----EDRALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSH 224
Query: 412 PKIADFGLARCFAAD 426
             + DFG A C   D
Sbjct: 225 AALCDFGHAVCLQPD 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 43/204 (21%)
Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLP 293
            R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV       
Sbjct: 16  PRGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTK 65
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
            G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P 
Sbjct: 66  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 113
Query: 352 RSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           RSL++F  ++        D N      KL + + +F +I     GL Y+H      IIHR
Sbjct: 114 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHR 169
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+K SN+ +++D   KI DFGLAR
Sbjct: 170 DLKPSNLAVNEDCELKILDFGLAR 193

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 43/204 (21%)
Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLP 293
            R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV       
Sbjct: 15  PRGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTK 64
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
            G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P 
Sbjct: 65  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 112
Query: 352 RSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           RSL++F  ++        D N      KL + + +F +I     GL Y+H      IIHR
Sbjct: 113 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHR 168
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+K SN+ +++D   KI DFGLAR
Sbjct: 169 DLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 43/204 (21%)
Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLP 293
            R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV       
Sbjct: 16  PRGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTK 65
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
            G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P 
Sbjct: 66  TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 113
Query: 352 RSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           RSL++F  ++        D N      KL + + +F +I     GL Y+H      IIHR
Sbjct: 114 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHR 169
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+K SN+ +++D   KI DFGLAR
Sbjct: 170 DLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 43/204 (21%)
Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLP 293
            R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV       
Sbjct: 16  PRGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTK 65
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
            G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P 
Sbjct: 66  TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 113
Query: 352 RSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           RSL++F  ++        D N      KL + + +F +I     GL Y+H      IIHR
Sbjct: 114 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHR 169
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+K SN+ +++D   KI DFGLAR
Sbjct: 170 DLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 82
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HR++   N ++  DFT KI DFG+ R
Sbjct: 143 GMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 43/204 (21%)
Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLP 293
            R S M ++R     Y   + K+     +E  E+  N  +P   +G G  GSV       
Sbjct: 15  PRGSHMSQERPTF--YRQELNKTI----WEVPERYQN-LSP---VGSGAYGSVCAAFDTK 64
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
            G  VAVK+L   F +       + E+ L+  ++H+N++ LL              + P 
Sbjct: 65  TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 112
Query: 352 RSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR 397
           RSL++F  ++        D N      KL + + +F +I     GL Y+H      IIHR
Sbjct: 113 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHR 168
Query: 398 DIKTSNILLDKDFTPKIADFGLAR 421
           D+K SN+ +++D   KI DFGLAR
Sbjct: 169 DLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 23  WEVPERYQN-LSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 127 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           ++LGQG  G VY G+  +       T VAVK +    + R+ + EF NE +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPN-------RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +V+LLG   +G  +L+V E + +       RSL     +          +   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+AYL+     + +HR++   N ++  DFT KI DFG+ R
Sbjct: 142 GMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 279 LGQGGAGSVYMG--SLPNGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +G G  G V  G   LP      VA+K L    T +   +F +E +++   +H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   +    +++ E++ N SLD F+  +         +   ++ G A G+ YL   ++  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            +HR +   NIL++ +   K++DFGL+R    D
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDD 162

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K L  G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFG A+   A+ 
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 216 VLSTTAFLMLSLFAAYAAYARLSKMKEDR--NNLGLYATSMKKSCLSFKY-ETLEKATNY 272
           V S  A  + SL   +AA    S+    +  +N G+  T   K  + ++Y E +  AT+ 
Sbjct: 21  VSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKP-VDYEYREEVHWATHQ 79
Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNL 329
                +LG+G  G V+ M     G   AVK++         E F    L++   +    +
Sbjct: 80  L----RLGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRI 128
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA-EGLAYLHG 388
           V L G   EGP   +  E +   SL Q + ++          R    LG A EGL YLH 
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP----EDRALYYLGQALEGLEYLH- 183
Query: 389 GSETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAAD 426
               RI+H D+K  N+LL  D +   + DFG A C   D
Sbjct: 184 --SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH----------- 326
           LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 327 --KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
             +N VK +    +     +  EY  NR+L   I  +N  +    ++ + +     E L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ--QRDEYWRLFRQILEALS 130
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           Y+H      IIHRD+K  NI +D+    KI DFGLA+
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 13  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 125
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 13  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 125
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFG A+   A+
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 23  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 127 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLL 333
           + LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  
Sbjct: 12  QTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   EG    L  EY     L   I         +  + F+ ++    G+ YLHG     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IG 124
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           I HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 18  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 122 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 29  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 84
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 85  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 132
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 133 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L++ + +P   L  ++ +         LLNW       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFG A+   A+
Sbjct: 134 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 174

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
           LG+G  G V + ++   T  AV   I + ++ VD       E+ +   + H+N+VK  G 
Sbjct: 14  LGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             EG    L  EY     L   I         +  + F+ ++    G+ YLHG     I 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG---IGIT 126
Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           HRDIK  N+LLD+    KI+DFGLA  F   +R  +   + GTL
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 24  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 128 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 216 VLSTTAFLMLSLFAAYAA-YARLSKM-KEDRNNLGLYATSMKKSCLSFKYETLEKATNYF 273
           V S  A  + SL   +++  A+L ++  E  +N G+  T   K      YE  E+  ++ 
Sbjct: 5   VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREE-VHWM 60
Query: 274 NPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNLV 330
               ++G+G  G V+ M     G   AVK++         E F    L++   +    +V
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIV 113
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L G   EGP   +  E +   SL Q I    +   L  ++    +    EGL YLH   
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH--- 167
Query: 391 ETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAAD 426
             RI+H D+K  N+LL  D +   + DFG A C   D
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 33/160 (20%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 26/170 (15%)
Query: 277 KKLGQGGAGSVYMGSLPNG--TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL-- 332
           K LG GG G V+  ++ N     VA+K+++    Q V     E+ +I  ++H N+VK+  
Sbjct: 17  KPLGCGGNGLVF-SAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFE 75
Query: 333 ------------LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
                       +G   E     +V EY+     +       +  LL  + R   +    
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARL-FMYQLL 130
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTH 429
            GL Y+H  +   ++HRD+K +N+ ++ +D   KI DFGLAR      +H
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFG A+   A+
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 177

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K L  G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 137 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 20  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 124 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 216 VLSTTAFLMLSLFAAYAA-YARLSKM-KEDRNNLGLYATSMKKSCLSFKYETLEKATNYF 273
           V S  A  + SL   +++  A+L ++  E  +N G+  T   K      YE  E+  ++ 
Sbjct: 21  VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREE-VHWM 76
Query: 274 NPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS--SIEHKNLV 330
               ++G+G  G V+ M     G   AVK++         E F    L++   +    +V
Sbjct: 77  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIV 129
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            L G   EGP   +  E +   SL Q I    +   L  ++    +    EGL YLH   
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH--- 183
Query: 391 ETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAAD 426
             RI+H D+K  N+LL  D +   + DFG A C   D
Sbjct: 184 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFG A+   A+
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 170

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K L  G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           + YL    + R++HRD+   N+L+      KI DFGLA+   A+ 
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 135 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 135 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 130 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 30  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELR 85
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 86  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 134 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 125 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 20/164 (12%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G  V +   I   R+        E  +E  +++S+++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEG 382
            ++ +LLG  +     L+  + +P   L  ++ +         LLNW       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + YL    + R++HRD+   N+L+      KI DFG A+   A+
Sbjct: 132 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 23  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 127 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 19/160 (11%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +      P+   VAVK L  +++ +  +D F  E  +IS   H+N
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQN 109
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           YL    E   IHRDI   N LL         KI DFG+AR
Sbjct: 170 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 17  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 72
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 73  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 120
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 121 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 146 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 129 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 119 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 18  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 122 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 18  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 122 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 24  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 128 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 128 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 24  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 128 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 18  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 122 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 125 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 20  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 124 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 41  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 96
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 97  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 145 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 33/160 (20%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H+N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 336 SIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKLLNWNKRFNIILGTAE 381
                       + P RSL++F  ++        D N      KL + + +F +I     
Sbjct: 100 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 146
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 147 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 13/168 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV--DEFFNEVNLISSIEHKNLVKLLG 334
           +KLG G  G V++    +     V + I   R  V  ++   E+ ++ S++H N++K+  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 335 CSIEGPESLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
              +     +V E       L++ +  + + K L+      ++      LAY H      
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QH 144
Query: 394 IIHRDIKTSNILLDKDFTP----KIADFGLARCFAADRTHVSTAVAGT 437
           ++H+D+K  NIL  +D +P    KI DFGLA  F +D    ST  AGT
Sbjct: 145 VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGT 189

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 134 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 119 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 121 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 119 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 120 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 120 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 119 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 18  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 122 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 134
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L++     K++DFGL+R +  D  + S+ 
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSV 170

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 123
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L++     K++DFGL+R +  D  + S+ 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSV 159

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 127
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L++     K++DFGL+R +  D  + S+ 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSV 163

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L++     K++DFGL+R +  D  + S+ 
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSV 164

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 7/156 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           RD+   N L++     K++DFGL+R +  D  + S+
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSS 163

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
           RD+   N L++     K++DFGL+R +  D  + S+ 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSV 179

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 24/159 (15%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H+ +V+     +
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 338 E-----GPES--------LLVYEYVPNRSLDQFIFDKNKTKLLN--WNKRFNIILGTAEG 382
           E      P +         +  EY  NR+L   I  +N  +  +  W + F  IL   E 
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW-RLFRQIL---EA 128
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L+Y+H      IIHR++K  NI +D+    KI DFGLA+
Sbjct: 129 LSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 6/151 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           K+LG G  G V  G       VA+K +I       DEF  E  ++ ++ H+ LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            +     ++ EY+ N  L  ++  +         +   +     E + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           RD+   N L++     K++DFGL+R    D 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS + H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 171 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 +  +V EYV    L  +I    + + +   + F  IL   +   Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLA 420
           +HRD+K  N+LLD     KIADFGL+
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 20/171 (11%)
Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIF-----NTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G  +P G ++ +   I      + RQ      + +  I S++H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYL 386
           +LLG    G    LV +Y+P  SL   +           LLNW  +       A+G+ YL
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               E  ++HR++   N+LL      ++ADFG+A     D   +  + A T
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 +  +V EYV    L  +I    + + +   + F  IL   +   Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLA 420
           +HRD+K  N+LLD     KIADFGL+
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 276 SKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLV 330
           ++ LG+G  G VY G   N       VAVK    + T    ++F +E  ++ +++H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLH 387
           KL+G   E P + ++ E  P   L  ++ ++NK  L    K   ++L + +    +AYL 
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLE 130
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
                  +HRDI   NIL+      K+ DFGL+R +  D  +   +V 
Sbjct: 131 S---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVT 174

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G V          VA+K++   + +    F  E+  +S + H N+VKL G  + 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
                LV EY    SL   +               +  L  ++G+AYLH      +IHRD
Sbjct: 73  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 399 IKTSNILLDKDFTP-KIADFGLA 420
           +K  N+LL    T  KI DFG A
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA 153

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 279 LGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+G  G VY G   N       VAVK    + T    ++F +E  ++ +++H ++VKL+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLHGGS 390
           G   E P + ++ E  P   L  ++ ++NK  L    K   ++L + +    +AYL    
Sbjct: 92  GIIEEEP-TWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLES-- 143
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
               +HRDI   NIL+      K+ DFGL+R +  D  +   +V 
Sbjct: 144 -INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVT 186

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI D+GLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G V          VA+K++   + +    F  E+  +S + H N+VKL G  + 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
                LV EY    SL   +               +  L  ++G+AYLH      +IHRD
Sbjct: 74  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 399 IKTSNILLDKDFTP-KIADFGLA 420
           +K  N+LL    T  KI DFG A
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA 154

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 276 SKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLV 330
           ++ LG+G  G VY G   N       VAVK    + T    ++F +E  ++ +++H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLAYLH 387
           KL+G   E P + ++ E  P   L  ++ ++NK  L    K   ++L + +    +AYL 
Sbjct: 73  KLIGIIEEEP-TWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLE 126
Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
                  +HRDI   NIL+      K+ DFGL+R +  D  +   +V 
Sbjct: 127 S---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVT 170

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS + H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 157 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEV 318
           KYE LEK          +G+G  G+V+   +      VA+KR+  +            E+
Sbjct: 3   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 52
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            L+  ++HKN+V+L        +  LV+E+  ++ L ++    N        K F  +  
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSF--LFQ 109
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
             +GL + H  +   ++HRD+K  N+L++++   K+ADFGLAR F
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAF 151

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 20/171 (11%)
Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIF-----NTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G  +P G ++ +   I      + RQ      + +  I S++H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYL 386
           +LLG    G    LV +Y+P  SL   +           LLNW  +       A+G+ YL
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               E  ++HR++   N+LL      ++ADFG+A     D   +  + A T
Sbjct: 150 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 197

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGSL---PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISS 323
           K  N      +LG G  GSV  G          VA+K L   T +   +E   E  ++  
Sbjct: 7   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 324 IEHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           +++  +V+L+G C  E    +LV E      L +F+  K +   +  +    ++   + G
Sbjct: 67  LDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMG 122
Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           + YL    E   +HRD+   N+LL      KI+DFGL++   AD ++ +   AG
Sbjct: 123 MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV     + +G  +AVK+L   F +       + E+ L
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 321 ISSIEHKNLVKLL-----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           +  ++H+N++ LL       S+E    + +  ++    L+  +      KL + + +F +
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-L 159
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           I     GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR
Sbjct: 160 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 65/133 (48%), Gaps = 9/133 (6%)
Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKN 362
              R  +++ + E+ ++  ++H N+VKL+    +  E  L  V+E V        + +  
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVP 129
Query: 363 KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
             K L+ ++         +G+ YLH     +IIHRDIK SN+L+ +D   KIADFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 423 FAADRTHVSTAVA 435
           F      +S  V 
Sbjct: 187 FKGSDALLSNTVG 199

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 23/155 (14%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ GS   G  VAVK  IF++R   DE  +F E  L +++   H+N++  + 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVK--IFSSR---DEKSWFRETELYNTVMLRHENILGFIA 98
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-- 388
             +    S     L+  Y    SL    +D  +   L+      I+L  A GLA+LH   
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 389 -GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
            G++ +  I HRD+K+ NIL+ K+    IAD GLA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 189

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 148 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 23/155 (14%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ GS   G  VAVK  IF++R   DE  +F E  L +++   H+N++  + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK--IFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-- 388
             +    S     L+  Y    SL    +D  +   L+      I+L  A GLA+LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 389 -GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
            G++ +  I HRD+K+ NIL+ K+    IAD GLA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 24/171 (14%)
Query: 277 KKLGQGGAGSVYMGSL----PNGTT--VAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L    P   T  VA+K L       + +EF +E  L + ++H N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFNII 376
           V LLG   +     +++ Y  +  L +F+              D+     L      +++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAAD 426
              A G+ YL   S   ++H+D+ T N+L+      KI+D GL R  +AAD
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 199

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 23/155 (14%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ GS   G  VAVK  IF++R   DE  +F E  L +++   H+N++  + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK--IFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-- 388
             +    S     L+  Y    SL    +D  +   L+      I+L  A GLA+LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 389 -GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
            G++ +  I HRD+K+ NIL+ K+    IAD GLA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 24/171 (14%)
Query: 277 KKLGQGGAGSVYMGSL----PNGTT--VAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L    P   T  VA+K L       + +EF +E  L + ++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIF-------------DKNKTKLLNWNKRFNII 376
           V LLG   +     +++ Y  +  L +F+              D+     L      +++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR-CFAAD 426
              A G+ YL   S   ++H+D+ T N+L+      KI+D GL R  +AAD
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 171 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 174 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 173 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 77/197 (39%), Gaps = 35/197 (17%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 81
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI--------------- 358
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+               
Sbjct: 82  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 359 -----FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK 413
                 DK   + L      +     A+G+A+L   +    IHRD+   N+LL      K
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK 198
Query: 414 IADFGLARCFAADRTHV 430
           I DFGLAR    D  ++
Sbjct: 199 IGDFGLARDIMNDSNYI 215

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 83/164 (50%), Gaps = 8/164 (4%)
Query: 277 KKLGQGGAG-SVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +K+G+G  G ++ + S  +G    +K +  +  + +  +E   EV ++++++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
               E     +V +Y     L + I +  K  L   ++  +  +     L ++H   + +
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           I+HRDIK+ NI L KD T ++ DFG+AR   +    ++ A  GT
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGT 188

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKR 372
              EV L+  ++H N++KL     +     +V E Y      D+ I    K K  + +  
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDA 123
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAAD 426
             II     G+ Y+H  +   I+HRD+K  NILL   +KD   KI DFGL+ CF  +
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKR 372
              EV L+  ++H N++KL     +     +V E Y      D+ I    K K  + +  
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDA 123
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAAD 426
             II     G+ Y+H  +   I+HRD+K  NILL   +KD   KI DFGL+ CF  +
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 108
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 109 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 432 TAVAG 436
               G
Sbjct: 166 AQTHG 170

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 163 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 112
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 113 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 432 TAVAG 436
               G
Sbjct: 170 AQTHG 174

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 30/143 (20%)
Query: 294 NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN 351
            G  VA+K+L   F +  +    + E+ L+  + H+N++ LL              + P+
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV------------FTPD 96
Query: 352 RSLDQF--------IFDKNKTKLLNWNK----RFN-IILGTAEGLAYLHGGSETRIIHRD 398
            +LD F            +  KL+   K    R   ++    +GL Y+H      IIHRD
Sbjct: 97  ETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRD 153
Query: 399 IKTSNILLDKDFTPKIADFGLAR 421
           +K  N+ +++D   KI DFGLAR
Sbjct: 154 LKPGNLAVNEDCELKILDFGLAR 176

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 106
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 107 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 432 TAVAG 436
               G
Sbjct: 164 AQTHG 168

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKR 372
              EV L+  ++H N++KL     +     +V E Y      D+ I    K K  + +  
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDA 123
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAAD 426
             II     G+ Y+H  +   I+HRD+K  NILL   +KD   KI DFGL+ CF  +
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 157 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 18  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQK 121
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DFGL R
Sbjct: 122 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 78/190 (41%), Gaps = 28/190 (14%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
           E  E   N     K LG G  G V       +G       VAVK L   +    DE    
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK------------ 361
            +E+ ++S + +H+N+V LLG    G   L++ EY     L  F+  K            
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 362 -NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            N  + L+     +     A+G+A+L   +    IHRD+   N+LL      KI DFGLA
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 213
Query: 421 RCFAADRTHV 430
           R    D  ++
Sbjct: 214 RDIMNDSNYI 223

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 73/168 (43%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL  C  +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 145
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 190

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 118
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 119 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 432 TAVAG 436
               G
Sbjct: 176 AQTHG 180

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+AR
Sbjct: 183 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISS 323
           E    Y +P+  +G G  GSV       +G  VA+K+L   F +  +    + E+ L+  
Sbjct: 39  ELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 97
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           ++H+N++ LL            Y++       Q    K      +  K   ++    +GL
Sbjct: 98  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGL 157
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
            Y+H      ++HRD+K  N+ +++D   KI DFGLAR   A+ T
Sbjct: 158 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 199

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 126
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 127 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 432 TAVAG 436
               G
Sbjct: 184 AQTHG 188

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQWVDEF--FNEVNLI-- 321
           +A   +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 -SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             + EH N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++      S  V
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQWVDEF--FNEVNLI-- 321
           +A   +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 -SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             + EH N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++      S  V
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 128
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 129 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 432 TAVAG 436
               G
Sbjct: 186 AQTHG 190

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 128
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 129 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 432 TAVAG 436
               G
Sbjct: 186 AQTHG 190

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 69
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 125
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 64
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRL--IFNTRQWVD 312
           K+C+S   +  E   +   P  +LG+G  G V  M  +P+G  +AVKR+    N+++   
Sbjct: 36  KACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKR 95
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF---IFDKNKTKLLNW 369
              +    + +++    V   G      +  +  E + + SLD+F   + DK +T  +  
Sbjct: 96  LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQT--IPE 152
Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +    I +   + L +LH  S+  +IHRD+K SN+L++     K+ DFG++
Sbjct: 153 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTT-VAVKRLIFNTRQWVDEF--FNEVNLI-- 321
           +A   +    ++G+G  G V+    L NG   VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 -SSIEHKNLVKLLG-CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             + EH N+V+L   C++   +      LV+E+V ++ L  ++ DK     +      ++
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++      S  V
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 66
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 63
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 471
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 472 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 432 TAVAG 436
               G
Sbjct: 529 AQTHG 533

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 470
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +  
Sbjct: 471 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 432 TAVAG 436
               G
Sbjct: 528 AQTHG 532

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 34  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 89
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 17/173 (9%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLI-SSIEHKNLVK 331
           F P   LG G  G++    + +   VAVKR++     + D    EV L+  S EH N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIR 82
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
              C+ +  +   +   +   +L +++  K+   L    +   ++  T  GLA+LH    
Sbjct: 83  YF-CTEKDRQFQYIAIELCAATLQEYVEQKDFAHL--GLEPITLLQQTTSGLAHLHS--- 136
Query: 392 TRIIHRDIKTSNILLDK-----DFTPKIADFGLARCFAADRTHVS--TAVAGT 437
             I+HRD+K  NIL+            I+DFGL +  A  R   S  + V GT
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 28/183 (15%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN--TRQWVD 312
           L  K E +      F   + LG+G  GSV    L         VAVK L  +      ++
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEG------PESLLVYEYVPNRSLDQFIFDKNKTKL 366
           EF  E   +   +H ++ KL+G S+        P  +++  ++ +  L  F+      + 
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE- 129
Query: 367 LNWNKRFNIILGT--------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG 418
                 FN+ L T        A G+ YL   S    IHRD+   N +L +D T  +ADFG
Sbjct: 130 ----NPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 419 LAR 421
           L+R
Sbjct: 183 LSR 185

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH----------- 326
           LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 327 --KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
             +N VK +    +     +  EY  N +L   I  +N  +    ++ + +     E L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ--QRDEYWRLFRQILEALS 130
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           Y+H      IIHRD+K  NI +D+    KI DFGLA+
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 278 KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLVKLL 333
           +LG G  GSV  G          VA+K L   T +   +E   E  ++  +++  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 334 G-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           G C  E    +LV E      L +F+  K +   +  +    ++   + G+ YL    E 
Sbjct: 403 GVCQAEA--LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEK 455
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
             +HR++   N+LL      KI+DFGL++   AD ++ +   AG
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISS 323
           E    Y +P+  +G G  GSV       +G  VA+K+L   F +  +    + E+ L+  
Sbjct: 21  ELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 79
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           ++H+N++ LL            Y++       Q    K      +  K   ++    +GL
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
            Y+H      ++HRD+K  N+ +++D   KI DFGLAR   A+ T
Sbjct: 140 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 279 LGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVD--EFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G VY+    N    VA+K++       +D      E+ +++ ++   +++L   
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 336 SIEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIIL-GTAEGLAYLHGGSET 392
            I  PE LL ++  Y+     D  +    KT +    +    IL     G  ++H   E+
Sbjct: 96  II--PEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH---ES 150
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
            IIHRD+K +N LL++D + KI DFGLAR   +D+
Sbjct: 151 GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLL 333
            + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +  ++   H+N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFI 102
Query: 334 GCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG- 388
               +      +  LV +Y  + SL    FD      +       + L TA GLA+LH  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 389 --GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
             G++ +  I HRD+K+ NIL+ K+ T  IAD GLA
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 7/125 (5%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           DE   E N++  +++  +V+++G   E    +LV E      L++++      K  N   
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN--- 112
Query: 372 RFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
              ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD     
Sbjct: 113 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 432 TAVAG 436
               G
Sbjct: 170 AQTHG 174

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI  FGLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI D GLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEV 318
           KYE LEK          +G+G  G+V+   +      VA+KR+  +            E+
Sbjct: 3   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 52
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            L+  ++HKN+V+L        +  LV+E+  ++ L ++    N        K F  +  
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSF--LFQ 109
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
             +GL + H  +   ++HRD+K  N+L++++   K+A+FGLAR F 
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 37/176 (21%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVN 319
           +E  E+  N  +P   +G G  GSV        G  VAVK+L   F +       + E+ 
Sbjct: 18  WEVPERYQN-LSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TK 365
           L+  ++H+N++ LL              + P RSL++F  ++        D N      K
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           L + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI DF LAR
Sbjct: 122 LTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 64/150 (42%), Gaps = 10/150 (6%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                 +  +V EYV    L  +I    +       + F  IL    G+ Y H      +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---GVDYCH---RHMV 137
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           +HRD+K  N+LLD     KIADFGL+   +
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS 167

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 279 LGQGGAGSVYMGSLPNG---TTVAVKRLI-FNTRQWVDEFFNEVNLISSI-EHKNLVKLL 333
           +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA------------- 380
           G         L  EY P+ +L  F+    K+++L  +  F I   TA             
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 381 ---EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               G+ YL   S+ + IHR++   NIL+ +++  KIADFGL+R
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI D GLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLI-FNTRQWVDEFFNEVNLISSIEHKNL 329
           + LG G  G VY G +      P+   VAVK L    + Q   +F  E  +IS   H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAY 385
           V+ +G S++     ++ E +    L  F+ +     ++   L      ++    A G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR 421
           L    E   IHRDI   N LL         KI DFG+A+
Sbjct: 157 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 33/175 (18%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF--IF--------DKNK----TKL 366
           +  ++H+N++ LL              + P RSL++F  ++        D N      KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            + + +F +I     GL Y+H      IIHRD+K SN+ +++D   KI D GLAR
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 335 -CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++     L   + +      L+  KR   +L    GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYI 141
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 335 -CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++     L   + +      L+  KR   +L    GL Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYI 140
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+
Sbjct: 141 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 20/155 (12%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+        +   +++F +   ++ V+ +   E+ + + + H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAEGL 383
           +++L     +     L+ EY P   L + +     FD+ +T          I+   A+ L
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA--------TIMEELADAL 136
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG 418
            Y HG    ++IHRDIK  N+LL      KIADFG
Sbjct: 137 MYCHG---KKVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 335 -CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++     L   + +      L+  KR   +L    GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYI 141
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--WVDEFFNEVNLISSIEHKNLVKLLG 334
           K+GQG  G V+       G  VA+K+++    +  +      E+ ++  ++H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 335 -CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            C  +            LV+++     L   + +      L+  KR   +L    GL Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYI 141
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
           H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F +   ++ V+ +   E+ + S + H N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           ++++     +     L+ E+ P   L + +    K    +  +    +   A+ L Y H 
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH- 132
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             E ++IHRDIK  N+L+      KIADFG +
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFGWS 162

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 19/166 (11%)
Query: 278 KLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSIEHKNLVKLLG 334
           K+G+G  G V+   +   G  VA+K+ + +    V +     E+ ++  ++H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 335 CSIEGPESLLVYEYVPN---RSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
                    LV+EY  +     LD++     ++  K + W         T + + + H  
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHKH 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
           +    IHRD+K  NIL+ K    K+ DFG AR       +    VA
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G G  GSV   Y   L     VAVK+L   F +       + E+ L+  ++H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 332 LL-----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           LL       SIE    + +   +    L+  +    K++ L+      ++     GL Y+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYI 147
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           H      IIHRD+K SN+ +++D   +I DFGLAR
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++ +  H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 91  I-IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDH 182

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
           F+  + LG+G  G+VY+        +   +++F +   ++ V+ +   E+ + S + H N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           ++++     +     L+ E+ P   L + +    K    +  +    +   A+ L Y H 
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH- 131
Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             E ++IHRDIK  N+L+      KIADFG +
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++ +  H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI-N 89
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVK 331
           S  LGQG   +V+ G     G   A+K  +FN   +   VD    E  ++  + HKN+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 332 LLGCSIEGP--ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           L     E      +L+ E+ P  SL   + + +    L  ++   ++     G+ +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL--- 128
Query: 390 SETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVS 431
            E  I+HR+IK  NI+     D     K+ DFG AR    D   VS
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 78/178 (43%), Gaps = 28/178 (15%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 89  IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEHKNLV 330
           +++G+G  G V+ G L  + T VAVK    + R+ +      +F  E  ++    H N+V
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L+G   +     +V E V  +  D   F + +   L       ++   A G+ YL    
Sbjct: 176 RLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               IHRD+   N L+ +    KI+DFG++R
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 16/169 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L +   VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
           +  IIHRD+K +NIL+      K+ DFG+AR  A     V  + AV GT
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 78/178 (43%), Gaps = 28/178 (15%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 112 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEHKNLV 330
           +++G+G  G V+ G L  + T VAVK    + R+ +      +F  E  ++    H N+V
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +L+G   +     +V E V  +  D   F + +   L       ++   A G+ YL    
Sbjct: 176 RLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
               IHRD+   N L+ +    KI+DFG++R
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 105
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 106 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 161
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADR 427
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +
Sbjct: 162 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 76/180 (42%), Gaps = 31/180 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGT 437
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +     + A  GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 106
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 107 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 162
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADR 427
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +
Sbjct: 163 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFF--NEVNLISSIEHKN 328
           +Y++  ++LG G  G V+         V V + I NT   +D++   NE+++++ + H  
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK--LLNWNKRFNIILGTAEGLAYL 386
           L+ L     +  E +L+ E++    L    FD+   +   ++  +  N +    EGL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 387 HGGSETRIIHRDIKTSNILLD--KDFTPKIADFGLARCFAADR-THVSTAVA 435
           H   E  I+H DIK  NI+ +  K  + KI DFGLA     D    V+TA A
Sbjct: 166 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 17/149 (11%)
Query: 279 LGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDE------FFNEVNLISSIEHKNLVK 331
           LG+G  G V + +       VA+K   F +RQ + +         E++ +  + H +++K
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L        + ++V EY      D +I +K +       + F  I+   E   Y H    
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFD-YIVEKKRMTEDEGRRFFQQIICAIE---YCH---R 126
Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            +I+HRD+K  N+LLD +   KIADFGL+
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLS 155

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDH 180

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 88
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 144
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADR 427
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +
Sbjct: 145 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 189

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 78/178 (43%), Gaps = 28/178 (15%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 107 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V
Sbjct: 166 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 78/178 (43%), Gaps = 28/178 (15%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 112 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 82
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N++KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 138
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADR 427
           + Y+H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +
Sbjct: 139 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 78/178 (43%), Gaps = 28/178 (15%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      E   +E+ ++S +  H N
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 329 LVKLLG-CSIEGPESLLVYEY--------VPNRSLDQFIFDKNKTKLLNWNKRF------ 373
           +V LLG C+I GP +L++ EY           R  D FI  K    ++  ++        
Sbjct: 105 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 374 -NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
            +     A+G+A+L   +    IHRD+   NILL      KI DFGLAR    D  +V
Sbjct: 164 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 137
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 137
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 89
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 107
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 200

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 95
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 152
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 188

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 335 CSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
             I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 122
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 167

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 86
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 143
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 93
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 150
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 37  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 94
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 151
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 186

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 28  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 85
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 142
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 177

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 86
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 143
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 93
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 150
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 30/174 (17%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNL 320
           +K    F   K LG+G   +V +   L      A+K  I   R  + E        E ++
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDV 60
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNI 375
           +S ++H   VKL     +  +      Y  N  L ++I     FD+  T+          
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-------- 112
Query: 376 ILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              TAE    L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 113 ---TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 160

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 30/174 (17%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNL 320
           +K    F   K LG+G   +V +   L      A+K  I   R  + E        E ++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDV 61
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNI 375
           +S ++H   VKL     +  +      Y  N  L ++I     FD+  T+          
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-------- 113
Query: 376 ILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              TAE    L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 114 ---TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 279 LGQGGAG---SVYMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKL-- 332
           +G+G  G   S Y     N   VA+K++  F  + +      E+ ++    H+N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 333 --LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +IE  + + +  ++    L + +    KT+ L+ +     +     GL Y+H  +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 19/177 (10%)
Query: 256 KSCLSFKYETLEK-ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV--D 312
           +S +   YE  E+  +  F   +K  Q G G  Y            KR + ++R+ V  +
Sbjct: 21  QSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK------KRRLXSSRRGVSRE 74
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
           E   EVN++  I H N++ L        + +L+ E V    L  F+ +K     L  ++ 
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEA 131
Query: 373 FNIILGTAEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TPKIA--DFGLARCFAA 425
              +    +G+ YLH     RI H D+K  NI LLDK+   P+I   DFG+A    A
Sbjct: 132 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 185

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 27/166 (16%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
           +G GG G V+      +G T  +KR+ +N     ++   EV  ++ ++H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC-W 73
Query: 338 EG----PES-------------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +G    PE+              +  E+    +L+Q+I +K + + L+      +     
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQIT 132
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +G+ Y+H     ++I+RD+K SNI L      KI DFGL      D
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 30/174 (17%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNL 320
           +K    F   K LG+G   +V +   L      A+K  I   R  + E        E ++
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDV 63
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNI 375
           +S ++H   VKL     +  +      Y  N  L ++I     FD+  T+          
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-------- 115
Query: 376 ILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              TAE    L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 116 ---TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 163

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 141
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G G  GSV   Y   L     VAVK+L   F +       + E+ L+  ++H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 332 LL-----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           LL       SIE    + +   +    L+  +    K + L+      ++     GL Y+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 147
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           H      IIHRD+K SN+ +++D   +I DFGLAR
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVK 331
           S  LGQG   +V+ G     G   A+K  +FN   +   VD    E  ++  + HKN+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 332 LLGCSIEGP--ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           L     E      +L+ E+ P  SL   + + +    L  ++   ++     G+ +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 390 SETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHV 430
            E  I+HR+IK  NI+     D     K+ DFG AR    D   V
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G G  GSV   Y   L     VAVK+L   F +       + E+ L+  ++H+N++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 332 LL-----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           LL       SIE    + +   +    L+  +    K + L+      ++     GL Y+
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 139
Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           H      IIHRD+K SN+ +++D   +I DFGLAR
Sbjct: 140 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 16/169 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L +   VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 30/174 (17%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNL 320
           +K    F   K LG+G   +V +   L      A+K  I   R  + E        E ++
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDV 62
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNI 375
           +S ++H   VKL     +  +      Y  N  L ++I     FD+  T+          
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-------- 114
Query: 376 ILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              TAE    L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 115 ---TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 162

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 16/169 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L +   VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 143
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 188

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 141
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 77/155 (49%), Gaps = 22/155 (14%)
Query: 279 LGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVD--EFFNEVNLISSIEHKNLVKLLGC 335
           LG G  G V+       G  +A K  I  TR   D  E  NE+++++ ++H NL++L   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDK--NKTKLLNWNKRFNIIL---GTAEGLAYLHGGS 390
                + +LV EYV    L   I D+  N T+L       + IL      EG+ ++H   
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-------DTILFMKQICEGIRHMH--- 204
Query: 391 ETRIIHRDIKTSNIL-LDKDFTP-KIADFGLARCF 423
           +  I+H D+K  NIL +++D    KI DFGLAR +
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 85/209 (40%), Gaps = 22/209 (10%)
Query: 234 YARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP 293
           +  L K K   N L  Y   +KK         L+     ++  K +G+G  G V +    
Sbjct: 44  FPALRKNKNIDNFLNRYEKIVKK------IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHK 97
Query: 294 NGTTVAVKRLI--FNTRQWVDE-FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYV 349
               V   +L+  F   +  D  FF E   I +  +   V  L C+ +  + L +V EY+
Sbjct: 98  ASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 157
Query: 350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD 409
           P   L   +   N      W K +     TAE +  L       +IHRD+K  N+LLDK 
Sbjct: 158 PGGDLVNLM--SNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 210
Query: 410 FTPKIADFGLARCFAADRT---HVSTAVA 435
              K+ADFG   C   D T   H  TAV 
Sbjct: 211 GHLKLADFG--TCMKMDETGMVHCDTAVG 237

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 38/178 (21%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC-- 335
           +G GG G V+      +G T  ++R+ +N  +       EV  ++ ++H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIVHYNGCWD 75
Query: 336 -----------SIEG----PES------------LLVYEYVPNRSLDQFIFDKNKTKLLN 368
                      S+E     PE+             +  E+    +L+Q+I +K + + L+
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLD 134
Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
                 +     +G+ Y+H     ++IHRD+K SNI L      KI DFGL      D
Sbjct: 135 KVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 189

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA+K++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN-----IILGTAEGLAYLHGGS 390
            I  P      E + +  + Q + + +  KLL      N      +     GL Y+H  +
Sbjct: 93  IIRAP----TIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 279 LGQGGAGSV--YMGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G V     +L N   VA++++  F  + +      E+ ++    H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNL-NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI-ND 92
Query: 336 SIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            I  P    + + Y+    ++  ++   KT+ L+ +     +     GL Y+H  +   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           +HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 277 KKLGQGGAGSV-YMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG- 334
           +KLG+GG   V  +  L +G   A+KR++ + +Q  +E   E ++     H N+++L+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 335 CSIE---GPESLLVYEYVPNRSL-DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           C  E     E+ L+  +    +L ++    K+K   L  ++   ++LG   GL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFG 418
                HRD+K +NILL  +  P + D G
Sbjct: 155 YA---HRDLKPTNILLGDEGQPVLMDLG 179

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 15/183 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFN 316
           L+ K +  E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   
Sbjct: 13  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 72
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++       +V   G      E  +  E++   SLDQ +    +       K   + 
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 129
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRT 428
           +   +GL YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+
Sbjct: 130 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 187
Query: 429 HVS 431
           ++S
Sbjct: 188 YMS 190

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G   +V +   L      A+K  I   R  + E        E +++S ++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFY-----------TAE 140
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHK 327
           F   + LG G  G V++  S  NG   A+K     ++   +Q V+   +E  ++S + H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHP 66
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GLA 384
            ++++ G   +  +  ++ +Y+    L  F   +   +  N   +F      AE    L 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFY----AAEVCLALE 120
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           YLH      II+RD+K  NILLDK+   KI DFG A+ +  D T+
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY 161

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 19/176 (10%)
Query: 257 SCLSFKYETLEK-ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV--DE 313
           S +   YE  E+  +  F   +K  Q G G  Y            KR + ++R+ V  +E
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK------KRRLSSSRRGVSREE 54
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              EVN++  I H N++ L        + +L+ E V    L  F+ +K     L  ++  
Sbjct: 55  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEAT 111
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TPKIA--DFGLARCFAA 425
             +    +G+ YLH     RI H D+K  NI LLDK+   P+I   DFG+A    A
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 6/141 (4%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE 338
           +G+G  G VY G       + +  +  +    +  F  EV       H+N+V  +G  + 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD 398
            P   ++      R+L   + D     +L+ NK   I     +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 399 IKTSNILLDKDFTPKIADFGL 419
           +K+ N+  D      I DFGL
Sbjct: 156 LKSKNVFYDNGKV-VITDFGL 175

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 19/181 (10%)
Query: 252 TSMKKSCLSFKYETLEK-ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW 310
           ++ ++  +   YE  E+  +  F   +K  Q G G  Y            KR + ++R+ 
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK------KRRLSSSRRG 56
Query: 311 V--DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLN 368
           V  +E   EVN++  I H N++ L        + +L+ E V    L  F+ +K     L 
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LT 113
Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI-LLDKDF-TPKIA--DFGLARCFA 424
            ++    +    +G+ YLH     RI H D+K  NI LLDK+   P+I   DFG+A    
Sbjct: 114 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170
Query: 425 A 425
           A
Sbjct: 171 A 171

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 273 FNPSKKLGQGG-AGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEH 326
           F   K LG+G  + +V    L      A+K  I   R  + E        E +++S ++H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRFNIILGTAE 381
              VKL     +  +      Y  N  L ++I     FD+  T+             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----------TAE 138
Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               L YLHG     IIHRD+K  NILL++D   +I DFG A+  + +
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVST 432
            YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S 
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVST 432
            YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S 
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 12/135 (8%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLGC 335
           K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-C 76
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGSE 391
           S      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH    
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 392 TRIIHRDIKTSNILL 406
            +IIHRD+K  NIL+
Sbjct: 134 LKIIHRDLKPQNILV 148

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTV--AVKRLIFNTRQWVDE 313
           +  L F+  T      Y+     +G+G  G V + ++  GT +  A K++     + VD 
Sbjct: 11  RENLYFQGSTKGDINQYYTLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDR 69
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
           F  E+ ++ S++H N+++L     +  +  LV E      L + +  K   ++   +   
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAA 126
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL--DKDFTP-KIADFGLARCFAAD---R 427
            I+      +AY H   +  + HRD+K  N L   D   +P K+ DFGLA  F      R
Sbjct: 127 RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 428 THVSTA 433
           T V T 
Sbjct: 184 TKVGTP 189

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVST 432
            YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S 
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 23/155 (14%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI--EHKNLVKLLG 334
           +G+G  G V+ G L +G +VAVK  IF++R   DE  +F E  + +++   H N++  + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK--IFSSR---DEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG-- 388
             +    S     L+  Y  + SL  F+    + + L  +    + +  A GLA+LH   
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEI 125
Query: 389 -GSETR--IIHRDIKTSNILLDKDFTPKIADFGLA 420
            G++ +  I HRD K+ N+L+  +    IAD GLA
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA 160

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVST 432
            YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S 
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLG 334
            K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY- 93
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGS 390
           CS      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH   
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 151
Query: 391 ETRIIHRDIKTSNILL 406
             +IIHRD+K  NIL+
Sbjct: 152 -LKIIHRDLKPQNILV 166

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLG 334
            K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY- 93
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGS 390
           CS      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH   
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 151
Query: 391 ETRIIHRDIKTSNILL 406
             +IIHRD+K  NIL+
Sbjct: 152 -LKIIHRDLKPQNILV 166

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVKLLG 334
            K LG G +G+V       G  VAVKR++ +   + D    E+ L++ S +H N+++   
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY- 75
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFN---IILGTAEGLAYLHGGS 390
           CS      L +   + N +L   +  KN + + L   K +N   ++   A G+A+LH   
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 391 ETRIIHRDIKTSNILL 406
             +IIHRD+K  NIL+
Sbjct: 134 -LKIIHRDLKPQNILV 148

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 15/184 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFN 316
           L+ K +  E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   
Sbjct: 21  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++       +V   G      E  +  E++   SLDQ +    K   +       + 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 137
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRT 428
           +   +GL YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+
Sbjct: 138 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 195
Query: 429 HVST 432
           ++S 
Sbjct: 196 YMSP 199

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 83  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 136
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 171

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 81/168 (48%), Gaps = 11/168 (6%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLI 321
           ++E   +   P  +LG+G  G V  M  +P+G  +AVKR+    N+++      +    +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF---IFDKNKTKLLNWNKRFNIILG 378
            +++    V   G      +  +  E + + SLD+F   + DK +T  +  +    I + 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQT--IPEDILGKIAVS 117
Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
             + L +LH  S+  +IHRD+K SN+L++     K+ DFG++     D
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 166

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 16/169 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L     VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 106 GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 159
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 194

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 80  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 133
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 168

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 81
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 132
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             R+IHRD+K  N+ L++D   KI DFGLA
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISS 323
           ++ +   + LG+G  G V +      G   AVK  + + RQ       +    EV L+  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQ 82
Query: 324 IEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           ++H N+ KL     +     LV E Y      D+ I  K  +++        II     G
Sbjct: 83  LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSG 138
Query: 383 LAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAADR 427
           + Y H   + +I+HRD+K  N+LL+   KD   +I DFGL+  F A +
Sbjct: 139 ITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 166

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 15/184 (8%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFN 316
           L+ K +  E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   
Sbjct: 56  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 115
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++       +V   G      E  +  E++   SLDQ +    K   +       + 
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 172
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRT 428
           +   +GL YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+
Sbjct: 173 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 230
Query: 429 HVST 432
           ++S 
Sbjct: 231 YMSP 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 81  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 134
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 169

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    K   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVST 432
            YL    + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S 
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 16/169 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L     VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 150
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 199

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 75  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLES---KR 128
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 163

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 113
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 170
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 84
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 141
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 142 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 107
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 164
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 165 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 209

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 80/192 (41%), Gaps = 43/192 (22%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT 307
           G++ TS KK  LS  Y+ +          KKLG G  G V    L       V+R I   
Sbjct: 25  GMFITS-KKGHLSEMYQRV----------KKLGSGAYGEVL---LCRDKVTHVERAIKII 70
Query: 308 RQWV------DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFD 360
           R+         +   EV ++  ++H N++KL     +     LV E Y      D+ I  
Sbjct: 71  RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH- 129
Query: 361 KNKTKLLNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFT 411
                      +FN      II     G+ YLH   +  I+HRD+K  N+LL   +KD  
Sbjct: 130 ---------RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDAL 177
Query: 412 PKIADFGLARCF 423
            KI DFGL+  F
Sbjct: 178 IKIVDFGLSAVF 189

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 16/169 (9%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           LG GG   V++   L     VAVK L   +     +   F  E    +++ H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 335 C----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
                +  GP   +V EYV   +L   +  +     +   +   +I    + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH--- 133
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
           +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 91
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 91
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 148
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 115
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 172
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 173 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 113
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 170
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 21/148 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
           FN S  LGQG    ++ G           + T V +K L    R + + FF   +++S +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII--LGTAEG 382
            HK+LV   G    G E++LV E+V   SLD ++  KNK  +       NI+  L  A+ 
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCI-------NILWKLEVAKQ 121
Query: 383 LAY-LHGGSETRIIHRDIKTSNILLDKD 409
           LA+ +H   E  +IH ++   NILL ++
Sbjct: 122 LAWAMHFLEENTLIHGNVCAKNILLIRE 149

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 15/171 (8%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTV--AVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
            Y+     +G+G  G V + ++  GT +  A K++     + VD F  E+ ++ S++H N
Sbjct: 9   QYYTLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +++L     +  +  LV E      L + +  K   ++   +    I+      +AY H 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH- 123
Query: 389 GSETRIIHRDIKTSNILL--DKDFTP-KIADFGLARCFAAD---RTHVSTA 433
             +  + HRD+K  N L   D   +P K+ DFGLA  F      RT V T 
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 98
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 155
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 156 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 200

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 158
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 215
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 216 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 260

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 117
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 174
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 175 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 219

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 79
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 136
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 134
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             R+IHRD+K  N+ L++D   KI DFGLA
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 134
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             R+IHRD+K  N+ L++D   KI DFGLA
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 83
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 140
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 141 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 87
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 138
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             R+IHRD+K  N+ L++D   KI DFGLA
Sbjct: 139 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 92
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 149
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 150 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 194

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 79
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 136
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 279 LGQGGAGSVYMGSLPNGTTV-----AVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           LG+GG    +  S  +   V       K L+    Q  ++   E+++  S+ H+++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 105
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGS 390
           G   +     +V E    RSL +    K +  L     R+    I+LG      YLH   
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGCQ----YLH--- 156
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             R+IHRD+K  N+ L++D   KI DFGLA
Sbjct: 157 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 80
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 137
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 138 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 79
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 136
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 87
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 144
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 145 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 189

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 13/126 (10%)
Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           +  K L+    Q  ++   E+++  S+ H+++V   G   +     +V E    RSL + 
Sbjct: 73  IVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL 131
Query: 358 IFDKNKTKLLNWNKRF---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI 414
              K +  L     R+    I+LG      YLH     R+IHRD+K  N+ L++D   KI
Sbjct: 132 --HKRRKALTEPEARYYLRQIVLGCQ----YLH---RNRVIHRDLKLGNLFLNEDLEVKI 182
Query: 415 ADFGLA 420
            DFGLA
Sbjct: 183 GDFGLA 188

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 279 LGQGGAGSVYMGSLPNGT-TVAVKRLIFNTRQWVD--EFFNEVNLISSIEHKNLVKLLGC 335
           +G+G  G VY+    N    VA+K++       +D      E+ +++ ++   +++L   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 336 SIEGPESLLVYE--YVPNRSLDQFIFDKNKTKLLNWNKRFNIIL-GTAEGLAYLHGGSET 392
            I  P+ LL ++  Y+     D  +    KT +    +    IL     G  ++H   E+
Sbjct: 94  II--PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ES 148
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
            IIHRD+K +N LL++D + K+ DFGLAR   +++
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 23/196 (11%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWV 311
           L +     E   +  N  K LG+G  G V       +       TVAVK L    T    
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 312 DEFFNEVNLISSI-EHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
               +E+ ++  I  H N+V LLG C+  G   +++ E+    +L  ++  K + + + +
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPY 133
Query: 370 NKRFNIIL----------GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL 419
              +   L            A+G+ +L   +  + IHRD+   NILL +    KI DFGL
Sbjct: 134 KDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGL 190
Query: 420 ARCFAADRTHVSTAVA 435
           AR    D  +V    A
Sbjct: 191 ARDIYKDPDYVRKGDA 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLAR 421
            +HRDI   N+L+  +   K+ DFGL+R
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 12/170 (7%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVN 319
           F  +T+E         + L +GG   VY    + +G   A+KRL+ N  +       EV 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 320 LISSIE-HKNLVKLLGCSIEGPES--------LLVYEYVPNRSLDQFIFDKNKTKLLNWN 370
            +  +  H N+V+    +  G E         LL+ E    + L +F+        L+ +
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCD 136
Query: 371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
               I   T   + ++H   +  IIHRD+K  N+LL    T K+ DFG A
Sbjct: 137 TVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 21/148 (14%)
Query: 273 FNPSKKLGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
           FN S  LGQG    ++ G           + T V +K L    R + + FF   +++S +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII--LGTAEG 382
            HK+LV   G  + G E++LV E+V   SLD ++  KNK  +       NI+  L  A+ 
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCI-------NILWKLEVAKQ 121
Query: 383 L-AYLHGGSETRIIHRDIKTSNILLDKD 409
           L A +H   E  +IH ++   NILL ++
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIRE 149

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 6/129 (4%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWN 370
             +EVNL+  ++H N+V+     I+   + L  V EY     L   I    K +  L+  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 371 KRFNIILGTAEGLAYLHGGSE--TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               ++      L   H  S+    ++HRD+K +N+ LD     K+ DFGLAR    D T
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-T 170
Query: 429 HVSTAVAGT 437
             + A  GT
Sbjct: 171 SFAKAFVGT 179

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK----L 332
           +G+G  G V         T VA+K++  F  + +      E+ ++    H+N++     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
              ++E    +    Y+    ++  ++   K++ L+ +     +     GL Y+H  +  
Sbjct: 111 RASTLEAMRDV----YIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            ++HRD+K SN+L++     KI DFGLAR    +  H
Sbjct: 165 -VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDH 200

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 7/123 (5%)
Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           V  K ++    Q  ++   E+ +  S+++ ++V   G   +     +V E    RSL + 
Sbjct: 74  VVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL 132
Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
              K +  +     R+  +  T +G+ YLH     R+IHRD+K  N+ L+ D   KI DF
Sbjct: 133 --HKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDF 186
Query: 418 GLA 420
           GLA
Sbjct: 187 GLA 189

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL- 332
           +K +G G  G VY   L  +G  VA+K+++ + R     F N E+ ++  ++H N+V+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLR 79
Query: 333 --LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
                S E  + +   LV +YVP    R    +   K    ++ + K +   L     LA
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FRSLA 136
Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           Y+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 7/123 (5%)
Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           V  K ++    Q  ++   E+ +  S+++ ++V   G   +     +V E    RSL + 
Sbjct: 74  VVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL 132
Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
              K +  +     R+  +  T +G+ YLH     R+IHRD+K  N+ L+ D   KI DF
Sbjct: 133 --HKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDF 186
Query: 418 GLA 420
           GLA
Sbjct: 187 GLA 189

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 7/123 (5%)
Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           V  K ++    Q  ++   E+ +  S+++ ++V   G   +     +V E    RSL + 
Sbjct: 74  VVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL 132
Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
              K +  +     R+  +  T +G+ YLH     R+IHRD+K  N+ L+ D   KI DF
Sbjct: 133 --HKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDF 186
Query: 418 GLA 420
           GLA
Sbjct: 187 GLA 189

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 72/166 (43%), Gaps = 22/166 (13%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKLLGC 335
           K +G G  G V+   L     VA+K+++ + R     F N E+ ++  ++H N+V L   
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAF 100
Query: 336 SIEGPESL------LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
                +        LV EYVP    R+   +   K    +L        +L     LAY+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYI 157
Query: 387 HGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRTHVS 431
           H      I HRDIK  N+LLD      K+ DFG A+   A   +VS
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 511
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+  +   K+ DFGL+R +  D T+
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTY 546

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F    ++G+G  G VY G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            +  G  ++  +  ++ EY+   S      D  K   L       I+    +GL YLH  
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHS- 134
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              R IHRDIK +N+LL +    K+ADFG+A
Sbjct: 135 --ERKIHRDIKAANVLLSEQGDVKLADFGVA 163

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 131
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+      K+ DFGL+R +  D T+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTY 166

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 7/123 (5%)
Query: 298 VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
           V  K ++    Q  ++   E+ +  S+++ ++V   G   +     +V E    RSL + 
Sbjct: 58  VVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL 116
Query: 358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
              K +  +     R+  +  T +G+ YLH     R+IHRD+K  N+ L+ D   KI DF
Sbjct: 117 --HKRRKAVTEPEARY-FMRQTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDF 170
Query: 418 GLA 420
           GLA
Sbjct: 171 GLA 173

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 5/127 (3%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWN 370
             +EVNL+  ++H N+V+     I+   + L  V EY     L   I    K +  L+  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 371 KRFNIILGTAEGLAYLHGGSE--TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
               ++      L   H  S+    ++HRD+K +N+ LD     K+ DFGLAR    D +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 429 HVSTAVA 435
              T V 
Sbjct: 172 FAKTFVG 178

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 80/203 (39%), Gaps = 23/203 (11%)
Query: 253 SMKKSCLSFKYET--LEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLI 304
            + + C    Y+    E   +  N  K LG+G  G V       +       TVAVK L 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 66
Query: 305 FN-TRQWVDEFFNEVNLISSI-EHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDK 361
              T        +E+ ++  I  H N+V LLG C+  G   +++ E+    +L  ++  K
Sbjct: 67  EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 126
Query: 362 NKT---------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP 412
                         L            A+G+ +L   +  + IHRD+   NILL +    
Sbjct: 127 RNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVV 183
Query: 413 KIADFGLARCFAADRTHVSTAVA 435
           KI DFGLAR    D  +V    A
Sbjct: 184 KIXDFGLARDIYKDPDYVRKGDA 206

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 273 FNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLV 330
           F    +LG G  G V+ +   P+G  +A K +    +  + ++   E+ ++       +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
              G      E  +  E++   SLDQ +    +       K   + +   +GL YL    
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYLR--E 125
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFG--------LARCFAADRTHVST 432
           + +I+HRD+K SNIL++     K+ DFG        +A  F   R+++S 
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSP 175

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 26/157 (16%)
Query: 278 KLGQGGAGSV-YMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLI-SSIEHKNLV 330
           ++G+G  GSV  M   P+G  +AVKR+    R  VDE        +++++  S +   +V
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI----RSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQF-------IFDKNKTKLLNWNKRFNIILGTAEGL 383
           +  G      +  +  E + + S D+F       + D    ++L       I L T + L
Sbjct: 85  QFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKAL 138
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            +L      +IIHRDIK SNILLD+    K+ DFG++
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI 337
           +G G  G VY G       +A  +++  T    +E   E+N++     H+N+    G  I
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 338 E-GPESL-----LVYEYVPNRSLDQFIFD-KNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +  P  +     LV E+    S+   I + K  T    W     I      GL++LH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH--- 146
Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
           + ++IHRDIK  N+LL ++   K+ DFG++     DRT
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRT 182

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFF--NEVNLISSIEHK 327
           +++F    +LG+G    VY             +++  T   VD+     E+ ++  + H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHP 108
Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N++KL        E  LV E V    L   I +K      +       IL   E +AYLH
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL---EAVAYLH 165
Query: 388 GGSETRIIHRDIKTSNILL---DKDFTPKIADFGLAR 421
              E  I+HRD+K  N+L      D   KIADFGL++
Sbjct: 166 ---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 29/175 (16%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAV-------KRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++G+G   +VY G L   TTV V       ++L  + RQ    F  E   +  ++H N+V
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 331 KLLGC---SIEGPESL-LVYEYVPNRSLDQFI--FDKNKTKLL-NWNKRFNIILGTAEGL 383
           +       +++G + + LV E   + +L  ++  F   K K+L +W ++        +GL
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGL 142
Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRTHVSTAVAGT 437
            +LH  +   IIHRD+K  NI +     + KI D GLA      R   + AV GT
Sbjct: 143 QFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGT 193

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 35/184 (19%)
Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNTRQWVDE-----FFNEVNLISSI-EHK 327
           K LG G  G V M +   G   T V+++  +   ++  D        +E+ +++ +  H+
Sbjct: 51  KVLGSGAFGKV-MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 328 NLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNK-----------TKLLNWNKRFNI 375
           N+V LLG C++ GP   L++EY     L  ++  K +            K L   +  N+
Sbjct: 110 NIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 376 I---------LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +            A+G+ +L   S    +HRD+   N+L+      KI DFGLAR   +D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 427 RTHV 430
             +V
Sbjct: 226 SNYV 229

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 141
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           SE +I HRDIK +N+LL +    K+ADFG+A
Sbjct: 142 SEKKI-HRDIKAANVLLSEHGEVKLADFGVA 171

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 279 LGQGGAGSV----YMGSLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLL 333
           +G+G  G V    YM        VA+K     T   V E F  E   +   +H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G   E P   ++ E      L  F+  +  +  L     +   L TA  LAYL      R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLES---KR 511
Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +HRDI   N+L+      K+ DFGL+R +  D T+
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTY 546

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 57/115 (49%), Gaps = 27/115 (23%)
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-----LNWNK 371
           E+ ++S +EH N++K+L           ++E   N+   Q + +K+ + L     ++ + 
Sbjct: 79  EIAILSRVEHANIIKVLD----------IFE---NQGFFQLVMEKHGSGLDLFAFIDRHP 125
Query: 372 RFNIILGT------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           R +  L +         + YL       IIHRDIK  NI++ +DFT K+ DFG A
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           SE +I HRDIK +N+LL +    K+ADFG+A
Sbjct: 122 SEKKI-HRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 7/164 (4%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNTRQWV-DEFFN 316
           L+ K +  E   + F    +LG G  G V  +   P+G  +A K +    +  + ++   
Sbjct: 4   LTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++       +V   G      E  +  E++   SLDQ + +  +       K   + 
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 120
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +    GLAYL    + +I+HRD+K SNIL++     K+ DFG++
Sbjct: 121 IAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 162

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 121
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           SE +I HRDIK +N+LL +    K+ADFG+A
Sbjct: 122 SEKKI-HRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++  +  ++ EY+   S      D  +   L+  +   I+    +GL YLH  
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH-- 136
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           SE +I HRDIK +N+LL +    K+ADFG+A
Sbjct: 137 SEKKI-HRDIKAANVLLSEHGEVKLADFGVA 166

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 71/174 (40%), Gaps = 28/174 (16%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-------WVDEFF-----NEVNLISSIEH 326
           +  G  G+V  G    G  VA+KR +FNT           D F       E+ L++   H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKR-VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNR----SLDQFIFDKNKTKLLNWNKRF--NIILGTA 380
            N++ L    +   E  +   Y+        L Q I D+         + F  +I+LG  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG-- 146
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--RTHVST 432
                LH   E  ++HRD+   NILL  +    I DF LAR   AD  +TH  T
Sbjct: 147 -----LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 71/174 (40%), Gaps = 28/174 (16%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-------WVDEFF-----NEVNLISSIEH 326
           +  G  G+V  G    G  VA+KR +FNT           D F       E+ L++   H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKR-VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNR----SLDQFIFDKNKTKLLNWNKRF--NIILGTA 380
            N++ L    +   E  +   Y+        L Q I D+         + F  +I+LG  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG-- 146
Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--RTHVST 432
                LH   E  ++HRD+   NILL  +    I DF LAR   AD  +TH  T
Sbjct: 147 -----LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLI----FNTRQWVDEFFNEVNLISSIEHKNLV 330
           +K +G G  G VY   L  +G  VA+K+++    F  R        E+ ++  ++H N+V
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIV 76
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLI----FNTRQWVDEFFNEVNLISSIEHKNLV 330
           +K +G G  G VY   L  +G  VA+K+++    F  R        E+ ++  ++H N+V
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIV 76
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 5/118 (4%)
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWN 370
             +EVNL+  ++H N+V+     I+   + L  V EY     L   I    K +  L+  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 371 KRFNIILGTAEGLAYLHGGSE--TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               ++      L   H  S+    ++HRD+K +N+ LD     K+ DFGLAR    D
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 74/214 (34%), Gaps = 64/214 (29%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLV 330
           F P + +G+GG G V+   +  +    A+KR+    R+   E    EV  ++ +EH  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 331 KLLGCSIEGPESLLVYEY------------------------VPNRSLDQFIFDKN---- 362
           +     +E P      E                         V  R +D F   KN    
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQ 126
Query: 363 ------------------KTKLLNWNKR------------FNIILGTAEGLAYLHGGSET 392
                             K  L +W  R             +I +  AE + +LH     
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            ++HRD+K SNI    D   K+ DFGL      D
Sbjct: 185 -LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 76/198 (38%), Gaps = 24/198 (12%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWV 311
           L +     E   +  N  K LG+G  G V       +       TVAVK L    T    
Sbjct: 16  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 75
Query: 312 DEFFNEVNLISSI-EHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKT----- 364
               +E+ ++  I  H N+V LLG C+  G   +++ E+    +L  ++  K        
Sbjct: 76  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 135
Query: 365 -------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF 417
                    L            A+G+ +L   +  + IHRD+   NILL +    KI DF
Sbjct: 136 TPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 418 GLARCFAADRTHVSTAVA 435
           GLAR    D   V    A
Sbjct: 193 GLARDIXKDPDXVRKGDA 210

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +++G+G  G V+ G + N T   VA+K + +      +++   E+ ++S  +   +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            K  G  ++G +  ++ EY+   S      D  +    +  +   ++    +GL YLH  
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLH-- 137
Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           SE +I HRDIK +N+LL +    K+ADFG+A
Sbjct: 138 SEKKI-HRDIKAANVLLSEQGDVKLADFGVA 167

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 63/135 (46%), Gaps = 13/135 (9%)
Query: 294 NGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV---KLLGCSIEGPE--SLLVY 346
            G  VA+K++   F+          E+ ++   +H N++    +L  ++   E  S+ V 
Sbjct: 79  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 138
Query: 347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL 406
             +    L Q I       L +       +L    GL Y+H     ++IHRD+K SN+L+
Sbjct: 139 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLL---RGLKYMHSA---QVIHRDLKPSNLLV 192
Query: 407 DKDFTPKIADFGLAR 421
           +++   KI DFG+AR
Sbjct: 193 NENCELKIGDFGMAR 207

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIE 325
           ++ +   KKLG G  G V +      G   A+K   +    T        +EV ++  ++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 326 HKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++KL     +     LV E Y      D+ I  +  +++        I+     G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVLSGTT 118
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCF 423
           YLH   +  I+HRD+K  N+LL+   +D   KI DFGL+  F
Sbjct: 119 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 157

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 270 TNYFNPSKKLGQGGAGSVYM-GSLPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIE 325
           ++ +   KKLG G  G V +      G   A+K   +    T        +EV ++  ++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 326 HKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H N++KL     +     LV E Y      D+ I  +  +++        I+     G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVLSGTT 135
Query: 385 YLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCF 423
           YLH   +  I+HRD+K  N+LL+   +D   KI DFGL+  F
Sbjct: 136 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 174

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLI----FNTRQWVDEFFNEVNLISSIEHKNLV 330
           +K +G G  G VY   L  +G  VA+K+++    F  R        E+ ++  ++H N+V
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHCNIV 76
Query: 331 KL---LGCSIEGPESL---LVYEYVPN---RSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           +L      S E  + +   LV +YVP    R    +   K    ++ + K +   L    
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI-YVKLYMYQL--FR 133
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
            LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 29/40 (72%), Gaps = 3/40 (7%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           GL Y+H     ++IHRD+K SN+L++++   KI DFG+AR
Sbjct: 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLAR 421
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLAR 421
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLAR 421
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 71/179 (39%), Gaps = 23/179 (12%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKT-----------KLLNWNKRFNII 376
           +V LLG C+  G   +++ E+    +L  ++  K                L         
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
              A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    A
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++  I+H N+V L      G    L+ + V    L   I +K             +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNIL---LDKDFTPKIADFGLAR 421
           I    + + YLH   +  I+HRD+K  N+L   LD+D    I+DFGL++
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 37/182 (20%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS 322
           E  E   +   P  +LG+G  G V     +P+G   AVKR+                 ++
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRAT--------------VN 72
Query: 323 SIEHKNLVKLLGCS---IEGPESLLVY------------EYVPNRSLDQF---IFDKNKT 364
           S E K L+  L  S   ++ P ++  Y              + + SLD+F   + DK +T
Sbjct: 73  SQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQT 132
Query: 365 KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
             +  +    I +   + L +LH  S+  +IHRD+K SN+L++     K  DFG++    
Sbjct: 133 --IPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLV 188
Query: 425 AD 426
            D
Sbjct: 189 DD 190

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 435 A 435
           A
Sbjct: 201 A 201

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 435 A 435
           A
Sbjct: 210 A 210

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 10/118 (8%)
Query: 316 NEVNLISSIEHKNLVKLLGC--SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
            E+ L+  + HKN+++L+    + E  +  +V EY       Q + D    K     +  
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC--VCGMQEMLDSVPEKRFPVCQAH 112
Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC---FAADRT 428
                  +GL YLH      I+H+DIK  N+LL    T KI+  G+A     FAAD T
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 435 A 435
           A
Sbjct: 247 A 247

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 16/167 (9%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNE 317
           L  K+E + K T     S+ LG+G    V    SL NG   AVK +           F E
Sbjct: 6   LPGKFEDMYKLT-----SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFRE 60
Query: 318 VNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           V  +   + +KN+++L+    +     LV+E +   S+   I    K K  N  +   ++
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVV 117
Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTP-KIADFGLA 420
              A  L +LH      I HRD+K  NIL +  +  +P KI DF L 
Sbjct: 118 RDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLG 161

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-------- 328
           +KLG G   +V++     G      +++ +   + +   +E+ L+ S+ + +        
Sbjct: 27  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 86
Query: 329 LVKLLG----CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+LL       + G    +V+E + +  L   I    +   L   K+  II    +GL 
Sbjct: 87  VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLD 144
Query: 385 YLHGGSETRIIHRDIKTSNILL 406
           YLH  ++ RIIH DIK  NILL
Sbjct: 145 YLH--TKCRIIHTDIKPENILL 164

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           GL +LH      I++RD+K  NILLDKD   KIADFG+ +
Sbjct: 131 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 435 A 435
           A
Sbjct: 212 A 212

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 435 A 435
           A
Sbjct: 201 A 201

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           GL +LH      I++RD+K  NILLDKD   KIADFG+ +
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 13/167 (7%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH 326
           +  N +   +K+G G  G +Y+G+ +  G  VA+K     T+    +   E  +   ++ 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQG 63
Query: 327 K-NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
              +  +  C  EG  +++V E +     D F F   K  L        ++L   + ++ 
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK------TVLLLADQMISR 117
Query: 386 LHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTH 429
           +        IHRD+K  N L+    K     I DFGLA+ +   RTH
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 13/167 (7%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH 326
           +  N +   +K+G G  G +Y+G+ +  G  VA+K     T+    +   E  +   ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQG 61
Query: 327 K-NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
              +  +  C  EG  +++V E +     D F F   K  L        ++L   + ++ 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK------TVLLLADQMISR 115
Query: 386 LHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTH 429
           +        IHRD+K  N L+    K     I DFGLA+ +   RTH
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 13/167 (7%)
Query: 268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH 326
           +  N +   +K+G G  G +Y+G+ + +G  VA+K     T+    +   E      ++ 
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKH--PQLHIESKFYKMMQG 63
Query: 327 K-NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
              +  +  C  EG  +++V E +     D F F   K  L        ++L   + ++ 
Sbjct: 64  GVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK------TVLLLADQMISR 117
Query: 386 LHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTH 429
           +        IHRD+K  N L+    K     I DFGLA+ +   RTH
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 75/181 (41%), Gaps = 25/181 (13%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 435 A 435
           A
Sbjct: 201 A 201

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 75/181 (41%), Gaps = 25/181 (13%)
Query: 277 KKLGQGGAGSVY------MGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V       +       TVAVK L    T        +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKN------KTKLLNWNKRFNII----- 376
           +V LLG C+  G   +++ E+    +L  ++  K       K    +  K F  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 377 --LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR    D   V    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 435 A 435
           A
Sbjct: 210 A 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L YLH  SE  +++RD+K  N++LDKD   KI DFGL +
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-------- 328
           +KLG G   +V++     G      +++ +   + +   +E+ L+ S+ + +        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 329 LVKLLG----CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+LL       + G    +V+E + +  L   I    +   L   K+  II    +GL 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLD 160
Query: 385 YLHGGSETRIIHRDIKTSNILL 406
           YLH  ++ RIIH DIK  NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILL 180

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 33/57 (57%), Gaps = 3/57 (5%)
Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            L +LH   +  II+RDIK  NILLD +    + DFGL++ F AD T  +    GT+
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	438
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-86
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-84
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-58
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-50
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-44
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-22
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-16
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-16
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-16
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	3e-16
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	2e-12
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-07
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  286 bits (733), Expect = 3e-94
 Identities = 79/181 (43%), Positives = 112/181 (61%), Gaps = 2/181 (1%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEV 318
            F    L+ A++ F+    LG+GG G VY G L +GT VAVKRL     Q  + +F  EV
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNIIL 377
            +IS   H+NL++L G  +   E LLVY Y+ N S+   + ++ +++  L+W KR  I L
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           G+A GLAYLH   + +IIHRD+K +NILLD++F   + DFGLA+      THV+TAV GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 438 L 438
           +
Sbjct: 199 I 199

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  264 bits (678), Expect = 3e-86
 Identities = 77/189 (40%), Positives = 111/189 (58%), Gaps = 15/189 (7%)

Query: 260 SFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVKRL----IFNTRQ 309
           SF +  L+  TN F+         K+G+GG G VY G + N TTVAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNW 369
              +F  E+ +++  +H+NLV+LLG S +G +  LVY Y+PN SL   +   + T  L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRT 428
           + R  I  G A G+ +LH   E   IHRDIK++NILLD+ FT KI+DFGLAR      +T
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 429 HVSTAVAGT 437
            +++ + GT
Sbjct: 190 VMTSRIVGT 198

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  259 bits (665), Expect = 4e-84
 Identities = 74/204 (36%), Positives = 114/204 (55%), Gaps = 5/204 (2%)

Query: 236 RLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNG 295
           + SK     N+    +  +           LE+ATN F+    +G G  G VY G L +G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 296 TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD 355
             VA+KR    + Q ++EF  E+  +S   H +LV L+G   E  E +L+Y+Y+ N +L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123

Query: 356 QFIFDKNKTKL-LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI 414
           + ++  +   + ++W +R  I +G A GL YLH  +   IIHRD+K+ NILLD++F PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180

Query: 415 ADFGLARCF-AADRTHVSTAVAGT 437
            DFG+++     D+TH+ST V GT
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGT 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  191 bits (488), Expect = 9e-58
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 20/194 (10%)

Query: 257 SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQ-WVDEFF 315
           S +    E L   +      +   +G  G V+         VAVK      +Q W +E+ 
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEY- 67

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
            EV  +  ++H+N+++ +G    G     +  L+  +    SL  F+    K  +++WN+
Sbjct: 68  -EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNE 122

Query: 372 RFNIILGTAEGLAYLH-------GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA 424
             +I    A GLAYLH        G +  I HRDIK+ N+LL  + T  IADFGLA  F 
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 425 ADRTHV-STAVAGT 437
           A ++   +    GT
Sbjct: 183 AGKSAGDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  171 bits (434), Expect = 9e-50
 Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 28/199 (14%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEV 318
           +           +     + +G+G  G+VY GSL +   VAVK     +      F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEK 56

Query: 319 N--LISSIEHKNLVKLLGCSIEGPES-----LLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
           N   +  +EH N+ + +              LLV EY PN SL +++         +W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112

Query: 372 RFNIILGTAEGLAYLH------GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
              +      GLAYLH         +  I HRD+ + N+L+  D T  I+DFGL+     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 426 DR-------THVSTAVAGT 437
           +R        + + +  GT
Sbjct: 173 NRLVRPGEEDNAAISEVGT 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  163 bits (415), Expect = 3e-47
 Identities = 53/164 (32%), Positives = 89/164 (54%), Gaps = 5/164 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +K+G G  G+V+     +G+ VAVK L+      + V+EF  EV ++  + H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
              + P   +V EY+   SL + +      + L+  +R ++    A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +HR++K+ N+L+DK +T K+ DFGL+R   A     S + AGT 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTP 203

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  157 bits (398), Expect = 1e-44
 Identities = 46/163 (28%), Positives = 65/163 (39%), Gaps = 10/163 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           + +G+G  G V          VA+K     +      F  E+  +S + H N+VKL G  
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +      LV EY    SL   +               +  L  ++G+AYLH      +IH
Sbjct: 71  LNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 397 RDIKTSNILLDKDFT-PKIADFGLARCFAADRTHVSTAVAGTL 438
           RD+K  N+LL    T  KI DFG A     D     T   G+ 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSA 167

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  154 bits (392), Expect = 4e-44
 Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 22/175 (12%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIF-------NTRQWVDEFFNEVNLISSIEHKN 328
           K++G+GG G V+ G  + + + VA+K LI           +   EF  EV ++S++ H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +VKL G     P   +V E+VP   L   +   +K   + W+ +  ++L  A G+ Y+  
Sbjct: 85  IVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQ- 139

Query: 389 GSETRIIHRDIKTSNILLDK-----DFTPKIADFGLARCFAADRTHVSTAVAGTL 438
                I+HRD+++ NI L           K+ADFGL++       H  + + G  
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNF 190

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (381), Expect = 1e-42
 Identities = 32/166 (19%), Positives = 66/166 (39%), Gaps = 13/166 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
            KL +  +G ++ G    G  + VK L     + +   +F  E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 335 CSIEGPESLL--VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
                P      +  ++P  SL   +  +    +++ ++     L  A G+A+LH   E 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            I    + + ++++D+D T +I+   +   F       S       
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAP 172

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  146 bits (370), Expect = 4e-41
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 20/174 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF----NTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + +G GG G VY      G  VAVK        +  Q ++    E  L + ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G  ++ P   LV E+     L++ +  K     +  +   N  +  A G+ YLH  +  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 393 RIIHRDIKTSNILLDKDFTP--------KIADFGLARCFAADRTHVSTAVAGTL 438
            IIHRD+K+SNIL+ +            KI DFGLAR +         + AG  
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAY 178

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  146 bits (369), Expect = 2e-40
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 22/176 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE--VNLISSIEHKNLVKLLG 334
           K++G+G  G V+MG    G  VAVK  +F T +    +F E  +     + H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVK--VFFTTE-EASWFRETEIYQTVLMRHENILGFIA 98

Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
             I+G  S     L+ +Y  N SL  ++    K+  L+      +   +  GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 391 ETR-----IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTL 438
            +      I HRD+K+ NIL+ K+ T  IAD GLA  F +D   V        GT 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  142 bits (360), Expect = 2e-39
 Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE--VNLISSIEHKNLVKLLG 334
           + +G+G  G V+ GS   G  VAVK  IF++R     +F E  +     + H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVK--IFSSRD-EKSWFRETELYNTVMLRHENILGFIA 69

Query: 335 CSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
             +    S     L+  Y    SL  ++    +   L+      I+L  A GLA+LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 391 ETR-----IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGT 437
                   I HRD+K+ NIL+ K+    IAD GLA   +     +   +    GT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  142 bits (359), Expect = 5e-39
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 6/161 (3%)

Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           + LG+G  G     +    G  + +K LI    +    F  EV ++  +EH N++K +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             +      + EY+   +L   I  K+      W++R +     A G+AYLH      II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           HRD+ + N L+ ++    +ADFGLAR    ++T      + 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  140 bits (354), Expect = 1e-38
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 11/165 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +++G G  G+VY G   +G  VAVK L     T Q +  F NEV ++    H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
            S     ++ V ++    SL   +            K  +I   TA G+ YLH      I
Sbjct: 88  YSTAPQLAI-VTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTL 438
           IHRD+K++NI L +D T KI DFGLA   +    +H    ++G++
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  138 bits (349), Expect = 1e-37
 Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 14/168 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF--NTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           + +G+G  G VY G   +G  VA++ +    +    +  F  EV       H+N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             +  P   ++      R+L   +  ++   +L+ NK   I     +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLAR----CFAADRTHVSTAVAGTL 438
           +H+D+K+ N+  D      I DFGL        A  R        G L
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  137 bits (347), Expect = 5e-37
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 22/176 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE--VNLISSIEHKNLVKLLG 334
           + +G+G  G V+ G    G  VAVK  IF++R+    +F E  +     + H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIA 103

Query: 335 CSI----EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH--- 387
                     +  LV +Y  + SL  ++        +       + L TA GLA+LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 388 --GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV---STAVAGTL 438
                +  I HRD+K+ NIL+ K+ T  IAD GLA    +    +        GT 
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (306), Expect = 2e-31
 Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 19/156 (12%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +KLG+GG   V +   L +G   A+KR++ + +Q  +E   E ++     H N+++L+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 336 SIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAY 385
            +    +     L+  +    +L   I      +L +            ++LG   GL  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +H        HRD+K +NILL  +  P + D G   
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  122 bits (308), Expect = 3e-31
 Identities = 43/181 (23%), Positives = 72/181 (39%), Gaps = 9/181 (4%)

Query: 244 RNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKR 302
                L   S      +   +            +++G+G  G V+ G L  + T VAVK 
Sbjct: 87  STQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146

Query: 303 L-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFD 360
                      +F  E  ++    H N+V+L+G C+ + P   +V E V       F+  
Sbjct: 147 CRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGGDFLTFL-- 203

Query: 361 KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           + +   L       ++   A G+ YL        IHRD+   N L+ +    KI+DFG++
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

Query: 421 R 421
           R
Sbjct: 261 R 261

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  122 bits (309), Expect = 5e-31
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 8/146 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           + +G+G  G V +G    G  VAVK +  +       F  E ++++ + H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             E     +V EY+   SL  ++  + +  +L  +      L   E + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N+L+ +D   K++DFGL +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (299), Expect = 9e-31
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 12/157 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  +   + ++  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              R IHRD+ T NIL++ +   KI DFGL +    D
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  118 bits (298), Expect = 1e-30
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 8/146 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           + +G+G  G V +G    G  VAVK +  +       F  E ++++ + H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             E     +V EY+   SL  ++  + +  +L  +      L   E + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N+L+ +D   K++DFGL +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  118 bits (299), Expect = 1e-30
 Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 15/158 (9%)

Query: 277 KKLGQGGAGSVYMGSLPN-----GTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L      Q    +  E++++ ++ H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C   G  SL LV EYVP  SL  ++        +   +         EG+AYLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH- 151

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
                 IHRD+   N+LLD D   KI DFGLA+     
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 1e-30
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 12/157 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           ++LG+G  GSV M          G  VAVK+L  +T + + +F  E+ ++ S++H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G C   G  +L L+ EY+P  SL  ++  +   + ++  K         +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              R IHRD+ T NIL++ +   KI DFGL +    D
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  118 bits (297), Expect = 2e-30
 Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 13/158 (8%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  G V +          G  VAVK L   +    + +   E+ ++ ++ H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           K  G C+ +G   + L+ E++P+ SL +++        +N  ++    +   +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               + +HRD+   N+L++ +   KI DFGL +    D
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  119 bits (299), Expect = 3e-30
 Identities = 43/191 (22%), Positives = 91/191 (47%), Gaps = 12/191 (6%)

Query: 250 YATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN-- 306
           +++ +     +  ++++EK    +   +K+G+G  G   +  S  +G    +K +  +  
Sbjct: 7   HSSGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62

Query: 307 TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
           + +  +E   EV ++++++H N+V+      E     +V +Y     L + I +  K  L
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVL 121

Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              ++  +  +     L ++H   + +I+HRDIK+ NI L KD T ++ DFG+AR   + 
Sbjct: 122 FQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

Query: 427 RTHVSTAVAGT 437
                  + GT
Sbjct: 179 VELARACI-GT 188

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  117 bits (295), Expect = 4e-30
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 11/151 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G+G  G VY G   +        A+K L      Q V+ F  E  L+  + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 332 LLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L+G          ++  Y+ +  L QFI  ++  +        +  L  A G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL---A 141

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           E + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  119 bits (301), Expect = 6e-30
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 6/145 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           KKLG G  G V+M +    T VAVK +   +   V+ F  E N++ +++H  LVKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ E++   SL  F+   ++       K  +     AEG+A++    +   IH
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+      KIADFGLAR
Sbjct: 308 RDLRAANILVSASLVCKIADFGLAR 332

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (294), Expect = 9e-30
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 12/156 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNG-----TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G            VA+K L   T  +   E  +E  +++S+++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG  +      L+ + +P   L  ++  +     +      N  +  A+G+ YL    
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + R++HRD+   N+L+      KI DFGLA+   A+
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  115 bits (291), Expect = 1e-29
 Identities = 53/145 (36%), Positives = 77/145 (53%), Gaps = 6/145 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L   +    D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+        L  NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 397 RDIKTSNILLDKDFTPKIADFGLAR 421
           RD++ +NIL+    + KIADFGLAR
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLAR 157

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (291), Expect = 2e-29
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 10/165 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
             LG+G  G VY G  L N   +A+K +     ++      E+ L   ++HKN+V+ LG 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF--NIILGTAEGLAYLHGGSETR 393
             E     +  E VP  SL   +  ++K   L  N++          EGL YLH   + +
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142

Query: 394 IIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           I+HRDIK  N+L++      KI+DFG ++  A       T   GT
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  116 bits (292), Expect = 2e-29
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)

Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
            +LG+G  GSV +          G  VAVK+L  +      +F  E+ ++ ++    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
             G     G +SL LV EY+P+  L  F+  +     L+ ++         +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              R +HRD+   NIL++ +   KIADFGLA+    D
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  119 bits (299), Expect = 2e-29
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 6/151 (3%)

Query: 277 KKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            KLG G  G VY G       TVAVK L  +T + V+EF  E  ++  I+H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
               P   ++ E++   +L  ++ + N+ + ++      +    +  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           HR++   N L+ ++   K+ADFGL+R    D
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  115 bits (290), Expect = 2e-29
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 24/165 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++LG+G  G V++    N         VAVK L   T     +F  E  L+++++H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQF-------------IFDKNKTKLLNWNKRFNII 376
           K  G C    P  ++V+EY+ +  L++F                +     L  ++  +I 
Sbjct: 81  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              A G+ YL   +    +HRD+ T N L+  +   KI DFG++R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  114 bits (288), Expect = 2e-29
 Identities = 49/146 (33%), Positives = 73/146 (50%), Gaps = 8/146 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V +G       VAVK +   +    DEFF E   +  + H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           S E P   +V EY+ N  L  ++  ++  K L  ++   +     EG+A+L      + I
Sbjct: 73  SKEYP-IYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126

Query: 396 HRDIKTSNILLDKDFTPKIADFGLAR 421
           HRD+   N L+D+D   K++DFG+ R
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR 152

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  114 bits (288), Expect = 3e-29
 Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 8/151 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           K+LG G  G V  G       VA+K +   +    DEF  E  ++ ++ H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
           + + P   ++ EY+ N  L  ++  +         +   +     E + YL      + +
Sbjct: 89  TKQRP-IFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           HRD+   N L++     K++DFGL+R    D
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  114 bits (288), Expect = 3e-29
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 21/161 (13%)

Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
           + LGQG    ++ G           + T V +K L    R + + FF   +++S + HK+
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           LV   G  + G E++LV E+V   SLD ++  K     +N   +  +    A  + +L  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL-- 129

Query: 389 GSETRIIHRDIKTSNILLDKDFTP--------KIADFGLAR 421
             E  +IH ++   NILL ++           K++D G++ 
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  118 bits (298), Expect = 3e-29
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 6/150 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
            KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F       K L   +  ++    A G+AY+        +H
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           RD++ +NIL+ ++   K+ADFGLAR    +
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDN 416

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  113 bits (286), Expect = 4e-29
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 8/151 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
           +++G G  G V++G   N   VA+K +        ++F  E  ++  + H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             + P   LV E++ +  L  ++  + +  L        + L   EG+AYL    E  +I
Sbjct: 73  LEQAP-ICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 396 HRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           HRD+   N L+ ++   K++DFG+ R    D
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  117 bits (295), Expect = 5e-29
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 6/150 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
            KLGQG  G V+MG+    T VA+K L   T    + F  E  ++  + H+ LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            E P   +V EY+   SL  F       K L   +  ++    A G+AY+        +H
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           RD++ +NIL+ ++   K+ADFGLAR    +
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDN 333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  114 bits (288), Expect = 5e-29
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 17/159 (10%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG+G  GSV  G+L         VAVK +    ++++ ++EF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 331 KLLG-CSIEGPES----LLVYEYVPNRSLDQFI---FDKNKTKLLNWNKRFNIILGTAEG 382
           +LLG C     +     +++  ++    L  ++     +   K +        ++  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           + YL   S    +HRD+   N +L  D T  +ADFGL++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  113 bits (285), Expect = 8e-29
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 8/152 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTT-VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG- 334
            KLG G  G VY G     +  VAVK L  +T + V+EF  E  ++  I+H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           C+ E P   ++ E++   +L  ++ + N+ ++ +      +    +  + YL    +   
Sbjct: 78  CTREPP-FYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL---EKKNF 132

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           IHRD+   N L+ ++   K+ADFGL+R    D
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  114 bits (287), Expect = 9e-29
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 23/164 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV 330
            +LG+G  G V++    N         VAVK L   +     +F  E  L++ ++H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQF------------IFDKNKTKLLNWNKRFNIIL 377
           +  G C+   P  L+V+EY+ +  L++F              +      L   +   +  
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             A G+ YL   +    +HRD+ T N L+ +    KI DFG++R
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  113 bits (284), Expect = 1e-28
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 15/174 (8%)

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKN 328
           +     ++G+G   +VY G        VA    +    T+     F  E  ++  ++H N
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 329 LVKLLGC---SIEGPESLLVY-EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+       +++G + +++  E + + +L  ++    + K++      +      +GL 
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQ 143

Query: 385 YLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           +LH      IIHRD+K  NI +     + KI D GLA    A       AV GT
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGT 193

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  113 bits (284), Expect = 1e-28
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 14/156 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVK 331
           K+LG G  G+V  G         TVAVK L          DE   E N++  +++  +V+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 332 LLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           ++G C  E    +LV E      L++++    + + +       ++   + G+ YL    
Sbjct: 83  MIGICEAESW--MLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           E+  +HRD+   N+LL      KI+DFGL++   AD
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (284), Expect = 1e-28
 Identities = 40/174 (22%), Positives = 73/174 (41%), Gaps = 17/174 (9%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIEHKNLV 330
           F P + LG+GG G V+   +  +    A+KR+    R+   ++   EV  ++ +EH  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 331 KLLGCSIEGPE---------SLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           +     +E             + +Y   +     +L  ++  +   +    +   +I L 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            AE + +LH      ++HRD+K SNI    D   K+ DFGL      D    + 
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (286), Expect = 1e-28
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 17/159 (10%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           ++LGQG  G VY G           T VA+K +    + +   EF NE +++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQF-------IFDKNKTKLLNWNKRFNIILGTAEG 382
           V+LLG   +G  +L++ E +    L  +       + +       + +K   +    A+G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +AYL   +  + +HRD+   N ++ +DFT KI DFG+ R
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  113 bits (285), Expect = 1e-28
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 12/156 (7%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+VY G            VA+K L   T  +   E  +E  +++S+++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG  +      L+ + +P   L  ++  +     +      N  +  A+G+ YL    
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           + R++HRD+   N+L+      KI DFGLA+   A+
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  112 bits (283), Expect = 2e-28
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 13/152 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + +G+G  G VY G+L +        AVK L  I +  + V +F  E  ++    H N++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVL 89

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            LLG C       L+V  Y+ +  L  FI  +N+T            L  A+G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL--- 144

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  113 bits (285), Expect = 2e-28
 Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 12/162 (7%)

Query: 277 KKLGQGGAGSVYMGSL-----PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           K LG G  G+V+ G            V +K +   + RQ      + +  I S++H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           +LLG         LV +Y+P  SL   +  +     L      N  +  A+G+ YL    
Sbjct: 79  RLLGLCPGSS-LQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           E  ++HR++   N+LL      ++ADFG+A     D   +  
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  112 bits (283), Expect = 2e-28
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 9/166 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFN--TRQWVDEFFNEVNLISSIEHKNLVKL 332
           KK+G+G    VY    L +G  VA+K++ IF+    +   +   E++L+  + H N++K 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               IE  E  +V E      L + I   K + +L+     +   +     L ++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            R++HRDIK +N+ +      K+ D GL R F++  T   + V GT
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 199

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  113 bits (284), Expect = 2e-28
 Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 18/160 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + LG+G  GSV    L         VAVK L         ++EF  E   +   +H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 331 KLLG-CSIEGPES-----LLVYEYVPNRSLDQFIFD---KNKTKLLNWNKRFNIILGTAE 381
           KL+G       +      +++  ++ +  L  F+           L        ++  A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           G+ YL   S    IHRD+   N +L +D T  +ADFGL+R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  111 bits (281), Expect = 3e-28
 Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 25/166 (15%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           ++LG+   G VY G L           VA+K L         +EF +E  L + ++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQF-------------IFDKNKTKLLNWNKRFNI 375
           V LLG  + + P   +++ Y  +  L +F               D+     L      ++
Sbjct: 75  VCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +   A G+ YL   S   ++H+D+ T N+L+      KI+D GL R
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  111 bits (279), Expect = 7e-28
 Identities = 52/157 (33%), Positives = 74/157 (47%), Gaps = 13/157 (8%)

Query: 277 KKLGQGGAGSVYMGSL--PNGTT--VAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +KLG G  G V  G    P+G T  VAVK L   + +  + +D+F  EVN + S++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           ++L G  +  P   +V E  P  SL   +  +               +  AEG+ YL   
Sbjct: 84  IRLYGVVLTPP-MKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL--- 137

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              R IHRD+   N+LL      KI DFGL R    +
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  112 bits (281), Expect = 1e-27
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           + +G+G  G VY G+L +        AVK L  I +  +    F  E  ++    H N++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 153

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
            LLG C       L+V  Y+ +  L  FI  +N+T            L  A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL--- 208

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +  + +HRD+   N +LD+ FT K+ADFGLAR
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  109 bits (274), Expect = 3e-27
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+G  G VY G   N       VAVK    +      ++F +E  ++ +++H ++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P + ++ E  P   L  ++  +     L         L   + +AYL     
Sbjct: 78  LIGIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ES 131

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              +HRDI   NIL+      K+ DFGL+R
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSR 161

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  110 bits (276), Expect = 3e-27
 Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 19/160 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +           VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+       ++   L      ++    A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 385 YLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLAR 421
           YL    E   IHRDI   N LL         KI DFG+AR
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  110 bits (277), Expect = 4e-27
 Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 19/160 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
           + LG G  G VY G +           VAVK L  + + +  +D F  E  +IS   H+N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+ +G S++     ++ E +    L  F+       ++   L      ++    A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 385 YLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLAR 421
           YL    E   IHRDI   N LL         KI DFG+AR
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  108 bits (272), Expect = 5e-27
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 10/153 (6%)

Query: 278 KLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLL 333
           +LG G  GSV  G          VA+K L   T +   +E   E  ++  +++  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G        +LV E      L +F+    K + +  +    ++   + G+ YL    E  
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            +HRD+   N+LL      KI+DFGL++   AD
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  108 bits (272), Expect = 5e-27
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 27/182 (14%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F   + +G GG G V+      +G T  +KR+ +N     ++   EV  ++ ++H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68

Query: 332 LLGCSIEGPESL----------------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
             GC                        +  E+    +L+Q+I +K + + L+      +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVA 435
                +G+ Y+H     ++I+RD+K SNI L      KI DFGL      D     T   
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182

Query: 436 GT 437
           GT
Sbjct: 183 GT 184

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  109 bits (274), Expect = 5e-27
 Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 25/167 (14%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V               TVAVK L    T        +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-------- 379
           +V LLG C+  G   +++ E+    +L  ++  K    +       ++            
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 380 -----AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  108 bits (273), Expect = 9e-27
 Identities = 43/164 (26%), Positives = 68/164 (41%), Gaps = 23/164 (14%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRL--IFNTRQWVDEFFNEVNLISSI-EHKNLV 330
             +G+G  G V    +         A+KR+    +     D F  E+ ++  +  H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT----------- 379
            LLG         L  EY P+ +L  F+      +        N    T           
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 380 --AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             A G+ YL   S+ + IHRD+   NIL+ +++  KIADFGL+R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  109 bits (273), Expect = 9e-27
 Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 25/170 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            ++G+G  G V+       G   AVK++     +       E+   + +    +V L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAYLHGG 389
             EGP   +  E +   SL          +L+              +    EGL YLH  
Sbjct: 119 VREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEGLEYLH-- 167

Query: 390 SETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVSTAVAGTL 438
              RI+H D+K  N+LL  D +   + DFG A C   D    S      +
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (271), Expect = 1e-26
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 31/173 (17%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V   +  +       TTVAVK L  N +   + +  +E N++  + H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT---------- 379
           +KL G   +    LL+ EY    SL  F+ +  K          +    +          
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 380 -----------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                      ++G+ YL   +E +++HRD+   NIL+ +    KI+DFGL+R
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  107 bits (270), Expect = 2e-26
 Identities = 50/169 (29%), Positives = 73/169 (43%), Gaps = 28/169 (16%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG G  G V   +           TVAVK L  +      +   +E+ ++S +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-------- 379
           +V LLG C+I GP +L++ EY     L  F+  K  + + +      +            
Sbjct: 89  IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 380 -------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                  A+G+A+L   +    IHRD+   NILL      KI DFGLAR
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  111 bits (278), Expect = 2e-26
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 10/154 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNG---TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKL 332
            +LG G  GSV  G          VA+K L   T +   +E   E  ++  +++  +V+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +G        +LV E      L +F+    K + +  +    ++   + G+ YL    E 
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEK 455

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
             +HR++   N+LL      KI+DFGL++   AD
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  106 bits (267), Expect = 2e-26
 Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 11/155 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           + +G+G  G V+ G   +       VA+K     T     ++F  E   +   +H ++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P   ++ E      L  F+  + +   L+           +  LAYL     
Sbjct: 81  LIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ES 134

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            R +HRDI   N+L+  +   K+ DFGL+R     
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  107 bits (270), Expect = 2e-26
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 31/173 (17%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
           + +G+G  G V+    P        T VAVK L    +     +F  E  L++  ++ N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQF---------------------IFDKNKTKLLN 368
           VKLLG    G    L++EY+    L++F                              L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             ++  I    A G+AYL   SE + +HRD+ T N L+ ++   KIADFGL+R
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  107 bits (268), Expect = 3e-26
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 12/156 (7%)

Query: 277 KKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G +G V  G L         VA+K L      +   +F +E +++   +H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 332 LLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L G  +     +++V EY+ N SLD F+  +         +   ++ G   G+ YL   S
Sbjct: 115 LEGVVTRGRL-AMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +   +HRD+   N+L+D +   K++DFGL+R    D
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  107 bits (268), Expect = 4e-26
 Identities = 36/168 (21%), Positives = 73/168 (43%), Gaps = 15/168 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNL--VKL 332
           K++G GG+  V+          A+K +       Q +D + NE+  ++ ++  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                   + + +V E   N  L+ ++  K     ++  +R +      E +  +H   +
Sbjct: 75  YD-YEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---Q 126

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTL 438
             I+H D+K +N L+      K+ DFG+A     D T V   +  GT+
Sbjct: 127 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  106 bits (268), Expect = 5e-26
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 26/168 (15%)

Query: 277 KKLGQGGAGSVYMGSLP--------NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L    T + + +  +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT------- 379
           KN++ LLG   +     ++ EY    +L +++  +    +        +           
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 380 ------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  106 bits (268), Expect = 5e-26
 Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 24/165 (14%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG G  G V   +            VAVK L         +   +E+ ++S + +H+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT-------- 379
           +V LLG C+  GP  L++ EY     L  F+  K++    +          +        
Sbjct: 112 IVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 380 ---AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
              A+G+A+L   +    IHRD+   N+LL      KI DFGLAR
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  105 bits (265), Expect = 8e-26
 Identities = 35/168 (20%), Positives = 72/168 (42%), Gaps = 15/168 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL--VKL 332
           K++G GG+  V+          A+K +         +D + NE+  ++ ++  +   ++L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                   + + +V E   N  L+ ++  K     ++  +R +      E +  +H   +
Sbjct: 94  YDY-EITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---Q 145

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTL 438
             I+H D+K +N L+      K+ DFG+A     D T V   +  GT+
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  106 bits (267), Expect = 9e-26
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 26/168 (15%)

Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V M               TVAVK L    T + + +  +E+ ++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT------- 379
           KN++ LLG   +     ++ EY    +L +++  +    +        +           
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 380 ------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 A G+ YL   +  + IHRD+   N+L+ ++   KIADFGLAR
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  106 bits (266), Expect = 1e-25
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 10/155 (6%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           K +G G  G V  G L        +VA+K L +  T +   +F  E +++   +H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L G   +    ++V EY+ N SLD F+  +         +   ++ G A G+ YL   S+
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              +HRD+   NIL++ +   K++DFGL R    D
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  105 bits (264), Expect = 1e-25
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 13/167 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNGT-----TVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLV 330
           K +G G  G VY G L   +      VA+K L      +   +F  E  ++    H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 331 KLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           +L G  S   P  +++ EY+ N +LD+F+  + K    +  +   ++ G A G+ YL   
Sbjct: 110 RLEGVISKYKP-MMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
           +    +HRD+   NIL++ +   K++DFGL+R    D     T   G
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (266), Expect = 2e-25
 Identities = 35/168 (20%), Positives = 72/168 (42%), Gaps = 15/168 (8%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNL--VKL 332
           K++G GG+  V+          A+K +       Q +D + NE+  ++ ++  +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                   + + +V E   N  L+ ++  K     ++  +R +      E +  +H   +
Sbjct: 122 YD-YEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---Q 173

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTL 438
             I+H D+K +N L+      K+ DFG+A     D T V   +  G +
Sbjct: 174 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  103 bits (258), Expect = 3e-25
 Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 9/169 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLL 333
             +G G  G         +G  +  K L +   T        +EVNL+  ++H N+V+  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 334 GCSIEGPESLL--VYEYVPNRSLDQFI-FDKNKTKLLNWNKRFNIILGTAEGLAYLH--G 388
              I+   + L  V EY     L   I     + + L+      ++      L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
                ++HRD+K +N+ LD     K+ DFGLAR    D +   T V GT
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GT 179

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (260), Expect = 4e-25
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 17/167 (10%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEH 326
           + +  S  LGQG   +V+ G     G   A+K  +FN   +   VD    E  ++  + H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 327 KNLVKLLGCSIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           KN+VKL     E   +       E+ P  SL   + + +    L  ++   ++     G+
Sbjct: 67  KNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 384 AYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAAD 426
            +L    E  I+HR+IK  NI+     D     K+ DFG AR    D
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  104 bits (262), Expect = 5e-25
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 26/168 (15%)

Query: 277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +              T VAVK L  + T + + +  +E+ ++  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT------- 379
           KN++ LLG   +     ++ EY    +L +++  +    L       +            
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 380 ------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                 A G+ YL   +  + IHRD+   N+L+ +D   KIADFGLAR
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  106 bits (267), Expect = 6e-25
 Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 11/155 (7%)

Query: 277 KKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVK 331
           + +G+G  G V+ G   +       VA+K      +    ++F  E   +   +H ++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P   ++ E      L  F+  + +   L+           +  LAYL     
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ES 509

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
            R +HRDI   N+L+  +   K+ DFGL+R     
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  103 bits (260), Expect = 6e-25
 Identities = 40/173 (23%), Positives = 64/173 (36%), Gaps = 31/173 (17%)

Query: 277 KKLGQGGAGSVYMGSLPNG------TTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG G  G V   +            VAVK L         +   +E+ +++ +  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT--------- 379
           +V LLG         L++EY     L  ++  K +    +  +  N              
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 380 -----------AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
                      A+G+ +L        +HRD+   N+L+      KI DFGLAR
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  104 bits (262), Expect = 6e-25
 Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 19/178 (10%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE---FFNEVNLISSIEH 326
           + +  S  LGQG   +V+ G     G   A+K  +FN   ++        E  ++  + H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 327 KNLVKLLGCSIEGPESLLVY---EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           KN+VKL     E   +       E+ P  SL   + + +    L  ++   ++     G+
Sbjct: 67  KNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 384 AYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            +L    E  I+HR+IK  NI+     D     K+ DFG AR    D     +   GT
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GT 178

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  102 bits (256), Expect = 1e-24
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 20/168 (11%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           F     LGQG  G V    +  +    A+K+ I +T + +    +EV L++S+ H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 332 LLGCSIEGPESL-------------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
                +E    +             +  EY  N +L   I   ++      ++ + +   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLFRQ 124

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
             E L+Y+H      IIHRD+K  NI +D+    KI DFGLA+     
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 1e-24
 Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 22/168 (13%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +YE L+           LG+G   +VY          VA+K++    R    +  N    
Sbjct: 11  RYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
            E+ L+  + H N++ LL          LV++++    L+  I D +     +  K +  
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY-- 117

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           +L T +GL YLH   +  I+HRD+K +N+LLD++   K+ADFGLA+ F
Sbjct: 118 MLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (260), Expect = 1e-24
 Identities = 46/174 (26%), Positives = 75/174 (43%), Gaps = 19/174 (10%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKNLVK 331
           F P   LG G  G++    + +   VAVKR++    +       EV  L  S EH N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIR 82

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
              C+ +  +   +  E     +L +++  + K       +   ++  T  GLA+LH   
Sbjct: 83  YF-CTEKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH--- 135

Query: 391 ETRIIHRDIKTSNILL-----DKDFTPKIADFGLARCFAADR--THVSTAVAGT 437
              I+HRD+K  NIL+            I+DFGL +  A  R      + V GT
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  102 bits (256), Expect = 2e-24
 Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 10/166 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLG 334
           + L +GG   VY    + +G   A+KRL+ N  +       EV  +  +  H N+V+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 335 CSIEGPES-------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            +  G E         L+   +    L +F+        L+ +    I   T   + ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
              +  IIHRD+K  N+LL    T K+ DFG A   +    +  +A
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (260), Expect = 2e-24
 Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 30/189 (15%)

Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKNL 329
           N     K LG G +G+V       G  VAVKR++     + D    E+  L  S +H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71

Query: 330 VKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLA 384
           ++   CS      L +  E     +L   +  KN      KL       +++   A G+A
Sbjct: 72  IRYY-CSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 385 YLHGGSETRIIHRDIKTSNILLD-------------KDFTPKIADFGLARCFAADRTHVS 431
           +LH     +IIHRD+K  NIL+              ++    I+DFGL +   + ++   
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 432 TA---VAGT 437
           T     +GT
Sbjct: 187 TNLNNPSGT 195

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =   99 bits (250), Expect = 7e-24
 Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 26/163 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+GG    +           A K     L+    Q  ++   E+++  S+ H+++V 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVG 79

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
             G   E  + + +V E    RSL     + +K +     K          +     G  
Sbjct: 80  FHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLRQIVLGCQ 129

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           YLH     R+IHRD+K  N+ L++D   KI DFGLA     D 
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (251), Expect = 9e-24
 Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 26/163 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+GG    +           A K     L+    Q  ++   E+++  S+ H+++V 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVG 105

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
             G   E  + + +V E    RSL     + +K +     K          +     G  
Sbjct: 106 FHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLRQIVLGCQ 155

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           YLH     R+IHRD+K  N+ L++D   KI DFGLA     D 
Sbjct: 156 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 29/181 (16%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +YE + +          +G G  G+VY      +G  VA+K +                 
Sbjct: 10  RYEPVAE----------IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59

Query: 317 -EVNL---ISSIEHKNLVKLL----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
            EV L   + + EH N+V+L+        +    + LV+E+V ++ L  ++ DK     L
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGL 117

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
                 +++     GL +LH      I+HRD+K  NIL+    T K+ADFGLAR ++   
Sbjct: 118 PAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 428 T 428
            
Sbjct: 175 A 175

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 31/182 (17%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE + K          +G+G  G V+   +   G  VA+K+ + +     D        
Sbjct: 4   KYEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVIKKIAL 50

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E+ ++  ++H NLV LL         L LV+EY  + ++   +    +    +  K   
Sbjct: 51  REIRMLKQLKHPNLVNLLEV-FRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI- 107

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR---TH-V 430
               T + + + H   +   IHRD+K  NIL+ K    K+ DFG AR            V
Sbjct: 108 -TWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163

Query: 431 ST 432
           +T
Sbjct: 164 AT 165

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 99.1 bits (248), Expect = 2e-23
 Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 28/170 (16%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
            ++ +EK          +G+G  G VY   +   G  VA+K++  +T     E       
Sbjct: 4   NFQKVEK----------IGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAI 50

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL-LNWNKRF 373
            E++L+  + H N+VKLL   I     L LV+E++  + L +F+     T + L   K +
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSY 108

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
             +    +GLA+ H     R++HRD+K  N+L++ +   K+ADFGLAR F
Sbjct: 109 --LFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 27/169 (15%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE LEK          +G+G  G+V+   +      VA+KR+  +     DE       
Sbjct: 3   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSAL 49

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E+ L+  ++HKN+V+L    +   + L LV+E+     L ++    N        K F 
Sbjct: 50  REICLLKELKHKNIVRLHDV-LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF- 106

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
            +    +GL + H      ++HRD+K  N+L++++   K+A+FGLAR F
Sbjct: 107 -LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 14/165 (8%)

Query: 263 YETLEKATNYFNPSK------KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF 315
            E L    +  +P K      K+GQG +G+VY    +  G  VA++++    +   +   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           NE+ ++   ++ N+V  L   + G E  +V EY+   SL   +        ++  +   +
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAV 121

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
                + L +LH     ++IHRDIK+ NILL  D + K+ DFG  
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 37/145 (25%), Positives = 72/145 (49%), Gaps = 6/145 (4%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
            +LG G  G VY   +   G   A K +   + + ++++  E+ ++++ +H  +VKLLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
                +  ++ E+ P  ++D  +      + L   +   +     E L +LH     RII
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLH---SKRII 139

Query: 396 HRDIKTSNILLDKDFTPKIADFGLA 420
           HRD+K  N+L+  +   ++ADFG++
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS 164

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 8/152 (5%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
              F+  +KLG+G  GSVY       G  VA+K         + E   E++++   +  +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPH 85

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +VK  G   +  +  +V EY    S+   I  + + K L  ++   I+  T +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH- 142

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
               R IHRDIK  NILL+ +   K+ADFG+A
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 97.8 bits (244), Expect = 5e-23
 Identities = 45/176 (25%), Positives = 67/176 (38%), Gaps = 13/176 (7%)

Query: 253 SMKKSCLSFKYETLEKATNY---FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR 308
              ++  S  Y+     + +   F    +LG G  G V+   S  +G   AVKR +   R
Sbjct: 36  EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR 95

Query: 309 QWVD--EFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTK 365
              D      EV     + +H   V+L     EG    L  E     SL Q    +    
Sbjct: 96  GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGA 152

Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
            L   + +  +  T   LA+LH      ++H D+K +NI L      K+ DFGL  
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 97.2 bits (243), Expect = 5e-23
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 26/168 (15%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----- 316
           KY  LEK          +G+G  G VY      G T A+K++        DE        
Sbjct: 3   KYHGLEK----------IGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIR 49

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++++  ++H N+VKL    I   + L LV+E++    L + +            K F  
Sbjct: 50  EISILKELKHSNIVKLYDV-IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-- 105

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           +L    G+AY H   + R++HRD+K  N+L++++   KIADFGLAR F
Sbjct: 106 LLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 26/168 (15%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN----- 316
           KY+ LEK          +G+G  G VY      G  VA+KR+  +     DE        
Sbjct: 22  KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
           E++L+  + H N+V L+   I     L LV+E++    L + + +       +  K +  
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY-- 124

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           +     G+A+ H   + RI+HRD+K  N+L++ D   K+ADFGLAR F
Sbjct: 125 LYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF 169

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.8 bits (244), Expect = 6e-23
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 8/152 (5%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
               +   K+G+G  G V +     +G  VAVK +    +Q  +  FNEV ++   +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +V++    + G E  ++ E++   +L   +        LN  +   +     + LAYLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLH- 158

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
                +IHRDIK+ +ILL  D   K++DFG  
Sbjct: 159 --AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 96.8 bits (242), Expect = 6e-23
 Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 25/156 (16%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             LG+G    VY   S+  G  VA+K    + ++     V    NEV +   ++H ++++
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQLKHPSILE 75

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           L     E    + LV E   N  +        K +     K F+       +     G+ 
Sbjct: 76  LYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQIITGML 126

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           YLH      I+HRD+  SN+LL ++   KIADFGLA
Sbjct: 127 YLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 46/169 (27%), Positives = 71/169 (42%), Gaps = 12/169 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           + +G G    V      P    VA+KR+ +   +  +DE   E+  +S   H N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAYLHG 388
             +   E  LV + +   S+   I      K  + +   +      I+    EGL YLH 
Sbjct: 81  SFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH- 138

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             +   IHRD+K  NILL +D + +IADFG++   A         V  T
Sbjct: 139 --KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 28/169 (16%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
            Y  L+K          LG+G   +VY G S      VA+K +        +E       
Sbjct: 3   TYIKLDK----------LGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAI 48

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            EV+L+  ++H N+V L    I   +SL LV+EY+ ++ L Q++ D      ++  K F 
Sbjct: 49  REVSLLKDLKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF- 105

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
            +     GLAY H     +++HRD+K  N+L+++    K+ADFGLAR  
Sbjct: 106 -LFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK 150

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 27/171 (15%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE L            +G+G  G V    +   G  VA+K+ + +     D+       
Sbjct: 26  KYENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAM 72

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E+ L+  + H+NLV LL    +  +   LV+E+V + ++   +            +++ 
Sbjct: 73  REIKLLKQLRHENLVNLLEV-CKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKY- 129

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA 425
            +     G+ + H      IIHRDIK  NIL+ +    K+ DFG AR  AA
Sbjct: 130 -LFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 41/184 (22%), Positives = 68/184 (36%), Gaps = 27/184 (14%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSI-EHKN 328
           F+  +K+G G  GSV+      +G   A+KR        VDE     EV   + + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT-KLLNWNKRFNIILGTAEGLAYLH 387
           +V+      E    L+  EY    SL   I +  +        +  +++L    GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 388 GGSETRIIHRDIKTSNILLDKD-------------------FTPKIADFGLARCFAADRT 428
                 ++H DIK SNI + +                       KI D G     ++ + 
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 429 HVST 432
               
Sbjct: 190 EEGD 193

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 10/163 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIEHKNLVKLLG 334
           +K+G+G  G V+ G        VA+K +     +  +++   E+ ++S  +   + K  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
             ++  +  ++ EY+   S    +    +   L+  +   I+    +GL YLH     + 
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 140

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           IHRDIK +N+LL +    K+ADFG+A      +   +T V GT
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GT 182

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 10/152 (6%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFF---NEVNLISSIEHKN 328
           F+  +++G G  G+VY    + N   VA+K++ ++ +Q  +++     EV  +  + H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            ++  GC +    + LV EY    + D     +   K L   +   +  G  +GLAYLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLH- 171

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
                +IHRD+K  NILL +    K+ DFG A
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.7 bits (238), Expect = 7e-22
 Identities = 31/161 (19%), Positives = 58/161 (36%), Gaps = 9/161 (5%)

Query: 277 KKLGQGGA--GSVYMG-SLPNGTTVAVKR--LIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             +G+G     +V +    P G  V V+R  L   + + V     E+++     H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
                I   E  +V  ++   S    +   +    +N      I+ G  + L Y+H    
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIH---H 146

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
              +HR +K S+IL+  D    ++         +       
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 33/174 (18%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +Y  + K          LG+G  G VY         TVA+KR+        +E       
Sbjct: 35  RYRRITK----------LGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAI 81

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            EV+L+  ++H+N+++L    I     L L++EY     L +++ DKN    +   K F 
Sbjct: 82  REVSLLKELQHRNIIELKSV-IHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSF- 137

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-----KIADFGLARCF 423
            +     G+ + H     R +HRD+K  N+LL           KI DFGLAR F
Sbjct: 138 -LYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 94.2 bits (235), Expect = 9e-22
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 29/172 (16%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           +++ LEK          LG G   +VY G +   G  VA+K +  ++    +E       
Sbjct: 6   QFKQLEK----------LGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAI 51

Query: 317 -EVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
            E++L+  ++H+N+V+L    I     L LV+E++ N  L +++  +         +   
Sbjct: 52  REISLMKELKHENIVRLYDV-IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109

Query: 375 I---ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           +        +GLA+ H   E +I+HRD+K  N+L++K    K+ DFGLAR F
Sbjct: 110 VKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 10/165 (6%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
            KLG GG  +VY+         VA+K +        + +  F  EV+  S + H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
           +    E     LV EY+   +L ++I        L+ +   N      +G+ + H   + 
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DM 130

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           RI+HRDIK  NIL+D + T KI DFG+A+  +      +  V GT
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 33/182 (18%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG--SLPNGTTVAVKRLIFNTRQWVDEFFN--- 316
           +YE + +          +G+G  G V+        G  VA+KR+   T    +E      
Sbjct: 12  QYECVAE----------IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---EEGMPLST 58

Query: 317 --EVNL---ISSIEHKNLVKLL----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL 366
             EV +   + + EH N+V+L         +    L LV+E+V ++ L  ++ DK     
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPG 116

Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           +      +++     GL +LH     R++HRD+K  NIL+      K+ADFGLAR ++  
Sbjct: 117 VPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

Query: 427 RT 428
             
Sbjct: 174 MA 175

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 47/183 (25%)

Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---- 316
           KYE L K          +GQG  G V+       G  VA+K+++        E F     
Sbjct: 18  KYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITAL 64

Query: 317 -EVNLISSIEHKNLVKLLG-------CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
            E+ ++  ++H+N+V L+               S+ LV+++           + +   LL
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLL 114

Query: 368 -NWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            N   +F       ++     GL Y+H     +I+HRD+K +N+L+ +D   K+ADFGLA
Sbjct: 115 SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

Query: 421 RCF 423
           R F
Sbjct: 172 RAF 174

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 94.4 bits (234), Expect = 6e-21
 Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 20/161 (12%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVKL 332
           ++LG GG G V        G  VA+K             + +  E+ ++  + H N+V  
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 333 LGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
                +G + L       L  EY     L +++        L       ++   +  L Y
Sbjct: 78  REV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 386 LHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCF 423
           LH   E RIIHRD+K  NI+L    +    KI D G A+  
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 92.1 bits (229), Expect = 8e-21
 Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 27/176 (15%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVK-----------------RLIFNTRQWVDEFFNEVN 319
           + L QG    + +    +    A+K                     + +   D+F NE+ 
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 320 LISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFI-----FDKNKTKLLNWNKRF 373
           +I+ I+++  +   G  I   + + ++YEY+ N S+ +F       DKN T  +      
Sbjct: 96  IITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            II       +Y+H  +E  I HRD+K SNIL+DK+   K++DFG +      +  
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 26/156 (16%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+G  G+VY+     +   +A+K L    +        +   EV + S + H N+++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILR 73

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           L G        + L+ EY P  ++    + +     L    +F+       I   A  L+
Sbjct: 74  LYGY-FHDATRVYLILEYAPLGTV----YRE-----LQKLSKFDEQRTATYITELANALS 123

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           Y H     R+IHRDIK  N+LL      KIADFG +
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 25/172 (14%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLV 330
           +  +K +G G  G VY      +G  VA+K+++ + R     F N E+ ++  ++H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110

Query: 331 KLLGCSIEGPESL------LVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFNI--ILGTA 380
           +L        E        LV +YVP  ++ +    + + K  L     +  +  +    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF--- 166

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
             LAY+H      I HRDIK  N+LLD D    K+ DFG A+       +VS
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 41/182 (22%), Positives = 81/182 (44%), Gaps = 19/182 (10%)

Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLI 321
            E   K  + F   +  GQG  G+V +G     G +VA+K+ +    ++ +     +  +
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNRELQIMQDL 73

Query: 322 SSIEHKNLVKLLGC----SIEGPESL---LVYEYVPNRSLDQFI--FDKNKTKLLNWNKR 372
           + + H N+V+L              +   +V EYVP+ +L +    + + +        +
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132

Query: 373 FNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTH 429
             +  ++     +  LH  S   + HRDIK  N+L+++ D T K+ DFG A+  +    +
Sbjct: 133 VFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

Query: 430 VS 431
           V+
Sbjct: 189 VA 190

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 90.1 bits (224), Expect = 7e-20
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 24/180 (13%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLIS 322
           +T E+    +   K +G G  G V+   L     VA+K+++ + R     F N E+ ++ 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMR 87

Query: 323 SIEHKNLVKLLGCSIEGPESL------LVYEYVPNRSLDQFI--FDKNKTKLLNWNKRFN 374
            ++H N+V L        +        LV EYVP  ++ +    + K K  +     +  
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLY 146

Query: 375 I--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP-KIADFGLARCFAADRTHVS 431
           +  +L     LAY+H      I HRDIK  N+LLD      K+ DFG A+   A   +VS
Sbjct: 147 MYQLL---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 26/176 (14%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRL--------IFNTRQWVDEFFNEVNLISSIEHK 327
           + LG GG   V++   L +   VAVK L         F  R     F  E    +++ H 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-----FRREAQNAAALNHP 72

Query: 328 NLVKLL--GCSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +V +   G +      L  +V EYV   +L   +  +     +   +   +I    + L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQAL 129

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
            + H   +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 21/161 (13%)

Query: 278 KLGQGGAGSVYMG---SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           K+G+G  G VY        +    A+K+              E+ L+  ++H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQ--IEGTGISMSACREIALLRELKHPNVISLQK 85

Query: 335 CSIE-GPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAYL 386
             +      + L+++Y     L   I     +K      +        ++    +G+ YL
Sbjct: 86  VFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCF 423
           H      ++HRD+K +NIL+  +       KIAD G AR F
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 26/165 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           + LG+G  G+VY+     N   +A+K L    +        +   E+ + S + H N+++
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILR 78

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLA 384
           +        + + L+ E+ P   L    + +     L  + RF+       +   A+ L 
Sbjct: 79  MYN-YFHDRKRIYLMLEFAPRGEL----YKE-----LQKHGRFDEQRSATFMEELADALH 128

Query: 385 YLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
           Y H   E ++IHRDIK  N+L+      KIADFG +    + R  
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 35/187 (18%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----------WVDEFFNEV 318
            + +  SK LG G  G V +         VA++  I + R+                 E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR--IISKRKFAIGSAREADPALNVETEI 191

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-----TKLLNWNKRF 373
            ++  + H  ++K+     +  +  +V E +    L   +    +      KL      F
Sbjct: 192 EILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----F 245

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHV 430
             +L     + YLH   E  IIHRD+K  N+LL   ++D   KI DFG ++      T +
Sbjct: 246 YQML---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 297

Query: 431 STAVAGT 437
              + GT
Sbjct: 298 MRTLCGT 304

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 13/152 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLG 334
           + +G G  G VY G  +  G   A+K ++  T    +E   E+N++     H+N+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88

Query: 335 CSIEGPESL------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
             I+           LV E+    S+   +    K   L       I      GL++LH 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH- 146

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             + ++IHRDIK  N+LL ++   K+ DFG++
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 39/165 (23%), Positives = 77/165 (46%), Gaps = 17/165 (10%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVY-MGSLPNGTTVAVKRLIFNT-RQWVDEFFNEVN-LI 321
           ++E   +   P  +LG+G  G V  M  +P+G  +AVKR+      Q       +++  +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------I 375
            +++    V   G      +  +  E + + SLD+F       ++++  +         I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114

Query: 376 ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            +   + L +LH  S+  +IHRD+K SN+L++     K+ DFG++
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 87.6 bits (217), Expect = 1e-18
 Identities = 36/169 (21%), Positives = 68/169 (40%), Gaps = 24/169 (14%)

Query: 278 KLGQGGAGSVYMG---SLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLL 333
            +  GG G +Y+    ++ NG  V +K L+ +   +       E   ++ + H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 334 -----GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
                      P   +V EYV  +SL +    K     L   +    +L     L+YLH 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH- 199

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
                +++ D+K  NI+L ++   K+ D G       +       + GT
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSF---GYLYGT 240

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 39/212 (18%), Positives = 67/212 (31%), Gaps = 20/212 (9%)

Query: 233 AYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL 292
                +K K D      YA  +K+  L  +    EK         KL   G    +   L
Sbjct: 20  GVVFEAKNKVDDC---NYA--IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74

Query: 293 PNGTTVAVKRLIFNTRQW------------VDEFFNEVNLISSIEHKNLVKLLGCSIEGP 340
                   + +     +             +D    ++  +     KN V  L  S    
Sbjct: 75  ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKV 134

Query: 341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK 400
              +  +     +L  ++  +   +        +I +  AE + +LH      ++HRD+K
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLK 191

Query: 401 TSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            SNI    D   K+ DFGL      D    + 
Sbjct: 192 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 19/173 (10%)

Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWV-DE 313
           ++ L+ K +  E   + F    +LG G  G V+  S  P+G  +A K +    +  + ++
Sbjct: 18  EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 77

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              E+ ++       +V   G      E  +  E++   SLD         ++L    R 
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRI 128

Query: 374 N------IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
                  + +   +GL YL    + +I+HRD+K SNIL++     K+ DFG++
Sbjct: 129 PEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 16/151 (10%)

Query: 277 KKLGQGGAGSVY-MGSLPNGTTVAVKRL-IFNTRQWVDEFFNEVN-LISSIEHKNLVKLL 333
            ++G+G  GSV  M   P+G  +AVKR+      +   +   +++ ++ S +   +V+  
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGLAYLH 387
           G      +  +  E + + S D+F     K      +          I L T + L +L 
Sbjct: 88  GALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFG 418
                +IIHRDIK SNILLD+    K+ DFG
Sbjct: 143 --ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 44/190 (23%), Positives = 74/190 (38%), Gaps = 35/190 (18%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQ----------WVDEFF 315
           +   + +  SK LG G  G V +         VA+K  I + R+                
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIK--IISKRKFAIGSAREADPALNVE 63

Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNK-----TKLLNWN 370
            E+ ++  + H  ++K+     +  +  +V E +    L   +    +      KL    
Sbjct: 64  TEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--- 119

Query: 371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADR 427
             F  +L     + YLH   E  IIHRD+K  N+LL   ++D   KI DFG ++      
Sbjct: 120 --FYQML---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GE 169

Query: 428 THVSTAVAGT 437
           T +   + GT
Sbjct: 170 TSLMRTLCGT 179

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 35/173 (20%), Positives = 59/173 (34%), Gaps = 24/173 (13%)

Query: 277 KKLGQGGAGSVYMGSLPN-GTTVAVKRL--------IFNTRQWVDEFFNEVNLISSIEHK 327
           + +G+GG G VY          VA+K +        +F TR        E      ++  
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-----MQREARTAGRLQEP 94

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           ++V +        +  +    +    L   +  +     L   +   I+      L   H
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH 151

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST--AVAGTL 438
                   HRD+K  NIL+  D    + DFG+A   A     ++      GTL
Sbjct: 152 ---AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTL 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 29/200 (14%)

Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI---FNT 307
             +  +   F   +    ++ +   + LG+G  G V +      G   AVK +       
Sbjct: 7   DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 66

Query: 308 RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL 366
           +   +    EV L+  ++H N++KL     E      LV E      L    FD+  ++ 
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYE-FFEDKGYFYLVGEVYTGGEL----FDEIISR- 120

Query: 367 LNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADF 417
               KRF+      II     G+ Y+H   + +I+HRD+K  N+LL    KD   +I DF
Sbjct: 121 ----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDF 173

Query: 418 GLARCFAADRTHVSTAVAGT 437
           GL+  F  + +       GT
Sbjct: 174 GLSTHF--EASKKMKDKIGT 191

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 51/200 (25%), Positives = 77/200 (38%), Gaps = 32/200 (16%)

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW- 310
            ++ +   F        +  +   KKLG G  G V +          A+K  I       
Sbjct: 19  DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK--IIRKTSVS 76

Query: 311 ---VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKL 366
                +   EV ++  ++H N++KL     E   +  LV E      L    FD+   + 
Sbjct: 77  TSSNSKLLEEVAVLKLLDHPNIMKLYD-FFEDKRNYYLVMECYKGGEL----FDEIIHR- 130

Query: 367 LNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADF 417
                +FN      II     G+ YLH   +  I+HRD+K  N+LL   +KD   KI DF
Sbjct: 131 ----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDF 183

Query: 418 GLARCFAADRTHVSTAVAGT 437
           GL+  F  +         GT
Sbjct: 184 GLSAVF--ENQKKMKERLGT 201

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 53/183 (28%), Positives = 74/183 (40%), Gaps = 32/183 (17%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
              +N    LG+G  G V            AVK  + N              EV L+  +
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK--VINKASAKNKDTSTILREVELLKKL 78

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IIL 377
           +H N++KL    +E   S  +V E      L    FD+   +     KRF+      II 
Sbjct: 79  DHPNIMKLFE-ILEDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIK 128

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
               G+ Y+H   +  I+HRD+K  NILL   +KD   KI DFGL+ CF   +       
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDR 183

Query: 435 AGT 437
            GT
Sbjct: 184 IGT 186

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 23/172 (13%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +     +G G  G V           VA+K++  +F           E+ +++ + H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 330 VKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTA 380
           VK+L   I  P+ +       +V E        +    +    L   + +  +  +L   
Sbjct: 115 VKVL--DIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKTLLYNLL--- 166

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            G+ Y+H      I+HRD+K +N L+++D + K+ DFGLAR         S 
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 27/182 (14%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIE 325
            + F   +KLG G  G V++     +G    +K    N  +    +++   E+ ++ S++
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK--TINKDRSQVPMEQIEAEIEVLKSLD 78

Query: 326 HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILG 378
           H N++K+     E   ++ +V E      L     ++  +      K  +      ++  
Sbjct: 79  HPNIIKIFEV-FEDYHNMYIVMETCEGGEL----LERIVSAQAR-GKALSEGYVAELMKQ 132

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVA 435
               LAY H      ++H+D+K  NIL          KI DFGLA  F       ST  A
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAA 187

Query: 436 GT 437
           GT
Sbjct: 188 GT 189

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 27/177 (15%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
              +     +G G  GSV       +G  VA+K+L   F +  +    + E+ L+  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 327 KNLVKLLGCSIEGPESL--------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--I 376
           +N++ LL   +  P S         LV  ++    L + +      K      ++ +  +
Sbjct: 83  ENVIGLL--DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQYLVYQM 135

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH-VST 432
           L   +GL Y+H      ++HRD+K  N+ +++D   KI DFGLAR   A+ T  V T
Sbjct: 136 L---KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 53/183 (28%), Positives = 74/183 (40%), Gaps = 32/183 (17%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
              +N    LG+G  G V            AVK  + N              EV L+  +
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK--VINKASAKNKDTSTILREVELLKKL 78

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IIL 377
           +H N++KL    +E   S  +V E      L    FD+   +     KRF+      II 
Sbjct: 79  DHPNIMKLFE-ILEDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIK 128

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
               G+ Y+H   +  I+HRD+K  NILL   +KD   KI DFGL+ CF   +       
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDR 183

Query: 435 AGT 437
            GT
Sbjct: 184 IGT 186

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 43/186 (23%), Positives = 67/186 (36%), Gaps = 30/186 (16%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDE--FFNEVNLI 321
           T      Y+     +G+G  G V +          A K          D   F  E+ ++
Sbjct: 3   TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVEDVDRFKQEIEIM 60

Query: 322 SSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------ 374
            S++H N+++L   + E    + LV E      L    F++   K     + F       
Sbjct: 61  KSLDHPNIIRLYE-TFEDNTDIYLVMELCTGGEL----FERVVHK-----RVFRESDAAR 110

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVS 431
           I+      +AY H   +  + HRD+K  N L      D   K+ DFGLA  F      + 
Sbjct: 111 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMM 165

Query: 432 TAVAGT 437
               GT
Sbjct: 166 RTKVGT 171

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 47/235 (20%), Positives = 72/235 (30%), Gaps = 53/235 (22%)

Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK-----RLIF 305
            S  +  L F+  +L +    ++    +GQG  G V +          A+K     ++  
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKT 364
              + V+    EV L+  + H N+ +L     E  + + LV E      L   +      
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 365 KLLNWNKRFNIILGTA-------------------------------------EGLAYLH 387
                                                                  L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 388 GGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRT---HVSTAVAGT 437
                 I HRDIK  N L   +K F  K+ DFGL++ F        +  T  AGT
Sbjct: 186 ---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 80.3 bits (199), Expect = 5e-17
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 31/174 (17%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSIEHKNLVKLL 333
           + LG G    V++      G   A+K           +    NE+ ++  I+H+N+V L 
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALK--CIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 334 GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAYL 386
               E      LV + V    L    FD+   +       +       +I      + YL
Sbjct: 73  D-IYESTTHYYLVMQLVSGGEL----FDRILER-----GVYTEKDASLVIQQVLSAVKYL 122

Query: 387 HGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           H   E  I+HRD+K  N+L    +++    I DFGL++     +  + +   GT
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGT 170

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 43/177 (24%), Positives = 70/177 (39%), Gaps = 30/177 (16%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRL--IFNTRQWVDEFFN---------EV 318
            + +   + +  G  G+V  G    G  VA+KR+    +  + V+   +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 319 NLISSIEHKNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
            L++   H N++ L    I             LV E +    L Q I    +  +   + 
Sbjct: 81  RLLNHFHHPNILGLR--DIFVHFEEPAMHKLYLVTELMRT-DLAQVI-HDQRIVISPQHI 136

Query: 372 RFNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
           ++ +  IL    GL  LH      ++HRD+   NILL  +    I DF LAR   AD
Sbjct: 137 QYFMYHIL---LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 38/172 (22%), Positives = 75/172 (43%), Gaps = 23/172 (13%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
            + +     +G+G  G VY+         VA+K++  +F           E+ +++ ++ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 327 KNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--IL 377
             +++L    +  P+ L       +V E      L +    K    L   + +  +  +L
Sbjct: 85  DYIIRLY--DLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKTILYNLL 139

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
               G  ++H      IIHRD+K +N LL++D + K+ DFGLAR   +++  
Sbjct: 140 ---LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.1 bits (196), Expect = 1e-16
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 32/183 (17%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
           ++ ++  ++LG+G    V        G   A K  I NT++       +   E  +   +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 62

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIIL 377
           +H N+V+L   SI+      LV++ V    L    F+    +     + +      + I 
Sbjct: 63  QHPNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAR-----EFYSEADASHCIQ 112

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
              E +AY H      I+HR++K  N+LL    K    K+ADFGLA     + +      
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 167

Query: 435 AGT 437
           AGT
Sbjct: 168 AGT 170

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 34/209 (16%), Positives = 60/209 (28%), Gaps = 31/209 (14%)

Query: 235 ARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG---- 290
           + LSK      N   +   +            +  +        LG+G    VY      
Sbjct: 32  SGLSKPVSSYPNTFEWQCKLPAIK---PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGD 88

Query: 291 --SLPNGTTVAVKRLIFNTRQWVDEFF---NEVNLISSIEHKNLVKLLGCSIEGPESLLV 345
                N     +K +      W  EF+     +  +        +K     +    S+LV
Sbjct: 89  LNDAKNKQKFVLK-VQKPANPW--EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145

Query: 346 YEYVPNRSLDQFI--FDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN 403
            E     +L   I  +     K++      +  +     +  +H   +  IIH DIK  N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202

Query: 404 ILLDKDFTP-----------KIADFGLAR 421
            +L   F              + D G + 
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSI 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 57/211 (27%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISS 323
           LE ++  ++  K LG G  G V     + +G   A+K+++ + R     + N E++++  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKV 56

Query: 324 IEHKNLVKLLGC-------------------------------SIEGPESL-------LV 345
           ++H N++KL+                                       +        ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 346 YEYVPNRSLDQFI--FDKNKTKLLNWNKRFNI--ILGTAEGLAYLHGGSETRIIHRDIKT 401
            EYVP+ +L + +  F ++   +        I  +      + ++H      I HRDIK 
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHSL---GICHRDIKP 169

Query: 402 SNILLD-KDFTPKIADFGLARCFAADRTHVS 431
            N+L++ KD T K+ DFG A+        V+
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 39/202 (19%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-------------IF 305
            +  +   K    +   +KLG G  G V +       +  A+K +               
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 306 NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKT 364
           N  ++ +E +NE++L+ S++H N++KL     E  +   LV E+     L    F++   
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGEL----FEQIIN 139

Query: 365 KLLNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIA 415
           +      +F+      I+     G+ YLH   +  I+HRDIK  NILL   +     KI 
Sbjct: 140 R-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIV 191

Query: 416 DFGLARCFAADRTHVSTAVAGT 437
           DFGL+  F   + +      GT
Sbjct: 192 DFGLSSFF--SKDYKLRDRLGT 211

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 15/153 (9%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHKNLVK 331
           K +G+G    V +   +  G  VA+K  I +  Q     + + F EV ++  + H N+VK
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 332 LLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           L    IE  ++L L+ EY     +  ++    + K      +F  I+     + Y H   
Sbjct: 79  LFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV---SAVQYCH--- 131

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           + RI+HRD+K  N+LLD D   KIADFG +  F
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 17/189 (8%), Positives = 40/189 (21%), Gaps = 36/189 (19%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + L  G    V++   +      A+K       N+R  ++         + +  ++  + 
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 333 LG----------CSIEG----------------PESLLVYEYVP---NRSLDQFIFDKNK 363
                        +++                    LL+                F    
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 364 TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
                      +        A L       ++H      N+ +  D    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 424 AADRTHVST 432
                  S 
Sbjct: 245 GTRGPASSV 253

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 45/188 (23%), Positives = 69/188 (36%), Gaps = 37/188 (19%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWV-----------DEFFNE 317
              + P + LG+G +  V      P     AVK  I +                +    E
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVK--IIDVTGGGSFSAEEVQELREATLKE 73

Query: 318 VNLISSI-EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF-- 373
           V+++  +  H N+++L   + E      LV++ +    L    FD    K          
Sbjct: 74  VDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGEL----FDYLTEK-----VTLSE 123

Query: 374 ----NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
                I+    E +  LH   +  I+HRD+K  NILLD D   K+ DFG +     D   
Sbjct: 124 KETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGE 178

Query: 430 VSTAVAGT 437
               V GT
Sbjct: 179 KLREVCGT 186

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 28/190 (14%), Positives = 52/190 (27%), Gaps = 37/190 (19%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTR--------------------------- 308
             LGQ    +         G +  V    F  R                           
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 309 -QWVDEFFNEVNLISSIEHKNLVKLLGC-SIEGPESLLVYEYVPNRSLDQF---IFDKNK 363
            +    F    +L+   + K ++++          S          +L  F   +   + 
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 364 T-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           T K L  + R  + L     LA LH      ++H  ++  +I+LD+     +  F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 423 FAADRTHVST 432
             A      +
Sbjct: 256 DGARVVSSVS 265

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 45/226 (19%), Positives = 84/226 (37%), Gaps = 32/226 (14%)

Query: 229 AAYAAYARLSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVY 288
           A   A A+     + +    LY  SM        +   ++    ++P   +G+G +  V 
Sbjct: 52  ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVR 111

Query: 289 MGS-LPNGTTVAVKRL--------IFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE 338
                  G   AVK +             +  +    E +++  +  H +++ L+  S E
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID-SYE 170

Query: 339 GPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAEGLAYLHGGSE 391
               + LV++ +    L    FD    K              +I+    E +++LH    
Sbjct: 171 SSSFMFLVFDLMRKGEL----FDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---A 218

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             I+HRD+K  NILLD +   +++DFG +             + GT
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGT 262

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 32/147 (21%), Positives = 65/147 (44%), Gaps = 8/147 (5%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT-RQWVDEFFNEVN-LISSIEHKNLVKLL 333
            ++G G  G V+       G  +AVK++  +  ++       +++ ++ S +   +V+  
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
           G  I   +  +  E +     ++    K     +       + +   + L YL    +  
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLK--EKHG 145

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLA 420
           +IHRD+K SNILLD+    K+ DFG++
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGIS 172

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 32/161 (19%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             LG+G  G V            AVK    + +            E+ L+  + HKN+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN----------IILGT 379
           L+     E  + + +V EY      +  + D          KRF           +I   
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP------EKRFPVCQAHGYFCQLI--- 119

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            +GL YLH      I+H+DIK  N+LL    T KI+  G+A
Sbjct: 120 -DGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA 156

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 32/193 (16%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEF 314
            F      K ++ ++  ++LG+G    V        G   A K  I NT++       + 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKL 75

Query: 315 FNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             E  +   ++H N+V+L   SI+      LV++ V    L    F+    +     + +
Sbjct: 76  EREARICRKLQHPNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAR-----EFY 125

Query: 374 ------NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA 424
                 + I    E +AY H      I+HR++K  N+LL    K    K+ADFGLA    
Sbjct: 126 SEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 181

Query: 425 ADRTHVSTAVAGT 437
            + +      AGT
Sbjct: 182 -NDSEAWHGFAGT 193

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 36/184 (19%), Positives = 67/184 (36%), Gaps = 26/184 (14%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVK-----RLIFNTRQWVDEFFNEVNLISS 323
            + +   + +G+G    V        G   AVK     +   +     ++   E ++   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NII 376
           ++H ++V+LL  +      L +V+E++    L   I  +           +      + +
Sbjct: 83  LKHPHIVELLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYM 136

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTA 433
               E L Y H   +  IIHRD+K   +LL   +     K+  FG+A             
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 434 VAGT 437
           V GT
Sbjct: 194 V-GT 196

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 16/177 (9%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD--EFFNEVNLISS 323
               +Y++  ++LG G  G V+       G     K    NT   +D     NE+++++ 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQ 104

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG 382
           + H  L+ L   + E    + L+ E++    L   I  ++    ++  +  N +    EG
Sbjct: 105 LHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEG 161

Query: 383 LAYLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           L ++H   E  I+H DIK  NI+    K  + KI DFGLA     +   +      T
Sbjct: 162 LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTAT 213

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 46/196 (23%), Positives = 70/196 (35%), Gaps = 36/196 (18%)

Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD 312
           MK S     Y+            K LG+G            +    AVK  I + R    
Sbjct: 1   MKDSPFYQHYD-------LDLKDKPLGEGSFSICRKCVHKKSNQAFAVK--IISKRM-EA 50

Query: 313 EFFNEVNLISSI-EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWN 370
               E+  +     H N+VKL            LV E +    L    F++ K K     
Sbjct: 51  NTQKEITALKLCEGHPNIVKLHE-VFHDQLHTFLVMELLNGGEL----FERIKKK----- 100

Query: 371 KRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLAR 421
           K F+      I+      ++++H   +  ++HRD+K  N+L    + +   KI DFG AR
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157

Query: 422 CFAADRTHVSTAVAGT 437
               D   + T    T
Sbjct: 158 LKPPDNQPLKTPC-FT 172

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 24/195 (12%), Positives = 54/195 (27%), Gaps = 37/195 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIF---NTRQWVDEFFNEVNLISS--------- 323
             LGQ    +         G +  V    F        + +   EV  +           
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 324 -------------IEHKNLVKLLGCSIEGPESLLVYEYVP-------NRSLDQFIFDKNK 363
                        ++     K++   ++  +  ++  +          ++  + +   + 
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 364 T-KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           T K L  + R  + L     LA LH      ++H  ++  +I+LD+     +  F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 423 FAADRTHVSTAVAGT 437
             A            
Sbjct: 261 DGASAVSPIGRGFAP 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 31/183 (16%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQW----VDEFFNEVNLISSI 324
           T  +   ++LG+G    V     +  G   A    I NT++       +   E  +   +
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM--IINTKKLSARDHQKLEREARICRLL 67

Query: 325 EHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIIL 377
           +H N+V+L   SI       L+++ V    L    F+    +     + +      + I 
Sbjct: 68  KHPNIVRLHD-SISEEGHHYLIFDLVTGGEL----FEDIVAR-----EYYSEADASHCIQ 117

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAV 434
              E + + H   +  ++HR++K  N+LL    K    K+ADFGLA     ++       
Sbjct: 118 QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174

Query: 435 AGT 437
            GT
Sbjct: 175 -GT 176

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 28/179 (15%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
           +++F    +LG+G    VY           A+K  +            E+ ++  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPN 109

Query: 329 LVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILGTAE 381
           ++KL     E P  + LV E V    L    FD+   K       +      + +    E
Sbjct: 110 IIKLKE-IFETPTEISLVLELVTGGEL----FDRIVEK-----GYYSERDAADAVKQILE 159

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            +AYLH   E  I+HRD+K  N+L      D   KIADFGL++    +   +   V GT
Sbjct: 160 AVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGT 213

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 48/195 (24%), Positives = 74/195 (37%), Gaps = 47/195 (24%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK----------------RLIFNTRQWVDEFFNEVN 319
            ++G+G  G V +  +  + T  A+K                     TR           
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 320 LISSIE----------HKNLVKLLGCSIEGPESL---LVYEYVPNRSLDQFIFDK-NKTK 365
            I  +           H N+VKL+   ++ P      +V+E V    +     +      
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP 133

Query: 366 LLNWNKRF---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC 422
           L     RF   ++I G    + YLH     +IIHRDIK SN+L+ +D   KIADFG++  
Sbjct: 134 LSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 423 FAADRTHVSTAVAGT 437
           F      +S    GT
Sbjct: 187 FKGSDALLSNT-VGT 200

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 22/153 (14%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNLVKL 332
           + LG+G  G V +  +      VAVK  I + ++ VD   N   E+ +   + H+N+VK 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKR--FNIILGTAEGLAYLH 387
            G          L  EY     L    FD+      +   + +  F+ ++    G+ YLH
Sbjct: 71  YGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH 122

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           G     I HRDIK  N+LLD+    KI+DFGLA
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLA 152

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 23/171 (13%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHK 327
              +     +G+G  G V       N   VA+K++  F  + +      E+ ++    H+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 328 NLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILG 378
           N++ +    I    ++       +V + +    L + +       L N +  + +  IL 
Sbjct: 86  NIIGIN--DIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQIL- 138

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
              GL Y+H  +   ++HRD+K SN+LL+     KI DFGLAR    D  H
Sbjct: 139 --RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 24/154 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN---EVNLISSIEHKNLVKL 332
           + LG+G  G V +  +      VAVK  I + ++ VD   N   E+ +   + H+N+VK 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKRF---NIILGTAEGLAYL 386
            G          L  EY     L    FD+      +   + +     ++     G+ YL
Sbjct: 71  YGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLM----AGVVYL 121

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           HG     I HRDIK  N+LLD+    KI+DFGLA
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLA 152

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 22/172 (12%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +   + +G G  G+V        G  VA+K+L   F +  +    + E+ L+  + H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 330 VKLL-----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTAE 381
           + LL       +++      LV  ++    L + +      KL     +F +  +L   +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM---KHEKLGEDRIQFLVYQML---K 139

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVST 432
           GL Y+H      IIHRD+K  N+ +++D   KI DFGLAR   ++ T +V T
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 28/178 (15%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
            + +   K LG GG G V+          VA+K+++    Q V     E+ +I  ++H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 329 LVKLL----------GCSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
           +VK+              +     L    +V EY+    L   +    +  LL  + R  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLF 125

Query: 375 I--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTH 429
           +  +L    GL Y+H  +   ++HRD+K +N+ ++ +D   KI DFGLAR      +H
Sbjct: 126 MYQLL---RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 46/192 (23%), Positives = 75/192 (39%), Gaps = 28/192 (14%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ--------W 310
           +FK + +E    +++  ++LG G    V        G   A K      RQ         
Sbjct: 4   TFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVC 58

Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNW 369
            +E   EV+++  + H N++ L     E    + L+ E V    L  F+  K     L+ 
Sbjct: 59  REEIEREVSILRQVLHPNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKES---LSE 114

Query: 370 NKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAA 425
            +  + I    +G+ YLH     +I H D+K  NI+L          K+ DFGLA     
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169

Query: 426 DRTHVSTAVAGT 437
           +       + GT
Sbjct: 170 EDGVEFKNIFGT 181

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 21/183 (11%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVD--EFFNEVN 319
           +K  ++++  ++LG G    V        G   A K    R    +R+ V   E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 320 LISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           ++  + H N++ L     E    + L+ E V    L  F+  K     L+  +  + I  
Sbjct: 68  ILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQ 123

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTP---KIADFGLARCFAADRTHVSTAV 434
             +G+ YLH     +I H D+K  NI+L DK+      K+ DFGLA     +       +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNI 178

Query: 435 AGT 437
            GT
Sbjct: 179 FGT 181

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 18/162 (11%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDE-----FFNEVNLISSIEHK 327
             LG G  G V+          V VK   +       W+++        E+ ++S +EH 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 328 NLVKLLGCSIEGPESL-LVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           N++K+L    E      LV E +     L  FI    +      +  F  ++     + Y
Sbjct: 90  NIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS---AVGY 145

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR 427
           L       IIHRDIK  NI++ +DFT K+ DFG A      +
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 45/155 (29%), Positives = 66/155 (42%), Gaps = 12/155 (7%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
             LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               I  P    +V EYV    L  +I    + + +   + F  IL     + Y H    
Sbjct: 77  YQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL---SAVDYCH---R 129

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
             ++HRD+K  N+LLD     KIADFGL+   +  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 22/168 (13%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
              +   K +G G  G V           VA+K+L   F  +      + E+ L+  + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 327 KNLVKLL-----GCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILG 378
           KN++ LL       S+E  + + +V E +   +L Q I    + +L +    + +  +L 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSYLLYQML- 137

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
              G+ +LH      IIHRD+K SNI++  D T KI DFGLAR     
Sbjct: 138 --CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 36/161 (22%), Positives = 68/161 (42%), Gaps = 11/161 (6%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           ++    +  ++ LG+G  G V+      +  T   K  +            E+++++   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIAR 59

Query: 326 HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H+N++ L   S E  E L +++E++    + + I        LN  +  + +    E L 
Sbjct: 60  HRNILHLHE-SFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQ 116

Query: 385 YLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCF 423
           +LH      I H DI+  NI+    +  T KI +FG AR  
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 43/185 (23%), Positives = 82/185 (44%), Gaps = 23/185 (12%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL-IFNTRQWVDEFFNEVNLI 321
             +   ++ F     LG+G  G V   +  P G  VA+K++  F+   +      E+ ++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63

Query: 322 SSIEHKNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN 374
              +H+N++ +   +I+ P+S        ++ E +    L + I   +   L + + ++ 
Sbjct: 64  KHFKHENIITIF--NIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQYF 117

Query: 375 I--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           I   L     +  LHG +   +IHRD+K SN+L++ +   K+ DFGLAR         S 
Sbjct: 118 IYQTL---RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 433 AVAGT 437
                
Sbjct: 172 PTGQQ 176

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 73.2 bits (180), Expect = 9e-15
 Identities = 18/150 (12%), Positives = 39/150 (26%), Gaps = 16/150 (10%)

Query: 278 KLGQGGAGSVYMG---SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
             G       +     +L     VA+  +          + E  +    +S I+   + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           +L         L+V E++   SL +           +       +   A      H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
             +       S + +  D    +A      
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 36/175 (20%), Positives = 73/175 (41%), Gaps = 12/175 (6%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
           +   ++++  ++LG G  G V+       G   A K ++       +    E+  +S + 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212

Query: 326 HKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           H  LV L   + E    + ++YE++    L + + D++    ++ ++    +    +GL 
Sbjct: 213 HPTLVNLHD-AFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLC 269

Query: 385 YLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           ++H   E   +H D+K  NI+    +    K+ DFGL      D         GT
Sbjct: 270 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGT 319

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 44/187 (23%), Positives = 81/187 (43%), Gaps = 31/187 (16%)

Query: 261 FKYETL----EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFF 315
           + YE+         +Y    +KLG+G    V+    + N   V VK L         +  
Sbjct: 23  WDYESHVVEWGNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 78

Query: 316 NEVNLISSI-EHKNLVKLLGCSIEGPES---LLVYEYVPNRSLDQFIFDKNKTKLLNWNK 371
            E+ ++ ++    N++ L    ++ P S    LV+E+V N    Q         L +++ 
Sbjct: 79  REIKILENLRGGPNIITLADI-VKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDI 132

Query: 372 RFNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRT 428
           RF +  IL   + L Y H      I+HRD+K  N+++D +    ++ D+GLA  +   + 
Sbjct: 133 RFYMYEIL---KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186

Query: 429 ---HVST 432
               V++
Sbjct: 187 YNVRVAS 193

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 12/155 (7%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
             LG G  G V +G     G  VAVK   R    +   V +   E+  +    H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
               I  P  + +V EYV    L  +I    +       + F  IL    G+ Y H    
Sbjct: 82  YQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL---SGVDYCHR--- 134

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
             ++HRD+K  N+LLD     KIADFGL+   +  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 21/180 (11%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVD--EFFNEVNLIS 322
            +++   ++LG G    V        G   A K    R + ++R+ V   E   EVN++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 323 SIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
            I H N++ L     E    + L+ E V    L  F+ +K     L  ++    +    +
Sbjct: 64  EIRHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILD 119

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           G+ YLH     RI H D+K  NI+L      +   K+ DFG+A    A        + GT
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGT 174

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 28/191 (14%)

Query: 253 SMKKSCLSFKYETLEKATNYFNPSKK------LGQGGAGSVYMGS-LPNGTTVAVKRL-- 303
           +M KS +  ++ ++E   + F   K+      +G G  G V           VA+K+L  
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97

Query: 304 IFNTRQWVDEFFNEVNLISSIEHKNLVKLL-----GCSIEGPESL-LVYEYVPNRSLDQF 357
            F  +      + E+ L+  + HKN++ LL       ++E  + + LV E +   +L Q 
Sbjct: 98  PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQV 156

Query: 358 IFDKNKTKLLNWNKRFNI--ILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA 415
           I    + +L +    + +  +L    G+ +LH      IIHRD+K SNI++  D T KI 
Sbjct: 157 I----QMELDHERMSYLLYQML---CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206

Query: 416 DFGLARCFAAD 426
           DFGLAR     
Sbjct: 207 DFGLARTAGTS 217

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 26/180 (14%)

Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW 310
            + K+  ++  Y          + ++ LG G  G V+       G  +A K  I  TR  
Sbjct: 78  VTAKQGAVNSFYT--------VSKTEILGGGRFGQVHKCEETATGLKLAAK--IIKTRGM 127

Query: 311 VD--EFFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTK 365
            D  E  NE+++++ ++H NL++L   + E    + LV EYV    L    FD+  +++ 
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGEL----FDRIIDESY 182

Query: 366 LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-DKDFTP-KIADFGLARCF 423
            L        +    EG+ ++H   +  I+H D+K  NIL  ++D    KI DFGLAR +
Sbjct: 183 NLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 21/183 (11%)

Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVK----RLIFNTRQWVD--EFFNEVN 319
           E   +Y++  ++LG G    V        G   A K    R   ++R+ V   +   EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 320 LISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           ++  I+H N++ L     E    + L+ E V    L  F+ +K     L   +    +  
Sbjct: 67  ILKEIQHPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQ 122

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARCFAADRTHVSTAV 434
              G+ YLH     +I H D+K  NI+L          KI DFGLA             +
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177

Query: 435 AGT 437
            GT
Sbjct: 178 FGT 180

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 71.6 bits (176), Expect = 6e-14
 Identities = 41/165 (24%), Positives = 63/165 (38%), Gaps = 34/165 (20%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLVKLLG 334
           K +G G  G   +         VAVK         +DE    E+    S+ H N+V+   
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 335 CSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN----------IILGTAEGL 383
             I  P  L ++ EY     L    +++     +    RF+          ++ G    +
Sbjct: 84  V-ILTPTHLAIIMEYASGGEL----YER-----ICNAGRFSEDEARFFFQQLLSG----V 129

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADFGLARCFAAD 426
           +Y H     +I HRD+K  N LLD    P  KI DFG ++     
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 24/176 (13%)

Query: 270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEH 326
              +     +G G  GSV        G  VAVK+L   F +       + E+ L+  ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 327 KNLVKLLGCSIEGPESL-------LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--IL 377
           +N++ LL        SL       LV   +    L+  +      KL + + +F I  IL
Sbjct: 88  ENVIGLLDV-FTPARSLEEFNDVYLVTHLMGA-DLNNIV---KCQKLTDDHVQFLIYQIL 142

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT-HVST 432
               GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR  A + T +V+T
Sbjct: 143 ---RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 29/180 (16%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHK 327
           T+ +   + +G G                 AVK  I +  +   +   E+  L+   +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK--IIDKSK--RDPTEEIEILLRYGQHP 76

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAE 381
           N++ L     +G    +V E +    L     DK   +     K F+      ++    +
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSEREASAVLFTITK 127

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL-DKDFTP---KIADFGLARCFAADRTHVSTAVAGT 437
            + YLH      ++HRD+K SNIL  D+   P   +I DFG A+   A+   + T    T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 21/159 (13%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + LG+G  G V + +       VA+K   R +            E++ +  + H +++KL
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDK--NKTKLLNWNKR--FNIILGTAEGLAYLH 387
               I  P  + +V EY         +FD    K ++     R  F  I+     + Y H
Sbjct: 75  YDV-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQII---CAIEYCH 125

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
                +I+HRD+K  N+LLD +   KIADFGL+      
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 41/184 (22%), Positives = 66/184 (35%), Gaps = 29/184 (15%)

Query: 255 KKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ---- 309
            ++      E       Y   SK+LG+G    V    S   G   A K      R+    
Sbjct: 15  TENLYFQSMENFNN--FYILTSKELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQD 70

Query: 310 WVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
              E  +E+ ++   +    ++ L     E    + L+ EY     +      +    + 
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHE-VYENTSEIILILEYAAGGEIFSLCLPELAEMV- 128

Query: 368 NWNKR-----FNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGL 419
             ++         IL   EG+ YLH   +  I+H D+K  NILL         KI DFG+
Sbjct: 129 --SENDVIRLIKQIL---EGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180

Query: 420 ARCF 423
           +R  
Sbjct: 181 SRKI 184

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 42/186 (22%), Positives = 66/186 (35%), Gaps = 36/186 (19%)

Query: 251 ATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ 309
           +T          Y+  E           LG+G    V    +L      AVK  I   + 
Sbjct: 2   STDSFSGRFEDVYQLQEDV---------LGEGAHARVQTCINLITSQEYAVK--IIEKQP 50

Query: 310 WVDE--FFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
                  F EV ++   + H+N+++L+    E     LV+E +   S+          + 
Sbjct: 51  GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKR- 105

Query: 367 LNWNKRFN------IILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADF 417
               + FN      ++   A  L +LH      I HRD+K  NIL    ++    KI DF
Sbjct: 106 ----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDF 158

Query: 418 GLARCF 423
            L    
Sbjct: 159 DLGSGI 164

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 24/176 (13%)

Query: 273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSI-EHKN 328
           +   KKLG+G  G V+       G  VAVK++   F         F E+ +++ +  H+N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 329 LVKLLGCSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLL-NWNKRFNI--ILGTAE 381
           +V LL  ++   ++     LV++Y+    L   I    +  +L   +K++ +  ++   +
Sbjct: 71  IVNLL--NVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVVYQLI---K 120

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            + YLH G    ++HRD+K SNILL+ +   K+ADFGL+R F   R   +      
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 43/168 (25%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFN---------EVNLISSIEH 326
             LG GG GSVY G  + +   VA+K +    +  + ++           EV L+  +  
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHV---EKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 327 K--NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN--------- 374
               +++LL    E P+S  L+ E        Q +FD      +                
Sbjct: 106 GFSGVIRLLDW-FERPDSFVLILERPEP---VQDLFDF-----ITERGALQEELARSFFW 156

Query: 375 -IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLA 420
            ++    E + + H      ++HRDIK  NIL+D +    K+ DFG  
Sbjct: 157 QVL----EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 47/157 (29%), Positives = 66/157 (42%), Gaps = 20/157 (12%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K LG+G   +V +   L      A+K L    I    + V     E +++S ++H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHP 90

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGL 383
             VKL   + +  E L     Y  N  L    + +          RF    I+      L
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAEIVSA----L 143

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            YLHG     IIHRD+K  NILL++D   +I DFG A
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 177

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.4 bits (166), Expect = 8e-13
 Identities = 34/198 (17%), Positives = 65/198 (32%), Gaps = 46/198 (23%)

Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNL 320
            T      +K+G+G  G V+     + T VA+K +            ++  +E   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 321 ISSIE---------HKNLVKLLGCSI---EGPESLL-VYEY----------VPNRSLDQF 357
              +           +  + L          P  LL  +++           P+   D  
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 358 IF------------DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL 405
           +F            ++ +TKL +     +I+      LA     +  R  HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVL 194

Query: 406 LDKDFTPKIADFGLARCF 423
           L K    K+      +  
Sbjct: 195 LKKTSLKKLHYTLNGKSS 212

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 37/175 (21%), Positives = 63/175 (36%), Gaps = 32/175 (18%)

Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKNLVKLL 333
            + LG G  G V        G   A+K  +        +   EV+    +    ++V +L
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK--LLYDSP---KARQEVDHHWQASGGPHIVCIL 88

Query: 334 GC---SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFN------IILGTAEGL 383
                   G   L ++ E +    L   I ++        ++ F       I+      +
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERG-------DQAFTEREAAEIMRDIGTAI 141

Query: 384 AYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAAD--RTHVSTA 433
            +LH      I HRD+K  N+L    +KD   K+ DFG A+    +  +T   T 
Sbjct: 142 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP 193

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 40/185 (21%), Positives = 69/185 (37%), Gaps = 35/185 (18%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVN-LISSIEHKN 328
           +Y   S+ LG G  G V    +       A+K  +        +   EV     + +  +
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCP---KARREVELHWRASQCPH 116

Query: 329 LVKLLGC---SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF------NIILG 378
           +V+++        G + L +V E +    L    F + + +    ++ F       I+  
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDR---GDQAFTEREASEIMKS 169

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAAD---RTHVST 432
             E + YLH      I HRD+K  N+L      +   K+ DFG A+   +     T   T
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226

Query: 433 A--VA 435
              VA
Sbjct: 227 PYYVA 231

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 29/162 (17%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLI-------------S 322
             LG+GG G+V+ G  L +   VA+K +    R  V  +    + +             +
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVI---PRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 323 SIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKR--FNIILGT 379
              H  +++LL    E  E   LV E  P  + D F +   K  L     R  F  ++  
Sbjct: 94  GGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVV-- 149

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLA 420
              + + H      ++HRDIK  NIL+D      K+ DFG  
Sbjct: 150 -AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 21/166 (12%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F+  K LG G  G V +     +G   A+K L    +   +Q ++   NE  ++ ++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGL 383
            LVKL   S +   +L +V EYV    +  F   +   +    + RF    I+L      
Sbjct: 102 FLVKLE-FSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----F 154

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            YLH      +I+RD+K  N+L+D+    ++ DFG A+     RT 
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTW 196

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 34/197 (17%)

Query: 259 LSFKYETLEKAT-NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDE 313
           L +K+   +    ++F   + LG+GG G V+   +   G   A K+L       R+    
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVP---------NRSLDQFIFDKNK 363
              E  +++ +  + +V L   + E    L LV   +          N   D   F + +
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290

Query: 364 TKLLNWNKRF---NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
                    F    I+ G    L +LH   +  II+RD+K  N+LLD D   +I+D GLA
Sbjct: 291 A-------IFYTAQIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

Query: 421 RCFAADRTHVSTAVAGT 437
               A +T       GT
Sbjct: 337 VELKAGQTKTKGYA-GT 352

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 39/182 (21%), Positives = 67/182 (36%), Gaps = 39/182 (21%)

Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVD 312
           +KK+ +   Y+   +          LG G  G V            A+K L     Q   
Sbjct: 10  IKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKML-----QDCP 55

Query: 313 EFFNEVN-LISSIEHKNLVKLLGC---SIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLL 367
           +   EV     + +  ++V+++        G + L +V E +    L    F + + +  
Sbjct: 56  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDR-- 109

Query: 368 NWNKRF------NIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFG 418
             ++ F       I+    E + YLH      I HRD+K  N+L      +   K+ DFG
Sbjct: 110 -GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165

Query: 419 LA 420
            A
Sbjct: 166 FA 167

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 45/179 (25%), Positives = 68/179 (37%), Gaps = 32/179 (17%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   + +G+G  G V +          A+K +         + V   F E+ ++  +EH 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHP 75

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE 381
            LV L   S +  E + +V + +    L         F +   KL              E
Sbjct: 76  FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-----------ICE 123

Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               L YL      RIIHRD+K  NILLD+     I DF +A     +    +  +AGT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGT 177

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 21/166 (12%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   + LG G  G V++  S  NG   A+K L    +   +Q V+   +E  ++S + H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHP 66

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRF---NIILGTAEGL 383
            ++++   + +  + + ++ +Y+    L  F   +   +  N   +F    + L     L
Sbjct: 67  FIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLA----L 119

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            YLH      II+RD+K  NILLDK+   KI DFG A+ +  D T+
Sbjct: 120 EYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY 161

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 17/171 (9%)

Query: 259 LSFKYETLEKAT-NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDE 313
           L +K+   +  T N F   + LG+GG G V    +   G   A K+L       R+    
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKR 372
             NE  ++  +  + +V L   + E  ++L LV   +    L   I+   +         
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289

Query: 373 FNIILGTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           F      AE   GL  LH     RI++RD+K  NILLD     +I+D GLA
Sbjct: 290 FY----AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 19/174 (10%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G  G V +          A+K L    +    +    F  E +++ + + K
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-TACFREERDVLVNGDSK 134

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GL 383
            +  L   + +   +L LV +Y     L   +  K + +L     RF +    AE    +
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAI 188

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             +H   +   +HRDIK  NIL+D +   ++ADFG       D T  S+   GT
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 19/174 (10%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           F   K +G+G    V +  +   G   A+K +    +    + V  F  E +++ + + +
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE-VSCFREERDVLVNGDRR 121

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE---GL 383
            + +L   + +    L LV EY     L   +  K   ++     RF +    AE    +
Sbjct: 122 WITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYL----AEIVMAI 175

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
             +H       +HRDIK  NILLD+    ++ADFG      AD T  S    GT
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 43/179 (24%), Positives = 68/179 (37%), Gaps = 31/179 (17%)

Query: 273 FNPSKKLGQGGAGSVYM-GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSIEHK 327
           +   K +G+G  G V +          A+K L    +         F+ E ++++     
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSP 129

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPN----RSLDQFIFDKNKTKLLNWNKRFNIILGTAE- 381
            +V+L   + +    L +V EY+P       +  +   +          RF      AE 
Sbjct: 130 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYT----AEV 177

Query: 382 --GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA-RCFAADRTHVSTAVAGT 437
              L  +H       IHRD+K  N+LLDK    K+ADFG   +          TAV GT
Sbjct: 178 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 21/170 (12%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVN---LISS 323
           N F+  + +G+GG G VY       G   A+K L       +Q      NE     L+S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE- 381
            +   +V +   +   P+ L  + + +    L               + RF      AE 
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFY----AAEI 301

Query: 382 --GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
             GL ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H
Sbjct: 302 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 25/178 (14%), Positives = 60/178 (33%), Gaps = 31/178 (17%)

Query: 277 KKLGQGGAGSVYMG---------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK 327
               +   G +Y           S P     ++K    + R + ++ F +      ++  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ-RAAKPLQVN 106

Query: 328 NLVKLLGCSIEG-PESLLVYEYVPNRSLDQFI----FDKNKTKLLNWNKRFNIILGTAEG 382
              KL    +   P       +  ++   +F+      ++    L+ + +  +   +   
Sbjct: 107 KWKKLYSTPLLAIPT---CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163

Query: 383 LA--------YLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARCFAADRTHV 430
           +A        +LH   E   +H ++   NI +D +   ++  A +G A  +     HV
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 27/161 (16%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F   K LG+G  G V +      G   A+K L   +   +  V     E  ++ +  H  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 329 LVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE- 381
           L  L   S +  + L  V EY     L      + +F +++ +              AE 
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----------GAEI 257

Query: 382 --GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              L YLH  SE  +++RD+K  N++LDKD   KI DFGL 
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 37/168 (22%), Positives = 65/168 (38%), Gaps = 31/168 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLG 334
           KK+G G  G + +G +L     VA+K     +R    +   E      +     + ++  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA--------YL 386
               G  + +V E +   SL+  +FD         ++ F+  L T   +A        Y+
Sbjct: 73  FGPCGKYNAMVLELL-GPSLED-LFDLC-------DRTFS--LKTVLMIAIQLISRMEYV 121

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPK-----IADFGLARCFAADRTH 429
           H      +I+RD+K  N L+ +          I DF LA+ +    T 
Sbjct: 122 H---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 37/185 (20%), Positives = 63/185 (34%), Gaps = 45/185 (24%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF------NTRQWVDE--FFNEVNLISSIEHKN 328
             +GQGG G +Y+  + +  +V             +      E  F+        I+   
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 329 LV---------KLLGCSIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI 375
                      K  G  +          ++ +      L Q I++ N        KRF+ 
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL-QKIYEAN-------AKRFS- 150

Query: 376 ILGTAEGLA--------YLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARCFAA 425
              T   L+        Y+H   E   +H DIK SN+LL+     ++   D+GLA  +  
Sbjct: 151 -RKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 426 DRTHV 430
           +  H 
Sbjct: 207 EGVHK 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 34/177 (19%), Positives = 63/177 (35%), Gaps = 32/177 (18%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           KK+G GG G +Y+          A   +    ++     F+E+        + + K    
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE-NGPLFSELKFY-----QRVAKKDCI 96

Query: 336 SIEGPESLLVYEYVPN-----RSLDQ------FIFD---KNKTKLLNWNKRFNI--ILGT 379
                   L Y  +P       +  +       + +    +  K+   N  F    +L  
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156

Query: 380 A----EGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI--ADFGLARCFAADRTHV 430
                + L Y+H   E   +H DIK +N+LL      ++  AD+GL+  +  +  H 
Sbjct: 157 GIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 33/156 (21%), Positives = 56/156 (35%), Gaps = 19/156 (12%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKN 328
           K LG+G  G V               TVAVK L    T        +E+ ++  I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 329 LVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           +V LLG C+  G   +++ E+    +L  ++           +KR   +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF 423
           G      I  D+K     +    +   + F   +  
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 19/42 (45%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           A+G+ +L   +  + IHRD+   NILL +    KI DFGLAR
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 34/182 (18%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI----------- 324
           +KLG G   +V++   + N T VA+K ++   + + +   +E+ L+  +           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 325 EHKNLVKLLGC-SIEGPESL---LVYEYVPNRSLDQFIFDKNKTKL-LNWNKRFNI-ILG 378
              +++KLL   + +GP  +   +V+E V   +L   I       + L + K+ +  +L 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLL- 141

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLD------KDFTPKIADFGLARCFAADR--THV 430
              GL Y+H      IIH DIK  N+L++           KIAD G A C+  +     +
Sbjct: 142 --LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHYTNSI 196

Query: 431 ST 432
            T
Sbjct: 197 QT 198

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 31/166 (18%), Positives = 69/166 (41%), Gaps = 27/166 (16%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLG 334
           +++G+G  G ++ G +L N   VA+K     +     +  +E      +     +  +  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTAE----GLAYLHG 388
              EG  ++LV + +   SL+  + D          ++F++  +   A+     +  +H 
Sbjct: 74  FGQEGLHNVLVIDLLG-PSLED-LLDLC-------GRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 389 GSETRIIHRDIKTSNILLDKDFTPK-----IADFGLARCFAADRTH 429
            S   +++RDIK  N L+ +  +       + DFG+ + +    T 
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 43/161 (26%), Positives = 65/161 (40%), Gaps = 28/161 (17%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F+  K LG+G  G V +      G   A+K L   +   +  V     E  ++ +  H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 329 LVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE- 381
           L  L   + +  + L  V EY     L      + +F + + +              AE 
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----------GAEI 114

Query: 382 --GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              L YLH      +++RDIK  N++LDKD   KI DFGL 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 34/166 (20%)

Query: 273 FNPSKKLGQGGAGSVYM----GSLPNGTTVAVK-----RLIFNTRQWVDEFFNEVNLISS 323
           F   + LG+GG G V+          G   A+K      ++ N +        E N++  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEE 77

Query: 324 IEHKNLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIIL 377
           ++H  +V L+  + +    L L+ EY+    L      + IF ++          F +  
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYL-- 127

Query: 378 GTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
             AE    L +LH   +  II+RD+K  NI+L+     K+ DFGL 
Sbjct: 128 --AEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 22/145 (15%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEF-FNEVNLISSIE--------H 326
           +KLG G   +V++   +     VA+K  +  + +   E   +E+ L+ S+          
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100

Query: 327 KNLVKLLGC-SIEGPESL---LVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           + +V+LL    I G       +V+E       L ++I  K+  + L       II    +
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWI-IKSNYQGLPLPCVKKIIQQVLQ 157

Query: 382 GLAYLHGGSETRIIHRDIKTSNILL 406
           GL YLH  ++ RIIH DIK  NILL
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILL 180

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 25/165 (15%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLG 334
           +K+G G  G +Y+G  +  G  VA+K     T+    +   E  +   ++    +  +  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNI--ILGTA----EGLAYLHG 388
           C  EG  +++V E +   SL+  +F+         +++F++  +L  A      + Y+H 
Sbjct: 73  CGAEGDYNVMVMELL-GPSLED-LFNFC-------SRKFSLKTVLLLADQMISRIEYIH- 122

Query: 389 GSETRIIHRDIKTSNILLDKDFTPK---IADFGLARCFAADRTHV 430
                 IHRD+K  N L+          I DFGLA+ +   RTH 
Sbjct: 123 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 43/162 (26%), Positives = 59/162 (36%), Gaps = 29/162 (17%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL---IFNTRQWVDEFFNEVN-LISSIEHK 327
           FN    LG+G  G V +          AVK L   +      V+    E   L    +  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 328 NLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIILGTAE 381
            L +L  C  +  + L  V EYV    L         F +                  AE
Sbjct: 403 FLTQLHSCF-QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-----------AAE 450

Query: 382 ---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              GL +L       II+RD+K  N++LD +   KIADFG+ 
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 29/167 (17%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLV-KLLG 334
           +K+G G  G +Y+G ++     VA+K     T+    +   E  +   ++    +  +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA--------YL 386
             +EG  ++LV + +   SL+  +F+         +++ +  L T   LA        ++
Sbjct: 71  FGVEGDYNVLVMDLL-GPSLED-LFNFC-------SRKLS--LKTVLMLADQMINRVEFV 119

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPK---IADFGLARCFAADRTHV 430
           H  S    +HRDIK  N L+          I DFGLA+ +    TH 
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 44/163 (26%), Positives = 66/163 (40%), Gaps = 31/163 (19%)

Query: 273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRL----IFNTRQWVDEFFNEVN-LISSIEH 326
           F+  K +G+G  G V +          AVK L    I   ++      +E N L+ +++H
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKH 98

Query: 327 KNLVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRF---NIIL 377
             LV L   S +  + L  V +Y+    L      +  F + +        RF    I  
Sbjct: 99  PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIAS 150

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
                L YLH      I++RD+K  NILLD      + DFGL 
Sbjct: 151 A----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 33/166 (19%)

Query: 273 FNPSKKLGQGGAGSVYM----GSLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSI 324
           F   K LG G  G V++         G   A+K L    I    +  +    E  ++  I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 325 EHKN-LVKLLGCSIEGPESL-LVYEYVPNRSL-----DQFIFDKNKTKLLNWNKRFNIIL 377
                LV L   + +    L L+ +Y+    L      +  F +++        +  +  
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QIYV-- 165

Query: 378 GTAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
              E    L +LH   +  II+RDIK  NILLD +    + DFGL+
Sbjct: 166 --GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 49.9 bits (120), Expect = 6e-07
 Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 6/45 (13%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            AE    L +LH   +  II+RD+K  N+LLD +   K+ADFG+ 
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 49.9 bits (120), Expect = 7e-07
 Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 6/45 (13%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            AE    L +LH      II+RD+K  NILLD++   K+ DFGL+
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 49.9 bits (120), Expect = 7e-07
 Identities = 19/45 (42%), Positives = 26/45 (57%), Gaps = 6/45 (13%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
            AE   GL +L       II+RD+K  N++LD +   KIADFG+ 
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 6/45 (13%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +AE    L YLH   E  II+RD+K  N+LLD +   K+ D+G+ 
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 49.5 bits (119), Expect = 9e-07
 Identities = 24/56 (42%), Positives = 32/56 (57%), Gaps = 8/56 (14%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR--CFAADRTH 429
            AE   GL +LH      I++RD+K  NILLDKD   KIADFG+ +       +T+
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 49.5 bits (119), Expect = 9e-07
 Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 6/45 (13%)

Query: 379 TAE---GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA 420
           +AE    L YLH   E  II+RD+K  N+LLD +   K+ D+G+ 
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 39/170 (22%), Positives = 63/170 (37%), Gaps = 30/170 (17%)

Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI------EHKNL 329
             +G+G  G V           VA+K +I N + ++++   EV L+  +          +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 330 VKLLG--------CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           V L          C        LV+E + + +L   +      + ++ N           
Sbjct: 119 VHLKRHFMFRNHLC--------LVFEML-SYNLYDLL-RNTNFRGVSLNLTRKFAQQMCT 168

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIADFGLARCFAADRTH 429
            L +L    E  IIH D+K  NILL        KI DFG + C    R +
Sbjct: 169 ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIY 216

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 40/191 (20%), Positives = 78/191 (40%), Gaps = 52/191 (27%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNE 317
           ++++YE L+           +G+G  G V           VA+K ++ N +++  +   E
Sbjct: 95  VAYRYEVLKV----------IGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEE 143

Query: 318 VNLISSI------EHKNLVKLLG--------CSIEGPESLLVYEYVPNRSLDQFIFD--- 360
           + ++  +         N++ +L         C        + +E      L   +++   
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--------MTFE-----LLSMNLYELIK 190

Query: 361 KNKTKLLNWN--KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP--KIAD 416
           KNK +  +    ++F   +   + L  LH   + RIIH D+K  NILL +      K+ D
Sbjct: 191 KNKFQGFSLPLVRKFAHSI--LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID 245

Query: 417 FGLARCFAADR 427
           FG + C+   R
Sbjct: 246 FGSS-CYEHQR 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	438
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.98
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.95
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.95
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.95
3niz_A	311	Rhodanese family protein; structural genomics, str	99.95
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.94
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.94
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.94
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.94
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.94
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.94
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.94
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.94
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.94
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.94
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.94
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.94
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.93
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.93
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.93
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.93
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.93
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.93
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.93
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.93
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.93
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.93
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.93
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.93
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.93
3bhy_A	283	Death-associated protein kinase 3; death associate	99.93
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.93
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.93
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.93
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.93
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.93
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.93
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.93
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.93
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.93
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.93
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.93
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.93
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.93
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.93
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.93
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.92
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.92
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.92
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.92
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.92
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.92
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.92
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.92
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.92
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.92
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.92
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.92
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.91
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.91
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.91
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.91
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.9
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.9
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.9
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.79
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.68
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.52
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.77
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.69
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.66
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.54
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.51
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.09
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.76
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.71
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.69
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.68
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.47
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.42
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.36
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.25
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.11
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.93
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.94
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.84
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	93.16
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.66
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.56
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.49

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-37  Score=292.45  Aligned_cols=165  Identities=25%  Similarity=0.456  Sum_probs=141.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|.+.+.||+|+||.||+|.+.      ++..||||+++..+....++|.+|+++|++++|||||+++|++.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45777899999999999999753      467899999987777777899999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccC----------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 013693          345 VYEYVPNRSLDQFIFDKN----------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  414 (438)
                      ||||+++|+|.++|+...          ....++|.+++.|+.||++||.|||   +.+||||||||+||||+.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          2356999999999999999999999   889999999999999999999999


Q ss_pred             ecccccccccCCCcee-eeeeeecC
Q 013693          415 ADFGLARCFAADRTHV-STAVAGTL  438 (438)
Q Consensus       415 ~DFGla~~~~~~~~~~-~~~~~Gt~  438 (438)
                      +|||+|+......... .....||+
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~  194 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPI  194 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECG
T ss_pred             CCcccceecCCCCceeecCceecCh
Confidence            9999999876544332 22355664

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.7e-37  Score=294.84  Aligned_cols=160  Identities=28%  Similarity=0.492  Sum_probs=143.4

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +.|+..++||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5688889999999999999954 579999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCce
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~  429 (438)
                      ++|+|.+++..    ..+++.++..|+.||+.||.|||   +.+||||||||+||||+.++++||+|||+|+.+..+...
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999843    35899999999999999999999   899999999999999999999999999999988665443


Q ss_pred             eeeeeeecC
Q 013693          430 VSTAVAGTL  438 (438)
Q Consensus       430 ~~~~~~Gt~  438 (438)
                      . ++.+|||
T Consensus       227 ~-~~~~GTp  234 (346)
T 4fih_A          227 R-KSLVGTP  234 (346)
T ss_dssp             B-CCCCSCG
T ss_pred             c-cccccCc
Confidence            2 3467885

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.6e-37  Score=289.90  Aligned_cols=162  Identities=27%  Similarity=0.354  Sum_probs=143.5

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++. ..+++.||||++...   .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            469999999999999999995 567999999999754   2344678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+|+.+..+
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999954   345999999999999999999999   899999999999999999999999999999998755


Q ss_pred             Cce-eeeeeeecC
Q 013693          427 RTH-VSTAVAGTL  438 (438)
Q Consensus       427 ~~~-~~~~~~Gt~  438 (438)
                      ... ...+.+|||
T Consensus       186 ~~~~~~~~~~GTp  198 (311)
T 4aw0_A          186 SKQARANSFVGTA  198 (311)
T ss_dssp             TTCCCBCCCCSCG
T ss_pred             CCcccccCcccCc
Confidence            433 334578886

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.5e-37  Score=293.10  Aligned_cols=165  Identities=25%  Similarity=0.443  Sum_probs=134.5

Q ss_pred             cCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|.+.++||+|+||.||+|.+.      +++.||||+++..+....++|.+|+++|++++|||||+++|++.+++..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            44666788999999999999754      467899999987777778899999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCC------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          345 VYEYVPNRSLDQFIFDKNK------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      ||||+++|+|.++++....            ..+++|.+++.|+.||++||.|||   +.+||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            9999999999999965422            246999999999999999999999   8899999999999999999999


Q ss_pred             EEecccccccccCCCc-eeeeeeeecC
Q 013693          413 KIADFGLARCFAADRT-HVSTAVAGTL  438 (438)
Q Consensus       413 kl~DFGla~~~~~~~~-~~~~~~~Gt~  438 (438)
                      ||+|||+|+.+..... ...+...||+
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~  224 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPI  224 (329)
T ss_dssp             EECCCC----------------CCCCG
T ss_pred             EEcccccceeccCCCcceecCcccccc
Confidence            9999999998765433 2333456664

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-37  Score=294.55  Aligned_cols=163  Identities=25%  Similarity=0.393  Sum_probs=136.4

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|++.+.||+|+||.||+|. ..+++.||||++...  .....+.+.+|+.+|++|+|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            579999999999999999995 457999999999754  34456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+++|+|.+++... ....+++.++..|+.||+.||.|||   +.+||||||||+||||+.++.+||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999643 3445789999999999999999999   8999999999999999999999999999999875432


Q ss_pred             ceeeeeeeecC
Q 013693          428 THVSTAVAGTL  438 (438)
Q Consensus       428 ~~~~~~~~Gt~  438 (438)
                      . ..+..+|||
T Consensus       180 ~-~~~~~~GT~  189 (350)
T 4b9d_A          180 E-LARACIGTP  189 (350)
T ss_dssp             H-HHHHHHSCC
T ss_pred             c-cccccCCCc
Confidence            2 123456775

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-36  Score=296.40  Aligned_cols=161  Identities=28%  Similarity=0.480  Sum_probs=144.4

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .+.|+..++||+|+||.||+|. ..+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            3568999999999999999995 457999999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      +++|+|.+++..    ..+++.++..|+.||+.||.|||   +.+||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999999843    34899999999999999999999   89999999999999999999999999999998865543


Q ss_pred             eeeeeeeecC
Q 013693          429 HVSTAVAGTL  438 (438)
Q Consensus       429 ~~~~~~~Gt~  438 (438)
                      .. ++.+|||
T Consensus       303 ~~-~~~~GTp  311 (423)
T 4fie_A          303 RR-KSLVGTP  311 (423)
T ss_dssp             CB-CCCEECT
T ss_pred             cc-cccccCc
Confidence            32 3567886

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-36  Score=283.17  Aligned_cols=162  Identities=30%  Similarity=0.439  Sum_probs=133.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..+++++.++||+|+||.||+|.+.+  .||||+++..  .....++|.+|+.++++++|||||+++|++.. +..+|||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34667788999999999999998753  6999998743  34556789999999999999999999998754 5689999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.++|+..  ...++|.+++.|+.||++||.|||   +.+||||||||+||||++++++||+|||+|+.....
T Consensus       111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            999999999999643  345999999999999999999999   889999999999999999999999999999987654


Q ss_pred             Cc-eeeeeeeecC
Q 013693          427 RT-HVSTAVAGTL  438 (438)
Q Consensus       427 ~~-~~~~~~~Gt~  438 (438)
                      .. ...+..+||+
T Consensus       186 ~~~~~~~~~~GT~  198 (307)
T 3omv_A          186 SGSQQVEQPTGSV  198 (307)
T ss_dssp             --------CCCCT
T ss_pred             CcceeecccccCC
Confidence            32 2334567885

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.3e-36  Score=286.68  Aligned_cols=164  Identities=25%  Similarity=0.378  Sum_probs=137.5

Q ss_pred             CCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .+++.++||+|+||.||+|.+.      +++.||||+++.. .....++|.+|+.++++++|||||+++|++.+++..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3456788999999999999763      4678999999754 33446789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC
Q 013693          345 VYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  411 (438)
                      ||||+++|+|.++|.....             ...++|.+++.|+.||++||.|||   +.+||||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            9999999999999965321             245899999999999999999999   889999999999999999999


Q ss_pred             eEEecccccccccCCCce-eeeeeeecC
Q 013693          412 PKIADFGLARCFAADRTH-VSTAVAGTL  438 (438)
Q Consensus       412 ~kl~DFGla~~~~~~~~~-~~~~~~Gt~  438 (438)
                      +||+|||+|+.+...... ..+...||+
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~  211 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPI  211 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred             EEECCcccceeccCCCceeEecccccCC
Confidence            999999999987543322 223455663

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-35  Score=280.82  Aligned_cols=154  Identities=25%  Similarity=0.435  Sum_probs=128.5

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC--------
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--------  340 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  340 (438)
                      ++|++.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            458889999999999999995 4578999999997653 445678999999999999999999999987654        


Q ss_pred             ----eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 013693          341 ----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (438)
Q Consensus       341 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  416 (438)
                          ..||||||+++|+|.+++.........++..++.|+.||++||.|||   +.+||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976555555677788999999999999999   89999999999999999999999999


Q ss_pred             ccccccccCCC
Q 013693          417 FGLARCFAADR  427 (438)
Q Consensus       417 FGla~~~~~~~  427 (438)
                      ||+|+.+..+.
T Consensus       162 FGla~~~~~~~  172 (299)
T 4g31_A          162 FGLVTAMDQDE  172 (299)
T ss_dssp             CCCC-------
T ss_pred             CccceecCCCc
Confidence            99999886543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-35  Score=275.67  Aligned_cols=156  Identities=27%  Similarity=0.342  Sum_probs=132.6

Q ss_pred             CCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeEEEEE
Q 013693          274 NPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLLVY  346 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  346 (438)
                      +..++||+|+||.||+|.. .++..||+|++...  .....+.|.+|+.+|++++|||||++++++.+    ++..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4567899999999999954 56899999999754  34456789999999999999999999999875    34589999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeC-CCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLD-KDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kl~DFGla~~~  423 (438)
                      ||+++|+|.+++..   ...+++..+..|+.||+.||.|||   +.+  ||||||||+||||+ .++.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999954   346899999999999999999999   666  99999999999997 4789999999999875


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      ....   ..+++|||
T Consensus       183 ~~~~---~~~~~GTp  194 (290)
T 3fpq_A          183 RASF---AKAVIGTP  194 (290)
T ss_dssp             CTTS---BEESCSSC
T ss_pred             CCCc---cCCcccCc
Confidence            4332   23567886

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.9e-35  Score=273.78  Aligned_cols=159  Identities=25%  Similarity=0.410  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|.. .+++.||||++...   .....+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999964 56899999999754   2334567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+ +|+|.+++..   ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6799999854   345999999999999999999999   899999999999999999999999999999987544


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ..  .++.+|||
T Consensus       166 ~~--~~~~~GT~  175 (275)
T 3hyh_A          166 NF--LKTSCGSP  175 (275)
T ss_dssp             -----------C
T ss_pred             Cc--cCCeeECc
Confidence            32  23467875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-35  Score=281.87  Aligned_cols=157  Identities=28%  Similarity=0.416  Sum_probs=132.8

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +.|+..++||+|+||.||+|. ..+++.||||+++...     ...+|+.++++++|||||++++++.+++..||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            457778899999999999995 4578999999997532     2357999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccccCCCc
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAADRT  428 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~~~~~~  428 (438)
                      ++|+|.+++...   ..+++.++..|+.||+.||.|||   +.+||||||||+||||+.++ ++||+|||+|+.+..+..
T Consensus       133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            999999999543   45999999999999999999999   89999999999999999887 699999999999875543


Q ss_pred             ee----eeeeeecC
Q 013693          429 HV----STAVAGTL  438 (438)
Q Consensus       429 ~~----~~~~~Gt~  438 (438)
                      ..    ...++|||
T Consensus       207 ~~~~~~~~~~~GT~  220 (336)
T 4g3f_A          207 GKSLLTGDYIPGTE  220 (336)
T ss_dssp             -------CCCCCCG
T ss_pred             ccceecCCccccCc
Confidence            22    12467885

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.1e-36  Score=282.64  Aligned_cols=161  Identities=25%  Similarity=0.255  Sum_probs=131.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc----cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|++.+.||+|+||.||+|..    .+++.||||++....  .....++.+|+++|++++|||||++++++.+++..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5699999999999999999954    247899999996532  2234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   345999999999999999999999   8999999999999999999999999999999765


Q ss_pred             CCCceeeeeeeecC
Q 013693          425 ADRTHVSTAVAGTL  438 (438)
Q Consensus       425 ~~~~~~~~~~~Gt~  438 (438)
                      ...... ++.+|||
T Consensus       178 ~~~~~~-~~~~GT~  190 (304)
T 3ubd_A          178 DHEKKA-YSFCGTV  190 (304)
T ss_dssp             ---CCC-CSCCCCG
T ss_pred             CCCccc-cccccCc
Confidence            544322 3467875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-34  Score=275.38  Aligned_cols=162  Identities=27%  Similarity=0.336  Sum_probs=131.3

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----eEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----ESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  346 (438)
                      ++|.+.++||+|+||.||+|.+ +|+.||||++...... ...+..|+..+.+++|||||+++|++.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4567788999999999999987 6899999998654322 223345677778899999999999998764    579999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----SETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      ||+++|+|.++++.    ..++|..+..|+.|+++||.|||+.     +.++||||||||+||||+.++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999953    3589999999999999999999942     23499999999999999999999999999999


Q ss_pred             cccCCCceee---eeeeecC
Q 013693          422 CFAADRTHVS---TAVAGTL  438 (438)
Q Consensus       422 ~~~~~~~~~~---~~~~Gt~  438 (438)
                      ..........   ...+||+
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~  176 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             EEETTTTEESCC-----CCG
T ss_pred             cccCCCCceeeecccccccc
Confidence            8876554332   2456775

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.7e-35  Score=280.32  Aligned_cols=176  Identities=27%  Similarity=0.373  Sum_probs=147.6

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEEEccC------CCEEEEEEeeecc-hhhHHHHHHHHHHHhccCC-Cceee
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEH-KNLVK  331 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~  331 (438)
                      .++.++++...++|++.+.||+|+||.||+|.+..      ++.||||++.... ....++|.+|+.+|++++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            45566778888999999999999999999996532      3579999997543 3456789999999999965 99999


Q ss_pred             EEeEEEeC-CeEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeC
Q 013693          332 LLGCSIEG-PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR  397 (438)
Q Consensus       332 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  397 (438)
                      ++|+|... +..+|||||+++|+|.++|+....             ...+++.+++.|+.||++||.|||   +.+||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence            99998765 568999999999999999965321             345899999999999999999999   8999999


Q ss_pred             CCCCCCeeeCCCCCeEEecccccccccCCCcee-eeeeeecC
Q 013693          398 DIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGTL  438 (438)
Q Consensus       398 dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~  438 (438)
                      ||||+|||+++++.+||+|||+|+.+..+.... .+...||+
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~  251 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  251 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence            999999999999999999999999886655433 33466764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.98  E-value=9.8e-33  Score=270.79  Aligned_cols=161  Identities=23%  Similarity=0.381  Sum_probs=135.2

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe------CCe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------GPE  341 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  341 (438)
                      ++|++.+.||+|+||.||+|. ..+|+.||||++...  .....+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            579999999999999999995 457999999999643  33445678899999999999999999998764      357


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .||||||++ |+|.+++..   ...+++.++..|+.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            899999995 689999843   456999999999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCc---eeeeeeeecC
Q 013693          422 CFAADRT---HVSTAVAGTL  438 (438)
Q Consensus       422 ~~~~~~~---~~~~~~~Gt~  438 (438)
                      .+.....   ...++.+||+
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~  226 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATR  226 (398)
T ss_dssp             CC-------CCCCCSSCCCC
T ss_pred             ecccCccccccccccceeCh
Confidence            8754322   2233567875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=5.2e-32  Score=262.75  Aligned_cols=150  Identities=23%  Similarity=0.372  Sum_probs=132.2

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcc----CCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (438)
                      .+....++|++.++||+|+||.||+|..+    .++.||||++....  ...++.+|+++|+.+ +||||+++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            34456678999999999999999999542    46789999986443  345688999999998 699999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEeccc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFG  418 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFG  418 (438)
                      +..+|||||+++|+|.+++.      .+++.++..++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999982      3899999999999999999999   8999999999999999876 799999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +|+....
T Consensus       164 la~~~~~  170 (361)
T 4f9c_A          164 LAQGTHD  170 (361)
T ss_dssp             TCEECTT
T ss_pred             CCcccCC
Confidence            9987654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=9.3e-32  Score=275.60  Aligned_cols=159  Identities=23%  Similarity=0.253  Sum_probs=135.6

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc---hhhHH---HHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVD---EFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ++|++.++||+|+||.||++. ..+++.||||++.+..   .....   ...+++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            568899999999999999995 4579999999997532   11222   2334567778889999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |||||++||+|.++|..   ...+++..+..++.||+.||.|||   +.+||||||||+||||+.+|++||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999954   345999999999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      .....   .+.+|||
T Consensus       343 ~~~~~---~t~~GTp  354 (689)
T 3v5w_A          343 SKKKP---HASVGTH  354 (689)
T ss_dssp             SSCCC---CSCCSCG
T ss_pred             CCCCC---CCccCCc
Confidence            65543   2457885

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=2.3e-31  Score=273.37  Aligned_cols=162  Identities=22%  Similarity=0.360  Sum_probs=143.2

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||++. ..+|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4679999999999999999995 457999999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC--CCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD--FTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kl~DFGla~~~~~~  426 (438)
                      +++|+|.+++..  ....+++.++..++.||+.||.|||   +.+|+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999853  2345899999999999999999999   8999999999999999854  89999999999998655


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ...  ...+||+
T Consensus       311 ~~~--~~~~GT~  320 (573)
T 3uto_A          311 QSV--KVTTGTA  320 (573)
T ss_dssp             SEE--EEECSSG
T ss_pred             Cce--eeeEECc
Confidence            432  3456775

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=1.3e-30  Score=259.42  Aligned_cols=173  Identities=23%  Similarity=0.224  Sum_probs=149.2

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEE
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (438)
                      +.+.+++...++|++.++||+|+||.||++... +++.||+|++....   ....+.+.+|+.++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445666677789999999999999999999654 57889999997532   22334588999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 013693          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (438)
Q Consensus       337 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  416 (438)
                      .+++..+|||||+++|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcc
Confidence            9999999999999999999999542  345899999999999999999999   89999999999999999999999999


Q ss_pred             ccccccccCCCceeeeeeeecC
Q 013693          417 FGLARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       417 FGla~~~~~~~~~~~~~~~Gt~  438 (438)
                      ||+|+.+..+.....+..+||+
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~  240 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTP  240 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCG
T ss_pred             hhhhhhcccCCCcccccccCCc
Confidence            9999988776655555566774

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=7.2e-30  Score=245.01  Aligned_cols=181  Identities=43%  Similarity=0.684  Sum_probs=154.3

Q ss_pred             cccccCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeE
Q 013693          257 SCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGC  335 (438)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~  335 (438)
                      ....++++++....++|+..+.||+|+||.||++...+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            345788999999999999999999999999999988789999999987543 2233468999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 013693          336 SIEGPESLLVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       336 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  414 (438)
                      +...+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||..+..+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997643 3345999999999999999999999322239999999999999999999999


Q ss_pred             ecccccccccCCCceeeeeeeec
Q 013693          415 ADFGLARCFAADRTHVSTAVAGT  437 (438)
Q Consensus       415 ~DFGla~~~~~~~~~~~~~~~Gt  437 (438)
                      +|||+++.+............||
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt  198 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGT  198 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSC
T ss_pred             ccCccccccCcccccccccccCC
Confidence            99999998876555444444455

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=7.9e-30  Score=244.29  Aligned_cols=163  Identities=39%  Similarity=0.671  Sum_probs=146.1

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (438)
                      .+.+.+++..+++|+..+.||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            45556667788999999999999999999999888999999998877666778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      +..++||||+++++|.+++..... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999854332 235899999999999999999999   8899999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++....
T Consensus       185 ~~~~~~~  191 (321)
T 2qkw_B          185 ISKKGTE  191 (321)
T ss_dssp             TCEECSS
T ss_pred             ccccccc
Confidence            9987654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=3.4e-29  Score=238.65  Aligned_cols=152  Identities=28%  Similarity=0.477  Sum_probs=137.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ++|...+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            5678889999999999999955 568999999987767777888999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++++|.+++...  ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999643  345899999999999999999999   8999999999999999999999999999999875443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=3.4e-29  Score=237.33  Aligned_cols=152  Identities=26%  Similarity=0.485  Sum_probs=138.3

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|+..+.||+|+||.||++. ..+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            4679999999999999999996 457899999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      +++++|.+++..    ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999953    34899999999999999999999   88999999999999999999999999999998765543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=9e-30  Score=251.62  Aligned_cols=173  Identities=23%  Similarity=0.221  Sum_probs=148.4

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEE
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (438)
                      +.+++++...++|++.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            44555666678899999999999999999965 478999999997532   23345688999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 013693          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (438)
Q Consensus       337 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  416 (438)
                      .+.+..+|||||+++|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++++||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEee
Confidence            9999999999999999999999543  235899999999999999999999   89999999999999999999999999


Q ss_pred             ccccccccCCCceeeeeeeecC
Q 013693          417 FGLARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       417 FGla~~~~~~~~~~~~~~~Gt~  438 (438)
                      ||+++.+..+........+||+
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~  227 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTP  227 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCG
T ss_pred             chhheeccCCCccccceecccc
Confidence            9999988766554444456664

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=7.1e-30  Score=252.20  Aligned_cols=169  Identities=22%  Similarity=0.245  Sum_probs=144.7

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ..+++...++|++.++||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            445555678899999999999999999965 468899999997532   2234568899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      ++..+|||||+++|+|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999999853    34899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCceeeeeeeecC
Q 013693          419 LARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       419 la~~~~~~~~~~~~~~~Gt~  438 (438)
                      +|+.+...........+||+
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~  233 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTP  233 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCG
T ss_pred             eeEeeccCCcccccCCcCCc
Confidence            99988765544434456664

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=5.5e-29  Score=238.55  Aligned_cols=162  Identities=28%  Similarity=0.426  Sum_probs=144.0

Q ss_pred             cccCHHHHHHHhcC----------CCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC
Q 013693          259 LSFKYETLEKATNY----------FNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK  327 (438)
Q Consensus       259 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  327 (438)
                      ..+++++++.+++.          |+..+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788888887765          556678999999999999654 7999999999876666677899999999999999


Q ss_pred             ceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013693          328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (438)
Q Consensus       328 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  407 (438)
                      ||+++++++...+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||   +.+|+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence            99999999999999999999999999999984    235899999999999999999999   88999999999999999


Q ss_pred             CCCCeEEecccccccccCCC
Q 013693          408 KDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       408 ~~~~~kl~DFGla~~~~~~~  427 (438)
                      .++.+||+|||+++.+..+.
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSS
T ss_pred             CCCcEEEeeeeeeeecccCc
Confidence            99999999999999876543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=7e-29  Score=238.27  Aligned_cols=155  Identities=24%  Similarity=0.439  Sum_probs=135.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-------  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  340 (438)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            456888999999999999999654 78999999997543 345678999999999999999999999986654       


Q ss_pred             --------------------------------------------------eEEEEEeccCCCCHHHHhhccCCCCcCCHH
Q 013693          341 --------------------------------------------------ESLLVYEYVPNRSLDQFIFDKNKTKLLNWN  370 (438)
Q Consensus       341 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~  370 (438)
                                                                        ..++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999776666667788


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          371 KRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       371 ~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      .++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  218 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE  218 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccch
Confidence            89999999999999999   8999999999999999999999999999999887653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=2.1e-28  Score=232.73  Aligned_cols=167  Identities=44%  Similarity=0.685  Sum_probs=149.7

Q ss_pred             cccccCHHHHHHHhcCCCCC------CccccCCceeEEEEEccCCCEEEEEEeeec----chhhHHHHHHHHHHHhccCC
Q 013693          257 SCLSFKYETLEKATNYFNPS------KKLGQGGAGSVYMGSLPNGTTVAVKRLIFN----TRQWVDEFFNEVNLISSIEH  326 (438)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  326 (438)
                      ....|++++++.++++|...      +.||+|+||.||+|.. +++.||||++...    .....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999999887      8999999999999987 6889999998643    23446789999999999999


Q ss_pred             CceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013693          327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (438)
Q Consensus       327 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  406 (438)
                      |||+++++++...+..++||||+++++|.+++........+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            9999999999999999999999999999999975545566999999999999999999999   8899999999999999


Q ss_pred             CCCCCeEEecccccccccCCC
Q 013693          407 DKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       407 ~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +.++.+||+|||+++......
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCS
T ss_pred             cCCCcEEEeeccccccccccc
Confidence            999999999999998876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=4.8e-29  Score=235.92  Aligned_cols=163  Identities=30%  Similarity=0.482  Sum_probs=135.0

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|+||.||++. ..+++.||+|++...   .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            4578899999999999999995 457899999998643   334467899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++...   ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999999543   45899999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      ..........||+
T Consensus       164 ~~~~~~~~~~gt~  176 (294)
T 4eqm_A          164 TSLTQTNHVLGTV  176 (294)
T ss_dssp             -----------CC
T ss_pred             ccccccCccccCc
Confidence            5433333344553

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=4.4e-29  Score=239.83  Aligned_cols=151  Identities=26%  Similarity=0.434  Sum_probs=136.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45788999999999999999954 67999999999754  3445677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999998543   45899999999999999999999   889999999999999999999999999999887654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=5.4e-29  Score=239.97  Aligned_cols=162  Identities=27%  Similarity=0.287  Sum_probs=138.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|+..+.||+|+||.||++.. .+++.||+|++...   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            35688899999999999999955 46899999999754   233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999999854   345899999999999999999999   88999999999999999999999999999987543


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      .... ....+||+
T Consensus       158 ~~~~-~~~~~gt~  169 (337)
T 1o6l_A          158 DGAT-MKTFCGTP  169 (337)
T ss_dssp             TTCC-BCCCEECG
T ss_pred             CCCc-ccccccCh
Confidence            3322 22345653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=7.6e-29  Score=240.51  Aligned_cols=163  Identities=26%  Similarity=0.347  Sum_probs=135.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||||++...   .....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            356799999999999999999954 46899999999754   233456788999999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |||||+++|+|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+|+..
T Consensus       101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999999543   45899999999999999999999   889999999999999999999999999999865


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      ...... ....+||+
T Consensus       175 ~~~~~~-~~~~~gt~  188 (353)
T 3txo_A          175 ICNGVT-TATFCGTP  188 (353)
T ss_dssp             CC----------CCG
T ss_pred             ccCCcc-ccccCCCc
Confidence            433322 22345653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.95  E-value=4.4e-29  Score=237.93  Aligned_cols=161  Identities=31%  Similarity=0.556  Sum_probs=133.9

Q ss_pred             CHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 013693          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (438)
Q Consensus       262 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (438)
                      ..++++...++|++.+.||+|+||.||++.. +++.||||++....  ....+++.+|+.++++++||||+++++++...
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3444445567888999999999999999976 68899999987543  44567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeCCCCCeEEecc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      +..++||||+++++|.+++........+++..++.++.||+.||.|||   +.+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999966544445999999999999999999999   788  999999999999999999999999


Q ss_pred             cccccccCC
Q 013693          418 GLARCFAAD  426 (438)
Q Consensus       418 Gla~~~~~~  426 (438)
                      |+++.....
T Consensus       184 g~a~~~~~~  192 (309)
T 3p86_A          184 GLSRLKAST  192 (309)
T ss_dssp             C--------
T ss_pred             CCCcccccc
Confidence            999865443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=1.5e-28  Score=240.47  Aligned_cols=153  Identities=29%  Similarity=0.532  Sum_probs=128.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc----CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.+.||+|+||.||+|...    ++..||||+++.. .....++|.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357889999999999999999764    5678999999754 34456789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999543  345899999999999999999999   8899999999999999999999999999999886


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      .+.
T Consensus       199 ~~~  201 (373)
T 2qol_A          199 DDP  201 (373)
T ss_dssp             ---
T ss_pred             cCC
Confidence            544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=2.4e-28  Score=233.66  Aligned_cols=149  Identities=26%  Similarity=0.353  Sum_probs=133.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5688899999999999999955 478999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999954   345899999999999999999999   89999999999999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=1.3e-28  Score=242.06  Aligned_cols=162  Identities=23%  Similarity=0.289  Sum_probs=136.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.++||+|+||.||++.. .+++.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+.+..+|
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            45688899999999999999965 46789999999754   233445688999999887 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+|+...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999998543   45899999999999999999999   8999999999999999999999999999998744


Q ss_pred             CCCceeeeeeeecC
Q 013693          425 ADRTHVSTAVAGTL  438 (438)
Q Consensus       425 ~~~~~~~~~~~Gt~  438 (438)
                      ..... ....+||+
T Consensus       205 ~~~~~-~~~~~gt~  217 (396)
T 4dc2_A          205 RPGDT-TSTFCGTP  217 (396)
T ss_dssp             CTTCC-BCCCCBCG
T ss_pred             cCCCc-cccccCCc
Confidence            33222 22355663

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.95  E-value=2.1e-28  Score=234.88  Aligned_cols=153  Identities=29%  Similarity=0.547  Sum_probs=133.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc----CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.+.||+|+||.||+|...    .+..||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356778899999999999999663    3456999999754 44456789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999543  345899999999999999999999   8999999999999999999999999999999886


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      .+.
T Consensus       203 ~~~  205 (325)
T 3kul_A          203 DDP  205 (325)
T ss_dssp             ---
T ss_pred             cCc
Confidence            543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.95  E-value=4e-28  Score=236.09  Aligned_cols=152  Identities=24%  Similarity=0.363  Sum_probs=135.0

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchh------hHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQ------WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      ..+.|++.+.||+|+||.||++.. .+++.||+|.+......      ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            346788999999999999999954 46899999999764321      34678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----CeEEecc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADF  417 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~DF  417 (438)
                      .++||||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999943   346899999999999999999999   88999999999999998776    7999999


Q ss_pred             cccccccCC
Q 013693          418 GLARCFAAD  426 (438)
Q Consensus       418 Gla~~~~~~  426 (438)
                      |+++.+...
T Consensus       164 G~a~~~~~~  172 (361)
T 2yab_A          164 GLAHEIEDG  172 (361)
T ss_dssp             SSCEECCTT
T ss_pred             CCceEcCCC
Confidence            999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=2.3e-28  Score=239.38  Aligned_cols=150  Identities=25%  Similarity=0.356  Sum_probs=134.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            5688899999999999999954 468899999997542   334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999954   345899999999999999999999   899999999999999999999999999999987544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=1.9e-28  Score=234.94  Aligned_cols=151  Identities=29%  Similarity=0.382  Sum_probs=132.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            36788999999999999999955 478999999987543 2334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999843   345899999999999999999999   899999999999999999999999999999877543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=2.8e-28  Score=235.92  Aligned_cols=149  Identities=25%  Similarity=0.298  Sum_probs=133.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|++.+.||+|+||.||++.. .+++.||+|++...   .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5688899999999999999965 46889999999754   334456788999999988 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999998543   45899999999999999999999   88999999999999999999999999999987543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=2e-28  Score=236.76  Aligned_cols=164  Identities=27%  Similarity=0.336  Sum_probs=137.9

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCe
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  341 (438)
                      ....++|++.+.||+|+||.||++.. .+++.||||++....   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            34557899999999999999999965 468899999997542   33456788999999987 99999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||+++|+|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            99999999999999999542   45899999999999999999999   8899999999999999999999999999998


Q ss_pred             cccCCCceeeeeeeec
Q 013693          422 CFAADRTHVSTAVAGT  437 (438)
Q Consensus       422 ~~~~~~~~~~~~~~Gt  437 (438)
                      ........ ....+||
T Consensus       167 ~~~~~~~~-~~~~~gt  181 (345)
T 1xjd_A          167 ENMLGDAK-TNTFCGT  181 (345)
T ss_dssp             CCCCTTCC-BCCCCSC
T ss_pred             hcccCCCc-ccCCCCC
Confidence            75433322 2234555

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=3.6e-28  Score=235.54  Aligned_cols=150  Identities=23%  Similarity=0.302  Sum_probs=134.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            5688899999999999999965 468999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999543   35899999999999999999999   899999999999999999999999999999987543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=3.2e-28  Score=226.82  Aligned_cols=152  Identities=30%  Similarity=0.477  Sum_probs=136.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|++.+.||+|+||.||++...++..||+|++..... ..+++.+|+.++.+++||||+++++++..++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467888999999999999999888888999999975432 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++++|.+++...  ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....+.
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            999999999543  345899999999999999999999   8899999999999999999999999999999876554

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.1e-27  Score=229.48  Aligned_cols=152  Identities=22%  Similarity=0.257  Sum_probs=135.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            46788999999999999999954 468899999987543 3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC--CCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~--~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++..  ....+++.++..++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999943  2345899999999999999999999   889999999999999987  789999999999988654


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       158 ~  158 (321)
T 1tki_A          158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            4

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=1.5e-28  Score=229.24  Aligned_cols=150  Identities=27%  Similarity=0.479  Sum_probs=135.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|+..+.||+|+||.||++...+++.||+|++..... ..+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            356888899999999999999887888999999975432 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++...  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999999543  345899999999999999999999   89999999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=4.3e-28  Score=236.94  Aligned_cols=154  Identities=29%  Similarity=0.474  Sum_probs=135.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc--------CCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (438)
                      .++|++.+.||+|+||.||+|...        ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999642        3457999999754 344567899999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  406 (438)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            999999999999999999965432             235899999999999999999999   8899999999999999


Q ss_pred             CCCCCeEEecccccccccCC
Q 013693          407 DKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       407 ~~~~~~kl~DFGla~~~~~~  426 (438)
                      +.++.+||+|||+++.+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCC
T ss_pred             CCCCCEEEccccCCcccCcc
Confidence            99999999999999977543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=3.7e-28  Score=230.13  Aligned_cols=151  Identities=28%  Similarity=0.417  Sum_probs=128.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch--------------------------hhHHHHHHHHHHHh
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--------------------------QWVDEFFNEVNLIS  322 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  322 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            35788999999999999999954 5688999999865421                          12356889999999


Q ss_pred             ccCCCceeeEEeEEEe--CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013693          323 SIEHKNLVKLLGCSIE--GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (438)
Q Consensus       323 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  400 (438)
                      +++||||+++++++.+  .+..++||||+++++|.+++    ....+++.++..++.||+.||.|||   +.+|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence            9999999999999987  56899999999999998765    3346999999999999999999999   8899999999


Q ss_pred             CCCeeeCCCCCeEEecccccccccCCC
Q 013693          401 TSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       401 p~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+|||++.++.+||+|||+++.+....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~  191 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD  191 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc
Confidence            999999999999999999999876543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.95  E-value=3.8e-28  Score=232.82  Aligned_cols=149  Identities=32%  Similarity=0.489  Sum_probs=130.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----eEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----ESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  345 (438)
                      .++|++.++||+|+||.||+|... ++.||||++..... ....+.+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467888999999999999999774 78999999865433 2345667999999999999999999998754    47999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC----------CeeeCCCCCCCeeeCCCCCeEEe
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET----------RIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      |||+++|+|.+++..    ..+++..++.++.|++.||.|||   +.          +|+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999943    34899999999999999999999   77          99999999999999999999999


Q ss_pred             cccccccccCCC
Q 013693          416 DFGLARCFAADR  427 (438)
Q Consensus       416 DFGla~~~~~~~  427 (438)
                      |||+++.+....
T Consensus       174 DFg~a~~~~~~~  185 (322)
T 3soc_A          174 DFGLALKFEAGK  185 (322)
T ss_dssp             CCTTCEEECTTS
T ss_pred             cCCccccccccc
Confidence            999998876544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.95  E-value=5.7e-28  Score=230.45  Aligned_cols=152  Identities=28%  Similarity=0.453  Sum_probs=133.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..++|++.+.||+|+||.||++...+++.||+|++....  ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            457789999999999999999988789999999987542  233567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++ +|.+++..  ....+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99975 88888754  3345899999999999999999999   889999999999999999999999999999987543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.95  E-value=1.8e-28  Score=238.32  Aligned_cols=166  Identities=28%  Similarity=0.419  Sum_probs=142.4

Q ss_pred             cccCHHHHHHHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCcee
Q 013693          259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLV  330 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv  330 (438)
                      ..+....++...++|++.+.||+|+||.||++.+      .+++.||||++... .....+.+.+|++++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3456677778889999999999999999999963      34578999999754 334457799999999999 799999


Q ss_pred             eEEeEEEeCCe-EEEEEeccCCCCHHHHhhccCC----------------------------------------------
Q 013693          331 KLLGCSIEGPE-SLLVYEYVPNRSLDQFIFDKNK----------------------------------------------  363 (438)
Q Consensus       331 ~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------  363 (438)
                      ++++++...+. .++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999887654 8999999999999999965432                                              


Q ss_pred             -----------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          364 -----------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       364 -----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                                       ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             122899999999999999999999   889999999999999999999999999999987554


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       247 ~  247 (359)
T 3vhe_A          247 P  247 (359)
T ss_dssp             T
T ss_pred             c
Confidence            3

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.95  E-value=1.4e-27  Score=234.27  Aligned_cols=153  Identities=25%  Similarity=0.341  Sum_probs=136.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46789999999999999999954 46899999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC--CCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK--DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~--~~~~kl~DFGla~~~~~~  426 (438)
                      +++++|.+++..  ....+++.++..++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999853  2345899999999999999999999   889999999999999974  578999999999988655


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       205 ~  205 (387)
T 1kob_A          205 E  205 (387)
T ss_dssp             S
T ss_pred             c
Confidence            4

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=4.9e-28  Score=236.08  Aligned_cols=166  Identities=19%  Similarity=0.196  Sum_probs=136.1

Q ss_pred             HHHhcCCCCCCccccCCceeEEEE------EccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC---CCceeeEEeEEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMG------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE---HKNLVKLLGCSI  337 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  337 (438)
                      +...++|.+.+.||+|+||.||+|      ...+++.||||++....   ..++.+|+.++..++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            344567888999999999999999      34568899999986543   345677777777775   999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccC--CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-------
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKN--KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-------  408 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-------  408 (438)
                      ..+..+|||||+++|+|.+++....  ....+++.+++.|+.||+.||.|||   +.+|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence            9999999999999999999996422  3456999999999999999999999   899999999999999988       


Q ss_pred             ----CCCeEEecccccccccCC-CceeeeeeeecC
Q 013693          409 ----DFTPKIADFGLARCFAAD-RTHVSTAVAGTL  438 (438)
Q Consensus       409 ----~~~~kl~DFGla~~~~~~-~~~~~~~~~Gt~  438 (438)
                          ++.+||+|||+|+.+... .....+...||+
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~  249 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS  249 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTT
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCC
Confidence                899999999999876522 222333455664

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=5.1e-28  Score=234.73  Aligned_cols=155  Identities=21%  Similarity=0.277  Sum_probs=134.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-----hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      .+.|++.+.||+|+||.||++.. .+++.||||++....     ....+.+.+|+.+++.++||||+++++++..++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45688999999999999999954 578999999986432     123577999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC---eEEecccc
Q 013693          344 LVYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFGL  419 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~DFGl  419 (438)
                      +||||+++++|.+.+.... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988875432 2345899999999999999999999   889999999999999976554   99999999


Q ss_pred             cccccCCC
Q 013693          420 ARCFAADR  427 (438)
Q Consensus       420 a~~~~~~~  427 (438)
                      ++.+....
T Consensus       180 a~~~~~~~  187 (351)
T 3c0i_A          180 AIQLGESG  187 (351)
T ss_dssp             CEECCTTS
T ss_pred             eeEecCCC
Confidence            99886543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.2e-27  Score=229.79  Aligned_cols=151  Identities=25%  Similarity=0.359  Sum_probs=134.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch------hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|++.+.||+|+||.||++.. .+++.||+|.+.....      ...+.+.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35688899999999999999955 4689999999975432      1356799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----CeEEeccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~DFG  418 (438)
                      ++||||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999943   346899999999999999999999   89999999999999998877    89999999


Q ss_pred             ccccccCC
Q 013693          419 LARCFAAD  426 (438)
Q Consensus       419 la~~~~~~  426 (438)
                      +++.+...
T Consensus       164 ~a~~~~~~  171 (326)
T 2y0a_A          164 LAHKIDFG  171 (326)
T ss_dssp             TCEECCTT
T ss_pred             CCeECCCC
Confidence            99987643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=3.3e-28  Score=233.73  Aligned_cols=151  Identities=25%  Similarity=0.325  Sum_probs=124.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc----cCCCEEEEEEeeecc----hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      .++|++.+.||+|+||.||++..    .+++.||+|++....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46788999999999999999965    478999999997542    2345568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999854   245889999999999999999999   8899999999999999999999999999998


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .....
T Consensus       170 ~~~~~  174 (327)
T 3a62_A          170 ESIHD  174 (327)
T ss_dssp             -----
T ss_pred             ccccC
Confidence            75433

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=9.7e-28  Score=233.67  Aligned_cols=153  Identities=25%  Similarity=0.340  Sum_probs=134.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ...++|++.+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456799999999999999999954 56899999999754  33456778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CCeEEecccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLAR  421 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~DFGla~  421 (438)
                      ||||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.+   +.+||+|||+++
T Consensus       106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999998843   345899999999999999999999   8899999999999999764   459999999998


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .+...
T Consensus       180 ~~~~~  184 (362)
T 2bdw_A          180 EVNDS  184 (362)
T ss_dssp             CCTTC
T ss_pred             EecCC
Confidence            87644

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=1.2e-28  Score=231.50  Aligned_cols=153  Identities=25%  Similarity=0.413  Sum_probs=134.0

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +...++|+..+.||+|+||.||++...++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            344567888999999999999999888888999999975432 3467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++...  ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999999542  345899999999999999999999   88999999999999999999999999999987643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=4e-28  Score=235.33  Aligned_cols=151  Identities=26%  Similarity=0.256  Sum_probs=133.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (438)
                      ..++|++.+.||+|+||.||++... +++.||||++...   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3467899999999999999999654 4789999999754   223456788999999988 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999999543   35899999999999999999999   889999999999999999999999999999875


Q ss_pred             cC
Q 013693          424 AA  425 (438)
Q Consensus       424 ~~  425 (438)
                      ..
T Consensus       172 ~~  173 (353)
T 2i0e_A          172 IW  173 (353)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=1e-27  Score=226.48  Aligned_cols=150  Identities=25%  Similarity=0.455  Sum_probs=131.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|++.+.||+|+||.||++.. .+++.||||++....  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5688899999999999999955 468999999997543  3345778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++ +|.+.+..  ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9976 55555533  2345899999999999999999999   889999999999999999999999999999987543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.95  E-value=3.9e-28  Score=237.88  Aligned_cols=153  Identities=26%  Similarity=0.412  Sum_probs=136.0

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ...++|++.+.||+|+||.||+|... +++.||||++... .....++|.+|+.++++++||||+++++++..++..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34567888899999999999999765 7899999998754 334456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++|+|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            9999999999999542  345899999999999999999999   89999999999999999999999999999987543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=7.3e-28  Score=227.02  Aligned_cols=150  Identities=29%  Similarity=0.478  Sum_probs=133.1

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.+.||+|+||.||++...+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688899999999999999987789999999996543  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            975 898888543  345899999999999999999999   889999999999999999999999999999887543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=9e-28  Score=239.72  Aligned_cols=154  Identities=22%  Similarity=0.291  Sum_probs=134.3

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ...++|++.+.||+|+||.||++. ..+++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            345678999999999999999994 5578999999987543  3445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCCeEEecccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLAR  421 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~DFGla~  421 (438)
                      ||||+++|+|.+.+...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+++
T Consensus        88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999988543   45899999999999999999999   88999999999999998   56789999999998


Q ss_pred             cccCCC
Q 013693          422 CFAADR  427 (438)
Q Consensus       422 ~~~~~~  427 (438)
                      .+....
T Consensus       162 ~~~~~~  167 (444)
T 3soa_A          162 EVEGEQ  167 (444)
T ss_dssp             CCCTTC
T ss_pred             EecCCC
Confidence            876544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=3e-28  Score=244.08  Aligned_cols=151  Identities=26%  Similarity=0.291  Sum_probs=124.9

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|+||.||++. ..+++.||||++...   .......+.+|+.+++.++||||+++++++...+..+||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            3568889999999999999995 457899999999753   334456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||   + .+|+||||||+|||++.++.+||+|||+|+...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999854   345899999999999999999999   6 899999999999999999999999999998754


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      .+
T Consensus       301 ~~  302 (446)
T 4ejn_A          301 KD  302 (446)
T ss_dssp             C-
T ss_pred             CC
Confidence            43

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=1.5e-27  Score=228.27  Aligned_cols=154  Identities=29%  Similarity=0.409  Sum_probs=135.4

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC--eEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  346 (438)
                      ++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999654 58999999997543 334577889999999999999999999988765  789999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCCeEEeccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLARC  422 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~DFGla~~  422 (438)
                      ||+++++|.+++........+++.+++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976555555999999999999999999999   8899999999999999    7788899999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +..+.
T Consensus       166 ~~~~~  170 (319)
T 4euu_A          166 LEDDE  170 (319)
T ss_dssp             CCTTC
T ss_pred             cCCCC
Confidence            76544

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.95  E-value=3.3e-28  Score=230.10  Aligned_cols=153  Identities=31%  Similarity=0.538  Sum_probs=132.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-----cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (438)
                      .++|++.+.||+|+||.||++.+     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            45688899999999999999973     36789999999877777778899999999999999999999998654  458


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++...  ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999543  335899999999999999999999   89999999999999999999999999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +..+.
T Consensus       164 ~~~~~  168 (295)
T 3ugc_A          164 LPQDK  168 (295)
T ss_dssp             -----
T ss_pred             ccCCc
Confidence            76543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=7.3e-28  Score=235.16  Aligned_cols=162  Identities=24%  Similarity=0.298  Sum_probs=128.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHH-HhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNL-ISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            35688999999999999999965 458899999997542   2334556777776 577899999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999854   345889999999999999999999   8999999999999999999999999999999754


Q ss_pred             CCCceeeeeeeecC
Q 013693          425 ADRTHVSTAVAGTL  438 (438)
Q Consensus       425 ~~~~~~~~~~~Gt~  438 (438)
                      ..... ....+||+
T Consensus       191 ~~~~~-~~~~~gt~  203 (373)
T 2r5t_A          191 EHNST-TSTFCGTP  203 (373)
T ss_dssp             CCCCC-CCSBSCCC
T ss_pred             cCCCc-cccccCCc
Confidence            33322 22345653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=2.4e-27  Score=226.73  Aligned_cols=153  Identities=29%  Similarity=0.501  Sum_probs=120.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            45789999999999999999965 468999999997553 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999885432   2245899999999999999999999   8899999999999999999999999999999875


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       160 ~~  161 (317)
T 2pmi_A          160 IP  161 (317)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=1.9e-28  Score=246.02  Aligned_cols=157  Identities=31%  Similarity=0.477  Sum_probs=138.3

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .+.++...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344556677888999999999999999988888899999997543 34678999999999999999999999986 6678


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            9999999999999999643 2235888999999999999999999   88999999999999999999999999999998


Q ss_pred             ccC
Q 013693          423 FAA  425 (438)
Q Consensus       423 ~~~  425 (438)
                      +..
T Consensus       334 ~~~  336 (454)
T 1qcf_A          334 IED  336 (454)
T ss_dssp             BCC
T ss_pred             cCC
Confidence            754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=1.7e-27  Score=243.16  Aligned_cols=163  Identities=26%  Similarity=0.320  Sum_probs=139.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|+..+.||+|+||.||++.. .+++.||||++....   ......+.+|+.+|++++||||+++++++.+.+..+||
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            45688889999999999999955 478999999997542   23456688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++|+|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986532 344899999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      ....  +..+||+
T Consensus       339 ~~~~--~~~~GT~  349 (576)
T 2acx_A          339 GQTI--KGRVGTV  349 (576)
T ss_dssp             TCCE--ECCCSCG
T ss_pred             Cccc--cccCCCc
Confidence            4432  2235653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=2e-27  Score=238.82  Aligned_cols=150  Identities=28%  Similarity=0.429  Sum_probs=135.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5688889999999999999965 478999999997542   234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999943   345899999999999999999999   899999999999999999999999999999987654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=3.4e-28  Score=231.94  Aligned_cols=152  Identities=25%  Similarity=0.426  Sum_probs=129.1

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe----
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE----  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  341 (438)
                      .++|++.+.||+|+||.||++. ..+++.||||++...   .....+.+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            4678899999999999999996 467899999999754   33445678999999999999999999999876543    


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||+++++|.+++...   ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            49999999999999999543   35899999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCC
Q 013693          422 CFAADR  427 (438)
Q Consensus       422 ~~~~~~  427 (438)
                      .+....
T Consensus       165 ~~~~~~  170 (311)
T 3ork_A          165 AIADSG  170 (311)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=6.6e-28  Score=233.10  Aligned_cols=159  Identities=26%  Similarity=0.417  Sum_probs=135.4

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSI  337 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  337 (438)
                      ++...++|++.+.||+|+||.||+|..      .++..||||++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            344567889999999999999999964      24568999999754 334567899999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCC--------------------CcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeC
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKT--------------------KLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR  397 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  397 (438)
                      ..+..++||||+++++|.+++......                    ..+++..++.++.||+.||.|||   +.+|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence            999999999999999999999654321                    34899999999999999999999   8999999


Q ss_pred             CCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          398 DIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       398 dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||||+|||++.++.+||+|||+++.+..+.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~  226 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDS  226 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCc
Confidence            999999999999999999999999876544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.3e-27  Score=240.30  Aligned_cols=149  Identities=23%  Similarity=0.395  Sum_probs=122.3

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----Ce
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  341 (438)
                      .++|++.+.||+|+||.||+|. ..+++.||||++...  .....+++.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            3679999999999999999995 447899999998653  344567899999999999999999999998543     56


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||+ +++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+|+
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5789998843   345899999999999999999999   8899999999999999999999999999999


Q ss_pred             cccC
Q 013693          422 CFAA  425 (438)
Q Consensus       422 ~~~~  425 (438)
                      .+..
T Consensus       205 ~~~~  208 (458)
T 3rp9_A          205 TVDY  208 (458)
T ss_dssp             CTTS
T ss_pred             hccC
Confidence            8754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=7.7e-28  Score=243.99  Aligned_cols=156  Identities=29%  Similarity=0.464  Sum_probs=137.9

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEccC-CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++...++|++.+.||+|+||.||+|.+.. +..||||++.... ...++|.+|+.+|++++||||+++++++...+..+|
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            33445678888999999999999997654 7899999997543 346789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++|+|.+++... ....+++..++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999999653 2345899999999999999999999   8899999999999999999999999999999875


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      .+
T Consensus       370 ~~  371 (495)
T 1opk_A          370 GD  371 (495)
T ss_dssp             TC
T ss_pred             CC
Confidence            44

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=2.3e-27  Score=241.40  Aligned_cols=164  Identities=26%  Similarity=0.361  Sum_probs=140.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|+..+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5688889999999999999965 468999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++|+|.+++..... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999865432 346999999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      ..... ...+||+
T Consensus       342 ~~~~~-~~~~GT~  353 (543)
T 3c4z_A          342 GQTKT-KGYAGTP  353 (543)
T ss_dssp             TCCCB-CCCCSCT
T ss_pred             CCccc-ccccCCc
Confidence            44322 2345664

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=9.2e-28  Score=231.23  Aligned_cols=149  Identities=25%  Similarity=0.409  Sum_probs=132.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788899999999999999964 678999999987532   233457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+ +|+|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 78898888543   45899999999999999999999   889999999999999999999999999999877544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=2.1e-27  Score=232.27  Aligned_cols=147  Identities=29%  Similarity=0.375  Sum_probs=127.1

Q ss_pred             CCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      .+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..+|||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999954 57899999999877666678899999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee--CCCCCeEEecccccccccCCC
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL--DKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill--~~~~~~kl~DFGla~~~~~~~  427 (438)
                      .+++...  ...+++.++..++.||+.||.|||   +.+|+||||||+|||+  +.++.+||+|||+++.+....
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            9988542  345899999999999999999999   8899999999999999  567899999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=5.1e-28  Score=233.62  Aligned_cols=158  Identities=32%  Similarity=0.519  Sum_probs=138.3

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (438)
                      .+....++|++.+.||+|+||.||++...      +++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34445678999999999999999999664      3478999999754 3445678999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCC---------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNK---------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH  396 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  396 (438)
                      ..+..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||   +.+|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence            99999999999999999999965321                     256899999999999999999999   889999


Q ss_pred             CCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          397 RDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       397 ~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||||+|||++.++.+||+|||+++.+..
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  226 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYS  226 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             CCCCcceEEECCCCeEEEeecCCCccccc
Confidence            99999999999999999999999987643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=4.6e-28  Score=235.42  Aligned_cols=162  Identities=27%  Similarity=0.309  Sum_probs=138.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEc----cCCCEEEEEEeeecc----hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGP  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  340 (438)
                      .++|++.+.||+|+||.||++..    .+++.||||+++...    ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35788999999999999999965    468999999986432    23456788899999999 6999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..+|||||+++++|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999999543   35899999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCCCceeeeeeeec
Q 013693          421 RCFAADRTHVSTAVAGT  437 (438)
Q Consensus       421 ~~~~~~~~~~~~~~~Gt  437 (438)
                      +.+..+.........||
T Consensus       207 ~~~~~~~~~~~~~~~gt  223 (355)
T 1vzo_A          207 KEFVADETERAYDFCGT  223 (355)
T ss_dssp             EECCGGGGGGGCGGGSC
T ss_pred             eecccCCCCcccCcccC
Confidence            97754433332333454

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.94  E-value=2.5e-27  Score=221.81  Aligned_cols=153  Identities=24%  Similarity=0.404  Sum_probs=137.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ..++|++.+.||+|+||.||++.. .++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            456788999999999999999955 4578999999987666667889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~DFGla~~~~  424 (438)
                      |+++++|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||++..+.
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999998854   345899999999999999999999   8899999999999999   788999999999998876


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      ...
T Consensus       161 ~~~  163 (277)
T 3f3z_A          161 PGK  163 (277)
T ss_dssp             TTS
T ss_pred             Ccc
Confidence            543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.94  E-value=1.7e-27  Score=227.00  Aligned_cols=156  Identities=29%  Similarity=0.467  Sum_probs=136.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      ..++|.+.+.||+|+||.||++..      .++..||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            456788899999999999999964      24578999999754 34556789999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCC---------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNK---------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIK  400 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  400 (438)
                      .++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||   +.+|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            9999999999999999965432                     234899999999999999999999   8899999999


Q ss_pred             CCCeeeCCCCCeEEecccccccccCCC
Q 013693          401 TSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       401 p~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+|||++.++.+||+|||+++.+....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~  204 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEED  204 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred             hheEEEcCCCCEEEccccccccccccc
Confidence            999999999999999999999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=1e-27  Score=231.73  Aligned_cols=160  Identities=25%  Similarity=0.264  Sum_probs=136.1

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-----chhhHHHHHHHHHHHhccCCCceeeEEeEE
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-----TRQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (438)
                      ..++....++|++.+.||+|+||.||++.. .++..||+|++...     .....+.+.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   97 (345)
T 3hko_A           18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY   97 (345)
T ss_dssp             CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence            345667778899999999999999999954 56889999998653     234567899999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHhhccC-------------------------------------CCCcCCHHHHHHHHHHH
Q 013693          337 IEGPESLLVYEYVPNRSLDQFIFDKN-------------------------------------KTKLLNWNKRFNIILGT  379 (438)
Q Consensus       337 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i  379 (438)
                      .+.+..++||||+++++|.+++....                                     ....+++..+..++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            99999999999999999999984210                                     01234677888999999


Q ss_pred             HHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC--CeEEecccccccccC
Q 013693          380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDF--TPKIADFGLARCFAA  425 (438)
Q Consensus       380 ~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~--~~kl~DFGla~~~~~  425 (438)
                      +.||.|||   +.+|+||||||+|||++.++  .+||+|||+++.+..
T Consensus       178 ~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          178 FSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            99999999   88999999999999998776  899999999997643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=1.9e-27  Score=233.37  Aligned_cols=155  Identities=29%  Similarity=0.459  Sum_probs=135.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc--------CCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      ..++|.+.+.||+|+||.||+|...        .+..||||++... .....+++.+|+++++++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4467888999999999999999642        2357999999754 344567899999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      ++..++||||+++++|.+++.....             ...+++.+++.|+.||+.||.|||   +.+|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            9999999999999999999965432             245899999999999999999999   889999999999999


Q ss_pred             eCCCCCeEEecccccccccCC
Q 013693          406 LDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++.++.+||+|||+++.+...
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~  244 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHI  244 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCC
T ss_pred             EcCCCcEEEcccCcccccccc
Confidence            999999999999999977543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=7.3e-28  Score=226.75  Aligned_cols=160  Identities=29%  Similarity=0.449  Sum_probs=140.1

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      +++...++|++.+.||+|+||.||++... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            33445677888999999999999999654 48899999987543 34678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++++|.+++... ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999999653 3355899999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCCce
Q 013693          424 AADRTH  429 (438)
Q Consensus       424 ~~~~~~  429 (438)
                      ..+...
T Consensus       162 ~~~~~~  167 (288)
T 3kfa_A          162 TGDTYT  167 (288)
T ss_dssp             CSSSSE
T ss_pred             cCCccc
Confidence            655443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.94  E-value=3e-27  Score=230.13  Aligned_cols=148  Identities=23%  Similarity=0.302  Sum_probs=129.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            45789999999999999999955 478999999997543 2346688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC--eEEeccccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--PKIADFGLARCFA  424 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--~kl~DFGla~~~~  424 (438)
                      +++++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.  +||+|||+++...
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999998542   35899999999999999999999   899999999999999987765  9999999998543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=2.5e-27  Score=228.39  Aligned_cols=154  Identities=27%  Similarity=0.333  Sum_probs=135.6

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--------hhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ...++|++.+.||+|+||.||++. ..+++.||||++....        ....+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            345679999999999999999995 5578899999997542        1234568899999999999999999999999


Q ss_pred             CCeEEEEEeccCCC-CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          339 GPESLLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       339 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                      .+..++||||+.+| +|.+++..   ...+++..+..|+.||+.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999777 99999854   335899999999999999999999   889999999999999999999999999


Q ss_pred             cccccccCCC
Q 013693          418 GLARCFAADR  427 (438)
Q Consensus       418 Gla~~~~~~~  427 (438)
                      |+++.+....
T Consensus       175 g~a~~~~~~~  184 (335)
T 3dls_A          175 GSAAYLERGK  184 (335)
T ss_dssp             TTCEECCTTC
T ss_pred             ccceECCCCC
Confidence            9999876544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.94  E-value=2.8e-27  Score=227.46  Aligned_cols=150  Identities=21%  Similarity=0.305  Sum_probs=132.4

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||+|. ..+++.||||++....  ..+.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            3578889999999999999996 4678999999986543  234688999999999 99999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC-----eEEeccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-----PKIADFGLARC  422 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-----~kl~DFGla~~  422 (438)
                      |+ +++|.+++...  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999999643  346999999999999999999999   889999999999999998887     99999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +....
T Consensus       160 ~~~~~  164 (330)
T 2izr_A          160 YIDPE  164 (330)
T ss_dssp             SBCTT
T ss_pred             eecCC
Confidence            76544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.94  E-value=4.6e-28  Score=242.99  Aligned_cols=157  Identities=31%  Similarity=0.503  Sum_probs=134.0

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      +.++...++|++.+.||+|+||.||+|.+..+..||||+++... ...++|.+|+.++++++||||+++++++.. +..+
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            33445567788899999999999999988777889999997543 235679999999999999999999999876 6789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++|+|.+++... ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       255 iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            999999999999999532 2345899999999999999999999   899999999999999999999999999999987


Q ss_pred             cCC
Q 013693          424 AAD  426 (438)
Q Consensus       424 ~~~  426 (438)
                      ..+
T Consensus       331 ~~~  333 (452)
T 1fmk_A          331 EDN  333 (452)
T ss_dssp             ---
T ss_pred             CCC
Confidence            643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=1.7e-28  Score=236.65  Aligned_cols=149  Identities=21%  Similarity=0.280  Sum_probs=124.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc--------hhhHHHHHHHHHHHhccC---------CCceeeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIE---------HKNLVKL  332 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  332 (438)
                      .++|++.+.||+|+||.||+|.. +++.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999987 78999999997653        223477889999999886         7777777


Q ss_pred             EeEEE------------------------------eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHH
Q 013693          333 LGCSI------------------------------EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEG  382 (438)
Q Consensus       333 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  382 (438)
                      .+.+.                              ..+..+|||||+++|++.+.+..    ..+++.++..|+.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            77543                              26789999999999976666622    458999999999999999


Q ss_pred             HHHhhcCCCCCeeeCCCCCCCeeeCCCC--------------------CeEEecccccccccC
Q 013693          383 LAYLHGGSETRIIHRDIKTSNILLDKDF--------------------TPKIADFGLARCFAA  425 (438)
Q Consensus       383 L~~LH~~~~~~iiH~dlkp~Nill~~~~--------------------~~kl~DFGla~~~~~  425 (438)
                      |.|||+  +.+|+||||||+|||++.++                    .+||+|||+|+.+..
T Consensus       174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            999992  37899999999999999887                    899999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.94  E-value=6.1e-27  Score=230.30  Aligned_cols=151  Identities=21%  Similarity=0.295  Sum_probs=135.1

Q ss_pred             hcCCCCCCccccC--CceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQG--GAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.++||+|  +||.||++.. .+++.||||++....  ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4568899999999  9999999965 478999999997543  4456778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998653 2345899999999999999999999   8999999999999999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.94  E-value=5.4e-27  Score=219.68  Aligned_cols=152  Identities=28%  Similarity=0.433  Sum_probs=134.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688899999999999999964 578999999996542   22346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++..  ....+++.+++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999954  2356899999999999999999999   88999999999999999999999999999988754


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       165 ~  165 (278)
T 3cok_A          165 P  165 (278)
T ss_dssp             -
T ss_pred             C
Confidence            3

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.94  E-value=4.1e-27  Score=223.11  Aligned_cols=153  Identities=25%  Similarity=0.511  Sum_probs=132.3

Q ss_pred             cCCCCCCccccCCceeEEEEE-----ccCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-----LPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PES  342 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  342 (438)
                      +.|+..+.||+|+||.||++.     ..+++.||+|++... .....+.+.+|+.++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            457888999999999999997     346889999999754 334457899999999999999999999999876  668


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++...  ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999999543  345899999999999999999999   89999999999999999999999999999998


Q ss_pred             ccCCCc
Q 013693          423 FAADRT  428 (438)
Q Consensus       423 ~~~~~~  428 (438)
                      +..+..
T Consensus       176 ~~~~~~  181 (302)
T 4e5w_A          176 IETDKE  181 (302)
T ss_dssp             CCTTCC
T ss_pred             ccCCCc
Confidence            865543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=219.12  Aligned_cols=150  Identities=31%  Similarity=0.425  Sum_probs=132.4

Q ss_pred             CCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          273 FNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      |.....||+|+||.||+|. ..+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            4556689999999999996 456889999999876666678899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEecccccccccC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAA  425 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGla~~~~~  425 (438)
                      ++|.+++........+++..+..++.|++.||.|||   +.+|+|+||||+|||++. ++.+||+|||+++.+..
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999976544456788999999999999999999   889999999999999987 89999999999988754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.94  E-value=8.6e-27  Score=220.74  Aligned_cols=152  Identities=29%  Similarity=0.416  Sum_probs=128.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhc--cCCCceeeEEeEEEeC----CeEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS--IEHKNLVKLLGCSIEG----PESL  343 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~  343 (438)
                      .++|++.+.||+|+||.||+|.. +++.||||++...   ..+.+.+|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46789999999999999999987 6899999998643   23455667766666  7999999999986643    4589


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----SETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      +||||+++|+|.+++.    ...+++..++.++.||+.||.|||..     .+.+|+||||||+|||++.++.+||+|||
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            9999999999999993    34589999999999999999999932     15789999999999999999999999999


Q ss_pred             ccccccCCCce
Q 013693          419 LARCFAADRTH  429 (438)
Q Consensus       419 la~~~~~~~~~  429 (438)
                      +++........
T Consensus       159 ~a~~~~~~~~~  169 (301)
T 3q4u_A          159 LAVMHSQSTNQ  169 (301)
T ss_dssp             TCEEEETTTTE
T ss_pred             Ceeeccccccc
Confidence            99887655443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=4.7e-27  Score=231.08  Aligned_cols=150  Identities=30%  Similarity=0.511  Sum_probs=124.4

Q ss_pred             HHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCC--e
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGP--E  341 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  341 (438)
                      ...++|++.+.||+|+||.||+|. ..+++.||||++...  .....+.+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            456789999999999999999995 457899999998543  3455677889999999997 999999999998654  6


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||++ ++|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 589998843    35889999999999999999999   8999999999999999999999999999999


Q ss_pred             cccC
Q 013693          422 CFAA  425 (438)
Q Consensus       422 ~~~~  425 (438)
                      .+..
T Consensus       158 ~~~~  161 (388)
T 3oz6_A          158 SFVN  161 (388)
T ss_dssp             ESSS
T ss_pred             cccc
Confidence            7743

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=7.8e-27  Score=222.77  Aligned_cols=149  Identities=25%  Similarity=0.331  Sum_probs=130.1

Q ss_pred             cCCCCC-CccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +.|++. +.||+|+||.||++.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            457764 7899999999999964 47899999999876656677899999999985 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC---eEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~DFGla~~~~  424 (438)
                      |+++++|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+++.+.
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999543   45899999999999999999999   889999999999999988765   9999999998775


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       166 ~  166 (316)
T 2ac3_A          166 L  166 (316)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=1.1e-27  Score=229.53  Aligned_cols=159  Identities=26%  Similarity=0.453  Sum_probs=123.8

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEccCC----CEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ++....++|++.+.||+|+||.||+|.....    ..||||++...  .....+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3344556799999999999999999976543    27999998754  34456789999999999999999999999987


Q ss_pred             CCeE------EEEEeccCCCCHHHHhhccC---CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC
Q 013693          339 GPES------LLVYEYVPNRSLDQFIFDKN---KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (438)
Q Consensus       339 ~~~~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  409 (438)
                      ....      ++||||+++++|.+++....   ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCC
Confidence            7655      99999999999999985432   2225899999999999999999999   8899999999999999999


Q ss_pred             CCeEEecccccccccCC
Q 013693          410 FTPKIADFGLARCFAAD  426 (438)
Q Consensus       410 ~~~kl~DFGla~~~~~~  426 (438)
                      +.+||+|||+++.+...
T Consensus       174 ~~~kl~Dfg~a~~~~~~  190 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSG  190 (323)
T ss_dssp             SCEEECCCCC-------
T ss_pred             CCEEEeecccccccccc
Confidence            99999999999877543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.94  E-value=3.2e-27  Score=235.55  Aligned_cols=150  Identities=25%  Similarity=0.411  Sum_probs=131.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----Ce
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  341 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...  .....+++.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46789999999999999999954 56889999999753  344567899999999999999999999998876     57


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||++ ++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 599999853   345899999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .....
T Consensus       178 ~~~~~  182 (432)
T 3n9x_A          178 TINSE  182 (432)
T ss_dssp             EC---
T ss_pred             ccccc
Confidence            87654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=3.3e-27  Score=232.81  Aligned_cols=155  Identities=28%  Similarity=0.407  Sum_probs=135.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC--eEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  345 (438)
                      .++|.+.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            35688899999999999999965 458999999997543 334567889999999999999999999988765  78999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCCeEEecccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIADFGLAR  421 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~DFGla~  421 (438)
                      |||+++++|.+++........+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999966544445999999999999999999999   8899999999999999    777889999999999


Q ss_pred             cccCCC
Q 013693          422 CFAADR  427 (438)
Q Consensus       422 ~~~~~~  427 (438)
                      .+..+.
T Consensus       165 ~~~~~~  170 (396)
T 4eut_A          165 ELEDDE  170 (396)
T ss_dssp             ECCCGG
T ss_pred             EccCCC
Confidence            876543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=5.6e-27  Score=223.25  Aligned_cols=151  Identities=26%  Similarity=0.385  Sum_probs=133.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            35788899999999999999965 458999999886542  334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999988743   345899999999999999999999   889999999999999999999999999999887643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=1.5e-27  Score=223.64  Aligned_cols=155  Identities=34%  Similarity=0.527  Sum_probs=135.0

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +...++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   86 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT   86 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence            34456788899999999999999988788899999986543 23567999999999999999999999876 45689999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++... ....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            999999999999532 1235899999999999999999999   899999999999999999999999999999987654


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       163 ~  163 (279)
T 1qpc_A          163 E  163 (279)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=4.9e-27  Score=225.45  Aligned_cols=153  Identities=29%  Similarity=0.462  Sum_probs=136.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-----cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEE--eCCeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI--EGPESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  343 (438)
                      ++|++.+.||+|+||.||++.+     .+++.||||++........+.+.+|+.++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688889999999999999973     467899999998777677788999999999999999999999887  455689


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999543  235899999999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCc
Q 013693          424 AADRT  428 (438)
Q Consensus       424 ~~~~~  428 (438)
                      .....
T Consensus       178 ~~~~~  182 (327)
T 3lxl_A          178 PLDKD  182 (327)
T ss_dssp             CTTCS
T ss_pred             ccCCc
Confidence            65443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=7.3e-27  Score=224.97  Aligned_cols=156  Identities=28%  Similarity=0.476  Sum_probs=135.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc--------cCCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      ..++|++.+.||+|+||.||++..        .++..||||++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            356788999999999999999965        24678999999754 344567899999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      .+..++||||+++++|.+++.....             ...+++.+++.++.||+.||.|||   +.+|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence            9999999999999999999965432             234899999999999999999999   889999999999999


Q ss_pred             eCCCCCeEEecccccccccCCC
Q 013693          406 LDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++.++.+||+|||+++.+....
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~  211 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNID  211 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTS
T ss_pred             EcCCCCEEEccccccccccccc
Confidence            9999999999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=1.4e-27  Score=229.63  Aligned_cols=160  Identities=31%  Similarity=0.453  Sum_probs=137.6

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEccC-C-----CEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPN-G-----TTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCS  336 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  336 (438)
                      .++...++|++.+.||+|+||.||++.... +     ..||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345556789999999999999999996532 2     47999999754 334567799999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHhhccCC-----------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          337 IEGPESLLVYEYVPNRSLDQFIFDKNK-----------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       337 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      ..++..++||||+++|+|.+++.....           ...+++..++.++.||+.||.|||   +.+|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence            999999999999999999999864321           345799999999999999999999   889999999999999


Q ss_pred             eCCCCCeEEecccccccccCCC
Q 013693          406 LDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++.++.+||+|||+++.+..+.
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~  218 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDS  218 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCT
T ss_pred             ECCCCeEEECcccccccccccc
Confidence            9999999999999999775443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.94  E-value=6e-27  Score=245.45  Aligned_cols=163  Identities=26%  Similarity=0.262  Sum_probs=139.0

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  343 (438)
                      ..++|++.++||+|+||.||++.. .+++.||||+++..   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            346788899999999999999964 46889999999754   234456788999999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |||||+++|+|.+++...   ..+++.++..++.||+.||.|||   +.+||||||||+||||+.++++||+|||+|+..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999999643   45899999999999999999999   889999999999999999999999999999975


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      ..+... ....+||+
T Consensus       493 ~~~~~~-~~~~~GT~  506 (674)
T 3pfq_A          493 IWDGVT-TKTFCGTP  506 (674)
T ss_dssp             CCTTCC-BCCCCSCS
T ss_pred             ccCCcc-cccccCCC
Confidence            444332 23456664

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=1.4e-27  Score=222.09  Aligned_cols=150  Identities=27%  Similarity=0.464  Sum_probs=134.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|+..+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            356888899999999999999887888999999975433 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++++|.+++...  ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999543  345899999999999999999999   88999999999999999999999999999987643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=5e-27  Score=227.58  Aligned_cols=150  Identities=28%  Similarity=0.375  Sum_probs=121.3

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ..++|++.+.||+|+||.||++... +++.||||++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567889999999999999999654 57899999987543  34568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGla~~~~  424 (438)
                      |+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999843   345899999999999999999999   889999999999999975   8899999999999775


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       203 ~~  204 (349)
T 2w4o_A          203 HQ  204 (349)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.94  E-value=1e-27  Score=229.43  Aligned_cols=163  Identities=28%  Similarity=0.454  Sum_probs=140.4

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEE
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL  333 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  333 (438)
                      +..++++...++|++.+.||+|+||.||+|...      .++.||+|.+... .......+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444556667788999999999999999999653      3678999998754 334456789999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHhhccC-------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013693          334 GCSIEGPESLLVYEYVPNRSLDQFIFDKN-------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (438)
Q Consensus       334 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  406 (438)
                      +++.+.+..++||||+++++|.+++....       ....+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999986432       1245789999999999999999999   8899999999999999


Q ss_pred             CCCCCeEEecccccccccCC
Q 013693          407 DKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       407 ~~~~~~kl~DFGla~~~~~~  426 (438)
                      +.++.+||+|||+++.....
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGG
T ss_pred             cCCCeEEECcCccccccccc
Confidence            99999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.94  E-value=5.1e-27  Score=223.79  Aligned_cols=151  Identities=26%  Similarity=0.267  Sum_probs=128.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec--chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|+..++||+|+||.||+|... +++.||||++...  ......++..|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            357999999999999999999654 7899999998643  223344555666666655 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+ +++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 67998888553  345999999999999999999999   78999999999999999999999999999988754


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       210 ~  210 (311)
T 3p1a_A          210 A  210 (311)
T ss_dssp             -
T ss_pred             C
Confidence            3

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.94  E-value=3.6e-27  Score=222.09  Aligned_cols=150  Identities=27%  Similarity=0.430  Sum_probs=133.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC-C-------CEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN-G-------TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      .++|++.+.||+|+||.||++.... +       ..||+|++........+.+.+|+.++++++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3568888999999999999995532 3       4799999977666677889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC--------eE
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--------PK  413 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--------~k  413 (438)
                      .++||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999643  334899999999999999999999   889999999999999988877        99


Q ss_pred             Eeccccccccc
Q 013693          414 IADFGLARCFA  424 (438)
Q Consensus       414 l~DFGla~~~~  424 (438)
                      |+|||+++...
T Consensus       162 l~Dfg~~~~~~  172 (289)
T 4fvq_A          162 LSDPGISITVL  172 (289)
T ss_dssp             ECCCCSCTTTS
T ss_pred             eccCccccccc
Confidence            99999997654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.94  E-value=4.2e-27  Score=224.16  Aligned_cols=158  Identities=32%  Similarity=0.438  Sum_probs=137.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (438)
                      ...++|++.+.||+|+||.||++..      .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++..+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3456788899999999999999964      346789999997543 34567899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCC---------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNK---------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  404 (438)
                      +..++||||+++++|.+++.....               ...+++.+++.++.||+.||.|||   +.+|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence            999999999999999999965432               225899999999999999999999   88999999999999


Q ss_pred             eeCCCCCeEEecccccccccCCCc
Q 013693          405 LLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       405 ll~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      |++.++.+||+|||+++.......
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~  200 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSN  200 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTT
T ss_pred             EEcCCCCEEEcccccccccccccc
Confidence            999999999999999998865543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.94  E-value=7.5e-27  Score=234.03  Aligned_cols=150  Identities=27%  Similarity=0.496  Sum_probs=132.8

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC-eEEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP-ESLLVY  346 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  346 (438)
                      ...++|++.+.||+|+||.||+|.+. ++.||||+++...  ..+.|.+|+.++++++||||+++++++...+ ..++||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            34567888899999999999999874 7899999997543  4578999999999999999999999987765 799999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||+++|+|.+++.... ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       267 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             ECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            9999999999996542 234789999999999999999999   8899999999999999999999999999998654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.94  E-value=2.4e-27  Score=222.53  Aligned_cols=153  Identities=24%  Similarity=0.370  Sum_probs=123.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ..++|++.+.||+|+||.||+|....    +..||+|++... .....+.+.+|+.++++++||||+++++++ .++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            34678889999999999999996532    456999988653 344567799999999999999999999997 456789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999999543  335899999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       167 ~~~~  170 (281)
T 1mp8_A          167 EDST  170 (281)
T ss_dssp             ----
T ss_pred             Cccc
Confidence            6543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=9.1e-27  Score=224.44  Aligned_cols=151  Identities=26%  Similarity=0.344  Sum_probs=134.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|.+.+.||+|+||.||++.. .+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            35688899999999999999955 45789999998754   334567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++...   ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999988542   45899999999999999999999   88999999999999999999999999999998754


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       194 ~  194 (335)
T 2owb_A          194 D  194 (335)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=1.1e-26  Score=219.45  Aligned_cols=151  Identities=26%  Similarity=0.346  Sum_probs=134.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|...+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888999999999999999654 5789999998754   234567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++...   ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999988542   45899999999999999999999   88999999999999999999999999999988754


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       168 ~  168 (294)
T 2rku_A          168 D  168 (294)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.94  E-value=5.3e-27  Score=226.82  Aligned_cols=161  Identities=24%  Similarity=0.378  Sum_probs=133.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCC--CceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4568889999999999999998888999999998754  34456789999999999986  9999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      || +.+++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999954   345899999999999999999999   88999999999999997 57899999999998865


Q ss_pred             CCcee-eeeeeecC
Q 013693          426 DRTHV-STAVAGTL  438 (438)
Q Consensus       426 ~~~~~-~~~~~Gt~  438 (438)
                      +.... .....||+
T Consensus       160 ~~~~~~~~~~~gt~  173 (343)
T 3dbq_A          160 DTTSVVKDSQVGTV  173 (343)
T ss_dssp             ----------CCCC
T ss_pred             ccccccCCCCcCCc
Confidence            44322 22344553

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.94  E-value=3.3e-27  Score=230.44  Aligned_cols=152  Identities=30%  Similarity=0.436  Sum_probs=132.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            466888999999999999999742      4668999998644 344566789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccC----CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---CeEEe
Q 013693          343 LLVYEYVPNRSLDQFIFDKN----KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIA  415 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~  415 (438)
                      ++||||+++|+|.+++....    ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996542    2245899999999999999999999   88999999999999998554   59999


Q ss_pred             ccccccccc
Q 013693          416 DFGLARCFA  424 (438)
Q Consensus       416 DFGla~~~~  424 (438)
                      |||+++.+.
T Consensus       227 DFG~a~~~~  235 (367)
T 3l9p_A          227 DFGMARDIY  235 (367)
T ss_dssp             CCHHHHHHH
T ss_pred             CCccccccc
Confidence            999998653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=8.9e-27  Score=223.09  Aligned_cols=151  Identities=25%  Similarity=0.361  Sum_probs=134.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchh------hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQ------WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|++.+.||+|+||.||++.. .+++.||+|.+......      ..+++.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45688999999999999999965 46899999999754321      356799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----CeEEeccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~DFG  418 (438)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954   345899999999999999999999   88999999999999999887    79999999


Q ss_pred             ccccccCC
Q 013693          419 LARCFAAD  426 (438)
Q Consensus       419 la~~~~~~  426 (438)
                      +++.+...
T Consensus       165 ~~~~~~~~  172 (321)
T 2a2a_A          165 LAHEIEDG  172 (321)
T ss_dssp             TCEECCTT
T ss_pred             cceecCcc
Confidence            99987654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=6.9e-27  Score=232.16  Aligned_cols=153  Identities=23%  Similarity=0.308  Sum_probs=128.8

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--------hhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (438)
                      ....++|.+.+.||+|+||.||+|. ..+++.||||++....        ......+.+|+.+|++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3456789999999999999999995 4568999999987532        122345889999999999999999999874


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CCeEE
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKI  414 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl  414 (438)
                       .+..++||||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.+   ..+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEE
Confidence             5568999999999999998843   346899999999999999999999   8899999999999999654   45999


Q ss_pred             ecccccccccCC
Q 013693          415 ADFGLARCFAAD  426 (438)
Q Consensus       415 ~DFGla~~~~~~  426 (438)
                      +|||+++.+...
T Consensus       284 ~DFG~a~~~~~~  295 (419)
T 3i6u_A          284 TDFGHSKILGET  295 (419)
T ss_dssp             CCSSTTTSCC--
T ss_pred             eecccceecCCC
Confidence            999999987643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.94  E-value=4.9e-27  Score=225.34  Aligned_cols=151  Identities=30%  Similarity=0.437  Sum_probs=129.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCE----EEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTT----VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|+..+.||+|+||.||+|.. .+++.    ||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            4677889999999999999964 34444    778877543 2334567889999999999999999999886 566899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999543  346899999999999999999999   8899999999999999999999999999999886


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      .+.
T Consensus       167 ~~~  169 (325)
T 3kex_A          167 PDD  169 (325)
T ss_dssp             CCT
T ss_pred             ccc
Confidence            554

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=5.8e-27  Score=223.21  Aligned_cols=152  Identities=18%  Similarity=0.245  Sum_probs=130.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            347799999999999999999965 468899999986542   3345779999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...   ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999543   45899999999999999999999   8899999999999999999999999999998775


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       186 ~~  187 (309)
T 2h34_A          186 DE  187 (309)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=7.5e-27  Score=219.76  Aligned_cols=154  Identities=25%  Similarity=0.393  Sum_probs=132.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|.+.+.||+|+||.||++.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            35688899999999999999954 568999999987653 3346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCCeEEecccccccc
Q 013693          348 YVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCF  423 (438)
Q Consensus       348 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~DFGla~~~  423 (438)
                      |+++++|.+++... .....+++..+..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543 22356899999999999999999999   8899999999999999   45678999999999877


Q ss_pred             cCC
Q 013693          424 AAD  426 (438)
Q Consensus       424 ~~~  426 (438)
                      ...
T Consensus       178 ~~~  180 (285)
T 3is5_A          178 KSD  180 (285)
T ss_dssp             ---
T ss_pred             CCc
Confidence            544

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=1.2e-26  Score=218.07  Aligned_cols=156  Identities=25%  Similarity=0.365  Sum_probs=134.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeec--chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (438)
                      ..++|++.+.||+|+||.||++... +++.||+|++...  ......++.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467889999999999999999654 7899999999754  334456788999999999 99999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCC-CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---------------
Q 013693          345 VYEYVPNRSLDQFIFDKNK-TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---------------  408 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---------------  408 (438)
                      ||||+++++|.+++..... ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999964321 245899999999999999999999   889999999999999984               


Q ss_pred             ----CCCeEEecccccccccCCC
Q 013693          409 ----DFTPKIADFGLARCFAADR  427 (438)
Q Consensus       409 ----~~~~kl~DFGla~~~~~~~  427 (438)
                          ...+||+|||+++......
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~  188 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ  188 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC
T ss_pred             ccCCceEEEEcccccccccCCcc
Confidence                4479999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=7.4e-27  Score=226.19  Aligned_cols=149  Identities=30%  Similarity=0.525  Sum_probs=131.6

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +.|+..+.||+|+||.||+|. ..+++.||||++....   ....+++.+|+.++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            457888999999999999996 4678999999997542   334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||++ |+|.+++...  ...+++.++..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 6888877432  345899999999999999999999   88999999999999999999999999999987754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=1.8e-26  Score=221.40  Aligned_cols=143  Identities=25%  Similarity=0.308  Sum_probs=124.8

Q ss_pred             CCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEeccCCCC
Q 013693          276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  353 (438)
                      .+.||+|+||.||++.. .+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+++..++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999955 46899999998643   3456789999999996 9999999999999999999999999999


Q ss_pred             HHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---CeEEecccccccccCCC
Q 013693          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---TPKIADFGLARCFAADR  427 (438)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~DFGla~~~~~~~  427 (438)
                      |.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++   .+||+|||+++......
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            9999954   345899999999999999999999   89999999999999997665   89999999998765543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=1.1e-26  Score=217.19  Aligned_cols=150  Identities=29%  Similarity=0.380  Sum_probs=134.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            45688899999999999999965 468999999987543 3445788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+++++|.+++..   ...+++.++..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||++..+..
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999843   345899999999999999999999   88999999999999999999999999999987653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=1.9e-26  Score=220.57  Aligned_cols=148  Identities=32%  Similarity=0.530  Sum_probs=131.1

Q ss_pred             CCCCCccccCCceeEEEEEc-----cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLL  344 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  344 (438)
                      |++.+.||+|+||.||++.+     .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48889999999999998854     257889999997553 34567799999999999999999999999884  57899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++..    ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999943    34899999999999999999999   8899999999999999999999999999999886


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      ...
T Consensus       186 ~~~  188 (318)
T 3lxp_A          186 EGH  188 (318)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.94  E-value=4.6e-27  Score=225.76  Aligned_cols=151  Identities=28%  Similarity=0.515  Sum_probs=126.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCC----EEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGT----TVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|+..+.||+|+||.||+|.. .+++    +||+|.+... .....+++.+|+.++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            4588889999999999999964 3444    3688877543 3345678999999999999999999999998755 789


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999653  345899999999999999999999   8899999999999999999999999999999886


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      ...
T Consensus       169 ~~~  171 (327)
T 3poz_A          169 AEE  171 (327)
T ss_dssp             TTC
T ss_pred             CCc
Confidence            544

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=1.4e-26  Score=225.70  Aligned_cols=159  Identities=20%  Similarity=0.386  Sum_probs=139.4

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch--------hhHHHHHHHHHHHhcc-CCCceeeE
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR--------QWVDEFFNEVNLISSI-EHKNLVKL  332 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l  332 (438)
                      ++......++|++.+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            4445566678999999999999999999664 799999999875431        2245688999999999 89999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       333 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      ++++...+..++||||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+|+||||+|||++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999954   245899999999999999999999   8899999999999999999999


Q ss_pred             EEecccccccccCCC
Q 013693          413 KIADFGLARCFAADR  427 (438)
Q Consensus       413 kl~DFGla~~~~~~~  427 (438)
                      ||+|||++..+....
T Consensus       240 kl~DfG~~~~~~~~~  254 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE  254 (365)
T ss_dssp             EECCCTTCEECCTTC
T ss_pred             EEEecCcccccCCCc
Confidence            999999999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=9.5e-27  Score=226.42  Aligned_cols=162  Identities=24%  Similarity=0.293  Sum_probs=140.3

Q ss_pred             ccccCHHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-----CCceee
Q 013693          258 CLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----HKNLVK  331 (438)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  331 (438)
                      ...+++++.....++|++.++||+|+||.||++.. .+++.||||++... ....+.+..|+.+++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34566666677788999999999999999999955 57899999998643 344566788999999986     999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---
Q 013693          332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---  408 (438)
Q Consensus       332 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---  408 (438)
                      +++++...+..++||||+ +++|.+++... ....+++.++..++.||+.||.|||   +.+|+||||||+|||++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccc
Confidence            999999999999999999 99999999653 2345899999999999999999999   899999999999999975   


Q ss_pred             ----------------------CCCeEEecccccccccC
Q 013693          409 ----------------------DFTPKIADFGLARCFAA  425 (438)
Q Consensus       409 ----------------------~~~~kl~DFGla~~~~~  425 (438)
                                            ++.+||+|||+|+....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence                                  78999999999987654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.94  E-value=5.8e-27  Score=223.47  Aligned_cols=165  Identities=27%  Similarity=0.410  Sum_probs=140.6

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceee
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVK  331 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~  331 (438)
                      .+....++...++|++.+.||+|+||.||++..      .+++.||||++.... ....+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            355566666778899999999999999999963      356889999997543 34456799999999999 7999999


Q ss_pred             EEeEEEeCC-eEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeC
Q 013693          332 LLGCSIEGP-ESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHR  397 (438)
Q Consensus       332 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  397 (438)
                      +++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||   +.+|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999988755 58999999999999999965432             123889999999999999999999   8899999


Q ss_pred             CCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          398 DIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       398 dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||||+|||++.++.+||+|||+++.+....
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  202 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDP  202 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             cCccceEEECCCCCEEECCCccccccccCc
Confidence            999999999999999999999999876544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=7.5e-28  Score=246.31  Aligned_cols=157  Identities=31%  Similarity=0.494  Sum_probs=137.0

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .+.++...++|++.++||+|+||.||+|.+..+..||||+++... ...++|.+|+.+|++++||||+++++++.. +..
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            334455567788899999999999999988878889999997543 235679999999999999999999999876 678


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      +|||||+++|+|.+++... ....+++.+++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       337 ~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             eEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            9999999999999999532 2245899999999999999999999   89999999999999999999999999999987


Q ss_pred             ccC
Q 013693          423 FAA  425 (438)
Q Consensus       423 ~~~  425 (438)
                      +..
T Consensus       413 ~~~  415 (535)
T 2h8h_A          413 IED  415 (535)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.9e-26  Score=221.90  Aligned_cols=155  Identities=30%  Similarity=0.491  Sum_probs=129.7

Q ss_pred             CHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc--CCCceeeEEeEEEeC
Q 013693          262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLLGCSIEG  339 (438)
Q Consensus       262 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~  339 (438)
                      ....-....++|++.+.||+|+||.||+|... ++.||||++....   ...+.+|.+++..+  +||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            33444556678999999999999999999874 8999999986433   23445555555554  899999999999887


Q ss_pred             ----CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC--------CeeeCCCCCCCeeeC
Q 013693          340 ----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET--------RIIHRDIKTSNILLD  407 (438)
Q Consensus       340 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~iiH~dlkp~Nill~  407 (438)
                          ...++||||+++++|.+++..    ..+++..++.++.|++.||.|||   ..        +|+||||||+|||++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEEC
Confidence                789999999999999999943    35899999999999999999999   66        999999999999999


Q ss_pred             CCCCeEEecccccccccCCC
Q 013693          408 KDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       408 ~~~~~kl~DFGla~~~~~~~  427 (438)
                      .++.+||+|||+++.+....
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~  196 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDT  196 (337)
T ss_dssp             TTSCEEECCCTTCEECC---
T ss_pred             CCCCEEEEeCCCceeecccc
Confidence            99999999999998776544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=2.5e-26  Score=217.93  Aligned_cols=150  Identities=26%  Similarity=0.432  Sum_probs=135.1

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .+.|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            3568888999999999999995 4568999999997543 3456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++++|.+++.    ...+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||+++.+...
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999983    245899999999999999999999   889999999999999999999999999999887654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=1.2e-26  Score=217.55  Aligned_cols=150  Identities=28%  Similarity=0.408  Sum_probs=131.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|+||.||++.. .++..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            45688899999999999999954 467899999986532   23356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999998543   45899999999999999999999   89999999999999999999999999999876543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.94  E-value=1.2e-26  Score=228.19  Aligned_cols=149  Identities=23%  Similarity=0.378  Sum_probs=130.0

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccC--CCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIE--HKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++++++  ||||+++++++..++..+|||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458899999999999999998878999999999754  3445678999999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      | +.+++|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+..+
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 5688999999643   35889999999999999999999   89999999999999995 579999999999988654


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       208 ~  208 (390)
T 2zmd_A          208 T  208 (390)
T ss_dssp             -
T ss_pred             C
Confidence            4

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=8.4e-27  Score=225.68  Aligned_cols=154  Identities=29%  Similarity=0.485  Sum_probs=127.2

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch-----hhHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-----QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (438)
                      ....++|++.+.||+|+||.||++... +++.||||++.....     ...+.+.+|+.++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999664 589999999875322     12346889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++||||+++ +|.+++..  ....+++.++..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 88888844  3345889999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCC
Q 013693          421 RCFAAD  426 (438)
Q Consensus       421 ~~~~~~  426 (438)
                      +.+...
T Consensus       160 ~~~~~~  165 (346)
T 1ua2_A          160 KSFGSP  165 (346)
T ss_dssp             STTTSC
T ss_pred             eeccCC
Confidence            987543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=222.57  Aligned_cols=153  Identities=31%  Similarity=0.537  Sum_probs=135.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-----cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC--eE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-----PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP--ES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  342 (438)
                      .++|++.+.||+|+||.||++..     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688889999999999999973     468899999998776667788999999999999999999999887654  68


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++...  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999643  245899999999999999999999   88999999999999999999999999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +..+.
T Consensus       195 ~~~~~  199 (326)
T 2w1i_A          195 LPQDK  199 (326)
T ss_dssp             CCSSC
T ss_pred             ccccc
Confidence            86554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=3.6e-26  Score=217.49  Aligned_cols=154  Identities=31%  Similarity=0.450  Sum_probs=128.1

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-----hhhHHHHHHHHHHHhccC---CCceeeEEeEEEe
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-----RQWVDEFFNEVNLISSIE---HKNLVKLLGCSIE  338 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  338 (438)
                      ...++|++.+.||+|+||.||++.. .+++.||||++....     ......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467899999999999999999964 568999999987432     112346678888877775   9999999999987


Q ss_pred             CC-----eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeE
Q 013693          339 GP-----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPK  413 (438)
Q Consensus       339 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  413 (438)
                      ..     ..++||||+. ++|.+++.... ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEE
Confidence            65     5899999997 59999986532 334899999999999999999999   88999999999999999999999


Q ss_pred             EecccccccccCC
Q 013693          414 IADFGLARCFAAD  426 (438)
Q Consensus       414 l~DFGla~~~~~~  426 (438)
                      |+|||+++.+...
T Consensus       161 l~Dfg~a~~~~~~  173 (308)
T 3g33_A          161 LADFGLARIYSYQ  173 (308)
T ss_dssp             ECSCSCTTTSTTC
T ss_pred             EeeCccccccCCC
Confidence            9999999877543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=1.8e-26  Score=220.33  Aligned_cols=153  Identities=25%  Similarity=0.362  Sum_probs=133.7

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESL  343 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  343 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            356789999999999999999964 6789999999987777777889999999999999999999999873    34789


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      +||||+++++|.+++... .....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999998542 23456899999999999999999999   88999999999999999999999999999876


Q ss_pred             cc
Q 013693          423 FA  424 (438)
Q Consensus       423 ~~  424 (438)
                      ..
T Consensus       184 ~~  185 (317)
T 2buj_A          184 AC  185 (317)
T ss_dssp             SC
T ss_pred             cc
Confidence            53

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=1.7e-26  Score=222.18  Aligned_cols=150  Identities=29%  Similarity=0.455  Sum_probs=129.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|+..+.||+|+||.||++.. .+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            5688899999999999999965 458999999986543  3345668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999888743   345899999999999999999999   889999999999999999999999999999877543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.94  E-value=8.4e-27  Score=234.31  Aligned_cols=148  Identities=30%  Similarity=0.430  Sum_probs=125.1

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC------C
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------P  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  340 (438)
                      .++|++.+.||+|+||.||++. ..+++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4678999999999999999994 556899999999754  344567889999999999999999999998755      3


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..+|||||+++ +|.+.+.     ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            57999999976 5666662     23889999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCC
Q 013693          421 RCFAAD  426 (438)
Q Consensus       421 ~~~~~~  426 (438)
                      +.....
T Consensus       212 ~~~~~~  217 (464)
T 3ttj_A          212 RTAGTS  217 (464)
T ss_dssp             -----C
T ss_pred             eecCCC
Confidence            987643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=2e-26  Score=218.03  Aligned_cols=151  Identities=27%  Similarity=0.433  Sum_probs=132.6

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe---------
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE---------  338 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  338 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346788999999999999999964 57899999999653 3446789999999999999999999998865         


Q ss_pred             ----CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 013693          339 ----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       339 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  414 (438)
                          .+..++||||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEE
Confidence                35689999999999999999643  345788999999999999999999   889999999999999999999999


Q ss_pred             ecccccccccC
Q 013693          415 ADFGLARCFAA  425 (438)
Q Consensus       415 ~DFGla~~~~~  425 (438)
                      +|||+++.+..
T Consensus       158 ~dfg~~~~~~~  168 (303)
T 1zy4_A          158 GDFGLAKNVHR  168 (303)
T ss_dssp             CCCCCCSCTTC
T ss_pred             eeCcchhhccc
Confidence            99999987753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.94  E-value=3.7e-26  Score=215.02  Aligned_cols=148  Identities=34%  Similarity=0.606  Sum_probs=127.8

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchh-------hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQ-------WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      ++|+..+.||+|+||.||++.. .+++.||+|++......       ..+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5688889999999999999965 57899999998654321       1267899999999999999999999986655  


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeCCCCC-----eEEe
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFT-----PKIA  415 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~-----~kl~  415 (438)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+  |+||||||+|||++.++.     +||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            7999999999999988543  446899999999999999999999   778  999999999999987776     9999


Q ss_pred             cccccccccC
Q 013693          416 DFGLARCFAA  425 (438)
Q Consensus       416 DFGla~~~~~  425 (438)
                      |||+++....
T Consensus       172 Dfg~~~~~~~  181 (287)
T 4f0f_A          172 DFGLSQQSVH  181 (287)
T ss_dssp             CCTTCBCCSS
T ss_pred             CCCccccccc
Confidence            9999986543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=6.6e-27  Score=224.82  Aligned_cols=153  Identities=27%  Similarity=0.470  Sum_probs=127.3

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ....++|++.+.||+|+||.||++. ..+++.||||++....  ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            4456789999999999999999995 5578999999997543  233567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee-----CCCCCeEEeccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL-----DKDFTPKIADFG  418 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill-----~~~~~~kl~DFG  418 (438)
                      +||||+++ +|.+++...   ..+++..+..|+.||+.||.|||   +.+|+||||||+|||+     +.++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999974 999998543   34899999999999999999999   8899999999999999     445569999999


Q ss_pred             ccccccCC
Q 013693          419 LARCFAAD  426 (438)
Q Consensus       419 la~~~~~~  426 (438)
                      +++.+...
T Consensus       183 ~a~~~~~~  190 (329)
T 3gbz_A          183 LARAFGIP  190 (329)
T ss_dssp             HHHHHC--
T ss_pred             CccccCCc
Confidence            99987643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=1.2e-26  Score=216.38  Aligned_cols=149  Identities=32%  Similarity=0.484  Sum_probs=122.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc----hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|+..+.||+|+||.||++.. .++.||||++....    ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35688889999999999999987 48899999986542    23356789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC---eeeCCCCCCCeeeCC--------CCCeEE
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR---IIHRDIKTSNILLDK--------DFTPKI  414 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---iiH~dlkp~Nill~~--------~~~~kl  414 (438)
                      |||+++++|.+++.    ...+++..++.++.|++.||.|||   +.+   |+||||||+|||++.        ++.+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            99999999999983    346899999999999999999999   666   999999999999986        678999


Q ss_pred             ecccccccccCC
Q 013693          415 ADFGLARCFAAD  426 (438)
Q Consensus       415 ~DFGla~~~~~~  426 (438)
                      +|||+++.+...
T Consensus       158 ~Dfg~~~~~~~~  169 (271)
T 3dtc_A          158 TDFGLAREWHRT  169 (271)
T ss_dssp             CCCCC-------
T ss_pred             ccCCcccccccc
Confidence            999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=1.6e-26  Score=223.25  Aligned_cols=149  Identities=23%  Similarity=0.345  Sum_probs=129.0

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||||++.....    ...+|++++.++ +||||+++++++.+++..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            456789999999999999999954 4688999999965432    345788888888 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC----CCeEEeccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD----FTPKIADFGLARC  422 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~----~~~kl~DFGla~~  422 (438)
                      ||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999854   345899999999999999999999   8899999999999998433    3599999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +....
T Consensus       170 ~~~~~  174 (342)
T 2qr7_A          170 LRAEN  174 (342)
T ss_dssp             CBCTT
T ss_pred             CcCCC
Confidence            76543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.93  E-value=2.1e-26  Score=216.08  Aligned_cols=151  Identities=27%  Similarity=0.474  Sum_probs=132.4

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe---------
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE---------  338 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  338 (438)
                      ..++|+..+.||+|+||.||++... +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567889999999999999999664 78999999997553    357789999999999999999998764         


Q ss_pred             -------CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC
Q 013693          339 -------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT  411 (438)
Q Consensus       339 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  411 (438)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||   +.+|+|+||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence                   44589999999999999999643 2346899999999999999999999   889999999999999999999


Q ss_pred             eEEecccccccccCCC
Q 013693          412 PKIADFGLARCFAADR  427 (438)
Q Consensus       412 ~kl~DFGla~~~~~~~  427 (438)
                      +||+|||+++.+....
T Consensus       161 ~kl~Dfg~~~~~~~~~  176 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG  176 (284)
T ss_dssp             EEECCCTTCEESSCCS
T ss_pred             EEECcchhheeccccc
Confidence            9999999999876543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.93  E-value=2.8e-26  Score=215.43  Aligned_cols=152  Identities=24%  Similarity=0.347  Sum_probs=133.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .++|++.+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            56789999999999999999954 56899999998754  3345577899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC---eEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~DFGla~~~  423 (438)
                      ||+++++|.+.+...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999998888543   45899999999999999999999   889999999999999976655   999999999877


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       159 ~~~~  162 (284)
T 3kk8_A          159 NDSE  162 (284)
T ss_dssp             CSSC
T ss_pred             ccCc
Confidence            6443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.93  E-value=1.4e-26  Score=218.31  Aligned_cols=150  Identities=34%  Similarity=0.518  Sum_probs=124.6

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ...++|++.+.||+|+||.||++...  ..||+|++...  .....+.+.+|+.++++++||||++++++. ..+..++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            44567899999999999999999864  36999998754  344567899999999999999999999965 55678999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++..  ....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            999999999999954  3455899999999999999999999   88999999999999999999999999999987654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.93  E-value=2.8e-26  Score=233.23  Aligned_cols=154  Identities=31%  Similarity=0.478  Sum_probs=132.7

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch-------------hhHHHHHHHHHHHhccCCCceeeEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR-------------QWVDEFFNEVNLISSIEHKNLVKLL  333 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~  333 (438)
                      ...++|.+.++||+|+||.||++.. .+++.||+|++.....             ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3567899999999999999999955 4688999999875321             3356789999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---
Q 013693          334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF---  410 (438)
Q Consensus       334 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---  410 (438)
                      +++.+.+..++||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999999988543   45899999999999999999999   88999999999999998765   


Q ss_pred             CeEEecccccccccCCC
Q 013693          411 TPKIADFGLARCFAADR  427 (438)
Q Consensus       411 ~~kl~DFGla~~~~~~~  427 (438)
                      .+||+|||+++.+..+.
T Consensus       187 ~~kl~Dfg~a~~~~~~~  203 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY  203 (504)
T ss_dssp             SEEECCCTTCEECCTTS
T ss_pred             cEEEEECCCCEEcCCCC
Confidence            69999999999876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.93  E-value=2e-26  Score=233.77  Aligned_cols=153  Identities=28%  Similarity=0.405  Sum_probs=130.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ..++|++.+.||+|+||.||++.. .++..||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            445688999999999999999965 468899999997542  33456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEeccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARC  422 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGla~~  422 (438)
                      |||+++|+|.+.+...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999888543   45899999999999999999999   889999999999999975   45599999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +....
T Consensus       189 ~~~~~  193 (494)
T 3lij_A          189 FENQK  193 (494)
T ss_dssp             CBTTB
T ss_pred             CCCCc
Confidence            76543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.4e-26  Score=222.91  Aligned_cols=151  Identities=29%  Similarity=0.531  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCceeEEEEEccC-----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN-----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|+..+.||+|+||.||+|....     +..||||++... .......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456667899999999999996542     235999999754 33445679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++...  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999543  345899999999999999999999   8899999999999999999999999999999876


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       199 ~~  200 (333)
T 1mqb_A          199 DD  200 (333)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.93  E-value=6.9e-27  Score=224.19  Aligned_cols=150  Identities=29%  Similarity=0.463  Sum_probs=127.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch-hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|.+.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5688899999999999999965 4789999999865432 2233566899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++ ++|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            97 5898888543  345899999999999999999999   899999999999999999999999999999876543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.9e-26  Score=214.95  Aligned_cols=151  Identities=26%  Similarity=0.465  Sum_probs=131.5

Q ss_pred             cCCCCCC-ccccCCceeEEEEEcc---CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSK-KLGQGGAGSVYMGSLP---NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|.+.+ .||+|+||.||+|...   ++..||||++... .....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999643   5778999999764 345567899999999999999999999998 56678999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++..  ....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999953  3445899999999999999999999   88999999999999999999999999999998865


Q ss_pred             CC
Q 013693          426 DR  427 (438)
Q Consensus       426 ~~  427 (438)
                      ..
T Consensus       163 ~~  164 (287)
T 1u59_A          163 DD  164 (287)
T ss_dssp             CS
T ss_pred             Cc
Confidence            44

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.93  E-value=1.8e-26  Score=218.72  Aligned_cols=150  Identities=25%  Similarity=0.447  Sum_probs=131.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ..++|++.+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4567889999999999999999654 589999999977666667889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |+++++|.+++...  ...+++..+..++.||+.||.|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999988543  345899999999999999999999   889999999999999999999999999997643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.93  E-value=2e-26  Score=221.64  Aligned_cols=156  Identities=27%  Similarity=0.382  Sum_probs=135.5

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEE-------
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSI-------  337 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------  337 (438)
                      +....+|++.++||+|+||.||++.. .+++.||||++........+.+.+|+.++.++. ||||+++++++.       
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            33445788999999999999999964 578999999998777777788999999999995 999999999984       


Q ss_pred             -eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeCCCCCeEE
Q 013693          338 -EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKI  414 (438)
Q Consensus       338 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kl  414 (438)
                       .....++||||+. |+|.+++........+++.+++.++.||+.||.|||   ..+  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEE
Confidence             3345899999995 799998865444556999999999999999999999   777  999999999999999999999


Q ss_pred             ecccccccccCC
Q 013693          415 ADFGLARCFAAD  426 (438)
Q Consensus       415 ~DFGla~~~~~~  426 (438)
                      +|||+++.+...
T Consensus       180 ~Dfg~~~~~~~~  191 (337)
T 3ll6_A          180 CDFGSATTISHY  191 (337)
T ss_dssp             CCCTTCBCCSSC
T ss_pred             ecCccceecccc
Confidence            999999987653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.93  E-value=1.5e-26  Score=240.05  Aligned_cols=144  Identities=28%  Similarity=0.481  Sum_probs=126.1

Q ss_pred             ccccCCceeEEEEEcc---CCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCCCC
Q 013693          278 KLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       278 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  353 (438)
                      .||+|+||.||+|.+.   ++..||||+++... ....+++.+|+.+|++++||||+++++++.. +..+|||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999653   45679999997643 3456789999999999999999999999876 56899999999999


Q ss_pred             HHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          354 LDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       354 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |.+++..  ....+++..+..|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..+.
T Consensus       422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999954  3456899999999999999999999   8899999999999999999999999999999876543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=7.8e-27  Score=239.67  Aligned_cols=149  Identities=17%  Similarity=0.229  Sum_probs=114.0

Q ss_pred             cccCCceeEEEE-EccCCCEEEEEEeeec----------chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEE
Q 013693          279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFN----------TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       279 lg~G~~g~Vy~~-~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .+.|+.|.+..+ +.-.|+.+++|.+...          .+...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            455555555544 3335889999998643          123456799999999999 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||++|++|.++|.+.   .++++.   .|+.||+.||+|||   +.|||||||||+||||+.++++||+|||+|+.+..+
T Consensus       322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999543   345554   48899999999999   899999999999999999999999999999988665


Q ss_pred             Cceeeeeeeec
Q 013693          427 RTHVSTAVAGT  437 (438)
Q Consensus       427 ~~~~~~~~~Gt  437 (438)
                      .+.. ++.+||
T Consensus       393 ~~~~-~t~vGT  402 (569)
T 4azs_A          393 CSWP-TNLVQS  402 (569)
T ss_dssp             -CCS-HHHHHH
T ss_pred             Cccc-cCceec
Confidence            4332 234455

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.93  E-value=3.1e-26  Score=218.01  Aligned_cols=154  Identities=25%  Similarity=0.435  Sum_probs=127.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35688899999999999999954 57899999998742   344567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          346 YEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999985421 2345899999999999999999999   8899999999999999999999999999998775


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       188 ~~  189 (310)
T 2wqm_A          188 SK  189 (310)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=1.2e-26  Score=221.10  Aligned_cols=161  Identities=27%  Similarity=0.492  Sum_probs=128.8

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEcc----CCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEE
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (438)
                      .+++....++|.+.+.||+|+||.||+|...    ++..||+|++...  .....+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3444455677888999999999999999553    3458999998754  344567899999999999999999999998


Q ss_pred             EeCC-----eEEEEEeccCCCCHHHHhhcc---CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013693          337 IEGP-----ESLLVYEYVPNRSLDQFIFDK---NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK  408 (438)
Q Consensus       337 ~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  408 (438)
                      ...+     ..++||||+++++|.+++...   .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcC
Confidence            8755     359999999999999998432   23456999999999999999999999   899999999999999999


Q ss_pred             CCCeEEecccccccccCC
Q 013693          409 DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       409 ~~~~kl~DFGla~~~~~~  426 (438)
                      ++.+||+|||+++.+...
T Consensus       183 ~~~~kl~Dfg~~~~~~~~  200 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSG  200 (313)
T ss_dssp             TSCEEECSCSCC------
T ss_pred             CCcEEEeecCcceecccc
Confidence            999999999999877543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.93  E-value=1.7e-26  Score=233.81  Aligned_cols=153  Identities=29%  Similarity=0.426  Sum_probs=134.2

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            456799999999999999999955 47899999998643  233467789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCCeEEeccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARC  422 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~DFGla~~  422 (438)
                      |||+++++|.+.+...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999988543   45899999999999999999999   88999999999999995   456899999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +....
T Consensus       174 ~~~~~  178 (486)
T 3mwu_A          174 FQQNT  178 (486)
T ss_dssp             BCCC-
T ss_pred             CCCCC
Confidence            76543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.93  E-value=6e-26  Score=213.99  Aligned_cols=149  Identities=26%  Similarity=0.349  Sum_probs=129.4

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLL  344 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  344 (438)
                      .|.+.+.||+|+||.||+|.. .++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            466778899999999999954 56889999998754  34456789999999999999999999998875    346899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeC-CCCCeEEecccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLD-KDFTPKIADFGLAR  421 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kl~DFGla~  421 (438)
                      ||||+++++|.+++...   ..+++..++.++.||+.||.|||   +.+  |+||||||+|||++ .++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999542   45899999999999999999999   777  99999999999997 78999999999998


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .....
T Consensus       181 ~~~~~  185 (290)
T 1t4h_A          181 LKRAS  185 (290)
T ss_dssp             GCCTT
T ss_pred             ccccc
Confidence            66544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.1e-26  Score=226.65  Aligned_cols=148  Identities=26%  Similarity=0.461  Sum_probs=124.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (438)
                      .++|+..+.||+|+||.||+|.. .+++.||||++...  .....+++.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46788899999999999999954 57899999998543  3445677899999999999999999999988663      


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++||||+ +++|.+++..    ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 8899999853    35899999999999999999999   889999999999999999999999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +....
T Consensus       176 ~~~~~  180 (367)
T 1cm8_A          176 RQADS  180 (367)
T ss_dssp             EECCS
T ss_pred             ccccc
Confidence            98654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.93  E-value=3.4e-26  Score=221.75  Aligned_cols=150  Identities=26%  Similarity=0.498  Sum_probs=129.4

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEe--------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--------  338 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  338 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35788999999999999999965 578999999986543  2334578899999999999999999999887        


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      .+..++||||+++ +|.+.+...  ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            4468999999975 777777432  345899999999999999999999   8899999999999999999999999999


Q ss_pred             ccccccC
Q 013693          419 LARCFAA  425 (438)
Q Consensus       419 la~~~~~  425 (438)
                      +++.+..
T Consensus       170 ~a~~~~~  176 (351)
T 3mi9_A          170 LARAFSL  176 (351)
T ss_dssp             TCEECCC
T ss_pred             hcccccc
Confidence            9998763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.93  E-value=3.9e-26  Score=214.31  Aligned_cols=151  Identities=26%  Similarity=0.356  Sum_probs=132.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecch------hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|++.+.||+|+||.||++... +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356888999999999999999654 689999999875421      1357799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----CeEEeccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~DFG  418 (438)
                      ++||||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999954   345899999999999999999999   88999999999999998877    89999999


Q ss_pred             ccccccCC
Q 013693          419 LARCFAAD  426 (438)
Q Consensus       419 la~~~~~~  426 (438)
                      +++.+...
T Consensus       158 ~~~~~~~~  165 (283)
T 3bhy_A          158 IAHKIEAG  165 (283)
T ss_dssp             TCEECC--
T ss_pred             cceeccCC
Confidence            99887543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.93  E-value=2.3e-26  Score=223.85  Aligned_cols=160  Identities=26%  Similarity=0.354  Sum_probs=134.1

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecch-----------hhHHHHHHHHHHHhccCCCce
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR-----------QWVDEFFNEVNLISSIEHKNL  329 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni  329 (438)
                      ...+++....++|++.+.||+|+||.||++...+++.||||++.....           ...+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            456778889999999999999999999999888899999999864321           223778999999999999999


Q ss_pred             eeEEeEEEeC-----CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013693          330 VKLLGCSIEG-----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (438)
Q Consensus       330 v~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  404 (438)
                      +++++++...     ...++||||++ ++|.+++..  ....+++..+..++.||+.||.|||   +.+|+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence            9999998543     36899999997 588888853  3346899999999999999999999   88999999999999


Q ss_pred             eeCCCCCeEEecccccccccCC
Q 013693          405 LLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       405 ll~~~~~~kl~DFGla~~~~~~  426 (438)
                      |++.++.+||+|||+++.....
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~  187 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD  187 (362)
T ss_dssp             EECTTCCEEECCTTC-------
T ss_pred             EEcCCCCEEEEecCcccccccc
Confidence            9999999999999999865443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=4.7e-26  Score=215.34  Aligned_cols=150  Identities=18%  Similarity=0.273  Sum_probs=132.4

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||++. ..+++.||||++....  ..+.+.+|+.+++.+ +|+||+++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            4578899999999999999996 4678999999986432  335688999999999 89999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC-----eEEeccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-----PKIADFGLARC  422 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-----~kl~DFGla~~  422 (438)
                      |+ +++|.+++...  ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999643  345899999999999999999999   899999999999999987766     99999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +....
T Consensus       161 ~~~~~  165 (298)
T 1csn_A          161 YRDPV  165 (298)
T ss_dssp             SBCTT
T ss_pred             ccccc
Confidence            86543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.93  E-value=2.4e-26  Score=223.59  Aligned_cols=149  Identities=26%  Similarity=0.394  Sum_probs=133.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            35688899999999999999955 46899999999765 34456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999543   35899999999999999999999   64 89999999999999999999999999998653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=1.7e-26  Score=225.05  Aligned_cols=152  Identities=20%  Similarity=0.340  Sum_probs=126.5

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccC------CCEEEEEEeeecchhhH-----------HHHHHHHHHHhccCCCceee
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWV-----------DEFFNEVNLISSIEHKNLVK  331 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  331 (438)
                      ..++|++.+.||+|+||.||+|....      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578999999999999999997654      47899999875532211           22445667788889999999


Q ss_pred             EEeEEEeC----CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013693          332 LLGCSIEG----PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD  407 (438)
Q Consensus       332 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  407 (438)
                      +++++...    ...+|||||+ +++|.+++...  ...+++.+++.|+.||+.||.|||   +.+|+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEe
Confidence            99998775    4589999999 99999999542  356999999999999999999999   88999999999999998


Q ss_pred             --CCCCeEEecccccccccCC
Q 013693          408 --KDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       408 --~~~~~kl~DFGla~~~~~~  426 (438)
                        .++.+||+|||+++.+...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGG
T ss_pred             cCCCCeEEEEECCcceecccC
Confidence              8899999999999887643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.93  E-value=2.1e-26  Score=216.07  Aligned_cols=153  Identities=28%  Similarity=0.417  Sum_probs=129.9

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ..++|++.+.||+|+||.||+|....    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34678889999999999999996532    336999998755 34456789999999999999999999999765 4568


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++++|.+++...  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            999999999999999543  345899999999999999999999   899999999999999999999999999999987


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       164 ~~~~  167 (281)
T 3cc6_A          164 EDED  167 (281)
T ss_dssp             ----
T ss_pred             cccc
Confidence            6543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.93  E-value=2.1e-26  Score=219.11  Aligned_cols=150  Identities=29%  Similarity=0.404  Sum_probs=125.4

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      ++|++.+.||+|+||.||++.. .++.||||++...  ...+.+.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            4677889999999999999987 4788999998543  34578999999999999999999999876  44799999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC-eEEecccccccccC
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT-PKIADFGLARCFAA  425 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-~kl~DFGla~~~~~  425 (438)
                      +++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||+++....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999976554456889999999999999999999432289999999999999988876 79999999987653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.93  E-value=1.3e-26  Score=219.61  Aligned_cols=157  Identities=29%  Similarity=0.432  Sum_probs=120.7

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ....++|++.+.||+|+||.||++.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34457899999999999999999965 468899999886542 3445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcc-----CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          345 VYEYVPNRSLDQFIFDK-----NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      ||||+++++|.+++...     .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999998531     12445899999999999999999999   88999999999999999999999999999


Q ss_pred             cccccCC
Q 013693          420 ARCFAAD  426 (438)
Q Consensus       420 a~~~~~~  426 (438)
                      ++.+...
T Consensus       168 ~~~~~~~  174 (303)
T 2vwi_A          168 SAFLATG  174 (303)
T ss_dssp             HHHCC--
T ss_pred             hheeccC
Confidence            9877543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.93  E-value=2.4e-26  Score=217.56  Aligned_cols=151  Identities=31%  Similarity=0.475  Sum_probs=129.6

Q ss_pred             cCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEE-eCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-EGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l  344 (438)
                      .+|++.+.||+|+||.||+|....    ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457778999999999999996532    235899988643 3445678999999999999999999999865 4567899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++..  ....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999954  3345889999999999999999999   8899999999999999999999999999998775


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       180 ~~  181 (298)
T 3f66_A          180 DK  181 (298)
T ss_dssp             CG
T ss_pred             cc
Confidence            43

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.93  E-value=3.1e-26  Score=214.21  Aligned_cols=151  Identities=26%  Similarity=0.402  Sum_probs=134.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|.+.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357888999999999999999654 78999999997542   23456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++++|.+++...   ..+++..+..++.||+.||.|||   +.+|+|+||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999999543   34899999999999999999999   88999999999999999999999999999988754


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       164 ~  164 (276)
T 2h6d_A          164 G  164 (276)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.93  E-value=5.2e-26  Score=215.12  Aligned_cols=153  Identities=24%  Similarity=0.380  Sum_probs=134.9

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---------hhhHHHHHHHHHHHhccC-CCceeeEEeEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---------RQWVDEFFNEVNLISSIE-HKNLVKLLGCS  336 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  336 (438)
                      ...++|++.+.||+|+||.||++.. .+++.||||++....         ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3457889999999999999999965 468899999997542         123467889999999995 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 013693          337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (438)
Q Consensus       337 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  416 (438)
                      ...+..++||||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999999954   245899999999999999999999   88999999999999999999999999


Q ss_pred             ccccccccCC
Q 013693          417 FGLARCFAAD  426 (438)
Q Consensus       417 FGla~~~~~~  426 (438)
                      ||+++.+...
T Consensus       168 fg~~~~~~~~  177 (298)
T 1phk_A          168 FGFSCQLDPG  177 (298)
T ss_dssp             CTTCEECCTT
T ss_pred             ccchhhcCCC
Confidence            9999887644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=1.3e-26  Score=222.15  Aligned_cols=162  Identities=27%  Similarity=0.407  Sum_probs=136.4

Q ss_pred             cccCHHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 013693          259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCS  336 (438)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  336 (438)
                      ..++++++....++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            3455556666788899999999999999999965 578999999987543 3356788999999999 899999999999


Q ss_pred             Ee------CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013693          337 IE------GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       337 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  410 (438)
                      ..      .+..++||||+++++|.+++... ....+++..+..++.||+.||.|||   +.+|+|+||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCC
Confidence            87      46789999999999999999643 2356899999999999999999999   88999999999999999999


Q ss_pred             CeEEecccccccccC
Q 013693          411 TPKIADFGLARCFAA  425 (438)
Q Consensus       411 ~~kl~DFGla~~~~~  425 (438)
                      .+||+|||++..+..
T Consensus       167 ~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDR  181 (326)
T ss_dssp             CEEECCCTTTC----
T ss_pred             CEEEeeCcCceecCc
Confidence            999999999987754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.93  E-value=2.7e-26  Score=217.86  Aligned_cols=151  Identities=25%  Similarity=0.336  Sum_probs=131.5

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ..++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            346788899999999999999965 4789999999986655555678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~DFGla~~~~  424 (438)
                      |+++++|.+++...   ..+++.++..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999988543   35899999999999999999999   8899999999999999   788999999999998654


Q ss_pred             C
Q 013693          425 A  425 (438)
Q Consensus       425 ~  425 (438)
                      .
T Consensus       161 ~  161 (304)
T 2jam_A          161 N  161 (304)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.93  E-value=4.1e-26  Score=214.43  Aligned_cols=149  Identities=26%  Similarity=0.403  Sum_probs=132.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5688899999999999999965 457889999986542   223467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999998543   35899999999999999999999   89999999999999999999999999999977654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.93  E-value=1.9e-26  Score=223.18  Aligned_cols=152  Identities=27%  Similarity=0.393  Sum_probs=134.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhh-----------------HHHHHHHHHHHhccCCCceeeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQW-----------------VDEFFNEVNLISSIEHKNLVKL  332 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  332 (438)
                      .++|++.+.||+|+||.||++.. +++.||||++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46789999999999999999987 89999999997542211                 1789999999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHH------hhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCee
Q 013693          333 LGCSIEGPESLLVYEYVPNRSLDQF------IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNIL  405 (438)
Q Consensus       333 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nil  405 (438)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||   + .+|+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence            9999999999999999999999998      532 12466999999999999999999999   6 89999999999999


Q ss_pred             eCCCCCeEEecccccccccCC
Q 013693          406 LDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++.++.+||+|||+++.+...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~  205 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK  205 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT
T ss_pred             EcCCCcEEEeccccccccccc
Confidence            999999999999999886543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.93  E-value=5.6e-26  Score=211.58  Aligned_cols=151  Identities=21%  Similarity=0.397  Sum_probs=133.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG--PESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  345 (438)
                      .++|++.+.||+|+||.||+|.. +++.||||++...  .....+.+.+|+.++++++||||+++++++...  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35688889999999999999987 4889999999754  344567899999999999999999999999887  788999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |||+++++|.+++... ....+++.+++.++.|++.||.|||   +.+  |+||||||+|||++.++.++|+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999999653 2335899999999999999999999   777  999999999999999999999999987665


Q ss_pred             cC
Q 013693          424 AA  425 (438)
Q Consensus       424 ~~  425 (438)
                      ..
T Consensus       164 ~~  165 (271)
T 3kmu_A          164 QS  165 (271)
T ss_dssp             SC
T ss_pred             cc
Confidence            43

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.93  E-value=3.6e-26  Score=225.51  Aligned_cols=146  Identities=24%  Similarity=0.286  Sum_probs=122.9

Q ss_pred             cCCCCC-CccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhc-cCCCceeeEEeEEEe----CCeEE
Q 013693          271 NYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISS-IEHKNLVKLLGCSIE----GPESL  343 (438)
Q Consensus       271 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~  343 (438)
                      ++|.+. ++||+|+||.||++.. .+++.||||++...     ..+.+|+.++.+ .+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            445554 6899999999999954 56899999998632     356788888754 489999999999876    56789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEeccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLA  420 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGla  420 (438)
                      |||||+++|+|.+++... ....+++.++..|+.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999653 2345899999999999999999999   889999999999999987   789999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +....
T Consensus       212 ~~~~~  216 (400)
T 1nxk_A          212 KETTS  216 (400)
T ss_dssp             EECC-
T ss_pred             cccCC
Confidence            97654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.93  E-value=5.4e-26  Score=216.72  Aligned_cols=152  Identities=32%  Similarity=0.505  Sum_probs=129.6

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ...++|++.+.||+|+||.||++.. .+++.||+|.+....  ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            4456789999999999999999965 458999999986543  3567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++..  ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.+...
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999853  2345899999999999999999999   899999999999999999999999999999877644

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.7e-26  Score=225.79  Aligned_cols=149  Identities=31%  Similarity=0.484  Sum_probs=121.4

Q ss_pred             CCCCCccccCCceeEEEEEcc--C--CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeEEEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP--N--GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLVY  346 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  346 (438)
                      |+..+.||+|+||.||+|...  +  ...||+|.+... .....+++.+|+.++++++||||+++++++.. ++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            556688999999999999653  2  236899988643 34556789999999999999999999998754 56789999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++++|.+++..  ....+++.+++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       171 e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          171 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             ECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999954  3345889999999999999999999   889999999999999999999999999999877543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.93  E-value=9.2e-26  Score=214.13  Aligned_cols=152  Identities=25%  Similarity=0.317  Sum_probs=129.0

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc----hhhHHHHHHHHHHHhccCCCceeeEEeEEE--eCCe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLGCSI--EGPE  341 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  341 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++....    ....+.+.+|+.++++++||||+++++++.  ..+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            347899999999999999999965 468899999997542    234577999999999999999999999984  4557


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++||||++++ |.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999876 76766443 3456899999999999999999999   8899999999999999999999999999998


Q ss_pred             cccC
Q 013693          422 CFAA  425 (438)
Q Consensus       422 ~~~~  425 (438)
                      .+..
T Consensus       158 ~~~~  161 (305)
T 2wtk_C          158 ALHP  161 (305)
T ss_dssp             ECCT
T ss_pred             ccCc
Confidence            8754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.93  E-value=4.9e-26  Score=218.45  Aligned_cols=150  Identities=28%  Similarity=0.497  Sum_probs=129.3

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCCE--EEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|++.+.||+|+||.||++... ++..  +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888999999999999999653 4554  499988753 334566789999999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhccC-------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          346 YEYVPNRSLDQFIFDKN-------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      |||+++++|.+++....             ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999996542             2346899999999999999999999   8999999999999999999999


Q ss_pred             EEecccccccc
Q 013693          413 KIADFGLARCF  423 (438)
Q Consensus       413 kl~DFGla~~~  423 (438)
                      ||+|||+++..
T Consensus       182 kL~Dfg~~~~~  192 (327)
T 1fvr_A          182 KIADFGLSRGQ  192 (327)
T ss_dssp             EECCTTCEESS
T ss_pred             EEcccCcCccc
Confidence            99999999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.93  E-value=3.9e-26  Score=231.06  Aligned_cols=153  Identities=29%  Similarity=0.422  Sum_probs=135.5

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            346788999999999999999955 478999999986532   3456789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCCeEEecccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLAR  421 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~DFGla~  421 (438)
                      ||||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999998854   345899999999999999999999   8899999999999999   567899999999999


Q ss_pred             cccCCC
Q 013693          422 CFAADR  427 (438)
Q Consensus       422 ~~~~~~  427 (438)
                      .+....
T Consensus       178 ~~~~~~  183 (484)
T 3nyv_A          178 HFEASK  183 (484)
T ss_dssp             HBCCCC
T ss_pred             Eccccc
Confidence            876543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.93  E-value=2.7e-26  Score=220.96  Aligned_cols=146  Identities=34%  Similarity=0.568  Sum_probs=121.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHH--HHHHhccCCCceeeEEeEEEe-----CCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNE--VNLISSIEHKNLVKLLGCSIE-----GPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~-----~~~~  342 (438)
                      .++|++.+.||+|+||.||+|.. +++.||||++.....   +.+..|  +..+..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46788899999999999999976 689999999865432   334444  444556899999999986543     2257


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC---------CeeeCCCCCCCeeeCCCCCeE
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET---------RIIHRDIKTSNILLDKDFTPK  413 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~iiH~dlkp~Nill~~~~~~k  413 (438)
                      ++||||+++|+|.+++..    ...++..++.++.||++||.|||   +.         +|+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence            899999999999999943    23588999999999999999999   67         999999999999999999999


Q ss_pred             EecccccccccCC
Q 013693          414 IADFGLARCFAAD  426 (438)
Q Consensus       414 l~DFGla~~~~~~  426 (438)
                      |+|||+++.+...
T Consensus       161 L~DFG~a~~~~~~  173 (336)
T 3g2f_A          161 ISDFGLSMRLTGN  173 (336)
T ss_dssp             ECCCTTCEECSSS
T ss_pred             Eeeccceeecccc
Confidence            9999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=6.7e-27  Score=229.11  Aligned_cols=151  Identities=18%  Similarity=0.198  Sum_probs=124.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHH---HHHhccCCCceeeEE-------eE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEV---NLISSIEHKNLVKLL-------GC  335 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  335 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...   .....+.+.+|+   .++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788889999999999999975 56899999999743   344567899999   556666899999998       66


Q ss_pred             EEeCC-----------------eEEEEEeccCCCCHHHHhhccCC----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 013693          336 SIEGP-----------------ESLLVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRI  394 (438)
Q Consensus       336 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  394 (438)
                      +...+                 ..+|||||+ +|+|.+++.....    ...+++..++.|+.||+.||.|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            65553                 278999999 6899999964311    123456888899999999999999   8899


Q ss_pred             eeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          395 IHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       395 iH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      +||||||+|||++.++.+||+|||+|+...
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~  257 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  257 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence            999999999999999999999999998643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.93  E-value=1.1e-25  Score=217.09  Aligned_cols=161  Identities=27%  Similarity=0.374  Sum_probs=137.6

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhc--cCCCceeeEEeEEE
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISS--IEHKNLVKLLGCSI  337 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  337 (438)
                      ......-....++|++.+.||+|+||.||++.. +++.||||++...   ..+.+.+|.+++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            344444566678899999999999999999987 5899999998543   34567788888887  78999999999998


Q ss_pred             eCC----eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeCCCCCCCeeeCC
Q 013693          338 EGP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----SETRIIHRDIKTSNILLDK  408 (438)
Q Consensus       338 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~dlkp~Nill~~  408 (438)
                      ..+    ..++||||+++++|.+++..    ..+++.+++.++.|++.||.|||..     ++.+|+||||||+|||++.
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence            876    78999999999999999953    3589999999999999999999932     1478999999999999999


Q ss_pred             CCCeEEecccccccccCCCc
Q 013693          409 DFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       409 ~~~~kl~DFGla~~~~~~~~  428 (438)
                      ++.+||+|||+++.......
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~  202 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATD  202 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTT
T ss_pred             CCCEEEEECCCceecccccc
Confidence            99999999999988766543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.93  E-value=1.8e-26  Score=217.69  Aligned_cols=152  Identities=27%  Similarity=0.470  Sum_probs=130.8

Q ss_pred             hcCCCCCC-ccccCCceeEEEEEc---cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          270 TNYFNPSK-KLGQGGAGSVYMGSL---PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       270 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      .++|.+.+ .||+|+||.||++..   ..++.||||++....  ....+++.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 899999999999943   246789999987542  33467899999999999999999999998 667789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++++|.+++...   ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999999542   45899999999999999999999   889999999999999999999999999999988


Q ss_pred             cCCCc
Q 013693          424 AADRT  428 (438)
Q Consensus       424 ~~~~~  428 (438)
                      .....
T Consensus       168 ~~~~~  172 (291)
T 1xbb_A          168 RADEN  172 (291)
T ss_dssp             CTTCS
T ss_pred             ccCCC
Confidence            65543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.93  E-value=4.6e-26  Score=218.74  Aligned_cols=165  Identities=24%  Similarity=0.363  Sum_probs=139.7

Q ss_pred             ccccCHHHHHHHhcCCCCC-CccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhcc-CCCceeeE
Q 013693          258 CLSFKYETLEKATNYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI-EHKNLVKL  332 (438)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l  332 (438)
                      .....++..+...++|.+. +.||+|+||.||++.. .+++.||+|++....  ......+.+|+.++..+ .||||+++
T Consensus        15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~   94 (327)
T 3lm5_A           15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL   94 (327)
T ss_dssp             -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            3445566677777888887 8899999999999954 468999999987542  33467889999999999 56999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---C
Q 013693          333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---D  409 (438)
Q Consensus       333 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~  409 (438)
                      ++++...+..++||||+++++|.+++... ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.   +
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A           95 HEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             EEEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTB
T ss_pred             EEEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCC
Confidence            99999999999999999999999998442 3356899999999999999999999   889999999999999987   7


Q ss_pred             CCeEEecccccccccCC
Q 013693          410 FTPKIADFGLARCFAAD  426 (438)
Q Consensus       410 ~~~kl~DFGla~~~~~~  426 (438)
                      +.+||+|||+++.+...
T Consensus       171 ~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             CCEEECCGGGCEEC---
T ss_pred             CcEEEeeCccccccCCc
Confidence            89999999999987544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=5.6e-26  Score=217.55  Aligned_cols=151  Identities=24%  Similarity=0.296  Sum_probs=127.4

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--------hhhHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG  339 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  339 (438)
                      ..++|++.+.||+|+||.||++.. .+++.||||++....        ......+.+|+.++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            456789999999999999999954 468899999986432        12234688999999999999999999998765


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC---eEEec
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIAD  416 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~D  416 (438)
                      + .++||||+++++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 8999999999999998843   346899999999999999999999   889999999999999987654   99999


Q ss_pred             ccccccccCC
Q 013693          417 FGLARCFAAD  426 (438)
Q Consensus       417 FGla~~~~~~  426 (438)
                      ||+++.+...
T Consensus       161 fg~~~~~~~~  170 (322)
T 2ycf_A          161 FGHSKILGET  170 (322)
T ss_dssp             CTTCEECCCC
T ss_pred             Cccceecccc
Confidence            9999887543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.93  E-value=6.1e-26  Score=216.56  Aligned_cols=148  Identities=28%  Similarity=0.466  Sum_probs=125.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEE-----------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI-----------  337 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  337 (438)
                      .++|++.+.||+|+||.||++... +++.||+|++........+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357888999999999999999654 58999999998777777788999999999999999999999873           


Q ss_pred             ---eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCCeE
Q 013693          338 ---EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPK  413 (438)
Q Consensus       338 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~k  413 (438)
                         ..+..++||||++ ++|.+++.    ...+++..+..++.|++.||.|||   +.+|+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence               3467899999997 69999983    245899999999999999999999   88999999999999997 567999


Q ss_pred             EecccccccccC
Q 013693          414 IADFGLARCFAA  425 (438)
Q Consensus       414 l~DFGla~~~~~  425 (438)
                      |+|||+++....
T Consensus       162 l~Dfg~~~~~~~  173 (320)
T 2i6l_A          162 IGDFGLARIMDP  173 (320)
T ss_dssp             ECCCTTCBCC--
T ss_pred             EccCccccccCC
Confidence            999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=4.4e-26  Score=213.49  Aligned_cols=154  Identities=25%  Similarity=0.388  Sum_probs=131.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  344 (438)
                      .++|++.+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++..  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            45788899999999999999955 46899999999754  34456789999999999999999999998754  568999


Q ss_pred             EEeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          345 VYEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGSETR-----IIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||   +.+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999986432 2345899999999999999999999   666     9999999999999999999999999


Q ss_pred             ccccccCC
Q 013693          419 LARCFAAD  426 (438)
Q Consensus       419 la~~~~~~  426 (438)
                      +++.+...
T Consensus       162 ~~~~~~~~  169 (279)
T 2w5a_A          162 LARILNHD  169 (279)
T ss_dssp             HHHHC---
T ss_pred             hheeeccc
Confidence            99887544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=4.6e-26  Score=222.04  Aligned_cols=149  Identities=23%  Similarity=0.395  Sum_probs=130.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----CeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  342 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            45789999999999999999954 56889999999754 334457899999999999999999999998765     368


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||++ ++|.+++..    ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 599998843    35899999999999999999999   88999999999999999999999999999998


Q ss_pred             ccCC
Q 013693          423 FAAD  426 (438)
Q Consensus       423 ~~~~  426 (438)
                      ....
T Consensus       178 ~~~~  181 (364)
T 3qyz_A          178 ADPD  181 (364)
T ss_dssp             CCGG
T ss_pred             cCCC
Confidence            7644

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=7e-26  Score=214.31  Aligned_cols=151  Identities=30%  Similarity=0.510  Sum_probs=130.3

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|+..+.||+|+||.||++.. .+++.||||++....  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            5688899999999999999965 468999999986543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |++ ++|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  156 (299)
T 2r3i_A           83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  156 (299)
T ss_dssp             CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence            997 5999998543 2345889999999999999999999   889999999999999999999999999999877543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=5.4e-26  Score=214.88  Aligned_cols=148  Identities=30%  Similarity=0.464  Sum_probs=128.0

Q ss_pred             CCCCCccccCCceeEEEEEcc-CC---CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE-EEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSLP-NG---TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES-LLVY  346 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~  346 (438)
                      |...++||+|+||.||+|... ++   ..+|+|.+... .....+.+.+|+.++++++||||+++++++...+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            455688999999999999643 22   37999998653 344567899999999999999999999999876655 9999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+.+++|.+++..  ....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999954  3455899999999999999999999   88999999999999999999999999999987644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=8.4e-26  Score=212.76  Aligned_cols=144  Identities=12%  Similarity=0.012  Sum_probs=127.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .++|++.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            356889999999999999999654 58999999997542   34457899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      |||+++++|.+++..    . ....++..|+.||+.||.|||   +.+|+||||||+|||++.++.+||+++|...
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999999932    1 355678899999999999999   8999999999999999999999999887654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.93  E-value=4e-26  Score=219.20  Aligned_cols=152  Identities=28%  Similarity=0.511  Sum_probs=124.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCE----EEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTT----VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      .++|++.+.||+|+||.||+|.. .+++.    ||+|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            35688899999999999999964 34544    577776533 3445678999999999999999999999988765 78


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +|+||+++++|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999999653  345899999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       168 ~~~~  171 (327)
T 3lzb_A          168 GAEE  171 (327)
T ss_dssp             ----
T ss_pred             cCcc
Confidence            5443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=7.8e-26  Score=221.97  Aligned_cols=154  Identities=27%  Similarity=0.413  Sum_probs=126.3

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----  339 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  339 (438)
                      ++...++|++.+.||+|+||.||+|. ..+++.||||++.....    ...+|+.+++.++||||+++++++...     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34556789999999999999999995 46789999999865432    234799999999999999999998543     


Q ss_pred             ---------------------------------CeEEEEEeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHH
Q 013693          340 ---------------------------------PESLLVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAY  385 (438)
Q Consensus       340 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~  385 (438)
                                                       ...++||||++ ++|.+.+... .....+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             34889999998 5887777432 234569999999999999999999


Q ss_pred             hhcCCCCCeeeCCCCCCCeeeC-CCCCeEEecccccccccCCC
Q 013693          386 LHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       386 LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||   +.+|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus       157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            99   89999999999999997 68899999999999875543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.93  E-value=2.7e-26  Score=223.83  Aligned_cols=148  Identities=30%  Similarity=0.436  Sum_probs=115.9

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC------C
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------P  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  340 (438)
                      .++|+..+.||+|+||.||+|. ..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4678999999999999999995 567899999998653  334567788999999999999999999998754      5


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++|+|++ +++|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 7899988842    45899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +....
T Consensus       180 ~~~~~  184 (367)
T 2fst_X          180 RHTAD  184 (367)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.93  E-value=1.2e-25  Score=215.76  Aligned_cols=145  Identities=23%  Similarity=0.391  Sum_probs=128.8

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEe--CCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIE--GPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++. ..+++.||||++....   .+.+.+|+.++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            568889999999999999995 5678999999986433   467889999999997 9999999999988  66789999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~~~  425 (438)
                      ||+++++|.+++.      .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+++.+..
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999883      3889999999999999999999   89999999999999999766 899999999987764


Q ss_pred             CC
Q 013693          426 DR  427 (438)
Q Consensus       426 ~~  427 (438)
                      ..
T Consensus       184 ~~  185 (330)
T 3nsz_A          184 GQ  185 (330)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=5e-26  Score=218.37  Aligned_cols=154  Identities=31%  Similarity=0.446  Sum_probs=130.8

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      ..++|++.+.||+|+||.||+|..      .++..||||++... ......++.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            356799999999999999999964      34678999999644 34456679999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCC----CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEE
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNK----TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKI  414 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl  414 (438)
                      .++||||+++++|.+++.....    ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999965432    245899999999999999999999   889999999999999984   456999


Q ss_pred             ecccccccccC
Q 013693          415 ADFGLARCFAA  425 (438)
Q Consensus       415 ~DFGla~~~~~  425 (438)
                      +|||+++....
T Consensus       185 ~Dfg~~~~~~~  195 (327)
T 2yfx_A          185 GDFGMARDIYR  195 (327)
T ss_dssp             CCCHHHHHHHC
T ss_pred             Ccccccccccc
Confidence            99999987643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=5.3e-26  Score=236.72  Aligned_cols=144  Identities=28%  Similarity=0.484  Sum_probs=125.6

Q ss_pred             CccccCCceeEEEEEcc---CCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+++.+|+.++++++||||+++++++. .+..+|||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999542   45789999997542  344678999999999999999999999986 4568899999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+|.+++..   ...+++.+++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..+.
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            999999953   345899999999999999999999   8899999999999999999999999999999886544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.93  E-value=4.2e-26  Score=220.69  Aligned_cols=149  Identities=19%  Similarity=0.286  Sum_probs=122.8

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc----CCCEEEEEEeeecchh-----------hHHHHHHHHHHHhccCCCceeeEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLIFNTRQ-----------WVDEFFNEVNLISSIEHKNLVKLLG  334 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  334 (438)
                      .++|++.+.||+|+||.||+|...    ++..+|||++......           ....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            356888999999999999999664    5788999998754321           1234678889999999999999999


Q ss_pred             EEEe----CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013693          335 CSIE----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       335 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  410 (438)
                      ++..    ....++||||+ +++|.+++...   ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCC
Confidence            9988    67899999999 99999998543   26999999999999999999999   88999999999999998877


Q ss_pred             --CeEEecccccccccC
Q 013693          411 --TPKIADFGLARCFAA  425 (438)
Q Consensus       411 --~~kl~DFGla~~~~~  425 (438)
                        .+||+|||+++.+..
T Consensus       189 ~~~~kL~Dfg~a~~~~~  205 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCP  205 (345)
T ss_dssp             TTSEEECCCTTCEESSG
T ss_pred             CCcEEEEeCCCceeccc
Confidence              999999999988754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=1.2e-25  Score=219.67  Aligned_cols=148  Identities=30%  Similarity=0.420  Sum_probs=124.8

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (438)
                      .++|++.+.||+|+||.||++. ..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            4678999999999999999995 456889999999753  3345677889999999999999999999988665      


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 7888873     23889999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCC
Q 013693          421 RCFAAD  426 (438)
Q Consensus       421 ~~~~~~  426 (438)
                      +.....
T Consensus       175 ~~~~~~  180 (371)
T 2xrw_A          175 RTAGTS  180 (371)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            877543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.92  E-value=7.1e-26  Score=238.37  Aligned_cols=148  Identities=22%  Similarity=0.354  Sum_probs=128.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc--CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-----
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP--NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-----  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  341 (438)
                      .++|++.+.||+|+||.||++...  +++.||||++... .....+.+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            367899999999999999999654  5889999998644 34456678999999999999999999999987765     


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .+|||||+++++|.+++..     .+++.+++.|+.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999887732     5899999999999999999999   8899999999999999886 99999999999


Q ss_pred             cccCC
Q 013693          422 CFAAD  426 (438)
Q Consensus       422 ~~~~~  426 (438)
                      .+...
T Consensus       230 ~~~~~  234 (681)
T 2pzi_A          230 RINSF  234 (681)
T ss_dssp             ETTCC
T ss_pred             hcccC
Confidence            87654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.92  E-value=8e-26  Score=212.96  Aligned_cols=153  Identities=33%  Similarity=0.485  Sum_probs=125.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc--CCC--EEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP--NGT--TVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|++.+.||+|+||.||++.+.  +++  .||||++...   .....+.+.+|+.++++++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            356888999999999999999643  333  6899988754   3345678999999999999999999999988765 8


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998543  345899999999999999999999   88999999999999999999999999999998


Q ss_pred             ccCCCc
Q 013693          423 FAADRT  428 (438)
Q Consensus       423 ~~~~~~  428 (438)
                      +.....
T Consensus       171 ~~~~~~  176 (291)
T 1u46_A          171 LPQNDD  176 (291)
T ss_dssp             CCC-CC
T ss_pred             cccccc
Confidence            865543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.92  E-value=8e-26  Score=212.87  Aligned_cols=153  Identities=24%  Similarity=0.355  Sum_probs=121.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .++|++.+.||+|+||.||++.. .+++.||+|++....  ....+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788899999999999999954 578999999997542  223334555566688889999999999999999999999


Q ss_pred             eccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          347 EYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       347 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||++ ++|.+++... .....+++..++.++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 4887777432 23456999999999999999999999   66 99999999999999999999999999998775


Q ss_pred             CC
Q 013693          425 AD  426 (438)
Q Consensus       425 ~~  426 (438)
                      ..
T Consensus       162 ~~  163 (290)
T 3fme_A          162 DD  163 (290)
T ss_dssp             --
T ss_pred             cc
Confidence            44

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.92  E-value=1.1e-25  Score=223.64  Aligned_cols=149  Identities=28%  Similarity=0.391  Sum_probs=122.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------eEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------ESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  343 (438)
                      .+|+..+.||+|+||.||+|.. .+++.||||++....    +.+.+|++++++++||||+++++++...+      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            3578889999999999999965 468999999986542    23457999999999999999999885421      367


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CCeEEecccccc
Q 013693          344 LVYEYVPNRSLDQFIFDK-NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLAR  421 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~DFGla~  421 (438)
                      +||||+++ +|.+.+... .....+++..+..++.||++||.|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 666555321 23456899999999999999999999   8999999999999999955 578999999999


Q ss_pred             cccCCC
Q 013693          422 CFAADR  427 (438)
Q Consensus       422 ~~~~~~  427 (438)
                      .+....
T Consensus       206 ~~~~~~  211 (420)
T 1j1b_A          206 QLVRGE  211 (420)
T ss_dssp             ECCTTC
T ss_pred             hcccCC
Confidence            875443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.92  E-value=6.7e-26  Score=212.30  Aligned_cols=149  Identities=28%  Similarity=0.504  Sum_probs=125.2

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-CeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-PESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||++.. .++.||||.+....  ..+.+.+|+.++++++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46788899999999999999977 58899999986443  456789999999999999999999987654 478999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +++++|.+++... ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999543 2234789999999999999999999   88999999999999999999999999999987654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.92  E-value=3.4e-25  Score=208.56  Aligned_cols=155  Identities=28%  Similarity=0.406  Sum_probs=135.3

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ....++|++.+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            34456799999999999999999965 478999999987542  334678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CCeEEeccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD---FTPKIADFGLA  420 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~DFGla  420 (438)
                      +||||+++++|.+++...   ..+++.+++.++.||+.||.|||   +.+|+|+||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999999888543   35899999999999999999999   8899999999999999754   47999999999


Q ss_pred             ccccCCC
Q 013693          421 RCFAADR  427 (438)
Q Consensus       421 ~~~~~~~  427 (438)
                      +.+....
T Consensus       172 ~~~~~~~  178 (287)
T 2wei_A          172 TCFQQNT  178 (287)
T ss_dssp             GTBCCCS
T ss_pred             eeecCCC
Confidence            8876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.92  E-value=1.1e-25  Score=221.74  Aligned_cols=150  Identities=27%  Similarity=0.367  Sum_probs=124.7

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe------EEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE------SLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l  344 (438)
                      .+|+..+.||+|+||.||++....+..+|+|++.....    ...+|+.+++.++||||+++++++...+.      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46888999999999999999887777799998865432    23479999999999999999999865443      789


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCCeEEecccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTPKIADFGLARCF  423 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~DFGla~~~  423 (438)
                      ||||++++.+............+++..+..++.||+.||.|||   +.+|+||||||+|||++ .++.+||+|||+|+.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987544444322223456899999999999999999999   88999999999999998 7999999999999987


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       193 ~~~~  196 (394)
T 4e7w_A          193 IAGE  196 (394)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            5443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.92  E-value=2.2e-25  Score=216.10  Aligned_cols=149  Identities=26%  Similarity=0.447  Sum_probs=130.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----CeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  342 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            46788899999999999999965 46889999999643 334566788999999999999999999987764     678


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 589998843    35899999999999999999999   88999999999999999999999999999998


Q ss_pred             ccCC
Q 013693          423 FAAD  426 (438)
Q Consensus       423 ~~~~  426 (438)
                      +...
T Consensus       162 ~~~~  165 (353)
T 2b9h_A          162 IDES  165 (353)
T ss_dssp             CC--
T ss_pred             cccc
Confidence            7643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.92  E-value=1.4e-25  Score=234.44  Aligned_cols=156  Identities=24%  Similarity=0.364  Sum_probs=132.7

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP  340 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  340 (438)
                      .+...++|++.+.||+|+||.||+|....    +..||||++... .....+.+.+|+.++++++||||+++++++. ++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            33445678888999999999999996532    457999998754 3444578999999999999999999999984 56


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++||||+++|+|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            689999999999999999543  335899999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCCC
Q 013693          421 RCFAADR  427 (438)
Q Consensus       421 ~~~~~~~  427 (438)
                      +.+....
T Consensus       539 ~~~~~~~  545 (656)
T 2j0j_A          539 RYMEDST  545 (656)
T ss_dssp             CSCCC--
T ss_pred             eecCCCc
Confidence            9876543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.92  E-value=3.8e-25  Score=209.53  Aligned_cols=147  Identities=24%  Similarity=0.299  Sum_probs=126.3

Q ss_pred             cCCCCC-CccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHH-hccCCCceeeEEeEEEe----CCeEE
Q 013693          271 NYFNPS-KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLI-SSIEHKNLVKLLGCSIE----GPESL  343 (438)
Q Consensus       271 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  343 (438)
                      ++|.+. +.||+|+||.||++.. .+++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 7899999999999954 57899999998632     3567888888 55599999999999887    66789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEeccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLA  420 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGla  420 (438)
                      +||||+++++|.+++... ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999653 3346899999999999999999999   899999999999999997   789999999999


Q ss_pred             ccccCC
Q 013693          421 RCFAAD  426 (438)
Q Consensus       421 ~~~~~~  426 (438)
                      +.....
T Consensus       168 ~~~~~~  173 (299)
T 3m2w_A          168 KETTGE  173 (299)
T ss_dssp             EECTTC
T ss_pred             cccccc
Confidence            877543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.92  E-value=1.6e-25  Score=221.46  Aligned_cols=149  Identities=26%  Similarity=0.406  Sum_probs=115.3

Q ss_pred             CCCC-CCccccCCceeEEEEEcc---CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeEEEE
Q 013693          272 YFNP-SKKLGQGGAGSVYMGSLP---NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLV  345 (438)
Q Consensus       272 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  345 (438)
                      .|+. .++||+|+||.||+|...   +++.||||++....  ....+.+|+.+|++++||||+++++++..  ....+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3554 568999999999999754   57899999986432  23468899999999999999999999965  6689999


Q ss_pred             EeccCCCCHHHHhhcc------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCCeEEe
Q 013693          346 YEYVPNRSLDQFIFDK------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL----DKDFTPKIA  415 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~  415 (438)
                      |||+++ +|.+++...      .....+++..+..|+.||+.||.|||   +.+|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999964 787777422      12234899999999999999999999   8899999999999999    677899999


Q ss_pred             cccccccccCC
Q 013693          416 DFGLARCFAAD  426 (438)
Q Consensus       416 DFGla~~~~~~  426 (438)
                      |||+|+.+...
T Consensus       175 Dfg~a~~~~~~  185 (405)
T 3rgf_A          175 DMGFARLFNSP  185 (405)
T ss_dssp             CTTCCC-----
T ss_pred             ECCCceecCCC
Confidence            99999987643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=5.1e-26  Score=220.70  Aligned_cols=147  Identities=18%  Similarity=0.283  Sum_probs=127.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC---------CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceee---------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN---------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK---------  331 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  331 (438)
                      .++|++.+.||+|+||.||++....         ++.||||.+...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3678899999999999999996653         789999998643     46889999999999999987         


Q ss_pred             ------EEeEEEe-CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013693          332 ------LLGCSIE-GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNI  404 (438)
Q Consensus       332 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  404 (438)
                            +++++.. ++..++||||+ +++|.+++... ....+++.+++.++.||+.||.|||   +.+|+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence                  6777776 67899999999 99999999643 2356999999999999999999999   88999999999999


Q ss_pred             eeCCCC--CeEEecccccccccCC
Q 013693          405 LLDKDF--TPKIADFGLARCFAAD  426 (438)
Q Consensus       405 ll~~~~--~~kl~DFGla~~~~~~  426 (438)
                      |++.++  .+||+|||+++.+...
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGG
T ss_pred             EEcCCCCceEEEecCcceeeccCC
Confidence            999988  9999999999887643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.92  E-value=7.3e-26  Score=215.85  Aligned_cols=160  Identities=21%  Similarity=0.362  Sum_probs=134.4

Q ss_pred             ccCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccC--CCceeeEEeE
Q 013693          260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIE--HKNLVKLLGC  335 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  335 (438)
                      .+.++.+....++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  ||||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34445555566789999999999999999998888999999999754  3445678999999999997  5999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 013693          336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       336 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      +..++..++||| +.+++|.+++...   ..+++.++..++.||++||.|||   +.+|+||||||+|||+++ +.+||+
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEEC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEe
Confidence            999999999999 5688999999543   45899999999999999999999   889999999999999964 799999


Q ss_pred             cccccccccCCC
Q 013693          416 DFGLARCFAADR  427 (438)
Q Consensus       416 DFGla~~~~~~~  427 (438)
                      |||+++.+....
T Consensus       169 Dfg~~~~~~~~~  180 (313)
T 3cek_A          169 DFGIANQMQPDT  180 (313)
T ss_dssp             CCSSSCC-----
T ss_pred             eccccccccCcc
Confidence            999999876543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.92  E-value=6.8e-25  Score=213.18  Aligned_cols=162  Identities=25%  Similarity=0.344  Sum_probs=122.7

Q ss_pred             HHHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 013693          263 YETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE  341 (438)
Q Consensus       263 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  341 (438)
                      .+......++|++.+.||+|+||.||++.. .+++.||||++.... .....+.+|+..++.++||||+++++++...+.
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            355667788999999999999999999965 568999999986543 334456788888999999999999999876443


Q ss_pred             -------EEEEEeccCCCCHHHHhh-ccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCe
Q 013693          342 -------SLLVYEYVPNRSLDQFIF-DKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTP  412 (438)
Q Consensus       342 -------~~lv~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~  412 (438)
                             .++||||+++ +|...+. .......+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcE
Confidence                   7899999986 5544432 223455689999999999999999999943 689999999999999996 8999


Q ss_pred             EEecccccccccCCC
Q 013693          413 KIADFGLARCFAADR  427 (438)
Q Consensus       413 kl~DFGla~~~~~~~  427 (438)
                      ||+|||+++.+....
T Consensus       172 kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE  186 (360)
T ss_dssp             EECCCTTCBCCCTTS
T ss_pred             EEeeCCCceecCCCC
Confidence            999999999876543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.92  E-value=3.3e-25  Score=209.19  Aligned_cols=152  Identities=24%  Similarity=0.383  Sum_probs=125.5

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEE-EeCCeEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS-IEGPESLLV  345 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv  345 (438)
                      ...++|++.+.||+|+||.||++.. .+++.||||++....  ..+.+.+|+.+++.++|++++..+..+ ...+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999964 678999999875432  234688999999999988777666654 677788999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARC  422 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~DFGla~~  422 (438)
                      |||+ +++|.+++...  ...+++.++..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 99999998532  345899999999999999999999   8899999999999999   7889999999999998


Q ss_pred             ccCCC
Q 013693          423 FAADR  427 (438)
Q Consensus       423 ~~~~~  427 (438)
                      +....
T Consensus       158 ~~~~~  162 (296)
T 4hgt_A          158 YRDAR  162 (296)
T ss_dssp             CBCTT
T ss_pred             ccCcc
Confidence            86554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=7.3e-26  Score=216.21  Aligned_cols=156  Identities=24%  Similarity=0.408  Sum_probs=132.3

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      ...++++...++|++.+.||+|+||.||+|....  .+|+|++...  .....+.+.+|+.++++++||||+++++++..
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            4445556667889999999999999999997643  5999998754  23345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      .+..++||||+++++|.+++..  ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             CCceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecC
Confidence            9999999999999999999954  2345899999999999999999999   88999999999999998 6799999999


Q ss_pred             cccccc
Q 013693          419 LARCFA  424 (438)
Q Consensus       419 la~~~~  424 (438)
                      +++...
T Consensus       175 ~~~~~~  180 (319)
T 2y4i_B          175 LFSISG  180 (319)
T ss_dssp             CCC---
T ss_pred             Cccccc
Confidence            988664

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=1.8e-25  Score=218.48  Aligned_cols=150  Identities=11%  Similarity=0.082  Sum_probs=112.9

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHHHHHHHHHhcc--CCCceeeEE-------eEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSI--EHKNLVKLL-------GCS  336 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  336 (438)
                      ..+|+..+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            44588899999999999999964 478999999998653   23456678885544444  699988755       444


Q ss_pred             EeC-----------------CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHH------HHHHHHHHHHHHHhhcCCCCC
Q 013693          337 IEG-----------------PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKR------FNIILGTAEGLAYLHGGSETR  393 (438)
Q Consensus       337 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~  393 (438)
                      ...                 ...+|||||++ ++|.+++...  ...+++..+      +.++.||+.||.|||   +.+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKG  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence            433                 33799999998 8999999653  223455556      678899999999999   899


Q ss_pred             eeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       394 iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |+||||||+|||++.++.+||+|||+|+....
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~  246 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT  246 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence            99999999999999999999999999997753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.92  E-value=3.4e-25  Score=212.19  Aligned_cols=152  Identities=28%  Similarity=0.448  Sum_probs=129.0

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc--cCCCEEEEEEeeecc--hhhHHHHHHHHHHHhcc---CCCceeeEEeEEE----
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL--PNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSI----  337 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  337 (438)
                      ..++|++.+.||+|+||.||++..  .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457799999999999999999975  467899999987543  22234577888887776   8999999999987    


Q ss_pred             -eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 013693          338 -EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIAD  416 (438)
Q Consensus       338 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  416 (438)
                       .....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999997 69999986532 334899999999999999999999   88999999999999999999999999


Q ss_pred             ccccccccC
Q 013693          417 FGLARCFAA  425 (438)
Q Consensus       417 FGla~~~~~  425 (438)
                      ||+++.+..
T Consensus       164 fg~~~~~~~  172 (326)
T 1blx_A          164 FGLARIYSF  172 (326)
T ss_dssp             CCSCCCCCG
T ss_pred             CcccccccC
Confidence            999987653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.92  E-value=3.3e-25  Score=216.55  Aligned_cols=147  Identities=27%  Similarity=0.449  Sum_probs=126.2

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE----
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES----  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  342 (438)
                      .++|...+.||+|+||.||+|. ..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4678889999999999999995 456899999999754  334467889999999999999999999999877654    


Q ss_pred             --EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          343 --LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       343 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                        ++||||+. ++|.+++.     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 58888872     23899999999999999999999   889999999999999999999999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +....
T Consensus       192 ~~~~~  196 (371)
T 4exu_A          192 RHADA  196 (371)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.92  E-value=1.4e-24  Score=218.49  Aligned_cols=151  Identities=23%  Similarity=0.407  Sum_probs=129.8

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC-CceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.++||+|+||.||++. ..+++.||||++.....  .+++.+|+++++.++| ++|..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            4679999999999999999996 46789999998764432  3458899999999976 566677777788889999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~DFGla~~~~  424 (438)
                      |+ +++|.+++...  ...+++.+++.|+.||+.||.|||   +.+|+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999542  345999999999999999999999   8899999999999999   688999999999999887


Q ss_pred             CCCc
Q 013693          425 ADRT  428 (438)
Q Consensus       425 ~~~~  428 (438)
                      ....
T Consensus       158 ~~~~  161 (483)
T 3sv0_A          158 DTST  161 (483)
T ss_dssp             CTTT
T ss_pred             CCcc
Confidence            6543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.92  E-value=3.2e-25  Score=215.16  Aligned_cols=147  Identities=27%  Similarity=0.443  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-----
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPE-----  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  341 (438)
                      .++|...+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35688889999999999999954 56899999998653  33446778999999999999999999999887654     


Q ss_pred             -EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          342 -SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       342 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                       .++||||++ ++|.+++.     ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 58887772     24899999999999999999999   889999999999999999999999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +....
T Consensus       174 ~~~~~  178 (353)
T 3coi_A          174 RHADA  178 (353)
T ss_dssp             TC---
T ss_pred             cCCCC
Confidence            87653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.92  E-value=9.8e-25  Score=209.31  Aligned_cols=153  Identities=27%  Similarity=0.392  Sum_probs=126.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVN-LISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .++|+..+.||+|+||.||++.. .+++.||||++.... .....++..|+. +++.++||||+++++++..++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            46788899999999999999965 468999999997642 334455666666 777889999999999999999999999


Q ss_pred             eccCCCCHHHHhhcc--CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDK--NKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      ||+++ +|.+++...  .....+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 887776421  12456899999999999999999999   67 9999999999999999999999999999877


Q ss_pred             cCC
Q 013693          424 AAD  426 (438)
Q Consensus       424 ~~~  426 (438)
                      ...
T Consensus       177 ~~~  179 (327)
T 3aln_A          177 VDS  179 (327)
T ss_dssp             ---
T ss_pred             ccc
Confidence            543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=9.8e-25  Score=217.26  Aligned_cols=150  Identities=21%  Similarity=0.264  Sum_probs=128.7

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc------CCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI------EHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  342 (438)
                      ..+|++.+.||+|+||.||+|. ..+++.||||++... ....+.+.+|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            4568889999999999999994 456899999998653 33345677888888877      577999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC--eEEeccccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT--PKIADFGLA  420 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--~kl~DFGla  420 (438)
                      ++||||+. ++|.+++... ....+++..+..|+.||+.||.|||   +.+|+||||||+|||++.++.  +||+|||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6899988653 3345899999999999999999999   889999999999999999887  999999999


Q ss_pred             ccccC
Q 013693          421 RCFAA  425 (438)
Q Consensus       421 ~~~~~  425 (438)
                      +....
T Consensus       250 ~~~~~  254 (429)
T 3kvw_A          250 CYEHQ  254 (429)
T ss_dssp             EETTC
T ss_pred             eecCC
Confidence            77543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.91  E-value=1.2e-25  Score=214.10  Aligned_cols=157  Identities=25%  Similarity=0.325  Sum_probs=125.2

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch------hhHHHHHHHHHHHhcc----CCCceeeE
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSI----EHKNLVKL  332 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l  332 (438)
                      .+.+...++|++.+.||+|+||.||++.. .+++.||||++.....      .....+.+|+.++.++    +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            34556678899999999999999999965 5688999999965432      2234567899999998    89999999


Q ss_pred             EeEEEeCCeEEEEEec-cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCC
Q 013693          333 LGCSIEGPESLLVYEY-VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDF  410 (438)
Q Consensus       333 ~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~  410 (438)
                      ++++...+..++|||+ +.+++|.+++...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++ .++
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCC
Confidence            9999999999999999 7899999999543   35899999999999999999999   88999999999999999 889


Q ss_pred             CeEEecccccccccCC
Q 013693          411 TPKIADFGLARCFAAD  426 (438)
Q Consensus       411 ~~kl~DFGla~~~~~~  426 (438)
                      .+||+|||+++.+...
T Consensus       178 ~~kl~dfg~~~~~~~~  193 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE  193 (312)
T ss_dssp             EEEECCCSSCEECCSS
T ss_pred             eEEEEEcchhhhcccC
Confidence            9999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.91  E-value=8.8e-25  Score=206.34  Aligned_cols=151  Identities=25%  Similarity=0.399  Sum_probs=128.6

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeE-EEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC-SIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++.....  .+.+.+|+.+++.++|++++..+.. ....+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46788999999999999999964 6789999999865432  3468899999999998876665555 466778899999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFA  424 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~DFGla~~~~  424 (438)
                      |+ +++|.+++...  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999532  345899999999999999999999   8899999999999999   488899999999999886


Q ss_pred             CCCc
Q 013693          425 ADRT  428 (438)
Q Consensus       425 ~~~~  428 (438)
                      ....
T Consensus       160 ~~~~  163 (296)
T 3uzp_A          160 DART  163 (296)
T ss_dssp             CTTT
T ss_pred             cccc
Confidence            6543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.91  E-value=3.5e-25  Score=228.49  Aligned_cols=155  Identities=26%  Similarity=0.366  Sum_probs=133.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEe------CCe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------GPE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  341 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999955 56899999998754 44556789999999999999999999998765      667


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCC---eEEeccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFT---PKIADFG  418 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~DFG  418 (438)
                      .++||||+++++|.+++........+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555556899999999999999999999   889999999999999987664   9999999


Q ss_pred             ccccccCCC
Q 013693          419 LARCFAADR  427 (438)
Q Consensus       419 la~~~~~~~  427 (438)
                      +++.+....
T Consensus       170 ~a~~~~~~~  178 (676)
T 3qa8_A          170 YAKELDQGE  178 (676)
T ss_dssp             CCCBTTSCC
T ss_pred             ccccccccc
Confidence            999876543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=6e-25  Score=216.19  Aligned_cols=135  Identities=28%  Similarity=0.417  Sum_probs=113.5

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC--------CCceeeEEeEEE---
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE--------HKNLVKLLGCSI---  337 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  337 (438)
                      .++|++.++||+|+||.||++. ..+++.||||++... ....+.+.+|+.+++.++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            4679999999999999999995 456889999998643 344677889999999985        788999999987   


Q ss_pred             -eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCCeeeCCCC
Q 013693          338 -EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       338 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~  410 (438)
                       .....++||||+ +++|.+.+... ....+++..+..++.||+.||.|||   +. +|+||||||+|||++.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccc
Confidence             455789999999 55666665432 2345899999999999999999999   76 999999999999998775

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.91  E-value=6.4e-25  Score=218.96  Aligned_cols=149  Identities=28%  Similarity=0.434  Sum_probs=120.3

Q ss_pred             CCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      .|...+.||+|+||+||.+...+++.||||++....   .+.+.+|+.++.++ +||||+++++++.+++..+|||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            344567899999999987766689999999986532   35678999999987 89999999999999999999999995


Q ss_pred             CCCHHHHhhccCCCC----cCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-------------CCeE
Q 013693          351 NRSLDQFIFDKNKTK----LLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD-------------FTPK  413 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-------------~~~k  413 (438)
                       |+|.+++.......    ..++..++.++.||+.||.|||   +.+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999996543211    1234456789999999999999   8899999999999999654             4899


Q ss_pred             EecccccccccCCC
Q 013693          414 IADFGLARCFAADR  427 (438)
Q Consensus       414 l~DFGla~~~~~~~  427 (438)
                      |+|||+++.+..+.
T Consensus       169 L~DFG~a~~~~~~~  182 (434)
T 2rio_A          169 ISDFGLCKKLDSGQ  182 (434)
T ss_dssp             ECCCTTCEECCC--
T ss_pred             EcccccceecCCCC
Confidence            99999999887654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.91  E-value=4.4e-25  Score=211.25  Aligned_cols=157  Identities=25%  Similarity=0.318  Sum_probs=133.7

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecch------hhHHHHHHHHHHHhccC--CCceeeEEe
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIE--HKNLVKLLG  334 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~  334 (438)
                      ++.+...++|++.+.||+|+||.||+|. ..+++.||||++.....      ...+.+.+|+.++++++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            3344556789999999999999999995 45789999999975432      12356788999999996  599999999


Q ss_pred             EEEeCCeEEEEEeccCC-CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCCe
Q 013693          335 CSIEGPESLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD-KDFTP  412 (438)
Q Consensus       335 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~  412 (438)
                      ++..++..++|||++.+ ++|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++ +++.+
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCE
Confidence            99999999999999976 899999854   345899999999999999999999   89999999999999999 78899


Q ss_pred             EEecccccccccCC
Q 013693          413 KIADFGLARCFAAD  426 (438)
Q Consensus       413 kl~DFGla~~~~~~  426 (438)
                      ||+|||+++.+...
T Consensus       190 kL~Dfg~~~~~~~~  203 (320)
T 3a99_A          190 KLIDFGSGALLKDT  203 (320)
T ss_dssp             EECCCTTCEECCSS
T ss_pred             EEeeCccccccccc
Confidence            99999999987643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=1.9e-24  Score=207.86  Aligned_cols=151  Identities=21%  Similarity=0.299  Sum_probs=130.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc--cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCc------eeeEEeEEEeCCe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL--PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN------LVKLLGCSIEGPE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  341 (438)
                      .++|++.+.||+|+||.||++..  .+++.||||++... ....+.+.+|+.+++.++|++      |+++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46788999999999999999964  46889999998643 344567889999999997765      9999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-------------
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-------------  408 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-------------  408 (438)
                      .++||||+ +++|.+++... ....+++.++..++.||+.||.|||   +.+|+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999998653 2345889999999999999999999   889999999999999987             


Q ss_pred             ------CCCeEEecccccccccCC
Q 013693          409 ------DFTPKIADFGLARCFAAD  426 (438)
Q Consensus       409 ------~~~~kl~DFGla~~~~~~  426 (438)
                            ++.+||+|||+++.....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~  190 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH  190 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC
T ss_pred             ccccccCCCceEeeCcccccCccc
Confidence                  678999999999876543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=7.8e-25  Score=223.55  Aligned_cols=138  Identities=20%  Similarity=0.290  Sum_probs=109.6

Q ss_pred             CCCCCccccCCceeEEEEEccCCCEEEEEEeeecc--------hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      +...++||+|+||.||++.. .++.+++|+.....        ....+++.+|++++++++||||+++..++...+..+|
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            34567899999999999955 57889999865321        1124568999999999999999976666668888899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++++|.+++..           +..++.|+++||.|||   +.+|+||||||+|||++.  ++||+|||+|+.+.
T Consensus       417 VmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          417 MMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            9999999999999843           4579999999999999   899999999999999998  99999999999986


Q ss_pred             CCC
Q 013693          425 ADR  427 (438)
Q Consensus       425 ~~~  427 (438)
                      ...
T Consensus       481 ~~~  483 (540)
T 3en9_A          481 LDE  483 (540)
T ss_dssp             CHH
T ss_pred             Ccc
Confidence            643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.91  E-value=9.1e-25  Score=217.49  Aligned_cols=148  Identities=27%  Similarity=0.419  Sum_probs=121.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ..+|+..++||+|+||.|+.....+++.||||++....   .+.+.+|+.+|+.+ +||||+++++++.+.+..+|||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            34577889999999999765555588999999986432   23467899999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-----CCCeEEecccccccc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-----DFTPKIADFGLARCF  423 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-----~~~~kl~DFGla~~~  423 (438)
                      ++ |+|.+++....  ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.     ...+||+|||+|+.+
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 59999996432  23555667889999999999999   889999999999999943     336889999999987


Q ss_pred             cCC
Q 013693          424 AAD  426 (438)
Q Consensus       424 ~~~  426 (438)
                      ...
T Consensus       174 ~~~  176 (432)
T 3p23_A          174 AVG  176 (432)
T ss_dssp             ---
T ss_pred             cCC
Confidence            654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.90  E-value=2.8e-24  Score=205.02  Aligned_cols=151  Identities=23%  Similarity=0.333  Sum_probs=116.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch--hhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR--QWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      .++|+..+.||+|+||.||++.. .+++.||||++.....  ...+.+.++..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            46688889999999999999965 4689999999975432  22334455556788889999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ||+ ++.+..+...  ....+++..+..++.|++.||.|||   .. +|+|+||||+|||++.++.+||+|||+++.+..
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 5556555532  2345899999999999999999999   64 999999999999999999999999999987654


Q ss_pred             C
Q 013693          426 D  426 (438)
Q Consensus       426 ~  426 (438)
                      .
T Consensus       178 ~  178 (318)
T 2dyl_A          178 D  178 (318)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.90  E-value=8.7e-24  Score=207.30  Aligned_cols=158  Identities=25%  Similarity=0.279  Sum_probs=131.3

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CC-----ceeeEEeEEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HK-----NLVKLLGCSI  337 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~  337 (438)
                      ..+...++|++.+.||+|+||.||+|.. .+++.||||++... ....+++.+|+.+++.++ |+     +|+++++++.
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3344567899999999999999999954 46889999998643 334567788999988885 44     4999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCCCeEEe
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTPKIA  415 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kl~  415 (438)
                      ..+..+|||||++ ++|.+++.... ...+++..+..++.|++.||.|||.. +.+|+||||||+|||++  .++.+||+
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            9999999999996 59999986532 34589999999999999999999942 47899999999999994  57889999


Q ss_pred             cccccccccCC
Q 013693          416 DFGLARCFAAD  426 (438)
Q Consensus       416 DFGla~~~~~~  426 (438)
                      |||+++.+...
T Consensus       204 DFG~a~~~~~~  214 (382)
T 2vx3_A          204 DFGSSCQLGQR  214 (382)
T ss_dssp             CCTTCEETTCC
T ss_pred             eccCceecccc
Confidence            99999887543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.90  E-value=7.2e-24  Score=204.21  Aligned_cols=150  Identities=22%  Similarity=0.264  Sum_probs=120.0

Q ss_pred             HhcCCCCC-CccccCCceeEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeE
Q 013693          269 ATNYFNPS-KKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPES  342 (438)
Q Consensus       269 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  342 (438)
                      ..++|.+. ++||+|+||.||++... +++.||||++..... .   ..+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-A---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-H---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-H---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            34667774 46999999999999554 689999999864321 1   1222334566799999999999876    4458


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEecccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGL  419 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGl  419 (438)
                      ++||||+++++|.+++... ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999653 2346999999999999999999999   889999999999999976   45699999999


Q ss_pred             cccccCC
Q 013693          420 ARCFAAD  426 (438)
Q Consensus       420 a~~~~~~  426 (438)
                      ++.....
T Consensus       178 ~~~~~~~  184 (336)
T 3fhr_A          178 AKETTQN  184 (336)
T ss_dssp             CEEC---
T ss_pred             ceecccc
Confidence            9876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.90  E-value=8.8e-24  Score=204.57  Aligned_cols=151  Identities=21%  Similarity=0.282  Sum_probs=128.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEcc-CC-CEEEEEEeeecchhhHHHHHHHHHHHhccCCCc------eeeEEeEEEeCCe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLP-NG-TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN------LVKLLGCSIEGPE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  341 (438)
                      .++|++.+.||+|+||.||++... ++ +.||+|++... ....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            467899999999999999999653 44 68999998643 344567889999999998776      9999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---------------
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL---------------  406 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---------------  406 (438)
                      .++||||+ +++|.+++... ....+++.++..++.||+.||.|||   +.+|+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66777766443 2345899999999999999999999   8999999999999999               


Q ss_pred             ----CCCCCeEEecccccccccCC
Q 013693          407 ----DKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       407 ----~~~~~~kl~DFGla~~~~~~  426 (438)
                          +.++.+||+|||+++.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~  195 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH  195 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC
T ss_pred             cccccCCCcEEEeecCcccccccc
Confidence                56789999999999875543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.89  E-value=7.4e-24  Score=206.81  Aligned_cols=151  Identities=25%  Similarity=0.340  Sum_probs=128.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-----------CCceeeEEeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----------HKNLVKLLGCSI  337 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  337 (438)
                      .++|++.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35788999999999999999964 57899999998643 334567889999999886           899999999988


Q ss_pred             eCC----eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCCeeeC-----
Q 013693          338 EGP----ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET-RIIHRDIKTSNILLD-----  407 (438)
Q Consensus       338 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~-----  407 (438)
                      ..+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||   +. +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence            654    789999999 889999986532 345899999999999999999999   76 999999999999994     


Q ss_pred             -CCCCeEEecccccccccCC
Q 013693          408 -KDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       408 -~~~~~kl~DFGla~~~~~~  426 (438)
                       ..+.+||+|||+++.+...
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~  191 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH  191 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC
T ss_pred             cCcceEEEcccccccccCCC
Confidence             4458999999999877543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.1e-23  Score=197.52  Aligned_cols=144  Identities=15%  Similarity=0.117  Sum_probs=114.8

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecch------------------hhHHHHHHHHHHHhccCC
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR------------------QWVDEFFNEVNLISSIEH  326 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h  326 (438)
                      .+......|.+.+.||+|+||.||+|...+++.||||.++....                  .....+.+|+.++++++|
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            34444455667799999999999999777799999999864321                  134568999999999994


Q ss_pred             CceeeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013693          327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILL  406 (438)
Q Consensus       327 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  406 (438)
                         +++.+++.. +..++||||+++++|.+ +..         .+...++.|++.||.|||   +.+|+||||||+|||+
T Consensus       164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl  226 (282)
T 1zar_A          164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             ---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence               555554433 55699999999999987 411         224569999999999999   8999999999999999


Q ss_pred             CCCCCeEEecccccccccCC
Q 013693          407 DKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       407 ~~~~~~kl~DFGla~~~~~~  426 (438)
                      + ++.+||+|||+|+.....
T Consensus       227 ~-~~~vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVEVGEE  245 (282)
T ss_dssp             E-TTEEEECCCTTCEETTST
T ss_pred             E-CCcEEEEECCCCeECCCC
Confidence            9 999999999999977544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.86  E-value=2.6e-22  Score=198.82  Aligned_cols=152  Identities=18%  Similarity=0.218  Sum_probs=114.7

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCC-Cce---------e-----
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEH-KNL---------V-----  330 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~ni---------v-----  330 (438)
                      .+.|...++||+|+||.||+|. ..+++.||||++....   ....+.+.+|+.+++.++| +|.         +     
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3456677899999999999996 5679999999987432   2336789999999999977 221         1     


Q ss_pred             -------eEEeEEEe-----CCeEEEEEeccCCCCHHHHhhc----cCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 013693          331 -------KLLGCSIE-----GPESLLVYEYVPNRSLDQFIFD----KNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI  394 (438)
Q Consensus       331 -------~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  394 (438)
                             .+..+...     ....+++|+++ +++|.+++..    ......+++..++.|+.||++||.|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                   11111111     12356777765 6899988841    123455888999999999999999999   8999


Q ss_pred             eeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          395 IHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       395 iH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      +||||||+|||++.++.+||+|||+++....
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~  263 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  263 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC
Confidence            9999999999999999999999999987543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=4e-21  Score=177.89  Aligned_cols=140  Identities=16%  Similarity=0.160  Sum_probs=108.4

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCE--EEEEEeeecchh------------------------hHHHHHHHHHHHhccC
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTT--VAVKRLIFNTRQ------------------------WVDEFFNEVNLISSIE  325 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  325 (438)
                      |++.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999976 67888  999987543111                        1135789999999998


Q ss_pred             CCce--eeEEeEEEeCCeEEEEEeccCC-C----CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 013693          326 HKNL--VKLLGCSIEGPESLLVYEYVPN-R----SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD  398 (438)
Q Consensus       326 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~d  398 (438)
                      |++|  +.+++.    +..+|||||+.+ |    +|.++...      .++..+..++.|++.+|.|||.  ..+|+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence            8864  444442    356899999942 3    66666421      2355678899999999999993  46899999


Q ss_pred             CCCCCeeeCCCCCeEEecccccccccCC
Q 013693          399 IKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       399 lkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |||+|||++.  .++|+|||+|.....+
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCHHHEEEcC--cEEEEECcccccCCCc
Confidence            9999999988  9999999999887544

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.79  E-value=9e-20  Score=143.92  Aligned_cols=77  Identities=22%  Similarity=0.430  Sum_probs=62.7

Q ss_pred             cccccccccC-CCeeEEEecCCCCcceEEEEEcCCCCChhhHHHHHHHHHhhccc-cCCCcceEEEcceeeEeEecccc
Q 013693            2 EILSQLITAN-THFATFNLNKTPYVPIYALAQCHLDLSHTDCLLCFAASRTKLPR-CLPSLSATIFFDGCFLRYDIYSF   78 (438)
Q Consensus         2 ~~l~~~~~~~-~~~~~~~~~~~~~~~vy~~~~C~~d~~~~~C~~Cl~~~~~~~~~-c~~~~~~~~~~~~C~~ry~~~~f   78 (438)
                      +.|++.++.+ .+|++......+.++||||+|||||+++++|..||+.++..++. |+++++|+||+++|+||||+++|
T Consensus        30 ~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           30 ADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            3455555544 35666653333334899999999999999999999999999988 78889999999999999999998

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.2e-18  Score=167.95  Aligned_cols=139  Identities=14%  Similarity=0.159  Sum_probs=99.3

Q ss_pred             CCCCCCccccCCceeEEEEEccCCCEEEEEEeeecch--------------hhHHH--------HHHHHHHHhccCCCce
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR--------------QWVDE--------FFNEVNLISSIEHKNL  329 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~ni  329 (438)
                      -|++...||+|++|.||+|...+|+.||||+++....              .....        ..+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3888899999999999999888999999998753210              00011        1245666666654443


Q ss_pred             eeEEeEEEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC
Q 013693          330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD  409 (438)
Q Consensus       330 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  409 (438)
                      ....-+...  ..+|||||+++++|.++..         ......++.||+.+|.+||   +.+||||||||.|||++++
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEE
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCC
Confidence            222111112  2379999999988865541         1234567899999999999   8899999999999999877


Q ss_pred             C----------CeEEeccccccccc
Q 013693          410 F----------TPKIADFGLARCFA  424 (438)
Q Consensus       410 ~----------~~kl~DFGla~~~~  424 (438)
                      +          .+.|+||+-+-...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999999776543

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.68  E-value=6.1e-17  Score=127.66  Aligned_cols=85  Identities=18%  Similarity=0.387  Sum_probs=75.4

Q ss_pred             hhHHHHHHHHHHHHHHHHHhcCCccccccc-----ceeeeeEeecCCCChhchHHHHHhhchhhhhcccCCccceEeccc
Q 013693          109 DGFVESVGYAVGNVSRIAVEKGGGFGAVKV-----MGVYALAQCWESLGRDGCRECLDKAGMRVRRSCRMRKEGRGFNAG  183 (438)
Q Consensus       109 ~~~~~~~~~~~~~l~~~a~~~~~~fa~~~~-----~~~y~l~QC~~dl~~~~C~~Cl~~~~~~~~~~c~~~~~G~v~~~~  183 (438)
                      ..|...+..++..|+..++.+..+|++...     ++||||+||++|+++.+|+.||..++.++++.|.+..+|+++..+
T Consensus        19 s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~   98 (108)
T 3a2e_A           19 SPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVD   98 (108)
T ss_dssp             CTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEETT
T ss_pred             ChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEECCC
Confidence            458899999999999988877767766532     389999999999999999999999999999988888888999999


Q ss_pred             ccccccCCcc
Q 013693          184 CYLRYSTDKF  193 (438)
Q Consensus       184 C~~ry~~~~f  193 (438)
                      |++||+.++|
T Consensus        99 C~lRY~~~~F  108 (108)
T 3a2e_A           99 CFIQYEQRSF  108 (108)
T ss_dssp             EEEEEESSCC
T ss_pred             EEEEEeCCcC
Confidence            9999999887

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.52  E-value=4.9e-14  Score=130.32  Aligned_cols=148  Identities=16%  Similarity=0.050  Sum_probs=115.7

Q ss_pred             HHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEE
Q 013693          266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       266 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  344 (438)
                      +......|+....++.|+.+.||+.... ++.+++|............+.+|+.+++.+ .|..+++++++....+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3444566877788888888999999754 689999998653223345688999999998 47788999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----------------------------------  389 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------  389 (438)
                      |||+++|.+|.+.+.        +......++.+++++|..||..                                   
T Consensus        88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999999987641        1122346788999999999951                                   


Q ss_pred             ---------------------CCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          390 ---------------------SETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       390 ---------------------~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                                           ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                 014589999999999998766677999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=1.2e-12  Score=120.38  Aligned_cols=130  Identities=18%  Similarity=0.142  Sum_probs=98.2

Q ss_pred             ccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCc--eeeEEeEEEeCCeEEEEEeccCCCCHHHH
Q 013693          280 GQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKLLGCSIEGPESLLVYEYVPNRSLDQF  357 (438)
Q Consensus       280 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  357 (438)
                      +.|..+.||+....+|..+++|.....   ....+.+|+.+++.+.+.+  +++++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            455668999998777888999987543   2356789999999985444  567899888888899999999998884  


Q ss_pred             hhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------------
Q 013693          358 IFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS-----------------------------------------------  390 (438)
Q Consensus       358 l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------------  390 (438)
                      ...      .+   ...++.++++.|..||...                                               
T Consensus       104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            211      11   1246777888888888421                                               


Q ss_pred             --------CCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          391 --------ETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       391 --------~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                              ...++|+|++|.|||++++..+.|+|||.+...
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                    122999999999999987766779999998654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.20  E-value=3e-11  Score=116.85  Aligned_cols=141  Identities=15%  Similarity=0.182  Sum_probs=106.1

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEee--ecc-hhhHHHHHHHHHHHhccC--CCceeeEEeEEEeC---CeEEEEEe
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLI--FNT-RQWVDEFFNEVNLISSIE--HKNLVKLLGCSIEG---PESLLVYE  347 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  347 (438)
                      .+.|+.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999999775 4678888775  322 123457889999999996  56688999988776   45899999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS-------------------------------------  390 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  390 (438)
                      |++|..+.+..     ...++..+...++.++++.|..||...                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99998774321     123678888889999999999999520                                     


Q ss_pred             ------------------CCCeeeCCCCCCCeeeCCCCC--eEEeccccccc
Q 013693          391 ------------------ETRIIHRDIKTSNILLDKDFT--PKIADFGLARC  422 (438)
Q Consensus       391 ------------------~~~iiH~dlkp~Nill~~~~~--~kl~DFGla~~  422 (438)
                                        ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999987653  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.77  E-value=1.1e-08  Score=96.41  Aligned_cols=137  Identities=20%  Similarity=0.212  Sum_probs=98.8

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCc--eeeEEeEEEeCC---eEEEEEecc
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKN--LVKLLGCSIEGP---ESLLVYEYV  349 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~  349 (438)
                      .+.++.|....||+..    ..+++|+...  ......+.+|..+|+.+ .+..  +++++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568899999999753    5688887542  23456788999999888 4433  455655544333   358999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG----------------------------------------  389 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------  389 (438)
                      +|.+|.+...     ..++..++..++.++++.|..||..                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865431     2356677777888888888888741                                        


Q ss_pred             ---------------CCCCeeeCCCCCCCeeeCC--CCCeEEecccccccc
Q 013693          390 ---------------SETRIIHRDIKTSNILLDK--DFTPKIADFGLARCF  423 (438)
Q Consensus       390 ---------------~~~~iiH~dlkp~Nill~~--~~~~kl~DFGla~~~  423 (438)
                                     ....++|+|++|.||++++  +..+.|+||+.+..-
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                           1145799999999999987  556899999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=7e-08  Score=90.93  Aligned_cols=137  Identities=20%  Similarity=0.193  Sum_probs=93.8

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC---ceeeEEeEEE-eCCeEEEEEeccCC
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK---NLVKLLGCSI-EGPESLLVYEYVPN  351 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  351 (438)
                      .+.++.|....||+.    +..+++|+.  ........+.+|..+|+.+.+.   .+++++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            345788888899987    567888874  2333456789999999999642   4667777764 45568899999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG------------------------------------------  389 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------  389 (438)
                      .++.+....     .++..+...++.++++.|..||..                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888663211     123344444444444444444421                                          


Q ss_pred             ---------------CCCCeeeCCCCCCCeeeCC---CCC-eEEecccccccc
Q 013693          390 ---------------SETRIIHRDIKTSNILLDK---DFT-PKIADFGLARCF  423 (438)
Q Consensus       390 ---------------~~~~iiH~dlkp~Nill~~---~~~-~kl~DFGla~~~  423 (438)
                                     ....++|+|++|.|||++.   ++. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2346799999999999987   455 489999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.66  E-value=1.7e-07  Score=86.43  Aligned_cols=135  Identities=16%  Similarity=0.138  Sum_probs=96.1

Q ss_pred             ccccCCce-eEEEEEcc-CCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          278 KLGQGGAG-SVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       278 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      .+..|..+ .||+.... ++..+++|+-...   ....+.+|...|+.+. +-.+.++++++.+++..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34455555 68987554 4567888976432   3456888999998883 44578899999999999999999999888


Q ss_pred             HHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 013693          355 DQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG---------------------------------------------  389 (438)
Q Consensus       355 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------------  389 (438)
                      .+....       .......+..+++..|.-||..                                             
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            766521       1122334555666666666631                                             


Q ss_pred             ----------CCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          390 ----------SETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       390 ----------~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                                ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      112379999999999999887778999998865

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.54  E-value=1.3e-07  Score=90.94  Aligned_cols=79  Identities=6%  Similarity=0.008  Sum_probs=56.0

Q ss_pred             Ccc-ccCCceeEEEEEcc-------CCCEEEEEEeeecc---hhhHHHHHHHHHHHhccC-C--CceeeEEeEEEeC---
Q 013693          277 KKL-GQGGAGSVYMGSLP-------NGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIE-H--KNLVKLLGCSIEG---  339 (438)
Q Consensus       277 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  339 (438)
                      +.| +.|....+|+....       ++..+++|......   ......+.+|..+++.+. +  ..+++++.+..+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999988654       25678888764332   111256788999999884 3  3577888887665   


Q ss_pred             CeEEEEEeccCCCCHH
Q 013693          340 PESLLVYEYVPNRSLD  355 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~  355 (438)
                      +..++|||+++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3578999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=3.1e-06  Score=82.64  Aligned_cols=75  Identities=11%  Similarity=0.119  Sum_probs=50.6

Q ss_pred             CCccccCCceeEEEEEcc-CCCEEEEEEeeecch-------hhHHHHHHHHHHHhccCC---CceeeEEeEEEeCCeEEE
Q 013693          276 SKKLGQGGAGSVYMGSLP-NGTTVAVKRLIFNTR-------QWVDEFFNEVNLISSIEH---KNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~l  344 (438)
                      .+.||.|..+.||++... +++.++||.......       ...+++..|.++++.+..   ..+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999654 468899997653211       123456789999888742   345566654  4555689


Q ss_pred             EEeccCCC
Q 013693          345 VYEYVPNR  352 (438)
Q Consensus       345 v~e~~~~g  352 (438)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=3.3e-06  Score=80.37  Aligned_cols=141  Identities=17%  Similarity=0.212  Sum_probs=80.2

Q ss_pred             CccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC--CceeeEEe------EEEeCCeEEEEEec
Q 013693          277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH--KNLVKLLG------CSIEGPESLLVYEY  348 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  348 (438)
                      +.|+.|..+.||+....++ .+++|+....    ..++..|..++..|..  -.+++++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3455567889999876544 5889988642    1334455666655531  12344443      22356778999999


Q ss_pred             cCCCCHH-----------HH---hhcc-CC---C-------CcCCHHHHH------------------------------
Q 013693          349 VPNRSLD-----------QF---IFDK-NK---T-------KLLNWNKRF------------------------------  373 (438)
Q Consensus       349 ~~~g~L~-----------~~---l~~~-~~---~-------~~l~~~~~~------------------------------  373 (438)
                      ++|.++.           ..   ++.. ..   .       ....|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           01   1110 00   0       011222110                              


Q ss_pred             -HHHHHHHHHHHHhhc----------CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          374 -NIILGTAEGLAYLHG----------GSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       374 -~i~~~i~~~L~~LH~----------~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                       .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             111223345566652          0257899999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.09  E-value=1.9e-05  Score=74.27  Aligned_cols=138  Identities=17%  Similarity=0.144  Sum_probs=92.9

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeEEEEEeccCCC
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE---HKNLVKLLGCSIEGPESLLVYEYVPNR  352 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  352 (438)
                      .+.|+.|....+|+... ++..+++|+....   ....+..|...|+.|.   ...+++++.+....+..++|||++++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            45689999999999876 4678888876532   3566889999998883   367889999988888999999999987


Q ss_pred             CHH--------HH---hhccCC-C------------------CcCCHHHHH---HHHH----------------HHHHHH
Q 013693          353 SLD--------QF---IFDKNK-T------------------KLLNWNKRF---NIIL----------------GTAEGL  383 (438)
Q Consensus       353 ~L~--------~~---l~~~~~-~------------------~~l~~~~~~---~i~~----------------~i~~~L  383 (438)
                      .+.        +.   |+.... .                  -.-+|.+.+   ++..                .+..-+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            642        11   222111 0                  012454332   1111                111112


Q ss_pred             -HHhh-cCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          384 -AYLH-GGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       384 -~~LH-~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                       ..|. ......++|+|+.+.|++++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             2342 12357899999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.99  E-value=2.8e-05  Score=72.16  Aligned_cols=78  Identities=19%  Similarity=0.199  Sum_probs=57.0

Q ss_pred             CCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-C--CceeeEEeEEEeCCeEEEEEecc
Q 013693          273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-H--KNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ....+.+|.|..+.||+....+|+.+.+|+...........|..|...|+.|. .  --+++++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            33456789999999999999999999999875444444456788999988883 2  2355666542    347899999


Q ss_pred             CCCCH
Q 013693          350 PNRSL  354 (438)
Q Consensus       350 ~~g~L  354 (438)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=3.5e-05  Score=75.75  Aligned_cols=73  Identities=12%  Similarity=0.163  Sum_probs=45.6

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecc----hh-----hHHHHHHHHHHHh-ccCCCceeeEEeEEEeCCeEEEE
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT----RQ-----WVDEFFNEVNLIS-SIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~-----~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      .+.||.|..+.||+... +++.++||......    ..     ....+..|+..+. ...+..+++++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45689999999999965 56789999533211    11     1223333333222 12335677777765  5677999


Q ss_pred             Eecc-CC
Q 013693          346 YEYV-PN  351 (438)
Q Consensus       346 ~e~~-~~  351 (438)
                      ||++ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.76  E-value=0.00011  Score=69.66  Aligned_cols=142  Identities=13%  Similarity=0.077  Sum_probs=74.9

Q ss_pred             CccccCCcee-EEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC--CceeeEEeEEEeCCeEEEEEeccCCCC
Q 013693          277 KKLGQGGAGS-VYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH--KNLVKLLGCSIEGPESLLVYEYVPNRS  353 (438)
Q Consensus       277 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  353 (438)
                      +.|+.|.... +|+....++..+++|......   ...+..|+.++..+..  -.+++++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565555444 667765446777777543321   1345667777777742  24567777643333  78999998766


Q ss_pred             HHHHhhcc---------------------CC--CCcCCHHHHH-------H-H------------HHHHHHHHHHhh---
Q 013693          354 LDQFIFDK---------------------NK--TKLLNWNKRF-------N-I------------ILGTAEGLAYLH---  387 (438)
Q Consensus       354 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-i------------~~~i~~~L~~LH---  387 (438)
                      +.+.+...                     ..  ...++.....       . +            ...+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65433210                     00  0111111100       0 0            001111222221   


Q ss_pred             cCCCCCeeeCCCCCCCeeeCCC----CCeEEecccccccc
Q 013693          388 GGSETRIIHRDIKTSNILLDKD----FTPKIADFGLARCF  423 (438)
Q Consensus       388 ~~~~~~iiH~dlkp~Nill~~~----~~~kl~DFGla~~~  423 (438)
                      ......++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1125689999999999999874    68999999988653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.71  E-value=0.00053  Score=64.64  Aligned_cols=159  Identities=15%  Similarity=0.103  Sum_probs=90.3

Q ss_pred             ccCHHHHHHHhcCCCC-----CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCC--ceeeE
Q 013693          260 SFKYETLEKATNYFNP-----SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHK--NLVKL  332 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l  332 (438)
                      ..+.+.+....+.|..     ...|+ |....||+....+|+.+++|...... .....+..|..++..+...  .++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            3445555555555533     23466 77789999877677789999886331 1234567788888877422  24444


Q ss_pred             EeE-----EEeCCeEEEEEeccCCCCHH-----HH---------hhcc----C--CCCcCCHHHH---------------
Q 013693          333 LGC-----SIEGPESLLVYEYVPNRSLD-----QF---------IFDK----N--KTKLLNWNKR---------------  372 (438)
Q Consensus       333 ~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~~----~--~~~~l~~~~~---------------  372 (438)
                      +..     ...++..+++||+++|..+.     ..         ++..    .  ....+++...               
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            442     23356678999999885432     11         1110    0  0011222111               


Q ss_pred             -------HHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          373 -------FNIILGTAEGLAYLHG-GSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       373 -------~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                             ...+..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   1111222222222211 1246789999999999999 4 899999987764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.69  E-value=0.00023  Score=66.89  Aligned_cols=160  Identities=12%  Similarity=0.132  Sum_probs=89.7

Q ss_pred             ccCHHHHHHHhcCCCCC-----CccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCc--eeeE
Q 013693          260 SFKYETLEKATNYFNPS-----KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN--LVKL  332 (438)
Q Consensus       260 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  332 (438)
                      .++.+++....+.|...     +.|+.|....+|+....++ .+++|.....  ...+.+..|..++..|...+  ++++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            35566777777777652     3466687889999876555 6788987642  12234667888877774222  3444


Q ss_pred             EeE------EEeCCeEEEEEeccCCCCHHH----H----------hhcc----CCC--C---cCCHHHHHH---------
Q 013693          333 LGC------SIEGPESLLVYEYVPNRSLDQ----F----------IFDK----NKT--K---LLNWNKRFN---------  374 (438)
Q Consensus       333 ~~~------~~~~~~~~lv~e~~~~g~L~~----~----------l~~~----~~~--~---~l~~~~~~~---------  374 (438)
                      +..      ....+..++++|+++|..+..    .          ++..    ...  .   ...|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            421      223567899999999865321    0          1111    000  0   011222110         


Q ss_pred             ---HHHHHHHHHHHhhc----CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          375 ---IILGTAEGLAYLHG----GSETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       375 ---i~~~i~~~L~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                         +...+.+.+.+++.    ....+++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               00113334444442    1245799999999999998876668999987753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.68  E-value=0.00011  Score=68.48  Aligned_cols=71  Identities=11%  Similarity=0.099  Sum_probs=45.1

Q ss_pred             CCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEecc-CCCC
Q 013693          276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYV-PNRS  353 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  353 (438)
                      .+.|+.|....+|+.     ..+++|+....... .....+|..+++.+...++ +++++.  ..+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577888999999988     56888877543222 1223568888877743223 466654  343457899999 6654


Q ss_pred             H
Q 013693          354 L  354 (438)
Q Consensus       354 L  354 (438)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.47  E-value=0.0003  Score=69.19  Aligned_cols=72  Identities=18%  Similarity=0.287  Sum_probs=48.6

Q ss_pred             CccccCCceeEEEEEccC--------CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEe
Q 013693          277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  347 (438)
                      +.|+.|-...+|+....+        +..+++|+.....  ..+.+.+|..+++.|...++ +++++.+.  +  .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            457788889999997643        4788888874311  11456689999988853333 67776543  2  38999


Q ss_pred             ccCCCCH
Q 013693          348 YVPNRSL  354 (438)
Q Consensus       348 ~~~~g~L  354 (438)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.42  E-value=0.00051  Score=68.02  Aligned_cols=73  Identities=11%  Similarity=0.015  Sum_probs=46.6

Q ss_pred             CccccCCceeEEEEEccC-CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          277 KKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      +.|+.|-...+|+....+ +..+++|+......... .-.+|..++..|...++ +++++.+.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            467778888999997754 47788887643322211 12578999998854444 57777662  2  359999987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.36  E-value=0.00038  Score=67.07  Aligned_cols=141  Identities=21%  Similarity=0.203  Sum_probs=82.1

Q ss_pred             CccccCCceeEEEEEcc--------CCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEe
Q 013693          277 KKLGQGGAGSVYMGSLP--------NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.|. +.-.+++++.+..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45767778889998764        2478899885332 223456678999998884 3334667766543    29999


Q ss_pred             ccCCCCHHHH-----------------hhccC--CCCcCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 013693          348 YVPNRSLDQF-----------------IFDKN--KTKLLN--WNKRFNIILGTAE-------------------GLAYLH  387 (438)
Q Consensus       348 ~~~~g~L~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~L~~LH  387 (438)
                      |++|.+|..-                 |+...  -.+...  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655311                 11110  011111  3344444433321                   122222


Q ss_pred             ----c-CCCCCeeeCCCCCCCeeeCCC----CCeEEeccccccc
Q 013693          388 ----G-GSETRIIHRDIKTSNILLDKD----FTPKIADFGLARC  422 (438)
Q Consensus       388 ----~-~~~~~iiH~dlkp~Nill~~~----~~~kl~DFGla~~  422 (438)
                          . .....++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 224578999999999999876    7899999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.25  E-value=0.0013  Score=62.33  Aligned_cols=67  Identities=7%  Similarity=0.046  Sum_probs=43.6

Q ss_pred             cCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC---CceeeEEeE------EEeCCeEEEEEeccCC
Q 013693          281 QGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH---KNLVKLLGC------SIEGPESLLVYEYVPN  351 (438)
Q Consensus       281 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lv~e~~~~  351 (438)
                      .|....||+....++ .+++|+......      ..|+.++..|..   |++++++..      ....+..+++|||++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333678999987666 899998754331      356666666631   224555432      2345778999999998


Q ss_pred             CCH
Q 013693          352 RSL  354 (438)
Q Consensus       352 g~L  354 (438)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.11  E-value=0.0008  Score=64.63  Aligned_cols=73  Identities=14%  Similarity=0.138  Sum_probs=44.1

Q ss_pred             CccccCCceeEEEEEccC---------CCEEEEEEeeecchhhHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCeEEEEE
Q 013693          277 KKLGQGGAGSVYMGSLPN---------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKN-LVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  346 (438)
                      +.|+.|....+|+....+         +..+++|+....... ......|..+++.+...+ .+++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            456777788999987543         267888876543222 223467888888884333 45676543  2  27899


Q ss_pred             eccCCCCH
Q 013693          347 EYVPNRSL  354 (438)
Q Consensus       347 e~~~~g~L  354 (438)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99988543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.94  E-value=0.016  Score=56.49  Aligned_cols=73  Identities=10%  Similarity=0.082  Sum_probs=47.4

Q ss_pred             CccccCCceeEEEEEccC--------CCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEe
Q 013693          277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +.|..|-...+|+....+        +..+++|+....... .-...+|..+++.+. +.-.+++++.+  .+  ++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            456667778899987653        578898886443222 223457888888884 33345666533  22  78999


Q ss_pred             ccCCCCH
Q 013693          348 YVPNRSL  354 (438)
Q Consensus       348 ~~~~g~L  354 (438)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.84  E-value=0.2  Score=48.34  Aligned_cols=30  Identities=27%  Similarity=0.387  Sum_probs=25.3

Q ss_pred             CeeeCCCCCCCeee------CCCCCeEEeccccccc
Q 013693          393 RIIHRDIKTSNILL------DKDFTPKIADFGLARC  422 (438)
Q Consensus       393 ~iiH~dlkp~Nill------~~~~~~kl~DFGla~~  422 (438)
                      .++|+|+.+.|||+      +++..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            45799999999999      4567899999988764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=93.16  E-value=0.018  Score=35.89  Aligned_cols=28  Identities=14%  Similarity=0.156  Sum_probs=11.6

Q ss_pred             eeEEEEeehhHHHHHHHHHHHHHHHHhh
Q 013693          210 GVMIAIVLSTTAFLMLSLFAAYAAYARL  237 (438)
Q Consensus       210 ~i~i~iv~~~~~~l~l~~~~~~~~~~~~  237 (438)
                      ..++++++|+++++++++.++++++||+
T Consensus        12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           12 TSIISAVVGILLVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             cchHHHHHHHHHHHHHHHHHHhheehhh
Confidence            3345555663333333333333333333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.66  E-value=1.4  Score=38.29  Aligned_cols=89  Identities=10%  Similarity=0.135  Sum_probs=64.8

Q ss_pred             CCCceeeEEeEEEeCCeEEEEEeccCCC-CHHHHhhccCCCCcCCHHHHHHHHHHHHHHHH-HhhcCCCCCeeeCCCCCC
Q 013693          325 EHKNLVKLLGCSIEGPESLLVYEYVPNR-SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA-YLHGGSETRIIHRDIKTS  402 (438)
Q Consensus       325 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~iiH~dlkp~  402 (438)
                      .||++  -..+-.+++...+.++.-+++ ++. .+      ..++..++++++.+|+.-.. +++     .-+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            57888  444456777777777765343 333 33      23677888999998887666 554     3578889999


Q ss_pred             CeeeCCCCCeEEecccccccccCCC
Q 013693          403 NILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       403 Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||+++.++.++|.-.|+-..+.+..
T Consensus       114 NL~f~~~~~p~i~hRGi~~~lpP~e  138 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESLPPDE  138 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTBSSCS
T ss_pred             eEEEeCCCcEEEEEcCCcccCCCCC
Confidence            9999999999999999877765543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.56  E-value=0.073  Score=52.55  Aligned_cols=62  Identities=6%  Similarity=0.019  Sum_probs=19.0

Q ss_pred             CCCCccccCCceeEEEEEccC-CCEEEE------EEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 013693          274 NPSKKLGQGGAGSVYMGSLPN-GTTVAV------KRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE  338 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  338 (438)
                      .+.+.||   ||.||+|.+.. ..+||+      |..+..  .++....+.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456676   99999997754 367888      766532  23344578889999999999999999887653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.49  E-value=1.7  Score=37.61  Aligned_cols=89  Identities=11%  Similarity=0.094  Sum_probs=65.2

Q ss_pred             CCCceeeEEeEEEeCCeEEEEEeccCC-CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013693          325 EHKNLVKLLGCSIEGPESLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (438)
Q Consensus       325 ~h~niv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  403 (438)
                      .||+++.. .+-.+.+...+.++.-+. -++..       -..++..++++++.+|+.-..+++     .-+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecce
Confidence            58888866 455666666666665432 22322       234778889999999988876665     24688899999


Q ss_pred             eeeCCCCCeEEecccccccccCC
Q 013693          404 ILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       404 ill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++.++.+++.-.|+-..+.+.
T Consensus       110 L~f~~~~~p~i~~RGik~~l~P~  132 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVDPL  132 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBSCC
T ss_pred             EEEcCCCCEEEEEccCccCCCCC
Confidence            99999999999999987766554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	438
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-43
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-40
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-38
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-37
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-36
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-29
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 1e-44
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 7/163 (4%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           +++G G  G+VY G       V +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
              P+  +V ++    SL   +            K  +I   TA+G+ YLH      IIH
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSIIH 127

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFA-ADRTHVSTAVAGTL 438
           RD+K++NI L +D T KI DFGLA   +    +H    ++G++
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 5e-44
 Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 9/176 (5%)

Query: 263 YETLEKATN---YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEV 318
           YE + +  N   ++    +LG G  G VY   +       A K +   + + ++++  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
           ++++S +H N+VKLL          ++ E+    ++D  + +  +   L  ++   +   
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQ 118

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           T + L YLH   + +IIHRD+K  NIL   D   K+ADFG++           + +
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 7e-44
 Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 6/162 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
           ++LG G  G V+MG     T VAVK L        D F  E NL+  ++H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
            + P   ++ EY+ N SL  F+   +  KL   NK  ++    AEG+A++    E   IH
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ERNYIH 132

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           RD++ +NIL+    + KIADFGLAR    +           +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 37/166 (22%), Positives = 71/166 (42%), Gaps = 7/166 (4%)

Query: 266 LEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-DEFFNEVNLISS 323
           +E   + F    +LG G  G V+     P+G  +A K +    +  + ++   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                +V   G      E  +  E++   SLDQ +    +   +       + +   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            YL    + +I+HRD+K SNIL++     K+ DFG++        +
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (383), Expect = 4e-43
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 10/167 (5%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ---WVDEFFNEVNLISSIE 325
              F+  +++G G  G+VY    + N   VA+K++ ++ +Q      +   EV  +  + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H N ++  GC +    + LV EY    + D     K     L   +   +  G  +GLAY
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           LH      +IHRD+K  NILL +    K+ DFG A   A   + V T
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 3e-42
 Identities = 40/166 (24%), Positives = 67/166 (40%), Gaps = 6/166 (3%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
               K+LG G  G V  G       VA+K  I       DEF  E  ++ ++ H+ LV+L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G   +     ++ EY+ N  L  ++ +          +   +     E + YL      
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE---SK 119

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           + +HRD+   N L++     K++DFGL+R    D    S      +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 1e-41
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 32/209 (15%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWV- 311
           L+ K  +LE   N     + +G+G  G V+    P        T VAVK L       + 
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL----- 366
            +F  E  L++  ++ N+VKLLG    G    L++EY+    L++F+   +   +     
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 367 ----------------LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF 410
                           L+  ++  I    A G+AYL    E + +HRD+ T N L+ ++ 
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENM 177

Query: 411 TPKIADFGLAR-CFAADRTHVSTAVAGTL 438
             KIADFGL+R  ++AD        A  +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPI 206

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 6/166 (3%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
               +++G G  G V++G   N   VA+K  I       ++F  E  ++  + H  LV+L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G  +E     LV+E++ +  L  +   + +  L        + L   EG+AYL    E 
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            +IHRD+   N L+ ++   K++DFG+ R    D+   ST     +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-40
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 6/162 (3%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
            KLGQG  G V+MG+    T VA+K  +       + F  E  ++  + H+ LV+L    
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 80

Query: 337 IEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIH 396
           +      +V EY+   SL  F+  +   K L   +  ++    A G+AY+        +H
Sbjct: 81  VSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVH 136

Query: 397 RDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           RD++ +NIL+ ++   K+ADFGLAR    +           +
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 6/180 (3%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
           S  Y+  E          KLG G  G VY G       TVAVK L  +T + V+EF  E 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 64

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++  I+H NLV+LLG     P   ++ E++   +L  ++ + N+ + ++      +   
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQ 123

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            +  + YL    +   IHRD+   N L+ ++   K+ADFGL+R    D           +
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 3e-40
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 8/163 (4%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
               + +G+G  G V +G    G  VAVK +          F  E ++++ + H NLV+L
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 333 LGCSIEGPESL-LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           LG  +E    L +V EY+   SL  ++  + +  +L  +      L   E + YL     
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---G 121

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
              +HRD+   N+L+ +D   K++DFGL +  ++ +      V
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (361), Expect = 5e-40
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 19/186 (10%)

Query: 261 FKYETLEKATNYFNPS---------KKLGQGGAGSVYMGSLP----NGTTVAVKRLIFN- 306
           F +E   +A   F            + +G G  G V  G L         VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 307 TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL 366
           T +   +F +E +++   +H N++ L G   +    +++ E++ N SLD F+   +    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 367 LNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD 426
               +   ++ G A G+ YL    +   +HRD+   NIL++ +   K++DFGL+R    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 427 RTHVST 432
            +  + 
Sbjct: 182 TSDPTY 187

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-38
 Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 9/173 (5%)

Query: 268 KATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSI 324
           +A +Y      +G G  G         +G  +  K L     T        +EVNL+  +
Sbjct: 2   RAEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 325 EHKNLVKLLGCSIEGPESLL--VYEYVPNRSLDQFIFDKNKTK-LLNWNKRFNIILGTAE 381
           +H N+V+     I+   + L  V EY     L   I    K +  L+      ++     
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 382 GLAYLH--GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
            L   H        ++HRD+K +N+ LD     K+ DFGLAR    D +    
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 9e-38
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 10/174 (5%)

Query: 268 KATNYFNPSKKLGQGGAGSVYMG---SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
           K  N      +LG G  GSV  G          VA+K L     +   +E   E  ++  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           +++  +V+L+G   +    +LV E      L +F+  K +   +  +    ++   + G+
Sbjct: 66  LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            YL    E   +HRD+   N+LL      KI+DFGL++   AD ++ +   AG 
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-37
 Identities = 48/169 (28%), Positives = 70/169 (41%), Gaps = 9/169 (5%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLV 330
           ++  + LG+G  G V +  +      VAVK + +       +    E+ +   + H+N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
           K  G   EG    L  EY     L   I        +              G+ YLH   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH--- 120

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD-RTHVSTAVAGTL 438
              I HRDIK  N+LLD+    KI+DFGLA  F  + R  +   + GTL
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-37
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 14/178 (7%)

Query: 264 ETLEKATNYFNPSKK------LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFN 316
           E L    +  +P KK      +GQG +G+VY    +  G  VA++++    +   +   N
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNII 376
           E+ ++   ++ N+V  L   + G E  +V EY+   SL   + +          +   + 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVC 122

Query: 377 LGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
               + L +LH     ++IHRDIK+ NILL  D + K+ DFG       +++  ST V
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 8e-37
 Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 20/184 (10%)

Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN---GTTVAVKRL--IFNTRQWVDE 313
           L  K  TLE         K+LG G  G+V  G         TVAVK L    N     DE
Sbjct: 3   LDRKLLTLE--------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 54

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              E N++  +++  +V+++G   E    +LV E      L++++        +      
Sbjct: 55  LLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNII 110

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA 433
            ++   + G+ YL    E+  +HRD+   N+LL      KI+DFGL++   AD  +    
Sbjct: 111 ELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167

Query: 434 VAGT 437
             G 
Sbjct: 168 THGK 171

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 8e-37
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 10/161 (6%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F   + LG+G  G+VY+     +   +A+K L            +   EV + S + H N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           +++L G   +     L+ EY P  ++ + +   +K    +  +    I   A  L+Y H 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH- 123

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
               R+IHRDIK  N+LL      KIADFG +    + R  
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 8e-37
 Identities = 50/179 (27%), Positives = 72/179 (40%), Gaps = 26/179 (14%)

Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQW-VDEFFNEVNLISSIE-HKN 328
           K LG G  G V   +           TVAVK L  +      +   +E+ ++S +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL---------------LNWNKRF 373
           +V LLG    G  +L++ EY     L  F+  K  + +               L+     
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           +     A+G+A+L        IHRD+   NILL      KI DFGLAR    D  +V  
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFF-NEVNLISSIEHKNLVKLLGC 335
           + +G+G  G V+ G    G  VAVK    ++R+    F   E+     + H+N++  +  
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 336 SIEGPESL----LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH---- 387
             +   +     LV +Y  + SL  ++        +       + L TA GLA+LH    
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 388 -GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTA---VAGTL 438
               +  I HRD+K+ NIL+ K+ T  IAD GLA    +    +  A     GT 
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  134 bits (339), Expect = 2e-36
 Identities = 34/159 (21%), Positives = 68/159 (42%), Gaps = 8/159 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           ++LG G  G V+       G   A K ++       +    E+  +S + H  LV L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
             +  E +++YE++    L + + D++    ++ ++    +    +GL ++H   E   +
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYV 146

Query: 396 HRDIKTSNILL--DKDFTPKIADFGLARCFAADRTHVST 432
           H D+K  NI+    +    K+ DFGL       ++   T
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 6e-36
 Identities = 42/191 (21%), Positives = 69/191 (36%), Gaps = 32/191 (16%)

Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQ-WVDEFFNEVNLISSIE-HKN 328
           K LG G  G V   +            VAVK L         +   +E+ +++ +  H+N
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKT--------------------KLLN 368
           +V LLG         L++EY     L  ++  K +                      +L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 369 WNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT 428
           +          A+G+ +L        +HRD+   N+L+      KI DFGLAR   +D  
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 429 HVS-TAVAGTL 438
           +V        +
Sbjct: 220 YVVRGNARLPV 230

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-35
 Identities = 53/175 (30%), Positives = 75/175 (42%), Gaps = 15/175 (8%)

Query: 273 FNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIE 325
               +KLG G  G V  G          +VAVK L   + +  + +D+F  EVN + S++
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           H+NL++L G  +  P   +V E  P  SL   +       LL    R    +  AEG+ Y
Sbjct: 70  HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGY 126

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH--VSTAVAGTL 438
           L      R IHRD+   N+LL      KI DFGL R    +  H  +        
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 15/175 (8%)

Query: 272 YFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKN 328
           +     ++G+G   +VY G        VA   L     T+     F  E  ++  ++H N
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 329 LVKLLGCSIEGPES----LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLA 384
           +V+         +     +LV E + + +L  ++    + K++      +      +GL 
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQ 126

Query: 385 YLHGGSETRIIHRDIKTSNILL-DKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
           +LH  +   IIHRD+K  NI +     + KI D GLA      R   + AV GT 
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTP 177

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-35
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 14/188 (7%)

Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQ-WVDEF 314
           + ++  +  ++   + ++ +G+G  G VY G+L +        AVK L   T    V +F
Sbjct: 16  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75

Query: 315 FNEVNLISSIEHKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
             E  ++    H N++ LLG  +    S L+V  Y+ +  L  FI   N+T         
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLI 133

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA---ADRTHV 430
              L  A+G+ +L      + +HRD+   N +LD+ FT K+ADFGLAR       D  H 
Sbjct: 134 GFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 431 STAVAGTL 438
            T     +
Sbjct: 191 KTGAKLPV 198

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-34
 Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 5/165 (3%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHK 327
              +     +G+G  G V       N   VA+K++  F  + +      E+ ++    H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
           N++ +           +   Y+    +   ++   KT+ L+ +     +     GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
                 ++HRD+K SN+LL+     KI DFGLAR    D  H   
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 5e-34
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 13/182 (7%)

Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSLPNGT-----TVAVKRL-IFNTRQWVDEFFNEV 318
           T E   +     K +G G  G VY G L   +      VA+K L    T +   +F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILG 378
            ++    H N+++L G   +    +++ EY+ N +LD+F+ +K+     +  +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRG 118

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD--RTHVSTAVAG 436
            A G+ YL        +HRD+   NIL++ +   K++DFGL+R    D   T+ ++    
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 437 TL 438
            +
Sbjct: 176 PI 177

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 6e-34
 Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 11/166 (6%)

Query: 277 KKLGQGGAGSVYMGSLPN----GTTVAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNLVK 331
           + +G+G  G V+ G   +       VA+K     T   V ++F  E   +   +H ++VK
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE 391
           L+G   E P   ++ E      L  F+  +  +  L+           +  LAYL     
Sbjct: 73  LIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE---S 126

Query: 392 TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            R +HRDI   N+L+  +   K+ DFGL+R       + ++     
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 37/168 (22%), Positives = 67/168 (39%), Gaps = 13/168 (7%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLIS---S 323
           N F+  + +G+GG G VY       G   A+K L       +Q      NE  ++S   +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
            +   +V +        +   + + +    L   +         +             GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS 431
            ++H      +++RD+K +NILLD+    +I+D GLA  F+  + H S
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  126 bits (318), Expect = 2e-33
 Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 8/162 (4%)

Query: 271 NYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           +Y++  ++LG G  G V+       G     K +            NE+++++ + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           + L     +  E +L+ E++    L   I  ++    ++  +  N +    EGL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144

Query: 390 SETRIIHRDIKTSNILLDKDFTP--KIADFGLARCFAADRTH 429
            E  I+H DIK  NI+ +       KI DFGLA     D   
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-33
 Identities = 41/164 (25%), Positives = 62/164 (37%), Gaps = 10/164 (6%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F   K LG+G   +V +   L      A+K L          V     E +++S ++H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
            VKL     +  +      Y  N  L ++I         +              L YLH 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH- 125

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
                IIHRD+K  NILL++D   +I DFG A+  + +      
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 4e-33
 Identities = 41/184 (22%), Positives = 73/184 (39%), Gaps = 23/184 (12%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPNG---TTVAVKRL-IFNTRQWVDEFFNEVNLISSIE-HK 327
                 +G+G  G V    +         A+KR+  + ++    +F  E+ ++  +  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFI-------------FDKNKTKLLNWNKRFN 374
           N++ LLG         L  EY P+ +L  F+                +    L+  +  +
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
                A G+ YL    + + IHRD+   NIL+ +++  KIADFGL+R          T  
Sbjct: 132 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186

Query: 435 AGTL 438
              +
Sbjct: 187 RLPV 190

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-32
 Identities = 43/173 (24%), Positives = 80/173 (46%), Gaps = 13/173 (7%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTT----VAVKRL-IFNTRQWVDEFFNEVNLISSIEH 326
           F   K LG G  G+VY G  +P G      VA+K L    + +   E  +E  +++S+++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
            ++ +LLG  +      L+ + +P   L  ++ +             N  +  A+G+ YL
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA-DRTHVSTAVAGTL 438
               + R++HRD+   N+L+      KI DFGLA+   A ++ + +      +
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  120 bits (301), Expect = 9e-32
 Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 19/176 (10%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---------IFNTRQWVDEFFNEVNLIS 322
           + P + LG+G +  V      P     AVK +             ++  +    EV+++ 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 323 SI-EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
            +  H N+++L           LV++ +    L  ++ +K     L+  +   I+    E
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLE 121

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
            +  LH   +  I+HRD+K  NILLD D   K+ DFG +     D       V GT
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGT 172

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 8/160 (5%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
           +K+G+G  G VY      G T A+K  RL             E++++  ++H N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
                   +LV+E++           +     L      + +L    G+AY H   + R+
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 395 IHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +HRD+K  N+L++++   KIADFGLAR F       +  +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 4e-31
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)

Query: 273 FNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL-IFNTRQWVDEFFNEVNLISSIE 325
              S++LGQG  G VY G           T VA+K +    + +   EF NE +++    
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKL-------LNWNKRFNIILG 378
             ++V+LLG   +G  +L++ E +    L  ++                + +K   +   
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 379 TAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF-AADRTHVSTAVAGT 437
            A+G+AYL+     + +HRD+   N ++ +DFT KI DFG+ R     D           
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 45/168 (26%), Positives = 67/168 (39%), Gaps = 15/168 (8%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
           +  +K +G G  G VY      +G  VA+K++     Q       E+ ++  ++H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77

Query: 332 LLGCSIEGPES------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
           L        E        LV +YVP              + L        +      LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 386 LHGGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVST 432
           +H      I HRDIK  N+LLD D    K+ DFG A+       +VS 
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-30
 Identities = 33/159 (20%), Positives = 62/159 (38%), Gaps = 9/159 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           + LG+G  G V+      +  T   K +             E+++++   H+N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69

Query: 336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRII 395
                E ++++E++    + + I        LN  +  + +    E L +LH      I 
Sbjct: 70  FESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 396 HRDIKTSNILLD--KDFTPKIADFGLARCFAADRTHVST 432
           H DI+  NI+    +  T KI +FG AR           
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-30
 Identities = 46/185 (24%), Positives = 66/185 (35%), Gaps = 26/185 (14%)

Query: 277 KKLGQGGAGSVYMG------SLPNGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNL 329
           K LG+G  G V               TVAVK L    T        +E+ ++  I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 330 VKLLG--CSIEGPESLLVYEYVPNRSLDQFIFDKNKT-------------KLLNWNKRFN 374
           V  L   C+  G   +++ E+    +L  ++  K                  L       
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 375 IILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV-STA 433
                A+G+ +L      + IHRD+   NILL +    KI DFGLAR    D  +V    
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 434 VAGTL 438
               L
Sbjct: 196 ARLPL 200

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 26/179 (14%)

Query: 277 KKLGQGGAGSVYMGSLP--------NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSI-EH 326
           K LG+G  G V +              T VAVK L    T + + +  +E+ ++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDK-------------NKTKLLNWNKRF 373
           KN++ LLG   +     ++ EY    +L +++  +             N  + L+     
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVST 432
           +     A G+ YL      + IHRD+   N+L+ +D   KIADFGLAR       +  T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 5e-30
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 8/165 (4%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNL 329
           F   +K+G+G  G VY   +   G  VA+K  RL   T         E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG 389
           VKLL       +  LV+E++          D +    +      + +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 390 SETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
              R++HRD+K  N+L++ +   K+ADFGLAR F       +  V
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (289), Expect = 9e-30
 Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 10/158 (6%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
           + LG G  G V++  S  NG   A+K L   I    + V+   +E  ++S + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
            G   +  +  ++ +Y+    L   +    +                   L YLH     
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLH---SK 123

Query: 393 RIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV 430
            II+RD+K  NILLDK+   KI DFG A+        +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (288), Expect = 1e-29
 Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 13/181 (7%)

Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNL 320
           ++  E   + ++    LG G    V +         VA+K +     +  +    NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTA 380
           +  I+H N+V L      G    L+ + V    L   I +K             +I    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 117

Query: 381 EGLAYLHGGSETRIIHRDIKTSNILL---DKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
           + + YLH   +  I+HRD+K  N+L    D+D    I+DFGL++    D   V +   GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172

Query: 438 L 438
            
Sbjct: 173 P 173

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 12/164 (7%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLV 330
             LG+G   +VY          VA+K++    R    +        E+ L+  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGS 390
            LL          LV++++           K+ + +L  +     +L T +GL YLH   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLH--- 117

Query: 391 ETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           +  I+HRD+K +N+LLD++   K+ADFGLA+ F +     +  V
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 46/170 (27%), Positives = 68/170 (40%), Gaps = 12/170 (7%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLIS-SIEHK 327
           F   K LG+G  G V++          A+K L   +      V+    E  ++S + EH 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            L  +            V EY+    L   I   +K    + ++          GL +LH
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120

Query: 388 GGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
                 I++RD+K  NILLDKD   KIADFG+ +         +T   GT
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GT 166

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  110 bits (276), Expect = 3e-28
 Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 16/178 (8%)

Query: 270 TNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIE 325
           ++ +   + LG GG   V++   L     VAVK L   +     +   F  E    +++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 326 HKNLVKLLGCSIE----GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAE 381
           H  +V +          GP   +V EYV   +L   +  +     +   +   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 382 GLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV--STAVAGT 437
            L + H   +  IIHRD+K +NI++      K+ DFG+AR  A     V  + AV GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 7e-27
 Identities = 45/181 (24%), Positives = 72/181 (39%), Gaps = 15/181 (8%)

Query: 268 KATNYFNPSKKLGQGGAGSVYMG--SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL--- 320
           +A   +    ++G+G  G V+        G  VA+KR+               EV +   
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQ---FIFDKNKTKLLNWNKRFNIIL 377
           + + EH N+V+L                +    +DQ      DK     +      +++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 378 GTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGT 437
               GL +LH     R++HRD+K  NIL+      K+ADFGLAR +        T+V  T
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 178

Query: 438 L 438
           L
Sbjct: 179 L 179

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 9/161 (5%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVK--RLIFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
           +K+G+G  G+V+   +      VA+K  RL  +          E+ L+  ++HKN+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR 393
                  +  LV+E+        F          +     + +    +GL + H      
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 394 IIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAV 434
           ++HRD+K  N+L++++   K+A+FGLAR F       S  V
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 2e-26
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 20/176 (11%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
            K+GQG  G V+       G  VA+K+++       +      E+ ++  ++H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 334 GCSIEGPES--------LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAY 385
                             LV+++  +           K      ++   ++     GL Y
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYY 132

Query: 386 LHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT---HVSTAVAGTL 438
           +H     +I+HRD+K +N+L+ +D   K+ADFGLAR F+  +    +  T    TL
Sbjct: 133 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-26
 Identities = 43/170 (25%), Positives = 66/170 (38%), Gaps = 11/170 (6%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKN 328
           F+  K LG+G  G V +      G   A+K L   +   +  V     E  ++ +  H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHG 388
           L  L            V EY     L   +   ++ ++    +           L YLH 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 389 GSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
                +++RDIK  N++LDKD   KI DFGL +   +D   + T   GT 
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 5e-26
 Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 22/188 (11%)

Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL------IFNTRQWVDE 313
           F+ E ++   +Y++  ++LG G    V        G   A K +              ++
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRF 373
              EV+++  I+H N++ L        + +L+ E V    L  F+ +K     L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116

Query: 374 NIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP----KIADFGLARCFAADRTH 429
             +     G+ YLH     +I H D+K  NI+L     P    KI DFGLA     D  +
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGN 171

Query: 430 VSTAVAGT 437
               + GT
Sbjct: 172 EFKNIFGT 179

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 7e-26
 Identities = 38/188 (20%), Positives = 67/188 (35%), Gaps = 27/188 (14%)

Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD 312
           +KK+ +   Y+   +          LG G  G V    +       A+K L     Q   
Sbjct: 4   IKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKML-----QDCP 49

Query: 313 EFFNEVN-LISSIEHKNLVKLLGC----SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLL 367
           +   EV     + +  ++V+++             L+V E +    L   I D+      
Sbjct: 50  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF- 108

Query: 368 NWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGLARCFA 424
              +   I+    E + YLH      I HRD+K  N+L      +   K+ DFG A+   
Sbjct: 109 TEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165

Query: 425 ADRTHVST 432
           +  +  + 
Sbjct: 166 SHNSLTTP 173

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (255), Expect = 3e-25
 Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 13/159 (8%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG- 334
           +K+G G  G +Y+G  +  G  VA+K     T+    +   E  +   ++    +  +  
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
           C  EG  +++V E +     D F F   K    +      +       + Y+H       
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH---SKNF 124

Query: 395 IHRDIKTSNIL---LDKDFTPKIADFGLARCFAADRTHV 430
           IHRD+K  N L     K     I DFGLA+ +   RTH 
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 43/198 (21%), Positives = 73/198 (36%), Gaps = 22/198 (11%)

Query: 237 LSKMKEDRNNLGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNG 295
           L+K KED           K    S     L++    F+  K LG G  G V +     +G
Sbjct: 19  LAKAKEDFLK--------KWETPSQNTAQLDQ----FDRIKTLGTGSFGRVMLVKHKESG 66

Query: 296 TTVAVKRL---IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNR 352
              A+K L        + ++   NE  ++ ++    LVKL     +     +V EYV   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 353 SLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP 412
            +   +    +    +                YLH      +I+RD+K  N+L+D+    
Sbjct: 127 EMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180

Query: 413 KIADFGLARCFAADRTHV 430
           ++ DFG A+        +
Sbjct: 181 QVTDFGFAKRVKGRTWTL 198

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 2e-24
 Identities = 39/171 (22%), Positives = 61/171 (35%), Gaps = 18/171 (10%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL------IFNTRQWVDEFFNEVNLISSI--EHK 327
             LG GG GSVY G  + +   VA+K +       +           EV L+  +     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 328 NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLH 387
            +++LL         +L+ E             +     L      +      E + + H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH 127

Query: 388 GGSETRIIHRDIKTSNILLDKD-FTPKIADFGLARCFAADRTHVSTAVAGT 437
                 ++HRDIK  NIL+D +    K+ DFG        +  V T   GT
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGT 172

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 4e-24
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 7/170 (4%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
           +T  +    +   + +G G  G+V        G  VA+K+L   F +  +    + E+ L
Sbjct: 11  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYE-YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           +  + H+N++ LL             + Y+    +   +    K + L  ++   ++   
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
            +GL Y+H      IIHRD+K  N+ +++D   KI DFGLAR   ++ T 
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 177

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 98.7 bits (245), Expect = 7e-24
 Identities = 27/160 (16%), Positives = 58/160 (36%), Gaps = 15/160 (9%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLG 334
           +++G+G  G ++ G +L N   VA+K      R    +  +E      +     +  +  
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRI 394
              EG  ++LV + +               +  +              +  +H   E  +
Sbjct: 69  FGQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 122

Query: 395 IHRDIKTSNILLDKDFTP-----KIADFGLARCFAADRTH 429
           ++RDIK  N L+ +  +       + DFG+ + +    T 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 4e-23
 Identities = 42/173 (24%), Positives = 64/173 (36%), Gaps = 15/173 (8%)

Query: 273 FNPSKKLGQGGAGSVYMG----SLPNGTTVAVKRL----IFNTRQWVDEFFNEVNLISSI 324
           F   K LG G  G V++         G   A+K L    I    +  +    E  ++  I
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 325 EHK-NLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
                LV L        +  L+ +Y+    L   +  + +                 E +
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GEIV 139

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAG 436
             L    +  II+RDIK  NILLD +    + DFGL++ F AD T  +    G
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 92.6 bits (229), Expect = 2e-21
 Identities = 34/158 (21%), Positives = 65/158 (41%), Gaps = 17/158 (10%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLG 334
           +KLG+G    V+   ++ N   V VK L         +   E+ ++ ++    N++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 335 CSIEGPESL--LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSET 392
              +       LV+E+V N    Q        + L        +    + L Y H     
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SM 148

Query: 393 RIIHRDIKTSNILLD-KDFTPKIADFGLARCFAADRTH 429
            I+HRD+K  N+++D +    ++ D+GLA  +   + +
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 3e-21
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 7/170 (4%)

Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNL 320
           +T+ +    +     +G G  GSV        G  VAVK+L   F +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 321 ISSIEHKNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGT 379
           +  ++H+N++ LL   +           Y+    +   + +  K + L  +    +I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 380 AEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH 429
             GL Y+H      IIHRD+K SN+ +++D   KI DFGLAR    + T 
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.8 bits (224), Expect = 9e-21
 Identities = 45/175 (25%), Positives = 70/175 (40%), Gaps = 20/175 (11%)

Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNL 329
           +   K +G G  G V           VA+K+L   F  +      + E+ L+  + HKN+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 330 VKLLGCSI------EGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGL 383
           + LL          E  +  LV E +          + +        +   ++     G+
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGI 132

Query: 384 AYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVSTAVAGTL 438
            +LH      IIHRD+K SNI++  D T KI DFGLAR      + + T    T 
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTR 182

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 5e-20
 Identities = 30/155 (19%), Positives = 55/155 (35%), Gaps = 20/155 (12%)

Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVK---------RLIFNTRQWVD-EFFNEVNLISSIEH 326
           K +G+G   +V+           VK         + +   R + D  F       +  E 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 327 KNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYL 386
           + L KL G ++        Y +  N  L + I  K   ++   N    ++    E +A  
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 387 HGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR 421
           +      I+H D+   N+L+  +    I DF  + 
Sbjct: 120 Y---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 77.4 bits (189), Expect = 3e-16
 Identities = 32/168 (19%), Positives = 59/168 (35%), Gaps = 18/168 (10%)

Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
           +KLG G   +V++   + N T VA+K  +   + + +   +E+ L+  +   +  K    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 336 SIEGPESLLVYEYVPNRSLDQF-------------IFDKNKTKLLNWNKRFNIILGTAEG 382
                  LL +      +                 +  K + + +       I      G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 383 LAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGLARCFAADRTH 429
           L Y+H      IIH DIK  N+L++  D    +    +A    A    
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	438
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.98
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.98
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.98
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.96
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.94
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.34
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.85
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.98

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=276.60  Aligned_cols=160  Identities=26%  Similarity=0.468  Sum_probs=142.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      ++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+++..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999964 579999999998766556778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCce
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~  429 (438)
                      ++|+|.+++..    ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+|+.+..+...
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999998843    35899999999999999999999   899999999999999999999999999999988655433


Q ss_pred             eeeeeeecC
Q 013693          430 VSTAVAGTL  438 (438)
Q Consensus       430 ~~~~~~Gt~  438 (438)
                      . ...+||+
T Consensus       173 ~-~~~~gt~  180 (293)
T d1yhwa1         173 R-STMVGTP  180 (293)
T ss_dssp             B-CCCCSCG
T ss_pred             c-cccccCC
Confidence            2 2345664

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-36  Score=277.04  Aligned_cols=162  Identities=29%  Similarity=0.388  Sum_probs=139.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5688999999999999999954 578999999997543 33456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCc
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      +++|+|.+++..   ...+++.++..++.||++||.|||   +.+|+||||||+|||+++++.+||+|||+|+.+..+..
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999843   346999999999999999999999   89999999999999999999999999999998865443


Q ss_pred             e-eeeeeeecC
Q 013693          429 H-VSTAVAGTL  438 (438)
Q Consensus       429 ~-~~~~~~Gt~  438 (438)
                      . ..+..+||+
T Consensus       159 ~~~~~~~~GT~  169 (271)
T d1nvra_         159 ERLLNKMCGTL  169 (271)
T ss_dssp             ECCBCCCCSCG
T ss_pred             cccccceeeCc
Confidence            2 334567875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-36  Score=281.78  Aligned_cols=168  Identities=28%  Similarity=0.419  Sum_probs=145.9

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      +++...++|++.+.||+|+||.||+|.+ .+++.||||+++.+. ...++|.+|+.+|++++|||||++++++.+++..+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            4445567788899999999999999965 458899999987543 34678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |||||+++|+|.+++... ....+++..++.|+.||++||.|||   +.+|+||||||+||||+.++.+||+|||+|+..
T Consensus        90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            999999999999998653 3456899999999999999999999   889999999999999999999999999999988


Q ss_pred             cCCCceeeeeeeec
Q 013693          424 AADRTHVSTAVAGT  437 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt  437 (438)
                      ..+.....+...||
T Consensus       166 ~~~~~~~~~~~~g~  179 (287)
T d1opja_         166 TGDTYTAHAGAKFP  179 (287)
T ss_dssp             CSSSSEEETTEEEC
T ss_pred             CCCCceeecccccc
Confidence            77665554445555

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-35  Score=272.87  Aligned_cols=162  Identities=27%  Similarity=0.454  Sum_probs=131.1

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      ++|+..+.||+|+||.||+|.+.+++.||||++.... ...++|.+|++++++++||||++++|++..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4678889999999999999998888899999997543 335679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCcee
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~  430 (438)
                      +|+|.+++..  ....+++..++.|+.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999854  3456899999999999999999999   8999999999999999999999999999999886655444


Q ss_pred             eeeeeecC
Q 013693          431 STAVAGTL  438 (438)
Q Consensus       431 ~~~~~Gt~  438 (438)
                      .....||+
T Consensus       159 ~~~~~gt~  166 (263)
T d1sm2a_         159 STGTKFPV  166 (263)
T ss_dssp             ------CT
T ss_pred             ecceecCc
Confidence            44445653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=276.13  Aligned_cols=166  Identities=32%  Similarity=0.489  Sum_probs=141.3

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +...++|++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|+.++++++|||||+++|++.+ +..+|||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            33456788899999999999999998888899999997543 345679999999999999999999998754 5679999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++... ....+++.+++.|+.||++||.|||   +.+|+||||||+||||++++.+||+|||+|+.+...
T Consensus        87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999987543 2335899999999999999999999   899999999999999999999999999999998765


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      .....+...||+
T Consensus       163 ~~~~~~~~~gt~  174 (272)
T d1qpca_         163 EYTAREGAKFPI  174 (272)
T ss_dssp             CEECCTTCCCCT
T ss_pred             ccccccccCCcc
Confidence            544444445553

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-35  Score=274.52  Aligned_cols=150  Identities=26%  Similarity=0.445  Sum_probs=137.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +.|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4588889999999999999954 578999999998777777889999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      ++|+|.+++.+.  ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999987543  345999999999999999999999   89999999999999999999999999999987643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-35  Score=272.96  Aligned_cols=163  Identities=32%  Similarity=0.481  Sum_probs=134.0

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ...++|++.+.||+|+||.||+|.++  ..||||+++..  +....+.|.+|+.++++++|||||++++++. .+..+||
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence            34577999999999999999999864  36999998754  4556788999999999999999999999875 4568999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++|+|.+++...  ...+++.+++.|+.||++||+|||   +.+||||||||+|||++.++.+||+|||+|+....
T Consensus        82 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          82 TQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            9999999999999543  345999999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCce-eeeeeeecC
Q 013693          426 DRTH-VSTAVAGTL  438 (438)
Q Consensus       426 ~~~~-~~~~~~Gt~  438 (438)
                      .... ..+...||+
T Consensus       157 ~~~~~~~~~~~gt~  170 (276)
T d1uwha_         157 WSGSHQFEQLSGSI  170 (276)
T ss_dssp             ---------CCCCG
T ss_pred             cCCcccccccccCc
Confidence            4332 223456664

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=266.32  Aligned_cols=159  Identities=30%  Similarity=0.439  Sum_probs=138.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4688899999999999999955 56899999998743   2334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++..   ...+++.++..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999954   345899999999999999999999   899999999999999999999999999999877654


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ..   ....||+
T Consensus       160 ~~---~~~~Gt~  168 (263)
T d2j4za1         160 RR---TTLCGTL  168 (263)
T ss_dssp             CC---EETTEEG
T ss_pred             cc---cccCCCC
Confidence            32   2345664

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-34  Score=262.20  Aligned_cols=161  Identities=24%  Similarity=0.386  Sum_probs=141.5

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVP  350 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  350 (438)
                      ++|+..++||+|+||.||+|.+++++.||||+++.... ..++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            67899999999999999999988888999999976433 35689999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCcee
Q 013693          351 NRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHV  430 (438)
Q Consensus       351 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~  430 (438)
                      +|+|.+++...  ...+++..++.++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+|+.+.......
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999997543  445889999999999999999999   8899999999999999999999999999999876554433


Q ss_pred             eeeeeec
Q 013693          431 STAVAGT  437 (438)
Q Consensus       431 ~~~~~Gt  437 (438)
                      .+...||
T Consensus       158 ~~~~~~t  164 (258)
T d1k2pa_         158 SVGSKFP  164 (258)
T ss_dssp             CCCSCCC
T ss_pred             ecccCCC
Confidence            3333444

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=269.36  Aligned_cols=162  Identities=26%  Similarity=0.340  Sum_probs=138.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|.. .+++.||||++...   .....+.+.+|++++++++||||+++++++.+++..+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5688999999999999999954 57899999999753   2334567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998854   345899999999999999999999   899999999999999999999999999999988754


Q ss_pred             Cce-eeeeeeecC
Q 013693          427 RTH-VSTAVAGTL  438 (438)
Q Consensus       427 ~~~-~~~~~~Gt~  438 (438)
                      ... .....+||+
T Consensus       162 ~~~~~~~~~~GT~  174 (288)
T d1uu3a_         162 SKQARANSFVGTA  174 (288)
T ss_dssp             --------CCCCG
T ss_pred             CcccccccccCCc
Confidence            433 233466774

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-35  Score=278.61  Aligned_cols=160  Identities=25%  Similarity=0.382  Sum_probs=139.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.++||+|+||.||+|.. .+++.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            56799999999999999999964 57899999999754 34446789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSE-TRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      |+++|+|.+++.+.   ..+++..+..++.||+.||.|||   + .+|+||||||+|||++.++++||+|||+|+.+...
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            99999999999543   45899999999999999999999   5 48999999999999999999999999999987543


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ..   +..+||+
T Consensus       159 ~~---~~~~GT~  167 (322)
T d1s9ja_         159 MA---NSFVGTR  167 (322)
T ss_dssp             TC------CCSS
T ss_pred             cc---ccccCCc
Confidence            22   2356764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-34  Score=270.04  Aligned_cols=151  Identities=28%  Similarity=0.516  Sum_probs=124.5

Q ss_pred             CCCCCCccccCCceeEEEEEccC-C---CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSLPN-G---TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +|++.++||+|+||.||+|.+.. +   ..||||++... .....++|.+|+.+|++++|||||+++|++..++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            34556899999999999997642 2   25889988654 4455678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++..  ....+++.+++.|+.||++||.|||   +.+|+||||||+||||+.++++||+|||+|+.+..+
T Consensus       107 Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             ECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999998854  3345899999999999999999999   899999999999999999999999999999988654


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       182 ~  182 (299)
T d1jpaa_         182 T  182 (299)
T ss_dssp             -
T ss_pred             C
Confidence            4

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=267.11  Aligned_cols=167  Identities=25%  Similarity=0.376  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--GPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  345 (438)
                      ++|++.+.||+|+||.||+|. ..+++.||||++...  .+...+.+.+|++++++++||||+++++++.+  ++..+||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            568899999999999999995 457899999999754  34456779999999999999999999999865  4568999


Q ss_pred             EeccCCCCHHHHhhccC-CCCcCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          346 YEYVPNRSLDQFIFDKN-KTKLLNWNKRFNIILGTAEGLAYLHGGS--ETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      |||+++|+|.+++.... ....+++..++.++.||+.||.|||+..  ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999985432 3456999999999999999999999321  13599999999999999999999999999999


Q ss_pred             ccCCCceeeeeeeecC
Q 013693          423 FAADRTHVSTAVAGTL  438 (438)
Q Consensus       423 ~~~~~~~~~~~~~Gt~  438 (438)
                      +..+.... +...|||
T Consensus       164 ~~~~~~~~-~~~~gt~  178 (269)
T d2java1         164 LNHDTSFA-KAFVGTP  178 (269)
T ss_dssp             C------------CCC
T ss_pred             cccCCCcc-ccCCCCc
Confidence            86554332 3456775

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-33  Score=269.82  Aligned_cols=154  Identities=26%  Similarity=0.346  Sum_probs=138.4

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||+|. ..+++.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3569999999999999999995 457999999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kl~DFGla~~~~~~  426 (438)
                      +++|+|.+++..  ....+++.++..|+.||+.||.|||   +.+|+||||||+||||+  .++.+||+|||+|+.+..+
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999988743  3445999999999999999999999   89999999999999997  6789999999999998765


Q ss_pred             Cc
Q 013693          427 RT  428 (438)
Q Consensus       427 ~~  428 (438)
                      ..
T Consensus       183 ~~  184 (352)
T d1koba_         183 EI  184 (352)
T ss_dssp             SC
T ss_pred             Cc
Confidence            43

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-33  Score=269.95  Aligned_cols=162  Identities=22%  Similarity=0.364  Sum_probs=142.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45799999999999999999954 57899999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCCCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD--KDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kl~DFGla~~~~~~  426 (438)
                      +++|+|.+++.+  ....+++.++..|+.||+.||.|||   +.+||||||||+|||++  .++.+||+|||+|+.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999853  2345999999999999999999999   89999999999999995  4678999999999988655


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ...  ....||+
T Consensus       180 ~~~--~~~~gT~  189 (350)
T d1koaa2         180 QSV--KVTTGTA  189 (350)
T ss_dssp             SCE--EEECSCT
T ss_pred             ccc--ceecCcc
Confidence            433  3355664

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=268.99  Aligned_cols=162  Identities=29%  Similarity=0.456  Sum_probs=132.1

Q ss_pred             hcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      .++|++.+.||+|+||.||+|.++++++||||++.... ...+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            46788999999999999999988888899999996443 34578999999999999999999999985 45689999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCce
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~  429 (438)
                      ++|+|..++... ....++|.+++.|+.||+.||.|||   +.+|+||||||+||||+.++++||+|||+|+.+......
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            999999988543 2345999999999999999999999   889999999999999999999999999999988655443


Q ss_pred             eeeeeeec
Q 013693          430 VSTAVAGT  437 (438)
Q Consensus       430 ~~~~~~Gt  437 (438)
                      ..+...||
T Consensus       170 ~~~~~~gt  177 (285)
T d1fmka3         170 ARQGAKFP  177 (285)
T ss_dssp             ------CC
T ss_pred             eecccccc
Confidence            33334454

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-33  Score=259.61  Aligned_cols=157  Identities=27%  Similarity=0.343  Sum_probs=132.2

Q ss_pred             CCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeEEEE
Q 013693          273 FNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE----GPESLLV  345 (438)
Q Consensus       273 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  345 (438)
                      |+..++||+|+||.||+|.. .+++.||+|++...  .....+.|.+|+++|++++|||||++++++..    +...+||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            35556899999999999954 56889999998754  34456789999999999999999999999875    3468999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeC-CCCCeEEeccccccc
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETR--IIHRDIKTSNILLD-KDFTPKIADFGLARC  422 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kl~DFGla~~  422 (438)
                      |||+++|+|.+++..   ...+++.++..++.||++||.|||   +.+  |+||||||+|||++ +++.+||+|||+|+.
T Consensus        91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            999999999999954   345899999999999999999999   666  99999999999996 578999999999987


Q ss_pred             ccCCCceeeeeeeecC
Q 013693          423 FAADRTHVSTAVAGTL  438 (438)
Q Consensus       423 ~~~~~~~~~~~~~Gt~  438 (438)
                      ......   ...+|||
T Consensus       165 ~~~~~~---~~~~GT~  177 (270)
T d1t4ha_         165 KRASFA---KAVIGTP  177 (270)
T ss_dssp             CCTTSB---EESCSSC
T ss_pred             ccCCcc---CCcccCc
Confidence            554332   2456775

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=269.20  Aligned_cols=161  Identities=27%  Similarity=0.291  Sum_probs=141.1

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||++. ..+++.||||++...   .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            568899999999999999995 467999999999754   2344677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999854   345899999999999999999999   899999999999999999999999999999987654


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      ... ....+|||
T Consensus       159 ~~~-~~~~~GT~  169 (337)
T d1o6la_         159 GAT-MKTFCGTP  169 (337)
T ss_dssp             TCC-BCCCEECG
T ss_pred             Ccc-cccceeCH
Confidence            332 23466775

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-34  Score=267.86  Aligned_cols=150  Identities=30%  Similarity=0.526  Sum_probs=133.5

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc---hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT---RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      +.|+..+.||+|+||.||+|. ..+++.||||++....   ....+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            358889999999999999995 5678899999997543   334567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|..++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999999876643   345899999999999999999999   899999999999999999999999999999976543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-34  Score=268.88  Aligned_cols=162  Identities=23%  Similarity=0.336  Sum_probs=124.1

Q ss_pred             HhcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc-hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT-RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ..+.|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            456799999999999999999954 568999999997543 233466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCCeEEecccccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCF  423 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~DFGla~~~  423 (438)
                      ||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||+.   +++.+||+|||+|+..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999954   345999999999999999999999   89999999999999994   5789999999999977


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      .....  ....+||+
T Consensus       161 ~~~~~--~~~~~GT~  173 (307)
T d1a06a_         161 DPGSV--LSTACGTP  173 (307)
T ss_dssp             --------------C
T ss_pred             cCCCe--eeeeeeCc
Confidence            54432  22356775

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-33  Score=260.83  Aligned_cols=152  Identities=26%  Similarity=0.456  Sum_probs=130.8

Q ss_pred             cCCCCCC-ccccCCceeEEEEEcc---CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSK-KLGQGGAGSVYMGSLP---NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|.+.+ +||+|+||.||+|.++   ++..||||+++.. .....++|.+|+++|++++|||||+++|++.. +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455556 4999999999999653   3457999999754 34556789999999999999999999999865 568999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++|+|.+++..  ....+++.++..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999999843  3346999999999999999999999   89999999999999999999999999999998876


Q ss_pred             CCc
Q 013693          426 DRT  428 (438)
Q Consensus       426 ~~~  428 (438)
                      ...
T Consensus       162 ~~~  164 (285)
T d1u59a_         162 DDS  164 (285)
T ss_dssp             CSC
T ss_pred             ccc
Confidence            543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4e-33  Score=263.70  Aligned_cols=158  Identities=26%  Similarity=0.344  Sum_probs=139.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5688899999999999999964 56899999999753   2344678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+|+.+...
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998853   345788899999999999999999   899999999999999999999999999999987644


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      .    +..+||+
T Consensus       158 ~----~~~~Gt~  165 (316)
T d1fota_         158 T----YTLCGTP  165 (316)
T ss_dssp             B----CCCCSCT
T ss_pred             c----ccccCcc
Confidence            3    2356775

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.7e-33  Score=258.98  Aligned_cols=159  Identities=25%  Similarity=0.395  Sum_probs=138.5

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecch---------hhHHHHHHHHHHHhccC-CCceeeEEeEEEeC
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTR---------QWVDEFFNEVNLISSIE-HKNLVKLLGCSIEG  339 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  339 (438)
                      ++|++.+.||+|+||+||++.. .+++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6789999999999999999954 5789999999975421         22346889999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGL  419 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGl  419 (438)
                      +..+|||||+++|+|.+++..   ...+++.++..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999954   345899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCceeeeeeeec
Q 013693          420 ARCFAADRTHVSTAVAGT  437 (438)
Q Consensus       420 a~~~~~~~~~~~~~~~Gt  437 (438)
                      |+.+......  +...||
T Consensus       157 a~~~~~~~~~--~~~~gt  172 (277)
T d1phka_         157 SCQLDPGEKL--REVCGT  172 (277)
T ss_dssp             CEECCTTCCB--CCCCSC
T ss_pred             eeEccCCCce--eeeecc
Confidence            9988654322  234555

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3e-33  Score=260.90  Aligned_cols=153  Identities=29%  Similarity=0.524  Sum_probs=127.9

Q ss_pred             cCCCCCCccccCCceeEEEEEccCC-----CEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNG-----TTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      +.|+..++||+|+||.||+|.++..     ..||||++... .....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577788999999999999976532     37999998654 34445679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+.++++.+++...  ...+++.+++.++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+|+.+.
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999887543  346999999999999999999999   8999999999999999999999999999999886


Q ss_pred             CCCc
Q 013693          425 ADRT  428 (438)
Q Consensus       425 ~~~~  428 (438)
                      .+..
T Consensus       162 ~~~~  165 (283)
T d1mqba_         162 DDPE  165 (283)
T ss_dssp             ----
T ss_pred             CCCc
Confidence            5543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.6e-33  Score=257.48  Aligned_cols=154  Identities=27%  Similarity=0.428  Sum_probs=129.0

Q ss_pred             CccccCCceeEEEEEccC---CCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEeccCC
Q 013693          277 KKLGQGGAGSVYMGSLPN---GTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPN  351 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  351 (438)
                      ++||+|+||.||+|.+++   ++.||||+++..  ++...++|.+|+.+|++++|||||+++|++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999996543   468999998643  33446789999999999999999999999864 567899999999


Q ss_pred             CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCceee
Q 013693          352 RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTHVS  431 (438)
Q Consensus       352 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  431 (438)
                      |+|.+++..   ...+++.+++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+........
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   345899999999999999999999   88999999999999999999999999999998876554433


Q ss_pred             e--eeeec
Q 013693          432 T--AVAGT  437 (438)
Q Consensus       432 ~--~~~Gt  437 (438)
                      +  ...||
T Consensus       166 ~~~~~~gt  173 (277)
T d1xbba_         166 AQTHGKWP  173 (277)
T ss_dssp             C----CCC
T ss_pred             cccccCCC
Confidence            2  34455

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.3e-33  Score=264.35  Aligned_cols=168  Identities=25%  Similarity=0.383  Sum_probs=137.7

Q ss_pred             HHhcCCCCCCccccCCceeEEEEEccC-C-----CEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 013693          268 KATNYFNPSKKLGQGGAGSVYMGSLPN-G-----TTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEG  339 (438)
Q Consensus       268 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  339 (438)
                      ...++|++.++||+|+||.||+|.... +     ..||+|++... .......+.+|+.++.++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            345678899999999999999996543 2     36999988644 344566799999999998 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHhhccCC--------------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC
Q 013693          340 PESLLVYEYVPNRSLDQFIFDKNK--------------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDI  399 (438)
Q Consensus       340 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl  399 (438)
                      +..+|||||+++|+|.++++....                    ...+++.+++.|+.||++||.|||   +.+||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence            999999999999999999965421                    245899999999999999999999   889999999


Q ss_pred             CCCCeeeCCCCCeEEecccccccccCCCcee-eeeeeecC
Q 013693          400 KTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGTL  438 (438)
Q Consensus       400 kp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~  438 (438)
                      ||+|||++.++.+||+|||+|+......... .....||+
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~  230 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV  230 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence            9999999999999999999999876654432 23455664

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-32  Score=256.10  Aligned_cols=152  Identities=26%  Similarity=0.362  Sum_probs=135.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc------hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT------RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPES  342 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  342 (438)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....      ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999965 578999999997532      12357799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----CeEEeccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF----TPKIADFG  418 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~DFG  418 (438)
                      +|||||+++|+|.+++...   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999999543   45999999999999999999999   89999999999999998776    59999999


Q ss_pred             ccccccCCC
Q 013693          419 LARCFAADR  427 (438)
Q Consensus       419 la~~~~~~~  427 (438)
                      +|+.+....
T Consensus       163 ~a~~~~~~~  171 (293)
T d1jksa_         163 LAHKIDFGN  171 (293)
T ss_dssp             TCEECTTSC
T ss_pred             hhhhcCCCc
Confidence            999876543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=4.8e-33  Score=261.93  Aligned_cols=161  Identities=32%  Similarity=0.501  Sum_probs=139.7

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEE
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCS  336 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  336 (438)
                      .+++...++|++.+.||+|+||.||+|.+.      +++.||||++... .....++|.+|+.+|++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556788999999999999999999753      3578999999754 334467899999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHhhccC---------------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 013693          337 IEGPESLLVYEYVPNRSLDQFIFDKN---------------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRII  395 (438)
Q Consensus       337 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii  395 (438)
                      ...+..++||||+++|+|.++++...                     ....+++.+++.|+.|++.||+|||   +.+||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence            99999999999999999999986422                     1234899999999999999999999   89999


Q ss_pred             eCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          396 HRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       396 H~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ||||||+|||++.++.+||+|||+|+.+....
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~  194 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSAD  194 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCc
Confidence            99999999999999999999999999875443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.9e-32  Score=256.84  Aligned_cols=152  Identities=22%  Similarity=0.255  Sum_probs=134.3

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      .++|++.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+++|+.++||||+++++++.+++..||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            46789999999999999999954 5788999999976543 345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC--CCeEEecccccccccCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKD--FTPKIADFGLARCFAAD  426 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kl~DFGla~~~~~~  426 (438)
                      +++|+|.+++..  ....+++.++..|+.||+.||.|||   +.+|+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999953  2335899999999999999999999   8999999999999999854  58999999999987654


Q ss_pred             C
Q 013693          427 R  427 (438)
Q Consensus       427 ~  427 (438)
                      .
T Consensus       158 ~  158 (321)
T d1tkia_         158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=2.5e-32  Score=261.72  Aligned_cols=158  Identities=23%  Similarity=0.300  Sum_probs=139.0

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  346 (438)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4689999999999999999954 57999999998743   2334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ||+.+|+|.+++...   ..+++.++..++.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999998543   35899999999999999999999   899999999999999999999999999999987643


Q ss_pred             CceeeeeeeecC
Q 013693          427 RTHVSTAVAGTL  438 (438)
Q Consensus       427 ~~~~~~~~~Gt~  438 (438)
                      .    ....||+
T Consensus       195 ~----~~~~Gt~  202 (350)
T d1rdqe_         195 T----WTLCGTP  202 (350)
T ss_dssp             B----CCCEECG
T ss_pred             c----ccccCcc
Confidence            3    2345664

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.3e-33  Score=257.94  Aligned_cols=163  Identities=22%  Similarity=0.329  Sum_probs=125.0

Q ss_pred             hcCCCCCCccccCCceeEEEEEccC----CCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      .++|++.+.||+|+||.||+|.+..    +..||||+++.. .....+.|.+|+.++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4678889999999999999996532    346889988643 3445678999999999999999999999985 567899


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ||||+++|+|.+++..  ....+++.+++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998754  3345899999999999999999999   8999999999999999999999999999999887


Q ss_pred             CCCceeeeeeeecC
Q 013693          425 ADRTHVSTAVAGTL  438 (438)
Q Consensus       425 ~~~~~~~~~~~Gt~  438 (438)
                      .......+...||+
T Consensus       160 ~~~~~~~~~~~gt~  173 (273)
T d1mp8a_         160 DSTYYKASKGKLPI  173 (273)
T ss_dssp             -----------CCG
T ss_pred             CCcceeccceecCc
Confidence            65544444455553

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=5.7e-32  Score=260.60  Aligned_cols=159  Identities=24%  Similarity=0.260  Sum_probs=134.2

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecc---hhhHHHH---HHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNT---RQWVDEF---FNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ++|++.++||+|+||.||+|.. .+|+.||||++....   ......+   .+|+.+++.++|||||++++++.+++..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5788999999999999999954 579999999986432   1122223   34577888889999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      |||||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999954   345889999999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCceeeeeeeecC
Q 013693          424 AADRTHVSTAVAGTL  438 (438)
Q Consensus       424 ~~~~~~~~~~~~Gt~  438 (438)
                      ......   ...||+
T Consensus       158 ~~~~~~---~~~GT~  169 (364)
T d1omwa3         158 SKKKPH---ASVGTH  169 (364)
T ss_dssp             SSSCCC---SCCSCG
T ss_pred             CCCccc---cccccc
Confidence            654432   345664

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.1e-32  Score=254.55  Aligned_cols=152  Identities=30%  Similarity=0.503  Sum_probs=130.2

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|++.+.||+|+||.||+|. ..+++.||||+++...  ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            578899999999999999995 4678999999996542  3346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      |+.++ +.+++.. .....+++.++..++.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|+....+.
T Consensus        82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99764 4444432 23455999999999999999999999   8999999999999999999999999999999876544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.8e-32  Score=254.52  Aligned_cols=161  Identities=27%  Similarity=0.347  Sum_probs=137.1

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec---chhhHHHHHHHHHHHh-ccCCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN---TRQWVDEFFNEVNLIS-SIEHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|++.+.||+|+||+||+|.. .+++.||||++...   .....+.+.+|..++. .++||||+++++++.+++..+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5688899999999999999954 57899999999754   2334566777877765 68999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccC
Q 013693          346 YEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAA  425 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~  425 (438)
                      |||+++|+|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++++||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954   345899999999999999999999   88999999999999999999999999999997765


Q ss_pred             CCceeeeeeeecC
Q 013693          426 DRTHVSTAVAGTL  438 (438)
Q Consensus       426 ~~~~~~~~~~Gt~  438 (438)
                      ..... +...||+
T Consensus       156 ~~~~~-~~~~gt~  167 (320)
T d1xjda_         156 GDAKT-NTFCGTP  167 (320)
T ss_dssp             TTCCB-CCCCSCG
T ss_pred             ccccc-cccCCCC
Confidence            44332 3345664

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-32  Score=255.46  Aligned_cols=175  Identities=27%  Similarity=0.380  Sum_probs=134.1

Q ss_pred             cCHHHHHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeE
Q 013693          261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKL  332 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l  332 (438)
                      ++.+.++...++|++.++||+|+||.||+|...      +++.||||+++.. .....+.+.+|..++.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            344555556678999999999999999999643      2468999999754 344566788888888887 68999999


Q ss_pred             EeEEEeCC-eEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 013693          333 LGCSIEGP-ESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRD  398 (438)
Q Consensus       333 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~d  398 (438)
                      ++++...+ ..++||||+++|+|.++++....             ...+++.+++.++.||++||.|||   +.+|||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCc
Confidence            99877654 68999999999999999964321             245899999999999999999999   89999999


Q ss_pred             CCCCCeeeCCCCCeEEecccccccccCCCcee-eeeeeecC
Q 013693          399 IKTSNILLDKDFTPKIADFGLARCFAADRTHV-STAVAGTL  438 (438)
Q Consensus       399 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~  438 (438)
                      |||+||||+.++.+||+|||+|+......... .+...||+
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~  200 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  200 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence            99999999999999999999999876554332 23456664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.2e-32  Score=253.71  Aligned_cols=156  Identities=28%  Similarity=0.412  Sum_probs=129.2

Q ss_pred             CCccccCCceeEEEEEc-cCCCEEEEEEeeecchh-----hHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEecc
Q 013693          276 SKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQ-----WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV  349 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  349 (438)
                      +++||+|+||+||+|.. .+++.||||+++.....     ..+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            57899999999999965 46899999998654221     2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCCce
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADRTH  429 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~  429 (438)
                      +++++..+.   .....+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..+...
T Consensus        83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            988777665   23456899999999999999999999   899999999999999999999999999999987654433


Q ss_pred             eeeeeeecC
Q 013693          430 VSTAVAGTL  438 (438)
Q Consensus       430 ~~~~~~Gt~  438 (438)
                      .. ..+||+
T Consensus       157 ~~-~~~gt~  164 (299)
T d1ua2a_         157 YT-HQVVTR  164 (299)
T ss_dssp             CC-CSCCCC
T ss_pred             cc-ceecCh
Confidence            22 234553

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-31  Score=254.60  Aligned_cols=162  Identities=26%  Similarity=0.450  Sum_probs=130.9

Q ss_pred             cCCCCCCccccCCceeEEEEEcc-CCC----EEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP-NGT----TVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLL  344 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  344 (438)
                      ++|++.++||+|+||.||+|.+. +++    +||+|++... .....++|.+|+.++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35888999999999999999653 443    6899988643 445567899999999999999999999998764 5678


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFA  424 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~  424 (438)
                      ++|++.+++|.+++..  ....+++..++.++.||++||.|||   +.+||||||||+|||++.++.+||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998854  3456899999999999999999999   8899999999999999999999999999999987


Q ss_pred             CCCceee-eeeeecC
Q 013693          425 ADRTHVS-TAVAGTL  438 (438)
Q Consensus       425 ~~~~~~~-~~~~Gt~  438 (438)
                      ....... ....||+
T Consensus       163 ~~~~~~~~~~~~gt~  177 (317)
T d1xkka_         163 AEEKEYHAEGGKVPI  177 (317)
T ss_dssp             TTCC--------CCT
T ss_pred             cccccccccccccCc
Confidence            6554332 2345663

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.8e-32  Score=255.69  Aligned_cols=161  Identities=29%  Similarity=0.447  Sum_probs=138.4

Q ss_pred             HHHHHhcCCCCCCccccCCceeEEEEEcc------CCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 013693          265 TLEKATNYFNPSKKLGQGGAGSVYMGSLP------NGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSI  337 (438)
Q Consensus       265 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  337 (438)
                      +++...++|++.+.||+|+||.||+|.+.      .+..||||+++.. .......|.+|+.++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34444577888999999999999999653      3578999999754 3444567999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHhhcc-------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013693          338 EGPESLLVYEYVPNRSLDQFIFDK-------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF  410 (438)
Q Consensus       338 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  410 (438)
                      .++..++||||+++|+|.+++...       .....+++..+..++.|+++||.|||   +.+|+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence            999999999999999999988532       22245789999999999999999999   88999999999999999999


Q ss_pred             CeEEecccccccccCCCc
Q 013693          411 TPKIADFGLARCFAADRT  428 (438)
Q Consensus       411 ~~kl~DFGla~~~~~~~~  428 (438)
                      ++||+|||+|+.+.....
T Consensus       171 ~~Kl~DFGla~~~~~~~~  188 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDY  188 (308)
T ss_dssp             CEEECCTTCCCGGGGGGC
T ss_pred             eEEEeecccceeccCCcc
Confidence            999999999998765443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.2e-31  Score=250.52  Aligned_cols=162  Identities=27%  Similarity=0.336  Sum_probs=131.1

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----eEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----ESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  346 (438)
                      +.|.+.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4567778999999999999987 6889999998644321 222334566667789999999999998754    589999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG-----SETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      ||+++|+|.+++++    ..++|..++.++.|++.||.|||..     ++++|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999954    3589999999999999999999942     24799999999999999999999999999999


Q ss_pred             cccCCCceee---eeeeecC
Q 013693          422 CFAADRTHVS---TAVAGTL  438 (438)
Q Consensus       422 ~~~~~~~~~~---~~~~Gt~  438 (438)
                      .+........   ....||+
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~  176 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             EEETTTTEECC----CCSCG
T ss_pred             cccCCCcceeccccceeccc
Confidence            9876554332   2355664

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=1.4e-31  Score=248.94  Aligned_cols=163  Identities=26%  Similarity=0.408  Sum_probs=132.6

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----e
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----E  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  341 (438)
                      .++|++.+.||+|+||.||+|. ..+++.||||+++..   +....+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            4679999999999999999995 467999999999754   3344567999999999999999999999988654    3


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .||||||+++++|.+++..   ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence            8999999999999998854   345899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCce--eeeeeeecC
Q 013693          422 CFAADRTH--VSTAVAGTL  438 (438)
Q Consensus       422 ~~~~~~~~--~~~~~~Gt~  438 (438)
                      ........  .....+||+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~  178 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTA  178 (277)
T ss_dssp             ECC----------------
T ss_pred             hhccccccccccccccCcc
Confidence            77543322  223456764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.5e-31  Score=249.91  Aligned_cols=151  Identities=28%  Similarity=0.446  Sum_probs=134.7

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecc--hhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.++||+|+||+||+|..++++.||||++....  ....+.+.+|+.+|++++||||+++++++..++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788999999999999999988889999999996543  33467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      +.++.+..+..   ....+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|.......
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            98877766653   3456999999999999999999999   8899999999999999999999999999999876543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=248.59  Aligned_cols=153  Identities=33%  Similarity=0.500  Sum_probs=125.2

Q ss_pred             cCCCCCCccccCCceeEEEEEcc--CC--CEEEEEEeeec---chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLP--NG--TTVAVKRLIFN---TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESL  343 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  343 (438)
                      ++|++.+.||+|+||.||+|.+.  ++  ..||||++...   .....++|.+|+.+|++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888899999999999999653  22  37899988653   34456789999999999999999999999965 4678


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +||||+++|+|.+++...  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999999887543  345999999999999999999999   899999999999999999999999999999998


Q ss_pred             cCCCce
Q 013693          424 AADRTH  429 (438)
Q Consensus       424 ~~~~~~  429 (438)
                      ......
T Consensus       162 ~~~~~~  167 (273)
T d1u46a_         162 PQNDDH  167 (273)
T ss_dssp             CC-CCE
T ss_pred             ccCCCc
Confidence            766543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-31  Score=250.40  Aligned_cols=152  Identities=28%  Similarity=0.490  Sum_probs=130.7

Q ss_pred             cCCCCCCccccCCceeEEEEEccC-CC--EEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPN-GT--TVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  345 (438)
                      ++|++.++||+|+||.||+|.+.+ +.  .||||++... .....++|.+|+++|+++ +|||||+++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            567788999999999999996643 43  5788887643 444567899999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhcc-------------CCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCe
Q 013693          346 YEYVPNRSLDQFIFDK-------------NKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTP  412 (438)
Q Consensus       346 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  412 (438)
                      |||+++|+|.++++..             .....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999653             23456999999999999999999999   8999999999999999999999


Q ss_pred             EEecccccccccC
Q 013693          413 KIADFGLARCFAA  425 (438)
Q Consensus       413 kl~DFGla~~~~~  425 (438)
                      ||+|||+|+....
T Consensus       167 kl~DfG~a~~~~~  179 (309)
T d1fvra_         167 KIADFGLSRGQEV  179 (309)
T ss_dssp             EECCTTCEESSCE
T ss_pred             EEccccccccccc
Confidence            9999999987653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=251.72  Aligned_cols=169  Identities=31%  Similarity=0.407  Sum_probs=142.6

Q ss_pred             HHHhcCCCCCCccccCCceeEEEEEc------cCCCEEEEEEeeec-chhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          267 EKATNYFNPSKKLGQGGAGSVYMGSL------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       267 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      +...++|++.++||+|+||.||+|.+      .+++.||||+++.. ......+|.+|+.+++++ +|||||++++++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            34456788899999999999999964      24568999999754 344566799999999999 79999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccC---------------CCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKN---------------KTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSN  403 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  403 (438)
                      .+..+|||||+++|+|.++++...               ....+++..+..++.||++||.|||   +.+++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccc
Confidence            999999999999999999986532               2235899999999999999999999   8999999999999


Q ss_pred             eeeCCCCCeEEecccccccccCCCceee-eeeeecC
Q 013693          404 ILLDKDFTPKIADFGLARCFAADRTHVS-TAVAGTL  438 (438)
Q Consensus       404 ill~~~~~~kl~DFGla~~~~~~~~~~~-~~~~Gt~  438 (438)
                      ||++.++.+||+|||+++.......... +...||+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~  211 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV  211 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccCh
Confidence            9999999999999999998876554332 3455653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-30  Score=246.37  Aligned_cols=147  Identities=31%  Similarity=0.508  Sum_probs=128.1

Q ss_pred             CCccccCCceeEEEEEccCC----CEEEEEEeee-cchhhHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeEEEEEecc
Q 013693          276 SKKLGQGGAGSVYMGSLPNG----TTVAVKRLIF-NTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLVYEYV  349 (438)
Q Consensus       276 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  349 (438)
                      .++||+|+||+||+|.+..+    ..||||+++. .+....++|.+|+++|++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999976432    3589999874 355567889999999999999999999999876 46899999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++++|.+++..  ....+++..++.++.|++.||.|||   +.+|+||||||+||||++++.+||+|||+++.+....
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999999854  3445788899999999999999999   8999999999999999999999999999999876543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-31  Score=244.01  Aligned_cols=149  Identities=28%  Similarity=0.503  Sum_probs=124.8

Q ss_pred             cCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeEEEEEecc
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE-GPESLLVYEYV  349 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  349 (438)
                      ++|++.+.||+|+||.||+|.+ .+.+||||+++..  ...++|.+|++++++++||||++++|++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4577789999999999999988 5789999999643  345779999999999999999999999865 45689999999


Q ss_pred             CCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCC
Q 013693          350 PNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAAD  426 (438)
Q Consensus       350 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~  426 (438)
                      ++|+|.+++... ....+++..++.|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            999999999643 2335899999999999999999999   889999999999999999999999999999976543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=247.92  Aligned_cols=158  Identities=23%  Similarity=0.264  Sum_probs=131.0

Q ss_pred             hcCCCCCC-ccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe----CCeE
Q 013693          270 TNYFNPSK-KLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE----GPES  342 (438)
Q Consensus       270 ~~~~~~~~-~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  342 (438)
                      .++|.+.+ .||+|+||.||+|. ..+++.||||+++.     .+.+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35687764 69999999999995 46789999999853     24577899987665 89999999999876    4568


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCCeEEecccc
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK---DFTPKIADFGL  419 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~DFGl  419 (438)
                      +|||||+++|+|.+++... ....+++.++..|+.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence            9999999999999999653 2346999999999999999999999   899999999999999975   56799999999


Q ss_pred             cccccCCCceeeeeeeecC
Q 013693          420 ARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       420 a~~~~~~~~~~~~~~~Gt~  438 (438)
                      |+........  ....||+
T Consensus       161 a~~~~~~~~~--~~~~gt~  177 (335)
T d2ozaa1         161 AKETTSHNSL--TTPCYTP  177 (335)
T ss_dssp             CEECCCCCCC--CCCSCCC
T ss_pred             eeeccCCCcc--ccccCCc
Confidence            9987654432  2345664

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.6e-31  Score=244.10  Aligned_cols=159  Identities=26%  Similarity=0.317  Sum_probs=133.4

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecch------hhHHHHHHHHHHHhccC--CCceeeEEeEEEeCCe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTR------QWVDEFFNEVNLISSIE--HKNLVKLLGCSIEGPE  341 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  341 (438)
                      ++|++.++||+|+||.||+|. ..+++.||||++.....      ....++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            578999999999999999995 45789999999875321      12345789999999996  8999999999999999


Q ss_pred             EEEEEeccCC-CCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCCeEEecccc
Q 013693          342 SLLVYEYVPN-RSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-DFTPKIADFGL  419 (438)
Q Consensus       342 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~DFGl  419 (438)
                      .++||||+.+ +++.+++..   ...+++.++..++.||++||.|||   +.+|+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 577777743   345899999999999999999999   899999999999999985 47999999999


Q ss_pred             cccccCCCceeeeeeeecC
Q 013693          420 ARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       420 a~~~~~~~~~~~~~~~Gt~  438 (438)
                      |+......   .+...||+
T Consensus       158 a~~~~~~~---~~~~~GT~  173 (273)
T d1xwsa_         158 GALLKDTV---YTDFDGTR  173 (273)
T ss_dssp             CEECCSSC---BCCCCSCG
T ss_pred             ceeccccc---ccccccCC
Confidence            98765432   23355664

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-30  Score=244.87  Aligned_cols=157  Identities=28%  Similarity=0.445  Sum_probs=131.5

Q ss_pred             HhcCCCCCCccccCCceeEEEEEccC--------CCEEEEEEeeecc-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 013693          269 ATNYFNPSKKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNT-RQWVDEFFNEVNLISSI-EHKNLVKLLGCSIE  338 (438)
Q Consensus       269 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  338 (438)
                      ..++|++.+.||+|+||.||+|....        +..||||+++.+. .....++.+|...+.++ +|||||++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34678888999999999999996422        2479999997653 34567889999999988 89999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCC-------------CCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNK-------------TKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNIL  405 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  405 (438)
                      ++..++||||+++|+|.+++.....             ...+++.+++.++.||+.||.|||   +.+||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccccee
Confidence            9999999999999999999965432             245899999999999999999999   899999999999999


Q ss_pred             eCCCCCeEEecccccccccCCCc
Q 013693          406 LDKDFTPKIADFGLARCFAADRT  428 (438)
Q Consensus       406 l~~~~~~kl~DFGla~~~~~~~~  428 (438)
                      ++.++.+||+|||+++.......
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~  190 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDY  190 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCT
T ss_pred             ecCCCCeEeccchhhcccccccc
Confidence            99999999999999998865443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.4e-30  Score=248.00  Aligned_cols=150  Identities=23%  Similarity=0.378  Sum_probs=126.9

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec-chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC----eEE
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP----ESL  343 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  343 (438)
                      .++|++.++||+|+||+||+|. ..+++.||||++... .....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            4568899999999999999994 568999999999754 3445678999999999999999999999987654    234


Q ss_pred             EEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 013693          344 LVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCF  423 (438)
Q Consensus       344 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~  423 (438)
                      +++|++.+|+|.+++..    ..+++.++..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55566779999999943    35899999999999999999999   899999999999999999999999999999887


Q ss_pred             cCC
Q 013693          424 AAD  426 (438)
Q Consensus       424 ~~~  426 (438)
                      ...
T Consensus       160 ~~~  162 (345)
T d1pmea_         160 DPD  162 (345)
T ss_dssp             CGG
T ss_pred             cCC
Confidence            544

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.3e-30  Score=239.05  Aligned_cols=151  Identities=25%  Similarity=0.418  Sum_probs=135.5

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCCeEEEEEe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      ++|++.++||+|+||+||+|. ..+++.||||+++..  .....+.+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            578999999999999999995 467899999999754  33456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccccCCC
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLARCFAADR  427 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~~~~~~  427 (438)
                      ++.+++|..++..   ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||.|+....+.
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999998887743   345889999999999999999999   8999999999999999999999999999999886544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.3e-30  Score=246.72  Aligned_cols=149  Identities=29%  Similarity=0.392  Sum_probs=124.1

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCceeeEEeEEEeC------CeEEE
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG------PESLL  344 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  344 (438)
                      .|+..++||+|+||+||+|.. .+++.||||++.....    .+.+|+.+|++++||||+++++++...      ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            477788999999999999965 5789999999975432    345799999999999999999998643      24789


Q ss_pred             EEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccc
Q 013693          345 VYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCF  423 (438)
Q Consensus       345 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~  423 (438)
                      ||||++++.+..+.........+++.++..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987654444432334556999999999999999999999   89999999999999999765 8999999999987


Q ss_pred             cCCC
Q 013693          424 AADR  427 (438)
Q Consensus       424 ~~~~  427 (438)
                      ....
T Consensus       174 ~~~~  177 (350)
T d1q5ka_         174 VRGE  177 (350)
T ss_dssp             CTTS
T ss_pred             cCCc
Confidence            6544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.1e-30  Score=244.48  Aligned_cols=161  Identities=27%  Similarity=0.307  Sum_probs=136.9

Q ss_pred             cCCCCCCccccCCceeEEEEEc----cCCCEEEEEEeeec----chhhHHHHHHHHHHHhccCC-CceeeEEeEEEeCCe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFN----TRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPE  341 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  341 (438)
                      ++|++.+.||+|+||+||+|..    .+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999953    24789999998643    23345678899999999976 899999999999999


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .+++|||+.+|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998543   34778899999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCceeeeeeeec
Q 013693          422 CFAADRTHVSTAVAGT  437 (438)
Q Consensus       422 ~~~~~~~~~~~~~~Gt  437 (438)
                      .+............||
T Consensus       178 ~~~~~~~~~~~~~~g~  193 (322)
T d1vzoa_         178 EFVADETERAYDFCGT  193 (322)
T ss_dssp             ECCGGGGGGGCGGGSC
T ss_pred             hhcccccccccccccc
Confidence            8765443333333444

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=1.6e-29  Score=240.80  Aligned_cols=145  Identities=23%  Similarity=0.382  Sum_probs=126.7

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeC--CeEEEEE
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEG--PESLLVY  346 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  346 (438)
                      ++|++.++||+|+||+||+|.. .+++.||||+++...   .+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999954 678999999986433   457889999999995 99999999998754  4689999


Q ss_pred             eccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccccC
Q 013693          347 EYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF-TPKIADFGLARCFAA  425 (438)
Q Consensus       347 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~DFGla~~~~~  425 (438)
                      ||+++++|..+.      +.+++.++..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997664      34899999999999999999999   89999999999999998654 699999999998765


Q ss_pred             CC
Q 013693          426 DR  427 (438)
Q Consensus       426 ~~  427 (438)
                      ..
T Consensus       183 ~~  184 (328)
T d3bqca1         183 GQ  184 (328)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-29  Score=243.43  Aligned_cols=150  Identities=26%  Similarity=0.454  Sum_probs=125.3

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGP------  340 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  340 (438)
                      .++|++.++||+|+||.||+|. ..+++.||||++...  .....+.+.+|+.+|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4679999999999999999995 457999999999753  3445678899999999999999999999988655      


Q ss_pred             eEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 013693          341 ESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLA  420 (438)
Q Consensus       341 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla  420 (438)
                      ..++||||+ +.+|..++.    ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence            479999999 667877763    245999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCC
Q 013693          421 RCFAADR  427 (438)
Q Consensus       421 ~~~~~~~  427 (438)
                      +......
T Consensus       169 ~~~~~~~  175 (346)
T d1cm8a_         169 RQADSEM  175 (346)
T ss_dssp             EECCSSC
T ss_pred             eccCCcc
Confidence            9876443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.4e-29  Score=238.51  Aligned_cols=152  Identities=26%  Similarity=0.478  Sum_probs=127.5

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe--------
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE--------  338 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  338 (438)
                      .++|++.++||+|+||+||+|.. .+++.||||++...  .....+++.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36789999999999999999964 57999999998644  33445678999999999999999999998765        


Q ss_pred             CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 013693          339 GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFG  418 (438)
Q Consensus       339 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFG  418 (438)
                      .+..++||||++++.+....   .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence            34689999999887766554   23456889999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCC
Q 013693          419 LARCFAADR  427 (438)
Q Consensus       419 la~~~~~~~  427 (438)
                      +++.+....
T Consensus       163 ~~~~~~~~~  171 (318)
T d3blha1         163 LARAFSLAK  171 (318)
T ss_dssp             TCEECCC--
T ss_pred             eeeeccccc
Confidence            998876433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=1.9e-28  Score=229.25  Aligned_cols=161  Identities=19%  Similarity=0.277  Sum_probs=134.5

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCC-CceeeEEeEEEeCCeEEEEEe
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEH-KNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  347 (438)
                      .++|++.+.||+|+||.||+|. ..+++.||||++....  ..+.+.+|+++++.++| +||+.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            3678999999999999999996 4568999999886432  23457889999999965 899999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-----CCCeEEeccccccc
Q 013693          348 YVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDK-----DFTPKIADFGLARC  422 (438)
Q Consensus       348 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-----~~~~kl~DFGla~~  422 (438)
                      |+ +++|.+++...  ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 68999988543  345899999999999999999999   899999999999999964     57899999999998


Q ss_pred             ccCCCce------eeeeeeecC
Q 013693          423 FAADRTH------VSTAVAGTL  438 (438)
Q Consensus       423 ~~~~~~~------~~~~~~Gt~  438 (438)
                      +......      ....++||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~  177 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTA  177 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCT
T ss_pred             cccCccccceeecccCceEEch
Confidence            8654322      122456875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.4e-29  Score=234.08  Aligned_cols=162  Identities=28%  Similarity=0.394  Sum_probs=129.7

Q ss_pred             hcCCCCCCccccCCceeEEEEEc-cC-CCEEEEEEeeecc--hhhHHHHHHHHHHHhcc---CCCceeeEEeEEEe----
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGSL-PN-GTTVAVKRLIFNT--RQWVDEFFNEVNLISSI---EHKNLVKLLGCSIE----  338 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  338 (438)
                      .++|++.++||+|+||.||+|.. .+ ++.||||+++...  ......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36799999999999999999964 34 5679999997542  22344567888887766   79999999998863    


Q ss_pred             -CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 013693          339 -GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADF  417 (438)
Q Consensus       339 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DF  417 (438)
                       ....+++|||++++++.....  .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence             346899999998877765543  23456899999999999999999999   899999999999999999999999999


Q ss_pred             cccccccCCCceeeeeeeecC
Q 013693          418 GLARCFAADRTHVSTAVAGTL  438 (438)
Q Consensus       418 Gla~~~~~~~~~~~~~~~Gt~  438 (438)
                      |+++.......  .....||+
T Consensus       161 g~~~~~~~~~~--~~~~~gT~  179 (305)
T d1blxa_         161 GLARIYSFQMA--LTSVVVTL  179 (305)
T ss_dssp             CSCCCCCGGGG--GCCCCCCC
T ss_pred             hhhhhhccccc--CCCcccCh
Confidence            99987654332  23355664

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.3e-29  Score=237.36  Aligned_cols=149  Identities=28%  Similarity=0.409  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEeC-----Ce
Q 013693          270 TNYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEG-----PE  341 (438)
Q Consensus       270 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  341 (438)
                      .++|++.++||+|+||+||+|. ..+++.||||++...  +....+++.+|+.+|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4679999999999999999995 567999999999754  334456789999999999999999999998643     34


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .++++||+.+|+|.+++.    ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence            567778888999999983    235999999999999999999999   8999999999999999999999999999998


Q ss_pred             cccC
Q 013693          422 CFAA  425 (438)
Q Consensus       422 ~~~~  425 (438)
                      ....
T Consensus       170 ~~~~  173 (348)
T d2gfsa1         170 HTDD  173 (348)
T ss_dssp             CCTG
T ss_pred             ccCc
Confidence            7643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.3e-28  Score=232.47  Aligned_cols=148  Identities=30%  Similarity=0.398  Sum_probs=120.6

Q ss_pred             cCCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeec--chhhHHHHHHHHHHHhccCCCceeeEEeEEEe------CCe
Q 013693          271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFN--TRQWVDEFFNEVNLISSIEHKNLVKLLGCSIE------GPE  341 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  341 (438)
                      ++|++.++||+|+||+||+|.. .+++.||||++...  .....+++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5789999999999999999954 57999999999754  34456678999999999999999999999864      367


Q ss_pred             EEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          342 SLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       342 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      .|+||||+.++.+ +.+.     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence            8999999976544 4442     34889999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCC
Q 013693          422 CFAADR  427 (438)
Q Consensus       422 ~~~~~~  427 (438)
                      ......
T Consensus       168 ~~~~~~  173 (355)
T d2b1pa1         168 TAGTSF  173 (355)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            876543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=1e-27  Score=225.05  Aligned_cols=149  Identities=25%  Similarity=0.425  Sum_probs=123.4

Q ss_pred             cCCCCCCccccCCceeEEEEE-ccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeEEEEEec
Q 013693          271 NYFNPSKKLGQGGAGSVYMGS-LPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL-VKLLGCSIEGPESLLVYEY  348 (438)
Q Consensus       271 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  348 (438)
                      ++|++.+.||+|+||.||+|. ..+++.||||++.....  .+++.+|+++++.++|+|+ +.+.++..+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            568999999999999999995 45789999998865432  3468899999999987665 5555666788889999999


Q ss_pred             cCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCCeEEecccccccccC
Q 013693          349 VPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLD---KDFTPKIADFGLARCFAA  425 (438)
Q Consensus       349 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~DFGla~~~~~  425 (438)
                      + +++|.+.+..  ....+++..+..++.|++.||+|||   +.+||||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 5566666533  3345899999999999999999999   89999999999999985   456799999999999875


Q ss_pred             CC
Q 013693          426 DR  427 (438)
Q Consensus       426 ~~  427 (438)
                      ..
T Consensus       159 ~~  160 (299)
T d1ckia_         159 AR  160 (299)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=7.9e-24  Score=184.92  Aligned_cols=136  Identities=15%  Similarity=0.165  Sum_probs=107.3

Q ss_pred             CCCCccccCCceeEEEEEccCCCEEEEEEeeecch------------------hhHHHHHHHHHHHhccCCCceeeEEeE
Q 013693          274 NPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTR------------------QWVDEFFNEVNLISSIEHKNLVKLLGC  335 (438)
Q Consensus       274 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  335 (438)
                      .+.++||+|+||.||+|...+|++||||+++....                  .......+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            34678999999999999878899999998753210                  012234578889999999999998865


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 013693          336 SIEGPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDFTPKIA  415 (438)
Q Consensus       336 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  415 (438)
                      .    ..+++|||+++..+.+          +++.....++.|++++|.|||   +.+|+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            3    2379999998765432          344556779999999999999   8999999999999999865 58999


Q ss_pred             cccccccccCCC
Q 013693          416 DFGLARCFAADR  427 (438)
Q Consensus       416 DFGla~~~~~~~  427 (438)
                      |||+|+....+.
T Consensus       145 DFG~a~~~~~~~  156 (191)
T d1zara2         145 DFPQSVEVGEEG  156 (191)
T ss_dssp             CCTTCEETTSTT
T ss_pred             ECCCcccCCCCC
Confidence            999998876443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.88  E-value=3.3e-23  Score=199.31  Aligned_cols=152  Identities=24%  Similarity=0.256  Sum_probs=121.2

Q ss_pred             CCCCCCccccCCceeEEEEEc-cCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-----------CCceeeEEeEEEe-
Q 013693          272 YFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-----------HKNLVKLLGCSIE-  338 (438)
Q Consensus       272 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~-  338 (438)
                      +|++.++||+|+||+||+|.. .+++.||||+++... ...+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            488999999999999999954 679999999997543 33467788999888875           5789999988764 


Q ss_pred             -CCeEEEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC------C
Q 013693          339 -GPESLLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGGSETRIIHRDIKTSNILLDKDF------T  411 (438)
Q Consensus       339 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~------~  411 (438)
                       ....++++++...+..............+++..+..++.||+.||.|||+  ..+|+||||||+||||+.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence             35667777777665544443334455678999999999999999999993  38999999999999997654      3


Q ss_pred             eEEecccccccccCC
Q 013693          412 PKIADFGLARCFAAD  426 (438)
Q Consensus       412 ~kl~DFGla~~~~~~  426 (438)
                      +||+|||.|......
T Consensus       171 ~kl~dfg~s~~~~~~  185 (362)
T d1q8ya_         171 IKIADLGNACWYDEH  185 (362)
T ss_dssp             EEECCCTTCEETTBC
T ss_pred             eeEeecccccccccc
Confidence            999999999876543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.90  E-value=7.3e-09  Score=93.00  Aligned_cols=150  Identities=17%  Similarity=0.079  Sum_probs=103.9

Q ss_pred             HHHHHHhcCCCCCCccccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeE
Q 013693          264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPES  342 (438)
Q Consensus       264 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  342 (438)
                      +++....+.|...+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45666666776655544444568998865 56677888876555445556788998888773 54578888888889999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCcCCHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 013693          343 LLVYEYVPNRSLDQFIFDKNKTKLLNWNKRFNIILGTAEGLAYLHGG---------------------------------  389 (438)
Q Consensus       343 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------  389 (438)
                      ++|||++++.++.+.....        .....++.++++.|..||..                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            9999999998886554211        11222344455555555521                                 


Q ss_pred             -----------------------CCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          390 -----------------------SETRIIHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       390 -----------------------~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                                             ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   112378999999999999877778999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.34  E-value=1e-06  Score=78.09  Aligned_cols=73  Identities=19%  Similarity=0.203  Sum_probs=54.0

Q ss_pred             cccCCc-eeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccC--CCceeeEEeEEEeCCeEEEEEeccCCCCH
Q 013693          279 LGQGGA-GSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE--HKNLVKLLGCSIEGPESLLVYEYVPNRSL  354 (438)
Q Consensus       279 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  354 (438)
                      +..|.. +.||+...+++..+++|......   ...+..|...++.+.  .-.+++++.+..+++..++|||+++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444543 57899988788888999764432   335677888887773  33467888888888899999999988655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.85  E-value=2.6e-05  Score=73.60  Aligned_cols=75  Identities=12%  Similarity=0.126  Sum_probs=49.5

Q ss_pred             CccccCCceeEEEEEccC-CCEEEEEEeeecc-------hhhHHHHHHHHHHHhccC-C--CceeeEEeEEEeCCeEEEE
Q 013693          277 KKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNT-------RQWVDEFFNEVNLISSIE-H--KNLVKLLGCSIEGPESLLV  345 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  345 (438)
                      +.||.|....||+....+ ++.++||.-.+..       +...++...|.+.|+.+. +  ..+++++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999997654 6789999654321       112345567888887662 2  456677655  45566899


Q ss_pred             EeccCCCC
Q 013693          346 YEYVPNRS  353 (438)
Q Consensus       346 ~e~~~~g~  353 (438)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00053  Score=62.46  Aligned_cols=135  Identities=14%  Similarity=0.109  Sum_probs=78.2

Q ss_pred             eeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce--eeEE-----eEEEeCCeEEEEEeccCCCCHH--
Q 013693          285 GSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL--VKLL-----GCSIEGPESLLVYEYVPNRSLD--  355 (438)
Q Consensus       285 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L~--  355 (438)
                      -.||+....+|+.+++|..++.. ...+++..|...+..|...+|  +..+     ......+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999998899999999876542 234567788888887743222  1111     1234567789999999874321  


Q ss_pred             ---HH------h---hc----c--CCCCcCCH-------------------H---HHHHHHHHHHHHHHHh-hcCCCCCe
Q 013693          356 ---QF------I---FD----K--NKTKLLNW-------------------N---KRFNIILGTAEGLAYL-HGGSETRI  394 (438)
Q Consensus       356 ---~~------l---~~----~--~~~~~l~~-------------------~---~~~~i~~~i~~~L~~L-H~~~~~~i  394 (438)
                         .+      +   +.    .  .....+++                   .   .....+.++...+.-+ ......++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11      0   00    0  00011111                   1   1122223333333222 12224578


Q ss_pred             eeCCCCCCCeeeCCCCCeEEeccccccc
Q 013693          395 IHRDIKTSNILLDKDFTPKIADFGLARC  422 (438)
Q Consensus       395 iH~dlkp~Nill~~~~~~kl~DFGla~~  422 (438)
                      ||+|+.|.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999744  46899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.10  E-value=0.0022  Score=57.71  Aligned_cols=158  Identities=12%  Similarity=0.032  Sum_probs=86.8

Q ss_pred             cCHHHHHHHhcCCCCCCcc-----ccCCceeEEEEEccCCCEEEEEEeeecchhhHHHHHHHHHHHhccCCCce--eeEE
Q 013693          261 FKYETLEKATNYFNPSKKL-----GQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL--VKLL  333 (438)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~  333 (438)
                      .+.++++...++|.+.+..     ..|---+.|+....++ .+++|+.....  ..+++..|+.++..|.+.++  +..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            4567888888999876543     3555567898877555 58889875431  23445567777777743222  2111


Q ss_pred             e------EEEeCCeEEEEEeccCCCCHHHH--------------hhc----c--CCC------------------CcCCH
Q 013693          334 G------CSIEGPESLLVYEYVPNRSLDQF--------------IFD----K--NKT------------------KLLNW  369 (438)
Q Consensus       334 ~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~~----~--~~~------------------~~l~~  369 (438)
                      -      +....+....++.++.+......              ++.    .  ...                  .....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      12335566777777766432110              000    0  000                  00011


Q ss_pred             HHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 013693          370 NKRFNIILGTAEGLAYLHG-GSETRIIHRDIKTSNILLDKDFTPKIADFGLAR  421 (438)
Q Consensus       370 ~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kl~DFGla~  421 (438)
                      ......+..+...+.-.+. .-..++||+|+.++||+++.+...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1111222222333333321 234689999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.98  E-value=0.0012  Score=61.87  Aligned_cols=72  Identities=18%  Similarity=0.278  Sum_probs=47.6

Q ss_pred             CccccCCceeEEEEEccC--------CCEEEEEEeeecchhhHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeEEEEEe
Q 013693          277 KKLGQGGAGSVYMGSLPN--------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIE-HKNLVKLLGCSIEGPESLLVYE  347 (438)
Q Consensus       277 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  347 (438)
                      +.|+.|-.-.+|+...++        ...|.+++.. .... .....+|..+++.+. +.-.+++++++..    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            567778888999987643        3456666554 3222 334568999999884 4434577777642    68999


Q ss_pred             ccCCCCH
Q 013693          348 YVPNRSL  354 (438)
Q Consensus       348 ~~~~g~L  354 (438)
                      |+++..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544